"Rank","Title","Status","Study Results","Conditions","Interventions","Locations","URL"
1,"Evaluate the Efficacy and Safety of ADCV01 as an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients","Recruiting","No Results Available","GBM","Biological: autologous dendritic cells","Taichung Veterans General Hospital, Taichung, Non-US, Taiwan|Chang-Gung Memorial Hospital at Lin-Ko, Taoyuan, Non-US, Taiwan|China Medical University Hospital, Taichung, Taiwan","https://ClinicalTrials.gov/show/NCT04115761"
2,"To Evaluate the Efficacy and Safety of CAN008 Combined With Re-irradiation (rRT) for Treating Patients With Recurrent Glioblastoma (GBM)","Unknown status","No Results Available","GBM","Drug: CAN008",,"https://ClinicalTrials.gov/show/NCT03746288"
3,"A Phase 0 Study of AZD1775 in Recurrent GBM Patients","Completed","No Results Available","Glioblastoma|GBM","Biological: AZD1775","Barrow Neurological Institute at St. Joseph's Hospital Medical Center, Phoenix, Arizona, United States","https://ClinicalTrials.gov/show/NCT02207010"
4,"Integrative Analysis of Human Glioblastoma Multiforme","Recruiting","No Results Available","GBM","Other: Normal brain tissue","Shanghai Tenth People's Hospital, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT03005132"
5,"Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients","Unknown status","No Results Available","GBM","Drug: Chlorogenic acid for Injection|Drug: Lomustine","Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT03758014"
6,"FET-PET for Evaluation of Response of Recurrent GBM to Avastin","Completed","Has Results","Glioblastoma Multiforme|GBM","Drug: 18F-FET","Brigham and Women's Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01756352"
7,"Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients","Terminated","No Results Available","Glioblastoma Multiforme (GBM)","Drug: Combined T3 and Methimazole treatment","Tel-Aviv Medical Center, Israel, Tel-Aviv, Israel","https://ClinicalTrials.gov/show/NCT02654041"
8,"CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM","Completed","No Results Available","Glioblastoma Multiforme (GBM)","Biological: HER.CAR CMV-specific CTLs","Houston Methodist Hospital, Houston, Texas, United States|Texas Children's Hospital, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01109095"
9,"Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221","Available","No Results Available","GBM|Glioblastoma Multiforme","Biological: DCVax-L","University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|UCLA Medical Center, Los Angeles, California, United States|Hoag Memorial Hospital, Newport Beach, California, United States|St. Joseph Hospital of Orange, Orange, California, United States|University of California, Irvine Medical Center, Orange, California, United States|University of Colorado Cancer Center, Aurora, Colorado, United States|Colorado Neurological Institute, Englewood, Colorado, United States|University of Florida, Gainesville, Florida, United States|Memorial Healthcare System Memorial Cancer Institute, Hollywood, Florida, United States|Cadence Cancer Center at Warrenville, Warrenville, Illinois, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Spectrum Health, Grand Rapids, Michigan, United States|John Nasseff Neuroscience Institute - Abott Northwestern Hospital, Minneapolis, Minnesota, United States|Saint Luke's Hospital of Kansas City, Kansas City, Missouri, United States|Washington University School of Medicine, St. Louis, Missouri, United States|John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States|Capital Health, Trenton, New Jersey, United States|North Shore University Hospital, Manhasset, New York, United States|Columbia University Medical Center Neurological Institute of New York, New York, New York, United States|Stony Brook University Hospital, Stony Brook, New York, United States|Ohio State University, Columbus, Ohio, United States|University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Saint Thomas Research Institute, Nashville, Tennessee, United States|Swedish Neuroscience Institute, Seattle, Washington, United States|Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT02146066"
10,"TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM","Completed","No Results Available","Glioblastoma Multiforme (GBM)","Drug: Mibefradil with Radiation","Yale University, New Haven, Connecticut, United States","https://ClinicalTrials.gov/show/NCT02202993"
11,"Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)","Terminated","Has Results","Recurrent Glioblastoma Multiforme (GBM)","Drug: Imatinib tablets|Drug: Hydroxyurea capsules","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00290771"
12,"Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma","Terminated","No Results Available","Glioblastoma (GBM)","Dietary Supplement: Ketogenic Diet|Radiation: Radiation therapy|Drug: Temozolomide","Barrow Neurological Institute at St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States","https://ClinicalTrials.gov/show/NCT02046187"
13,"Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT","Recruiting","No Results Available","Glioblastoma|GBM|Recurrent GBM","Radiation: Intra-operative Radiation Therapy - IORT","Southeastern Spine Neurosurgery, Chattanooga, Tennessee, United States","https://ClinicalTrials.gov/show/NCT04763031"
14,"Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma","Active, not recruiting","No Results Available","GBM|Glioblastoma","Other: Ketogenic Diet|Radiation: Standard-of-care radiation|Drug: Standard-of-care Temozolomide","Cedars Sinai Medical Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT03451799"
15,"Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM)","Terminated","Has Results","Solid Tumors (Phase 1)|Relapsed/Recurrent GBM (Phase 2)","Drug: USL311|Drug: Lomustine","Washington University, Saint Louis, Missouri, United States|University of Oklahoma Stephenson Cancer Center, Oklahoma City, Oklahoma, United States|University of Texas/MD Anderson Cancer Center, Houston, Texas, United States|South Texas Accelerated Research Therapeutics (START), San Antonio, Texas, United States|UT Health San Antonio Cancer Center, San Antonio, Texas, United States|South Texas Accelerated Research Therapeutics (START) - FJD, Madrid, Spain","https://ClinicalTrials.gov/show/NCT02765165"
16,"A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme","Recruiting","No Results Available","Recurrent Glioblastoma Multiforme(GBM)","Drug: ACT001|Drug: ACT001 + Pembrolizumab","UT MD Anderson Cancer Center, Dept of Neuro-Oncology, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT05053880"
17,"BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)","Completed","Has Results","GBM|Glioblastoma Multiforme|Gliosarcoma","Drug: PSMA ADC","Rhode Island Hospital, Providence, Rhode Island, United States|UT Southwestern, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT01856933"
18,"Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients","Terminated","Has Results","Glioblastoma Multiforme","Drug: Axitinib|Radiation: Radiation Therapy","University of Cincinnati, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT01508117"
19,"Avelumab With Laser Interstitial Therapy for Recurrent Glioblastoma","Completed","No Results Available","Glioblastoma|GBM","Drug: Avelumab|Combination Product: MRI-guided LITT therapy","Icahn School of Medicine at Mount Sinai, New York, New York, United States","https://ClinicalTrials.gov/show/NCT03341806"
20,"131I-IPA and Concurrent XRT in Recurrent GBM","Active, not recruiting","No Results Available","Glioblastoma Multiforme","Radiation: 4-L-[131I]iodo-phenylalanine (131I-IPA)","Lake Macquarie Private Hospital, Gateshead, New South Wales, Australia|Kepler University Clinic, Linz, Austria|Medical University of Vienna, Vienna, Austria|The Netherlands Cancer Institute, Amsterdam, Netherlands|UMC Utrecht Cancer Center, Utrecht, Netherlands","https://ClinicalTrials.gov/show/NCT03849105"
21,"Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Multiforme (GBM) WHO Grade IV","Drug: Cabazitaxel","Hämatologisch onkologische Praxis, Augsburg, Germany|Stiftungsklinikum Mittelrhein GmbH, Koblenz, Germany|Lars Bullinger, MD, Ulm, Germany","https://ClinicalTrials.gov/show/NCT01866449"
22,"Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma","Recruiting","No Results Available","Glioblastoma Multiforme (GBM)","Drug: Hyperpolarized 13C Pyruvate","University of California, San Francisco, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT04019002"
23,"Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma","Active, not recruiting","No Results Available","MGMT-unmethylated Glioblastoma (GBM)|GBM","Drug: Nivolumab|Drug: Ipilimumab|Radiation: Radiation Therapy (RT)","New York University School of Medicine, New York, New York, United States","https://ClinicalTrials.gov/show/NCT03367715"
24,"Combined Treatment of Camrelizumab and Bevacizumab for Adult Patients With Recurrent Glioblastoma (GBM)","Recruiting","No Results Available","Recurrent Glioblastoma","Drug: Camrelizumab and Bevacizumab","Beijing Sanbo Brain Hospital, Beijing, China","https://ClinicalTrials.gov/show/NCT04952571"
25,"TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM","Unknown status","No Results Available","Glioblastoma Multiforme","Device: NovoTTF-200A|Radiation: Radiotherapy|Drug: Temozolomide","Tel Aviv Sourasky Medical Center, Tel Aviv, Israel","https://ClinicalTrials.gov/show/NCT03780569"
26,"A Study to Evaluate the Safety of 2-OHOA Added to Standard of Care in Newly-diagnosed Glioblastoma Patients","Completed","No Results Available","Glioblastoma (GBM)","Drug: 2-OHOA|Radiation: RT|Drug: TMZ","Institut Catala d'Oncologia, Hospital Germans Trias I Pujol, Badalona, Cataluña, Spain|Hospital Universitari de Girona Dr. Josep Trueta, Institut Català d'Oncologia, Girona, Cataluña, Spain|Hospital Duran i Reynals, Institut Català d'Oncologia, L'Hospitalet De Llobregat, Cataluña, Spain","https://ClinicalTrials.gov/show/NCT03867123"
27,"Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)","Recruiting","No Results Available","Glioblastoma, Adult","Drug: Pembrolizumab at 7 days prior|Drug: Pembrolizumab at 14 days post|Drug: Pembrolizumab at 35 days post|Procedure: Laser Interstitial Thermotherapy","University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT03277638"
28,"NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBM","Unknown status","No Results Available","Glioblastoma","Device: NovoTTF-200A","Tel Aviv saurasky medical center, Tel Aviv, Israel","https://ClinicalTrials.gov/show/NCT03869242"
29,"ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)","Recruiting","No Results Available","Glioblastoma Multiforme","Biological: Autologous Dendritic Cell/Tumor Antigen, ADCTA","Chang Gung Memorial Hospital, Chiayi branch, Chiayi City, Taiwan|Chang Gung Memorial Hospital, Kaohsiung branch, Kaohsiung City, Taiwan|Chang Gung Memorial Hospital, Keelung branch, Keelung, Taiwan|Taichung Veterans General Hospital, Taichung City, Taiwan|National Cheng Kung University Hospital, Tainan City, Taiwan|Chi Mei Medical Center, Tainan City, Taiwan|Chang Gung Memorial Hospital, Linkou branch, Taoyuan City, Taiwan","https://ClinicalTrials.gov/show/NCT04277221"
30,"6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM)","Not yet recruiting","No Results Available","MGMT-Methylated Glioblastoma","Other: Delay of TMZ|Other: Standard of Care (SOC) Adjuvant TMZ (no intervention","University of Maryland, Baltimore, Maryland, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT04926168"
31,"Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM","Recruiting","No Results Available","Glioblastoma Multiforme","Device: Optune®","Grandview Cancer Center, Birmingham, Alabama, United States|St. Joseph's Hospital and Medical Center - Barrow Neurological Institute, Phoenix, Arizona, United States|Mayo Clinic- Arizona, Phoenix, Arizona, United States|University of Arizona Cancer Center, Tucson, Arizona, United States|Highlands Oncology Group, Fayetteville, Arkansas, United States|City of Hope National Medical Center, Duarte, California, United States|TRIO - St. Jude Heritage Healthcare/St. Jude Medical Center, Fullerton, California, United States|University of California at San Diego - Moores Cancer Center, La Jolla, California, United States|Norris Comprehensive Cancer Center at USC, Los Angeles, California, United States|Cedars - Sinai Medical Center, Los Angeles, California, United States|Providence St. Joseph Medical Center and The Roy and Patricia Disney Family Cancer Center, Los Angeles, California, United States|Hoag Memorial Hospital - Hoag Cancer Center, Newport Beach, California, United States|St. Joseph Hospital of Orange, Orange, California, United States|St. Joseph's Hospital, Orange, California, United States|University of California - Irvine/UCI Medical Center, Orange, California, United States|Stanford University Cancer Institute, Palo Alto, California, United States|Sharp Memorial Hospital - X-Ray Medical Group Radiation Oncology, San Diego, California, United States|University of California San Francisco Medical Center, San Francisco, California, United States|John Wayne Cancer Institute at St. John's Health Center, Santa Monica, California, United States|Stanford Cancer Institute, Stanford, California, United States|University of Colorado Cancer Center Anschutz, Aurora, Colorado, United States|HCA Research Institute - Blue Sky Neurology - Denver, Englewood, Colorado, United States|Hartford Healthcare Medical Group - Hartford Hospital The Gray Cancer Center, New London, Connecticut, United States|Lynn Cancer Institute, Marcus Neuroscience Institute, Boca Raton, Florida, United States|Baptist Health - Jacksonville, Jacksonville, Florida, United States|Mayo Clinic, Jacksonville, Florida, United States|AdventHealth, Orlando, Florida, United States|Orlando Health UF Health Cancer Center, Orlando, Florida, United States|H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa, Florida, United States|Piedmont Healthcare Brain Tumor Center, Atlanta, Georgia, United States|The Emory Clinic - Emory Healthcare - Winship Cancer Institute, Atlanta, Georgia, United States|Rush University Medical Center, Chicago, Illinois, United States|Parkview Cancer Institute - Fort Wayne Radiation Oncology Associates, Fort Wayne, Indiana, United States|The University of Kansas Cancer Center, Overland Park, Kansas, United States|St. Elizabeth, Edgewood, Kentucky, United States|University of Louisville - James Graham Brown Cancer Center, Louisville, Kentucky, United States|Norton Cancer Institute, Louisville, Kentucky, United States|NeuroMedical Center - Mary Bird Cancer Center, Baton Rouge, Louisiana, United States|LSU Health Sciences Center, New Orleans, New Orleans, Louisiana, United States|Ochsner Health System, New Orleans, Louisiana, United States|Maine Medical Partners Neurology - Neurosurgery & Spine Associates, South Portland, Maine, United States|John Hopkins School of Medicine, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Tufts Medical Center, Boston, Massachusetts, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Abbott Northwestern Hospital - Givens Brain Tumor Center, Minneapolis, Minnesota, United States|University of Minnesota Health Clinics and Surgery Center, Minneapolis, Minnesota, United States|University of Missouri - Ellis Fischel Cancer Center, Columbia, Missouri, United States|Health Midwest Ventures Group, Inc - Sarah Cannon HCA Midwest Brain and Spine, Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|JFK Neuroscience Institute, HMH JFK University Medical Center, Edison, New Jersey, United States|Hackensack University Medical Center - John Theurer Cancer Center, Hackensack, New Jersey, United States|Northwell Health System Brain Tumor Center, Lake Success, New York, United States|NYU Langone - Laura & Issac Perimutter Cancer Center, New York, New York, United States|Mount Sinai - Icahn School of Medicine, New York, New York, United States|New York Presbyterian - Columbia University, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|University of North Carolina Brain Tumor Program - UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States|Novant Health Medical Center Huntersville, Charlotte, North Carolina, United States|Vidant Medical Center, Greenville, North Carolina, United States|Forsyth Medical Center-Novant Health, Winston-Salem, North Carolina, United States|Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|University of Cincinnati Cancer Institute, Cincinnati, Ohio, United States|Case Western - University Hospitals Case Medical Center, Cleveland, Ohio, United States|The James Cancer Hospital and Solove Research Institute - Arthur G James Cancer Hospital, Columbus, Ohio, United States|Oregon Health & Science University, Portland, Oregon, United States|Geisinger Health System, Danville, Pennsylvania, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Allegheny Health Network, Pittsburgh, Pennsylvania, United States|UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|MUSC Radiation Oncology Brain & Spine Tumor Program, Charleston, South Carolina, United States|SCRI - Tennessee Oncology, Chattanooga, Tennessee, United States|West Cancer Center - Germantown, Germantown, Tennessee, United States|SCRI - Tennessee Oncology, Nashville, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Texas Oncology Midtown - Austin Brain Tumor Center, Austin, Texas, United States|Baylor Charles A. Sammons Cancer Center - Baylor University Medical Center, Dallas, Texas, United States|John Peter Smith Health Network - JPS Cancer Center, Fort Worth, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|UT Health Mischer Neuroscience - Memorial Herman - UT Neurosciences, Houston, Texas, United States|San Antonio Cancer Institute, San Antonio, Texas, United States|Baylor Scott & White Medical Center, Temple, Texas, United States|The University of Vermont Medical Center - University of Vermont Cancer Center, Burlington, Vermont, United States|Massey Cancer Center - VCU Medical Center, Richmond, Virginia, United States|Swedish Health Services, Seattle, Washington, United States|UW Medical Center - Alvord Brain Tumor Center, Seattle, Washington, United States|West Virginia University Cancer Institute, Morgantown, West Virginia, United States|GenesisCare St Vincent's Hospital, Darlinghurst, New South Wales, Australia|GenesisCare Newcastle, Gateshead, New South Wales, Australia|GenesisCare Hurstville - Centre for radiation oncology Waratah Private Hospital, Hurstville, New South Wales, Australia|GenesisCare Wesley - Wesley Medical Centre, Brisbane, Queensland, Australia|GenesisCare Kurralta Park, Kurralta Park, South Australia, Australia|Innsbruck University Hospital, Innsbruck, Austria|Kepler University Hospital, Linz, Austria|University Hospital Salzburg, Salzburg, Austria|Hospital Erasme, Brussels, Belgium|University Hospital Liege - Sart Tilman, Liège, Belgium|BC Cancer Agency Vancouver Centre, Vancouver, British Columbia, Canada|The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, Canada|CHUM Centre de Recherche, Montréal, Quebec, Canada|Universite de Sherbrooke - Sherbrooke Centre Hospitalier Universita, Sherbrooke, Quebec, Canada|Masaryk Memorial Cancer Institute, Brno, Czechia|University Hospital Plzeň, Pilsen, Czechia|Na Homolce Hospital, Prague, Czechia|Institut de cancérologie de l'Ouest, Angers, France|Pierre Wertheimer Hospital, Bron, France|Marseille University Hospital Timone, Marseille, France|University Hospital Nice, Nice, France|Pitié-Salpêtrière University Hospital, Paris, France|Institute Cancer Westerly Nantes, Saint Herblain, France|University Institute Cancer Toulouse Oncopole, Toulouse, France|Gustave Roussy Institute, Villejuif, France|University Hospital Berlin, Berlin, Germany|University Hospital Essen, Essen, Germany|University Medical Center Freiburg, Freiburg, Germany|University Hospital Leipzig, Leipzig, Germany|Rechts der Isar Hospital, Munich, Germany|University Hospital Tübingen, Tübingen, Germany|Rambam Medical Center, Haifa, Israel|Hadassah Medical Center - Ein Kerem, Jerusalem, Israel|Rabin Medical Center, Petah Tikva, Israel|Sheba Medical Center, Ramat Gan, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|Lausanne University Hospital, Lausanne, Switzerland|University Hospital Zurich, Zürich, Switzerland","https://ClinicalTrials.gov/show/NCT04471844"
32,"MRSI to Predict Response to RT/TMZ ± Belinostat in GBM","Active, not recruiting","No Results Available","Glioblastoma Multiforme of Brain","Radiation: Standard Radiation Therapy|Drug: Standard Temozolomide|Drug: Belinostat","Emory University/Winship Cancer Institute, Atlanta, Georgia, United States|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT02137759"
33,"INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)","Active, not recruiting","No Results Available","Glioblastoma","Biological: INO-5401|Biological: INO-9012|Biological: Cemiplimab|Radiation: Radiation Therapy|Drug: Temozolomide","City of Hope, Duarte, California, United States|Stanford University, School of Medicine, Palo Alto, California, United States|University of California, San Francisco, San Francisco, California, United States|University of Miami - Sylvester Comprehensive Cancer Center, Miami, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|Emory University School of Medicine, Atlanta, Georgia, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|Rutgers University - Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|New York University Langone Medical Center; Perlmutter Cancer Center, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Columbia University Medical Center The Neurological Institute of New York, New York, New York, United States|New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, New York, United States|University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States|Stephenson Cancer Center, Oklahoma City, Oklahoma, United States|Oregon Health & Science University, Portland, Oregon, United States|University of Pennsylvania Health System: Penn Medicine, Philadelphia, Pennsylvania, United States|UPMC Cancer Center Neuro-Oncology; UPMC Cancer Pavilion, Pittsburgh, Pennsylvania, United States|Texas Oncology, Austin, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT03491683"
34,"DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab","Recruiting","No Results Available","Glioblastoma","Biological: Human CMV pp65-LAMP mRNA-pulsed autologous DCs|Drug: Temozolomide|Biological: Varlilumab|Biological: Td|Biological: Unpulsed DCs","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT03688178"
35,"Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent Glioblastoma","Terminated","Has Results","c-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBM","Drug: INC280|Drug: Buparlisib","Dana Farber Cancer Institute SC, Boston, Massachusetts, United States|Columbia University Medical Center- New York Presbyterian Dept of Oncology, New York, New York, United States|Memorial Sloan Kettering Cancer Center Neurology, New York, New York, United States|Duke University Medical Center Duke - Baker, Durham, North Carolina, United States|University of Texas MD Anderson Cancer Center SC-3, Houston, Texas, United States|Novartis Investigative Site, Bonn, Germany|Novartis Investigative Site, Heidelberg, Germany|Novartis Investigative Site, Tübingen, Germany|ErasmusMC Cancer Institute - Neurooncology, RM G3-55, Rotterdam, Netherlands|University Medical Center Utrecht, Rm Q05.4.300, P.O. Box 85500, Utrecht, Netherlands|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, St. Gallen, Switzerland","https://ClinicalTrials.gov/show/NCT01870726"
36,"A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)","Completed","Has Results","Glioblastoma Multiforme","Biological: ICT-107|Biological: Placebo DC","University of Alabama at Birbingham School of Medicine, South Birmingham, Alabama, United States|Arizona Cancer Center, Tucson, Arizona, United States|UC San Diego Moores Cancer Center, La Jolla, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Northwestern Memorial Hospital, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|Jewish Hospital Medical Center, Louisville, Kentucky, United States|Johns Hopkins University School of Medicine, Baltimore, Maryland, United States|Massachusetss General Hospital, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|New Jersey Neuroscience Institute, Edison, New Jersey, United States|Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|The Long Island Brain Tumor Center at Neurological Surgery, PC, Great Neck, New York, United States|NYU Clinical Cancer Center, New York, New York, United States|Weil Cornell Medical College, New York, New York, United States|Wake Forest University, Winston Salem, North Carolina, United States|Case Comprehensive Cancer Center, Cleveland, Ohio, United States|Cleveland Clinic Rose Ella Burkhardt Brain Tumor and Neuro Oncology Center, Cleveland, Ohio, United States|Penn State Hershey Medical Center, Hershey, Pennsylvania, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Sammons Cancer Center (Baylor), Dallas, Texas, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States|University of Virginia Health System, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT01280552"
37,"ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme","Recruiting","No Results Available","Glioblastoma Multiforme (GBM)","Drug: ADI-PEG20|Drug: Temozolomide","Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan","https://ClinicalTrials.gov/show/NCT04587830"
38,"MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)","Not yet recruiting","No Results Available","Glioblastoma|Glioblastoma Multiforme","Drug: MBM-02","Georgetown, Washington, District of Columbia, United States","https://ClinicalTrials.gov/show/NCT04874506"
39,"Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)","Not yet recruiting","No Results Available","Glioblastoma Multiforme","Drug: Dichloroacetate (DCA)|Genetic: Genotype","Johns Hopkins Bayview Med Ctr, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT05120284"
40,"Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)","Completed","No Results Available","Glioblastoma Multiforme","Drug: Bevacizumab","Dartmouth Hithcock Medcial Center, Lebanon, New Hampshire, United States","https://ClinicalTrials.gov/show/NCT01091792"
41,"Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma","Unknown status","No Results Available","Glioblastoma Multiforme|GBM|Gliosarcoma","Drug: AR-67 (7-t-butyldimethylsiltyl-10-hydroxy-camptothecin)","Northwestern University - Robert H Lurie Comprehensive Cancer Center, Chicago, Illinois, United States|University of Kentucky - Markey Cancer Center, Lexington, Kentucky, United States|North Shore - Long Island Jewish Hospital/Monter Cancer Center, Lake Success, New York, United States|Duke University Medical Center - The Preston Robert Tisch Brain Tumor Center, Durham, North Carolina, United States|Derrick L Davis Forsyth Regional Cancer Center, Winston-Salem, North Carolina, United States|The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio, United States|University of Utah - Huntsman Cancer Center, Salt Lake City, Utah, United States|University of Calgary - Tom Baker Cancer Center, Calgary, Alberta, Canada|University of Alberta - Cross Cancer Institute, Edmonton, Alberta, Canada","https://ClinicalTrials.gov/show/NCT01124539"
42,"Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients","Suspended","No Results Available","Glioblastoma",,"Rambam medical center, Haifa, Israel|Rabin medical center, Petah tikva, Israel|Sourasky medical center, Tel Aviv, Israel|Sheba medical center, Tel HaShomer, Israel","https://ClinicalTrials.gov/show/NCT04219475"
43,"Role of Repeat Resection in Recurrent Glioblastoma","Not yet recruiting","No Results Available","Recurrent Glioblastoma|Glioblastoma - Category","Procedure: Repeat Surgical Management of Recurrent GBM","University of Alberta Division of Neurosurgery, Edmonton, Alberta, Canada","https://ClinicalTrials.gov/show/NCT04838782"
44,"Niraparib/TTFields in GBM","Recruiting","No Results Available","Glioblastoma|Recurrent Glioblastoma|GBM","Drug: Niraparib|Device: Optune|Procedure: Planned surgical resection","Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT04221503"
45,"Biomarkers for Prognosis of Glioblastoma (GBM)","Completed","No Results Available","Glioblastoma",,"University of Nebraska Medical Center, Omaha, Nebraska, United States","https://ClinicalTrials.gov/show/NCT01493219"
46,"Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects","Active, not recruiting","No Results Available","Glioblastoma Multiforme","Biological: VBI-1901","University of California, Los Angeles Neuro-Oncology Program, Los Angeles, California, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|The Neurological Institute of New York Columbia University Medical Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT03382977"
47,"Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM","Unknown status","No Results Available","Glioblastoma","Procedure: Gross total resection and Gliadel(R) wafers implanted|Radiation: GammaKnife(R) stereotactic Radiosurgery|Radiation: Standard fractionated radiation therapy|Drug: Temozolomide","Barrow Neurological Institute at St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States","https://ClinicalTrials.gov/show/NCT02085304"
48,"A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)","Active, not recruiting","Has Results","Glioblastoma Multiforme","Drug: ACP-196","Research Site, Los Angeles, California, United States|Research Site, Palo Alto, California, United States|Research Site, Boston, Massachusetts, United States|Research Site, Boston, Massachusetts, United States|Research Site, Boston, Massachusetts, United States|Research Site, New York, New York, United States|Research Site, Vancouver, Washington, United States","https://ClinicalTrials.gov/show/NCT02586857"
49,"GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients","Recruiting","No Results Available","Recurrent Glioblastoma","Drug: GX-I7|Drug: Bevacizumab","Seoul St.Mary's Hospital of the Catholic University of Korea, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT05191784"
50,"Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM","Recruiting","No Results Available","Glioblastoma Multiforme","Drug: MBG453","Stanford University, Stanford, California, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT03961971"
51,"Nativis Voyager for Newly Diagnosed GBM","Unknown status","No Results Available","Glioblastoma Multiforme","Device: Nativis Voyager","Center for Neurosciences, Tucson, Arizona, United States|California Cancer Care Associates, Encinitas, California, United States|John Wayne Cancer Institute @ Providence St Johns Health Center, Santa Monica, California, United States|Associated Neurologists of Southern CT, PC, Fairfield, Connecticut, United States|Boca Raton Regional Hospital, Boca Raton, Florida, United States|Cancer Care Collaborative, Austin, Texas, United States|Baylor Scott and White Health, Temple, Texas, United States","https://ClinicalTrials.gov/show/NCT03276286"
52,"Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM","Active, not recruiting","No Results Available","Glioblastoma","Drug: Nivolumab|Drug: Standard Dose Bevacizumab|Drug: Low Dose Bevacizumab","Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT03452579"
53,"VB-111 in Surgically Accessible Recurrent/Progressive GBM","Recruiting","No Results Available","Glioblastoma|Recurrent Glioblastoma","Drug: VB11|Procedure: Surgery|Other: Placebo|Drug: Bevacizumab","Dana-Farber Cancer Institute, Boston, Massachusetts, United States|UT Health San Antonio MD Anderson Cancer Center (Mays Cancer Center), San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT04406272"
54,"A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)","Recruiting","No Results Available","Adult Glioblastoma","Biological: Autologous total tumor mRNA and pp65 full length (fl) lysosomal associated membrane protein (LAMP) mRNA loaded DOTAP liposome vaccine administered intravenously (RNA loaded lipid particles, RNA-LPs)","UF Health, Gainesville, Florida, United States","https://ClinicalTrials.gov/show/NCT04573140"
55,"Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)","Terminated","No Results Available","Glioblastoma Multiforme","Drug: Lucanthone|Drug: Temozolomide (TMZ)|Radiation: Radiation|Drug: Placebo","UCSD Moores Cancer Center, La Jolla, California, United States|UCI Medical Center, Orange, California, United States|Dent Neurologic Institute, Amherst, New York, United States|Fairview Hospital Moll Cancer Center/Cleveland Clinic, Cleveland, Ohio, United States|Cleveland Clinic, Cleveland, Ohio, United States|Hillcrest Hospital Hirsh Cancer Center/Cleveland Clinic, Mayfield, Ohio, United States|Gujarat Cancer Research Institute, Ahmedabad, Gujarat, India|Jaslok Hospital & Research Centre, Mumbai, Maharashtra, India|Bhagwan Mahaveer Cancer Hospital & Reseach Centre, Jaipur, Rajasthan, India|Chittaranjan National Cancer Institute, Kolkata, West Bengal, India","https://ClinicalTrials.gov/show/NCT01587144"
56,"Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects","Terminated","Has Results","Glioblastoma","Drug: Trans Sodium Crocetinate plus SOC|Other: Standard of Care (SOC)","University of California, Irvine, California, United States|Scott Peak, M.D., Redwood City, California, United States|John Wayne Cancer Institute @ Providence Saint John's Health Center, Santa Monica, California, United States|Piedmont Cancer, Atlanta, Georgia, United States|John B. Amos Cancer Center, Columbus, Georgia, United States|Abbott Northwestern Hospital, Minneapolis, Minnesota, United States|John Theurer Cancer Center, Hackensack, New Jersey, United States|UNM Comprehensive Cancer Center, Albuquerque, New Mexico, United States|North Shore University Hospital, Manhasset, New York, United States|Mount Sinai Hospital, New York, New York, United States|Providence Portland Medical Center, Portland, Oregon, United States|Scott Lindhorst, M.D., Charleston, South Carolina, United States|Neuro Oncology Associates, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT03393000"
57,"Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)","Active, not recruiting","No Results Available","Glioblastoma","Drug: Pembrolizumab|Biological: HSPPC-96|Drug: Temozolomide|Other: Placebo","Cedars Sinai Medical Center, Los Angeles, California, United States|Piedmont Hospital, Atlanta, Georgia, United States|Northshore University Health System, Evanston, Illinois, United States|Advocate Lutheran General Hospital, Park Ridge, Illinois, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, United States|Henry Ford Health Systems, Detroit, Michigan, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|MUSC Hollings Cancer Center, Charleston, South Carolina, United States|Baylor University Medical Center, Dallas, Texas, United States|University Of Texas SW Medical Center, Dallas, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|University of Utah, Salt Lake City, Utah, United States|University of Washington Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT03018288"
58,"Post-approval Study of NovoTTF-100A in Recurrent GBM Patients","Terminated","No Results Available","Recurrent Glioblastoma Multiforme","Device: NovoTTF-100A","University of Alabama at Birmingham, Birmingham, Alabama, United States|Barrow Neurology Clinics, Phoenix, Arizona, United States|University of California San Diego Moores Cancer Center, La Jolla, California, United States|Keck Medical Center of USC, Los Angeles, California, United States|Sylvester Comprehensive Cancer Center, Miami, Florida, United States|University of Illinois at Chicago, Chicago, Illinois, United States|University of Kentucky, Markey Cancer Center, Lexington, Kentucky, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Washington University School of Medicine, Division of Oncology, St. Louis, Missouri, United States|The Long Island Brain Tumor Center, Lake Success, New York, United States|Geisinger Health System, Danville, Pennsylvania, United States|Baylor Research Institute, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT01756729"
59,"Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab","Withdrawn","No Results Available","Glioblastoma Multiforme (GBM)","Drug: Fluciclitite , PET imaging, and Bevacizumab","Huntsman Cancer Institute, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT01788280"
60,"Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan","Terminated","No Results Available","Glioblastoma Multiforme","Biological: ALECSAT|Drug: Bevacizumab/Irinotecan","Aalborg Universityhospital, Department of Oncology, Aalborg, Hobrovej 18-22, Denmark|Aarhus University Hospital, Department of Oncology, Aarhus, Nørrebrogade 44, Denmark|Odense University Hospital, Department of Oncology, Odense, Sdr. Boulevard 29, Denmark|Department of Oncology, Rigshospitalet, Copenhagen, Denmark","https://ClinicalTrials.gov/show/NCT02060955"
61,"A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM)","Terminated","No Results Available","Glioblastoma Multiforme","Drug: Fludarabine|Drug: Cyclophosphamide|Biological: CMV Specific Cytotoxic T Lymphocytes (CTL)",,"https://ClinicalTrials.gov/show/NCT00990496"
62,"Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)","Completed","No Results Available","Glioblastoma Multiforme","Device: NovoTTF-100A device|Drug: Temozolomide","University of Alabama at Birmingham, Birmingham, Alabama, United States|Barrow Neurology Clinics, Phoenix, Arizona, United States|City of Hope, Duarte, California, United States|University of California San Diego Moores Cancer Center (UCSD), La Jolla, California, United States|University of Southern California (USC), Los Angeles, California, United States|University of Colorado Denver, Aurora, Colorado, United States|UF Health Cancer Center at Orlando Health, Orlando, Florida, United States|H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States|Emory University, Winship Cancer Institute, Atlanta, Georgia, United States|University of Illinois at Chicago (UIC), Chicago, Illinois, United States|University of Kentucky, Markey Cancer Center, Lexington, Kentucky, United States|Norton Cancer Institute, Louisville, Kentucky, United States|Maine Medical Center, Scarborough, Maine, United States|The Johns Hopkins Hospital, Baltimore, Maryland, United States|Tufts Medical Center, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Lahey Clinic Medical Center, Burlington, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|Washington University School of Medicine, Division of Oncology, St. Louis, Missouri, United States|New Jersey Neuroscience Center - JFK Medical Center, Edison, New Jersey, United States|John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States|Weill Cornell Medical College, New York, New York, United States|Mount Sinai Medical Center, Department of Neurosurgery, New York, New York, United States|Columbia University Medical Center, New York, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|The Ohio State University Arthur G. James Cancer Hospital and Solove Research Institute, Columbus, Ohio, United States|Geisinger Health System, Danville, Pennsylvania, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Pennsylvania Hospital, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania, United States|UT Southwestern Medical Center, Dallas, Texas, United States|Baylor, Dallas, Texas, United States|Methodist Hospital, Houston, Texas, United States|Methodist Neurological Institute, Houston, Texas, United States|The University of Texas Health Science Center at Houston (UTHSC), Houston, Texas, United States|Scott and White Healthcare, Temple, Texas, United States|Memorial Hermann The Woodlands, The Woodlands, Texas, United States|University of Virginia Health System, Charlottesville, Virginia, United States|Swedish Neuroscience Institute, Seattle, Washington, United States|University of Washington/Seattle Cancer Care Alliance, Seattle, Washington, United States|University Hospital Graz, Graz, Austria|Medical University of Vienna, Vienna, Austria|SMZ-Süd/Kaiser-Franz-Josef-Spital, Vienna, Austria|Tom Baker Cancer Center, Calgary, Alberta, Canada|CancerCare Manitoba, Winnipeg, Manitoba, Canada|Juravinski Cancer Centre, Hamilton,, Ontario, Canada|The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada|Notre-Dame Hospital (CHUM), Montreal, Quebec, Canada|Montreal Neurological Institute, Montreal, Quebec, Canada|McGill - Gerald Bronfman Centre for Clinical Research in Oncology -, Montreal, Quebec, Canada|(CHUS) Centre Hospitalier Universitaire de Sherbrooke, Service de Neurochirurgie, Sherbrooke, Quebec, Canada|Na Homolce Hospital, Prague, Czech Republic|CHU Amiens Sud-Salouel, Amiens, France|CHU Angers, Angers, France|Hôpital Saint André Centre Hospitalier Universitaire (CHU) des Hôpitaux de Bordeaux, Bordeaux, France|Hospital of Neurology Pierre Wertheimer, Lyon, France|Group Hospitals Pitie-Salpetriere, Paris, France|Centre Hospitalo-Universitaire de Toulouse Purpan, Toulouse, France|University Medical Center Hamburg-Eppendorf, Hamburg, Germany|Medical University Heidelberg, Heidelberg, Germany|University Hospital of Schleswig-Holstein, Kiel, Germany|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|Az. Ospedaliero-Universitaria - Ospedali Riuniti, Ancona, Italy|Ospedale Lecco, Lecco, Italy|C. Besta Neurological Institute, Milan, Italy|Foundation Hospital Greater Policlinico, Milan, Italy|Istituti Fisioterapici Ospitalieri - Istituto Nazionale dei Tumori Regina Elena, Rome, Italy|Asan Medical Center, Asan, Korea, Republic of|Yeungnam University Hospital, Daegu, Korea, Republic of|Chungnam National University Hospital (CNUH), Daejeon, Korea, Republic of|Samsung Medical Center (SMC), Seoul, Korea, Republic of|Seoul National University Bundang Hospital (SNUBH), Seoul, Korea, Republic of|Seoul National University Hospital (SNUH), Seoul, Korea, Republic of|The Catholic University of Korea, Seoul St. Mary's Hospital (CMC Seoul), Seoul, Korea, Republic of|Yonsei University Severance Hospital (YUHS), Seoul, Korea, Republic of|Ajou University Hospital (AUH), Suwon, Korea, Republic of|Hospital Universitari Germans Trias i Pujol, Badalona, Spain|Hospital Clinic i Provincial de Barcelona, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Universitari de Bellvitge-ICO Duran i Reynals, Barcelona, Spain|Fundacion Jimenes Diaz, Madrid, Spain|Hospital 12 de Octubre, Servicio de Oncología Médica, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Clínica Universidad de Navarra, Pamplona, Spain|Karolinska Institute, Stockholm, Sweden|Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland|UniversitätsSpital Zürich, Zurich, Switzerland","https://ClinicalTrials.gov/show/NCT00916409"
63,"A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia","Completed","No Results Available","Glioblastoma Multiforme","Device: Voyager","St. Vincent's Hospital Melbourne, Melbourne, Victoria, Australia","https://ClinicalTrials.gov/show/NCT02507102"
64,"A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)","Unknown status","No Results Available","Glioblastoma Multiforme","Device: Nativis Voyager RFE Therapy","University of Alabama at Birmingham (UAB), Birmingham, Alabama, United States|Center for Neurosciences, Tucson, Arizona, United States|cCARE - California Cancer Associates for Research & Excellence, Encinitas, California, United States|John Wayne Cancer Institute @ Providecne St. Johns Health Center, Santa Monica, California, United States|Associated Neurologists of Southern CT, P.C., Fairfield, Connecticut, United States|Boca Raton Regional Hospital, Boca Raton, Florida, United States|University of Kansas Medical Center (KUMC), Kansas City, Kansas, United States|Providence Brain & Spine Institute, Portland, Oregon, United States|Cancer Care Collaborative, Austin, Texas, United States|Baylor Scott & White Health, Temple, Texas, United States|Virginia Mason Hospital & Medical Center, Seattle, Washington, United States|Swedish Medical Center, Seattle, Washington, United States|St Vincent's Hospital Melbourne, Melbourne, Australia","https://ClinicalTrials.gov/show/NCT02296580"
65,"Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)","Terminated","Has Results","Glioblastoma Multiforme","Drug: Everolimus|Procedure: Surgery","UCLA, Los Angeles, California, United States|Northwestern University, Chicago, Illinois, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Duke University - Preston Robert Tisch Brain Tumor Center, Durham, North Carolina, United States|University of Cincinnati, Cincinnati, Ohio, United States|Seattle Cancer Care Alliance, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00515086"
66,"AV-GBM-1 vs Control as Adjunctive Therapy After RT/TMZ for Newly Diagnosed GBM","Not yet recruiting","No Results Available","Primary Glioblastoma","Biological: AV-GBM-1|Biological: Autologous monocytes",,"https://ClinicalTrials.gov/show/NCT05100641"
67,"Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)","Completed","No Results Available","Recurrent Glioblastoma Multiforme","Device: NovoTTF-100A","Northwestern University, Chicago, Illinois, United States|University of Illinois in Chicago, Chicago, Illinois, United States|Evanston Northwestern Healthcare, Evanston, Illinois, United States|Boston University Medical Center, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Lahey Clinic Medical Center, Burlington, Massachusetts, United States|NJ Neuroscience Institute - JFK Medical Center, Edison, New Jersey, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|Columbia University Medical Center, New York, New York, United States|University Hospitals of Cleveland, Cleveland, Ohio, United States|Cleveland Clinic, Cleveland, Ohio, United States|University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania, United States|University of Virginia, Charlottesville, Virginia, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|University Hospital Graz, Graz, Austria|FN Brno - Masaryk University, Brno, Czech Republic|Na Homolce Hospital, Prague, Czech Republic|Hospital of Neurology Lyon - University Claude Bernard Lyon 1, Lyon, France|Group Hospitals Pitie-Salpetriere, Paris, France|University Hospital Augsburg, Augsburg, Germany|University Medical Center Hamburg-Eppendorf, Hamburg, Germany|University Hospital of Schleswig-Holstein, Kiel, Germany|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland","https://ClinicalTrials.gov/show/NCT00379470"
68,"Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab","Recruiting","No Results Available","Glioblastoma|Recurrent Glioblastoma|GBM|Recurrent GBM","Radiation: Radiation: Intra-operative Radiation Therapy - IORT|Drug: Bevacizumab|Drug: Avastin","Providence Saint John's Health Center, Santa Monica, California, United States","https://ClinicalTrials.gov/show/NCT04681677"
69,"An Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease (GOOD-IDES)","Completed","No Results Available","Anti-Glomerular Basement Membrane Disease","Biological: HMed-IdeS","Department of Internal Medicine IV (Nephrology and Hypertension), Innsbruck, Austria|Department of Department of nephrology, First Faculty of Medicine and General Teaching Hospital and Charles University in Prague, Czech Republic,, Prague, Czechia|Department of Department of Nephrology, Rigshospitalet, Copenhagen, Copenhagen, Denmark|PH USI UNTR, service du Pr Rondeau, Hôpital Tenon, Paris, Paris Cedex 20, France|Department of Nephrology, Hemodialysis, Apheresis, and Transplantation, CHUGA (centre hospitalier universitaire Grenoble-Alpes), Grenoble, France|Centre Hospitalier Régional Universitaire de Lille, Nephrology Service, Lille, France|Nephrology Service CHU Bichat, Paris, France|Department of Nephrology and Organ Transplant, CHU Rangueil, Toulouse, France|Karolinska University Hospital Huddinge, Stockholm, Sweden|Department of Nephrology, Uppsala University Hospital, Uppsala, Sweden","https://ClinicalTrials.gov/show/NCT03157037"
70,"Bevacizumab w / Temozolomide PET & Vascular MRI For GBM","Completed","Has Results","Recurrent Glioblastoma","Device: MRI-PET|Device: TMZ-PET","Massachuesett General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01987830"
71,"Trial of AEO in New Glioblastoma (GBM)","Not yet recruiting","No Results Available","Glioblastoma Multiforme","Drug: Anhydrous Enol-Oxaloacetate (AEO)|Other: Standard of Care",,"https://ClinicalTrials.gov/show/NCT04450160"
72,"Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM","Recruiting","No Results Available","Glioblastoma|Glioblastoma Multiforme|GBM|Brain Cancer","Procedure: Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)","Lenox Hill Brain Tumor Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT03630289"
73,"The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients","Unknown status","No Results Available","GBM|Depression","Drug: Escitalopram|Drug: placebo","The Tel Aviv Sourasky Medical Center, Tel Aviv, Israel","https://ClinicalTrials.gov/show/NCT02623231"
74,"Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM","Active, not recruiting","No Results Available","Glioblastoma Multiforme","Drug: Nivolumab|Drug: Temozolomide","Duke University Medical Center, Durham, North Carolina, United States|Campbelltown Hospital, Campbelltown, New South Wales, Australia|Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia|Gosford Hospital, Gosford, New South Wales, Australia|Newcastle Private Hospital, New Lambton Heights, New South Wales, Australia|Port Macquarie Hospital, Port Macquarie, New South Wales, Australia|Prince of Wales Hospital, Randwick, New South Wales, Australia|Royal North Shore Hospital, Saint Leonards, New South Wales, Australia|Wollongong Hospital, Wollongong, New South Wales, Australia|Royal Brisbane and Women's Hospital, Herston, Queensland, Australia|Icon Cancer Centre, South Brisbane, Queensland, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Flinders Medical Centre, Bedford Park, South Australia, Australia|Royal Hobart Hospital, Hobart, Tasmania, Australia|Monash Medical Centre, Clayton, Victoria, Australia|Austin Hospital, Heidelberg, Victoria, Australia|Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia|Epworth Healthcare, Richmond, Victoria, Australia|Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia","https://ClinicalTrials.gov/show/NCT04195139"
75,"Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities","Terminated","No Results Available","Glioblastoma Multiforme","Other: dynamic contrast enhanced magnetic resonance imaging","Yale University School of Medicine, New Haven, Connecticut, United States","https://ClinicalTrials.gov/show/NCT00589095"
76,"PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma","Completed","No Results Available","Glioblastoma|GBM|Glioblastoma Multiforme","Drug: PF-00299804","Massachusetts General Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Cleveland Clinic, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT01112527"
77,"Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)","Active, not recruiting","No Results Available","Glioblastoma",,"University of Alabama at Birmingham, Birmingham, Alabama, United States|UC Davis, Sacramento, California, United States|University of Miami, Miami, Florida, United States|Northwestern University, Chicago, Illinois, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Washington University Medical School, Saint Louis, Missouri, United States|Montefiore Medical Center, Bronx, New York, United States|Columbia University Medical Center, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|SUNY Stony Brook, Stony Brook, New York, United States|University of Cincinnati, Cincinnati, Ohio, United States|Ohio State University, Columbus, Ohio, United States|Oregon Health & Science University, Portland, Oregon, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Vanderbilt University, Nashville, Tennessee, United States|University of Texas Southwestern, Dallas, Texas, United States|University of Utah, Salt Lake City, Utah, United States|Swedish Neuroscience Institute, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT02997423"
78,"Surgical Nivolumab And Ipilimumab For Recurrent GBM","Recruiting","No Results Available","Glioblastoma|GBM|Glioblastoma Multiforme|Grade IV Astrocytoma","Drug: Nivolumab-Placebo|Drug: Nivolumab|Drug: Ipilimumab-Placebo|Drug: Ipilimumab|Procedure: Surgery","Dana Farber Cancer Institute, Boston, Massachusetts, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT04606316"
79,"HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM","Recruiting","No Results Available","Glioblastoma|Anaplastic Astrocytoma","Drug: ADV/HSV-tk (gene therapy)","Houston Methodist Neurological Institute, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03603405"
80,"Feasibility of Individualized Therapy for Recurrent GBM","Recruiting","No Results Available","Recurrent Glioblastoma","Drug: Individualized therapy","University of California San Francisco, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT03681028"
81,"FET-PET Directed Simultaneous In-field Boost for Primary GBM","Completed","No Results Available","Glioblastoma Multiforme","Radiation: Moderately Hypofractionated Radiotherapy using Simultaneous In-Field Boost","The Franciszek Lukaszczyk Oncology Center, Bydgoszcz, Poland","https://ClinicalTrials.gov/show/NCT04790097"
82,"Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma","Completed","Has Results","Glioblastoma|GBM|Glioma","Drug: Trans Sodium Crocetinate (TSC)","St. Joseph's Medical Center Barrow Neurology Clinics, Phoenix, Arizona, United States|University of Arkansas Winthrop P. Rockefeller Cancer Institute, Little Rock, Arkansas, United States|USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|The George Washington University Medical Center, Washington, D.C., District of Columbia, United States|University of Florida McKnight Brain Institute, Gainesville, Florida, United States|Emory University Winship Cancer Institute, Atlanta, Georgia, United States|Northwestern University Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Kentucky Markey Cancer Center, Lexington, Kentucky, United States|North Shore University Hospital, Manhasset, New York, United States|Forsyth Regional Cancer Center, Winston-Salem, North Carolina, United States|Penn State University Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Baylor University Medical Center, Dallas, Texas, United States|University of Texas Health Science Center Memorial Hermann Medical Center, Houston, Texas, United States|UVA Health Sciences Center Emily Couric Clinical Cancer Center, Charlottesville, Virginia, United States|Froedtert & Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01465347"
83,"A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma","Recruiting","No Results Available","Glioblastoma","Drug: Temozolomide|Drug: Lomustine|Drug: Regorafenib|Radiation: Radiation|Drug: Paxalisib|Drug: VAL-083","University of Alabama at Birmingham, Birmingham, Alabama, United States|Cedars Sinai - Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, United States|University of California, Los Angeles, Los Angeles, California, United States|St. Joseph Hospital, Orange, California, United States|University of Colorado Denver, Aurora, Colorado, United States|Yale Cancer Center / Smilow Cancer Hospital, New Haven, Connecticut, United States|Mayo Clinic Cancer Center, Jacksonville, Florida, United States|Sylvester Comprehensive Cancer Center, Miami, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|Piedmont Atlanta Hospital, Atlanta, Georgia, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|LSU Health Sciences Center - New Orleans, New Orleans, Louisiana, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|Abbott Northwestern Hospital, Minneapolis, Minnesota, United States|Mayo Clinic Cancer Center - Rochester, Rochester, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Washington University School of Medicine - Siteman Cancer Center, Saint Louis, Missouri, United States|Perlmutter Cancer Center, NYU Langone Health, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Columbia University Medical Center, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Comprehensive Cancer Center of Wake Forest, Winston-Salem, North Carolina, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Cleveland Clinic, Cleveland, Ohio, United States|Ohio State University Cancer Center, Columbus, Ohio, United States|University of Pennsylvania - Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina - Hollings Cancer Center, Charleston, South Carolina, United States|Texas Oncology - Austin, Austin, Texas, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|University of Utah - Huntsman Cancer Institute, Salt Lake City, Utah, United States|University of Virginia Health, Charlottesville, Virginia, United States|University of Washington Medical Center, Seattle, Washington, United States|Froedtert Hospital/Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, Canada|Montreal Neurological Institute and Hospital, McGill University, Montréal, Quebec, Canada|Université de Sherbrooke, Sherbrooke, Quebec, Canada","https://ClinicalTrials.gov/show/NCT03970447"
84,"Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma","Terminated","No Results Available","Glioblastoma","Drug: Cyclophosphamide|Biological: IMA950 plus GM-CSF|Biological: IMA950|Drug: Imiquimod","Neuro-Oncology Branch of the National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT01403285"
85,"CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM","Not yet recruiting","No Results Available","Glioblastoma","Drug: 5x10(7) CART-EGFR-IL13Ra2|Drug: 1x107 CART-EGFR-IL13Ra2|Drug: 1x10(8) CART-EGFR-IL13Ra2|Drug: 5x108 CART-EGFR-IL13Ra2|Drug: Cyclophosphamide|Drug: Fludarabine",,"https://ClinicalTrials.gov/show/NCT05168423"
86,"UNITE Study: Understanding New Interventions With GBM ThErapy","Terminated","Has Results","Glioblastoma Multiforme","Drug: Steroid eye drops|Drug: Vasoconstrictor eye drops|Other: Cold compress|Drug: Ophthalmic steroid ointment|Drug: Depatuxizumab mafodotin|Drug: Temozolomide|Radiation: Radiation","Usc /Id# 164235, Los Angeles, California, United States|Moffitt Cancer Center /ID# 164234, Tampa, Florida, United States|Rush University Medical Center /ID# 171003, Chicago, Illinois, United States|Northshore University Health System-Evanston /ID# 164221, Evanston, Illinois, United States|CDH-Delnor Health System /ID# 169909, Warrenville, Illinois, United States|Columbia University Medical Center /ID# 164220, New York, New York, United States|Levine Cancer Ins, Carolina Me /ID# 171271, Charlotte, North Carolina, United States|UT Health Science Ctr-Houston /ID# 164223, Houston, Texas, United States|Baylor Scott & White Medical Center- Temple /ID# 170792, Temple, Texas, United States|Royal North Shore Hospital /ID# 169673, Saint Leonards, New South Wales, Australia|Calvary Mater Newcastle /ID# 169672, Waratah, New South Wales, Australia|Royal Brisbane and Women's Hospital /ID# 169674, Herston, Queensland, Australia|Austin Hospital /ID# 169671, Heidelberg, Victoria, Australia|Universitaetsklinik Heidelberg /ID# 169970, Heidelberg, Baden-Wuerttemberg, Germany|Universitaetsklinikum Leipzig /ID# 169969, Leipzig, Sachsen, Germany|Klinikum Univ. Regensburg /ID# 169963, Regensburg, Germany|Universitatsklinikum Tubingen /ID# 169965, Tuebingen, Germany|Vrije Universiteit Medisch Centrum /ID# 170152, Amsterdam, Netherlands|Universitair Medisch Centrum Utrecht /ID# 170149, Utrecht, Netherlands|Guy's and St Thomas' NHS Found /ID# 207752, London, London, City Of, United Kingdom|Queen Elizabeth Hospital - BIRMINGHAM /ID# 200657, Birmingham, United Kingdom|Castle Hill Hospital /ID# 200662, Cottingham, United Kingdom","https://ClinicalTrials.gov/show/NCT03419403"
87,"Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM","Recruiting","No Results Available","Glioblastoma Multiforme","Device: TTFields","Nemocnice Na Homolce, Prague, Czechia","https://ClinicalTrials.gov/show/NCT04492163"
88,"Personalized Radiation Therapy for GBM","Recruiting","No Results Available","Glioblastoma","Radiation: Radation Therapy","Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT03477513"
89,"Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)","Withdrawn","No Results Available","Glioblastoma","Drug: Cilengitide|Drug: Bevacizumab|Behavioral: Questionnaire",,"https://ClinicalTrials.gov/show/NCT01782976"
90,"CART-EGFRvIII + Pembrolizumab in GBM","Completed","No Results Available","Glioblastoma","Biological: CART-EGFRvIII T cells|Biological: Pembrolizumab","Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT03726515"
91,"Bioenergetic Profiling and Cognition in GBM Patients","Recruiting","No Results Available","Glioblastoma","Procedure: Cognitive Assessment|Diagnostic Test: Blood Collection|Diagnostic Test: Bioenergetic Profiling","Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT03939858"
92,"Combined Approach to Resection of Glioblastoma (GBM) by 5-Aminolevulinic Acid (5-ALA) and Intraoperative Magnetic Resonance Imaging (MRI)","Unknown status","No Results Available","Glioblastoma","Procedure: diagnostic 5-ALA and MRI for tumor resection","UniversitätsSpital Zürich, Zurich, Switzerland","https://ClinicalTrials.gov/show/NCT01208909"
93,"Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma","Terminated","No Results Available","Glioblastoma","Drug: Cannabis|Drug: Temozolomide|Radiation: Radiation Therapy","Columbia University Medical Center- Department of Radiation Oncology, New York, New York, United States|New York State Psychiatric Institute, New York, New York, United States","https://ClinicalTrials.gov/show/NCT03246113"
94,"Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients","Not yet recruiting","No Results Available","Glioblastoma Multiforme","Drug: levetiracetam",,"https://ClinicalTrials.gov/show/NCT02815410"
95,"Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma","Completed","Has Results","Glioblastoma","Drug: Durvalumab|Radiation: Standard radiotherapy|Biological: Bevacizumab","Research Facility, Los Angeles, California, United States|Research Facility, San Francisco, California, United States|Research Facility, Baltimore, Maryland, United States|Research Facility, Boston, Massachusetts, United States|Research Facility, Boston, Massachusetts, United States|Research Facility, Saint Louis, Missouri, United States|Research Facility, New York, New York, United States|Research Facility, Melbourne, Australia","https://ClinicalTrials.gov/show/NCT02336165"
96,"A Phase 2 Study of BGJ398 in Patients With Recurrent GBM","Completed","Has Results","Recurrent Glioblastoma or Other Glioma Subtypes","Drug: BGJ398","Novartis Investigative Site, Los Angeles, California, United States|University of California San Francisco Dept of Onc., San Francisco, California, United States|Novartis Investigative Site, Chicago, Illinois, United States|Novartis Investigative Site, Boston, Massachusetts, United States|Novartis Investigative Site, New York, New York, United States|Novartis Investigative Site, Columbus, Ohio, United States|Novartis Investigative Site, Dallas, Texas, United States|Novartis Investigative Site, Dallas, Texas, United States|Novartis Investigative Site, Houston, Texas, United States|Novartis Investigative Site, Melbourne, Victoria, Australia|Novartis Investigative Site, Leuven, Belgium|University Medical Center Utrecht, Utrecht, The Netherlands, Netherlands|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, Hospitalet de LLobregat, Catalunya, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Zürich, Switzerland","https://ClinicalTrials.gov/show/NCT01975701"
97,"A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma","Completed","No Results Available","Glioblastoma Multiforme","Radiation: Hypofractionated Intensity-Modulated Radiation Therapy|Drug: Temozolomide","University of Colorado Cancer Center, Aurora, Colorado, United States","https://ClinicalTrials.gov/show/NCT00792012"
98,"Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients","Not yet recruiting","No Results Available","Glioblastoma Multiforme","Other: Biomarker based treatment (Temozolomide monotherapy or Radiotherapy monotherapy)|Combination Product: Chemo-Radiotherapy consisting of 40 Gy in 15 daily fractions with concurrent temozolomide.","Cross Cancer Institute, Edmonton, Alberta, Canada","https://ClinicalTrials.gov/show/NCT04765514"
99,"Immunohistochemical Assessment of Programmed Death ligand1 and LC3B in GBM","Not yet recruiting","No Results Available","Glioblastoma Multiforme",,,"https://ClinicalTrials.gov/show/NCT04284306"
100,"Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM","Recruiting","No Results Available","Glioblastoma","Radiation: CCRT|Drug: Temozolomide|Drug: Siroquine","Taipei Veterans General Hospital, Taipei City, Taiwan|Tri-Service General Hospital, Taipei City, Taiwan","https://ClinicalTrials.gov/show/NCT03008148"
101,"Pembrolizumab +/- Bevacizumab for Recurrent GBM","Completed","Has Results","Glioblastoma","Drug: Pembrolizumab|Drug: Bevacizumab","University of California, Los Angeles, Los Angeles, California, United States|University of California, San Francisco, San Francisco, California, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Memorial Sloan-Kettering Cancer, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|UT, MD Anderson Cancer Center, Houston, Texas, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT02337491"
102,"URINARY VEGF Levels in GBM Patients on Radiation Treatment Protocol","Unknown status","No Results Available","Glioblastoma",,"tel Aviv Sourasky Medical Center, Tel Aviv, Israel","https://ClinicalTrials.gov/show/NCT00392548"
103,"BG & TMZ Therapy of Glioblastoma Multiforme","Active, not recruiting","No Results Available","Glioblastoma Multiforme","Biological: MGMTP140K-encoding retroviral vector|Drug: O6-benzylguanine|Drug: temozolomide|Other: laboratory biomarker analysis|Procedure: autologous hematopoietic stem cell transplantation|Procedure: in vitro-treated peripheral blood stem cell transplantation|Radiation: radiation therapy","University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT01269424"
104,"Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Multiforme","Drug: ABT-414|Drug: Temozolomide|Radiation: Whole Brain Radiation",,"https://ClinicalTrials.gov/show/NCT01800695"
105,"Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme","Completed","Has Results","Glioblastoma Multiforme","Drug: Bevacizumab|Drug: Temozolomide|Radiation: RT (Radiation Therapy)","University of Colorado Denver, University of Colorado Cancer Center, Aurora, Colorado, United States","https://ClinicalTrials.gov/show/NCT01209442"
106,"IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM","Recruiting","No Results Available","Recurrent Glioblastoma|Refractory Glioblastoma","Biological: IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells|Biological: Ipilimumab|Biological: Nivolumab|Other: Quality-of-Life Assessment|Other: Questionnaire Administration","City of Hope Medical Center, Duarte, California, United States","https://ClinicalTrials.gov/show/NCT04003649"
107,"Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)","Completed","No Results Available","Glioblastoma Multiforme","Drug: bevacizumab and Irinotecan and radiotherapy|Drug: Bevacizumab and Temozolomide and radiotherapy","Rigshospitalet, Copenhagen, Denmark|Odense Hospital, Odense, Denmark|Århus Hospital, Århus, Denmark","https://ClinicalTrials.gov/show/NCT00817284"
108,"A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent Glioblastoma Multiforme (GBM)","Unknown status","No Results Available","Glioblastoma|Astrocytoma, Grade IV","Drug: EGFR(V)-EDV-Dox","John Hopkins Hospital, Baltimore, Maryland, United States|Lenox Hill Hospital, Northwell Health, New York, New York, United States","https://ClinicalTrials.gov/show/NCT02766699"
109,"Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients","Unknown status","No Results Available","Glioblastoma","Drug: supra-early TEMODAL® chemotherapy|Drug: standard TEMODAL® chemotherapy|Radiation: Radiotherapy 60Gy","Beijing Tiantan Hospital, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT02520635"
110,"TRC105 for Recurrent Glioblastoma","Terminated","Has Results","Glioblastoma Multiforme","Drug: TRC105","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT01778530"
111,"Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma","Recruiting","No Results Available","Recurrent Glioblastoma","Diagnostic Test: ChemoID assay|Drug: Chemotherapy","Kaiser Permanente, Los Angeles, California, United States|Keck School of Medicine of the University of Southern California, Los Angeles, California, United States|Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States|Maine Medical Center Research Institute, Scarborough, Maine, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|University of Cincinnati Cancer Institute, Cincinnati, Ohio, United States|Toledo University, Toledo, Ohio, United States|Providence Cancer Center Oncology, Portland, Oregon, United States|St. Luke's University Health Network, Bethlehem, Pennsylvania, United States|The Penn State Univeristy College of Medicine, Hershey, Pennsylvania, United States|Thomas Jefferson University Hospitals, Philadelphia, Pennsylvania, United States|Allegheny Health Network, Pittsburgh, Pennsylvania, United States|Charleston Area Medical Center, Charleston, West Virginia, United States","https://ClinicalTrials.gov/show/NCT03632135"
112,"Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma","Completed","No Results Available","Glioblastoma","Biological: ALECSAT|Radiation: Radiotherapy|Drug: Temozolomide","Sahlgrenska University Hospital, Göteborg, Sweden|Ryhov hospital, Jönköping, Sweden|Skånes university hospital, Lund, Sweden|Karolinska University hospital, Stockholm, Sweden","https://ClinicalTrials.gov/show/NCT02799238"
113,"Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)","Completed","No Results Available","Glioblastoma Multiforme","Drug: AEE788","University of California at Los Angeles, Los Angeles, California, United States|University of California, San Francisco, San Francisco, California, United States|The Brain Tumor Center at Duke, Duke University Medical Center, Box 3624 DUMC, Trent Drive, Durham, North Carolina, United States|University of Texas, MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00116376"
114,"A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification","Active, not recruiting","No Results Available","Glioblastoma|Gliosarcoma","Drug: Temozolomide|Drug: ABT-414|Radiation: Radiation|Drug: Placebo for ABT-414","St. Josephs Hospital and Med Center /ID# 144149, Phoenix, Arizona, United States|Highlands Oncology Group /ID# 142050, Springdale, Arkansas, United States|Universtiy of Southern California /ID# 147543, Los Angeles, California, United States|University of California, Los Angeles /ID# 149239, Los Angeles, California, United States|Sharp Memorial Hospital /ID# 148193, San Diego, California, United States|Univ California, San Francisco /ID# 145889, San Francisco, California, United States|Duplicate_St. John's Health Center /ID# 148192, Santa Monica, California, United States|Cedars-Sinai Medical Center-West Hollywood /ID# 148472, West Hollywood, California, United States|Univ of Colorado Cancer Center /ID# 148194, Aurora, Colorado, United States|Associated Neurologists of Sou /ID# 147701, Fairfield, Connecticut, United States|Yale University /ID# 144170, New Haven, Connecticut, United States|Christiana Care Health Service /ID# 144127, Newark, Delaware, United States|Boca Raton Regional Hospital /ID# 163659, Boca Raton, Florida, United States|Holy Cross Hospital /ID# 156764, Fort Lauderdale, Florida, United States|Baptist Hospital Miami /ID# 152451, Miami, Florida, United States|Advent Health /ID# 144128, Orlando, Florida, United States|Moffitt Cancer Center /ID# 144130, Tampa, Florida, United States|Piedmont Hospital /ID# 145892, Atlanta, Georgia, United States|Winship Cancer Institute of Emory University /ID# 144015, Atlanta, Georgia, United States|Northwestern University Feinberg School of Medicine /ID# 147895, Chicago, Illinois, United States|The University of Chicago Medical Center /ID# 144158, Chicago, Illinois, United States|NorthShore University HealthSystem /ID# 144017, Evanston, Illinois, United States|Northwestern Medicine Cancer Center - Warrenville /ID# 148476, Warrenville, Illinois, United States|Parkview Research Ctr, Hosp /ID# 144150, Fort Wayne, Indiana, United States|Univ Kansas Cancer Ctr - Overl /ID# 145895, Westwood, Kansas, United States|Maine Medical Partners Neurolo /ID# 160864, Scarborough, Maine, United States|Tufts Medical Center /ID# 145897, Boston, Massachusetts, United States|Massachusetts General Hospital /ID# 144145, Boston, Massachusetts, United States|Dana-Farber Cancer Institute /ID# 148475, Boston, Massachusetts, United States|Wayne State University /ID# 145890, Detroit, Michigan, United States|Henry Ford Health System /ID# 145896, Detroit, Michigan, United States|Duplicate_St. Joseph Mercy Hospital /ID# 144143, Ypsilanti, Michigan, United States|Mmcorc /Id# 144146, Saint Louis Park, Minnesota, United States|Washington University-School of Medicine /ID# 144174, Saint Louis, Missouri, United States|Nebraska Methodist Hospital /ID# 144140, Omaha, Nebraska, United States|University of Nebraska Medical Center /ID# 145899, Omaha, Nebraska, United States|MD Anderson Cancer Center at Cooper - Camden /ID# 145891, Camden, New Jersey, United States|Rutgers Cancer Institute of New Jersey /ID# 148190, New Brunswick, New Jersey, United States|Columbia University Medical Center /ID# 144020, New York, New York, United States|Univ Rochester Med Ctr /ID# 144166, Rochester, New York, United States|Levine Cancer Ins, Carolina Me /ID# 144124, Charlotte, North Carolina, United States|University of Cincinnati /ID# 144164, Cincinnati, Ohio, United States|Duplicate_Univ Hosp Cleveland /ID# 144153, Cleveland, Ohio, United States|Cleveland Clinic Main Campus /ID# 144023, Cleveland, Ohio, United States|The Ohio State University /ID# 144016, Columbus, Ohio, United States|University of Toledo /ID# 156763, Toledo, Ohio, United States|Univ Oklahoma HSC /ID# 144161, Oklahoma City, Oklahoma, United States|St. Luke's Hospital /ID# 148191, Bethlehem, Pennsylvania, United States|Penn State University and Milton S. Hershey Medical Center /ID# 147525, Hershey, Pennsylvania, United States|University of Pennsylvania /ID# 157623, Philadelphia, Pennsylvania, United States|Thomas Jefferson University /ID# 144191, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center /ID# 145893, Philadelphia, Pennsylvania, United States|Allegheny General Hospital /ID# 144126, Pittsburgh, Pennsylvania, United States|University of Pennsylvania Medical Center - Shadyside /ID# 144159, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina /ID# 144141, Charleston, South Carolina, United States|Austin Cancer Centers /ID# 151061, Austin, Texas, United States|Baylor Sammons Cancer Center /ID# 155542, Dallas, Texas, United States|The University of Texas Health Science Center at Houston /ID# 144013, Houston, Texas, United States|University of Texas MD Anderson Cancer Center /ID# 144018, Houston, Texas, United States|Duplicate_Scott and White Medical Center /ID# 160743, Temple, Texas, United States|Intermountain Medical Center /ID# 144142, Murray, Utah, United States|University of Utah /ID# 144160, Salt Lake City, Utah, United States|Inova Health System /ID# 152956, Falls Church, Virginia, United States|Virginia Commonwealth University Medical Center Main Hospital /ID# 149014, Richmond, Virginia, United States|Virginia Mason Medical Center /ID# 144022, Seattle, Washington, United States|University of Washington /ID# 144162, Seattle, Washington, United States|Univ of Wisconsin Hosp/Clinics /ID# 144167, Madison, Wisconsin, United States|Froedtert Memorial Lutheran Hospital /ID# 144139, Milwaukee, Wisconsin, United States|Sanatorio Parque /ID# 142825, Rosario, Santa Fe, Argentina|Duplicate_Instituto Med Alex Flem /ID# 142884, Buenos Aires, Argentina|Liverpool Hospital /ID# 144392, Liverpool, New South Wales, Australia|Duplicate_The Prince of Wales Hospital /ID# 144882, Randwick, New South Wales, Australia|Royal North Shore Hospital /ID# 143870, St Leonards, New South Wales, Australia|Calvary Mater Newcastle /ID# 143860, Waratah, New South Wales, Australia|Southern Medical Day Care Centre /ID# 143868, Wollongong, New South Wales, Australia|Princess Alexandra Hospital /ID# 143857, Woolloongabba, Queensland, Australia|Royal Adelaide Hospital /ID# 143867, Adelaide, South Australia, Australia|Calvary North Adelaide Hospita /ID# 143866, Adelaide, South Australia, Australia|St Vincent's Hospital Melbourne /ID# 143858, Fitzroy Melbourne, Victoria, Australia|Duplicate_Austin Hospital /ID# 143859, Heidelberg, Victoria, Australia|St John Of God Subiaco Hospital /ID# 143869, Subiaco, Western Australia, Australia|Medizinische Universitaet Graz /ID# 141982, Graz, Steiermark, Austria|Medizinische Universitaet Wien /ID# 141981, Vienna, Wien, Austria|Duplicate_Medizinische Universitat Innsbruck,Universitatsklinik fur Innere Mediz /ID# 141984, Innsbruck, Austria|Kepler Universitätsklinikum GmbH - Neuromed Campus /ID# 141983, Linz, Austria|UCL Saint-Luc /ID# 141648, Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium|Grand Hôpital de Charleroi /ID# 141645, Charleroi, Hainaut, Belgium|UZ Gent /ID# 141647, Gent, Oost-Vlaanderen, Belgium|Universitair Ziekenhuis Leuven /ID# 143872, Leuven, Vlaams-Brabant, Belgium|Duplicate_Centre Hospitalier Jolimont /ID# 143873, La Louvière, Belgium|CHU de Liege /ID# 162860, Liege, Belgium|Duplicate_UCL Mont Godinne /ID# 141644, Yvoir, Belgium|Liga Norte Riograndense Contra o Câncer /ID# 143878, Natal, Rio Grande Do Norte, Brazil|Hospital Sao Lucas da PUCRS /ID# 143879, Porto Alegre, Rio Grande Do Sul, Brazil|Fundacao Pio XII - Hospital de Cancer de Barretos /ID# 143876, Barretos, Sao Paulo, Brazil|Instituto do Câncer do Estado de São Paulo - ICESP /ID# 144031, São Paulo, Sao Paulo, Brazil|Instituto Nacional de Câncer José de Alencar Gomes da Silva (INCA) /ID# 143877, Rio de Janeiro, Brazil|Duplicate_Cancer Care Manitoba /ID# 149253, Winnipeg, Manitoba, Canada|QE II Health Sciences Centre /ID# 151600, Halifax, Nova Scotia, Canada|Juravinski Cancer Centre /ID# 152117, Hamilton, Ontario, Canada|Victoria Hospital /ID# 144184, London, Ontario, Canada|Ottawa Hospital Research Institute /ID# 150120, Ottawa, Ontario, Canada|Princess Margaret Cancer Centre /ID# 166277, Toronto, Ontario, Canada|Duplicate_Hospital Maisonneuve-Rosemont /ID# 149315, Montreal, Quebec, Canada|Duplicate_Jewish General Hospital /ID# 144029, Montreal, Quebec, Canada|Royal Victoria Hospital / McGill University Health Centre /ID# 144187, Montreal, Quebec, Canada|CHUM - Notre-Dame Hospital /ID# 144027, Montréal, Quebec, Canada|CHU de Quebec-Universite Laval /ID# 144189, Quebec City, Quebec, Canada|CHUS - Hopital Fleurimont /ID# 149771, Sherbrooke, Quebec, Canada|Anhui Provincial Hospital /ID# 166320, Hefei, Anhui, China|SanboBrain Hospital Capital Medical University /ID# 166422, Beijing, Beijing, China|Peking Union Medical College Hospital /ID# 157430, Beijing, Beijing, China|Sun Yat-Sen University Cancer Center /ID# 143919, Guangzhou, Guangdong, China|Duplicate_Xiangya Hospital Central South University /ID# 166791, Changsha, Hunan, China|The First Affiliated Hospital of Soochow University /ID# 165596, Suzhou, Jiangsu, China|Duplicate_Tangdu Hospital /ID# 143920, Xi'an, Shaanxi, China|Duplicate_Huashan Hospital of Fudan University /ID# 159999, Shanghai, Shanghai, China|Duplicate_The Second Affiliated Hospital of ZUSM /ID# 165593, Hangzhou, Zhejiang, China|Beijing Tian Tan Hospital, Capital Medical University /ID# 167160, Beijing, China|The First Affiliated Hospital of Fujian Medical University /ID# 159166, Fuzhou, China|Duplicate_Shengjing Hospital of China Medical University /ID# 167016, Shenyang, China|Duplicate_Tianjin Med Univ General Hosp /ID# 143923, Tianjin, China|Tongji Hospital Tongji Medical College Huazhong University of Science and Techno /ID# 163820, Wuhan, China|Hospital Pablo Tobon Uribe /ID# 143780, Medellín, Antioquia, Colombia|Instituto Medico de Alta Tecnologia Oncomédica S.A /ID# 147223, Monteria, Cordoba, Colombia|Administradora del Country_S.A-Clinica Del Country /ID# 143881, Bogota, Cundinamarca, Colombia|Oncologos del Occidente S.A /ID# 147713, Pereira, Risaralda, Colombia|Centro Medico Imbanaco de Cali /ID# 143882, Cali, Colombia|Masarykuv onkologicky ustav /ID# 143884, Brno, Czechia|Duplicate_FN Hradec Kralove /ID# 143885, Hradec Kralove, Czechia|Krajska nemocnice Liberec, a.s. /ID# 142024, Liberec, Czechia|Duplicate_Univ Hosp Ostrava-Poruba /ID# 143883, Ostrava, Czechia|Fakultni Nemocnice v Motole /ID# 142023, Praha, Czechia|AP-HM - Hopital de la Timone /ID# 143911, Marseille CEDEX 05, Bouches-du-Rhone, France|CHRU Lille - Hopital Claude Huriez /ID# 143915, Lille, Hauts-de-France, France|Hopital Avicenne - APHP /ID# 143910, Bobigny, Ile-de-France, France|Duplicate_Gustave Roussy /ID# 143912, Villejuif Cedex, Ile-de-France, France|Institut de Cancérologie de l'Ouest René Gauducheau /ID# 143914, St Herblain CEDEX, Loire-Atlantique, France|CHU Nice -Hopital Pasteur /ID# 143916, Nice CEDEX 1, Provence-Alpes-Cote-d Azur, France|Insititut de Cancerologie /ID# 143908, Angers, France|Hopital Pitie Salpetriere /ID# 143917, Paris, France|Universitaetsklinik Heidelberg /ID# 143927, Heidelberg, Baden-Wuerttemberg, Germany|Universitaetsklinikum Tuebingen Medizinische Klinik /ID# 143926, Tubingen, Baden-Wuerttemberg, Germany|Universitaetsklinikum Leipzig /ID# 143962, Leipzig, Sachsen, Germany|Universitaetsklinikum Knappschaftskrankenhaus Bochum GmbH /ID# 143961, Bochum, Germany|Prince of Wales Hospital /ID# 143952, Hong Kong, Hong Kong|Beaumont Hospital /ID# 142969, Beaumont, Dublin, Ireland|The Chaim Sheba Medical Center /ID# 143960, Ramat Gan, Tel-Aviv, Israel|Tel Aviv Sourasky Medical Center /ID# 143956, Tel Aviv-Yafo, Tel-Aviv, Israel|Rambam Health Care Campus /ID# 143959, Haifa, Israel|Gastroenterology Institute, Division of Medicine /ID# 143958, Jerusalem, Israel|Rabin Medical Center /ID# 143957, Petakh Tikva, Israel|Duplicate_Duplicate_AOU Citta della Salute Scienza /ID# 141801, Turin, Piemonte, Italy|Fondazione IRCCS Istituto Neurologico Carlo Besta /ID# 141800, Milan, Italy|Istituto Oncologico Veneto /ID# 143821, Padova, Italy|Duplicate_Regina Elena National Cancer I /ID# 141795, Rome, Italy|National Cancer Center /ID# 141845, Goyang, Gyeonggido, Korea, Republic of|Duplicate_Yonsei University Health System, Severance hospital. /ID# 141846, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Seoul National University Hospital /ID# 143886, Seoul, Korea, Republic of|Samsung Medical Center /ID# 143887, Seoul, Korea, Republic of|The Catholic University of Korea, Seoul St. Mary's Hospital /ID# 141844, Seoul, Korea, Republic of|Centro Medico Zambrano Hellion /ID# 143845, San Pedro Garza Garcia, Nuevo Leon, Mexico|Vrije Universiteit Medisch Centrum /ID# 143889, Amsterdam, Netherlands|Haaglanden Medisch Centrum /ID# 141405, Den Haag, Netherlands|Universitair Medisch Centrum Groningen /ID# 141408, Groningen, Netherlands|Maastricht Universitair Medisch Centrum /ID# 143585, Maastricht, Netherlands|Universitair Medisch Centrum Utrecht /ID# 141406, Utrecht, Netherlands|Duplicate_Canterbury District Health Boa /ID# 143861, Christchurch, New Zealand|Duplicate_Wellington Hospital (Capital and Coast District Health Board) /ID# 143890, Wellington, New Zealand|CCA Braga - Hospital de Braga /ID# 141940, Braga, Portugal|Centro Hospitalar Universitário do Algarve, EPE - Hospital Faro /ID# 141939, Faro, Portugal|IPO Lisboa FG, EPE /ID# 141938, Lisboa, Portugal|Centro Hospitalar Universitário de Lisboa Norte, EPE - Hospital de Santa Maria /ID# 141941, Lisboa, Portugal|Centro Hospitalar Universitario de Sao Joao, EPE /ID# 142830, Porto, Portugal|Regional Clinical Hospital of Kaliningrad region /ID# 141702, Kaliningrad, Kaliningradskaya Oblast, Russian Federation|State budgetary healthcare institution Republican Clinical Oncology Dispensary /ID# 141706, Ufa, Kirovskaya Oblast, Russian Federation|GEMC - European Medical Center /ID# 141703, Moscow, Moskovskaya Oblast, Russian Federation|Federal State Budgetary Scientific Institution N.N. Blokhin /ID# 141707, Moscow, Moskva, Russian Federation|National Medical Research Center for Neurosurgery n.a. N. N. Burdenko /ID# 141701, Moscow, Moskva, Russian Federation|Federal State Treatment and Rehabilitation center /ID# 141704, Moscow, Moskva, Russian Federation|Sverdlovsk Regional Oncology Dispensary /ID# 141700, Yekaterinburg, Sverdlovskaya Oblast, Russian Federation|National University Hospital /ID# 143933, Singapore, Singapore|National Cancer Ctr Singapore /ID# 143932, Singapore, Singapore|University of Free State, Universitas Annex (National Hospital Grounds) /ID# 144064, Bloemfontein, Free State, South Africa|Netcare Unitas Hospital /ID# 152936, Centurion, Gauteng, South Africa|The Oncology Centre /ID# 143950, Durban, Kwazulu-Natal, South Africa|Netcare Oncology Intervent Ctr /ID# 143951, Cape Town, Western Cape, South Africa|Cape Town Oncology Trials /ID# 143948, Cape Town, Western Cape, South Africa|Rondebosch Oncology Center /ID# 143949, Cape Town, Western Cape, South Africa|Hospital Regional de Malaga /ID# 143902, Málaga, Malaga, Spain|Hospital Clinic de Barcelona /ID# 143906, Barcelona, Spain|Hospital Santa Creu i Sant Pau /ID# 143900, Barcelona, Spain|Hospital Clinico Universitario San Carlos /ID# 143901, Madrid, Spain|Hospital Universitario 12 de Octubre /ID# 143930, Madrid, Spain|Hospital Universitario HM Sanchinarro /ID# 143496, Madrid, Spain|Hospital General Universitario de Valencia /ID# 143903, Valencia, Spain|Kantonsspital Aarau AG /ID# 141885, Aarau, Aargau, Switzerland|Universitätsspital Zürich /ID# 141887, Zürich, Zuerich, Switzerland|Duplicate_EOC Ospedale Regionale di Bellinzona e Valli /ID# 143936, Bellinzona, Switzerland|Inselspital, Universitätsspital Bern /ID# 141886, Bern, Switzerland|National Taiwan University Hospital /ID# 143940, Taipei City, Taiwan|Taipei Veterans General Hosp /ID# 143955, Taipei City, Taiwan|Linkou Chang Gung Memorial Ho /ID# 143941, Taoyuan City, Taiwan|Guy's and St Thomas' NHS Foundation Trust /ID# 142652, London, London, City Of, United Kingdom|University Hospitals Birmingham NHS Foundation Trust /ID# 154592, Birmingham, United Kingdom|Velindre University NHS Trust /ID# 141996, Cardiff, United Kingdom|Duplicate_NHS Tayside /ID# 141651, Dundee, United Kingdom|NHS Lothian /ID# 141802, Edinburgh, United Kingdom|Leeds Teaching Hospitals NHS Trust /ID# 141653, Leeds, United Kingdom|University College London Hospitals NHS Foundation Trust /ID# 142658, London, United Kingdom|Duplicate_The Newcastle Upon Tyne Hospitals NHS Foundation Trust /ID# 141999, Newcastle Upon Tyne, United Kingdom|Duplicate_Royal Marsden Hospital /ID# 142827, Sutton, United Kingdom","https://ClinicalTrials.gov/show/NCT02573324"
115,"Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma|Brain Tumor|GBM","Drug: Pembrolizumab|Drug: Vorinostat|Drug: Temozolomide|Radiation: Radiotherapy","H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States","https://ClinicalTrials.gov/show/NCT03426891"
116,"A Dose Escalation Phase I Study Of Human- Recombinant Bone Morphogenetic Protein 4 Administrated Via CED In GBM Patients","Active, not recruiting","No Results Available","Glioblastoma","Drug: hrBMP4","Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|Istituto Neurologico Carlo Besta, Milano, Italy|VU University Medical Center, Amsterdam, Netherlands|Erasmus University Medical Center, Department of Neurosurgery, Rotterdam, Netherlands","https://ClinicalTrials.gov/show/NCT02869243"
117,"Impact of Bevacizumab on Symptom Burden and Neurological Deficits in Patients With Recurrent Glioblastoma","Completed","No Results Available","Glioblastoma|Angiogenesis","Other: Observation of neurological deficits","University Hospital Regensburg, Regensburg, Germany","https://ClinicalTrials.gov/show/NCT04974983"
118,"Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients","Recruiting","No Results Available","Glioblastoma Multiform|Recurrent Glioblastoma","Biological: NK cell therapy","Royan institute, Tehran, Iran, Islamic Republic of","https://ClinicalTrials.gov/show/NCT05108012"
119,"HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM","Recruiting","No Results Available","Glioblastoma Multiforme|Astrocytoma, Grade III","Drug: ADV/HSV-tk (gene therapy)","Houston Methodist Neurological Institute, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03596086"
120,"A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma","Unknown status","No Results Available","Glioblastoma","Drug: Temozolomide|Device: Optune",,"https://ClinicalTrials.gov/show/NCT03687034"
121,"Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan","Completed","Has Results","Glioblastoma|Gliosarcoma","Drug: Temo + Avastin|Drug: VP-16 + Avastin","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00613028"
122,"Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM","Completed","Has Results","Glioblastoma Multiforme","Drug: poly ICLC|Drug: temozolomide|Radiation: radiation therapy","Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa, Florida, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00262730"
123,"Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM","Recruiting","No Results Available","Glioblastoma","Radiation: Radiation Therapy|Biological: Personalized NeoAntigen Vaccine|Drug: Pembrolizumab|Drug: Temozolomide","Massachusetts General Hospital, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT02287428"
124,"A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma","Completed","Has Results","Glioblastoma","Drug: BBI608|Drug: Temozolomide","Laura and Isaac Perlmutter Cancer Center, New York, New York, United States|University of Calgary, Calgary, Alberta, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT02315534"
125,"Abemaciclib + Pembrolizumab In Glioblastoma","Withdrawn","No Results Available","Glioblastoma","Drug: Pembrolizumab|Drug: Abemaciclib","Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT04118036"
126,"Retrospective Evaluation of Melanocortin Receptor 4 Polymorphisms in Patients With GBM Treated With Radiochemotherapy","Completed","No Results Available","Glioblastoma",,"Division of Radiotherapy, Department Of Oncology, University Hospital of Pisa, Pisa, Italy","https://ClinicalTrials.gov/show/NCT02458508"
127,"Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma","Recruiting","No Results Available","Recurrent Glioblastoma","Drug: Personalized drug combination","Oslo University Hospital, Oslo, Norway","https://ClinicalTrials.gov/show/NCT05043701"
128,"Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)","Completed","No Results Available","Recurrent Glioblastoma Multiforme","Drug: Panzem NCD|Drug: Temozolomide","The Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00481455"
129,"Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM","Terminated","No Results Available","Recurrent Glioblastoma|Recurrent Gliosarcoma","Biological: EGFRvIII-CARs","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT03283631"
130,"Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM","Active, not recruiting","No Results Available","Glioblastoma Multiforme","Drug: Metformin","Montreal Neurological Institute - McGill University Health Centre, Montréal, Quebec, Canada","https://ClinicalTrials.gov/show/NCT02780024"
131,"A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma","Drug: fluzoparil|Drug: temozolomide",,"https://ClinicalTrials.gov/show/NCT04552977"
132,"Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM","Completed","Has Results","Recurrent Glioblastoma Multiforme","Drug: Sorafenib and Temozolomide","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00597493"
133,"INtraoperative photoDYnamic Therapy of GliOblastoma","Active, not recruiting","No Results Available","Glioblastoma","Device: ""perPDT""|Drug: GLIOLAN","Hôpital Roger Salengro, CHRU, Lille, France","https://ClinicalTrials.gov/show/NCT03048240"
134,"Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma","Drug: Onfekafusp alfa|Drug: Temozolomide",,"https://ClinicalTrials.gov/show/NCT04443010"
135,"Tamoxifen Versus Etoposide After First Recurrence in GBM Patients","Not yet recruiting","No Results Available","Glioblastoma Multiforme","Drug: Tamoxifen|Drug: Etoposide","Cross Cancer Institute, Edmonton, Alberta, Canada","https://ClinicalTrials.gov/show/NCT04765098"
136,"Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM)","Terminated","Has Results","Glioblastoma","Drug: Dasatinib|Drug: Lomustine","Local Institution, Paris Cedex, France|Local Institution, Bologna, Italy|Local Institution, Nijmegen, Netherlands|Local Institution, Rotterdam, Netherlands|Local Institution, Lausanne, Switzerland","https://ClinicalTrials.gov/show/NCT00948389"
137,"Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma","Terminated","Has Results","Glioblastoma","Radiation: Intensity Modulated Radiation Therapy|Drug: Temozolomide|Behavioral: Functional Assessment of Cancer Therapy-Brain (FACT-Br)|Radiation: Stereotactic Radiosurgery Boost|Radiation: Simultaneous Integrated Boost|Device: 3D MRSI","University of Miami, Miami, Florida, United States","https://ClinicalTrials.gov/show/NCT02394665"
138,"Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma","Drug: Pembrolizumab|Drug: Bevacizumab|Radiation: Re-irradiation","Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Columbia University / Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Hospital of the University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT03661723"
139,"RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM","Completed","Has Results","Glioblastoma Multiforme","Radiation: Radiation therapy|Drug: Temozolomide|Drug: Bevacizumab|Drug: Everolimus","Clearview Cancer Institute, Huntsville, Alabama, United States|Florida Cancer Specialists, Fort Myers, Florida, United States|Northeast Georgia Medical Center, Gainesville, Georgia, United States|Consultants in Blood Disorders and Cancer, Louisville, Kentucky, United States|Center for Cancer and Blood Disorders, Bethesda, Maryland, United States|Grand Rapids Clinical Oncology Program, Grand Rapids, Michigan, United States|St. Louis Cancer Care, Chesterfield, Missouri, United States|Research Medical Center, Kansas City, Missouri, United States|Methodist Cancer Center, Omaha, Nebraska, United States|South Carolina Oncology Associates, PA, Columbia, South Carolina, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, United States|Peninsula Cancer Institute, Newport News, Virginia, United States|Virginia Cancer Institute, Richmond, Virginia, United States","https://ClinicalTrials.gov/show/NCT00805961"
140,"INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)","Active, not recruiting","No Results Available","Glioblastoma","Drug: Temozolomide|Drug: Neratinib","University of Alabama at Birmingham, Birmingham, Alabama, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Mayo Clinic, Rochester, Minnesota, United States|Columbia University Medical Center, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Cleveland Clinic, Cleveland, Ohio, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Lifespan / Rhode Island Hospital, Providence, Rhode Island, United States|UT MD Anderson Cancer Center, Houston, Texas, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States|University of Virginia Health System, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT02977780"
141,"Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy","Terminated","No Results Available","Glioblastoma Multiforme","Drug: Neuradiab + Radiotherapy + Temozolomide|Drug: Radiation Therapy + Temozolomide",,"https://ClinicalTrials.gov/show/NCT00615186"
142,"Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Multiforme","Radiation: Radiotherapy","Fundacion Escuela de Medicina Nuclear, Mendoza, Argentina|N.N. Alexandrov National Cancer Centre of Belarus, Minsk, Belarus|Irmandade de Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Brazil|Hospital ""A.C. Camargo"", Fundacao ""Antonio Prudente"", Sao Paulo, Brazil|Wilson Roa Professional Corporation, Edmonton, Canada|Instituto de Radiomedicina (IRAM), Santiago, Chile|Regionaalhailga, Tallinn, Estonia|High Technology Medical Center, University Clinic, Tbilisi, Georgia|Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India|Cipto Magunkusumo General Hospital, University of Indonesia, Jakarta, Indonesia|ICORG The All Ireland Cooperative Oncology, Dublin, Ireland|Marie Curie- Sklodowska Institute of Oncology, Warsaw, Poland|Division of Therapeutic Radiology and Oncology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand|Institut National de Cancer Salah Aziz, Ministere de la Sante Publique, Tunis, Tunisia|Ege University Hospital, Izmir, Turkey","https://ClinicalTrials.gov/show/NCT01450449"
143,"Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma","Drug: Temozolomide|Drug: Bavituximab|Radiation: Radiation","Dana Farber Cancer Institute, Boston, Massachusetts, United States|Massachusetts general Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT03139916"
144,"TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma","Drug: TN-TC11G|Drug: Temozolomide Oral Product|Radiation: Radiotherapy","Institut Català d'Oncología L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain|Hospital Universitario Son Espases, Palma de Mallorca, Mallorca, Spain|Consorcio Hospitalario Provincial de Castellón, Castelló, Valencia, Spain|Hospital del Mar, Barcelona, Spain|Complejo Hospitalario Regional Virgen de las Nieves, Granada, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Regional Universitario de Malaga, Malaga, Spain|Hospital Clínico Universitario de Salamanca, Salamanca, Spain","https://ClinicalTrials.gov/show/NCT03529448"
145,"Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)","Terminated","Has Results","Glioblastoma Multiforme|Gliosarcoma","Drug: Gliadel|Radiation: Radiation Therapy|Drug: Avastin|Drug: Temodar","The Preston Robert Tisch Brain Tumor Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01186406"
146,"Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma","Completed","No Results Available","Glioblastoma","Drug: Temozolomide+Metformin|Drug: Temozolomide+Placebo","National Cancer Center Korea, Ilsan, Gyeonggi-Do, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-Do, Korea, Republic of|Ajou University Hospital, Suwon-si, Gyeonggi-Do, Korea, Republic of|Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-Do, Korea, Republic of|Incheon St. Mary's Hospital, Incheon, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Severance Hospital, Seoul, Korea, Republic of|Konkuk University Hospital, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Seoul St Mary's Hospital, Seoul, Korea, Republic of|Saint Vincent's Hospital, Korea, Suwon-si, Korea, Republic of","https://ClinicalTrials.gov/show/NCT03243851"
147,"Bosutinib in Adult Patients With Recurrent Glioblastoma","Completed","Has Results","Glioblastoma","Drug: bosutinib","Massachusetts General Hospital, Boston, Massachusetts, United States|Dana=Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01331291"
148,"Tumor Electric Fields Treatment System for Glioblastoma","Recruiting","No Results Available","Glioblastoma","Device: Tumor Electric Fields Treatment System","Xiangya Hospital Central South University, Changsha, Hunan, China","https://ClinicalTrials.gov/show/NCT04417933"
149,"Glioblastoma Response Prediction to Apatinib","Recruiting","No Results Available","Glioblastoma","Other: genetic characteristic","Capital Medical University Sanbo Brain Hospital, Beijing, China","https://ClinicalTrials.gov/show/NCT04814329"
150,"Glioma Modified Atkins-based Diet in Patients With Glioblastoma","Completed","No Results Available","Glioblastoma Multiforme","Other: Diet modification","The Johns Hopkins Hospital, Baltimore, Maryland, United States|Wake Forest School of Medicine, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT02286167"
151,"Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM","Terminated","No Results Available","Glioblastoma Multiforme","Drug: Temodar (Temozolomide)|Dietary Supplement: Hominex-2","U.T.M.D. Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00508456"
152,"A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)","Completed","No Results Available","Glioblastoma","Drug: VB-111 + bevacizumab|Drug: Bevacizumab","University of Alabama, Birmingham, Alabama, United States|Highlands Oncology Group, Rogers, Arizona, United States|University of California Irvine Medical Center, Irvine, California, United States|University of California Los Angeles, Los Angeles, California, United States|The Center for Cancer Prevention and Treatment, Orangevale, California, United States|Kaiser Permanente - Redwood City Medical Center, Redwood City, California, United States|University of California, San Diego, California, United States|University of California San Francisco, San Francisco, California, United States|Stanford University, Stanford, California, United States|Colorado Neurological Institute, Denver, Colorado, United States|The George Washington University Medical Faculty Associates, Washington, District of Columbia, United States|University of Florida Preston A. Wells, Jr. Center for Brain Tumor Therapy, Gainesville, Florida, United States|Orlando Health, Orlando, Florida, United States|Piedmont Physicians Neuro-Oncology, Atlanta, Georgia, United States|Northwestern University, Chicago, Illinois, United States|The University of Chicago, Chicago, Illinois, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|University of Kentucky, Lexington, Kentucky, United States|University of Louisville, Louisville, Kentucky, United States|Louisiana State University Health Science Center, Shreveport, Louisiana, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|Metro-MN Community Oncology Research Consortium, Minneapolis, Minnesota, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Dent Neurosciences Research Center, Amherst, New York, United States|North Shore University Hospital, Lake Success, New York, United States|Columbia University Medical Center, New York, New York, United States|Derald H. Ruttenberg Treatment Center, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Stony Brook University, Neurology Associates of Stony Brook, Stony Brook, New York, United States|SUNY Upstate Medical University, Syracuse, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Texas Oncology-Austin Midtown, Austin, Texas, United States|Baylor Health Neuro-Oncology Associates, Dallas, Texas, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|: University of Texas, HSC, Houston, Texas, United States|MD Anderson, Houston, Texas, United States|UTHSCSA, San Antonio, Texas, United States|Huntsman Cancer Institute at The University of Utah, Salt Lake City, Utah, United States|University of Virginia, Charlottesville, Virginia, United States|Swedish Medical Center, Seattle, Washington, United States|University of Wisconsin, Madison, Wisconsin, United States|Tom Baker Cancer Centre, Calgary, Alberta, Canada|London Health Sciences Centre, London, Ontario, Canada|Ottawa Hospital, Ottawa, Ontario, Canada|Sunnybrook Health Science Centre, Toronto, Ontario, Canada|Rambam Medical Center, Haifa, Israel|Hadassah Medical Center, Jerusalem, Israel|Rabin Medical Center, Petach Tikvah, Israel|Chaim Sheba Medical Center, Ramat Gan, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel","https://ClinicalTrials.gov/show/NCT02511405"
153,"Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma","Terminated","No Results Available","Adult Glioblastoma","Other: Laboratory Biomarker Analysis|Biological: Pembrolizumab|Radiation: Radiation Therapy|Drug: Temozolomide","Northwestern University, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT02530502"
154,"Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma","Drug: Gallium maltolate (500 mg)|Drug: Gallium maltolate (1,000 mg)|Drug: Gallium maltolate (1,500 mg)|Drug: Gallium maltolate (recommended phase 2 dose)",,"https://ClinicalTrials.gov/show/NCT04319276"
155,"A Dose Escalation Study to Estimate MTD, DLTs and Pharmacokinetics After a Single Intracranial Dose of SI-053 as an add-on to the Current Standard of Care, in Adult Patients With Newly Diagnosed GBM","Not yet recruiting","No Results Available","Newly Diagnosed Glioblastoma Multiforme","Drug: SI-053",,"https://ClinicalTrials.gov/show/NCT04967690"
156,"hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)","Not yet recruiting","No Results Available","Glioblastoma Multiforme|Glioblastoma Multiforme, Adult|Supratentorial Glioblastoma|Supratentorial Gliosarcoma","Biological: P140K-MGMT|Drug: O6-benzylguanine|Radiation: Photon Based Radiotherapy|Drug: temozolomide|Drug: Filgrastim|Drug: carmustine","NIH-Clinical Center, Bethesda, Maryland, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT05052957"
157,"Prognosis and Therapeutic Biomarkers for Glioblastoma Patients","Terminated","No Results Available","Glioblastoma","Device: Optune","Baylor Scott and White Medical Center, Temple, Texas, United States","https://ClinicalTrials.gov/show/NCT03403803"
158,"A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients","Completed","No Results Available","Glioblastoma Multiforme","Biological: ALECSAT cell based immunotherapy","Department of Neurosurgery, Rigshospitalet, Copenhagen, Denmark","https://ClinicalTrials.gov/show/NCT01588769"
159,"LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients","Recruiting","No Results Available","Glioblastoma|GBM|Glioma","Drug: Abemaciclib|Drug: LY3214996","Chandler Regional Medical Center, Chandler, Arizona, United States|St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|HonorHealth Scottsdale Osborn Medical Center, Scottsdale, Arizona, United States","https://ClinicalTrials.gov/show/NCT04391595"
160,"Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme","Terminated","No Results Available","Glioblastoma Multiforme|GBM|Brain Cancer","Biological: Autologous CMV-specific CTL","Texas Children's Hospital, Houston, Texas, United States|The Methodist Hospital, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01205334"
161,"A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme","Active, not recruiting","No Results Available","Glioblastoma|GBM|Glioblastoma Multiforme","Drug: Ascorbate|Drug: Temozolomide|Radiation: Radiation therapy","Holden Comprehensive Cancer Center at the University of Iowa, Iowa City, Iowa, United States","https://ClinicalTrials.gov/show/NCT01752491"
162,"A Dose-finding Study of Birabresib (MK-8628) in Participants With Recurrent Glioblastoma Multiforme (MK-8628-002)","Terminated","Has Results","Glioblastoma Multiforme","Drug: Birabresib",,"https://ClinicalTrials.gov/show/NCT02296476"
163,"BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma","Completed","No Results Available","Glioblastoma Multiforme|Glioblastoma|GBM","Drug: Nanoliposomal Irinotecan|Drug: Temozolomide","Rhode Island Hospital, Providence, Rhode Island, United States","https://ClinicalTrials.gov/show/NCT03119064"
164,"Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib","Unknown status","No Results Available","Recurrent Glioblastoma","Drug: Anlotinib","Shandong cancer hospital, Jinan, Shandong, China","https://ClinicalTrials.gov/show/NCT04004975"
165,"Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Multiforme","Drug: XL184","University of California, Los Angeles, Los Angeles, California, United States|University of California, San Francisco, San Francisco, California, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|Duke University, The Preston Robert Tisch Brain Tumor Center, Durham, North Carolina, United States|University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States|University of Virginia Health System, Charlottesville, Virginia, United States|University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00704288"
166,"Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression","Active, not recruiting","No Results Available","Glioma|Glioblastoma|Glioblastoma Multiforme|GBM|Brain Cancer","Drug: VAL-083 (Dianhydrogalactitol)","Sun Yat-Sen University Cancer Center, Guangzhou, China","https://ClinicalTrials.gov/show/NCT03050736"
167,"Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma","Terminated","No Results Available","Glioblastoma","Drug: Macitentan in combination with RT and TMZ","MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02254954"
168,"A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma","Completed","No Results Available","Glioblastoma","Drug: Bevacizumab|Drug: Lomustine|Drug: Placebo|Radiation: Radiotherapy|Drug: Temozolomide|Drug: SOC Agent","Medizinische Universität Graz; Universitätsklinik für Neurologie, Graz, Austria|Uniklinik fuer Neurologie, Medizinische Universitaet Innsbruck; Department fuer Neurologie, Innsbruck, Austria|Kepler Universitätsklinikum GmbH - Neuromed Campus; Innere Medizin mit Neuroonkologie, Linz, Austria|Lkh Salzburg - Univ. Klinikum Salzburg; Iii. Medizinische Abt., Salzburg, Austria|Medizinische Universität Wien; Univ.Klinik für Innere Medizin I - Abt. für Onkologie, Wien, Austria|Kaiser-Franz-Josef-Spital; Neurologische Abteilung, Wien, Austria|MBAL Serdika EOOD, Sofia, Bulgaria|Tom Baker Cancer Centre; Dept of Medicine, Calgary, Alberta, Canada|McGill University; Montreal Neurological Institute; Oncology, Montreal, Quebec, Canada|Clinical Hospital Centre Zagreb, Zagreb, Croatia|Tartu University Hospital; Clinic of Hematology and Oncology, Tartu, Estonia|HOPITAL JEAN MINJOZ; Oncologie, Besancon, France|Hopital Avicenne; Neurologie, Bobigny, France|Hopital Saint Andre; Département de Radiothérapie Et D'Oncologie Médicale, Bordeaux, France|Hopital neurologique Pierre Wertheimer - CHU Lyon; Neurologie, Bron, France|Hopital Cote De Nacre; Unite Neurologie Generale, Caen, France|Centre Georges Francois Leclerc; Oncologie 3, Dijon, France|Hopital Roger Salengro; Service de Neurologie, Lille, France|Hopital de La Timone - CHU de Marseille; Service de neuro-oncologie - Hôpital Adultes - 12ème étage, Marseille, France|Hôpital Central; Departement de Neuro-Oncologie, Nancy, France|Hopital Pitié Salpétrière - CHU; Service de neurologie 2 - Mazarin, Paris, France|Hopital Purpan, Toulouse Cedex 9, France|Agioi Anargyroi Anticancer Hospital; Radiotherapeutic Clinic, Kifisia, Greece|Hygeia Hospital, Marousi, Greece|Papageorgiou General Hospital; Medical Oncology, Thessaloniki, Greece|Ospedale Bellaria; U.O. Oncologia Medica, Bologna, Emilia-Romagna, Italy|IFO - Istituto Regina Elena; Oncologia Medica, Roma, Lazio, Italy|Fondazione IRCCS Istituto Neurologico C. Besta; Neuro-oncologia Sperimentale e Terapia Genica, Milano, Lombardia, Italy|Azienda Ospedaliera Le Molintte di Torino; Dipartimento Di Neurologia - Oncologia, Torino, Piemonte, Italy|IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Seconda, Padova, Veneto, Italy|Riga East Clinical University hospital, Clinic Gailezers, Dept of Neurosurgery, Riga, Latvia|IPO de Coimbra; Servico de Oncologia Medica, Coimbra, Portugal|Hospital de Santa Maria; Servico de Oncologia Medica, Lisboa, Portugal|Hospital de Sao Joao; Servico de Oncologia, Porto, Portugal|Institutul Oncologic Prof. Dr. Al. Trestioreanu Bucuresti, Bucuresti, Romania|Institut Oncologic Ion Chiricuta; Departament Radioterapie, Cluj-napoca, Romania|Spital Clinic Judetean Mures; Oncologie, Targu Mures, Romania|Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia, Badalona, Barcelona, Spain|Hospital Universitario Reina Sofia; Servicio de Oncologia, Córdoba, Cordoba, Spain|IInstituto Oncologico de San Sebastian, Oncologikoa; Servicio de Oncologia, San Sebastian, Guipuzcoa, Spain|Hospital Universitario Son Espases; Servicio de Oncologia, Palma De Mallorca, Islas Baleares, Spain|Hospital de Cruces; Servicio de Oncologia, Bilbao, Vizcaya, Spain|Hospital Universitario Infanta Cristina; Servicio de Oncologia, Badajoz, Spain|Hospital del Mar; Servicio de Oncologia, Barcelona, Spain|Hospital Duran i Reynals; Oncologia, Barcelona, Spain|Hospital Ramon y Cajal; Servicio de Oncologia, Madrid, Spain|Hosp. Clinico San Carlos, Madrid, Spain|Hospital Universitario 12 de Octubre; Servicio de Oncologia, Madrid, Spain|Hospital Universitario La Paz; Servicio de Oncologia, Madrid, Spain|HOSPITAL DE MADRID NORTE SANCHINARRO- CENTRO INTEGRAL ONCOLOGICO CLARA CAMPAL; Servicio de Oncologia, Madrid, Spain|Hospital Regional Universitario Carlos Haya; Servicio de Oncologia, Malaga, Spain|Hospital Clinico Universitario de Salamanca; Servicio de Oncologia, Salamanca, Spain|Universitetssjukhuset; Onkologkliniken, Linkoeping, Sweden|Norrlands Universitetssjukhus; Cancer Centrum, Umea, Sweden|Akademiska sjukhuset, Onkologkliniken, Uppsala, Sweden|Adana City Hospital, Medical Oncology, Adana, Turkey|Baskent Universitesi Tıp Fakultesi; Ic Hastalıkları Anabilim Dalı Tıbbi Onkoloji Bilim Dalı, Ankara, Turkey|Dokuz Eylul Uni ; Medical Oncology, Izmir, Turkey|Kocaeli University Faculty of Medicine; Medical oncology, Izmit, Turkey|Bristol Haematology and Oncology Centre, Bristol, United Kingdom|Addenbrookes Hospital; Dept of Oncology, Cambridge, United Kingdom|University College Hospital; Department of Oncology, London, United Kingdom|Christie Hospital Nhs Trust; Medical Oncology, Manchester, United Kingdom|Royal Marsden Hospital; Dept of Medical Oncology, Sutton, United Kingdom","https://ClinicalTrials.gov/show/NCT01860638"
169,"Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid","Recruiting","No Results Available","Glioblastoma","Other: Platelet level determination","Centre Henri Becquerel, Rouen, France","https://ClinicalTrials.gov/show/NCT02617745"
170,"Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform","Completed","Has Results","Glioblastoma","Drug: Temozolomide|Procedure: Radiotherapy|Drug: BIBW2992","Addenbrooke's Hospital, Cambridge, United Kingdom|Ninewells Hospital & Medical School, Dundee, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom|The Christie Hospital, Manchester, United Kingdom|The Royal Marsden Hospital, Sutton, United Kingdom","https://ClinicalTrials.gov/show/NCT00977431"
171,"Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma","Recruiting","No Results Available","Glioblastoma","Device: Radiation|Drug: Concurrent Chemotherapy (Temozolomide)|Drug: Adjuvant Chemotherapy (Temozolomide)","Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT04747145"
172,"Trial of Combination TTF(Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma","Terminated","No Results Available","Recurrent Glioblastoma","Drug: Nivolumab 240 mg IV|Drug: Nivolumab 3 mg/kg|Drug: Ipilimumab 1 mg/kg|Device: NovoTTF200A (Optune)","Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, United States","https://ClinicalTrials.gov/show/NCT03430791"
173,"A Phase 1 Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)","Recruiting","No Results Available","Glioblastoma Multiforme","Drug: ERAS-801","Sarah Cannon Research Institute (Tennessee Oncology), Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT05222802"
174,"Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma","Recruiting","No Results Available","Recurrent Glioblastoma|Refractory Glioblastoma","Drug: B7-H3 CAR-T|Drug: Temozolomide","the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China","https://ClinicalTrials.gov/show/NCT04385173"
175,"Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme","Completed","No Results Available","Adult Brain Glioblastoma|Glioblastoma Multiforme","Biological: SL-701; poly-ICLC (polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethyl cellulose)|Drug: Bevacizumab","University of Alabama, Birmingham, Alabama, United States|Barrow Neurological Institute, Phoenix, Arizona, United States|Center for Neurosciences, Tucson, Arizona, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|George Washington University, Washington, District of Columbia, United States|University of Florida, Gainesville, Florida, United States|Piedmont Cancer Institute, Atlanta, Georgia, United States|Northwestern University, Chicago, Illinois, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|Columbia University Medical Center, New York, New York, United States|Cleveland Clinic, Cleveland, Ohio, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Baylor Charles A Sammons Cancer Center, Dallas, Texas, United States|University of Virginia, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT02078648"
176,"Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma","Other: Biorepository","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT04657146"
177,"Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients","Completed","No Results Available","Glioblastoma","Drug: Temozolomide|Radiation: Radiation Therapy","CHRU Hautepierre, Strasbourg, Alsace, France|CHU de Bordeaux, Bordeaux, Aquitaine, France|CHU Cote de Nacre, Caen, Basse Normandie, France|Center Eugene Marquis, Rennes, Brittany, France|CHU La Salpetriere, Paris, Ile de France, France|CHRU de Lille, Lille, Nord Pas-de-Calais, France|CHU La Timone, Marseille, Paca, France|CHU de Poitiers, Poitiers, Poitou-Charentes, France|CHU de Grenoble, Grenoble, Rhone-Alpes, France|CHU de Lyon, Lyon, Rhone-Alpes, France","https://ClinicalTrials.gov/show/NCT01345370"
178,"Exercise in Patients With Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma","Behavioral: Exercise","Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT03390569"
179,"Study of Niacin in Glioblastoma","Recruiting","No Results Available","Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype","Drug: Niacin CRT","Tom Baker Cancer Centre, Calgary, Alberta, Canada","https://ClinicalTrials.gov/show/NCT04677049"
180,"FMISO PET Study of Glioblastoma","Completed","Has Results","Recurrent Glioblastoma","Device: FMISO PET|Device: MRI|Drug: Bevacizumab|Drug: CCNU","Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT02076152"
181,"Discerning Pseudoprogression vs True Tumor Growth in GBMs","Completed","No Results Available","Glioblastoma","Other: Study subjects",,"https://ClinicalTrials.gov/show/NCT02905643"
182,"PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation","Completed","Has Results","Glioblastoma Multiforme","Drug: PPX (CT2103)|Drug: Temozolomide","UCSD Cancer Center, La Jolla, California, United States|Maine Medical Center, Scarborough, Maine, United States|UMASS Medical Center Cancer Center, Worcester, Massachusetts, United States|SUNY Medical Center, Syracuse, New York, United States|PSU, Hershey, Pennsylvania, United States|Thomas Jefferson University Cancer Center, Philadelphia, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|UT Southwestern Cancer Center, Dallas, Texas, United States|University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT01402063"
183,"Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)","Completed","Has Results","Glioblastoma","Drug: Temozolomide|Radiation: Radiotherapy",,"https://ClinicalTrials.gov/show/NCT00686725"
184,"Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma","Terminated","No Results Available","Glioblastoma","Drug: Phase 1 Dose Escalation|Drug: Phase 1b|Drug: Ancillary Study","MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01499251"
185,"A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma","Completed","Has Results","Patients With Newly Diagnosed Glioblastoma","Drug: PLX3397|Radiation: Radiation Therapy|Drug: Temozolomide","Northwestern Memorial Hospital, Chicago, Illinois, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Columbia University Medical Center, New York, New York, United States|James Cancer Hospital/Ohio State University, Columbia, Ohio, United States|Huntsman Cancer Institute University of Utah, Salt Lake City, Utah, United States|Seattle Cancer Care Alliance, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT01790503"
186,"Pre-operative RT and TMZ in Patients With Newly Diagnosed GBM Diagnosed Glioblastoma. A Phase I Study. (PARADIGMA)","Withdrawn","No Results Available","Glioblastoma Multiforme, Adult","Drug: Temozolomide|Radiation: Pre-Operative Radiation","McGill University Health Centre-Cedars Cancer Centre, Montréal, Québec, Canada, Canada","https://ClinicalTrials.gov/show/NCT03480867"
187,"DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma","Recruiting","No Results Available","Glioblastoma|Glioblastoma, Adult","Drug: DNX-2440 injection","Clinica Universidad de Navarra, Pamplona, Navarra, Spain","https://ClinicalTrials.gov/show/NCT03714334"
188,"Radiomics for Prediction of Survival in GBM","Completed","No Results Available","Glioblastoma|Glioma|Astrocytoma",,"Maastricht Radiation Oncology (MAASTRO clinic), Maastricht, Limburg, Netherlands","https://ClinicalTrials.gov/show/NCT02666066"
189,"Mathematical Model-Adapted Radiation In Glioblastoma","Active, not recruiting","Has Results","Recurrent Glioblastoma","Radiation: Mathematical Model-Adapted Radiation Fractionation Schedule","Brigham and Women's Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT03557372"
190,"Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma","Completed","No Results Available","Glioblastoma Multiforme","Drug: G-202","University of California, San Diego Moores Cancer Center, La Jolla, California, United States","https://ClinicalTrials.gov/show/NCT02067156"
191,"Molecular Profiling in Guiding Individualized Treatment Plan in Adults With Recurrent/Progressive Glioblastoma","Completed","Has Results","Adult Glioblastoma","Other: specialized tumor board recommendation","University of California, San Francisco, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT02060890"
192,"Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse","Completed","No Results Available","Glioblastoma Multiforme","Drug: 131I-chTNT-1/B MAb (Cotara)","Barrow Neurological Institute, Phoenix, Arizona, United States|University of Pennsylvania, Department of Neurosurgery, Philadelphia, Pennsylvania, United States|Medical University of South Carolina, Charleston,, South Carolina, United States|Amrita Institute of Medical Sciences and Research Center,, Cochin, Kerala, India|Manipal Institute for Neurological Disorders,, Bangalore, India|Department of Neurosurgery Jaslok Hospital and Research Centre, Mumbai, India|All India Instutite of Medical Sciences, New Delhi, India","https://ClinicalTrials.gov/show/NCT00677716"
193,"APG101 in Glioblastoma","Completed","No Results Available","Glioblastoma Multiforme","Drug: APG101|Procedure: Blood drawing","Medizinische Universität Graz, Universitätsklinik für Neurologie Landeskrankenhaus Graz, Graz, Austria|Universitätsklinik für Neurologie, Landeskrankenhaus Innsbruck, Innsbruck, Austria|Landesnervenklinik Wagner-Jauregg, Innere Medizin mit Neuroonkologie, Linz, Austria|Allgemeines Krankenhaus der Stadt Wien, Klinische Onkologie, Wien, Austria|Charite Universitätsmedizin Berlin, Klinik für Neurochirugie, Berlin, Germany|Neurologische Universitätsklinik am Knappschaftskrankenhaus, Bochum, Germany|Neurologische Universitätsklinik Bonn, Schwerpunkt klinische Neuroonkologie, Bonn, Germany|Universitätsklinik Dresden, Klinik und Poliklinik für Neurochirurgie, Dresden, Germany|Klinikum Frankfurt/Oder, Klinik für Strahlentherapie/Radioonkologie, Frankfurt/Oder, Germany|Universitätsklinik Hamburg, Klinik für Neurochirugie, Hamburg, Germany|Universitätsklinik Heidelberg, Abteilung Neuroonkologie, Heidelberg, Germany|Universität Leipzig, Klinik für Strahlentherapie, Leipzig, Germany|Universitätsmedizin Mannheim, Klinik für Neurochirurgie, Mannheim, Germany|Philipps-Universität Marburg, Klinik für Neurologie, Marburg, Germany|LMU München, Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Campus Großhadern & Campus Innenstadt, München, Germany|Klinik und Poliklinik für Strahlentherapie/Radiologische Onkologie, Klinikum rechts der Isar, TU München, München, Germany|Städt. Kliniken München GmbH, Klinikum Bogenhausen, Abt. Neurochirurgie, München, Germany|Klinik und Poliklinik der Universität Regensburg, Im Bezirksklinikum, Regensburg, Germany|Klinikum Stuttgart, Neurozentrum Neurochirurgie, Stuttgart, Germany|Universitätsklinikum Tuebingen, Strahlenonkologie, Tuebingen, Germany|Uniklinik Ulm, Klinik für Strahlentherapie und Radioonkologie, Ulm, Germany","https://ClinicalTrials.gov/show/NCT01071837"
194,"Monocyte Antigen Carrier Cells for Newly Diagnosed GBM","Not yet recruiting","No Results Available","Glioblastoma|Glioma, Malignant","Biological: MT-201-GBM monocyte vaccine","The Preston Robert Tisch Brain Tumor Center at Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT04741984"
195,"Physical Training in Glioblastoma Patients During Cytotoxic Therapy","Recruiting","No Results Available","Glioblastoma","Other: Personal Training Program","Universitätsklinikum Münster, Münster, Nordrhein-Westfalen, Germany","https://ClinicalTrials.gov/show/NCT05015543"
196,"A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma","Completed","No Results Available","Glioblastoma","Drug: Temozolomide|Drug: Aprepitant|Drug: Minocycline|Drug: Disulfiram|Drug: Celecoxib|Drug: Sertraline|Drug: Captopril|Drug: Itraconazole|Drug: Ritonavir|Drug: Auranofin","University of Ulm School of Medicine, Ulm, Baden-Württemberg, Germany","https://ClinicalTrials.gov/show/NCT02770378"
197,"Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma","Recruiting","No Results Available","Glioblastoma","Radiation: SRT to the resection cavity","Dept. Radiation Oncology, Munich, Bavaria, Germany","https://ClinicalTrials.gov/show/NCT02715297"
198,"Improving Treatment of Glioblastoma: Distinguishing Progression From Pseudoprogression","Recruiting","No Results Available","Glioblastoma",,"Royal Sussex County Hospital, Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom|Velindre Cancer Centre, Velindre University NHS Trust, Cardiff, United Kingdom|Ninewells Hospital and Medical School, NHS Tayside, Dundee, United Kingdom|Hull Royal Infirmary, Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom|Leeds General Infirmary, The Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom|Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|King's College Hospital, King's College Hospital NHS Trust, London, United Kingdom|Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom|National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, United Kingdom|The Christie Hospital, The Christie NHS Foundation Trust, Manchester, United Kingdom|The Freeman Hospital, Newcastle upon Tyne hospitals NHS foundation trust, Newcastle Upon Tyne, United Kingdom|The Royal Marsden Hospital, Royal Marsden NHS Foundation Trust, Sutton, United Kingdom","https://ClinicalTrials.gov/show/NCT04359745"
199,"A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme","Completed","Has Results","Glioblastoma Multiforme","Drug: MEDI-575","Research Site, Tucson, Arizona, United States|Research Site, Los Angeles, California, United States|Research Site, Stanford, California, United States|Research Site, Chicago, Illinois, United States|Research Site, Boston, Massachusetts, United States|Research Site, Detroit, Michigan, United States|Research Site, New York, New York, United States|Research Site, Canton, Ohio, United States|Research Site, Pittsburgh, Pennsylvania, United States|Research Site, Nashville, Tennessee, United States|Research Site, San Antonio, Texas, United States|Research Site, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT01268566"
200,"IA Carboplatin + Radiotherapy in Relapsing GBM","Unknown status","No Results Available","Glioblastoma Multiforme|Relapse","Drug: IA Carbo+ Radiation","CHUS, Sherbrooke, Quebec, Canada","https://ClinicalTrials.gov/show/NCT03672721"
201,"Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme","Recruiting","No Results Available","Glioblastoma","Procedure: Standard surgery|Radiation: Intraoperative radiotherapy|Radiation: Radiochemotherapy|Drug: Temozolomide","Barrow Neurological Institute (SJHMC), Phoenix, Arizona, United States|Stritch School of Medicine Loyola University, Maywood, Illinois, United States|Long Island Jewish Medical Center, North Shore University Hospital, Lake Success, New York, United States|Lenox Hill Hospital, Hofstra Northwell School of Medicine, New York, New York, United States|West Virginia University, Morgantown, West Virginia, United States|Hospital Alemão Oswaldo Cruz, São Paulo, Brazil|Montreal Neurological Institute and Hospital, Montréal, Quebec, Canada|Klinikum Augsburg, Augsburg, Germany|Charité - Universitätsmedizin, Berlin, Germany|St. Georg, Leipzig, Germany|University Hospital Mannheim, Mannheim, Germany|Technical University of Munich (TUM), Department of Radiation Oncology, Munich, Germany|Klinikum Stuttgart, Stuttgart, Germany|Helios University Hospital Wuppertal, Wuppertal, Germany|Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of|Clinica Delgado-AUNA, Lima, Peru|Catalan Institute of Oncology (ICO), Barcelona, Spain|Hospital Reina Sofia, Córdoba, Spain|The London Clinic, London, United Kingdom","https://ClinicalTrials.gov/show/NCT02685605"
202,"IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Glioblastoma","Unknown status","No Results Available","Glioblastoma","Drug: 68Ga-BBN-IRDye800CW|Device: PET/NIRF|Procedure: PET/NIR fluorescent imaging-guided surgery","Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT02910804"
203,"Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme","Active, not recruiting","No Results Available","Glioblastoma|Glioblastoma Multiforme","Drug: Disulfiram|Dietary Supplement: Copper gluconate|Drug: Temozolomide","Aurora Health Care, Aurora St. Luke's Medical Center, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT03363659"
204,"Repurposing Chlorpromazine in the Treatment of Glioblastoma","Recruiting","No Results Available","Glioblastoma Multiforme|MGMT-Unmethylated Glioblastoma","Drug: Chlorpromazine Pill","Regina Elena Cancer Institute, Roma, Lazio, Italy|Carlo Besta Neurological Institute, Milano, Lombardia, Italy|Istituto Oncologico Veneto, Padova, Veneto, Italy","https://ClinicalTrials.gov/show/NCT04224441"
205,"A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma","Completed","Has Results","Glioblastoma","Drug: Bevacizumab 25 mg in 1 ml subcutaneously daily","Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University Winship Cancer Institutute, Atlanta, Georgia, United States","https://ClinicalTrials.gov/show/NCT02157103"
206,"Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea","Completed","No Results Available","Glioblastoma","Drug: Activated T lymphocyte(Immuncell-LC)","Hanyang University Guri Hospital, Guri, Gyeonggi-Do, Korea, Republic of|Gyunghee University Medical Center, Seoul, Korea, Republic of|Konkuk University, Seoul, Korea, Republic of|Korea University Anam Hospital, Seoul, Korea, Republic of|Samsung Seoul Medical Center, Seoul, Korea, Republic of|Seoul Asan Medical Center, Seoul, Korea, Republic of|Yeonsei University Medical Center, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT00807027"
207,"Amgen 386 for Recurrent Glioblastoma","Completed","Has Results","Glioblastoma Multiforme","Drug: Amgen 386|Drug: Bevacizumab","University of California Los Angeles, Los Angeles, California, United States|Massachusetts General Hosptial, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|University of Massachusetts, Worcester, Worcester, Massachusetts, United States|New York - Presbyterian/Columbia University Medical Center, New York, New York, United States|University of Virginia, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT01290263"
208,"Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study","Unknown status","No Results Available","Glioblastoma Multiforme","Other: ketogenic diet","MidAtlantic Epilepsy and Sleep Center, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT01865162"
209,"Combination of Stereotactic Radiosurgery and Enhanced Immunotherapy for Recurrent Glioblastomas(inSituVac2)(CSREIG)","Recruiting","No Results Available","Recurrent Glioblastoma","Combination Product: Combined stereotactic radiosurgery and enhanced immunotherapy","Beijing Tiantan Hospital, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT05131711"
210,"Epothilone in Recurrent Glioblastoma Patients","Completed","No Results Available","Glioblastoma","Drug: ZK 219477","Istituto Nazionale Neurologico, Milan, Italy","https://ClinicalTrials.gov/show/NCT00397072"
211,"uPAR-PET/MRI in Glioblastoma Multiforme","Unknown status","No Results Available","Glioblastoma Multiforme","Drug: One injection of 68Ga-NOTA-AE105|Device: PET/MRI","Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark","https://ClinicalTrials.gov/show/NCT02945826"
212,"AB154 Combined With AB122 for Recurrent Glioblastoma","Recruiting","No Results Available","Glioblastoma","Drug: AB122|Drug: AB154|Drug: Placebo","Yale University, New Haven, Connecticut, United States","https://ClinicalTrials.gov/show/NCT04656535"
213,"A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.","Not yet recruiting","No Results Available","Glioblastoma","Drug: [177Lu]Lu-DOTA-TATE|Drug: [68Ga]Ga-DOTA-TATE|Other: Temozolomide|Other: Radiotherapy",,"https://ClinicalTrials.gov/show/NCT05109728"
214,"Trial of Hypofractionated Radiation Therapy for Glioblastoma","Unknown status","No Results Available","Glioblastoma","Radiation: Hypofractionated radiation therapy|Radiation: Standard radiation therapy","Cross Cancer Institute, Edmonton, Alberta, Canada","https://ClinicalTrials.gov/show/NCT02206230"
215,"TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine","Recruiting","No Results Available","Glioblastoma Multiforme|Recurrent Glioblastoma","Combination Product: TTFields and SRS","The Franciszek Lukaszczyk Oncology Center, Bydgoszcz, Poland","https://ClinicalTrials.gov/show/NCT04671459"
216,"Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma","Terminated","No Results Available","Glioblastoma","Drug: Cetuximab|Drug: Cilengitide EMD 121974","Onze-Lieve-Vrouwziekenhuis, Aalst, Belgium|ZNA Middelheim, Antwerpen, Belgium|GHdC Charleroi, Charleroi, Belgium|ZOL Campus Sint-Jan, Genk, Belgium|UZ Gent, Gent, Belgium|UCL de Mont-Godinne, Yvoir, Belgium","https://ClinicalTrials.gov/show/NCT01044225"
217,"Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma","Drug: Capecitabine|Drug: Bevacizumab","Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT02669173"
218,"Carbon Ion Radiotherapy for Primary Glioblastoma","Completed","No Results Available","Primary Glioblastoma","Radiation: Carbon Ion Radiotherapy|Radiation: Proton Radiotherapy","University Hospital of Heidelberg, Department of Radiation Oncology, Heidelberg, Germany","https://ClinicalTrials.gov/show/NCT01165671"
219,"Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma","Recruiting","No Results Available","Glioblastoma","Drug: Gliolan|Device: Intraoperative PDT","Hôpital Erasme, Clinique Universitaire de Bruxelles, Brussels, Belgium|Hopital Roger Salengro, CHU Lille, Lille, France","https://ClinicalTrials.gov/show/NCT04391062"
220,"Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Glioblastoma","Drug: PF-04449913|Drug: Temozolomide Oral Capsule","Institut Catalá de Oncología Badalona/Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Clínic i Provincial de Barcelona, Barcelona, Spain|Institut Catalá de Oncología Girona/Hospital Universitari Dr. Josep Trueta, Girona, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Universitario Virgen del Rocio, Sevilla, Spain|Hospital Universitario y Politécnico La Fe, Valencia, Spain","https://ClinicalTrials.gov/show/NCT03466450"
221,"Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA","Completed","No Results Available","Glioblastoma Multiforme (GBM)|ANAPLASTIC ASTROCYTOMA (AOA)|GBM|Anaplastic Astrocytoma","Drug: Superselective Intraarterial Cerebral Infusion of Cetuximab","Lenox Hill Brain Tumor Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01238237"
222,"18F-PSMA PET/CT for Visualization of Glioblastoma Multiforme","Active, not recruiting","No Results Available","Glioblastoma Multiforme","Other: 18F-PSMA-1007 PET tracer","Radboud University Medical Center, Nijmegen, Gelderland, Netherlands","https://ClinicalTrials.gov/show/NCT04588454"
223,"Feasibility Study on LITT for Newly Diagnosed Glioblastoma","Terminated","No Results Available","Glioblastoma","Device: NeuroBlate System|Drug: Radiation therapy and temozolomide","Washington University, Saint Louis, Missouri, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02880410"
224,"Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)","Unknown status","No Results Available","Glioblastoma","Biological: Personalized cellular vaccine","Guangdong 999 Brain Hospital, Guangzhou, Guangdong, China","https://ClinicalTrials.gov/show/NCT02709616"
225,"Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma","Completed","No Results Available","Glioblastomas","Drug: Temozolomide|Drug: Bevacizumab|Radiation: Standard radiation therapy","Grupo Español de Investigacion en Neurooncologia, Madrid, Spain","https://ClinicalTrials.gov/show/NCT01102595"
226,"Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma","Recruiting","No Results Available","Glioblastoma Multiforme","Diagnostic Test: Amantadine Hydrochloride","CancerCare Manitoba, Winnipeg, Manitoba, Canada","https://ClinicalTrials.gov/show/NCT04530006"
227,"Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme","Terminated","No Results Available","Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV)","Drug: Chemotherapy with Temodar.|Radiation: Radiation therapy","Ummc Msgcc, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT01822275"
228,"Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma.","Not yet recruiting","No Results Available","Glioblastoma","Radiation: Radiotherapy","Shanghai Proton and Heavy Ion Center, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT04536649"
229,"Glioblastoma Radiotherapy Using IMRT or Proton Beams","Recruiting","No Results Available","Glioblastoma","Radiation: Proton irradiation|Radiation: Photon irradiation","Universitätsklinikum Heidelberg, Heidelberg, Germany|Universitätsklinikum Gießen und Marburg, Marburg, Germany|Klinikum Stuttgart, Stuttgart, Germany","https://ClinicalTrials.gov/show/NCT04752280"
230,"Efficiency of Vaccination With Lysate-loaded Dendritic Cells in Patients With Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Glioblastoma","Biological: Autologous, tumor lysate-loaded, mature dendritic cells (DC)|Drug: standard therapy","Klinik für Neurologie, Knappschaftskrankenhaus Bochum, Bochum, Northrhine Westphalia, Germany|Klinik für Neurochirurgie, Sana Kliniken Duisburg, Duisburg, Northrhine Westphalia, Germany|Neurochirurgische Klinik, Universitätsklinikum Düsseldorf, Düsseldorf, Northrhine Westphalia, Germany|Klinik für Allgemeine Neurologie, Universitätsklinikum Münster, Münster, Northrhine Westphalia, Germany|Helios Klinikum Krefeld, Klinik für Neurochirurgie, Krefeld, Germany","https://ClinicalTrials.gov/show/NCT03395587"
231,"Glioblastoma Targeted Treatment Option Maximization by WGS","Not yet recruiting","No Results Available","Glioblastoma","Diagnostic Test: whole genome sequencing",,"https://ClinicalTrials.gov/show/NCT05186064"
232,"TTFields In GErmany in Routine Clinical Care","Active, not recruiting","No Results Available","Glioblastoma","Device: TTFields","Clinical center Aschaffenburg-Alzenau, Aschaffenburg, Bavaria, Germany","https://ClinicalTrials.gov/show/NCT03258021"
233,"Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)","Unknown status","No Results Available","Glioblastoma","Biological: Personalized cellular vaccine","Guangdong 999 Brain Hospital, Guangzhou, Guangdong, China","https://ClinicalTrials.gov/show/NCT02808364"
234,"GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients","Completed","No Results Available","Glioblastoma","Drug: APVAC1 vaccine plus Poly-ICLC and GM-CSF|Drug: APVAC2 vaccine plus Poly-ICLC and GM-CSF","Rigshospitalet, The Finsen Centre, Department of Oncology, Copenhagen, Denmark|Neurologische Klinik & Nationales Centrum für Tumorerkrankungen Heidelberg, Heidelberg, Germany|Zentrum für Neurologie und Klinik für Neurochirurgie, Tübingen, Germany|Leiden University Medical Center, Department of Medical Oncology, Leiden, Netherlands|Vall d'Hebron University Hospital, Barcelona, Spain|Hôpitaux Universitaires de Genève, Geneva 14, Switzerland","https://ClinicalTrials.gov/show/NCT02149225"
235,"Chloroquine for Glioblastoma.","Active, not recruiting","No Results Available","Glioblastoma","Drug: Oral tablet|Drug: Placebo","Private clinics, Cairo, Egypt","https://ClinicalTrials.gov/show/NCT04772846"
236,"NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy","Recruiting","No Results Available","Glioblastoma","Other: Tumor samples from patients treated with TTFields at initial diagnosis.|Device: Tumor samples from patients treated with TTFields at tumor recurrence.","Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT03194971"
237,"Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme","Enrolling by invitation","No Results Available","Glioblastoma Multiforme of Brain|Glioblastoma Multiforme","Biological: Antigen-specific IgT cells","Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China|Department of Neurosurgery, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China","https://ClinicalTrials.gov/show/NCT03170141"
238,"Surgery for Recurrent Glioblastoma","Recruiting","No Results Available","Glioblastoma","Procedure: Surgery followed by adjuvant second-line therapy|Procedure: Second-line therapy alone","Universitätsklinikum Innsbruck, Innsbruck, Austria|Helios Klinikum Erfurt, Erfurt, Germany|Department of Neurosurgery, Universitätsklinikum Frankfurt, Frankfurt, Germany|Dep. of Neurosurgery, Universitätsklinikum Freiburg, Freiburg, Germany|Universitätsklinikum Gießen und Marburg, Giessen, Germany|Department of Neurosurgery, Universitätsklinikum Köln, Köln, Germany|Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany|Universitätsklinikum Münster, Münster, Germany|Department of Neurosurgery, Hospital of Larissa & General Hospital of Larissa, Larissa, Greece|Department of Neurosurgery, AHEPA University Hospital, Thessaloníki, Greece|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Milano, Italy|Department of Neurosurgery, Centro Hospitalar Universitário Lisboa Norte - Hospital de Santa Maria, Lisboa, Portugal|Department of Neurosurgery, Spitalul Clinic De Urgență ""Bagdasar-Arseni"", Bucharest, Romania|Kantonsspital Aarau, Aarau, Switzerland|Universitätsspital Basel, Basel, Switzerland|Dep. of Neurosurgery, Bern University Hospital, Bern, Switzerland|Dep. of Neurosurger, Hôpitaux Universitaires de Genève, Geneva, Switzerland|Dep. of Neurosurgery, Centre hospitalier universitaire vaudois, Lausanne, Switzerland|Ospedale Regionale di Lugano, Lugano, Switzerland|Kantonsspital Luzern, Luzern, Switzerland|Department of Neurosurgery, Kantonsspital St. Gallen, Saint Gallen, Switzerland|Dep. of Neurosurgery, University Hospital of Zurich, Zurich, Switzerland","https://ClinicalTrials.gov/show/NCT02394626"
239,"Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma:a Pilot Study","Unknown status","No Results Available","Glioblastoma Multiforme","Dietary Supplement: Ketogenic diet|Dietary Supplement: Standard diet","Beijing Tiantan Hospital, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT02939378"
240,"Spatial Analysis and Validation of Glioblastoma on 7 T MRI","Terminated","No Results Available","Glioblastoma","Device: 7 T MRI|Procedure: Biopsy","Maastricht Radiation Oncology (MAASTRO clinic), Maastricht, Limburg, Netherlands","https://ClinicalTrials.gov/show/NCT02062372"
241,"Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Glioblastoma","Drug: Anlotinib Hydrochloride|Drug: Placebo|Radiation: Radiation Therapy|Drug: Temozolomide","The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China|Beijing TianTan Hospital,Capital Medical University, Beijing, Beijing Province, China|The Sixth Madical Center of PLA General Hospital, Beijing, Beijing, China|The General Hospital of the People's Liberation Army (PLAGH), Beijing, Beijing, China|Chongqing University Cancer Hospital, Chongqing, Chongqing Province, China|Fujian Provincial Cancer Hospital, Fuzhou, Fujian, China|Lanzhou University Second Hospital, Lanzhou, Gansu, China|The First Hospital of Lanzhou University, Lanzhou, Gansu, China|Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China|Shenzhen People's Hospital, Shenzhen, Guangdong, China|The Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China|The affiliated hospital of xuzhou medical university, Xuzhou, Jiangsu, China|The First Affiliated Hospital of NanChang University, Nanchang, Jiangxi, China|Jiangxi Cancer Hospital, Nanchang, Jiangxi, China|Gansu Provincial Hospital, Gansu, Lanzhou Province, China|Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China|Fudan University shabghai cancer center, Shanghai, Shanghai, China|The Second Affiliated Hospital of PLA Air Force Medical University, Xian, Shanxi, China|West China Hospital，Sichuan University, Chengdu, Sichuan, China|Tianjin Medical University General Hospital, Tianjin, Tianjin, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China","https://ClinicalTrials.gov/show/NCT04959500"
242,"Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma","Completed","Has Results","Glioblastoma","Drug: 5-ALA|Drug: Gliadel wafers|Radiation: Radiotherapy as normal based on standard clinical protocols determined by the neuro-oncologist|Drug: Concomitant chemotherapy as normal based on standard clinical protocols determined by the neuro-oncologist|Drug: Adjuvant chemotherapy as normal based on standard clinical protocols determined by the neuro-oncologist","Addenbrooke's Hospital, Cambridge, England, United Kingdom|Royal Preston Hospital, Preston, Lancashire, United Kingdom|Ninewells Hospital, Dundee, United Kingdom|Southern General Hospital, Glasgow, United Kingdom|Hull Royal Infirmary, Hull, United Kingdom|Leeds General Infirmary, Leeds, United Kingdom|The Walton Centre, Liverpool, United Kingdom|King's College Hospital, London, United Kingdom|University College London Hospital/ National Hospital for Neurology and Neurosurgery, London, United Kingdom|Royal Hallamshire Hospital, Sheffield, United Kingdom","https://ClinicalTrials.gov/show/NCT01310868"
243,"Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Multiforme","Radiation: Radiochemotherapy","Dresden University of Technology, University Hospital Carl Gustav Carus, Department of Radiation Oncology; and DKTK partner site Dresden, Dresden, Saxony, Germany","https://ClinicalTrials.gov/show/NCT01873469"
244,"SCH-900105 in Recurrent Glioblastoma","Withdrawn","No Results Available","Glioblastoma","Drug: SCH 900105",,"https://ClinicalTrials.gov/show/NCT01189513"
245,"Immunological and Functional Characterization of Cellular Population CD45+ Infiltrating Human Glioblastoma","Completed","No Results Available","Glioblastoma","Other: no intervention","CHU Amiens-Picardie, Amiens, France","https://ClinicalTrials.gov/show/NCT03687099"
246,"Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma","Drug: Poly-ICLC|Device: Tumor Treating Fields|Biological: Peptides","Icahn School of Medicine at Mount Sinai, New York, New York, United States","https://ClinicalTrials.gov/show/NCT03223103"
247,"CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme","Unknown status","No Results Available","Glioblastoma Multiforme","Drug: CT-322|Drug: Temozolomide|Procedure: Radiation Therapy","University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|University of Chicago Medical Center, Chicago, Illinois, United States|University of Kentucky Hospital, Lexington, Kentucky, United States|Washington University Cancer Center, St. Louis, Missouri, United States|SUNY Upstate Medical University, Syracuse, New York, United States|Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00768911"
248,"Procarbazine and Lomustine in Recurrent Glioblastoma","Unknown status","No Results Available","Recurrent Glioblastoma Multiforme","Drug: lomustine and procarbazine","Ajou University Hospital, Wonchon-dong, Suwon, Korea, Republic of","https://ClinicalTrials.gov/show/NCT01737346"
249,"A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma","Terminated","Has Results","Recurrent Glioblastoma","Drug: PLX3397","University California, Los Angeles, Los Angeles, California, United States|University California, San Francisco, San Francisco, California, United States|Dana Faber Cancer Institute, Boston, Massachusetts, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|University of Texas, MD Anderson Cancer Center, Houston, Texas, United States|Huntsman Cancer Institute University of Utah, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT01349036"
250,"Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme","Terminated","No Results Available","Glioblastoma Multiforme","Drug: TLN-4601","Sloan-Kettering Institute for Cancer Research, New York, New York, United States|Duke University, Durham, North Carolina, United States|Ottawa Health Research Institute, Ottawa, Ontario, Canada|The Pencer Brain Tumor Center, Princess Margaret Hospital, Toronto, Ontario, Canada|Hôpital Notre-Dame du CHUM, Montreal, Quebec, Canada|Royal Victoria Hospital, Montreal, Quebec, Canada|Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada|L'Hotel-Dieu de Quebec, Quebec, Canada","https://ClinicalTrials.gov/show/NCT00730262"
251,"Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent Glioblastoma","Terminated","No Results Available","Glioblastoma","Drug: F-MISO|Other: Cerebral magnetic resonance imagery|Drug: Bevacizumab|Other: Clinical examination","UHToulouse, Toulouse, France","https://ClinicalTrials.gov/show/NCT02841332"
252,"Iodine-125 Brachytherapy Together With Chemotherapy in Patients With Newly Diagnosed Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma","Other: Iodine-125+Chemotherapy|Other: Surgical resection+Radiochemotherapy",,"https://ClinicalTrials.gov/show/NCT04856852"
253,"Early Diagnosis of Pseudoprogression Using 11C-Methionine PET-MRI After Concomitant Radiochemotherapy Treatment for Glioblastoma.","Recruiting","No Results Available","Glioblastoma","Other: 11C-Methionine PET-MRI","Hopices Civils de Lyon, Bron, France","https://ClinicalTrials.gov/show/NCT03739333"
254,"Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade","Completed","No Results Available","Glioblastoma","Drug: Nivolumab|Drug: BMS-986016","Emory University, Atlanta, Georgia, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT03493932"
255,"A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma","Recruiting","No Results Available","Glioblastoma Multiforme","Drug: Selinexor|Drug: Temozolomide (TMZ)|Drug: Lomustine (CCNU)|Radiation: Standard Fractionated Radiation therapy (RT)|Drug: Bevacizumab|Device: TTField|Drug: Carmustine","University of Alabama, Birmingham, Alabama, United States|University of Southern California (USC Norris Comprehensive Cancer Center and LAC+USC Medical Center), Los Angeles, California, United States|University of California, San Francisco, California, United States|Baptist Hospital of Miami Cancer Institute, 8900 North Kendall Drive, Miami, Florida, United States|Piedmont Healthcare, Atlanta, Georgia, United States|Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Hackensack Meridian Health, 92 Second Street, Hackensack, New Jersey, United States|Atlantic Health Systems Hospital Corp., Morristown, New Jersey, United States|Northwell Health, Lake Success, New York, United States|Columbia University Irving Medical Center, New York, New York, United States|Lenox Hill Hospital-Northwell Health, New York, New York, United States|Cleveland Clinic, Cleveland, Ohio, United States|MD Anderson Cancer Center, Houston, Texas, United States|University of Utah - Huntsman Cancer Institute, Salt Lake City, Utah, United States|University of Washington - Alvord Brain Tumor Center, Seattle, Washington, United States|Princess Margaret Hospital (PMH), Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT04421378"
256,"Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas","Recruiting","No Results Available","Adult Glioblastoma","Device: 3 Tesla magnetic resonance imaging|Device: Chemical exchange saturation transfer MRI|Device: Diffusion weighted MRI|Device: Dynamic susceptibility contrast MRI","Asan Medical Center, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT02613988"
257,"Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma","Recruiting","No Results Available","Recurrent Glioblastoma","Biological: Camrelizumab plus GSC-DCV|Biological: Camrelizumab plus Placebo","Huashan Hospital, Fudan University, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT04888611"
258,"V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer","Unknown status","No Results Available","Glioblastoma Multiforme|Glioma of Brain","Biological: V-Boost","Immunitor LLC, Ulaanbaatar, Mongolia","https://ClinicalTrials.gov/show/NCT03916757"
259,"Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients","Completed","No Results Available","Glioblastoma","Drug: Sunitinib|Radiation: Radiation","Grupo Español de Investigacion en Neurooncologia, Madrid, Spain","https://ClinicalTrials.gov/show/NCT01100177"
260,"Ketogenic Diet for Recurrent Glioblastoma","Completed","Has Results","Recurrent Glioblastoma","Dietary Supplement: TAVARLIN","Senckenberg Institute of Neurooncology, Frankfurt, Germany|Department of General Neurology and Hertie-Institute of Clinical Brain Research, University of Tuebingen, Tuebingen, Germany","https://ClinicalTrials.gov/show/NCT00575146"
261,"Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients","Recruiting","No Results Available","Glioblastoma","Drug: Olaptesed pegol|Radiation: Radiotherapy|Drug: Bevacizumab|Drug: Pembrolizumab","Klinik und Poliklinik für Neurologie Schwerpunkt Klinische Neuroonkologie, Bonn, Germany|Klinik für Neurologie, Essen, Germany|Klinik für Strahlentherapie und Radioonkologie, Leipzig, Germany|Klinik für Strahlentherapie und Radioonkologie, Mannheim, Germany|Klinik für Neurologie mit Institut für Translationale Neurologie, Münster, Germany|Abteilung Neurologie mit interdisziplinärem Schwerpunkt Neuroonkologie, Tübingen, Germany","https://ClinicalTrials.gov/show/NCT04121455"
262,"Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients","Completed","No Results Available","Glioblastoma Multiforme|Healthy Volunteers","Other: GBM Patients|Other: Normal Controls","University of Florida, Gainesville, Florida, United States","https://ClinicalTrials.gov/show/NCT01135875"
263,"A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma","Completed","No Results Available","Glioblastoma","Drug: BKM120 + temozolomide|Drug: BKM120 +temozolomide with/without radiotherapy","Highlands Oncology Group Highlands Oncology, Fayetteville, Arkansas, United States|Dana Farber Cancer Institute SC (1), Boston, Massachusetts, United States|University of Texas/MD Anderson Cancer Center MD Anderson DeGrout, Houston, Texas, United States|Novartis Investigative Site, Melbourne, Victoria, Australia|Novartis Investigative Site, Hamilton, Ontario, Canada|Novartis Investigative Site, Toronto, Ontario, Canada|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, Madrid, Spain","https://ClinicalTrials.gov/show/NCT01473901"
264,"Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection","Completed","No Results Available","Glioblastoma Multiforme","Biological: autologous dendritic cells","Clínica Universidad de Navarra, Pamplona, Spain","https://ClinicalTrials.gov/show/NCT01006044"
265,"A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme","Recruiting","No Results Available","Glioblastoma Multiforme, Adult","Drug: Berubicin|Drug: Lomustine","Barrow Neurological Institute, Phoenix, Arizona, United States|Mayo Clinic, Phoenix, Arizona, United States|Southern California Permanente Medical Group, Los Angeles, California, United States|University of California Irvine, Orange, California, United States|University of Califonia San Diego Moores Cancer Center, San Diego, California, United States|University of California San Francisco, San Francisco, California, United States|Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, California, United States|HCA Healthcare Research Institute, Englewood, Colorado, United States|Mayo Clinic Florida, Jacksonville, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|Piedmont Healthcare, Atlanta, Georgia, United States|Rush University Cancer Center, Chicago, Illinois, United States|University of Kentucky, Lexington, Kentucky, United States|Tulane Cancer Center Clinic, New Orleans, Louisiana, United States|Tufts Medical Center, Boston, Massachusetts, United States|University of Minnesota, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Saint Luke's Cancer Institute, Kansas City, Missouri, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Hackensack Meridian Health, Hackensack, New Jersey, United States|Rutgers University, Piscataway, New Jersey, United States|Atlantic Healthcare, Summit, New Jersey, United States|Roswell Park Cancer Center, Buffalo, New York, United States|Weill Cornell, New York, New York, United States|Duke University School of Medicine, Durham, North Carolina, United States|Ohio State University, Columbus, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Austin Cancer Center, Austin, Texas, United States|Texas Oncology PA, Austin, Texas, United States|Baylor Research Institute, Dallas, Texas, United States|University of Texas Health Science Center, Houston, Texas, United States|Huntsman Cancer Center, Salt Lake City, Utah, United States|Swedish Medical Center, Seattle, Washington, United States|Hopital Pierre Wertheimer, Lyon, France|Hopital de La Timone, Marseille, France|Institut de Recherche en Cancerologie de Montpellier, Montpellier, France|Hopital Pitie-Salpetriere, Paris, France|Hopital Saint-Louis, Paris, France|Institut de Cancerologie de l'Ouest, Saint-Herblain, France|nstitut Universitaire du Cancer de Toulouse-, Toulouse, France|Institut de Cancerologie Gustave-Roussy, Villejuif, France|Hospital Universitari Germans Trias i Pujol, Badalona, Spain|Hospital Ramón y Cajal, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario Virgen Macarena, Sevilla, Spain|Kantonsspital Graubünden, Chur, Switzerland|University Hospital Zurich, Zürich, Switzerland","https://ClinicalTrials.gov/show/NCT04762069"
266,"Supramarginal Resection in Glioblastoma","Recruiting","No Results Available","Glioblastoma","Procedure: Supramarginal resection|Procedure: Conventional surgery","Medical University of Vienna, Vienna, Austria|Odense University Hospital, Odense, Denmark|Helsinki University Hospital, Helsinki, Finland|Kuopio University Hospital, Kuopio, Finland|Oulu University Hospital, Oulu, Finland|Tampere University Hospital, Tampere, Finland|Turku University Hospital, Turku, Finland|Haukeland University Hospital, Bergen, Norway|Oslo University Hospital, Rikshospitalet, Oslo, Norway|Ullevål University Hospital, Oslo, Norway|University Hospital North Norway, Tromsø, Norway|St Olavs Hospital, Trondheim, Norway|Sahlgrenska University Hospital,, Göteborg, Sweden|Linköping University Hospital, Linköping, Sweden|Skåne University Hospital, Lund, Sweden|Karolinska University Hospital, Stockholm, Sweden|University Hospital of Umeå, Umeå, Sweden|Uppsala University Hospital, Uppsala, Sweden","https://ClinicalTrials.gov/show/NCT04243005"
267,"Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma","Drug: Anlotinib Hydrochloride|Radiation: Radiation therapy|Drug: Temozolomide","Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin, Guangxi, China|Liuzhou Worker's Hospital, Liuzhou, Guangxi, China|Liuzhou People's Hospital, Liuzhou, Guangxi, China|Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China|Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi, China|People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China|Yulin First Hospital, Yulin, Guangxi, China","https://ClinicalTrials.gov/show/NCT04157478"
268,"A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)","Completed","No Results Available","Glioblastoma","Drug: bevacizumab|Drug: irinotecan",,"https://ClinicalTrials.gov/show/NCT00345163"
269,"89Zr-RO5323441 PET Imaging in Glioblastoma","Withdrawn","No Results Available","Glioblastoma","Radiation: Molecular imaging with 89Zr-RO5323441","University Medical Center Groningen, Groningen, Netherlands","https://ClinicalTrials.gov/show/NCT01622764"
270,"Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma Multiforme","Recruiting","No Results Available","Glioblastoma Multiforme","Other: Standard Treatment Plus Metabolic Therapy Program","Waikato Hospital, Hamilton, Waikato, New Zealand","https://ClinicalTrials.gov/show/NCT04730869"
271,"A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Glioblastoma","Drug: CC-90010|Drug: Temozolomide|Radiation: Radiotherapy","Aalborg Universitets hospital, Aalborg, Denmark|Rigshospitalet University Hospital, Copenhagen, Denmark|Odense University, Region South, Odense, Denmark|Ospedale San Raffaele, Milano, Italy|Istituto Clinico Humanitas, Milan, Italy|Istituto Oncologico Veneto, Padova, Italy|Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy|The Netherlands Cancer Instiute Antoni Van Leeuwenhoekziekenhuis, Amsterdam, Netherlands|Leids Universitair Medisch Centrum, Leiden, Netherlands|Erasmus Universitair Medisch Centrum, Rotterdam, Netherlands|University Medical Center Utrecht, Utrecht, Netherlands|Oslo University Hospital, Rikshospitalet HF, Oslo, Norway|Hospital del Mar, Barcelona, Spain|Hospital Val d´Hebron, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Durán i Reynals - Instituto Catalàn de Oncologìa ICO, Hospitalet de Llobregat, Barcelona, Spain|Hospital Ramon y Cajal, Madrid, Spain|Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain|Hospital Doce de Octubre, Madrid, Spain|Hospital Virgen del Rocio, Sevilla, Spain|Hospital Universitario La Fe, Valencia, Spain|Sahlgrenska University Hospital, Goteborg, Sweden|Skanes Universitetssjukhus - Lund - Onkologiska Klinik, Lund, Sweden|Karolinska University Hospital Huddinge, Solna, Sweden|Uppsala University, Uppsala, Sweden","https://ClinicalTrials.gov/show/NCT04324840"
272,"Sacituzumab Govitecan in Recurrent Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma","Drug: Sacituzumab Govitecan","Dana Farber Cancer Institute, Boston, Massachusetts, United States|Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas, United States|University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT04559230"
273,"Preoperative Chemoradiation for Glioblastoma","Completed","No Results Available","Glioblastoma","Drug: Temozolomide|Radiation: partial brain irradiation|Procedure: stereotactic biopsy of brain tumor|Procedure: craniotomy and tumor resection","Tampa General Hospital, Tampa, Florida, United States","https://ClinicalTrials.gov/show/NCT02092038"
274,"A Phase III Study of Re-Irradiation in Recurrent Glioblastoma","Withdrawn","No Results Available","Recurrent Glioblastoma","Drug: TMZ plus concurrent re-irradiation|Drug: Temozolomide","Cross Cancer Institute, Edmonton, Alberta, Canada","https://ClinicalTrials.gov/show/NCT01830101"
275,"Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma","Completed","No Results Available","Glioblastoma","Drug: Sirolimus|Drug: Vandetanib","Massachusetts General Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Instiute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00821080"
276,"Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma","Completed","No Results Available","Glioblastoma","Drug: CpG-ODN","Hopital Salpetriere, Paris, France|Hopital Lariboisiere, Paris, France","https://ClinicalTrials.gov/show/NCT00190424"
277,"EAP for the Treatment of Glioblastoma With PVSRIPO","Available","No Results Available","Glioblastoma","Biological: PVSRIPO","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT04599647"
278,"Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Glioblastoma","Drug: Camrelizumab|Radiation: radiation|Drug: Temozolomide","Peking Union Medical College Hospital, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT04583020"
279,"A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma","Drug: Ipilimumab",,"https://ClinicalTrials.gov/show/NCT05074992"
280,"Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma","Recruiting","No Results Available","Glioblastoma","Radiation: Re-irradiation (RT)|Drug: Bevacizumab|Drug: Nivolumab|Procedure: Re-resection","Hartford Healthcare (Data Collection), Hartford, Connecticut, United States|Miami Cancer Institute Baptist Health South Florida (Data Collection Only), Miami, Florida, United States|Indiana University (Data Collection Only), Indianapolis, Indiana, United States|Memoral Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States|Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States|Memorial Sloan Kettering Commack, Commack, New York, United States|Memorial Sloan Kettering Westchester, Harrison, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Memorial Sloan Kettering Nassau, Uniondale, New York, United States|Lehigh Valley Health Network (Data Collection Only), Allentown, Pennsylvania, United States|University of Vermont Medical Center (Data Collection Only), Burlington, Vermont, United States","https://ClinicalTrials.gov/show/NCT03743662"
281,"Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.","Completed","No Results Available","Glioblastoma Multiforme","Drug: H-1PV","Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany","https://ClinicalTrials.gov/show/NCT01301430"
282,"Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom","Recruiting","No Results Available","Glioblastoma","Device: Point-of-care Portable Perfusion Phantom (P4)","University of Alabama at Birmingham, Birmingham, Alabama, United States","https://ClinicalTrials.gov/show/NCT05140902"
283,"Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma","Terminated","Has Results","Glioblastoma","Drug: cediranib maleate|Drug: gefitinib|Drug: Placebo","University College Hospital, London, England, United Kingdom|Queen Elizabeth Hospital, Birmingham, United Kingdom|Bristol Haematology and Oncology Centre, Bristol, United Kingdom|Addenbrooke's Hospital, Cambridge, United Kingdom|Royal Surrey County Hospital, Guildford, United Kingdom|Castle Hill Hospital, Hull, United Kingdom|Charing Cross Hospital, London, United Kingdom|The Christie NHS Foundation Trust, Manchester, United Kingdom|Southampton General Hospital, Southampton, United Kingdom|Royal Marsden Hospital, Sutton, United Kingdom","https://ClinicalTrials.gov/show/NCT01310855"
284,"A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy","Active, not recruiting","No Results Available","Glioblastoma","Drug: DSP-7888 Dosing Emulsion|Drug: Bevacizumab","University of Alabama at Birmingham, Birmingham, Alabama, United States|Center for Neurosciences, Tucson, Arizona, United States|Highlands Oncology Group, Fayetteville, Arkansas, United States|UCSD- Moores Cancer Center, La Jolla, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|Neuro-Oncology/ US Irvine Medical Center, Orange, California, United States|Sansum Clinic, Santa Barbara, California, United States|John Wayne Cancer Institute, Santa Monica, California, United States|Rocky Mountain Cancer Center, Denver, Colorado, United States|Piedmont brain tumor center, Atlanta, Georgia, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Kentucky / Department of Internal Medicine / Markey Cancer Center, Lexington, Kentucky, United States|Norton Cancer Institute, Louisville, Kentucky, United States|Tufts Medical Center, Boston, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|Abbott Northwestern Hospital, Minneapolis, Minnesota, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Dent Neurosciences Research Center, Amherst, New York, United States|Weill Cornell Medicine, New York, New York, United States|Columbia University Medical Center/ Neurological Institute of NY, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|University Hospitals of Cleveland, Cleveland, Ohio, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|University of Toledo, Toledo, Ohio, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|University OF Tennessee Academic Medical Center Cancer Institute, Knoxville, Tennessee, United States|Texas Oncology Austin Midtown, Austin, Texas, United States|Baylor Scott and White, Dallas, Texas, United States|Houston Methodist, Houston, Texas, United States|Mischer Neuroscience Associates/Memorial Hermann Hospital, Houston, Texas, United States|Renovatio Clinical, The Woodlands, Texas, United States|Virginia Cancer Specialists, PC, Fairfax, Virginia, United States|Swedish Medical Center, Seattle, Washington, United States|University of Wisconsin Hospital, Madison, Wisconsin, United States|CancerCare Manitoba, Winnipeg, Manitoba, Canada|Montreal Neurological Institute and Hospital, Montreal, Quebec, Canada|University of Sherbrooke, Sherbrooke, Quebec, Canada|Hokkaido University Hospital, Sapporo, Hokkaido, Japan|Kagoshima University Hospital, Kagoshima-shi, Kagoshima, Japan|Niigata University Medical and Dental Hospital, Chuo Ku, Niigata, Japan|Osaka International Cancer Institute, Otemae Chuo-ku, Osaka, Japan|The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan|National Cancer Center Hospital, Chuo-ku, Tokyo, Japan|Hiroshima University Hospital, Hiroshima, Japan|Kumamoto University Hospital, Kumamoto, Japan|University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan|National Hospital Organization Kyoto Medical Center, Kyoto, Japan|Tokyo Women's Medical University Hospital, Shinjuku-Ku, Japan|Yamagata University Hospital, Yamagata, Japan|Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of|Gangnam Severance Hospital, Gangnam-gu, Seoul, Korea, Republic of|Samsung Medical Center, Gangnam-gu, Seoul, Korea, Republic of|Seoul National University Hospital, Jongno-gu, Seoul, Korea, Republic of|The Catholic University of Korea, Seoul St. Mary's Hospital, Seocho-gu, Seoul, Korea, Republic of|Severance Hospital, Seodaemun-gu, Seoul, Korea, Republic of|China Medical University Hospital, Yude Road, Taichung, Taiwan|National Taiwan University Hospital, Chung-Shan South Road, Taipei, Taiwan|Chang Gung Memorial Hospital, Taoyuan City, Taiwan","https://ClinicalTrials.gov/show/NCT03149003"
285,"Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma","Drug: Paxalisib|Drug: Metformin|Other: Ketogenic Diet","Weill Cornell Medicine, New York, New York, United States","https://ClinicalTrials.gov/show/NCT05183204"
286,"A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.","Unknown status","No Results Available","Glioblastoma","Procedure: FDG-PET",,"https://ClinicalTrials.gov/show/NCT01083719"
287,"Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM","Completed","No Results Available","Glioblastoma|Gliosarcoma","Drug: Temodar and O6-Benzylguanine","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00612989"
288,"Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma","Radiation: gamma knife radiosurgery (15 Gy to 50% isodose)","Department of Radiotherapy University Hospital Mannheim, Mannheim, Germany","https://ClinicalTrials.gov/show/NCT03055208"
289,"A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma","Withdrawn","No Results Available","Glioblastoma","Drug: ONC201","University of Minnesota, Minneapolis, Minnesota, United States","https://ClinicalTrials.gov/show/NCT04629209"
290,"Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Multiforme","Drug: Temozolomide and SCH66336","UTMD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00038493"
291,"A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)","Recruiting","No Results Available","Glioblastoma|Glioblastoma Multiforme","Drug: BPM31510|Other: Vitamin K1|Drug: Temozolomide (TMZ)|Radiation: Radiation","Cedars-Sinai Medical Center, Los Angeles, California, United States|Stanford University Cancer Center, Palo Alto, California, United States|Sarcoma Oncology Research Center, Santa Monica, California, United States|Mount Sinai Hospital, New York, New York, United States","https://ClinicalTrials.gov/show/NCT04752813"
292,"Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma","Radiation: Magnetic Resonance Imaging (MRI)","Medical University of South Carolina, Charleston, South Carolina, United States","https://ClinicalTrials.gov/show/NCT01604590"
293,"Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma","Procedure: Biospecimen Collection|Drug: Lidocaine|Procedure: Resection","University of California Davis Comprehensive Cancer Center, Sacramento, California, United States","https://ClinicalTrials.gov/show/NCT04716699"
294,"A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma","Drug: Gefitinib","Research Site, Linköping, Sweden|Research Site, Stockholm, Sweden|Research Site, Umeå, Sweden","https://ClinicalTrials.gov/show/NCT00238797"
295,"INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study","Completed","No Results Available","Glioblastoma Multiforme","Radiation: Intraoperative Radiotherapy (Applicator Surface Dose: 20-40 Gy)","Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany","https://ClinicalTrials.gov/show/NCT02104882"
296,"Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence","Terminated","No Results Available","Glioblastoma Multiforme","Drug: Avastin","Brain & Spine Surgeons of New York, White Plains, New York, United States","https://ClinicalTrials.gov/show/NCT01526837"
297,"MR-guided LITT Therapy in Patients With Primary Irresectable Glioblastoma","Recruiting","No Results Available","Glioblastoma","Procedure: Laser ablation thermal therapy","Radboud UMC, Nijmegen, Netherlands","https://ClinicalTrials.gov/show/NCT04596930"
298,"Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma Multiforme","Drug: Pembrolizumab|Radiation: Stereotactic Radiation Therapy|Procedure: Surgical Resection","Cedars-Sinai Medical Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT04977375"
299,"Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma","Drug: Lomustine|Drug: Imipramine Hydrochloride",,"https://ClinicalTrials.gov/show/NCT04863950"
300,"A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging","Recruiting","No Results Available","Glioblastoma","Other: Ketogenic Diet|Drug: Metformin","Columbia University, New York, New York, United States|Weill Cornell Medicine, New York, New York, United States","https://ClinicalTrials.gov/show/NCT04691960"
301,"Vitamin D for Treatment of Glioblastoma Multiforme","Unknown status","No Results Available","Glioblastoma Multiforme","Other: Surgery|Radiation: Radiotherapy to tumour bed and/or residual tumour|Drug: Temozolomide|Drug: Vitamin D3","Soroka University Medical Center, Beer Sheva, Israel","https://ClinicalTrials.gov/show/NCT01181193"
302,"Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research","Completed","No Results Available","Recurrent Glioblastoma","Drug: Gefitnib","University Hospital Zürich, Zürich, Switzerland","https://ClinicalTrials.gov/show/NCT00250887"
303,"Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma","Recruiting","No Results Available","Glioblastoma|Recurrent Glioblastoma|GBM|Newly Diagnosed Glioblastoma","Drug: MN-166|Drug: Temozolomide","Dana-Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT03782415"
304,"The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections","Not yet recruiting","No Results Available","Glioblastoma","Procedure: Awake mapping under local anesthesia|Procedure: Asleep mapping under general anesthesia|Procedure: Resection under general anesthesia without mapping","University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium|Erasmus MC, Rotterdam, Zuid-Holland, Netherlands|Medical Center Haaglanden, The Hague, Zuid-Holland, Netherlands","https://ClinicalTrials.gov/show/NCT04708171"
305,"Precoce Medical Care by the Mobil Support for Patients With Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma","Other: supportive care","ICM Val d'Aurelle, Montpellier, France","https://ClinicalTrials.gov/show/NCT04516733"
306,"Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM","Active, not recruiting","No Results Available","Glioblastoma Multiforme|Brain Tumor","Drug: Bevacizumab","Lenox Hill Brain Tumor Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01811498"
307,"Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma","Drug: Daratumumab","West Virginia University Cancer Institute Mary Babb Randolph Cancer Center, Morgantown, West Virginia, United States","https://ClinicalTrials.gov/show/NCT04922723"
308,"Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma","Recruiting","No Results Available","Glioblastoma|Recurrent Glioblastoma","Drug: Verteporfin","Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States","https://ClinicalTrials.gov/show/NCT04590664"
309,"Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma","Active, not recruiting","No Results Available","Newly Diagnosed Glioblastoma","Biological: AV-GBM-1","Scripps Health, La Jolla, California, United States|UC San Diego Moores Cancer Center, La Jolla, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States|UC Irvine Medical Center, Orange, California, United States|UC Davis Comprehensive Cancer Center, Sacramento, California, United States|John Wayne Cancer Institute, Santa Monica, California, United States|Norton Cancer Institute, Louisville, Kentucky, United States|Rutgers Cancer Institute, New Brunswick, New Jersey, United States","https://ClinicalTrials.gov/show/NCT03400917"
310,"Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme","Completed","Has Results","Glioblastoma Multiforme","Drug: Bevacizumab|Drug: BKM120","Yale School of Medicine, New Haven, Connecticut, United States|Florida Cancer Specialists, Fort Myers, Florida, United States|Florida Hospital Cancer Institute, Orlando, Florida, United States|Florida Cancer Specialists, Saint Petersburg, Florida, United States|Center for Cancer and Blood Disorders, Bethesda, Maryland, United States|Grand Rapids Oncology Program, Grand Rapids, Michigan, United States|Nebraska Methodist Hospital, Omaha, Nebraska, United States|Tennessee Oncology, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT01349660"
311,"A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma","Unknown status","No Results Available","Glioblastoma","Other: Chemoradiation Therapy|Other: Adjuvant Therapy","Shandong Cancer Hospital and Institute, Jinan, Shandong, China","https://ClinicalTrials.gov/show/NCT01939574"
312,"AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Glioblastoma","Drug: Polysiloxane Gd-Chelates based nanoparticles (AGuIX)|Radiation: radiotherapy|Drug: Temozolomide","CHU de Brest, Brest, France|Centre Jean Perrin, Clermont-Ferrand, France|CHU de Grenoble, Grenoble, France|Centre Léon Berard, Lyon, France|Institut de Cancérologie de l'Ouest, Saint Herblain, France|Institut de Cancérologie Strasbourg Europe, Strasbourg, France","https://ClinicalTrials.gov/show/NCT04881032"
313,"The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma","Completed","No Results Available","Glioblastoma Multiforme","Drug: NVX-108","St. Vincents Hospital Sydney, Darlinghurst, New South Wales, Australia|Flinders Medical Centre, Adelaide, South Australia, Australia|Nucleus Network, Melbourne, Victoria, Australia|Epworth Center, Melbourne, Victoria, Australia","https://ClinicalTrials.gov/show/NCT02189109"
314,"Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma","Recruiting","No Results Available","Glioblastoma","Combination Product: Temozolomide","The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China","https://ClinicalTrials.gov/show/NCT04829097"
315,"Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)","Active, not recruiting","No Results Available","Glioblastoma|Gliosarcoma|Recurrent Brain Neoplasm","Biological: Anti-LAG-3 Monoclonal Antibody BMS 986016|Biological: Anti-PD-1|Other: Pharmacological Study|Other: Laboratory Biomarker Analysis|Biological: Anti-CD137","UAB Comprehensive Cancer Center, Birmingham, Alabama, United States|Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|Abrams Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT02658981"
316,"Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma","Completed","No Results Available","Glioblastoma Multiforme","Drug: Atorvastatin|Drug: Temozolomide|Radiation: Radiotherapy","King Fahad Medical City, Riyadh, Saudi Arabia","https://ClinicalTrials.gov/show/NCT02029573"
317,"Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma","Completed","No Results Available","Naive Unresectable Glioblastoma","Drug: Avastin + Campto / radiotherapy + Temodal + Avastin (4 cures)|Drug: Temodal/radiotherapy","Centre Georges François Leclerc, Dijon, Bourgogne, France","https://ClinicalTrials.gov/show/NCT01022918"
318,"Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma","Drug: UCPVax","CHU Besançon, Besançon, France|CHU Bordeaux, Bordeaux, France|Centre Georges François Leclerc, Dijon, France|Hôpital Saint-Louis, Paris, France","https://ClinicalTrials.gov/show/NCT04280848"
319,"A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma|Glioblastoma Multiforme","Drug: Ferumoxytol injection|Drug: Pharmacological ascorbate|Radiation: External beam radiation therapy|Drug: Temozolomide",,"https://ClinicalTrials.gov/show/NCT04900792"
320,"A Trial of KB004 in Patients With Glioblastoma","Completed","No Results Available","Glioblastoma","Drug: KB004","Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia|Austin Health, Heidelberg, Victoria, Australia","https://ClinicalTrials.gov/show/NCT03374943"
321,"Nimotuzumab in Adults With Glioblastoma Multiforma","Completed","No Results Available","Adults With Glioblastoma Multiforma","Drug: nimotuzumab","Dep. Neurosurgery, Univ. Hamburg, Hamburg, Germany","https://ClinicalTrials.gov/show/NCT00753246"
322,"A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)","Terminated","Has Results","Malignant Glioma|Glioblastoma Multiforme|Gliosarcoma","Drug: Gliadel/Avastin/CPT-11","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00735436"
323,"Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma","Completed","No Results Available","Glioblastoma","Drug: aldoxorubicin","City of Hope National Medical Center, Duarte, California, United States|Sarcoma Oncology Center, Santa Monica, California, United States|Ochsner Health System, New Orleans, Louisiana, United States|Texas Oncology-Austin Midtown, Austin, Texas, United States","https://ClinicalTrials.gov/show/NCT02014844"
324,"Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme","Recruiting","No Results Available","Glioblastoma","Biological: Dendritic Cells Vaccine","UOC Neuro-oncologia Molecolare, Milano, Italy","https://ClinicalTrials.gov/show/NCT04801147"
325,"A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma","Recruiting","No Results Available","Glioblastoma","Drug: RO7428731","Peter MacCallum Cancer Centre; Medical Oncology, Melbourne, Victoria, Australia","https://ClinicalTrials.gov/show/NCT05187624"
326,"Dose-Escalation Study of Carboplatin Administration Into the Brain for Glioblastoma Multiforme","Withdrawn","No Results Available","Glioblastoma Multiforme","Drug: Peritumoural carboplatin administration.","Department of Neurosurgery, Bristol, United Kingdom","https://ClinicalTrials.gov/show/NCT01317212"
327,"Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma","Recruiting","No Results Available","Glioblastoma","Drug: INCMGA00012|Drug: INCAGN01876|Drug: SRS|Procedure: Brain surgery","Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT04225039"
328,"Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma","Terminated","No Results Available","Glioblastoma","Radiation: Radiotherapy|Radiation: Experimental arm","Clinique Claude Bernard, Albi, France|Centre Jean Perrin, Clermont-ferrand, France|Centre Georges François Leclerc, Dijon, France|Hospices Civils de Lyon (Hôpital Lyon Sud/Hôpital P. Wertheimer), Lyon, France|Centre Leon Berard, Lyon, France|AP HM - Hôpital La Timone, Marseille, France|Centre Val d'Aurelle, Montpellier, France|Institut de Cancerologie Lucien Neuwirth, Saint-Priest-En-Jarez, France|Centre Paul Strauss, Strasbourg, France|CHU de Strasbourg, Strasbourg, France|Institut Claudius REGAUD, Toulouse, France|Centre Marie Curie, Valence, France","https://ClinicalTrials.gov/show/NCT01507506"
329,"Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma","Drug: Treatment with hP1A8","University of Minnesota, Minneapolis, Minnesota, United States","https://ClinicalTrials.gov/show/NCT04642937"
330,"Dendritic Cell Vaccination With Standard Postoperative Chemoradiation for the Treatment of Adult Glioblastoma","Recruiting","No Results Available","Glioblastoma","Biological: TH-1 Dendritic Cell Immunotherapy","Cooper University Hospital, Camden, New Jersey, United States","https://ClinicalTrials.gov/show/NCT04552886"
331,"Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Multiforme","Drug: Azixa","Barrow Neurological Institute, Phoenix, Arizona, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|Stanford University, Stanford, California, United States|Northwestern University, Chicago, Illinois, United States|Tufts Medical Center, Boston, Massachusetts, United States|Lahey Clinic, Burlington, Massachusetts, United States|University of Massachusettes, Worcester, Massachusetts, United States|Darthmouth -Hitchcock Medical Center, Lebanon, New Hampshire, United States|Columbia University, New York, New York, United States|SCCA/University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00892931"
332,"A Randomized Phase II Clinical Trial on the Efficacy of Axitinib as a Monotherapy or in Combination With Lomustine for the Treatment of Patients With Recurrent Glioblastoma","Completed","No Results Available","Glioblastoma Multiforme","Drug: axitinib|Drug: Axitinib plus Lomustine","UZ Brussel, Brussel, Belgium","https://ClinicalTrials.gov/show/NCT01562197"
333,"Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen","Recruiting","No Results Available","Glioblastoma","Drug: anlotinib combined with dose-dense temozolomide","Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China","https://ClinicalTrials.gov/show/NCT04547855"
334,"TMS Electrochemotherapy for Glioblastoma Multiforme","Withdrawn","No Results Available","Glioblastoma","Device: TMS",,"https://ClinicalTrials.gov/show/NCT02283944"
335,"CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)","Not yet recruiting","No Results Available","Glioblastoma","Drug: CM93",,"https://ClinicalTrials.gov/show/NCT04933422"
336,"Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma","Unknown status","No Results Available","Glioblastoma","Biological: Anlotinib|Drug: Temozolomide Capsule","Zhejiang cancer hospital, Hangzhou, Zhejiang, China","https://ClinicalTrials.gov/show/NCT04119674"
337,"Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)","Completed","Has Results","Brain Cancer|Glioblastoma","Drug: Standard Dose Bevacizumab|Drug: Low Dose Bevacizumab|Drug: Lomustine","University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01067469"
338,"Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma","Completed","No Results Available","Adult Glioblastoma","Drug: LY2228820|Drug: Temozolomide|Radiation: radiotherapy","CHU Amiens Sud-Salouel, Amiens, France|Institut Bergonié, Bordeaux, France|Centre François Baclesse, Caen, France|Centre Jean Perrin, Clermont-Ferrand, France|Centre Georges François Leclerc, Dijon, France|Centre Paul Strauss, Strasbourg, France","https://ClinicalTrials.gov/show/NCT02364206"
339,"Evaluation of [18F]-FMISO for Non Operated Glioblastoma","Completed","No Results Available","Glioblastoma","Procedure: 18F]-FMISO PET-CT","CHU de Bordeaux - Hôpital Pellegrin, Bordeaux, France","https://ClinicalTrials.gov/show/NCT00906893"
340,"Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Glioblastoma","Radiation: Radiation Therapy|Drug: Temozolomide Oral Product","University of Pittsburgh Medical Center, Radiation Oncology, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT04019262"
341,"Function and Composition of Regulatory B Cells in Participants With Glioblastoma","Recruiting","No Results Available","Glioblastoma, Adult","Drug: Dexamethasone","Amsterdam Medical Universities, Amsterdam, Noord-Holland, Netherlands","https://ClinicalTrials.gov/show/NCT04128774"
342,"Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Glioblastoma","Radiation: Dose-Intensified Radiotherapy|Drug: Temozolomide|Drug: Adjuvant temozolomide","University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States","https://ClinicalTrials.gov/show/NCT04574856"
343,"A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression","Not yet recruiting","No Results Available","Glioblastoma","Drug: L19TNF|Drug: Lomustine","Universitatspital Zurich - Klinik fur Neurologie & Hirntumorzentrum, Zürich, Switzerland","https://ClinicalTrials.gov/show/NCT04573192"
344,"A Study of Abemaciclib in Recurrent Glioblastoma","Recruiting","No Results Available","Glioblastoma","Drug: Abemaciclib|Procedure: Surgery","University of California Los Angeles, Los Angeles, California, United States|University of California, San Francisco, San Francisco, California, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|UT, M.D. Anderson Cancer Center, Houston, Texas, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT02981940"
345,"Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens","Terminated","Has Results","Glioblastoma|Glioblastoma Multiforme","Drug: 5-day TMZ|Drug: 21-day TMZ|Biological: PEP-CMV: Component A|Drug: Tetanus-Diphtheria booster|Drug: Tetanus Pre-Conditioning|Biological: PEP-CMV: Component B","The Preston Robert Tisch Brain Tumor Center at Duke, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT02864368"
346,"Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma","Recruiting","No Results Available","Glioblastoma","Procedure: Blood drawl","Dana-Farber Cancer Institute & Harvard Medical School, Boston, Massachusetts, United States|Universitaetsklinikum Wien - AKH uniklinieken, Vienna, Austria|Hopitaux Universitaires Bordet-Erasme, Brussel, Belgium|CHU Lyon - Hopital neurologique Pierre Wertheimer, Bron, France|CHRU de Lille, Lille, France|Hopitaux de Marseille - Hôpital de La Timone (APHM), Marseille, France|Institut du Cancer de Montpellier, Montpellier, France|CHU de Nice - Hopital Pasteur, Nice, France|Hopitaux de Paris - Hopital Saint-Louis, Paris, France|Hopitaux de Paris - La Pitie Salpetriere, Paris, France|CHU d'Amiens - CHU Amiens - Hopital Sud, Salouël, France|Universitaetsklinikum Bonn, Bonn, Germany|Universitaetsklinikum Carl Gustav Carus, Dresden, Germany|Universitaetsklinikum - Essen, Essen, Germany|Ronellenfitsch Michael, Frankfurt, Germany|Universitaetsklinikum Freiburg, Freiburg, Germany|UniversitaetsKlinikum Heidelberg, Heidelberg, Germany|Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern, Muenchen, Germany|Technische Universitaet Muenchen - Klinikum Rechts Der Isar, Muenchen, Germany|Universitaetsklinikum Regensburg, Regensburg, Germany|Hygeia Hospital, Athens, Greece|Azienda Ospedaliera Di Padova - Istituto Oncologico Veneto IRCCS, Padova, Italy|Azienda Ospedaliera Città della Salute e della Scienza di Torino - Ospedale San Giovanni, Torino, Italy|Amsterdam UMC - locatie VUmc, Amsterdam, Netherlands|Erasmus MC, Rotterdam, Netherlands|Centre Hospitalier Universitaire Vaudois - Lausanne, Lausanne, Switzerland|Univ. Spital Zurich, Zürich, Switzerland","https://ClinicalTrials.gov/show/NCT03770468"
347,"Treatment Intensification With Temozolomide in Adults With a Glioblastoma","Recruiting","No Results Available","Glioblastoma","Drug: Intensified protocol|Drug: Stupp protocol","Centre Hospitalier d'Amiens, Amiens, France|ICO Centre Paul Papin, Angers, France|Centre François Baclesse, Caen, France|Centre Jean Perrin, Clermont-Ferrand, France|Hôpitaux Civils de Colmar, Colmar, France|Centre Georges François Leclerc, Dijon, France|CHU Grenoble Alpes, Grenoble, France|CHU de Limoges, Limoges, France|Centre Léon Bérard, Lyon, France|CHU La Timone, Marseille, France|ICM Val d'Aurelle, Montpellier, France|CHRU Nancy, Nancy, France|ICO Centre René Gauducheau, Nantes, France|CHU de Nice - Hôpital de Cimiez, Nice, France|APHP La Pitié Salpêtrière, Paris, France|CH René Dubos, Pontoise, France|Institut Cancérologie Loire, Saint-Priest-en-Jarez, France|Centre Paul Strauss, Strasbourg, France|CHRU Tours, Tours, France","https://ClinicalTrials.gov/show/NCT03663725"
348,"A Pilot Study Evaluating in Vivo PARP-1 Expression with18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Glioblastoma","Recruiting","No Results Available","Glioblastoma","Drug: 18F-FluorThanatrace","University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT04221061"
349,"PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs","Completed","No Results Available","Glioblastoma","Drug: PTK787/ZK 222584|Drug: Temozolomide|Procedure: Radiation Therapy","Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00385853"
350,"Metronomic Temozolamide in Patients With Recurrent Glioblastoma","Unknown status","No Results Available","Glioblastoma","Drug: Temozolamide, irinotecan",,"https://ClinicalTrials.gov/show/NCT01308632"
351,"Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)","Terminated","Has Results","Brain Cancer|Glioblastoma Multiforme","Drug: Vorinostat|Drug: Erlotinib|Drug: Temozolomide","University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01110876"
352,"Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma","Terminated","No Results Available","Glioblastoma","Drug: I-124-CLR1404","City of Hope, Duarte, California, United States|Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|University of Maryland School of Medicine, Baltimore, Maryland, United States|Cleveland Clinic, Cleveland, Ohio, United States|Ohio State University Medical Center, Columbus, Ohio, United States|Kettering Medical Center, Kettering, Ohio, United States|Hospital of University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Wisconsin, Madison, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01898273"
353,"HMPL-813 in Treating Patients With Glioblastoma","Recruiting","No Results Available","Glioblastoma","Drug: epitinib succinate","Huashan Hospital, Shanghai, Shanghai, China|The second hospital affiliated to Zhejiang University Medical School, Hanzhou, Zhejiang, China","https://ClinicalTrials.gov/show/NCT03231501"
354,"F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery","Unknown status","No Results Available","Glioblastoma","Procedure: Computed Tomography|Other: Fluciclovine F18|Procedure: Positron Emission Tomography","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03926507"
355,"Bortezomib and Temozolomide in Recurrent Glioblastoma With Unmethylated MGMT Promoter (BORTEM-17)","Recruiting","No Results Available","Glioblastoma","Drug: Bortezomib and Temozolomide Phase IB|Drug: Bortezomib and Temozolomide Phase II","Haukeland University Hospital, Bergen, Norway|Oslo University Hospital, Oslo, Norway","https://ClinicalTrials.gov/show/NCT03643549"
356,"Chlorpromazine and Standard of Care in Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma Multiforme","Drug: Chlorpromazine|Drug: Temozolomide|Radiation: Radiation Therapy","University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States","https://ClinicalTrials.gov/show/NCT05190315"
357,"PreOperative Brain Irradiation in Glioblastoma","Recruiting","No Results Available","Glioblastoma Multiforme","Radiation: Preoperative brain irradiation (single fraction)","The Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom","https://ClinicalTrials.gov/show/NCT03582514"
358,"Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults","Completed","No Results Available","Glioblastoma","Radiation: radiotherapy|Drug: temozolomide","Centre Georges François Leclerc, Dijon, Bourgogne, France","https://ClinicalTrials.gov/show/NCT01043536"
359,"Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma","Recruiting","No Results Available","Glioblastoma","Biological: Personalized neoantigen DNA vaccine supplied by Geneos Therapeutics|Device: CELLECTRA®2000 EP Device supplied by Geneos Therapeutics|Drug: Plasmid encoded IL-12","Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT04015700"
360,"Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA","Recruiting","No Results Available","Glioblastoma Multiforme|Anaplastic Astrocytoma","Drug: Bevacizumab","Lenox Hill Brain Tumor Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01269853"
361,"Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Glioblastoma","Drug: Ibrutinib|Radiation: Radiation|Drug: Temozolomide (TMZ)","Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT03535350"
362,"Bioavailability of Disulfiram and Metformin in Glioblastomas","Terminated","No Results Available","Glioblastoma","Drug: Disulfiram|Drug: Metformin","Sahlgrenska University Hospital, Göteborg, Sweden","https://ClinicalTrials.gov/show/NCT03151772"
363,"Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Glioblastoma|Newly Diagnosed Glioblastoma","Device: Optune|Drug: Gadolinium|Drug: Temozolomide|Radiation: Stereotactic radiosurgery (SRS)","Stanford University, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT04474353"
364,"Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma","Completed","No Results Available","Glioblastoma","Drug: nelfinavir","Maastricht Radiation Oncology, Maastricht, Netherlands","https://ClinicalTrials.gov/show/NCT00694837"
365,"Phase I EGFR BATs in Newly Diagnosed Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma|Glioblastoma Multiforme","Drug: EGFR BATs with TMZ following SOC RT/TMZ|Drug: Weekly EGFR BATs following SOC RT/TMZ","University of Virginia, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT03344250"
366,"NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme","Terminated","No Results Available","Glioblastoma|Brain Neoplasms","Device: NovoTTF-100A|Procedure: Quality-of-life assessment|Genetic: Laboratory biomarker analysis","University of Florida, Gainesville, Florida, United States|Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT01954576"
367,"Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma","Completed","No Results Available","Glioblastoma","Biological: Ad-RTS-hIL-12|Drug: Veledimex|Drug: Cemiplimab-Rwlc","Cedars Sinai, Los Angeles, California, United States|University of California - San Francisco, San Francisco, California, United States|Baptist MD Anderson Cancer Center, Jacksonville, Florida, United States|Northwestern Memorial Hospital, Chicago, Illinois, United States|Brigham and Women's, Boston, Massachusetts, United States|JFK Medical Center, Edison, New Jersey, United States|NYU Langone Health, New York, New York, United States","https://ClinicalTrials.gov/show/NCT04006119"
368,"Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA","Completed","No Results Available","Glioblastoma Multiforme|Anaplastic Astrocytoma","Drug: Super-Selective Intraarterial Intracranial Infusion of Temozolomide","Lenox Hill Brain Tumor Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01180816"
369,"Spectral Analysis Probe to Identify Glioblastoma Cells","Terminated","No Results Available","Glioblastoma",,"University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States","https://ClinicalTrials.gov/show/NCT03293888"
370,"In Situ Immune Parameters and Their Prognostic Role on the Survival of Patients With Glioblastoma","Recruiting","No Results Available","Glioblastoma",,"Centre Georges François Leclerc, Dijon, France|CHU de DIJON, Dijon, France|CHU de Nantes, Saint-Herblain, France|Università di Florence, Florence, Italy|Azienda Ospedaliera Università di Padova, Padova, Italy","https://ClinicalTrials.gov/show/NCT03481231"
371,"Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients","Recruiting","No Results Available","Glioblastomas","Diagnostic Test: Feasibility study for the realization of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT for identification of early recurrence in patients treated with radiotherapy for glioblastoma.","Hôpital Pierre WERTHEIMER - HCL, BRON Cedex, France|Centre Léon Berard, Lyon, France","https://ClinicalTrials.gov/show/NCT03903419"
372,"Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma","Withdrawn","No Results Available","Glioblastoma|Glioblastoma Multiforme","Radiation: External beam radiation therapy","University of Iowa Department of Radiation Oncology, Iowa City, Iowa, United States","https://ClinicalTrials.gov/show/NCT03506139"
373,"Tivozanib for Recurrent Glioblastoma","Completed","Has Results","Glioblastoma","Drug: Tivozanib","Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01846871"
374,"Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma","Completed","No Results Available","Recurrent Glioblastoma Planned for Reoperation","Drug: Patupilone",,"https://ClinicalTrials.gov/show/NCT00715013"
375,"Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Glioblastoma","Recruiting","No Results Available","Glioblastoma","Procedure: MRI with Arterial Spin Labeling (ASL)","UT Southwestern Medical Center, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT03922984"
376,"Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma","Suspended","No Results Available","Glioblastoma Multiforme|Anaplastic Astrocytoma","Drug: Bevacizumab and Carboplatin","Lenox Hill Brain Tumor Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01386710"
377,"Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI","Recruiting","No Results Available","Glioblastoma","Device: Standard Magnetic Resonance Imaging (MRI)|Device: Advanced MRI.","Froedtert Hospital & Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT03297125"
378,"Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma","Unknown status","No Results Available","Glioblastoma","Drug: Apatinib|Drug: Temozolomide（TMZ）","Fuzhou General Hospital, Fuzhou, Fujian, China","https://ClinicalTrials.gov/show/NCT03567135"
379,"Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma","Completed","No Results Available","Glioblastoma","Biological: Nimotuzumab|Drug: Temozolomide|Radiation: Radiotherapy","Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China|Guangdong Brain Hospital, Guangdong, China|The First Affiliated Hospital/School of Clinical Medicine of Guangdong, Guangdong, China|The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China|Shenzhen People's Hospital, Shenzhen, China","https://ClinicalTrials.gov/show/NCT03388372"
380,"Glioblastoma: Validation and Comparison Between Primary Tumor and Its Murine Model","Recruiting","No Results Available","Glioblastoma","Device: 7 Tesla MRI, no contrast agent","CHUV, University Hospital Lausanne, Lausanne, VD, Switzerland","https://ClinicalTrials.gov/show/NCT02904525"
381,"OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Glioblastoma","Drug: OKN 007|Drug: Temozolomide|Radiation: Photon/Proton IMRT","Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States","https://ClinicalTrials.gov/show/NCT03587038"
382,"Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102","Completed","No Results Available","Glioblastoma","Biological: Ad-RTS-hIL-12|Drug: veledimex","Cedars-Sinai Medical Center, Los Angeles, California, United States|Northwestern Memorial Hospital, Chicago, Illinois, United States|NYU - Langone Health, New York, New York, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03679754"
383,"PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma","Recruiting","No Results Available","Glioblastoma","Drug: 5-aminolevulinic acid","Uniklinik Köln, Köln, Germany|Klinikum der Universität München, München, Germany|Universitätsklinikum Münster, Münster, Germany","https://ClinicalTrials.gov/show/NCT03897491"
384,"A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma","Withdrawn","No Results Available","Glioblastoma","Biological: PF-04856884",,"https://ClinicalTrials.gov/show/NCT01225510"
385,"A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma","Active, not recruiting","No Results Available","Newly Diagnosed Glioblastoma","Drug: Marizomib|Drug: Temozolomide|Radiation: radiotherapy","Mayo Clinic Scottsdale, Scottsdale, Arizona, United States|University of California at Irvine, Orange, California, United States|University of California, San Francisco, California, United States|John Wayne Cancer Institute, Santa Monica, California, United States|University of Florida, Gainesville, Florida, United States|Mayo Clinic, Jacksonville, Florida, United States|Mayo Clinic, Rochester, Minnesota, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|Penn State College of Medicine, Hershey Medical Center-Penn State Neuroscience Institute, Hershey, Pennsylvania, United States|Innsbruck Universitaetsklinik, Innsbruck, Austria|Kepler University Hospital, Linz, Austria|Medical University Vienna - General Hospital AKH, Vienna, Austria|Onze Lieve Vrouw Ziekenhuis, Aalst, Belgium|GasthuisZusters Antwerpen - Sint-Augustinus, Antwerpen, Belgium|Hopitaux Universitaires Bordet-Erasme - Hopital Universitaire Erasme, Bruxelles, Belgium|Cliniques Universitaires Saint-Luc, Bruxelles, Belgium|Grand Hopital de Charleroi - Grand Hôpital de Charleroi - Site Notre Dame, Charleroi, Belgium|Universitair Ziekenhuis Gent, Gent, Belgium|C.H.U. Sart-Tilman, Liège, Belgium|Saint John Regional Hospital, Saint John, New Brunswick, Canada|London Regional Cancer Center, London, Ontario, Canada|Ottawa Health Research Institute, Ottawa, Ontario, Canada|Windsor Regional Cancer Centre, Windsor, Ontario, Canada|Centre Hospitalier Universitaire de Sherbrooke-Fleurimont, Sherbrooke, Quebec, Canada|BCCA - Abbotsford Centre, Abbotsford, Canada|Tom Baker Cancer Centre, Calgary, Canada|QEII Health Sciences Centre-Capital District Health Authority, Halifax, Canada|Hamilton Health Sciences, Juravinski Cancer Centre, Hamilton, Canada|Kingston Health Sciences Centre, Kingston, Canada|Montreal Neurological Institute and Hospital McGill University, Montréal, Canada|CHUM - Centre Hospitalier de l'Université de Montreal - Hopital Notre-Dame, Montréal, Canada|Hopital Du Sacre-Coeur De Montreal, Montréal, Canada|CHU de Quebec-Hopital l'Enfant-Jesus (HEJ), Québec, Canada|Allan Blair Cancer Centre, Regina, Canada|Sault Area Hospital, Sault Ste. Marie, Canada|Regional Cancer Program of Hopital Reg. de Sudbury Reg. Hospital, Sudbury, Canada|Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Canada|University Health Network - Oci / Princess Margaret Hospital, Toronto, Canada|Centre hospitalier regional de Trois-Rivieres, Trois-Rivières, Canada|BC Cancer Agency, Vancouver, Canada|Bcca - Vancouver Island Cancer Centre, Victoria, Canada|Cancercare Manitoba, Winnipeg, Canada|Aarhus University Hospitals - Aarhus University Hospital (440), Aarhus, Denmark|University Hospitals Copenhagen - Rigshospitalet, Copenhagen, Denmark|Centre Hospitalier Departemental Vendée, La Roche-sur-Yon, Vendee, France|CHU de Lyon - CHU Lyon - Hopital neurologique Pierre Wertheimer, Bron, France|CHRU de Lille, Lille, France|Institut de Cancerologie de l'Ouest, Nantes, France|Assistance Publique - Hopitaux de Paris - La Pitie Salpetriere, Paris, France|Gustave Roussy, Villejuif, France|Universitaetsklinikum Bonn, Bonn, Germany|Universitaetsklinik Erlangen-Neurologische Klinik (3031), Erlangen, Germany|Klinikum Der J.W. Goethe Universitaet-Klinik und Poliklinik fur Neurochirurgie, Frankfurt, Germany|UniversitaetsKlinikum Heidelberg - Head Hospital, Heidelberg, Germany|Universitaetsklinikum Leipzig-Klinik für Strahlentherapie und Radioonkologie, Leipzig, Germany|Johannes Gutenberg Universitaetskliniken - Mainz University Medical Center, Mainz, Germany|UniversitaetsMedizin Mannheim, Mannheim, Germany|Technische Universitaet Muenchen - Klinikum Rechts Der Isar, Muenchen, Germany|Universitaetskliniken Regensburg, Regensburg, Germany|Universitaetsklinikum Tuebingen- Crona Kliniken, Tuebingen, Germany|Catharina Ziekenhuis, Eindhoven, North Brabant, Netherlands|Spaarne Gasthuis - Vrije Universiteit Medisch Centrum, Amsterdam, Netherlands|The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam, Netherlands|Medisch Centrum Haaglanden - Westeinde, Den Haag, Netherlands|University Medical Center Groningen, Groningen, Netherlands|Academisch Ziekenhuis Maastricht, Maastricht, Netherlands|Radboud University Medical Center Nijmegen, Nijmegen, Netherlands|Erasmus MC, Rotterdam, Netherlands|Universitair Medisch Centrum - Academisch Ziekenhuis, Utrecht, Netherlands|Oslo University Hospital - Radiumhospitalet, Oslo, Norway|Institut Catala d'Oncologia - ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia), Badalona, Spain|Hospital Clinic Universitari de Barcelona, Barcelona, Spain|Institut Catala D'Oncologia, L'Hospitalet De Llobregat, Spain|Hospital Universitario 12 De Octubre, Madrid, Spain|Clinica Universidad de Navarra - Clinica Universitaria De Navarra, Pamplona, Spain|University Hospital of Geneva, Geneva, Switzerland|Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland|Kantonsspital, Saint Gallen, Switzerland|UniversitaetsSpital, Zürich, Switzerland|NHS Lothian - Western General Hospital, Edinburgh, United Kingdom|Guy's and St Thomas' NHS - Guy s and St Thomas' NHS - Guy's Hospital, London, United Kingdom|Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital, Sheffield, United Kingdom","https://ClinicalTrials.gov/show/NCT03345095"
386,"Using Genomic Analysis to Guide Individual Treatment in Glioblastoma","Completed","No Results Available","Glioblastoma","Other: Observational study, no intervention","New York University Langone Medical Center, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Rockefeller University, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|Lenox Hill Hospital, New York, New York, United States|North Shore University Hospital, New York, New York, United States|Montefiore Medical Center, The Bronx, New York, United States","https://ClinicalTrials.gov/show/NCT02725684"
387,"Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma","Drug: Ferumoxytol|Other: Laboratory Biomarker Analysis|Procedure: Magnetic Resonance Imaging|Biological: Pembrolizumab","OHSU Knight Cancer Institute, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT03347617"
388,"Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma","Suspended","No Results Available","Glioblastoma|Glioblastoma Multiforme","Procedure: MRI","University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT02769806"
389,"First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma","Recruiting","No Results Available","Glioblastoma, Adult","Biological: Multiple dose of EO2401","Dana Farber Cancer Institute, Boston, Massachusetts, United States|Centre Georges François Leclerc, Dijon, France|Hôpital Pitié-Salpétrière, Paris, France|Klinik und Poliklinik für Neurologie Universitätsklinikum Bonn, Bonn, Germany|Universitätsklinikum Frankfurt Goethe-Universität Dr. Senckenbergisches Institut für Neuroonkologie, Frankfurt am Main, Germany|Neurologische Klinik & Nationales Zentrum für Tumorenerkrankungen Heidelberg Universitätsklinikum Heidelberg, Heidelberg, Germany|Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany|Zentrum für Neuroonkologie Universitätsklinikum Tübingen, Tübingen, Germany|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Institit Catala D'Oncologia - Hospital Duran i Reynals, Hospitalet De Llobregat, Spain","https://ClinicalTrials.gov/show/NCT04116658"
390,"Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma","Completed","No Results Available","Glioblastoma","Drug: Temozolomide in both arms","Landesnervenklinik Wagner-Jauregg, Linz, Austria|Medical University Vienna, Department of Internal Medicine I, Wien, Austria|Charite, Department of Neurosurgery, Berlin, Germany|Knappschaftskrankenhaus, Department of Neurology, Bochum, Germany|University Hospital Bonn, Department of Neurology, Bonn, Germany|University Hospital Düsseldorf, Düsseldorf, Germany|Klinikum der Johann-Wolfgang von Goethe-Universität, Dr. Senckenbergisches Institut für Neuroonkologie, Zentrum für Neurologie und Neurochirurgie, Frankfurt, Germany|University Hospital Freiburg, Freiburg, Germany|University Hospital Heidelberg, Department of Neurooncology, Heidelberg, Germany|Saarland University, Department of Neurosurgery, Homburg/ Saar, Germany|Klinik für Allgemeine Neurochirurgie, Köln, Germany|Klinik und Poliklinik für Neurochirurgie, Leipzig, Germany|Ludwig Maximilians University of Munich , Grosshadern Hospital, Department of Neurosurgery, Munich, Germany|University of Regensburg, Department of Neurology, Regensburg, Germany|University Hospital Zurich, Department of Neurology, Zurich, CH, Switzerland|Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland","https://ClinicalTrials.gov/show/NCT00941460"
391,"A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma - the ImmuneSense Study","Not yet recruiting","No Results Available","Glioblastoma Multiforme|Glioblastoma","Biological: IGV-001 Cell Immunotherapy|Biological: Placebo|Procedure: Standard of Care (SOC): Radiation Therapy|Drug: SOC: Temozolomide","Investigation Site, Newark, Delaware, United States|Investigation Site, Boston, Massachusetts, United States|Investigation Site, Detroit, Michigan, United States|Investigation Site, Lebanon, New Hampshire, United States|Investigation Site, Hackensack, New Jersey, United States|Investigation Site, New York, New York, United States|Investigation Site, Cleveland, Ohio, United States|Investigation Site, Hershey, Pennsylvania, United States|Investigation Site, Philadelphia, Pennsylvania, United States|Investigation Site, Pittsburgh, Pennsylvania, United States|Investigation Site, Providence, Rhode Island, United States","https://ClinicalTrials.gov/show/NCT04485949"
392,"Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma","Recruiting","No Results Available","Glioblastoma","Other: FDG PET|Other: CT scan|Other: Magnetic resonance imaging (MRI)","CHU de Nimes, Nîmes, France","https://ClinicalTrials.gov/show/NCT04566185"
393,"Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy","Recruiting","No Results Available","Glioblastoma","Biological: Dendritic cell immunization|Drug: Adjuvant temozolomide","Oslo University Hospital, Oslo, Norway","https://ClinicalTrials.gov/show/NCT03548571"
394,"Intracranial Injection of NK-92/5.28.z Cells in Patients With Recurrent HER2-positive Glioblastoma","Recruiting","No Results Available","Glioblastoma","Biological: NK-92/5.28.z","Johann W. Goethe University Hospital, Department of Neurosurgery, Frankfurt, Germany|Johann W. Goethe University Hospital, Senckenberg Institute of Neurooncology, Frankfurt, Germany","https://ClinicalTrials.gov/show/NCT03383978"
395,"Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma","Completed","Has Results","Glioblastoma","Drug: Ixazomib","Emory University/Winship Cancer Institute, Atlanta, Georgia, United States","https://ClinicalTrials.gov/show/NCT02630030"
396,"A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102","Completed","No Results Available","Glioblastoma","Biological: Ad-RTS-hIL-12|Drug: veledimex|Drug: Nivolumab","Northwestern Memorial Hospital, Chicago, Illinois, United States|Brigham & Women's Hospital, Boston, Massachusetts, United States|University of Minnesota, Minneapolis, Minnesota, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03636477"
397,"Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma","Recruiting","No Results Available","Glioblastoma","Drug: Temozolomide|Radiation: Radiation Therapy|Device: NovoTTF-200A Device|Procedure: Tumor Treating Fields Therapy","Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT03477110"
398,"Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas","Completed","Has Results","Glioblastoma","Drug: Depatuxizumab mafodotin|Drug: Temozolomide|Drug: Lomustine","Lucile Packard Children's Hosp /ID# 153678, Palo Alto, California, United States|Children's Hospital Colorado /ID# 153677, Aurora, Colorado, United States|Univ of Colorado Cancer Center /ID# 134882, Aurora, Colorado, United States|Sarah Cannon Research Institute at HealthONE - Denver /ID# 141798, Denver, Colorado, United States|Rush University Medical Center /ID# 137542, Chicago, Illinois, United States|Dana-Farber Cancer Institute /ID# 154210, Boston, Massachusetts, United States|Long Island Brain Tumor Center /ID# 134496, Lake Success, New York, United States|Weill Cornell Medicine /ID# 152656, New York, New York, United States|Cleveland Clinic Main Campus /ID# 137540, Cleveland, Ohio, United States|University of Pittsburgh MC /ID# 134491, Pittsburgh, Pennsylvania, United States|Tennessee Oncology, PLLC /ID# 134492, Nashville, Tennessee, United States|UT Southwestern Medical Center /ID# 136718, Dallas, Texas, United States|Swedish Medical Center /ID# 136719, Seattle, Washington, United States|Port Macquarie Base Hospital /ID# 134569, Port Macquarie, New South Wales, Australia|Sydney Children's Hospital /ID# 153533, Randwick, New South Wales, Australia|Royal North Shore Hospital /ID# 147092, Saint Leonards, New South Wales, Australia|Calvary Mater Newcastle /ID# 134570, Waratah, New South Wales, Australia|Southern Medical Day Care Ctr /ID# 134495, Wollongong, New South Wales, Australia|Royal Brisbane and Women's Hospital /ID# 147091, Herston, Queensland, Australia|Royal Adelaide Hospital /ID# 135208, Adelaide, South Australia, Australia|Royal Hobart Hospital /ID# 135209, Hobart, Tasmania, Australia|Barwon Health University Hospital Geelong /ID# 134493, Geelong, Victoria, Australia|Royal Children's Hospital /ID# 157624, Melbourne, Victoria, Australia|University Hospital St. Polten /ID# 139070, St. Pölten, Niederoesterreich, Austria|LKH-Univ. Klinikum Graz /ID# 139071, Graz, Austria|Kepler Universitätsklinikum GmbH - Neuromed Campus /ID# 139068, Linz, Austria|Cliniques Universitaires Saint Luc /ID# 139391, Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium|Grand Hôpital de Charleroi /ID# 139342, Charleroi, Hainaut, Belgium|UZ Gent /ID# 152944, Gent, Oost-Vlaanderen, Belgium|AZ St-Jan Brugge-Oostende AV /ID# 137927, Brugge, West-Vlaanderen, Belgium|ZNA Middelheim /ID# 137926, Antwerp, Belgium|UZ Leuven /ID# 137925, Leuven, Belgium|Montreal Neurological Institut /ID# 136309, Montreal, Quebec, Canada|Fakultni Nemocnice v Motole /ID# 139509, Prague 5, Praha 5, Czechia|Masarykuv onkologikcy ustav /ID# 139508, Brno, Czechia|FN Hradec Kralove /ID# 139510, Hradec Kralove, Czechia|Univ Hosp Ostrava-Poruba /ID# 139507, Ostrava, Czechia|Helsinki Univ Central Hospital /ID# 140078, Helsinki, Finland|Helsinki Univ Central Hospital /ID# 153069, Helsinki, Finland|Turku University Hospital /ID# 140861, Turku, Finland|CHRU Lille - Hôpital Claude Huriez /ID# 137916, Lille CEDEX, Hauts-de-France, France|Centre Oscar Lambret /ID# 169619, Lille, Hauts-de-France, France|CHU-Hopital Avicenne /ID# 137910, Bobigny, Ile-de-France, France|Gustave Roussy /ID# 137912, Villejuif, Ile-de-France, France|Institut de Cancer de l'Ouest /ID# 137914, St Herblain CEDEX, Loire-Atlantique, France|Hopital de la Timone /ID# 137911, Marseille CEDEX 05, Provence-Alpes-Cote-d Azur, France|CHU de Nice /ID# 137917, Nice CEDEX 1, Provence-Alpes-Cote-d Azur, France|Centre Leon Berard /ID# 137918, Lyon CEDEX 08, Rhone, France|Institut de Cancer de l'Ouest /ID# 137909, Angers, France|Hospices Civils de Lyon /ID# 137913, Bron, France|Hopital Pitie Salpetriere /ID# 145887, Paris, France|Universitaetsklinik Heidelberg /ID# 137924, Heidelberg, Baden-Wuerttemberg, Germany|Universitatsklinik Regensburg /ID# 137920, Ratisbon, Bayern, Germany|Univ Klinik Eppendorf Hamburg /ID# 137921, Hamburg, Germany|LMU Klinikum der Universität München /ID# 137922, Munich, Germany|Universitatsklinikum Tubingen /ID# 137923, Tuebingen, Germany|Pecsi Tudomanyegyetem /ID# 136111, Pécs, Pecs, Hungary|Semmelweis Egyetem /ID# 152578, Budapest, Hungary|National Institute of Oncology /ID# 135970, Budapest, Hungary|Orszagos Klinikai Idegtudomany /ID# 135971, Budapest, Hungary|Debreceni Egyetem Klinikai Központ /ID# 135969, Debrecen, Hungary|Cork University Hospital /ID# 136828, Cork, Ireland|Beaumont Hospital /ID# 136829, Dublin, Ireland|Ospedale Bellaria.Azienda USL IRCCS.Istituto delle Scienze Neurologiche di Bolog /ID# 138335, Bologna, Italy|Ospedale Generale di Bolzano /ID# 138338, Bolzano, Italy|Fondazione IRCCS Istituto Neurologico Carlo Besta /ID# 140395, Milan, Italy|Istituto Oncologico Veneto /ID# 138336, Padova, Italy|Azienda Ospedaliera Sant' Andrea /ID# 138337, Rome, Italy|Seoul National Univ Bundang ho /ID# 136841, Seongnam, Gyeonggido, Korea, Republic of|Samsung Medical Center /ID# 136842, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Seoul National University Hospital /ID# 136840, Seoul, Korea, Republic of|Hospital Zambrano Hellion /ID# 138076, San Pedro Garza García, Mexico|Vrije Universiteit Medisch Centrum /ID# 137221, Amsterdam, Netherlands|Universitair Medisch Centrum Groningen /ID# 138266, Groningen, Netherlands|Erasmus Medisch Centrum /ID# 136981, Rotterdam, Netherlands|Haaglanden Medisch Centrum /ID# 137222, The Hague, Netherlands|Universitair Medisch Centrum Utrecht /ID# 137219, Utrecht, Netherlands|Prinses Maxima Centrum /ID# 204409, Utrecht, Netherlands|Uniwersyteckie Centrum Kliniczne /ID# 137919, Gdansk, Mazowieckie, Poland|Wojewodzkie Wielospecjalistycz /ID# 137654, Lodz, Poland|National University Hospital /ID# 135951, Singapore, Singapore|National Cancer Ctr Singapore /ID# 135952, Singapore, Singapore|KK Women's & Children Hospital /ID# 153676, Singapore, Singapore|Instituto Catalán de Oncología (ICO) Badalona /ID# 140976, Badalona, Barcelona, Spain|Clinica Universitar de Navarra - Pamplona /ID# 140047, Pamplona, Navarra, Comunidad, Spain|Instituto Catalan de Oncologia (ICO) & Hosp. de Bellvitge /ID# 137688, Barcelona, Spain|Hospital Universitario Nino /ID# 153800, Madrid, Spain|Hosp Univ 12 de Octubre /ID# 137908, Madrid, Spain|Centre Hospitalier Univ Vaudoi /ID# 137929, Lausanne, Switzerland|University Hospital Zurich /ID# 137930, Zurich, Switzerland|China Medical University Hosp /ID# 136976, Taichung City, Taichung, Taiwan|National Taiwan Univ Hosp /ID# 136975, Taipei City, Taipei, Taiwan|Taichung Veterans General Hosp /ID# 136977, Taichung City, Taiwan|Taipei Veterans General Hosp /ID# 136974, Taipei City, Taiwan|Linkou Chang Gung Memorial Ho /ID# 136944, Taoyuan City, Taiwan|Guy's and St Thomas' NHS Found /ID# 140312, London, London, City Of, United Kingdom|Univ Hospitals Birmingham NHS Foundation trust /ID# 136978, Birmingham, United Kingdom|Gartnavel General Hospital /ID# 136979, Glasgow, United Kingdom|Hull and East Yorkshire NHS /ID# 136917, Hull, United Kingdom|University College Hospitals /ID# 136879, London, United Kingdom|Great Ormond St Hospital NHS /ID# 153421, London, United Kingdom|Christie NHS Foundation Trust /ID# 140313, Manchester, United Kingdom","https://ClinicalTrials.gov/show/NCT02343406"
399,"CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma","Unknown status","No Results Available","Glioblastoma",,,"https://ClinicalTrials.gov/show/NCT03152708"
400,"FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma","Recruiting","No Results Available","Glioblastoma","Procedure: Computed Tomography|Radiation: Fludeoxyglucose F-18|Procedure: Positron Emission Tomography","UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT02902757"
401,"Intra-tumoral Ipilimumab Plus Intravenous Nivolumab Following the Resection of Recurrent Glioblastoma","Recruiting","No Results Available","Glioblastoma","Drug: Ipilimumab (YervoyTM, 50 mg/10 mL solution)|Drug: Nivolumab (OpdivoTM, 40 mg/4mL solution)","Universitair Ziekenhuis Brussel, Brussels, Belgium","https://ClinicalTrials.gov/show/NCT03233152"
402,"A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma","Completed","No Results Available","Glioblastoma Multiforme","Biological: ICT-121 DC vaccine","University of Alabama at Birmingham, Birmingham, Alabama, United States|UC San Diego Moores Cancer Center, La Jolla, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|JFK New Jersey Neuroscience Institute, Edison, New Jersey, United States|Penn State Hershey Neuroscience Institute, Hershey, Pennsylvania, United States|Baylor Research Institute - Charles A. Sammons Cancer Center, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT02049489"
403,"Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma","Unknown status","No Results Available","Glioblastoma Multiforme","Drug: Sunitinib|Drug: Temozolomide|Radiation: Radiation Therapy","Tom Baker Cancer Center and University of Calgary, Calgary, Alberta, Canada|McGill University Health Centre, Montreal, Quebec, Canada","https://ClinicalTrials.gov/show/NCT02928575"
404,"Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma","Completed","Has Results","Recurrent Glioblastoma","Drug: Cediranib|Drug: Lomustine Chemotherapy|Drug: Placebo Cediranib","Research Site, Birmingham, Alabama, United States|Research Site, Pheonix, Arizona, United States|Research Site, Los Angeles, California, United States|Research Site, New Haven, Connecticut, United States|Research Site, Gainesville, Florida, United States|Research Site, Jacksonville, Florida, United States|Research Site, Chicago, Illinois, United States|Research Site, Evanston, Illinois, United States|Research Site, Kansas City, Kansas, United States|Research Site, Boston, Massachusetts, United States|Research Site, Detroit, Michigan, United States|Research Site, Amherst, New York, United States|Research Site, New York, New York, United States|Research Site, Cincinnati, Ohio, United States|Research Site, Cleveland, Ohio, United States|Research Site, Columbus, Ohio, United States|Research Site, Philadelphia, Pennsylvania, United States|Research Site, Pittsburgh, Pennsylvania, United States|Research Site, Houston, Texas, United States|Research Site, Seattle, Washington, United States|Research Site, Morgantown, West Virginia, United States|Research Site, Camperdown, Australia|Research Site, Heidelberg, Australia|Research Site, Nedlands, Australia|Research Site, Parkville, Australia|Research Site, St Leonards, Australia|Research Site, Woodville, Australia|Research Site, Graz, Austria|Research Site, Brussels (Anderlecht), Belgium|Research Site, Brussels (Jette), Belgium|Research Site, Brussels (Woluwé-St-Lambert), Belgium|Research Site, Leuven, Belgium|Research Site, Calgary, Alberta, Canada|Research Site, Toronto, Ontario, Canada|Research Site, Montreal, Quebec, Canada|Research Site, Liberec, Czech Republic|Research Site, Bobigny, France|Research Site, Marseille, France|Research Site, Paris cedex 13, France|Research Site, Rennes, France|Research Site, Saint Herblain, France|Research Site, Villejuif, France|Research Site, Berlin, Germany|Research Site, Bielefeld, Germany|Research Site, Dresden, Germany|Research Site, Düsseldorf, Germany|Research Site, Göttingen, Germany|Research Site, Hannover, Germany|Research Site, Heidelberg, Germany|Research Site, Kiel, Germany|Research Site, Leipzig, Germany|Research Site, Nordhausen, Germany|Research Site, Regensburg, Germany|Research Site, Amsterdam, Netherlands|Research Site, Den Haag, Netherlands|Research Site, Groningen, Netherlands|Research Site, Maastricht, Netherlands|Research Site, Rotterdam, Netherlands|Research Site, Glasgow, United Kingdom|Research Site, London, United Kingdom|Research Site, Manchester, United Kingdom|Research Site, Sutton, United Kingdom","https://ClinicalTrials.gov/show/NCT00777153"
405,"Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme","Completed","Has Results","Glioblastoma Multiforme|Glioblastoma - Category","Drug: Bevacizumab|Procedure: Magnetic Resonance Spectroscopy (MRS)|Procedure: Border Zone Stereotactic Radiosurgery (BZ-SRS)","University of Pittsburgh, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT02120287"
406,"Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma","Withdrawn","No Results Available","Glioblastoma","Drug: G-202","John Wayne Cancer Institute, Santa Monica, California, United States","https://ClinicalTrials.gov/show/NCT02876003"
407,"NG101m Adjuvant Therapy in Glioblastoma Patients","Not yet recruiting","No Results Available","Glioblastoma Multiforme","Radiation: Intensity-modulated radiation therapy|Drug: Temozolomide|Drug: NG101m","Yvonne Kew MD, PLLC, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04373785"
408,"The Addition of Chloroquine to Chemoradiation for Glioblastoma","Completed","No Results Available","Glioblastoma Multiforme","Drug: Chloroquine|Radiation: Radiotherapy|Drug: Temozolomide","Maastricht Radiation Oncology, Maastricht, Netherlands","https://ClinicalTrials.gov/show/NCT02378532"
409,"Natural Progesterone for the Treatment of Recurrent Glioblastoma","Recruiting","No Results Available","Gliosarcoma|Recurrent Glioblastoma","Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Biological: Therapeutic Progesterone","Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States","https://ClinicalTrials.gov/show/NCT05091866"
410,"B7-H3 CAR-T for Recurrent or Refractory Glioblastoma","Recruiting","No Results Available","Recurrent Glioblastoma|Refractory Glioblastoma","Drug: Temozolomide|Biological: B7-H3 CAR-T","the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China|Huzhou Central Hospital, Huzhou, Zhejiang, China|Ningbo Yinzhou People's Hospital, Ningbo, Zhejiang, China","https://ClinicalTrials.gov/show/NCT04077866"
411,"Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma","Terminated","No Results Available","Glioblastoma","Radiation: irradiation","Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland","https://ClinicalTrials.gov/show/NCT00115453"
412,"Regorafenib in Relapsed Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma Multiforme","Drug: Regorafenib|Drug: Lomustine","IRCCS ""Saverio de Bellis, Castellana Grotte, BA, Italy|Ospedale di Bellaria, Bologna, BO, Italy|Azienda Ospedaliera ""G.Rummo"", Benevento, BR, Italy|istituto Scientifico Romagnolo per lo Studio e Cura dei Tumori, Cesena, FC, Italy|Istituto Neurologico C. Besta IRCCS, Milano, MI, Italy|Istituto Oncologico Veneto IRCCS, Oncologia Medica 1, Padova, PD, Italy|Ospedale Santa Chiara, Pisa, PI, Italy|Azienda Ospedaliero Universitaria S. Maria della Misericordia, Udine, UD, Italy|Istituto Nazionale Tumori Regina Elena, Roma, Italy|Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Torino, Italy","https://ClinicalTrials.gov/show/NCT02926222"
413,"Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma","Completed","No Results Available","Glioblastoma",,"Universitat Politècnica de València, Valencia, Spain","https://ClinicalTrials.gov/show/NCT03439332"
414,"Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme","Completed","Has Results","Glioblastoma Multiforme of Brain","Drug: Antineoplaston therapy (Atengenal + Astugenal)","Burzynski Clinic, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00003456"
415,"Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma","Recruiting","No Results Available","Recurrent Glioblastoma","Drug: Regorafenib","Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT04051606"
416,"Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, in Combination With Bevacizumab in Patients With Recurrent Glioblastoma","Unknown status","No Results Available","Glioblastoma","Drug: Monoclonal antibody|Drug: Bevacizumab|Biological: Blood sample|Device: Dynamic Contrast Enhanced magnetic resonance imaging (DCE-MRI)","Assistance Publique des Hôpitaux de Marseille, Marseille, France","https://ClinicalTrials.gov/show/NCT03631836"
417,"Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma","Completed","Has Results","Glioblastoma","Drug: Ponatinib","Massachusetts General Hospital, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT02478164"
418,"Sonodynamic Therapy With ExAblate System in Glioblastoma Patients","Not yet recruiting","No Results Available","Glioblastoma Multiforme","Drug: 5-Aminolevulinic Acid",,"https://ClinicalTrials.gov/show/NCT04845919"
419,"Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma","Not yet recruiting","No Results Available","Recurrent Glioblastoma","Biological: NKG2D CAR-T",,"https://ClinicalTrials.gov/show/NCT04717999"
420,"Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma","Completed","No Results Available","Glioblastoma","Drug: Chlorogenic acid","Beijing Shijitan Hospital,Capital Medical University, Beijing, China","https://ClinicalTrials.gov/show/NCT02728349"
421,"Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Multiforme","Drug: Verubulin|Drug: Temozolomide & Radiation Therapy","Stanford University, Stanford, California, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01285414"
422,"A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1","Recruiting","No Results Available","Glioblastoma","Drug: Enzastaurin Hydrochloride|Other: Placebo|Drug: Temozolomide|Radiation: Radiotherapy","University of Alabama at Birmingham, Birmingham, Alabama, United States|Barrow Neurological Institute, Phoenix, Arizona, United States|Mayo Clinic - Arizona, Scottsdale, Arizona, United States|City of Hope Comprehensive Cancer Center - Duarte, Duarte, California, United States|The University of Southern California, Los Angeles, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|University of California Irvine Health Chao Family Comprehensive Cancer Center, Orange, California, United States|University of California San Diego Moores Cancer Center, San Diego, California, United States|University of California San Francisco Helen Diller Family Comprehensive CA Ctr, San Francisco, California, United States|University of Colorado Hospital Anschutz Cancer Pavilion, Aurora, Colorado, United States|Blue Sky Neurology, Englewood, Colorado, United States|Smilow Cancer Hospital - New Haven, New Haven, Connecticut, United States|Lynn Cancer Institute, Boca Raton, Florida, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|Sylvester Comprehensive Cancer Center, Miami, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Kentucky Markey Cancer Center, Lexington, Kentucky, United States|Norton Cancer Institute - Multidisciplinary Clinic, Louisville, Kentucky, United States|University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|John Nasseff Neuroscience Institute, Minneapolis, Minnesota, United States|Masonic Cancer Center, Minneapolis, Minnesota, United States|Mayo Clinic - Rochester, Rochester, Minnesota, United States|Washington University School of Medicine Center for Advanced Medicine, Saint Louis, Missouri, United States|Hackensack Meridian Health - JFK Medical Center, Edison, New Jersey, United States|New York University Medical Oncology Associates, New York, New York, United States|New York - Presbyterian - Weill Cornell Medical Center, New York, New York, United States|Messino Cancer Centers, Asheville, North Carolina, United States|Wake Forest Baptist Health - Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|The Ohio State University - The James Cancer Hospital and Solove Research Institute, Columbus, Ohio, United States|Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Penn Medicine - Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh, Pennsylvania, United States|SCRI - Tennessee Oncology - Nashville - Centennial, Nashville, Tennessee, United States|Vanderbilt - Ingram Cancer Center, Nashville, Tennessee, United States|Austin Cancer Center - Park St. David's, Austin, Texas, United States|Baylor University Medical Center, Dallas, Texas, United States|Lynn Cancer Institute, Houston, Texas, United States|University of Texas Health Science Center at Houston (UT Health), Houston, Texas, United States|Mays Cancer Center, San Antonio, Texas, United States|University of Utah, Salt Lake City, Utah, United States|Seattle Cancer Care Alliance, Seattle, Washington, United States|British Columbia Cancer Agency - Abbotsford, Abbotsford, British Columbia, Canada|British Columbia Cancer Agency - Victoria, Victoria, British Columbia, Canada|The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada|Hôpital Fleurimont, Sherbrooke, Quebec, Canada|First Affiliated Hospital of USTC - Anhui Provincial Hospital, Hefei, Anhui, China|Beijing Tian Tan Hospital, Capital Medical University, Beijing, Beijing, China|Sanbo Brain Hospital, Capital Medical University, Beijing, Beijing, China|Peking Union Medical College Hospital, Beijing, Beijing, China|Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China|Shenzhen Second People's Hospital, Shenzhen, Guangdon, China|Tongji Hospital, Wuhan, Hubei, China|Shengjing Hospital - Nanhu Campus, Shenyang, Liaoning, China|Tangdu Hospital, Xian, Shaanxi, China|Huashan Hospital Affiliated to Fudan University, Shanghai, Shanghai, China|Tianjin Huanhu Hospital, Jinnan, Tianjin, China|General Hospital of Tianjin Medical University, Tianjin, Tianjin, China","https://ClinicalTrials.gov/show/NCT03776071"
423,"Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Glioblastoma","Biological: IDO1 Inhibitor BMS-986205|Biological: Nivolumab|Radiation: Radiation Therapy|Drug: Temozolomide","Northwestern University, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT04047706"
424,"2-OHOA With RT and TMZ for Adults With Glioblastoma","Recruiting","No Results Available","Primary Glioblastoma|Glioblastoma Multiforme","Drug: 2-OHOA|Drug: TMZ|Radiation: RT","Institut Cancerologie de L'Ouest (ICO), Angers, France|Gustave Roussy University Hospital, Rennes, France|Institut universitaire du cancer, Toulouse, France|Reaserch Fund of the Hadassah Medical Organization, Jerusalem, Israel|Istituto Nazionale Neurologico Carlo Besta, Milan, Italy|Istituto Nazionale Tumori ""Regina Elena"", Roma, Italy|University of Turin, Turin, Italy|Hospital Universitari i Politécnic La Fe., Valencia, Comunidad Valenciana, Spain|Hospital Clinic, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Vall d'Hebron, Barcelona, Spain|Hospital Universitario 12 De Octubre, Madrid, Spain|Hospital Parc Tauli, Sabadell, Spain|Freeman Hospital's Northern Centre of Cancer Care, Newcastle, Newcastle Upon Tyne, United Kingdom|Cambridge university hospital, Cambridge, United Kingdom|The Royal Marsden Hospital, London, United Kingdom","https://ClinicalTrials.gov/show/NCT04250922"
425,"Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma","Withdrawn","No Results Available","Glioblastoma","Drug: Dichloroacetate (DCA)",,"https://ClinicalTrials.gov/show/NCT00703859"
426,"Image-derived Prediction of Response to Chemo-radiation in Glioblastoma","Terminated","No Results Available","Glioblastoma","Radiation: Radiotherapy|Drug: Temozolomide","Department of Oncology, Section for Radiotherapy, Rigshospitalet, Copenhagen, Denmark","https://ClinicalTrials.gov/show/NCT02329795"
427,"Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens","Withdrawn","No Results Available","Glioblastoma","Biological: PEP-CMV",,"https://ClinicalTrials.gov/show/NCT01854099"
428,"Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma","Terminated","No Results Available","Glioblastoma","Biological: NeoVax|Biological: Nivolumab|Biological: Ipilimumab|Procedure: Research blood draw|Procedure: Leukapheresis for research","Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT03422094"
429,"Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma","Not yet recruiting","No Results Available","Refractory Glioblastoma","Drug: Elemene|Drug: Temozolomide","Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China","https://ClinicalTrials.gov/show/NCT04674527"
430,"Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma","Completed","No Results Available","Glioblastoma","Biological: Avelumab|Radiation: Hypofractionated radiation therapy (HFRT)","University of California, Los Angeles (UCLA), Los Angeles, California, United States|UCSF Medical Center, San Francisco, California, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Laura & Isaac Perlmutter Cancer Center & NYU Langone Medical Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT02968940"
431,"Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma","Suspended","No Results Available","Glioblastoma","Other: Tumor Biopsy","University of Michigan, Ann Arbor, Michigan, United States","https://ClinicalTrials.gov/show/NCT03287063"
432,"Irinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent Glioblastoma","Recruiting","No Results Available","Recurrent Glioblastoma","Drug: Bevacizumab，Irinotecan and Re-radiotherapy","Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT05201326"
433,"Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery","Withdrawn","No Results Available","Glioblastoma","Procedure: Diffusion Weighted Imaging|Drug: Gadolinium|Other: Laboratory Biomarker Analysis|Procedure: Magnetic Resonance Imaging|Procedure: Perfusion Magnetic Resonance Imaging",,"https://ClinicalTrials.gov/show/NCT02590497"
434,"A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma","Completed","No Results Available","Glioblastoma","Drug: Vorinostat|Drug: Bevacizumab|Drug: Irinotecan","H. Lee Moffitt Cancer Center & Research Institute, Inc., Tampa, Florida, United States","https://ClinicalTrials.gov/show/NCT00762255"
435,"Neoadjuvant Nivolumab in Glioblastoma","Completed","No Results Available","Glioblastoma Multiforme","Drug: Nivolumab","Clinica Universidad de Navarra, Pamplona, Navarra, Spain","https://ClinicalTrials.gov/show/NCT02550249"
436,"Hypofractionated Radiation Therapy for Glioblastoma","Unknown status","No Results Available","Glioblastoma Multiforme","Radiation: Hypofractionated radiation therapy","Instituto do Cancer do Estado de São Paulo (ICESP) - FMUSP, São Paulo, Sao Paulo, Brazil","https://ClinicalTrials.gov/show/NCT03212235"
437,"Prolonged Adjuvant Temozolomide vs ""Stop & Go"" in Glioblastoma Patients","Unknown status","No Results Available","Glioblastoma","Drug: Temozolomide","Cliniques Universitaires Saint-Luc, Brussels, Europe, Belgium","https://ClinicalTrials.gov/show/NCT00643825"
438,"TH-302 in Combination With Bevacizumab for Glioblastoma","Completed","Has Results","Glioblastoma","Drug: Bevacizumab|Drug: TH-302","Dana-Farber Cancer Institute, Boston, Massachusetts, United States|University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT02342379"
439,"Memantine for Recurrent Glioblastoma","Terminated","Has Results","Glioblastoma","Drug: memantine","University of Rochester Medical Center, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT01260467"
440,"Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma","Terminated","No Results Available","Glioblastoma","Radiation: Stereotactic Radiosurgery|Drug: Nivolumab|Drug: Valproate","University of Virginia, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT02648633"
441,"Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1)","Withdrawn","No Results Available","Glioblastoma Multiforme","Drug: IL-4PE",,"https://ClinicalTrials.gov/show/NCT00797940"
442,"Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma Multiforme","Drug: Retifanlimab|Drug: Temozolomide|Radiation: Radiation Therapy","Johns Hopkins Medical Institution, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT05083754"
443,"RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.","Recruiting","No Results Available","Glioblastoma","Biological: Autologous DCs derived from PBMC loaded with RNA encoding the human CMV matrix protein pp65-flLAMP plus GM-CSF","University of Florida Health Shands Hospital, Gainesville, Florida, United States","https://ClinicalTrials.gov/show/NCT04963413"
444,"Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Glioblastoma|MGMT-Unmethylated Glioblastoma","Drug: Microtubule-Targeted Agent BAL101553|Radiation: Radiation Therapy|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study","UAB Comprehensive Cancer Center, Birmingham, Alabama, United States|Johns Hopkins University, Baltimore, Maryland, United States|Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|Abrams Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT03250299"
445,"Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM","Terminated","No Results Available","Astrocytoma, Grade IV|Giant Cell Glioblastoma|Glioblastoma Multiforme|Cyclophosphamide|Immunosuppressive Agents|Immunologic Factors|Physiological Effects of Drugs|Molecular Mechanisms of Pharmacological Action|Antiviral Agents|Anti-infective Agents|Analgesics, Non-narcotic|Analgesics|Sensory System Agents|Peripheral Nervous System Agents","Biological: CYNK001-IV|Biological: CYNK001-IT","The Univeristy of Texas MD ANderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04489420"
446,"An Efficacy Study Of Ortataxel In Recurrent Glioblastoma","Completed","No Results Available","Glioblastoma","Drug: Ortataxel","Ospedale di Lecco, Lecco, Italy|A.O. OSpedale Niguarda Ca' Granda, Milano, Italy|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy|Carlo Besta Neurological Foundation, Milan, Italy|Fondazione ""Salvatore Maugeri"", Pavia, Italy|IRCCS Fondazione ""Casimiro Mondino"", Pavia, Italy|Istituti Fisioterapici Ospitalieri, Rome, Italy","https://ClinicalTrials.gov/show/NCT01989884"
447,"Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme","Completed","Has Results","Glioblastoma Multiforme of the Brain","Drug: Antineoplaston therapy (Atengenal + Astugenal)","Burzynski Clinic, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00003474"
448,"Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma","Completed","No Results Available","Glioblastoma","Procedure: Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging|Drug: Ferumoxytol|Drug: Gadoteridol|Procedure: Magnetic Resonance Imaging","Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|OHSU Knight Cancer Institute, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT02359097"
449,"A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioblastoma With Elevated Mutational Burden","Recruiting","No Results Available","Recurrent Glioblastoma|Secondary Glioblastoma","Biological: Ipilimumab|Biological: Nivolumab","Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States|Anchorage Radiation Therapy Center, Anchorage, Alaska, United States|Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States|Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States|Alaska Women's Cancer Care, Anchorage, Alaska, United States|Anchorage Oncology Centre, Anchorage, Alaska, United States|Katmai Oncology Group, Anchorage, Alaska, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Cancer Center at Saint Joseph's, Phoenix, Arizona, United States|Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States|Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Mercy Hospital Fort Smith, Fort Smith, Arkansas, United States|CHI Saint Vincent Cancer Center Hot Springs, Hot Springs, Arkansas, United States|Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande, California, United States|Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States|UC San Diego Moores Cancer Center, La Jolla, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|Pacific Central Coast Health Center-San Luis Obispo, San Luis Obispo, California, United States|Mission Hope Medical Oncology - Santa Maria, Santa Maria, California, United States|Torrance Memorial Physician Network - Cancer Care, Torrance, California, United States|Torrance Memorial Medical Center, Torrance, California, United States|University of Colorado Hospital, Aurora, Colorado, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, United States|Rocky Mountain Cancer Centers-Penrose, Colorado Springs, Colorado, United States|Porter Adventist Hospital, Denver, Colorado, United States|Mercy Medical Center, Durango, Colorado, United States|Southwest Oncology PC, Durango, Colorado, United States|Saint Anthony Hospital, Lakewood, Colorado, United States|Littleton Adventist Hospital, Littleton, Colorado, United States|Longmont United Hospital, Longmont, Colorado, United States|Rocky Mountain Cancer Centers-Longmont, Longmont, Colorado, United States|Parker Adventist Hospital, Parker, Colorado, United States|Saint Mary Corwin Medical Center, Pueblo, Colorado, United States|Beebe South Coastal Health Campus, Frankford, Delaware, United States|Beebe Medical Center, Lewes, Delaware, United States|Delaware Clinical and Laboratory Physicians PA, Newark, Delaware, United States|Helen F Graham Cancer Center, Newark, Delaware, United States|Medical Oncology Hematology Consultants PA, Newark, Delaware, United States|Christiana Care Health System-Christiana Hospital, Newark, Delaware, United States|Beebe Health Campus, Rehoboth Beach, Delaware, United States|TidalHealth Nanticoke / Allen Cancer Center, Seaford, Delaware, United States|Christiana Care Health System-Wilmington Hospital, Wilmington, Delaware, United States|Holy Cross Hospital, Fort Lauderdale, Florida, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|Low Country Cancer Care, Savannah, Georgia, United States|Memorial Health University Medical Center, Savannah, Georgia, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States|Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, United States|Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, United States|Walter Knox Memorial Hospital, Emmett, Idaho, United States|Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho, United States|Idaho Urologic Institute-Meridian, Meridian, Idaho, United States|Saint Luke's Cancer Institute - Meridian, Meridian, Idaho, United States|Saint Alphonsus Medical Center-Nampa, Nampa, Idaho, United States|Saint Luke's Cancer Institute - Nampa, Nampa, Idaho, United States|Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, United States|Kootenai Cancer Clinic, Sandpoint, Idaho, United States|Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho, United States|Saint Anthony's Health, Alton, Illinois, United States|Rush - Copley Medical Center, Aurora, Illinois, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, United States|Illinois CancerCare-Canton, Canton, Illinois, United States|Memorial Hospital of Carbondale, Carbondale, Illinois, United States|SIH Cancer Institute, Carterville, Illinois, United States|Illinois CancerCare-Carthage, Carthage, Illinois, United States|Centralia Oncology Clinic, Centralia, Illinois, United States|Northwestern University, Chicago, Illinois, United States|University of Illinois, Chicago, Illinois, United States|Carle on Vermilion, Danville, Illinois, United States|Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Illinois CancerCare-Dixon, Dixon, Illinois, United States|Carle Physician Group-Effingham, Effingham, Illinois, United States|Crossroads Cancer Center, Effingham, Illinois, United States|Illinois CancerCare-Eureka, Eureka, Illinois, United States|NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, United States|NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois, United States|NorthShore University HealthSystem-Highland Park Hospital, Highland Park, Illinois, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States|Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, United States|Illinois CancerCare-Macomb, Macomb, Illinois, United States|Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, United States|Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Illinois CancerCare-Pekin, Pekin, Illinois, United States|OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center, Pekin, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|OSF Saint Francis Radiation Oncology at Peoria Cancer Center, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Illinois CancerCare-Peru, Peru, Illinois, United States|Valley Radiation Oncology, Peru, Illinois, United States|Illinois CancerCare-Princeton, Princeton, Illinois, United States|North Shore Medical Center, Skokie, Illinois, United States|Southern Illinois University School of Medicine, Springfield, Illinois, United States|Springfield Clinic, Springfield, Illinois, United States|Memorial Medical Center, Springfield, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|The Carle Foundation Hospital, Urbana, Illinois, United States|Illinois CancerCare - Washington, Washington, Illinois, United States|Rush-Copley Healthcare Center, Yorkville, Illinois, United States|Baptist Health Floyd, New Albany, Indiana, United States|Mary Greeley Medical Center, Ames, Iowa, United States|McFarland Clinic PC - Ames, Ames, Iowa, United States|McFarland Clinic PC-Boone, Boone, Iowa, United States|Saint Anthony Regional Hospital, Carroll, Iowa, United States|Medical Oncology and Hematology Associates-West Des Moines, Clive, Iowa, United States|Mercy Cancer Center-West Lakes, Clive, Iowa, United States|Alegent Health Mercy Hospital, Council Bluffs, Iowa, United States|Greater Regional Medical Center, Creston, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa, United States|Broadlawns Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Laurel, Des Moines, Iowa, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|Iowa Lutheran Hospital, Des Moines, Iowa, United States|McFarland Clinic PC-Trinity Cancer Center, Fort Dodge, Iowa, United States|Trinity Regional Medical Center, Fort Dodge, Iowa, United States|McFarland Clinic PC-Jefferson, Jefferson, Iowa, United States|McFarland Clinic PC-Marshalltown, Marshalltown, Iowa, United States|Methodist West Hospital, West Des Moines, Iowa, United States|Mercy Medical Center-West Lakes, West Des Moines, Iowa, United States|Cancer Center of Kansas - Chanute, Chanute, Kansas, United States|Cancer Center of Kansas - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas - El Dorado, El Dorado, Kansas, United States|Central Care Cancer Center - Garden City, Garden City, Kansas, United States|Central Care Cancer Center - Great Bend, Great Bend, Kansas, United States|Cancer Center of Kansas-Independence, Independence, Kansas, United States|Cancer Center of Kansas-Kingman, Kingman, Kansas, United States|Cancer Center of Kansas-Liberal, Liberal, Kansas, United States|Cancer Center of Kansas-Manhattan, Manhattan, Kansas, United States|Cancer Center of Kansas - McPherson, McPherson, Kansas, United States|Cancer Center of Kansas - Newton, Newton, Kansas, United States|Cancer Center of Kansas - Parsons, Parsons, Kansas, United States|Cancer Center of Kansas - Pratt, Pratt, Kansas, United States|Cancer Center of Kansas - Salina, Salina, Kansas, United States|Cancer Center of Kansas - Wellington, Wellington, Kansas, United States|Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita, Kansas, United States|Ascension Via Christi Hospitals Wichita, Wichita, Kansas, United States|Cancer Center of Kansas - Wichita, Wichita, Kansas, United States|Cancer Center of Kansas - Winfield, Winfield, Kansas, United States|Flaget Memorial Hospital, Bardstown, Kentucky, United States|Commonwealth Cancer Center-Corbin, Corbin, Kentucky, United States|Baptist Health Lexington, Lexington, Kentucky, United States|Saint Joseph Radiation Oncology Resource Center, Lexington, Kentucky, United States|Saint Joseph Hospital East, Lexington, Kentucky, United States|Saint Joseph London, London, Kentucky, United States|Jewish Hospital, Louisville, Kentucky, United States|Saints Mary and Elizabeth Hospital, Louisville, Kentucky, United States|UofL Health Medical Center Northeast, Louisville, Kentucky, United States|Jewish Hospital Medical Center South, Shepherdsville, Kentucky, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|Bronson Battle Creek, Battle Creek, Michigan, United States|IHA Hematology Oncology Consultants-Brighton, Brighton, Michigan, United States|Saint Joseph Mercy Brighton, Brighton, Michigan, United States|IHA Hematology Oncology Consultants-Canton, Canton, Michigan, United States|Saint Joseph Mercy Canton, Canton, Michigan, United States|Caro Cancer Center, Caro, Michigan, United States|IHA Hematology Oncology Consultants-Chelsea, Chelsea, Michigan, United States|Saint Joseph Mercy Chelsea, Chelsea, Michigan, United States|Hematology Oncology Consultants-Clarkston, Clarkston, Michigan, United States|Newland Medical Associates-Clarkston, Clarkston, Michigan, United States|Ascension Saint John Hospital, Detroit, Michigan, United States|Great Lakes Cancer Management Specialists-Doctors Park, East China Township, Michigan, United States|Genesee Cancer and Blood Disease Treatment Center, Flint, Michigan, United States|Genesee Hematology Oncology PC, Flint, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, United States|Academic Hematology Oncology Specialists, Grosse Pointe Woods, Michigan, United States|Great Lakes Cancer Management Specialists-Van Elslander Cancer Center, Grosse Pointe Woods, Michigan, United States|Michigan Breast Specialists-Grosse Pointe Woods, Grosse Pointe Woods, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Ascension Borgess Cancer Center, Kalamazoo, Michigan, United States|Borgess Medical Center, Kalamazoo, Michigan, United States|Sparrow Hospital, Lansing, Michigan, United States|Hope Cancer Clinic, Livonia, Michigan, United States|Saint Mary Mercy Hospital, Livonia, Michigan, United States|Great Lakes Cancer Management Specialists-Macomb Medical Campus, Macomb, Michigan, United States|Michigan Breast Specialists-Macomb Township, Macomb, Michigan, United States|Saint Mary's Oncology/Hematology Associates of Marlette, Marlette, Michigan, United States|Mercy Health Mercy Campus, Muskegon, Michigan, United States|Lakeland Hospital Niles, Niles, Michigan, United States|Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores, Michigan, United States|21st Century Oncology-Pontiac, Pontiac, Michigan, United States|Hope Cancer Center, Pontiac, Michigan, United States|Newland Medical Associates-Pontiac, Pontiac, Michigan, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, United States|Spectrum Health Reed City Hospital, Reed City, Michigan, United States|Great Lakes Cancer Management Specialists-Rochester Hills, Rochester Hills, Michigan, United States|Ascension Saint Mary's Hospital, Saginaw, Michigan, United States|Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan, United States|Lakeland Medical Center Saint Joseph, Saint Joseph, Michigan, United States|Marie Yeager Cancer Center, Saint Joseph, Michigan, United States|Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan, United States|Ascension Saint Joseph Hospital, Tawas City, Michigan, United States|Munson Medical Center, Traverse City, Michigan, United States|Advanced Breast Care Center PLLC, Warren, Michigan, United States|Great Lakes Cancer Management Specialists-Macomb Professional Building, Warren, Michigan, United States|Macomb Hematology Oncology PC, Warren, Michigan, United States|Michigan Breast Specialists-Warren, Warren, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan, United States|Metro Health Hospital, Wyoming, Michigan, United States|Huron Gastroenterology PC, Ypsilanti, Michigan, United States|IHA Hematology Oncology Consultants-Ann Arbor, Ypsilanti, Michigan, United States|Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Minnesota Oncology - Burnsville, Burnsville, Minnesota, United States|Cambridge Medical Center, Cambridge, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Unity Hospital, Fridley, Minnesota, United States|Fairview Clinics and Surgery Center Maple Grove, Maple Grove, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|Health Partners Inc, Minneapolis, Minnesota, United States|Monticello Cancer Center, Monticello, Minnesota, United States|New Ulm Medical Center, New Ulm, Minnesota, United States|Fairview Northland Medical Center, Princeton, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, United States|Lakeview Hospital, Stillwater, Minnesota, United States|Sanford Thief River Falls Medical Center, Thief River Falls, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Rice Memorial Hospital, Willmar, Minnesota, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States|Sanford Cancer Center Worthington, Worthington, Minnesota, United States|Fairview Lakes Medical Center, Wyoming, Minnesota, United States|Saint Louis Cancer and Breast Institute-Ballwin, Ballwin, Missouri, United States|Central Care Cancer Center - Bolivar, Bolivar, Missouri, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, United States|Southeast Cancer Center, Cape Girardeau, Missouri, United States|Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States|Parkland Health Center - Farmington, Farmington, Missouri, United States|Capital Region Southwest Campus, Jefferson City, Missouri, United States|Freeman Health System, Joplin, Missouri, United States|Mercy Hospital Joplin, Joplin, Missouri, United States|Delbert Day Cancer Institute at PCRMC, Rolla, Missouri, United States|Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, United States|Saint Louis Cancer and Breast Institute-South City, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Mercy Hospital South, Saint Louis, Missouri, United States|Missouri Baptist Medical Center, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, United States|Mercy Hospital Springfield, Springfield, Missouri, United States|CoxHealth South Hospital, Springfield, Missouri, United States|Missouri Baptist Sullivan Hospital, Sullivan, Missouri, United States|Missouri Baptist Outpatient Center-Sunset Hills, Sunset Hills, Missouri, United States|Mercy Hospital Washington, Washington, Missouri, United States|Community Hospital of Anaconda, Anaconda, Montana, United States|Billings Clinic Cancer Center, Billings, Montana, United States|Bozeman Deaconess Hospital, Bozeman, Montana, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, United States|Great Falls Clinic, Great Falls, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Saint Patrick Hospital - Community Hospital, Missoula, Montana, United States|Community Medical Hospital, Missoula, Montana, United States|CHI Health Saint Francis, Grand Island, Nebraska, United States|CHI Health Good Samaritan, Kearney, Nebraska, United States|Saint Elizabeth Regional Medical Center, Lincoln, Nebraska, United States|Cancer Partners of Nebraska - Pine Lake, Lincoln, Nebraska, United States|Southeast Nebraska Cancer Center - 68th Street Place, Lincoln, Nebraska, United States|Alegent Health Immanuel Medical Center, Omaha, Nebraska, United States|Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, United States|Alegent Health Lakeside Hospital, Omaha, Nebraska, United States|Creighton University Medical Center, Omaha, Nebraska, United States|Midlands Community Hospital, Papillion, Nebraska, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Morristown Medical Center, Morristown, New Jersey, United States|Capital Health Medical Center-Hopewell, Pennington, New Jersey, United States|Overlook Hospital, Summit, New Jersey, United States|Randolph Hospital, Asheboro, North Carolina, United States|Messino Cancer Centers, Asheville, North Carolina, United States|Cone Health Cancer Center at Alamance Regional, Burlington, North Carolina, United States|Cone Health Cancer Center, Greensboro, North Carolina, United States|Vidant Medical Center, Greenville, North Carolina, United States|Cone Heath Cancer Center at Mebane, Mebane, North Carolina, United States|Sanford Bismarck Medical Center, Bismarck, North Dakota, United States|Sanford South University Medical Center, Fargo, North Dakota, United States|Southpointe-Sanford Medical Center Fargo, Fargo, North Dakota, United States|Sanford Medical Center Fargo, Fargo, North Dakota, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States|University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio, United States|Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio, United States|Bethesda North Hospital, Cincinnati, Ohio, United States|TriHealth Cancer Institute-Westside, Cincinnati, Ohio, United States|TriHealth Cancer Institute-Anderson, Cincinnati, Ohio, United States|University of Cincinnati Cancer Center-West Chester, West Chester, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma, United States|Saint Alphonsus Medical Center-Baker City, Baker City, Oregon, United States|Saint Charles Health System, Bend, Oregon, United States|Clackamas Radiation Oncology Center, Clackamas, Oregon, United States|Providence Cancer Institute Clackamas Clinic, Clackamas, Oregon, United States|Bay Area Hospital, Coos Bay, Oregon, United States|Providence Newberg Medical Center, Newberg, Oregon, United States|Saint Alphonsus Medical Center-Ontario, Ontario, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|Saint Charles Health System-Redmond, Redmond, Oregon, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, United States|Christiana Care Health System-Concord Health Center, Chadds Ford, Pennsylvania, United States|Pocono Medical Center, East Stroudsburg, Pennsylvania, United States|Lehigh Valley Hospital-Hazleton, Hazleton, Pennsylvania, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States|Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|Saint Joseph Regional Cancer Center, Bryan, Texas, United States|Parkland Memorial Hospital, Dallas, Texas, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|Inova Schar Cancer Institute, Fairfax, Virginia, United States|Inova Fairfax Hospital, Falls Church, Virginia, United States|Providence Regional Cancer System-Aberdeen, Aberdeen, Washington, United States|PeaceHealth Saint Joseph Medical Center, Bellingham, Washington, United States|Harrison HealthPartners Hematology and Oncology-Bremerton, Bremerton, Washington, United States|Harrison Medical Center, Bremerton, Washington, United States|Highline Medical Center-Main Campus, Burien, Washington, United States|Providence Regional Cancer System-Centralia, Centralia, Washington, United States|Swedish Cancer Institute-Edmonds, Edmonds, Washington, United States|Saint Elizabeth Hospital, Enumclaw, Washington, United States|Providence Regional Cancer Partnership, Everett, Washington, United States|Saint Francis Hospital, Federal Way, Washington, United States|Swedish Cancer Institute-Issaquah, Issaquah, Washington, United States|Kadlec Clinic Hematology and Oncology, Kennewick, Washington, United States|Providence Regional Cancer System-Lacey, Lacey, Washington, United States|Saint Clare Hospital, Lakewood, Washington, United States|PeaceHealth Saint John Medical Center, Longview, Washington, United States|Harrison HealthPartners Hematology and Oncology-Poulsbo, Poulsbo, Washington, United States|Pacific Gynecology Specialists, Seattle, Washington, United States|Swedish Medical Center-Ballard Campus, Seattle, Washington, United States|Swedish Medical Center-First Hill, Seattle, Washington, United States|Swedish Medical Center-Cherry Hill, Seattle, Washington, United States|PeaceHealth United General Medical Center, Sedro-Woolley, Washington, United States|Providence Regional Cancer System-Shelton, Shelton, Washington, United States|Franciscan Research Center-Northwest Medical Plaza, Tacoma, Washington, United States|Northwest Medical Specialties PLLC, Tacoma, Washington, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, United States|Providence Saint Mary Regional Cancer Center, Walla Walla, Washington, United States|Providence Regional Cancer System-Yelm, Yelm, Washington, United States|United Hospital Center, Bridgeport, West Virginia, United States|WVUH-Berkely Medical Center, Martinsburg, West Virginia, United States|West Virginia University Healthcare, Morgantown, West Virginia, United States|Camden Clark Medical Center, Parkersburg, West Virginia, United States|Mayo Clinic Health System-Eau Claire Clinic, Eau Claire, Wisconsin, United States|Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States|Mayo Clinic Health System-Franciscan Healthcare, La Crosse, Wisconsin, United States|ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin, United States|ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States|ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States|UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States|Billings Clinic-Cody, Cody, Wyoming, United States|Welch Cancer Center, Sheridan, Wyoming, United States|Pan American Center for Oncology Trials LLC, San Juan, Puerto Rico","https://ClinicalTrials.gov/show/NCT04145115"
450,"A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients","Recruiting","No Results Available","Glioblastoma Multiforme","Drug: Valganciclovir Tablets|Drug: Temozolomide 120 mg|Radiation: Radiotherapy 60 Gy|Drug: Placebo oral tablet","SE01 Karolinska University Hospital, Solna, Stockholm, Sweden","https://ClinicalTrials.gov/show/NCT04116411"
451,"Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas","Completed","No Results Available","Glioblastoma","Device: iMRI-guided surgery|Drug: 5-ALA-guided surgery","Department of Neurosurgery, Universitätsklinikum Bonn, Bonn, Germany, Bonn, Germany|Department of Neurosurgery, Universität zu Köln, Köln, Germany, Cologne, Germany|Städtisches Klinikum Dresden Friedrichstadt, Dresden, Germany|Department of Neurosurgery, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Düsseldorf, Germany|Department of Neurosurgery, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany|Department of Neurosurgery, Johann Wolfgang Goethe-University Frankfurt am Main, Frankfurt a.M., Germany|Department of Neurosurgery, Georg-August-Universität Göttingen, Göttingen,, Göttingen, Germany|Department of Neurosurgery, University of Ulm, Hospital Günzburg,, Günzburg, Germany|Asklepios Klinik Hamburg, Klinik für Neurochirurgie, Hamburg, Germany|International Neuroscience Institute Hannover, Hannover, Germany, Hannover, Germany|Department of Neurosurgery, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany|Department of Neurosurgery, University of Schleswig-Holstein, Kiel, Germany, Kiel, Germany|Department of Neurosurgery, Westfälische Wilhelms-Universität Münster, Münster, Germany, Münster, Germany|Department of Neurosurgery, Eberhard Karls University, Tübingen,, Tübingen, Germany|Department of Neurosurgery, Julius-Maximilians-Universität Würzburg, Würzburg, Germany","https://ClinicalTrials.gov/show/NCT02379572"
452,"89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme","Completed","Has Results","Glioblastoma","Drug: 89Zr-J591|Device: PET/CT Scan|Device: MRI|Other: Blood draw","Memorial Sloan Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT02410577"
453,"Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy","Terminated","No Results Available","Glioblastoma Multiforme","Drug: TPI 287|Drug: Bevacizumab","University of Alabama at Birmingham, Birmingham, Alabama, United States|H Lee Moffitt Cancer Center and Research Institute, Inc., Tampa, Florida, United States|Northwestern Medical Faculty Foundation, Chicago, Illinois, United States|Washington University, School of Medicine, Saint Louis, Missouri, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States|University of Rochester Medical Center, Rochester, New York, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Memorial Hermann Hospital, Houston, Texas, United States|University of Virginia Health System, Charlottesville, Virginia, United States|Swedish Neuroscience Institute, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT02047214"
454,"Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)","Active, not recruiting","No Results Available","Glioblastoma|Glioblastoma, WHO Grade IV","Drug: Temozolomide (TMZ)|Device: Optune System|Drug: Pembrolizumab","University of Florida Health, Gainesville, Florida, United States","https://ClinicalTrials.gov/show/NCT03405792"
455,"Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients","Completed","No Results Available","Glioblastoma Multiforme|Brain Tumor|Glioblastoma|Glioma|Neoplasms|Neoplasms, Nerve Tissue","Device: NaviFUS System","Linkou Chang Gung Memorial Hospital, Taoyuan City, Taiwan","https://ClinicalTrials.gov/show/NCT03626896"
456,"Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study","Completed","No Results Available","Glioblastoma","Procedure: Surgery (based on preoperative multimodal MRI) followed by the standard radio-chemotherapy stupp protocol","CHU Rangueil, Toulouse, France|Institut Claudius REGAUD, Toulouse, France","https://ClinicalTrials.gov/show/NCT01872221"
457,"MET-PET for Newly Diagnosed Glioblastoma","Completed","No Results Available","Glioblastoma","Device: C-11 methionine PET","Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01867593"
458,"Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme","Completed","Has Results","Glioblastoma Multiforme","Biological: Autologous Dendritic Cell|Drug: Temozolomide|Procedure: Radiotherapy|Biological: Dendritic Cell Vaccine","Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States","https://ClinicalTrials.gov/show/NCT00323115"
459,"A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma","Recruiting","No Results Available","Glioblastoma","Radiation: Hypofractionated stereotactic radiation therapy|Drug: Durvalumab","Institut de Cancerologie de L'Ouest, Angers, France|Hopital Avicenne, Bobigny, France|Centre Francois Baclesse, Caen, France|Centre Georges Francois Leclerc, Dijon, France|Institut Regional Du Cancer de Montpellier, Montpellier, France|Hopital Pitie Salpetriere, Paris, France|Institut Curie, Saint Cloud, France|Centre Paul Strauss, Strasbourg, France|Institut Claudius Regaud, Toulouse, France|Institut Gustave Roussy, Villejuif, France","https://ClinicalTrials.gov/show/NCT02866747"
460,"Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Multiforme","Drug: Zarnestra|Procedure: standard Radiation therapy","Centre Jean Perrin, Clermont Ferrand, France|Institut Claudius Regaud, Toulouse, France","https://ClinicalTrials.gov/show/NCT00209989"
461,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status","Completed","Has Results","Glioblastoma","Drug: Cilengitide|Drug: Temozolomide|Radiation: Radiotherapy","Please Contact U.S. Medical Information Located in, Rockland, Massachusetts, United States|Please Contact the Merck KGaA Communication Center Located in, Darmstadt, Germany","https://ClinicalTrials.gov/show/NCT00689221"
462,"Efficacy of Distant Healing in Glioblastoma Treatment","Completed","No Results Available","Glioblastoma","Procedure: Distant Healing","California Pacific Medical Center Research Institute, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT00029783"
463,"Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma","Terminated","No Results Available","Glioblastoma Multiforme","Drug: CYT997|Drug: Carboplatin","Royal North Shore Hospital, St-Leonards, New South Wales, Australia|Gold Coast Hospital, Southport, Queensland, Australia|Flinders Medical Centre, Bedford Park, South Australia, Australia|Monash Medical Centre, Melbourne, Victoria, Australia","https://ClinicalTrials.gov/show/NCT00650949"
464,"Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma|Gliosarcoma","Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Sapanisertib|Procedure: Therapeutic Conventional Surgery","University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States|UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States|UCSF Medical Center-Parnassus, San Francisco, California, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Case Western Reserve University, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT02133183"
465,"Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM","Recruiting","No Results Available","Glioblastoma Multiforme (GBM)|Glioblastoma|Glioma of Brain|Glioblastoma, Adult|Brain Tumor|Brain Tumor, Primary|Brain Tumor Adult|Cancer|Brain Cancer","Drug: Capecitabine|Drug: Temozolomide","Lenox Hill Brain Tumor Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT03213002"
466,"Determination of Immune Phenotype in Glioblastoma Patients","Recruiting","No Results Available","Glioblastoma Multiforme","Procedure: Surgery","Department of Neurosurgery, Ulm, Germany","https://ClinicalTrials.gov/show/NCT02751138"
467,"Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)","Terminated","No Results Available","Glioblastoma","Drug: imatinib mesylate","Rio Grande, Brazil","https://ClinicalTrials.gov/show/NCT00171938"
468,"Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma|Gliosarcoma","Drug: Atezolizumab|Radiation: Radiation Therapy|Drug: Temozolomide","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03174197"
469,"Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene","Unknown status","No Results Available","Newly Diagnosed Non Methylated Glioblastoma Multiforme Grade 4","Drug: Cilengitide","Royal North Shore Hospital, Sydney, New South Wales, Australia","https://ClinicalTrials.gov/show/NCT01124240"
470,"Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide","Completed","No Results Available","Glioblastoma","Drug: Temozolomide|Drug: Disulfiram|Dietary Supplement: Copper gluconate","Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT01907165"
471,"Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma","Suspended","No Results Available","Glioblastoma Multiforme","Drug: TPI 287|Drug: Bevacizumab","University of Alabama at Birmingham, Birmingham, Alabama, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States|The Long Island Brain Tumor Center at Neurological Surgery, P.C., Commack, New York, United States|The Long Island Brain Tumor Center at Neurological Surgery, P.C., Lake Success, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Memorial Hermann Hospital, Houston, Texas, United States|Swedish Neuroscience Institute, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT01933815"
472,"A Study Evaluating Temferon in Patients With Glioblastoma & Unmethylated MGMT","Recruiting","No Results Available","Glioblastoma Multiforme","Drug: Temferon","Ospedale San Raffaele, Milan, Italy|Fondazione IRCCS Istituto Neurologico ""Carlo Besta"", Milan, Italy|Policlinico Universitario Fondazione Agostino Gemelli, Rome, Italy","https://ClinicalTrials.gov/show/NCT03866109"
473,"Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme","Completed","No Results Available","Recurrent Glioblastoma Multiforme","Drug: buparlisib|Drug: carboplatin|Drug: lomustine|Drug: placebo","Barrow Neurological Insitute St. Joseph's Hospital, Phoenix, Arizona, United States|Highlands Oncology Group, Fayetteville, Arkansas, United States|Northwestern University, Chicago, Illinois, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|MD Anderson Cancer Center/University of Texas, Houston, Texas, United States|Novartis Investigative Site, Heidelberg, Victoria, Australia|Novartis Investigative Site, Parkville, Victoria, Australia|Novartis Investigative Site, Leuven, Belgium|Novartis Investigative Site, Toronto, Ontario, Canada|Novartis Investigative Site, Marseille Cedex 05, France|Novartis Investigative Site, Paris Cedex 13, France|Novartis Investigative Site, Saint Herblain cedex, France|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, Hospitalet de LLobregat, Catalunya, Spain","https://ClinicalTrials.gov/show/NCT01934361"
474,"A Study in Recurrent Glioblastoma (GB)","Active, not recruiting","No Results Available","Glioblastoma","Drug: LY2157299 monohydrate|Drug: Lomustine|Drug: Placebo","For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Birmingham, Alabama, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., La Jolla, California, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., San Francisco, California, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Cleveland, Ohio, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dallas, Texas, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., St. Leonards, New South Wales, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Heidelberg, Victoria, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Parkville, Victoria, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Edegem, Belgium|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Gent, Belgium|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Liège, Belgium|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Toronto, Ontario, Canada|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Montreal, Quebec, Canada|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bobigny, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Lyon, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Marseille, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Nancy, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Paris, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bonn, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Frankfurt, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Hamburg, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Heidelberg, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bologna, Italy|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Terni, Italy|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Udine, Italy|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Lodz, Poland|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Barcelona, Spain","https://ClinicalTrials.gov/show/NCT01582269"
475,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status","Completed","Has Results","Glioblastoma","Drug: Cilengitide (2-times weekly)|Drug: cilengitide (5-times weekly)|Drug: Temozolomide|Radiation: Radiotherapy","Please Contact U.S. Medical Information Located in, Rockland, Massachusetts, United States|Please Contact the Merck KGaA Communication Center Located in, Darmstadt, Germany","https://ClinicalTrials.gov/show/NCT00813943"
476,"Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme","Unknown status","No Results Available","Glioblastoma Multiforme","Drug: MPC-6827 + Carboplatin","The Angeles Clinic and Research Institute, Los Angeles, California, United States|Emory University, Atlanta, Georgia, United States|Mt. Sinai School of Medicine, New York, New York, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, United States|Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT00635557"
477,"Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma","Completed","No Results Available","Glioblastoma","Drug: Bevacizumab|Radiation: Radiation therapy","Department of Neurology, University Hospital Zurich, Zurich, Switzerland","https://ClinicalTrials.gov/show/NCT01443676"
478,"FDG PET Imaging in Diagnosing Patients With Glioblastoma","Unknown status","No Results Available","Brain Glioblastoma","Procedure: Computed Tomography|Radiation: Fludeoxyglucose F-18|Procedure: Magnetic Resonance Imaging|Procedure: Positron Emission Tomography","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02885272"
479,"ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard Chemotherapy","Unknown status","No Results Available","Glioblastoma Multiforme","Device: BBB Disruption with Chemotherapy Arm","Severance Hospital, Yonsei University Health System, Seoul, Seodaemun-gu, Korea, Republic of","https://ClinicalTrials.gov/show/NCT03712293"
480,"Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme","Active, not recruiting","No Results Available","Recurrent Glioblastoma Multiforme","Radiation: Stereotactic hypofractionated RT 5x5Gy|Radiation: Stereotactic hypofractionated RT 5x7Gy","Hospital das Clinicas da Faculdade de Medicina da USP, Sao Paulo, SP, Brazil","https://ClinicalTrials.gov/show/NCT01464177"
481,"Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.","Completed","Has Results","Glioblastoma","Drug: Temozolomide","Hospital Universitari Germans Trias i Pujol/ICO Badalona, Badalona, Barcelona, Spain|Institut Català d'Oncologia L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain|Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain|Hospital Son Espases, Palma de Mallorca, Mallorca, Spain|Hospital Universitario Sant Joan de Reus, Reus, Tarragona, Spain|Consorcio Hospitalario Provincial de Castellón, Castelló, Valencia, Spain|Hospital del Mar, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|Hospital General de Ciudad Real, Ciudad Real, Spain|Hospital Dr. Josep Trueta de Girona, Girona, Spain|Hospital Arnau de Vilanova, Lleida, Spain|Hospital Universitario Lucus Augusti, Lugo, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Universitario Clínico San Carlos, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Clínico Universitario de Salamanca, Salamanca, Spain|Hospital Universitario Virgen del Rocío, Sevilla, Spain|Consorcio Hospital General Universitario de Valencia, Valencia, Spain|Hospital Universitario Miguel Servet, Zaragoza, Spain","https://ClinicalTrials.gov/show/NCT02209948"
482,"TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma","Active, not recruiting","No Results Available","Recurrent Glioblastoma","Drug: TTAC-0001 and pembrolizumab combination","Austin Hospital, Heidelberg, Victoria, Australia|Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia","https://ClinicalTrials.gov/show/NCT03722342"
483,"A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70","Recruiting","No Results Available","Glioblastoma","Radiation: Hypofractionated radiotherapy|Drug: Temozolomide","James Graham Brown Cancer Center, Louisville, Kentucky, United States","https://ClinicalTrials.gov/show/NCT01985087"
484,"VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma","Recruiting","No Results Available","Recurrent Glioblastoma","Biological: VXM01|Biological: Avelumab","Neurology Clinic and National Center for Tumor Diseases, Heidelberg, Germany|Neurology Clinic, Mannheim, Germany","https://ClinicalTrials.gov/show/NCT03750071"
485,"Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)","Unknown status","No Results Available","Glioblastoma Multiforme|Glioblastoma","Biological: Single arm, open-label","China Medical University Hospital, Taichung, Taiwan","https://ClinicalTrials.gov/show/NCT02772094"
486,"NVX-108 Combined With Radiation & TMZ, and During Maintenance Phase for Newly-diagnosed Glioblastoma Multiforme","Not yet recruiting","No Results Available","Glioblastoma Multiforme","Drug: NVX-108|Drug: Placebo Saline Infusion",,"https://ClinicalTrials.gov/show/NCT03862430"
487,"Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme","Completed","Has Results","Adult Glioblastoma Multiforme","Biological: olaratumab|Biological: ramucirumab","UAB Comprehensive Cancer Center, Birmingham, Alabama, United States|Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States|University of California San Francisco Medical Center, San Francisco, California, United States|H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa, Florida, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States|University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00895180"
488,"TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab","Recruiting","No Results Available","Recurrent Glioblastoma","Drug: TTAC-0001","Stanford Avanced Medical Center, Stanford, California, United States|Florida Hospital Cancer Institute & Florida Hospital Orlando, Orlando, Florida, United States|Austin Hospital, Heidelberg, Victoria, Australia","https://ClinicalTrials.gov/show/NCT03856099"
489,"Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS","Recruiting","No Results Available","Glioblastoma Multiforme","Drug: Regorafenib 40 MG Oral Tablet [STIVARGA]","Ospedale Generale Regionale "" F.Miulli "", Acquaviva Delle Fonti, BA, Italy|Policlinico Universitario di Bari, Bari, BA, Italy|IRCCS ""Saverio de Bellis"", Castellana Grotte, BA, Italy|Ospedlae S. Martino, Belluno, BL, Italy|Ospedale Bellaria, Bologna, BO, Italy|Ospedale Perrino, Brindisi, BR, Italy|Università e ASST Spedali Civili, Brescia, BS, Italy|Irst-Irccs, Meldola, FC, Italy|Ospedale Santa Maria Annunziata, Bagno A Ripoli, FI, Italy|Azienda Ospedaliera Universitaria Careggi, Firenze, FI, Italy|Ospedale Civile di Livorno, Livorno, LO, Italy|Ospedale Generale Provinciale, Macerata, MC, Italy|AOU Policlinico ""G.Martino"", Messina, ME, Italy|Istituto Neurologico C. Besta IRCCS, Milano, MI, Italy|Ospedale Humanitas, Rozzano, MI, Italy|Ospedale del Mare, Napoli, NL, Italy|Fondazione Istiuto Giglio Cefalù, Cefalù, PA, Italy|Aulss6 Euganea Padova Sud Ospedali Riuniti, Piove Di Sacco, PD, Italy|Azienda Ospedaliero Universitaria di Pisa, Pisa, PI, Italy|Istituto Nazionale Tumori Regina Elena -IFO, Roma, RM, Italy|Policlinico Universitario Gemelli, Roma, RM, Italy|Ospedale di Rovigo, Rovigo, RO, Italy|Azienda Ospedaliero Universitaria di Siena, Siena, SI, Italy|Azienda Ospedaliero Universitaria della Città della Salute e della Scienza, Torino, TO, Italy|Azienda Ospedaliera Santa Maria, Terni, TR, Italy|Ospedale San Donà di Piave _Azienda ULSS 4 "" Veneto Orientale"", San Dona di Piave, VE, Italy|AULSS 7 Distretto 2 Ospedale Santorso, Santorso, VI, Italy|AULSS 9 Scaligera Ospedale Mater Salutis, Legnago, VR, Italy|Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy","https://ClinicalTrials.gov/show/NCT04810182"
490,"Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma","Recruiting","No Results Available","Recurrent Glioblastoma","Biological: Dendritic Cell Tumor Cell Lysate Vaccine|Biological: Pembrolizumab|Other: Placebo Administration|Drug: Poly ICLC","UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT04201873"
491,"5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Multiforme","Drug: Temozolomide","Sibley Hospital, Washington, District of Columbia, United States|Suburban Hospital, Washington, District of Columbia, United States|SKCCC at Johns Hopkins (East Baltimore), Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT03291990"
492,"A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Multiforme","Drug: CAN008","Chang Gung Memorial Hospital, Linkou, Taipei, Taiwan|National Taiwan University Hospital, Taipei, Taiwan","https://ClinicalTrials.gov/show/NCT02853565"
493,"Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme","Active, not recruiting","No Results Available","Glioblastoma Multiforme","Drug: TIL|Drug: PD1-TIL","Huashan hospital, Fudan University, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT03347097"
494,"CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type","Not yet recruiting","No Results Available","Astrocytoma, Grade IV|Glioblastoma|Giant Cell Glioblastoma|Glioblastoma Multiforme","Biological: CYNK-001 systemic and Intra cavity administration",,"https://ClinicalTrials.gov/show/NCT05218408"
495,"Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma","Completed","Has Results","Glioblastoma","Drug: BKM120|Procedure: Surgery","University of California, Los Angeles, Los Angeles, California, United States|University of California, San Francisco, San Francisco, California, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|UT, MD Anderson Cancer Center, Houston, Texas, United States|Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT01339052"
496,"SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme","Unknown status","No Results Available","Glioblastoma Multiforme","Drug: Sunitinib","LKH Feldkirch, Feldkirch, Austria|Medical University Innsbruck, Innsbruck, Austria|LNK Wagner-Jauregg, Linz, Austria|Paracelsus Medical University, Salzburg, Austria|Medical University Vienna, Vienna, Austria|Kaiser-Franz-Josef Spital Wien, Wien, Austria|University Hospital of Heidelberg, Heidelberg, Baden-Württemberg, Germany|University Hospital of Mannheim, Mannheim, Baden-Württemberg, Germany|University Hospital of Bonn, Bonn, Nordrhein-Westfalen, Germany|University Hospital of Berlin, Berlin, Germany","https://ClinicalTrials.gov/show/NCT00535379"
497,"Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Multiforme","Radiation: Ultrafractionated brain irradiation|Drug: Temozolomide",,"https://ClinicalTrials.gov/show/NCT03310372"
498,"Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma","Not yet recruiting","No Results Available","Glioma|Glioblastoma","Device: TTFields","Zhongnan hospital, Wuhan, Hubei, China","https://ClinicalTrials.gov/show/NCT04902586"
499,"Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma","Completed","No Results Available","Glioblastoma",,"Washington University School of Medicine/Barnes-Jewish Hospital, St. Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT01880008"
500,"SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)","Recruiting","No Results Available","Newly Diagnosed Glioblastoma","Biological: SurVaxM","Dana Farber Cancer Institute, Boston, Massachusetts, United States|Atlantic Health, Summit, New Jersey, United States|Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States","https://ClinicalTrials.gov/show/NCT05163080"
501,"HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma","Completed","Has Results","Recurrent Glioblastoma","Drug: HIF-2alpha Inhibitor PT2385|Other: Pharmacological Study|Other: Laboratory Biomarker Analysis|Other: Pharmacogenomic Study","UAB Comprehensive Cancer Center, Birmingham, Alabama, United States|Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|Abrams Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT03216499"
502,"Pembrolizumab for Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Newly Diagnosed Glioblastoma","Drug: Pembrolizumab","University Hospital Bern / Inselspital, Bern, Switzerland|University Hospital Lausanne, CHUV, Lausanne, Switzerland|University Hospital Zurich, Zürich, Switzerland","https://ClinicalTrials.gov/show/NCT03899857"
503,"Radiation Boost for Newly Diagnosed Glioblastoma Multiforme","Terminated","No Results Available","Glioblastoma Multiforme","Drug: temozolomide|Procedure: Brachytherapy|Procedure: External Beam Radiation Therapy","Methodist University Hospital, Memphis, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00376103"
504,"Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)","Active, not recruiting","No Results Available","Glioblastoma Multiforme|Anaplastic Glioma","Drug: Vorinostat|Drug: Isotretinoin|Procedure: Surgical Resection|Drug: Temozolomide","University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00555399"
505,"NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma, Adult","Device: NovoTTF-200A|Drug: Temozolomide|Radiation: 3D conformal or intensity modulated radiation therapy (IMRT)","John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States","https://ClinicalTrials.gov/show/NCT03232424"
506,"A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma","Completed","Has Results","Glioblastoma|Glioblastoma Multiforme","Drug: TRC105|Drug: Bevacizumab","University of Cincinnati, Cincinnati, Ohio, United States|University Hospitals of Cleveland, Cleveland, Ohio, United States|Cleveland Clinic, Cleveland, Ohio, United States|Ohio State University, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT01564914"
507,"Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma|Recurrent Glioblastoma","Drug: Adavosertib|Radiation: Radiation Therapy|Drug: Temozolomide","University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States|UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States|UCSF Medical Center-Parnassus, San Francisco, California, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01849146"
508,"MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma","Device: MRI-guided Laser Heat Ablation (MLA)|Drug: Doxorubicin|Other: Blood draw - dendritic cells|Device: Dynamic Susceptibility Contrast Magnetic Resonance Imaging","Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT01851733"
509,"Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme","Unknown status","No Results Available","Glioblastoma Multiforme","Biological: anti-EGFRvIII CAR T cells|Drug: cyclophosphamide|Drug: Fludarabine","Sanbo Brain Hospital Capital Medical University, Beijing, China","https://ClinicalTrials.gov/show/NCT02844062"
510,"mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Multiforme","Drug: AZD2014","Tom Baker Cancer Centre, Calgary, Alberta, Canada|CancerCare Manitoba, Winnipeg, Manitoba, Canada|QEII Health Sciences Centre, Halifax, Nova Scotia, Canada|University Health Network, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT02619864"
511,"Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme","Unknown status","No Results Available","Glioblastoma Multiforme","Biological: Anti-PD-L1 CSR T cells|Drug: Cyclophosphamide|Drug: Fludarabine","Sanbo Brain Hospital Capital Medical University, Beijing, China","https://ClinicalTrials.gov/show/NCT02937844"
512,"A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme","Active, not recruiting","No Results Available","Glioblastoma Multiforme","Drug: Temozolomide|Radiation: radiation therapy|Drug: Ascorbic Acid","Holden Comprehensive Cancer Center, Iowa City, Iowa, United States","https://ClinicalTrials.gov/show/NCT02344355"
513,"Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma","Completed","No Results Available","Glioblastoma","Drug: TMZ",,"https://ClinicalTrials.gov/show/NCT01364064"
514,"Trial to Evaluate the Safety of TTAC-0001(Tanibirumab) in Recurrent Glioblastoma","Completed","No Results Available","Recurrent Glioblastoma","Drug: TTAC-0001",,"https://ClinicalTrials.gov/show/NCT03033524"
515,"A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression","Completed","Has Results","Glioblastoma","Drug: PX-866","Tom Baker Cancer Centre, Calgary, Alberta, Canada|BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada|CancerCare Manitoba, Winnipeg, Manitoba, Canada|QEII Health Sciences Centre, Halifax, Nova Scotia, Canada|London Regional Cancer Program, London, Ontario, Canada|Univ. Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada|Allan Blair Cancer Centre, Regina, Saskatchewan, Canada","https://ClinicalTrials.gov/show/NCT01259869"
516,"Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery","Recruiting","No Results Available","Glioblastoma Multiforme of Brain","Biological: Autologous dendritic cells pulsed with multiple neoantigen peptides.|Drug: Temozolomide adjuvant chemotherapy","Beijing Tiantan Hospital, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT04968366"
517,"Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma","Completed","Has Results","Recurrent Glioblastoma","Drug: Disulfiram/Copper|Drug: Temozolomide (TMZ)","Beaumont Hospital, Royal Oak, Michigan, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|John Theurer Cancer Center, Hackensack, New Jersey, United States|Lenox Hill Hospital, New York, New York, United States|University of Cincinnati, Cincinnati, Ohio, United States|Vanderbilt Ingram Cancer Center, Nashville, Tennessee, United States|Baylor University Medical Center, Dallas, Texas, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT03034135"
518,"Anlotinib Combined With STUPP for MGMT Nonmethylated Glioblastoma","Recruiting","No Results Available","MGMT-Unmethylated Glioblastoma","Drug: Anlotinib","The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China","https://ClinicalTrials.gov/show/NCT04725214"
519,"Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma","Completed","No Results Available","Glioblastoma","Drug: Pegylated Liposomal Doxorubicine","University of Regensburg, Department of Neurology, Regensburg, Germany","https://ClinicalTrials.gov/show/NCT00944801"
520,"Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)","Not yet recruiting","No Results Available","Recurrent Glioblastoma Multiforme","Drug: Berubicin Hydrochloride",,"https://ClinicalTrials.gov/show/NCT04915404"
521,"AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme","Unknown status","No Results Available","Glioblastoma Multiforme","Drug: AQ4N|Drug: Temozolomide|Procedure: Radiotherapy","University of California, Los Angeles, Los Angeles, California, United States|Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States|Henry Ford Health Systems, Detroit, Michigan, United States|Duke University Medical Center, Durham, North Carolina, United States|Baylor Research Institute, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT00394628"
522,"Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma Patients","Terminated","No Results Available","Glioblastoma Multiforme","Drug: PQR309","University Hospital Zurich, Neurology, Zurich, Switzerland","https://ClinicalTrials.gov/show/NCT02850744"
523,"[18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin )","Completed","No Results Available","Glioma Glioblastoma Multiforme","Drug: Axumin, Intravenous Solution","Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT03990285"
524,"Radiotherapy Planning Using Fluciclovine PET in Patients With Newly Diagnosed Glioblastoma","Not yet recruiting","No Results Available","Newly Diagnosed Glioblastoma","Drug: Fluciclovine PET guided Radiotherapy",,"https://ClinicalTrials.gov/show/NCT04840069"
525,"Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma","Suspended","No Results Available","Glioblastoma Multiforme","Biological: ICT-107|Biological: Placebo","University of Alabama at Birmingham, Birmingham, Alabama, United States|Dignity Health - St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|City of Hope Cancer Center, Duarte, California, United States|UCSD Moores Cancer Center, La Jolla, California, United States|Southern California Permanente Medical Group, Los Angeles, California, United States|University of Southern California, Los Angeles, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|University of California Irvine Chao Family Cancer Center, Orange, California, United States|Kaiser Permanente, Redwood City, California, United States|Kaiser Permanente, Sacramento, California, United States|John Wayne Cancer Institute, Santa Monica, California, United States|Stanford Cancer Institute, Stanford, California, United States|University of Colorado Denver, Aurora, Colorado, United States|Associated Neurologists of Southern Connecticut, Fairfield, Connecticut, United States|Smilow Cancer Hospital, New Haven, Connecticut, United States|Christiana Care Health Services, Newark, Delaware, United States|Delray Medical Center, Boca Raton, Florida, United States|Boca Raton Regional Hospital Lynn Cancer Institute, Boca Raton, Florida, United States|Piedmont Hospital, Atlanta, Georgia, United States|Georgia Regents University, Augusta, Georgia, United States|Northwestern University, Chicago, Illinois, United States|NorthShore University Health System, Evanston, Illinois, United States|University of Iowa, Iowa City, Iowa, United States|University of Kentucky, Lexington, Kentucky, United States|Norton Cancer Institute, Louisville, Kentucky, United States|Johns Hopkins University School of Medicine, Baltimore, Maryland, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Harvard Medical School Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|University of Michigan Health System, Ann Arbor, Michigan, United States|John Nasseff Neuroscience Institute, Minneapolis, Minnesota, United States|Metro-Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota, United States|JFK New Jersey Neuroscience Institute, Edison, New Jersey, United States|New Mexico Cancer Care Alliance, Albuquerque, New Mexico, United States|North Shore University Hospital, Lake Success, New York, United States|Perlmutter Cancer Center, New York, New York, United States|Mount Sinai Medical Center, New York, New York, United States|Columbia University Medical Center, New York, New York, United States|Weil Cornell Medical Center, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|The Ohio State University Medical Center, Columbus, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Penn State College of Medicine Hershey Medical Center, Hershey, Pennsylvania, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, Pennsylvania, United States|University of Tennessee Medical Cancer Institute, Knoxville, Tennessee, United States|Texas Oncology, Austin, Texas, United States|Baylor Health Charles Sammons Cancer Center, Dallas, Texas, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|University of Texas Health Science Center Memorial Hermann Hospital, Houston, Texas, United States|CTRC at UTHSCSA, San Antonio, Texas, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States|University of Virginia Health System, Charlottesville, Virginia, United States|Ivy Center for Advanced Brain Tumor Treatment Swedish Medical Center, Seattle, Washington, United States|University of Washington Medical Center, Seattle, Washington, United States|Medical University Innsbruck, Dept. of Neurology, Innsbruck, Austria|Kepler Universitätsklinikum, Neuromed Campus, Linz, Austria|University Clinic for Neurology, Salzburg, Austria|Juravinski Cancer Centre, Hamilton, Ontario, Canada|Princess Margaret Hospital, Toronto, Ontario, Canada|Montreal Neurological Institute & Hospital, Montreal, Quebec, Canada|CHUS Service de Neurochirurgie, Sherbrooke, Quebec, Canada","https://ClinicalTrials.gov/show/NCT02546102"
526,"Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma","Active, not recruiting","No Results Available","Recurrent Glioblastoma","Biological: Bevacizumab|Drug: Cediranib|Drug: Cediranib Maleate|Drug: Olaparib","UC San Diego Moores Cancer Center, La Jolla, California, United States|University of Colorado Hospital, Aurora, Colorado, United States|Smilow Cancer Hospital-Derby Care Center, Derby, Connecticut, United States|Smilow Cancer Hospital Care Center-Fairfield, Fairfield, Connecticut, United States|Smilow Cancer Hospital Care Center - Guiford, Guilford, Connecticut, United States|Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States|Smilow Cancer Center/Yale-New Haven Hospital, New Haven, Connecticut, United States|Yale University, New Haven, Connecticut, United States|Smilow Cancer Hospital-Orange Care Center, Orange, Connecticut, United States|Smilow Cancer Hospital-Torrington Care Center, Torrington, Connecticut, United States|Smilow Cancer Hospital Care Center-Trumbull, Trumbull, Connecticut, United States|Smilow Cancer Hospital-Waterbury Care Center, Waterbury, Connecticut, United States|Smilow Cancer Hospital Care Center - Waterford, Waterford, Connecticut, United States|Moffitt Cancer Center, Tampa, Florida, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Siteman Cancer Center-South County, Saint Louis, Missouri, United States|Siteman Cancer Center at Christian Hospital, Saint Louis, Missouri, United States|Siteman Cancer Center at Saint Peters Hospital, Saint Peters, Missouri, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT02974621"
527,"Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme","Withdrawn","No Results Available","Glioblastoma Multiforme","Drug: TransMID™","University of California-San Diego, La Jolla, California, United States|University of Southern California, Los Angeles, California, United States|University of Colorado Health Sciences Center, Denver, Colorado, United States|Yale University, New Haven, Connecticut, United States|Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|University of Chicago, Chicago, Illinois, United States|University of Iowa Hospitals in Clinics, Cedar Rapids, Iowa, United States|University of Kentucky Medical Center, Lexington, Kentucky, United States|Johns Hopkins Medical Center, Baltimore, Maryland, United States|NINDS National Institutes of Health, Bethesda, Maryland, United States|Fairview University Medical Center, Minneapolis, Minnesota, United States|Saint Louis University Hospital, St. Louis, Missouri, United States|Cooper University Hospital, Camden, New Jersey, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Columbia University Medical Center, New York,, New York, United States|SUNY Upstate Medical University at Syracuse, Syracuse, New York, United States|New York Medical College, Valhalla, New York, United States|University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States|Legacy Emanuel Hospital and Technology Center, Portland, Oregon, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Semmes-Murphey Neurologic Institute, Memphis, Tennessee, United States|University of Utah, Salt Lake City, Utah, United States|Medical College of Virginia, Richmond, Virginia, United States|Neville Knuckey, MD, Nedlands, Western Australia, Australia","https://ClinicalTrials.gov/show/NCT00083447"
528,"Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Glioblastoma Multiforme","Drug: Disulfiram|Drug: Copper Gluconate|Procedure: Surgery|Radiation: Radiation|Drug: Temozolomide","Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT02715609"
529,"Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study","Active, not recruiting","No Results Available","Glioblastoma Multiforme of Brain","Other: Ketogenic Diet|Other: Standardized Diet","MidAtlantic Epilepsy and Sleep Center, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT02302235"
530,"Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme","Recruiting","No Results Available","Glioblastoma Multiforme","Drug: Temozolomide|Radiation: Subventricular Zone radiation|Radiation: Neural Progenitor Cell Sparing radiation","Sibley Memorial Hospital, Washington, District of Columbia, United States|The SKCCC at Johns Hopkins, Baltimore, Maryland, United States|Suburban Hospital, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT02177578"
531,"Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme","Recruiting","No Results Available","Glioblastoma Multiforme","Drug: Bevacizumab","Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT02285959"
532,"Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.","Recruiting","No Results Available","MGMT-Unmethylated Glioblastoma","Drug: Anlotinib|Drug: AK105|Radiation: Radiotherapy","The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China","https://ClinicalTrials.gov/show/NCT05033587"
533,"A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma","Completed","No Results Available","Glioblastoma","Drug: Bevacizumab|Drug: Onartuzumab|Drug: Placebo","University of Alabama At Birmingham; Neuro-Oncology, Birmingham, Alabama, United States|Cedars Sinai Medical Center; Neurosurgery, Los Angeles, California, United States|UCLA, Los Angeles, California, United States|USCF - Neurosurgery, San Francisco, California, United States|Stanford Comprehensive Cancer Center, Stanford, California, United States|University of Colorado, Aurora, Colorado, United States|Florida Cancer Specialists - Englewood, Englewood, Florida, United States|Florida Cancer Specialists (St. Petersburg - St. Anthony's Professional Building), Saint Petersburg, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|North Western Univ; Neurology, Chicago, Illinois, United States|Northshore University Health System; Cardiology, Evanston, Illinois, United States|Henry Ford Health System, Detroit, Michigan, United States|Duke University Medical Center, Durham, North Carolina, United States|Hatton Research Institutes, Cincinnati, Ohio, United States|Sarah Cannon Cancer Center - Tennessee Oncology, Pllc, Nashville, Tennessee, United States|Baylor Research Inst., Dallas, Texas, United States|University of Virgina, Charlottesville, Virginia, United States|Virginia Cancer Institute, Richmond, Virginia, United States|Seattle Cancer Care Alliance; Investigational Drug Service, Seattle, Washington, United States|Hamilton Health Sciences - Juravinski Cancer Centre, Hamilton, Ontario, Canada|London Health Sciences Centre, London, Ontario, Canada|Sunnybrook Health Science Centre, Toronto, Ontario, Canada|Princess Margaret Hospital; Pencer Brain Tumour Centre, 18-727, Toronto, Ontario, Canada|McGill University; Montreal Neurological Institute; Oncology, Montreal, Quebec, Canada|CHUS Hopital Fleurimont; CRC, Sherbrooke, Quebec, Canada|Hopital Avicenne; Neurologie, Bobigny, France|Hopital neurologique Pierre Wertheimer - CHU Lyon; Neurologie, Bron, France|Hopital Roger Salengro, Lille, France|Hopital de La Timone - CHU de Marseille; Service de neuro-oncologie - Hôpital Adultes - 12ème étage, Marseille, France|Centre Val Aurelle Paul Lamarque; Medecine B3, Montpellier, France|Hôpital Central; Departement de Neuro-Oncologie, Nancy, France|Hopital Pitié Salpétrière - CHU; Service de neurologie 2 - Mazarin, Paris, France|Ico Rene Gauducheau; Oncologie, Saint Herblain, France|Hopital Purpan, Toulouse Cedex 9, France|Universitätsklinikum Bonn; Medizinische Klinik und Poliklinik I; Allgemeine Innere Medizin, Bonn, Germany|Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie, Frankfurt am Main, Germany|Universitatsklinikum Hamburg-Eppendorf; Klinik und Poliklinik fur Neurochirurgie, Hamburg, Germany|Ärztehaus Velen, Ibbenbühren, Germany|Universitätsklinikum Köln, Köln, Germany|Klinikum der Johannes Gutenberg Uni Mainz; Studienz. Neurologie, Klinik und Poliklinik Neurologie, Mainz, Germany|Uni Klinikum München - Großhardern; Med. Klinik U. Poliklinik III - Abt. Onkologie u. Hämatologie, München, Germany|Pius-Hospital, Oldenburg, Germany|Ospedale Bellaria; U.O. Oncologia Medica, Bologna, Emilia-Romagna, Italy|Presidio Ospedaliero Marconi Bufalini; U.O. di Oncologia, Cesena, Emilia-Romagna, Italy|A.O. Universitaria Di Parma; Oncologia Medica, Parma, Emilia-Romagna, Italy|Spedali Civili di Brescia, Brescia, Lombardia, Italy|Fondazione IRCCS Ospedale Maggiore Policlinico; Gastroenterologia, Milano, Lombardia, Italy|Fondazione IRCCS Istituto Neurologico C. Besta; Neuro-oncologia Sperimentale e Terapia Genica, Milano, Lombardia, Italy|Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino, Piemonte, Italy|Az. Osp. Pisana Ospedale S. Chiara; U.O. Di Reumatologia, Pisa, Toscana, Italy|Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia, Badalona, Barcelona, Spain|Clinica Universitaria de Navarra; Servicio de Oncologia, Pamplona, Navarra, Spain|Hospital Clinic i Provincial; Servicio de Farmacia, Barcelona, Spain|Institut Catala d Oncologia Hospital Duran i Reynals, Barcelona, Spain|Hospital Ramon y Cajal; Servicio de Oncologia, Madrid, Spain|HOSPITAL DE MADRID NORTE SANCHINARRO- CENTRO INTEGRAL ONCOLOGICO CLARA CAMPAL; Servicio de Oncologia, Madrid, Spain|Hospital Regional Universitario Carlos Haya; Servicio de Oncologia, Malaga, Spain|HUG; Oncologie, Geneve, Switzerland|Universitätsspital Zürich; Klinik für Neurologie, Zürich, Switzerland|Bristol Haematology and Oncology Centre, Bristol, United Kingdom|Sarah Cannon Research Institute, London, United Kingdom|Nottingham City Hospital; David Evans Centre, Nottingham, United Kingdom","https://ClinicalTrials.gov/show/NCT01632228"
534,"Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme","Completed","Has Results","Glioblastoma Multiforme","Biological: bevacizumab|Drug: dasatinib|Other: placebo","Mayo Clinic Scottsdale, Scottsdale, Arizona, United States|Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States|Palchak David MD, Pismo Beach, California, United States|Aurora Presbyterian Hospital, Aurora, Colorado, United States|Boulder Community Hospital, Boulder, Colorado, United States|Boulder Community Hospital, Boulder, Colorado, United States|Penrose Cancer Center at Penrose Hospital, Colorado Springs, Colorado, United States|St. Anthony Central Hospital, Denver, Colorado, United States|Porter Adventist Hospital, Denver, Colorado, United States|Presbyterian - St. Luke's Medical Center, Denver, Colorado, United States|St. Joseph Hospital, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|North Colorado Medical Center, Greeley, Colorado, United States|Sky Ridge Medical Center, Lone Tree, Colorado, United States|Hope Cancer Care Center at Longmont United Hospital, Longmont, Colorado, United States|McKee Medical Center, Loveland, Colorado, United States|St. Mary - Corwin Regional Medical Center, Pueblo, Colorado, United States|Exempla Lutheran Medical Center, Wheat Ridge, Colorado, United States|Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center, Hartford, Connecticut, United States|Beebe Medical Center, Lewes, Delaware, United States|Tunnell Cancer Center at Beebe Medical Center, Lewes, Delaware, United States|CCOP - Christiana Care Health Services, Newark, Delaware, United States|Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, District of Columbia, United States|Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital, Fort Lauderdale, Florida, United States|Memorial Cancer Institute at Memorial Regional Hospital, Hollywood, Florida, United States|Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|Ella Milbank Foshay Cancer Center at Jupiter Medical Center, Jupiter, Florida, United States|CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States|Florida Hospital Cancer Institute at Florida Hospital Orlando, Orlando, Florida, United States|John B Amos Cancer Center, Columbus, Georgia, United States|Kapiolani Medical Center at Pali Momi, 'Aiea, Hawaii, United States|Oncare Hawaii, Incorporated - Pali Momi, 'Aiea, Hawaii, United States|Cancer Research Center of Hawaii, Honolulu, Hawaii, United States|Oncare Hawaii Inc-POB II, Honolulu, Hawaii, United States|OnCare Hawaii, Incorporated - Lusitana, Honolulu, Hawaii, United States|Queen's Cancer Institute at Queen's Medical Center, Honolulu, Hawaii, United States|Straub Clinic and Hospital, Incorporated, Honolulu, Hawaii, United States|University of Hawaii, Honolulu, Hawaii, United States|Kuakini Medical Center, Honolulu, Hawaii, United States|OnCare Hawaii, Incorporated - Kuakini, Honolulu, Hawaii, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States|Castle Medical Center, Kailua, Hawaii, United States|Kauai Medical Clinic, Lihue, Hawaii, United States|Wilcox Memorial Hospital and Kauai Medical Clinic, Lihue, Hawaii, United States|Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center, Boise, Idaho, United States|Rush-Copley Cancer Care Center, Aurora, Illinois, United States|Illinois CancerCare - Bloomington, Bloomington, Illinois, United States|Illinois CancerCare - Canton, Canton, Illinois, United States|Illinois CancerCare - Carthage, Carthage, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|Eureka Community Hospital, Eureka, Illinois, United States|Illinois CancerCare - Eureka, Eureka, Illinois, United States|Galesburg Clinic, PC, Galesburg, Illinois, United States|Illinois CancerCare - Havana, Havana, Illinois, United States|Illinois CancerCare - Kewanee Clinic, Kewanee, Illinois, United States|Illinois CancerCare - Macomb, Macomb, Illinois, United States|Illinois CancerCare - Monmouth, Monmouth, Illinois, United States|BroMenn Regional Medical Center, Normal, Illinois, United States|Community Cancer Center, Normal, Illinois, United States|Illinois CancerCare - Community Cancer Center, Normal, Illinois, United States|Community Hospital of Ottawa, Ottawa, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Oncology Hematology Associates of Central Illinois, PC - Ottawa, Ottawa, Illinois, United States|Ottawa Regional Hospital and Healthcare Center, Ottawa, Illinois, United States|Cancer Treatment Center at Pekin Hospital, Pekin, Illinois, United States|Illinois CancerCare - Pekin, Pekin, Illinois, United States|Proctor Hospital, Peoria, Illinois, United States|CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States|Oncology Hematology Associates of Central Illinois, PC - Peoria, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|Illinois CancerCare - Peru, Peru, Illinois, United States|Illinois Valley Community Hospital, Peru, Illinois, United States|Illinois CancerCare - Princeton, Princeton, Illinois, United States|Illinois CancerCare - Spring Valley, Spring Valley, Illinois, United States|CCOP - Carle Cancer Center, Urbana, Illinois, United States|St. Francis Hospital Cancer Care Services, Indianapolis, Indiana, United States|Reid Hospital & Health Care Services, Richmond, Indiana, United States|McFarland Clinic, PC, Ames, Iowa, United States|Cedar Rapids Oncology Association, Cedar Rapids, Iowa, United States|Mercy Hospital, Cedar Rapids, Iowa, United States|Oncology Associates at Mercy Medical Center, Cedar Rapids, Iowa, United States|Medical Oncology and Hematology Associates - West Des Moines, Clive, Iowa, United States|Mercy Cancer Center - West Lakes, Clive, Iowa, United States|CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States|John Stoddard Cancer Center at Iowa Methodist Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates at John Stoddard Cancer Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates at Mercy Cancer Center, Des Moines, Iowa, United States|Mercy Cancer Center at Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|John Stoddard Cancer Center at Iowa Lutheran Hospital, Des Moines, Iowa, United States|Mercy Cancer Center at Mercy Medical Center - North Iowa, Mason City, Iowa, United States|Siouxland Hematology-Oncology Associates, LLP, Sioux City, Iowa, United States|Mercy Medical Center - Sioux City, Sioux City, Iowa, United States|St. Luke's Regional Medical Center, Sioux City, Iowa, United States|Methodist West Hospital, West Des Moines, Iowa, United States|Mercy Medical Center-West Lakes, West Des Moines, Iowa, United States|Cancer Center of Kansas - Chanute, Chanute, Kansas, United States|Cancer Center of Kansas, PA - Chanute, Chanute, Kansas, United States|Cancer Center of Kansas - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas, PA - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas - El Dorado, El Dorado, Kansas, United States|Cancer Center of Kansas, PA - El Dorado, El Dorado, Kansas, United States|Cancer Center of Kansas - Fort Scott, Fort Scott, Kansas, United States|Cancer Center of Kansas-Independence, Independence, Kansas, United States|Cancer Center of Kansas, PA - Kingman, Kingman, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|Cancer Center of Kansas, PA - Liberal, Liberal, Kansas, United States|Cancer Center of Kansas - Newton, Newton, Kansas, United States|Cancer Center of Kansas, PA - Newton, Newton, Kansas, United States|Cancer Center of Kansas - Parsons, Parsons, Kansas, United States|Cancer Center of Kansas, PA - Parsons, Parsons, Kansas, United States|Cancer Center of Kansas - Pratt, Pratt, Kansas, United States|Cancer Center of Kansas, PA - Pratt, Pratt, Kansas, United States|Cancer Center of Kansas - Salina, Salina, Kansas, United States|Cancer Center of Kansas, PA - Salina, Salina, Kansas, United States|Cancer Center of Kansas - Wellington, Wellington, Kansas, United States|Cancer Center of Kansas, PA - Wellington, Wellington, Kansas, United States|Associates in Women's Health - Wichita, Wichita, Kansas, United States|Associates in Womens Health, PA - North Review, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Medical Arts Tower, Wichita, Kansas, United States|Cancer Center of Kansas - Main Office, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Wichita, Wichita, Kansas, United States|CCOP - Wichita, Wichita, Kansas, United States|Via Christi Cancer Center at Via Christi Regional Medical Center, Wichita, Kansas, United States|Wesley Medical Center, Wichita, Kansas, United States|Cancer Center of Kansas - Winfield, Winfield, Kansas, United States|Cancer Center of Kansas, PA - Winfield, Winfield, Kansas, United States|Harold Alfond Center for Cancer Care, Augusta, Maine, United States|CancerCare of Maine at Eastern Maine Medical Center, Bangor, Maine, United States|Union Hospital of Cecil County, Elkton, Maryland, United States|Bixby Medical Center, Adrian, Michigan, United States|Hickman Cancer Center at Bixby Medical Center, Adrian, Michigan, United States|Toledo Clinic Cancer Centers - Adrian, Adrian, Michigan, United States|Toledo Clinic Cancer Centers-Adrian, Adrian, Michigan, United States|Saint Joseph Mercy Cancer Center, Ann Arbor, Michigan, United States|CCOP - Michigan Cancer Research Consortium, Ann Arbor, Michigan, United States|Oakwood Cancer Center at Oakwood Hospital and Medical Center, Dearborn, Michigan, United States|Saint John Hospital and Medical Center, Detroit, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Van Elslander Cancer Center at St. John Hospital and Medical Center, Grosse Pointe Woods, Michigan, United States|Foote Memorial Hospital, Jackson, Michigan, United States|Sparrow Regional Cancer Center, Lansing, Michigan, United States|St. Mary Mercy Hospital, Livonia, Michigan, United States|Community Cancer Center of Monroe, Monroe, Michigan, United States|Mercy Memorial Hospital - Monroe, Monroe, Michigan, United States|Toledo Clinic Cancer Centers-Monroe, Monroe, Michigan, United States|St. Joseph Mercy Oakland, Pontiac, Michigan, United States|Mercy Regional Cancer Center at Mercy Hospital, Port Huron, Michigan, United States|Saint Joseph Mercy Port Huron, Port Huron, Michigan, United States|Seton Cancer Institute at Saint Mary's - Saginaw, Saginaw, Michigan, United States|St. John Macomb Hospital, Warren, Michigan, United States|MeritCare Bemidji, Bemidji, Minnesota, United States|Sanford Clinic North-Bemidji, Bemidji, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy and Unity Cancer Center at Mercy Hospital, Coon Rapids, Minnesota, United States|Essentia Health - Duluth Clinic, Duluth, Minnesota, United States|CCOP - Duluth, Duluth, Minnesota, United States|Essentia Health Saint Mary's Medical Center, Duluth, Minnesota, United States|Miller - Dwan Medical Center, Duluth, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Mercy and Unity Cancer Center at Unity Hospital, Fridley, Minnesota, United States|Hutchinson Area Health Care, Hutchinson, Minnesota, United States|HealthEast Cancer Care at St. John's Hospital, Maplewood, Minnesota, United States|Minnesota Oncology - Maplewood, Maplewood, Minnesota, United States|Virginia Piper Cancer Institute at Abbott - Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center - Minneapolis, Minneapolis, Minnesota, United States|New Ulm Medical Center, New Ulm, Minnesota, United States|Humphrey Cancer Center at North Memorial Outpatient Center, Robbinsdale, Minnesota, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CentraCare Clinic - River Campus, Saint Cloud, Minnesota, United States|Coborn Cancer Center, Saint Cloud, Minnesota, United States|Saint Cloud Hospital, Saint Cloud, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|Park Nicollet Cancer Center, Saint Louis Park, Minnesota, United States|Regions Hospital Cancer Care Center, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|St. Francis Cancer Center at St. Francis Medical Center, Shakopee, Minnesota, United States|Lakeview Hospital, Stillwater, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Willmar Cancer Center at Rice Memorial Hospital, Willmar, Minnesota, United States|Minnesota Oncology - Woodbury, Woodbury, Minnesota, United States|Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|St. Vincent Healthcare Cancer Care Services, Billings, Montana, United States|Frontier Cancer Center and Blood Institutes-Billings, Billings, Montana, United States|Hematology-Oncology Centers of the Northern Rockies - Billings, Billings, Montana, United States|Billings Clinic - Downtown, Billings, Montana, United States|Billings Clinic, Billings, Montana, United States|Bozeman Deaconess Cancer Center, Bozeman, Montana, United States|Bozeman Deaconess Hospital, Bozeman, Montana, United States|St. James Healthcare Cancer Care, Butte, Montana, United States|Benefis Healthcare - Sletten Cancer Institute, Great Falls, Montana, United States|Benefis Sletten Cancer Institute, Great Falls, Montana, United States|St. Peter's Hospital, Helena, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Montana Cancer Specialists at Montana Cancer Center, Missoula, Montana, United States|Montana Cancer Center at St. Patrick Hospital and Health Sciences Center, Missoula, Montana, United States|Saint Francis Cancer Treatment Center at Saint Francis Memorial Health Center, Grand Island, Nebraska, United States|Cancer Resource Center - Lincoln, Lincoln, Nebraska, United States|Nebraska Cancer Research Center, Lincoln, Nebraska, United States|Callahan Cancer Center at Great Plains Regional Medical Center, North Platte, Nebraska, United States|CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|Immanuel Medical Center, Omaha, Nebraska, United States|Alegant Health Cancer Center at Bergan Mercy Medical Center, Omaha, Nebraska, United States|Alegent Health Lakeside Hospital, Omaha, Nebraska, United States|Lakeside Hospital, Omaha, Nebraska, United States|Creighton University Medical Center, Omaha, Nebraska, United States|UNMC Eppley Cancer Center at the University of Nebraska Medical Center, Omaha, Nebraska, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|Nevada Cancer Research Foundation CCOP, Las Vegas, Nevada, United States|New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care, Concord, New Hampshire, United States|New Hampshire Oncology-Hematology PA, Concord, New Hampshire, United States|New Hampshire Oncology - Hematology, PA - Hooksett, Hooksett, New Hampshire, United States|Lakes Region General Hospital, Laconia, New Hampshire, United States|Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Cooper Hospital University Medical Center, Camden, New Jersey, United States|Valley Hospital - Ridgewood, Ridgewood, New Jersey, United States|Cancer Institute of New Jersey at Cooper - Voorhees, Voorhees, New Jersey, United States|Mount Kisco Medical Group at Northern Westchester Hospital, Mount Kisco, New York, United States|Mount Sinai Medical Center, New York, New York, United States|Wayne Memorial Hospital, Incorporated, Goldsboro, North Carolina, United States|Kinston Medical Specialists, Kinston, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Medcenter One Hospital Cancer Care Center, Bismarck, North Dakota, United States|Mid Dakota Clinic, PC, Bismarck, North Dakota, United States|Sanford Bismarck Medical Center, Bismarck, North Dakota, United States|St. Alexius Medical Center Cancer Center, Bismarck, North Dakota, United States|MeritCare Broadway, Fargo, North Dakota, United States|Sanford Clinic North-Fargo, Fargo, North Dakota, United States|Dakota Cancer Institute at Dakota Clinic - South University, Fargo, North Dakota, United States|Essentia Health Cancer Center-South University Clinic, Fargo, North Dakota, United States|Sanford Medical Center-Fargo, Fargo, North Dakota, United States|Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States|Altru Cancer Center at Altru Hospital, Grand Forks, North Dakota, United States|Wood County Oncology Center, Bowling Green, Ohio, United States|Charles M. Barrett Cancer Center at University Hospital, Cincinnati, Ohio, United States|University of Cincinnati, Cincinnati, Ohio, United States|Grandview Hospital, Dayton, Ohio, United States|Good Samaritan Hospital, Dayton, Ohio, United States|David L. Rike Cancer Center at Miami Valley Hospital, Dayton, Ohio, United States|Samaritan North Cancer Care Center, Dayton, Ohio, United States|CCOP - Dayton, Dayton, Ohio, United States|Community Cancer Center, Elyria, Ohio, United States|Hematology Oncology Center, Elyria, Ohio, United States|Blanchard Valley Medical Associates, Findlay, Ohio, United States|Middletown Regional Hospital, Franklin, Ohio, United States|Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States|Wayne Hospital, Greenville, Ohio, United States|Charles F. Kettering Memorial Hospital, Kettering, Ohio, United States|Lima Memorial Hospital, Lima, Ohio, United States|Northwest Ohio Oncology Center, Maumee, Ohio, United States|St. Charles Mercy Hospital, Oregon, Ohio, United States|Toledo Clinic - Oregon, Oregon, Ohio, United States|Flower Hospital Cancer Center, Sylvania, Ohio, United States|Mercy Hospital of Tiffin, Tiffin, Ohio, United States|Toledo Hospital, Toledo, Ohio, United States|St. Vincent Mercy Medical Center, Toledo, Ohio, United States|Medical University of Ohio Cancer Center, Toledo, Ohio, United States|University of Toledo, Toledo, Ohio, United States|St. Anne Mercy Hospital, Toledo, Ohio, United States|Toledo Clinic Cancer Centers-Toledo, Toledo, Ohio, United States|Toledo Clinic, Incorporated - Main Clinic, Toledo, Ohio, United States|UVMC Cancer Care Center at Upper Valley Medical Center, Troy, Ohio, United States|Fulton County Health Center, Wauseon, Ohio, United States|Precision Radiotherapy at University Pointe, West Chester, Ohio, United States|Ruth G. McMillan Cancer Center at Greene Memorial Hospital, Xenia, Ohio, United States|Cancer Care Associates - Norman, Norman, Oklahoma, United States|Cancer Care Associates - Mercy Campus, Oklahoma City, Oklahoma, United States|Legacy Mount Hood Medical Center, Gresham, Oregon, United States|Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, United States|Legacy Meridian Park Hospital, Tualatin, Oregon, United States|Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest, Allentown, Pennsylvania, United States|Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Geisinger Medical Center-Cancer Center Hazelton, Hazleton, Pennsylvania, United States|Geisinger Medical Group, State College, Pennsylvania, United States|Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|McLeod Regional Medical Center, Florence, South Carolina, United States|Cancer Centers of the Carolinas - Faris Road, Greenville, South Carolina, United States|Cancer Centers of the Carolinas - Grove Commons, Greenville, South Carolina, United States|Greenville Health System Cancer Institute-Butternut, Greenville, South Carolina, United States|Greenville Health System Cancer Institute-Faris, Greenville, South Carolina, United States|Greenville Hospital Cancer Center, Greenville, South Carolina, United States|CCOP - Greenville, Greenville, South Carolina, United States|Cancer Centers of the Carolinas - Greer Medical Oncology, Greer, South Carolina, United States|Cancer Centers of the Carolinas - Seneca, Seneca, South Carolina, United States|Greenville Health System Cancer Institute-Seneca, Seneca, South Carolina, United States|Cancer Centers of the Carolinas - Spartanburg, Spartanburg, South Carolina, United States|Greenville Health System Cancer Institute-Spartanburg, Spartanburg, South Carolina, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States|Avera Cancer Institute, Sioux Falls, South Dakota, United States|Sanford Cancer Center at Sanford USD Medical Center, Sioux Falls, South Dakota, United States|Fredericksburg Oncology, Incorporated, Fredericksburg, Virginia, United States|Legacy Salmon Creek Hospital, Vancouver, Washington, United States|Gundersen Lutheran Center for Cancer and Blood, La Crosse, Wisconsin, United States|Froedtert and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Westfields Hospital/Cancer Center of Western Wisconsin, New Richmond, Wisconsin, United States|Oconomowoc Memorial Hospital-ProHealth Care Inc, Oconomowoc, Wisconsin, United States|Regional Cancer Center at Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States|Waukesha Memorial Hospital Regional Cancer Center, Waukesha, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00892177"
535,"Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma, Adult","Drug: Paxalisib (GDC-0084)","University of California Los Angeles - Jonsson Comprehensive Cancer Center, Los Angeles, California, United States|University of Colorado Cancer Center, Aurora, Colorado, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States|University of Oklahoma Health Sciences Center (Stephenson Cancer Center), Oklahoma City, Oklahoma, United States|MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03522298"
536,"Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme","Recruiting","No Results Available","Glioblastoma Multiforme",,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00083512"
537,"Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0","Recruiting","No Results Available","Glioblastoma","Drug: Sacituzumab Govitecan","Mays Cancer Center, UT Health San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT03995706"
538,"Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme","Active, not recruiting","No Results Available","Glioblastoma Multiforme","Drug: Pazopanib","Centre Antoine Lacassagne, Nice, Cedex 2, France","https://ClinicalTrials.gov/show/NCT02331498"
539,"Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma","Recruiting","No Results Available","Glioblastoma Multiforme, Adult","Drug: Stereotactic biopsy followed by stereotactical photodynamic therapy with 5-aminolevulinic acid|Procedure: Stereotactic biopsy","Medizinische Fakultät Carl Gustav Carus, Klinik und Poliklinik für Neurochirurgie, Dresden, Germany|Universitätsklinikum Düsseldorf, Klinik für Neurochirurgie, Abteilung Funktionelle NC & Stereotaxie, Düsseldorf, Germany|Universitätsklinikum Essen, Klinik für Neurochirurgie und Wirbelsäulenchirurgie, Essen, Germany|LMU München, Campus Großhadern, Neurochirurgische Klinik und Poliklinik, München, Germany|Universitätsklinikum Münster, Klinik und Poliklinik für Neurochirurgie, Münster, Germany","https://ClinicalTrials.gov/show/NCT04469699"
540,"Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas","Unknown status","No Results Available","Glioblastoma, Adult","Device: Radiotherapy","CHU Besançon, Besançon, France|Centre Georges François Leclerc, Dijon, France|Centre d'oncologie et de radiothérapie, Mâcon, France|Institut de cancérologie de Lorraine, Nancy, France|Paul Strauss, Strasbourg, France|Centre de Cancérologie Des Dentellières, Valenciennes, France","https://ClinicalTrials.gov/show/NCT03181477"
541,"VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM","Terminated","No Results Available","Glioblastoma Multiforme|Glioblastoma|Glioma|GBM|Brain Cancer","Drug: VAL-083, Dianhydrogalactitol|Drug: Physician's Choice of Salvage Therapy - temozolomide|Drug: Physician's Choice of Salvage Therapy - lomustine|Drug: Physician's Choice of Salvage Therapy - carboplatin","Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|University of California, San Francisco - Division of Neuro-Oncology, San Francisco, California, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|Atlantic Neuroscience Institute - Brain Tumor Center of NJ, Summit, New Jersey, United States|Dent Neurosciences Research Center, Amherst, New York, United States","https://ClinicalTrials.gov/show/NCT03149575"
542,"Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients","Completed","No Results Available","Glioblastoma","Drug: Temozolomide and lomustine|Drug: Temozolomide","Depatment of Neurosurgery, Charité, University Hospital Berlin, Berlin, Germany|Department of Neurology, University Hospital Bochum, Bochum, Germany|Department of Neurology, University Hospital Bonn, Bonn, Germany|Department of Neurosurgery, University Hospital Cologne, Cologne, Germany|Department of Neurosurgery, University Hospital Dresden, Dresden, Germany|Department of Neurosurgery, University Hospital Duesseldorf, Duesseldorf, Germany|Department of Neurosurgery, University Hospital Frankfurt, Frankfurt, Germany|Department of Radiooncology, University Hospital Leipzig, Leipzig, Germany|Department of Neurosurgery, University of Heidelberg, Medical Faculty of Mannheim, Mannheim, Germany|Department of Neurosurgery, University Hospital Muenster, Muenster, Germany|Department of Neurosurgery, University Hospital Munich (LMU), Munich, Germany|Department of Neurology, University Hospital Regensburg, Regensburg, Germany","https://ClinicalTrials.gov/show/NCT01149109"
543,"A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)","Completed","No Results Available","Glioblastoma","Drug: Erlotinib HCl (OSI-774)",,"https://ClinicalTrials.gov/show/NCT00337883"
544,"The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Multiforme","Drug: IL13-PE38QQR|Procedure: surgery and catheter placement (2 procedures)|Drug: prolifespan 20 with carmustine implant (GLIADEL® Wafer)|Procedure: surgery and wafer placement (1 procedure)","University of Alabama at Birmingham - Division of Neurosurgery, Birmingham, Alabama, United States|City of Hope National Medical Center, Duarte, California, United States|Los Angeles County/USC, Los Angeles, California, United States|Cedars-Sinai Medical Center - Neurological Institute, Los Angeles, California, United States|University of California - Los Angeles Neuro-Oncology Program, Los Angeles, California, United States|University of California San Francisco - Dept. of Neurological Surgery, San Francisco, California, United States|University of Colorado Hospital - Anschutz Cancer Pavillion, Aurora, Colorado, United States|Yale University School of Medicine - Department of Neurosurgery, New Haven, Connecticut, United States|Florida Hospital Neuroscience Institute, Orlando, Florida, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Emory University, Atlanta, Georgia, United States|Northwestern Medical Faculty Foundation, Inc. - Dept of Neurological Surgery, Chicago, Illinois, United States|CINN at Rush Unversity Medical School, Chicago, Illinois, United States|University of Chicago Medical Center, Chicago, Illinois, United States|Evanston Northwestern Healthcare, Evanston, Illinois, United States|The Johns Hopkins University, Baltimore, Maryland, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Health Systems, Detroit, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|St. Louis University, St. Louis, Missouri, United States|Memorial Sloan Kettering Cancer Center Department of Neurology, New York, New York, United States|Weill Cornell Medical College - Department of Neurological Surgery, New York, New York, United States|Columbia University Medical Center - Neurological Institute, New York, New York, United States|Carolina Neurosurgery & Spine Assoc., Charlotte, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|Wake Forest University Health Sciences - Department of Neurosurgery, Winston-Salem, North Carolina, United States|Cleveland Clinic Foundation Department of Neurological Surgery, Cleveland, Ohio, United States|The Ohio State University Medical Center, Columbus, Ohio, United States|Oregon Health & Science University, Portland, Oregon, United States|The Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Baptist Memorial Hospital, Memphis, Tennessee, United States|UT Southwestern Medical Center, Dallas, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States|Huntsman Cancer Insitute, Salt Lake City, Utah, United States|University of Virginia Health Systems - Department of Neurological Surgery, Charlottesville, Virginia, United States|Benaroya Research Institute at Virginia Mason Medical Center, Seattle, Washington, United States|West Virginia University Department of Neurosurgery, Morgantown, West Virginia, United States|University of Wisconsin Hospital and Clinic, Madison, Wisconsin, United States|Calgary Health Region, Calgary, Alberta, Canada|Walter MacKenzie Health Sciences Center, Edmonton, Alberta, Canada|Cancer Care Manitoba, Winnepeg, Manitoba, Canada|London Regional Cancer Center, London, Ontario, Canada|Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada|Montreal Neurological Institute and Hospital, Montreal, Quebec, Canada|Royal University Hospital, Saskatoon, Saskatchewan, Canada|Toronto Western Hospital Division of Neurosurgery, Toronto, Canada|Techniche Universität Dresden Klinik und Poliklinik für Neurochirurgie, Dresden, Germany|Universitätsklinikum Hamburg-Eppendorf - Klinik für Neurochirurgie, Hamburg, Germany|Klinikum der Universität Heidelberg, Heidelberg, Germany|Universitätsklinikum Schleswig-Holstein - Klinik für Neurochirurgie, Kiel, Germany|Ludwig-Maximilians-Universität München - Klinikum Großhadern - Neurochirurgische Klinik und Poliklinik, München, Germany|Rabin Medical Center - Department of Neurosurgery, Petach Tikva, Israel|Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel|Sheba Medical Center - Department of Neurosurgery, Tel Hashomer, Israel|Academisch Ziekenhuis Groningen Afd. Neurochirurgie, Groningen, Netherlands|Erasmus University MC, Rotterdam, Rotterdam, Netherlands|Institute of Neurological Sciences, Glasgow, United Kingdom|The Walton Centre for Neurology & Neurosurgery, Liverpool, United Kingdom","https://ClinicalTrials.gov/show/NCT00076986"
545,"Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma","Terminated","Has Results","RECURRENT GLIOBLASTOMA","Genetic: SGT-53|Drug: Temozolomide","MD Anderson Cancer Center, Houston, Texas, United States|China Medical University Hospital, Taichung, Taiwan","https://ClinicalTrials.gov/show/NCT02340156"
546,"ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme","Active, not recruiting","No Results Available","Glioblastoma|Gliosarcoma","Drug: ERC1671|Drug: GM-CSF|Drug: Cyclophosphamide|Drug: Oral Control (Sucrose pill)|Drug: Injectable control (Sodium Chloride Injection United States Pharmacopeia (USP) (0.9%))|Drug: Bevacizumab/Bevacizumab Biosimilar","University of California, Irvine, Orange, California, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01903330"
547,"Specific Preoperative Dynamic Contrast-enhanced MRI Semi-quantitative Markers Can Correlate With Vascularity in Specific Areas of the Glioblastoma Tissue and Predict Recurrence","Completed","No Results Available","Glioblastoma","Other: Dynamic contrast-enhanced MRI","Department of Neurosurgery, Cairo University Faculty of Medicine, Cairo, Egypt","https://ClinicalTrials.gov/show/NCT04846257"
548,"Enzastaurin Versus Lomustine in Glioblastoma","Completed","No Results Available","Glioblastoma","Drug: enzastaurin|Drug: lomustine","For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Phoenix, Arizona, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tucson, Arizona, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Berkeley, California, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Los Angeles, California, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., San Francisco, California, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Aurora, Colorado, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Newark, Delaware, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tampa, Florida, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Atlanta, Georgia, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Honolulu, Hawaii, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Chicago, Illinois, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Peoria, Illinois, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Iowa City, Iowa, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Kansas City, Kansas, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Baltimore, Maryland, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bethesda, Maryland, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Boston, Massachusetts, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Detroit, Michigan, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Minneapolis, Minnesota, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Rochester, Minnesota, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Columbia, Missouri, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Saint Louis, Missouri, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Omaha, Nebraska, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Las Vegas, Nevada, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Lebanon, New Hampshire, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Albuquerque, New Mexico, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Santa Fe, New Mexico, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Buffalo, New York, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., New York, New York, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Winston-Salem, North Carolina, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Columbus, Ohio, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Pittsburgh, Pennsylvania, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Memphis, Tennessee, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Nashville, Tennessee, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dallas, Texas, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Houston, Texas, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Lubbock, Texas, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., San Antonio, Texas, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Salt Lake City, Utah, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Charlottesville, Virginia, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Seattle, Washington, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madison, Wisconsin, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Liverpool, New South Wales, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., St Leonards, New South Wales, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Auchenflower, Queensland, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Heidelberg, Victoria, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Nedlands, Western Australia, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Graz, Austria|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Innsbruck, Austria|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Linz, Austria|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Wien, Austria|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Brussels, Belgium|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Leuven, Belgium|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Liège, Belgium|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., London, Ontario, Canada|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Ottawa, Ontario, Canada|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Toronto, Ontario, Canada|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Lyon, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Marseille, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Nancy, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Paris, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Poitiers, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bonn, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dresden, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Freiburg, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Heidelberg, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., München, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tübingen, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mumbai, India|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., New Delhi, India|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Vellore, India|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bologna, Italy|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Milano, Italy|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Napoli, Italy|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Roma, Italy|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Torino, Italy|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Ciudad Obregon, Mexico|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Guadalajara, Mexico|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mexico City, Mexico|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Monterrey, Mexico|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tijuana, Mexico|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tlalpan, Mexico|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Toluca, Mexico|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Amsterdam, Netherlands|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Den Haag, Netherlands|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Maastricht, Netherlands|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Rotterdam, Netherlands|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Lublin, Poland|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Warsaw, Poland|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Badalona, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Hospitalet Llobregat, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madrid, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Oviedo, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Valencia, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bristol, Avon, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Cambridge, Cambridgeshire, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Edinburgh, Scotland, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Glasgow, Scotland, United Kingdom","https://ClinicalTrials.gov/show/NCT00295815"
549,"Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme","Active, not recruiting","No Results Available","Glioblastoma Multiforme of Brain","Biological: avelumab","Clinique Neuro-Outaouais, Gatineau, Quebec, Canada","https://ClinicalTrials.gov/show/NCT03047473"
550,"Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma","Completed","No Results Available","Newly-diagnosed Glioblastoma","Drug: Losartan|Drug: Placebo","Neurology Department - Avicenne Hospital, Bobigny, France","https://ClinicalTrials.gov/show/NCT01805453"
551,"Efficacy Study of Oral Arginine to Improve Immune Function in Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Multiforme","Drug: arginine in powder form|Drug: Silica and cellulose placebo powder","Inova Outpatient Surgery Clinic and Inova Fairfax Hospital, Fairfax, Virginia, United States","https://ClinicalTrials.gov/show/NCT02017249"
552,"Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475","Unknown status","No Results Available","Glioblastoma","Drug: MK - 3475|Biological: Suppressor of the PI3K/Akt pathways","Dana-Farber Cancer Institute, Boston, Massachusetts, United States|M D Anderson Cancer Center, Houston, Texas, United States|UCL- Cliniques Universitaires Saint Luc, Brussels, Belgium|St Johannes Hospital, Duisburg, Germany|Spedali Civili di Brescia, Brescia, Italy|IRCCS San Raffaele, Milan, Italy|Lower-Silesian Oncology Centre, Wroclaw, Lower-Silesian, Poland|Pavlov State Medical University, St. Petersburg, Russian Federation|Hospital Universitario Germans Trias I Pujol, Barcelona,, Spain|Universitätsklinik für Frauenheilkunde, Bern, Switzerland|Regional Cancer Center, Dnepropetrovsk, Ukraine|National Institute of Cancer, Kiev, Ukraine|Royal Victoria Hospital, Belfast, Ulster, United Kingdom","https://ClinicalTrials.gov/show/NCT02430363"
553,"Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Recurrence Of Glioblastoma Multiforme","Terminated","No Results Available","Glioblastoma","Biological: Dendritic Cells Vaccine",,"https://ClinicalTrials.gov/show/NCT04002804"
554,"Multi Peptide Vaccination With XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Glioblastoma Multiforme of Brain","Drug: Multipeptide plus XS15","University Hospital Tübingen, Tübingen, BW, Germany","https://ClinicalTrials.gov/show/NCT04842513"
555,"BIBF 1120 in Recurrent Glioblastoma Multiforme","Completed","No Results Available","Recurrent Glioblastoma","Drug: BIBF1120","Rigshospitalet, Copenhagen, Denmark","https://ClinicalTrials.gov/show/NCT01251484"
556,"Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells","Withdrawn","No Results Available","Glioblastoma|Glioblastoma Multiforme","Drug: Carvedilol","WVU Cancer Institute - Mary Babb Randolph Cancer Center, Morgantown, West Virginia, United States","https://ClinicalTrials.gov/show/NCT03980249"
557,"Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)","Completed","Has Results","Glioblastoma","Radiation: Radiotherapy|Drug: Temozolomide",,"https://ClinicalTrials.gov/show/NCT00684567"
558,"A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)","Recruiting","No Results Available","Newly Diagnosed Glioblastoma","Drug: TJ107|Drug: TJ107 placebo","Shenzhen Second People's Hospital, Shenzhen, Guangdong, China|Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China|Tongji Hospital, Tongji Medical College of HUST, Wuhan, Hubei, China|Jiangsu Province Hospital, Nanjing, Jiangsu, China|The Second Affiliated Hospital Of Nanchang University, Nanchang, Jiangxi, China|Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China|Shengjing Hospital of China Medical University, Shenyang, Liaoning, China|General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China|Tangdu Hospital of The Fourth Military Medical University of Chinese PLA, Xi'an, Shaanxi, China|Beijing Tiantan Hospital, Capital Medical University, Beijing, China|Peking Union Medical College Hospital, Beijing, China|Chongqiong Cancer Hospital, Chongqing, China|Huashan Hospital Affiliated to Fudan University, Shanghai, China|Tianjin Huanhu Hospital, Tianjin, China|Tianjin Medical University Cancer Institute & Hospital, Tianjin, China|Prince of Wales Hospital, Hong Kong, Hong Kong","https://ClinicalTrials.gov/show/NCT04600817"
559,"Carvedilol With Chemotherapy in Second Line Glioblastoma and Response of Circulating Tumor Cells","Terminated","No Results Available","Glioblastoma Multiforme|Glioblastoma","Drug: Carvedilol","WVU Cancer Institute - Mary Babb Randolph Cancer Center, Morgantown, West Virginia, United States","https://ClinicalTrials.gov/show/NCT03861598"
560,"Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Newly Diagnosed Glioblastoma","Biological: GX-I7|Other: Placebo","St. Vincent Hospital, Suwon-si, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04065087"
561,"Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma","Terminated","No Results Available","Glioblastoma|Glioblastoma Multiforme","Drug: Nivolumab|Drug: Anti-GITR Monoclonal Antibody MK-4166|Drug: IDO1 inhibitor INCB024360|Drug: Ipilimumab","Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT03707457"
562,"Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma","Unknown status","No Results Available","First or Second Recurrence of Glioblastoma","Drug: Dovitinib","Department of Neurology and Center of Integrated Oncology, University Hospital Bonn, Bonn, Germany","https://ClinicalTrials.gov/show/NCT01972750"
563,"A Phase I Study of Immunotherapy With GSC -Loaded Dendritic Cells in Patients With Recurrent Glioblastoma","Completed","No Results Available","de Novo Glioblastoma","Biological: GSC-loaded autologous dendritic cells",,"https://ClinicalTrials.gov/show/NCT02820584"
564,"A Panobinostat Presurgery","Withdrawn","No Results Available","Recurrent Glioblastoma","Drug: panobinostat","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01115036"
565,"Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform","Unknown status","No Results Available","Glioblastoma Multiforme","Drug: Temozolomide|Drug: Disulfiram|Drug: Copper","Olympion Medical Center, Patras, Greece","https://ClinicalTrials.gov/show/NCT01777919"
566,"Dose-escalation Study to Evaluate the Safety and Tolerability of GX-I7 in Patients With Glioblastoma","Completed","No Results Available","Newly Diagnosed Glioblastoma","Drug: GX-I7","The Catholic University of Korea Seoul St. Mary's Hospital, Seoul, Seocho, Korea, Republic of","https://ClinicalTrials.gov/show/NCT03619239"
567,"Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme","Completed","Has Results","Glioblastoma Multiforme","Radiation: Radiation Therapy|Drug: Temozolomide|Drug: Sorafenib","Florida Cancer Specialists, Fort Myers, Florida, United States|Northeast Georgia Medical Center, Gainesville, Georgia, United States|Center for Cancer and Blood Disorders, Bethesda, Maryland, United States|Grand Rapids Clinical Oncology Program, Grand Rapids, Michigan, United States|Methodist Cancer Center, Omaha, Nebraska, United States|Oncology Hematology Care, Cincinnati, Ohio, United States|Spartanburg Regional Medical Center, Spartanburg, South Carolina, United States|Tennessee Oncology, Nashville, Tennessee, United States|South Texas Oncology and Hematology, San Antonio, Texas, United States|Virginia Cancer Institute, Richmond, Virginia, United States","https://ClinicalTrials.gov/show/NCT00544817"
568,"A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma","Completed","Has Results","Glioblastoma Multiforme","Drug: bevacizumab [Avastin]|Drug: fotemustine","Napoli, Campania, Italy|Bologna, Emilia-Romagna, Italy|Roma, Lazio, Italy|Genova, Liguria, Italy|Milano, Lombardia, Italy|Milano, Lombardia, Italy|San Giovanni Rotondo, Puglia, Italy|Terni, Umbria, Italy|Padova, Veneto, Italy|Treviso, Veneto, Italy","https://ClinicalTrials.gov/show/NCT01474239"
569,"An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse","Completed","No Results Available","Glioblastoma Multiforme",,"Kaohisung, Taiwan|Taipei, Taiwan|Taipei, Taiwan","https://ClinicalTrials.gov/show/NCT01618747"
570,"NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse","Withdrawn","No Results Available","Adult Brain Glioblastoma|Recurrent Adult Brain Neoplasm","Procedure: Electric Field Therapy|Biological: Bevacizumab|Drug: Carmustine|Other: Quality-of-Life Assessment","University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|Piedmont Hospital, Atlanta, Georgia, United States","https://ClinicalTrials.gov/show/NCT02348255"
571,"Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Multiforme","Drug: Temozolomide, bevacizumab and bortezomib","Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University Winship Cancer Institute, Atlanta, Georgia, United States","https://ClinicalTrials.gov/show/NCT01435395"
572,"Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma","Unknown status","No Results Available","Glioblastoma","Drug: Temozolomide|Drug: Temozolomide plus Thalidomide","University Zurich, Departement of Neurosurgery, Zurich, Switzerland","https://ClinicalTrials.gov/show/NCT00521482"
573,"A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma","Completed","Has Results","Glioblastoma","Drug: Bevacizumab|Drug: Temozolomide|Radiation: Radiation therapy|Drug: Placebo","University of Alabama At Birmingham; Neuro-Oncology, Birmingham, Alabama, United States|UCLA, Los Angeles, California, United States|University of Colorado, Aurora, Colorado, United States|Moffitt Cancer Center, Tampa, Florida, United States|Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr, Evanston, Illinois, United States|Henry Ford Health System, Detroit, Michigan, United States|Hatton Research Institutes, Cincinnati, Ohio, United States|Sarah Cannon Cancer Center and Research Institute, Nashville, Tennessee, United States|University of Virgina, Charlottesville, Virginia, United States|Prince of Wales Hospital; Department of Medical Oncology, Randwick, New South Wales, Australia|North Shore Private Hospital; Northern Specialist Centre, St Leonards, New South Wales, Australia|Royal North Shore Hospital; Department of Medical Oncology, St Leonards, New South Wales, Australia|Princess AleXandra Hospital; Department of Medical Oncology, Woolloongabba, Queensland, Australia|Calvary North Adelaide; North Adeliade Oncology Centre, North Adelaide, South Australia, Australia|Royal Melbourne Hospital; Hematology and Medical Oncology, Parkville, Victoria, Australia|Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia|Clin Univ de Bxl Hôpital Erasme, Bruxelles, Belgium|Cliniques Universitaires St-Luc, Bruxelles, Belgium|UZ Antwerpen, Edegem, Belgium|AZ Sint Lucas (Sint Lucas), Gent, Belgium|CHU Sart-Tilman, Liège, Belgium|AZ Delta (Campus Wilgenstraat), Roeselare, Belgium|Tom Baker Cancer Centre-Calgary, Calgary, Alberta, Canada|Cross Cancer Institute ; Dept of Medical Oncology, Edmonton, Alberta, Canada|BC Cancer Agency, Vancouver Clinic; Dept. of Medical Oncology, Vancouver, British Columbia, Canada|CancerCare Manitoba; Neuro-Oncology, Winnipeg, Manitoba, Canada|Hamilton Health Sciences - Juravinski Cancer Centre, Hamilton, Ontario, Canada|Cancer Centre of Southeastern Ontario; Kingston General Hospital, Kingston, Ontario, Canada|London Health Sciences Centre, London, Ontario, Canada|Ottawa Hospital Regional Cancer Centre; Neuro-Oncology, Ottawa, Ontario, Canada|Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada|Princess Margaret Hospital; Pencer Brain Tumour Centre, 18-727, Toronto, Ontario, Canada|Hopital Notre-Dame, Montreal, Quebec, Canada|McGill University; Montreal Neurological Institute; Oncology, Montreal, Quebec, Canada|Chuq - Hopital Hotel Dieu de Quebec, Quebec City, Quebec, Canada|Saskatoon Cancer Centre; Uni of Saskatoon Campus, Saskatoon, Saskatchewan, Canada|Aalborg Universitetshospital, Klinik Kirurgi-Kræft, Onkologisk afd., Aalborg, Denmark|Righospitalet, Hæmatologisk Klinik, København Ø, Denmark|Odense Universitetshospital, Onkologisk Afdeling R, Odense, Denmark|Hopital Avicenne; Rhumatologie, Bobigny, France|Hopital Saint Andre; Département de Radiothérapie Et D'Oncologie Médicale, Bordeaux, France|Institut Bergonie; Gastro Enterologie Oncologie, Bordeaux, France|Hopital neurologique Pierre Wertheimer - CHU Lyon; Neurologie, Bron, France|Centre Jean Perrin; Hopital De Jour, Clermont Ferrand, France|Hopital Beaujon; Oncologie, Clichy, France|Centre Georges François Leclerc, Dijon, France|Hopital de La Timone - CHU de Marseille; Service de neuro-oncologie - Hôpital Adultes - 12ème étage, Marseille, France|Centre Val Aurelle Paul Lamarque; Medecine B3, Montpellier, France|Hôpital Central; Departement de Neuro-Oncologie, Nancy, France|Hopital Pitié Salpétrière - CHU; Service de neurologie 2 - Mazarin, Paris, France|Universitätsklinikum ""Carl Gustav Carus""; Klinik und Poliklinik für Neurochirurgie, Dresden, Germany|Justus-Liebig-Universität Giessen; Neurochirurgische Klinik, Gießen, Germany|Universitatsklinikum Hamburg-Eppendorf; Klinik und Poliklinik fur Neurochirurgie, Hamburg, Germany|Universitatsklinikum Heidelberg; Abteilung Neuroonkologie, Heidelberg, Germany|Ärztehaus Velen, Ibbenbühren, Germany|Klinikum der Johannes Gutenberg Uni Mainz; Studienz. Neurologie, Klinik und Poliklinik Neurologie, Mainz, Germany|Uni Klinikum München - Großhardern; Med. Klinik U. Poliklinik III - Abt. Onkologie u. Hämatologie, München, Germany|Univ General Hosp Heraklion; Medical Oncology, Heraklion, Greece|University Hospital of Larissa; Oncology, Larissa, Greece|Papageorgiou General Hospital; Medical Oncology, Thessaloniki, Greece|Dr Stephen Yau; Clinical oncology, Hong Kong, Hong Kong|Hong Kong Sanatorium & Hospital; Comprehensive Oncology Centre, Hong Kong, Hong Kong|Queen Mary Hospital; Microbiology Dept., Hong Kong, Hong Kong|Magyar Honvedseg Egeszsegugyi Kozpont, Budapest, Hungary|Borsod-Abaúj-Zemplén Megyei Kórház és Egyetemi Oktató Kórház; Neurosurgery, Miskolc, Hungary|Pécsi Tudományegyetem Áok; Onkoterapias Intezet, Pecs, Hungary|Rambam Medical Center; Oncology, Haifa, Israel|Hadassah Hebrew University Hospital; Leslie and Michael Gaffin Center for Neuro-Oncology, Jerusalem, Israel|Rabin MC; Davidof Center - Oncology Institute, Petach Tikva, Israel|Chaim Sheba MC; Pediatric Hematology Oncology, Tel Hashomer, Israel|Ausl Di Bologna-Ospedale Bellaria;U.O. Oncologia Medica, Bologna, Emilia-Romagna, Italy|Ospedale Bufalini, Forli, Emilia-Romagna, Italy|Fondazione IRCCS Istituto Neurologico C. Besta; Neuro-oncologia Sperimentale e Terapia Genica, Milano, Lombardia, Italy|Azienda Ospedaliera Le Molintte di Torino; Dipartimento Di Neurologia - Oncologia, Torino, Piemonte, Italy|Az. Osp. S. Maria; Dept. Di Oncologia Medica, Terni, Umbria, Italy|Ospedale di Treviso, Universita di Padova; Neurosurgery Dept, Treviso, Veneto, Italy|Hiroshima University Hospital; Neurosurgery, Hiroshima, Japan|Tsukuba University Hospital; Neurology, Ibaraki, Japan|Kumamoto University Hospital; Neurosurgery, Kumamoto, Japan|Kitano Hospital; Neurosurgery, Osaka, Japan|Saitama Medical University International Medical Center; Clinical and Medical Oncology, Saitama, Japan|National Cancer Center Hospital; Neurosurgery, Tokyo, Japan|Komagome Hospital; Neurosurgery, Tokyo, Japan|Kyorin University Hospital; Neurosurgery, Tokyo, Japan|Pusan National University Hospital; Neuro Sugery, Busan, Korea, Republic of|Kyungpook National University Hosital; Neuro Sugery, Daegu, Korea, Republic of|National Cancer Centre; Neurosurgery Dept, Goyang-si, Korea, Republic of|Chonnam National University Hwasun Hospital, Jeollanam-do, Korea, Republic of|Seoul National Uni Hospital; Dept. of Internal Medicine/Hematology/Oncology, Seoul, Korea, Republic of|Asan Medical Center; Medical Oncology, Seoul, Korea, Republic of|Yonsei University Severance Hospital; Medical Oncology, Seoul, Korea, Republic of|Samsung Medical Center; Neurosurgery Department, Seoul, Korea, Republic of|VU MEDISCH CENTRUM; Dept. of Medical Oncology, Amsterdam, Netherlands|Catharina Ziekenhuis; Dept of Internal Medicin, Eindhoven, Netherlands|Utrecht University Medical Centre; Dept of Medical Oncology and UPC, Utrecht, Netherlands|Auckland city hospital; Auckland Regional Cancer Centre and Blood Service, Auckland, New Zealand|Christchurch Hospital; Dept of Oncology, Christchurch, New Zealand|Waikato Hospital; Regional Cancer Center, Hamilton, New Zealand|Bialostockie Centrum Onkologii; Oddzial Onkologii Klinicznej, Bialystok, Poland|Centrum Onkologii;Im. Franciszka Lukaszczyka;Onkologii, Bydgoszcz, Poland|Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie; Klinika Neurochirurgii i Neurochirurgii Dzi, Lublin, Poland|IPO de Coimbra; Servico de Oncologia Medica, Coimbra, Portugal|IPO de Lisboa; Servico de Neurologia, Lisboa, Portugal|Hospital de Santa Maria; Servico de Oncologia Medica, Lisboa, Portugal|Hospital de Sao Joao; Servico de Oncologia, Porto, Portugal|Institut Oncologic Prof. Dr. Alexandru Trestioreanu; Departament Radioterapie, Bucharest, Romania|Institut Oncologic Ion Chiricuta; Departament Radioterapie, Cluj-napoca, Romania|Spital Clinic Judetean Mures; Oncologie, Targu Mures, Romania|N.N.Burdenko Main Military Clinical Hospital; Oncology Dept, Moscow, Russian Federation|Russian Research Oncology Center n.a. N.N. Blokhin of the RAMS; Department of Neurosurgery, Moscow, Russian Federation|Scientific Research Neurosurgery Institute; Dept. of Neurooncology, Moscow, Russian Federation|Institution of Higher Professional Learning Military; Neurooncology, St. Petersburg, Russian Federation|Hospital Clínic i Provincial; Servicio de Hematología y Oncología, Barcelona, Spain|Institut Catala d Oncologia Hospital Duran i Reynals, Barcelona, Spain|Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia, Barcelona, Spain|Hospital Ramon y Cajal; Servicio de Oncologia, Madrid, Spain|Hospital Universitario La Paz; Servicio de Oncologia, Madrid, Spain|Hospital Regional Universitario Carlos Haya; Servicio de Oncologia, Malaga, Spain|Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia, Valencia, Spain|Sahlgrenska Universitetssjukhuset; Jubileumskliniken, Göteborg, Sweden|Skånes University Hospital, Skånes Department of Onclology, Lund, Sweden|Norrlands Universitetssjukhus; Cancer Centrum, Umea, Sweden|Akademiska sjukhuset, Onkologkliniken, Uppsala, Sweden|HUG; Oncologie, Geneve, Switzerland|Queen Elizabeth Medical Centre; Neurosurgery, Birmingham, United Kingdom|Bristol Haematology and Oncology Centre, Bristol, United Kingdom|The Royal Marsden NHS Foundation Trust; Oncology, London, United Kingdom|Northern Centre for Cancer Care;Oncology, Newcastle Upon Tyne, United Kingdom|Nottingham City Hospital; Dept of Haematology, Nottingham, United Kingdom|Queen's Hospital; Oncology, Romford, United Kingdom|Weston Park Hospital; Cancer Clinical Trials Centre, Sheffield, United Kingdom|Royal Marsden Hospital; Dept of Medical Oncology, Sutton, United Kingdom|The Clatterbridge Cancer Ctr For Oncolgy, Wirral, United Kingdom","https://ClinicalTrials.gov/show/NCT00943826"
574,"Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma","Terminated","Has Results","Adult Brain Glioblastoma","Other: Treatment|Drug: Methoxyamine|Drug: Temozolomide","University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States|UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States|UCSF Medical Center-Parnassus, San Francisco, California, United States|Adult Brain Tumor Consortium, Baltimore, Maryland, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Henry Ford Cancer Institute¿Downriver, Brownstown, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Henry Ford West Bloomfield Hospital, West Bloomfield, Michigan, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Case Western Reserve University, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT02395692"
575,"Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)","Completed","Has Results","Glioblastoma","Procedure: Primary surgical treatment|Radiation: Radiotherapy|Drug: Temozolomide",,"https://ClinicalTrials.gov/show/NCT00704808"
576,"PVSRIPO for Recurrent Glioblastoma (GBM)","Active, not recruiting","Has Results","GBM|Glioblastoma|Glioma|Malignant Glioma","Biological: Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01491893"
577,"A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients","Active, not recruiting","No Results Available","Recurrent Glioblastoma","Biological: Nivolumab|Biological: Bevacizumab|Biological: Ipilimumab","University of Alabama at Birmingham, Birmingham, Alabama, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|UCLA Neuro-Oncology Program, Los Angeles, California, United States|The Regents of the University of California, San Francisco, San Francisco, California, United States|Anschutz Cancer Pavilion, Aurora, Colorado, United States|Yale University School Of Medicine, New Haven, Connecticut, United States|Georgetown University, Washington, District of Columbia, United States|Moffitt Cancer Center, Tampa, Florida, United States|Winship Cancer Institute, Atlanta, Georgia, United States|Johns Hopkins University School Of Medicine, Baltimore, Maryland, United States|Beth Israel Deaconess Med Ctr, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Levine Cancer Institute, Charlotte, North Carolina, United States|Preston Robert Tisch Brain Tumor Center at Duke University, Durham, North Carolina, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Cleveland Clinic, Cleveland, Ohio, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Medical University Of South Carolina, Charleston, South Carolina, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University Of Texas Md Anderson Cancer Ctr, Houston, Texas, United States|University of Virginia Health System, Charlottesville, Virginia, United States|University of Washington - Seattle Cancer Care Alliance, Seattle, Washington, United States|Swedish Neuroscience Institute, Seattle, Washington, United States|Local Institution, Liverpool, New South Wales, Australia|Local Institution, East Bentleigh, Victoria, Australia|Local Institution, Heidelberg, Victoria, Australia|Local Institution, Nedlands, Western Australia, Australia|Local Institution, Brussels, Belgium|Local Institution, Bruxelles, Belgium|Aarhus University Hospital, Aarhus C, Denmark|Odense University Hospital, Odense C, Denmark|Local Institution, Bron cedex, France|Local Institution, Marseille Cedex 5, France|Local Institution, Paris cedex 13, France|Local Institution, Paris, France|Universitaetsklinikum Bonn, Bonn, Germany|Klinikum Der J. W. Goethe-Universitaet Frankfurt/Main, Frankfurt Am Main, Germany|Local Institution, Heidelberg, Germany|Universitaetsklinikum Muenster, Muenster, Germany|Local Institution, Bologna, Italy|Local Institution, Milano, Italy|Local Institution, Siena, Italy|Azienda Ospedaliera Citta della Salute e della Scienza, Torino, Italy|Local Institution, Amsterdam, Netherlands|Local Institution, Groningen, Netherlands|Local Institution, Gdansk, Poland|Local Institution, Warszawa, Poland|Local Institution, Barcelona, Spain|Local Institution, Madrid, Spain|Local Institution, Madrid, Spain|Local Institution, Pamplona, Spain|Centre hospitalier universitaire Vaudois (CHUV), Lausanne, Switzerland|UniversitaetsSpital Zurich, Zuerich, Switzerland|Local Institution, London, Greater London, United Kingdom|Local Institution, Manchester, Greater Manchester, United Kingdom|Local Institution, Liverpool, United Kingdom","https://ClinicalTrials.gov/show/NCT02017717"
578,"Calorie-restricted, Ketogenic Diet and Transient Fasting During Reirradiation for Patients With Recurrent Glioblastoma","Completed","Has Results","Recurrent Glioblastoma","Dietary Supplement: calorie-restricted ketogenic diet and transient fasting|Dietary Supplement: standard nutrition","Dr. Senckenberg Institute of Neurooncology, Frankfurt, Germany|University of Tuebingen, Tuebingen, Germany","https://ClinicalTrials.gov/show/NCT01754350"
579,"Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma","Completed","No Results Available","Glioblastoma or Malignant Glioma","Drug: AMG 596|Drug: AMG 404","University of California Los Angeles, Los Angeles, California, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Royal North SHore Hospital, St Leonards, New South Wales, Australia|Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia|Gustave Roussy, Villejuif, France|UniversitÃ¤tsklinikum Carl Gustav Carus der Technischen UniversitÃ¤t Dresden, Dresden, Germany|Universitatsklinikum Hamburg-Eppendorf, Hamburg, Germany|Universitaetsklinikum Wuerzburg, WÃ¼rzburg, Germany|Vrije Universiteit Medisch Centrum, Amsterdam, Netherlands|Hospital Universitari Germans Trias i Pujol, Badalona, CataluÃ±a, Spain","https://ClinicalTrials.gov/show/NCT03296696"
580,"Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients","Recruiting","No Results Available","Glioblastoma Multiforme of Brain","Biological: Dendritic cell vaccine plus temozolomide chemotherapy","Antwerp University Hospital, Edegem, Antwerp, Belgium","https://ClinicalTrials.gov/show/NCT02649582"
581,"Bevacizumab and Lomustine for Recurrent GBM","Completed","No Results Available","Glioblastoma Multiforme|Cognition Disorders|Disability Evaluation","Biological: bevacizumab|Drug: lomustine|Genetic: DNA methylation analysis|Other: laboratory biomarker analysis|Procedure: cognitive assessment|Procedure: quality-of-life assessment","Medisch Centrum Haaglanden - Westeinde, Den Haag, Netherlands|Erasmus MC - Daniel den Hoed Cancer Center, Rotterdam, Netherlands","https://ClinicalTrials.gov/show/NCT01290939"
582,"Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM","Active, not recruiting","No Results Available","Glioblastoma|Cancer of Brain|Glioblastoma Multiforme|Brain Tumor","Device: Tumor Treating Fields|Drug: Temozolomide|Radiation: Radiation Therapy","University of California San Francisco, San Francisco, California, United States|Providence St. Vincent Medical Center, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT03705351"
583,"VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma","Completed","No Results Available","Glioblastoma","Drug: VXM01","Neurology Clinic and National Center for Tumor Diseases, Heidelberg, Germany","https://ClinicalTrials.gov/show/NCT02718443"
584,"Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients","Completed","Has Results","Glioblastoma|Glioblastoma Multiforme|Gliosarcoma","Drug: enzastaurin|Drug: temozolomide|Radiation: radiation therapy","For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT00402116"
585,"NOA-12: BIBF1120 and R-RT in Glioblastoma","Terminated","No Results Available","Glioblastoma Multiforme","Drug: BIBF 1120|Radiation: radiotherapy","University Hospital Heidelberg, Department of Neurooncology, Heidelberg, Baden-Württemberg, Germany|University Hospital Heidelberg, Department of Pharmacology, Heidelberg, Baden-Württemberg, Germany","https://ClinicalTrials.gov/show/NCT01666600"
586,"Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Multiforme","Drug: VB-111|Drug: Bevacizumab","Dana Farber Cancer Institute, Boston, Massachusetts, United States|Duke University Medical Center, Durham, North Carolina, United States|Uthsc- Ctrc, San Antonio, Texas, United States|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel","https://ClinicalTrials.gov/show/NCT01260506"
587,"A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Multiforme","Drug: Temsirolimus|Drug: Bevacizumab","Rigshospitalet, Copenhagen, Denmark","https://ClinicalTrials.gov/show/NCT00800917"
588,"A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma","Completed","No Results Available","Glioblastoma Multiforme","Drug: RO5323441 + bevacizumab [Avastin]|Drug: bevacizumab [Avastin]","København Ø, Denmark|Marseille, France|Zürich, Switzerland|Manchester, United Kingdom","https://ClinicalTrials.gov/show/NCT01308684"
589,"A Study of Bevacizumab and Extended Treatment of Temozolomide in Patients With Recurrent Glioblastoma Multiforme","Completed","Has Results","Glioblastoma Multiforme","Drug: bevacizumab [Avastin]|Drug: temozolomide","Barcelona, Spain|Barcelona, Spain|Barcelona, Spain|Madrid, Spain|Madrid, Spain|Madrid, Spain|Valencia, Spain|Valencia, Spain","https://ClinicalTrials.gov/show/NCT01115491"
590,"Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence","Active, not recruiting","No Results Available","Recurrent Glioblastoma","Drug: Pembrolizumab|Drug: SurVaxM|Drug: Sargramostim|Drug: Montanide ISA 51","Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT04013672"
591,"Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM","Withdrawn","No Results Available","Astrocytoma, Grade IV|Giant Cell Glioblastoma|Glioblastoma Multiforme","Radiation: External-beam radiation therapy|Drug: Temozolomide",,"https://ClinicalTrials.gov/show/NCT00943462"
592,"Effect of Deep TMS on the Permeability of the BBB in Patients With Glioblastoma Multiforme: a Pilot Study","Completed","No Results Available","Glioblastoma Multiforme of Brain","Device: Deep Transcranial Magnetic Stimulation (dTMS)",,"https://ClinicalTrials.gov/show/NCT02474966"
593,"Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas","Completed","Has Results","Glioblastoma|Gliosarcoma","Drug: Avastin and Temozolomide","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00612339"
594,"Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients","Unknown status","No Results Available","Glioblastoma|Brain Cancer","Drug: Combination of TG6002 and 5-flucytosine (5-FC, Ancotil®)","Groupe Hospitalier Pitié-Salpêtrière, Paris, France","https://ClinicalTrials.gov/show/NCT03294486"
595,"Neoadjuvant Chemoradiation for Resectable Glioblastoma","Recruiting","No Results Available","Glioblastoma|Surgery|High Grade Glioma","Radiation: Neoadjuvant chemoradiation|Drug: Drug Therapy with Temozolomide (benzolamide) (Standard of Care)|Procedure: Surgery post Radiation and Temozolomide (benzolamide)","Geisinger Medical Center, Danville, Pennsylvania, United States|Geisinger Wyoming Valley Medical Center, Wilkes-Barre, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT04209790"
596,"Prevention of Thrombocytopenia in Glioblastoma Patients","Terminated","No Results Available","Thrombocytopenia|Glioblastoma","Drug: Romiplostim","CHRU de Lille, Hôpital Roger Salengro,Clinique de Neurochirurgie, Lille, France|Hôpital Neurologique Pierre Wertheimer, Lyon,, Lyon, France|AP-HM,Hôpital La Timone, AP-HM, Marseille, Marseille, France|AH-HP, Hôpital Pitié-Salpêtrière, Service de Neurologie 2, Paris, France","https://ClinicalTrials.gov/show/NCT02227576"
597,"Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme","Withdrawn","No Results Available","Glioblastoma Multiforme","Drug: BCNU Wafer|Drug: Irinotecan|Drug: Bevacizumab","University of Cincinnati, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT00984438"
598,"Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis","Completed","No Results Available","Glioblastoma|Brain Metastases","Drug: ceritinib 750mg","Barrow Brain and Spine, Phoenix, Arizona, United States","https://ClinicalTrials.gov/show/NCT02605746"
599,"Chloroquine for Treatment of Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Multiforme","Drug: Chloroquine","National Institute of Neurology and Neurosurgery, Mexico City, Mexico","https://ClinicalTrials.gov/show/NCT00224978"
600,"Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme","Completed","Has Results","Glioblastoma Multiforme","Drug: Bevacizumab and Temozolomide","The University of Chicago, Chicago, Illinois, United States|NorthShore University health system, Evanston, Illinois, United States|University of Michigan, Ann Arbor, Michigan, United States|Medical college of Wisconsin, Milwaukee, Wisconsin, United States|Waukesha health care, Waukesha, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00590681"
601,"Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification","Completed","No Results Available","Recurrent/Refractory Glioblastoma","Drug: crenolanib","MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02626364"
602,"Immunoadsorption in Anti-GBM Glomerulonephritis.","Recruiting","No Results Available","Anti-glomerular Basement Membrane Glomerulonephritis","Device: Immunoadsorption (Immunosorba)","University Medical Center Groningen, Groningen, Gromiongen, Netherlands","https://ClinicalTrials.gov/show/NCT02765789"
603,"Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma|Vaccination","Biological: Autologous Dendritic Cells (DC) vaccine|Drug: Temozolomide","Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, FC, Italy","https://ClinicalTrials.gov/show/NCT04523688"
604,"DC Migration Study for Newly-Diagnosed GBM","Completed","Has Results","Glioblastoma|Astrocytoma, Grade IV|Giant Cell Glioblastoma|Glioblastoma Multiforme","Biological: Unpulsed DCs|Biological: Td|Biological: Human CMV pp65-LAMP mRNA-pulsed autologous DCs|Biological: 111In-labeled DCs|Drug: Temozolomide|Drug: Saline|Drug: Basiliximab","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT02366728"
605,"Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)","Unknown status","No Results Available","Glioblastoma Multiforme","Drug: Cetuximab|Drug: Temozolomide|Procedure: Radiation therapy","University of Heidelberg, Heidelberg, Baden-Württemberg, Germany","https://ClinicalTrials.gov/show/NCT00311857"
606,"Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma","Drug: Edotecarin|Drug: Temozolomide|Drug: Carmustine (BCNU)|Drug: Lomustine (CCNU)","Pfizer Investigational Site, Phoenix, Arizona, United States|Pfizer Investigational Site, Little Rock, Arkansas, United States|Pfizer Investigational Site, New Haven, Connecticut, United States|Pfizer Investigational Site, Orlando, Florida, United States|Pfizer Investigational Site, Atlanta, Georgia, United States|Pfizer Investigational Site, Chicago, Illinois, United States|Pfizer Investigational Site, Evanston, Illinois, United States|Pfizer Investigational Site, Edgewood, Kentucky, United States|Pfizer Investigational Site, Edgweood, Kentucky, United States|Pfizer Investigational Site, Lexington, Kentucky, United States|Pfizer Investigational Site, Boston, Massachusetts, United States|Pfizer Investigational Site, Lebanon, New Hampshire, United States|Pfizer Investigational Site, Edison, New Jersey, United States|Pfizer Investigational Site, Summit, New Jersey, United States|Pfizer Investigational Site, Cincinnati, Ohio, United States|Pfizer Investigational Site, Philadelphia, Pennsylvania, United States|Pfizer Investigational Site, Pittsburgh, Pennsylvania, United States|Pfizer Investigational Site, Dallas, Texas, United States|Pfizer Investigational Site, Charlottesville, Virginia, United States|Pfizer Investigational Site, St. Leonards, New South Wales, Australia|Pfizer Investigational Site, East Bentleigh, Victoria, Australia|Pfizer Investigational Site, Clayton, Australia|Pfizer Investigational Site, Graz, Austria|Pfizer Investigational Site, Wien, Austria|Pfizer Investigational Site, Calgary, Alberta, Canada|Pfizer Investigational Site, Vancouver, British Columbia, Canada|Pfizer Investigational Site, Winnipeg, Manitoba, Canada|Pfizer Investigational Site, Moncton, New Brunswick, Canada|Pfizer Investigational Site, Halifax, Nova Scotia, Canada|Pfizer Investigational Site, Hamilton, Ontario, Canada|Pfizer Investigational Site, Ottawa, Ontario, Canada|Pfizer Investigational Site, Toronto, Ontario, Canada|Pfizer Investigational Site, Split, Croatia|Pfizer Investigational Site, Zagreb, Croatia|Pfizer Investigational Site, Hradec Kralove, Czech Republic|Pfizer Investigational Site, Praha 5, Czech Republic|Pfizer Investigational Site, Lyon, France|Pfizer Investigational Site, Nantes St. Herblain, France|Pfizer Investigational Site, Berlin, Germany|Pfizer Investigational Site, Mainz, Germany|Pfizer Investigational Site, Regensburg, Germany|Pfizer Investigational Site, Tuebingen, Germany|Pfizer Investigational Site, Bangalore, India|Pfizer Investigational Site, Bologna, Italy|Pfizer Investigational Site, Padova, Italy|Pfizer Investigational Site, Moscow, Russian Federation|Pfizer Investigational Site, Cape Town, South Africa|Pfizer Investigational Site, Pretoria, South Africa|Pfizer Investigational Site, Badalona, Spain|Pfizer Investigational Site, Hospitalet de Llobregat, Spain|Pfizer Investigational Site, Oviedo, Spain|Pfizer Investigational Site","https://ClinicalTrials.gov/show/NCT00068952"
607,"Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma Multiforme","Withdrawn","No Results Available","Glioblastoma Multiforme","Drug: Tandutinib, bevacizumab, and temozolomide",,"https://ClinicalTrials.gov/show/NCT00904852"
608,"Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma","Completed","No Results Available","Recurrent Glioblastoma (WHO-Grade IV Glioma)","Drug: Axitinib|Drug: Avelumab","UZ Brussel, Brussel, Belgium","https://ClinicalTrials.gov/show/NCT03291314"
609,"Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme","Completed","Has Results","Glioblastoma Multiforme","Drug: Temozolomide|Drug: R115777","MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00050986"
610,"Gut Microbiota and Glioblastoma Multiforme Prognosis","Unknown status","No Results Available","Gut Microbiota, Glioblastoma Multiforme, Microglia, Tumor Related Macrophagocyte, Prognosis","Other: Chemotherapy with temozolomide or no chemotherapy",,"https://ClinicalTrials.gov/show/NCT03631823"
611,"Safety and Efficacy of Talampanel in Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Multiforme","Drug: Talampanel|Radiation: Radiation Therapy (RT) 5 days a week +|Drug: temozolomide(TMZ) 75mg|Drug: adjuvant TMZ 200mg",,"https://ClinicalTrials.gov/show/NCT00267592"
612,"Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed Glioblastoma","Completed","Has Results","Glioblastoma Multiforme","Drug: Enzastaurin 500 milligram (mg) Once Daily (QD)|Drug: Enzastaurin 250 mg Twice Daily (BID)","For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Berlin, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Erlangen, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Frankfurt, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Freiburg, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Hamburg, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Heidelberg, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Leipzig, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mannheim, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Regensburg, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Ulm, Germany","https://ClinicalTrials.gov/show/NCT00509821"
613,"Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma","Completed","Has Results","Glioblastoma Multiforme/Anaplastic Astrocytoma","Drug: temozolomide|Radiation: Hypofractionated radiation therapy|Radiation: Intensity-modulated radiation therapy","Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT00841555"
614,"DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors","Completed","No Results Available","Glioblastoma or Gliosarcoma","Drug: Single intratumoral injection of DNX-2401|Drug: Interferon-gamma","Moffitt Cancer Center, Tampa, Florida, United States|The Ohio State University, Columbus, Ohio, United States|Baylor University: Charles A. Sammons Cancer Center, Dallas, Texas, United States|UT MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02197169"
615,"Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM","Completed","Has Results","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma","Radiation: radiation therapy|Drug: carboxyamidotriazole|Other: pharmacological study","University of Alabama Birmingham, Birmingham, Alabama, United States|Moffitt Cancer Center, Tampa, Florida, United States|Emory University/Winship Cancer Institute, Atlanta, Georgia, United States|Johns Hopkins University, Baltimore, Maryland, United States|Henry Ford Hospital, Detroit, Michigan, United States|Wake Forest University, Winston-Salem, North Carolina, United States|University of Pennsylavania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00004146"
616,"Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment","Terminated","No Results Available","Recurrent Glioblastoma","Biological: [18F]fluoromisonidazole|Drug: Bevacizumab|Radiation: positron emission tomography (PET/CT).","Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT03573986"
617,"Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma","Recruiting","No Results Available","Glioblastoma Multiforme|Glioblastoma, Adult|Glioma of Brain|Glioblastoma Multiforme of Brain","Drug: IMA950/Poly-ICLC|Drug: IMA950/Poly-ICLC and pembrolizumab","University Hospitals of Geneva, Geneva, Switzerland","https://ClinicalTrials.gov/show/NCT03665545"
618,"An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas","No longer available","No Results Available","Glioblastoma|Glioma of Brain","Biological: Ipilimumab","University ""Mother Theresa"" Hospital Center; Oncology Department, Tirana, Albania|University Clinical Center of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina|Complex Oncology Center, Plovdiv, Bulgaria|Clinical Hospital Osijek; Dept For Oncology & Radiotherapy, Osijek, Croatia|Institut of Oncology Al. Trestioreanu Bucharest; Oncology, Bucharest,, Romania|Regional Oncology Hospital, Irkutsk, Russian Federation|Rostov Cancer Research Institute, Rostov-on-Don, Russian Federation|Primorsky Regional Oncology Center, Vladivostok, Russian Federation|Clinical Hospital Center Bezanijska kosa; Clinic for Oncology, Belgrade, Serbia|Inselspital Bern; Medizinische Onkologie, Bern, Switzerland|Stadtspital Triemli; Frauenklinik, Zürich, Switzerland","https://ClinicalTrials.gov/show/NCT03460782"
619,"Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)","Completed","Has Results","Glioblastoma Multiforme","Drug: Cilengitide 500 mg|Drug: Cilengitide 2000 mg","University of Alabama at Birmingham, Birmingham, Alabama, United States|Barrow Neurological Institute, Phoenix, Arizona, United States|UCLA Medical Center, Los Angeles, California, United States|Denise Damek, Aurora, Colorado, United States|Northwestern University, Chicago, Illinois, United States|Indiana University Medical Center, Indianapolis, Indiana, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|University of Massachusetts, Worcester, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|Washington University, Saint Louis, Missouri, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Good Samaritan Hospital/Tri Health Hatton Center, Cincinnati, Ohio, United States|Baylor University Medical Center at Dallas, Dallas, Texas, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, United States|University of Vermont/Fletcher Allen Healthcare, Burlington, Vermont, United States|University of Virginia Health System, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT00093964"
620,"AZD7451 for Recurrent Gliomas","Completed","No Results Available","Glioblastoma Multiforme","Drug: AZD7451","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT01468324"
621,"Curcumin Bioavailability in Glioblastoma Patients","Completed","No Results Available","Patient Harboring Glioblastoma That Will Undergo Surgery",,"Department of Neurosurgery, Johann Wolfgang Goethe-University, Frankfurt, Hessen, Germany","https://ClinicalTrials.gov/show/NCT01712542"
622,"Ketogenic Diets as an Adjuvant Therapy in Glioblastoma","Completed","No Results Available","Glioblastoma|Glioblastoma Multiforme|Glioblastoma, Adult","Other: MKD|Other: MCT","Univeristy of Liverpool/ The Walton Centre NHS Foundation Trust, Liverpool, Merseyside, United Kingdom","https://ClinicalTrials.gov/show/NCT03075514"
623,"Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma Multiforme (Grade IV) of Cerebellum","Drug: Crizotinib","Institut Català D'Oncologia L'Hospitalet (Ico), L'Hospitalet de Llobregat, Barcelona, Spain|Hospital Del Mar, Barcelona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain","https://ClinicalTrials.gov/show/NCT02270034"
624,"Proteome-based Personalized Immunotherapy of Glioblastoma","Unknown status","No Results Available","Glioblastoma","Biological: Dendritic vaccine, allogeneic hematopoietic stem cells, cytotoxic lymphocytes|Biological: Dendritic vaccine, autologous hematopoietic stem cells, cytotoxic lymphocytes","ZAO ""NeuroVita Clinic of Interventional and Restorative Neurology and Therapy"", Moscow, Russian Federation","https://ClinicalTrials.gov/show/NCT01759810"
625,"Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme","Terminated","No Results Available","Primary Glioblastoma Multiforme","Other: Gliadel Wafer, Temodar and Radiotherapy","Holden Comprehensive Cancer Clinic, Iowa City, Iowa, United States","https://ClinicalTrials.gov/show/NCT00574964"
626,"Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme","Active, not recruiting","No Results Available","Newly Diagnosed Glioblastoma Multiforme","Other: Lapatinib/Temozolomide/radiation","UCLA, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT01591577"
627,"Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme","Completed","No Results Available","Recurrent Glioblastoma Multiforme","Drug: 131-I-chTNT-1/B MAB","Barrow Neurological Institute, Phoenix, Arizona, United States|University Hospitals Case Medical Center, Cleveland, Ohio, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States","https://ClinicalTrials.gov/show/NCT00509301"
628,"MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy","Completed","Has Results","Adult Brain Glioblastoma","Drug: Gadolinium|Drug: Ferumoxytol Non-Stoichiometric Magnetite|Other: Dynamic Contrast-Enhanced Magnetic Resonance Imaging|Other: Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging|Other: Diffusion Weighted Imaging|Other: MRI-Based Angiogram","OHSU Knight Cancer Institute, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT00660543"
629,"Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma|Diffuse Glioma","Drug: NMS-03305293 + TMZ|Drug: Lomustine","Mayo Clinic Cancer Center, Rochester, Minnesota, United States|IRCCS Istituto Neurologico Carlo Besta, Milan, Italy|Erasmus Medical Center, Rotterdam, Netherlands|University Hospital Zurich, Zurich, Switzerland","https://ClinicalTrials.gov/show/NCT04910022"
630,"Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma","Completed","Has Results","Malignant Glioma|Recurrent Glioblastoma","Drug: vorinostat|Drug: bevacizumab","Baylor University Medical Center, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT01266031"
631,"Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma","Completed","No Results Available","Recurrent Glioblastoma Multiforme","Drug: Panzem Nanocrystal Colloidal Dispersion","The Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00306618"
632,"Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner","Terminated","No Results Available","Neoplasms|Glioblastoma","Other: stress","University Hospital Basel, Basel, Switzerland|Kantonsspital Luzern, Luzern, Switzerland|University Hospital Neurology, Zürich, Switzerland","https://ClinicalTrials.gov/show/NCT02129335"
633,"Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer","Unknown status","No Results Available","Glioblastoma Multiforme|Glioblastoma|GBM|Grade IV Astrocytoma|Glioma|Brain Cancer|Brain Tumor","Drug: Dendritic cell immunotherapy","University of Alabama at Birmingham, Birmingham, Alabama, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Sutter East Bay Neuroscience Institute-Eden Medical Center, Castro Valley, California, United States|City of Hope, Duarte, California, United States|UCSD Moores Cancer Center, La Jolla, California, United States|Kaiser Permanente - Los Angeles, Los Angeles, California, United States|UCLA Medical Center, Los Angeles, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States|St. Joseph Hospital of Orange, Orange, California, United States|University of California, Irvine Medical Center, Orange, California, United States|Kaiser Permanente - Redwood City, Redwood City, California, United States|Sutter Institute for Medical Research, Sacramento, California, United States|University of Colorado Cancer Center, Aurora, Colorado, United States|Colorado Neurological Institute, Englewood, Colorado, United States|Georgetown University Medical Center, Washington, District of Columbia, United States|University of Florida, Gainesville, Florida, United States|Memorial Cancer Institute, Hollywood, Florida, United States|Mount Sinai Community Clinical Oncology Program, Miami Beach, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|Piedmont Atlanta Hospital, Atlanta, Georgia, United States|Rush University Medical Center, Chicago, Illinois, United States|Illinois Cancer Care, Peoria, Illinois, United States|Cadence Cancer Center, Warrenville, Illinois, United States|IU Simon Cancer Center, Indianapolis, Indiana, United States|University of Kansas Cancer Center, Westwood, Kansas, United States|Markey Cancer Center/University of Kentucky, Lexington, Kentucky, United States|Norton Cancer Institute, Louisville, Kentucky, United States|Tufts Medical Center, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|University of Michigan Cancer Center, Ann Arbor, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Spectrum Health, Grand Rapids, Michigan, United States|John Nasseff Neuroscience Institute at Abbott Northwestern Hospital, Minneapolis, Minnesota, United States|St. Luke's Hospital, Kansas City, Missouri, United States|Washington University School of Medicine, St. Louis, Missouri, United States|The Brain Tumor Center at JFK Medical Center, Edison, New Jersey, United States|John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States|The Valley Hospital, Ridgewood, New Jersey, United States|Overlook Hospital, Summit, New Jersey, United States|Capital Health Regional Medical Center, Trenton, New Jersey, United States|Long Island Brain Tumor Center at Neurological Surgery, P.C., Lake Success, New York, United States|North Shore University Hospital, Manhasset, New York, United States|New York University Clinical Cancer Center, New York, New York, United States|Mount Sinai Medical Center, New York, New York, United States|Columbia University Medical Center, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Stony Brook Medicine, Stony Brook, New York, United States|Brain and Spine Surgeons of New York and Northern Westchester Hospital, White Plains, New York, United States|University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|University of Cincinnati Cancer Institute, Cincinnati, Ohio, United States|University Hospitals Seidman Cancer Center, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University, Columbus, Ohio, United States|OhioHealth, Columbus, Ohio, United States|Oklahoma University Health Science Center, Oklahoma City, Oklahoma, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Jefferson Hospital for Neuroscience, Philadelphia, Pennsylvania, United States|Temple University School of Medicine, Philadelphia, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Medical University of South Carolina Hospitals and Clinics, Charleston, South Carolina, United States|Saint Thomas Research Institute, Nashville, Tennessee, United States|Vanderbilt Ingram Cancer Center, Nashville, Tennessee, United States|Baylor Research Institute, Dallas, Texas, United States|The Methodist Hospital, Houston, Texas, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States|Cancer Therapy & Research at University of Texas Health Science Center San Antonio, San Antonio, Texas, United States|Benaroya Research Institute at Virginia Mason, Seattle, Washington, United States|Swedish Hospital Neuroscience Research, Seattle, Washington, United States|Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin, United States|Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada|CHUS - Hôpital Fleurimont, Sherbrooke, Quebec, Canada|Universitätsklinikum Heidelberg Neurochirurgische Klinik, Heidelberg, Baden-Württemberg, Germany|Katharinenhospital, Stuttgart, Baden-Württemberg, Germany|Universitätsklinikum FrankfurtKlinik und Poliklinik für Neurochirurgie, Frankfurt, Hesse, Germany|Universitätsklinikum Bonn Nervenklinik (Zentrum), Klinik und Poliklinik für Neurochirurgie, Bonn, North Rhine-Westphalia, Germany|Universitätsklinikum Klinik für allgemeine Neurochirurgie, Köln, North Rhine-Westphalia, Germany|BG-Kliniken Bergmannstrost, Klinik für Neurochirurgie, Halle, Saxony-Anhalt, Germany|Klinik für Neurochirurgie, Klinikum Chemnitz gGmbH, Chemnitz, Saxony, Germany|Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Saxony, Germany|Neurochirurgische Klinik, Hamburg, Germany|Addenbrookes NHS Trust, Cambridge, Cambridgeshire, East Anglia, United Kingdom|Kings College Hosital NHS Foundation Trust, London, Greater London, United Kingdom|University College Hospital London, London, Greater London, United Kingdom|University Hospital of Birmingham NHS Foundation Trust, Birmingham, West Midlands, United Kingdom","https://ClinicalTrials.gov/show/NCT00045968"
634,"A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma|Brain Tumor","Drug: Temozolomide, Tamoxifen, Maprotiline",,"https://ClinicalTrials.gov/show/NCT04200066"
635,"Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma","Terminated","Has Results","Glioblastoma","Drug: Aspirin|Drug: Placebo","The University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00790452"
636,"Disulfiram in Recurrent Glioblastoma","Completed","No Results Available","Glioma|Glioblastoma","Drug: Disulfiram|Dietary Supplement: Copper|Drug: Alkylating Agents","Cancer Clinic, St.Olavs University Hospital, Trondheim, Norway|Dept. of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden|Ryhov County Hospital, Jönköping, Sweden|Linköping University Hospital, Linkoping, Sweden|Lund University Hospital, Lund, Sweden|Karolinska University Hospital, Stockholm, Sweden|Uppsala University Hospital, Uppsala, Sweden|Örebro University Hospital, Örebro, Sweden","https://ClinicalTrials.gov/show/NCT02678975"
637,"Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma","Recruiting","No Results Available","Adult Glioblastoma|Magnetic Resonance Imaging|Bevacizimab","Diagnostic Test: 3-Tesla conventional magnetic resonance imaging|Diagnostic Test: Advanced imaging without contrast use|Diagnostic Test: Dynamic susceptibility contrast-weighted imaging","Asan Medical Center, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04143425"
638,"Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues","Recruiting","No Results Available","Glioblastoma|Malignant Solid Neoplasm","Procedure: Biospecimen Collection","Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT04822688"
639,"The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in Patients","Active, not recruiting","No Results Available","Glioblastoma|Glioblastoma Multiforme|Glioma, Malignant","Biological: EGFRvIII-specific hinge-optimized CD3 ζ-stimulatory/41BB-co-stimulatory Chimeric Antigen Receptor autologous T-lymphocytes","Jyväskylä Central Hospital, Jyväskylä, Finland|University Of Oulu, Oulu, Finland|Apollo Hospital, New Delhi, India","https://ClinicalTrials.gov/show/NCT05063682"
640,"Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields","Recruiting","No Results Available","Glioblastoma|Skin Toxicity","Drug: Clindamycin Phosphate|Drug: Triamcinolone Acetonide","Northwestern University, Evanston, Illinois, United States|Tufts Medical Center, Boston, Massachusetts, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Hackensack Meridian Health, Hackensack, New Jersey, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Columbia University, New York, New York, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT04469075"
641,"Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)","Terminated","Has Results","RECURRENT GLIOBLASTOMA|Brain Tumor","Device: Optune(NOVOTTF-100A)","Ummc Msgcc, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT01925573"
642,"Measuring Non-Enhancing Glioblastoma Progression","Completed","No Results Available","Brain Tumor|Glioblastoma","Procedure: MRI/MRS Scan","UT MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00777686"
643,"Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma","Withdrawn","No Results Available","Glioblastoma|Glioma","Procedure: Computed Tomography|Radiation: Fludeoxyglucose F-18|Procedure: Positron Emission Tomography","UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT02919332"
644,"Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma","Completed","No Results Available","Glioblastoma|Brain Tumor","Drug: Bevacizumab|Behavioral: Modified Atkins Diet","University of Cincinnati, Cincinnati, Ohio, United States|University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive cancer Center, Cleveland, Ohio, United States|OhioHealth Research and Innovation Institute, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT02768389"
645,"ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma","Withdrawn","No Results Available","Recurrent Glioblastoma|Recurrent Gliosarcoma|Recurrent Supratentorial Glioblastoma|Supratentorial Gliosarcoma","Drug: Akt/ERK Inhibitor ONC201|Radiation: Radiation Therapy|Procedure: Resection","UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT04854044"
646,"Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.","Terminated","No Results Available","Glioblastoma|Molecular Disease","Other: Correlation between molecular anomalies of the primary tumor and circulating tumor DNA","CHU Amiens Picardie, Amiens, Picardie, France","https://ClinicalTrials.gov/show/NCT03115138"
647,"Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status","Completed","No Results Available","Glioblastoma Multiforme|Primary Brain Tumor","Drug: Temozolomide|Drug: Bevacizumab","Groupe Hospitalier Pitié-Salpêtrière, Paris, France","https://ClinicalTrials.gov/show/NCT02898012"
648,"Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial","Not yet recruiting","No Results Available","Glioblastoma|Glioblastoma Multiforme|Glioblastoma Multiforme of Brain|Glioblastoma Multiforme, Adult","Drug: Posaconazole Pill","Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT04825275"
649,"Virus DNX2401 and Temozolomide in Recurrent Glioblastoma","Completed","No Results Available","Glioblastoma Multiforme|Recurrent Tumor","Procedure: DNX2401 and Temozolomide","Clinica Universidad de Navarra, Pamplona, Navarra, Spain","https://ClinicalTrials.gov/show/NCT01956734"
650,"TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma","Terminated","No Results Available","Glioblastoma Multiforme|Glioblastoma|Malignant Glioma|GBM","Drug: Bevacizumab|Device: Optune|Other: Brain MRI|Other: Quality of Life Questionnaires","University of Florida, Gainesville, Florida, United States|Washington University, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT02663271"
651,"Dose-Intense Temozolomide in Recurrent Glioblastoma","Completed","Has Results","Glioblastoma|Gliosarcoma","Drug: Temozolomide","Tufts Medical Center, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|Wake Forest Univsersity, Winston-Salem, North Carolina, United States|University Of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00657267"
652,"Pilot Study of Abemaciclib With Bevacizumab in Recurrent Glioblastoma Patients With Loss of CDKN2A/B or Gain or Amplification of CDK4/6","Active, not recruiting","No Results Available","GBM|Glioblastoma|Brain Tumor|Brain Tumor, Recurrent","Drug: Abemaciclib|Drug: Bevacizumab","UT Southwestern Medical Center, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT04074785"
653,"Sulfasalazine and Stereotactic Radiosurgery for Recurrent Glioblastoma","Recruiting","No Results Available","Glioma|Glioblastoma|Recurrent Glioblastoma","Drug: Sulfasalazine","Haukeland University Hospital, Bergen, Norway","https://ClinicalTrials.gov/show/NCT04205357"
654,"Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma","Unknown status","No Results Available","Glioblastomas|Gliosarcoma","Other: Hyperbaric Oxygen Therapy","Long Island Brain Tumor Center at Neurological surgery P.C., Commack, New York, United States|Long Island Brain Tumor Center at Neurological Surgery P.C., Great Neck, New York, United States","https://ClinicalTrials.gov/show/NCT00936052"
655,"Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma","Active, not recruiting","No Results Available","Giant Cell Glioblastoma|Glioblastoma|Gliosarcoma","Biological: bevacizumab|Drug: temozolomide|Other: laboratory biomarker analysis|Other: immunohistochemistry staining method|Genetic: microarray analysis|Genetic: DNA methylation analysis","Kaiser Foundation Hospital, Los Angeles, California, United States|University of California, Los Angeles, Los Angeles, California, United States|Kaiser Permanente at San Diego, San Diego, California, United States","https://ClinicalTrials.gov/show/NCT01149850"
656,"Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas","Completed","Has Results","Glioblastoma|Gliosarcoma|Brain Tumor","Drug: Avastin|Drug: Temozolomide|Radiation: Radiation Therapy (XRT)|Drug: Irinotecan","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00597402"
657,"TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study","Not yet recruiting","No Results Available","Glioblastoma","Device: TTFields","University Hospital Essen, Essen, Germany","https://ClinicalTrials.gov/show/NCT04717739"
658,"Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study)","Active, not recruiting","No Results Available","High Grade Glioma","Other: Diffusion tensor Imaging (DTI)","Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom","https://ClinicalTrials.gov/show/NCT03294434"
659,"A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma","Withdrawn","No Results Available","Glioblastoma|Glioma","Drug: Bevacizumab|Biological: Peptide Vaccine|Drug: Poly-ICLC as immune adjuvant|Drug: Keyhole limpet hemocyanin (KLH)","NYU Perlmutter Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT02754362"
660,"GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification","Recruiting","No Results Available","Glioblastoma, Adult|EGFR Amplification","Drug: GC1118","Samsung Medical Center, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT03618667"
661,"Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)","Recruiting","No Results Available","Glioma|Glioblastoma","Drug: Hydroxyurea|Drug: Temozolomide","VU University Medical Center, Amsterdam, Noord-Holland, Netherlands","https://ClinicalTrials.gov/show/NCT03463733"
662,"Multimodality MRI and Liquid Biopsy in GBM","Enrolling by invitation","No Results Available","Glioblastoma Multiforme|Brain Tumor, Adult: Glioblastoma|Brain Tumor, Recurrent|Brain Tumor, Primary","Diagnostic Test: Post Feraheme Infusion MRI","University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT04776980"
663,"Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma","Completed","Has Results","Glioblastoma|Recurrent Glioblastoma|Brain Tumor","Drug: Tesevatinib","Center for Neurosciences, Tucson, Arizona, United States|City of Hope, Duarte, California, United States|University of California, San Francisco (UCSF), San Francisco, California, United States|University of Colorado Cancer Center, Aurora, Colorado, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Columbia University, Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Cleveland Clinic, Cleveland, Ohio, United States|UT MD Anderson Cancer Center, Houston, Texas, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT02844439"
664,"Bevacizumab With or Without Surgery for Adult Glioblastomas","Withdrawn","No Results Available","Glioblastoma|Brain Neoplasm","Procedure: Craniotomy",,"https://ClinicalTrials.gov/show/NCT01413438"
665,"Derivation of Tumor Specific Hybridomas","Terminated","No Results Available","Glioblastoma","Biological: Tumor Vaccine",,"https://ClinicalTrials.gov/show/NCT01702792"
666,"Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma","Completed","No Results Available","Glioblastoma|Giant Cell Glioblastoma|Gliosarcoma","Drug: XL184|Drug: temozolomide|Radiation: Radiation Therapy","UCLA, Los Angeles, California, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|Beth Israel Medical Center, New York, New York, United States|Duke University Medical Center; The Preston Robert Tisch Brain Tumor Center, Durham, North Carolina, United States|MD Anderson Cancer Center, Houston, Texas, United States|University of Virginia Health System/Division of Neuro-Oncology, Charlottesville, Virginia, United States|University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00960492"
667,"Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Gliosarcoma|Newly Diagnosed|Glioblastoma","Drug: Selinexor|Drug: Temozolomide|Radiation: Generic Radiation therapy (RT)","National Institutes of Health Clinical Center, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT04216329"
668,"Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM","Recruiting","No Results Available","Recurrent Glioblastoma","Drug: ASC40 tablets|Drug: Placebo tablets|Drug: Bevacizumab","Beijing Tiantan Hospital，Capital Medical University, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT05118776"
669,"A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse","Unknown status","No Results Available","Glioblastoma","Drug: Temozolomide",,"https://ClinicalTrials.gov/show/NCT02330991"
670,"Immune Modulatory DC Vaccine Against Brain Tumor","Enrolling by invitation","No Results Available","Diffuse Intrinsic Pontine Glioma or Glioblastoma","Biological: Immunomodulatory DC vaccine to target DIPG and GBM","Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China|Shenzhen Children's Hospital, Shenzhen, Guangdong, China|Department of Neurosurgery, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China","https://ClinicalTrials.gov/show/NCT03914768"
671,"ABI-009 (Nab-rapamycin) in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma","Active, not recruiting","No Results Available","High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma","Drug: ABI-009|Drug: Bevacizumab|Drug: Temozolomide|Drug: Lomustine|Radiation: Radiation|Drug: Marizomib","St. Joseph Heritage Healthcare, Fullerton, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States|John Wayne Cancer Institute, Santa Monica, California, United States","https://ClinicalTrials.gov/show/NCT03463265"
672,"Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma","Unknown status","No Results Available","Glioblastoma|Glioma","Drug: Ribociclib","University of Virginia Health System, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT02345824"
673,"CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma","Active, not recruiting","No Results Available","Astrocytoma|Glioblastoma","Drug: CC-90010","Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|Moffit Cancer Center, Tampa, Florida, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain","https://ClinicalTrials.gov/show/NCT04047303"
674,"Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma","Not yet recruiting","No Results Available","First Progression of MGMT Promoter-methylated Glioblastoma","Drug: Lomustine|Drug: Romiplostim",,"https://ClinicalTrials.gov/show/NCT04933942"
675,"The Addition of Chloroquine to Chemoradiation for Glioblastoma,","Not yet recruiting","No Results Available","Glioblastoma|Astrocytoma, Grade IV","Drug: Chloroquine",,"https://ClinicalTrials.gov/show/NCT02432417"
676,"Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma","Withdrawn","No Results Available","Glioblastoma|Gliosarcoma","Drug: Temozolomide|Radiation: Radiation|Drug: Sorafenib",,"https://ClinicalTrials.gov/show/NCT02599090"
677,"Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma","Recruiting","No Results Available","Glioblastoma|Gliosarcoma","Drug: Mycophenolate Mofetil|Radiation: Radiation Therapy|Procedure: Re-resection (as part of standard of care)|Drug: Temozolomide","University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States","https://ClinicalTrials.gov/show/NCT04477200"
678,"Expanded Access (Compassionate Use) Treatment Protocol Rindopepimut","No longer available","No Results Available","Recurrent GBM","Biological: rindopepimut",,"https://ClinicalTrials.gov/show/NCT03068650"
679,"Glycemic Impact on Glioblastoma Outcomes","Withdrawn","No Results Available","Glioblastoma Multiforme|Hyperglycemia",,"Princess Margaret Cancer Centre, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT03235934"
680,"Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM","Terminated","No Results Available","Glioblastoma Multiforme|High-Grade Glioma","Drug: Gliadel wafer|Drug: Temozolomide|Radiation: External Beam Radiation Therapy","Methodist University Hospital, Memphis, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00548938"
681,"Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma","Completed","No Results Available","Glioblastoma|Brain Tumor","Biological: Dendritic cell vaccine with mRNA from tumor stem cells",,"https://ClinicalTrials.gov/show/NCT00846456"
682,"WBSI Guided Personalized Delivery of TTFields","Not yet recruiting","No Results Available","GBM|Glioma Glioblastoma Multiforme|Tumor, Brain","Diagnostic Test: Whole Brain Spectroscopy Imaging Array Mapping Layout",,"https://ClinicalTrials.gov/show/NCT05086497"
683,"Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma","Completed","No Results Available","Glioblastoma|Brain Tumor","Drug: Sunitinib","Massachusetts General Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00864864"
684,"Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma|Gliosarcoma","Drug: Lomustine|Radiation: Photon Beam Radiation Therapy|Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Drug: Temozolomide",,"https://ClinicalTrials.gov/show/NCT05095376"
685,"Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme","Unknown status","No Results Available","Recurrent Glioma (Glioblastoma Multiforme)","Radiation: Radiation Therapy","Department of Radiotherapy, University Hospital Freiburg, Freiburg i. Br., Baden-Wuerttemberg, Germany","https://ClinicalTrials.gov/show/NCT01252459"
686,"The Safety and Efficacy of DCA for the Treatment of Brain Cancer","Completed","No Results Available","Malignant Gliomas, Glioblastoma Multiforme","Drug: Dichloroacetate (DCA)","University of Alberta Hospital, Edmonton, Alberta, Canada","https://ClinicalTrials.gov/show/NCT00540176"
687,"Nedisertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma","Recruiting","No Results Available","Glioblastoma|Gliosarcoma","Drug: Nedisertib|Radiation: Radiation Therapy|Procedure: Resection|Drug: Temozolomide","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04555577"
688,"Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT.","Completed","Has Results","Glioblastoma|Brain Tumor, Recurrent","Drug: PF-299804 (Dacomitinib)","Hospital Universitari Germans Trias I Pujol de Badalona, Badalona, Barcelona, Spain|Institut Català D'Oncologia L'Hospitalet (Ico), L'Hospitalet de Llobregat, Barcelona, Spain|Hospital Universitario A Coruña, A Coruna, Coruña (A), Spain|Hospital Del Mar, Barcelona, Spain|Hospital de La Santa Creu I Sant Pau, Barcelona, Spain|Complejo Hospitalario Regional Virgen de Las Nieves, Granada, Spain|Hospital Ramón Y Cajal, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Regional Universitario de Malaga, Malaga, Spain|Complejo Hospitalario Universitario Insular-Materno Infantil, Palmas de Gran Canaria, Spain|Hospital Universitario Y Politécnico La Fe, Valencia, Spain","https://ClinicalTrials.gov/show/NCT01520870"
689,"Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery","Active, not recruiting","Has Results","Recurrent Glioblastoma|Recurrent Adult Brain Tumor|Gliosarcoma","Biological: HSPPC-96|Drug: bevacizumab","Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States|Anchorage Radiation Therapy Center, Anchorage, Alaska, United States|Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States|Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States|Alaska Regional Hospital, Anchorage, Alaska, United States|Alaska Women's Cancer Care, Anchorage, Alaska, United States|Anchorage Oncology Centre, Anchorage, Alaska, United States|Katmai Oncology Group, Anchorage, Alaska, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Mercy Cancer Center-Hot Springs, Hot Springs, Arkansas, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Kaiser Permanente-Deer Valley Medical Center, Antioch, California, United States|Sutter Auburn Faith Hospital, Auburn, California, United States|Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, United States|Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States|Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States|Mills - Peninsula Hospitals, Burlingame, California, United States|Sutter Cancer Centers Radiation Oncology Services-Cameron Park, Cameron Park, California, United States|Eden Hospital Medical Center, Castro Valley, California, United States|Sutter Davis Hospital, Davis, California, United States|Epic Care-Dublin, Dublin, California, United States|Bay Area Breast Surgeons Inc, Emeryville, California, United States|Epic Care Partners in Cancer Care, Emeryville, California, United States|Kaiser Permanente-Fremont, Fremont, California, United States|Fresno Cancer Center, Fresno, California, United States|Kaiser Permanente, Fresno, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|Contra Costa Regional Medical Center, Martinez, California, United States|Memorial Medical Center, Modesto, California, United States|Kaiser Permanente-Modesto, Modesto, California, United States|Palo Alto Medical Foundation-Camino Division, Mountain View, California, United States|Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View, California, United States|Alta Bates Summit Medical Center - Summit Campus, Oakland, California, United States|Bay Area Tumor Institute, Oakland, California, United States|Kaiser Permanente Oakland-Broadway, Oakland, California, United States|Kaiser Permanente-Oakland, Oakland, California, United States|Palo Alto Medical Foundation Health Care, Palo Alto, California, United States|Stanford Cancer Institute, Palo Alto, California, United States|Kaiser Permanente-Rancho Cordova Cancer Center, Rancho Cordova, California, United States|Kaiser Permanente-Redwood City, Redwood City, California, United States|Kaiser Permanente-Richmond, Richmond, California, United States|Rohnert Park Cancer Center, Rohnert Park, California, United States|Kaiser Permanente-Roseville, Roseville, California, United States|Sutter Cancer Centers Radiation Oncology Services-Roseville, Roseville, California, United States|Sutter Roseville Medical Center, Roseville, California, United States|The Permanente Medical Group-Roseville Radiation Oncology, Roseville, California, United States|Sutter General Hospital, Sacramento, California, United States|Kaiser Permanente-South Sacramento, Sacramento, California, United States|South Sacramento Cancer Center, Sacramento, California, United States|Kaiser Permanente - Sacramento, Sacramento, California, United States|California Pacific Medical Center-Pacific Campus, San Francisco, California, United States|Kaiser Permanente-San Francisco, San Francisco, California, United States|UCSF Medical Center-Mount Zion, San Francisco, California, United States|UCSF Medical Center-Parnassus, San Francisco, California, United States|Kaiser Permanente-Santa Teresa-San Jose, San Jose, California, United States|Kaiser Permanente San Leandro, San Leandro, California, United States|Kaiser Permanente-San Rafael, San Rafael, California, United States|Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States|Palo Alto Medical Foundation-Santa Cruz, Santa Cruz, California, United States|Kaiser Permanente-Santa Rosa, Santa Rosa, California, United States|Sutter Pacific Medical Foundation, Santa Rosa, California, United States|Kaiser Permanente Cancer Treatment Center, South San Francisco, California, United States|Kaiser Permanente-South San Francisco, South San Francisco, California, United States|Kaiser Permanente-Stockton, Stockton, California, United States|Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California, United States|Sutter Cancer Centers Radiation Oncology Services-Vacaville, Vacaville, California, United States|Kaiser Permanente Medical Center-Vacaville, Vacaville, California, United States|Kaiser Permanente-Vallejo, Vallejo, California, United States|Sutter Solano Medical Center/Cancer Center, Vallejo, California, United States|Kaiser Permanente-Walnut Creek, Walnut Creek, California, United States|Rocky Mountain Cancer Centers-Aurora, Aurora, Colorado, United States|The Medical Center of Aurora, Aurora, Colorado, United States|Boulder Community Hospital, Boulder, Colorado, United States|Rocky Mountain Cancer Centers-Boulder, Boulder, Colorado, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, United States|Rocky Mountain Cancer Centers-Penrose, Colorado Springs, Colorado, United States|Porter Adventist Hospital, Denver, Colorado, United States|Colorado Blood Cancer Institute, Denver, Colorado, United States|Presbyterian - Saint Lukes Medical Center - Health One, Denver, Colorado, United States|Rocky Mountain Cancer Centers-Midtown, Denver, Colorado, United States|SCL Health Saint Joseph Hospital, Denver, Colorado, United States|Rocky Mountain Cancer Centers-Rose, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|Colorado Cancer Research Program NCORP, Denver, Colorado, United States|Mercy Medical Center, Durango, Colorado, United States|Southwest Oncology PC, Durango, Colorado, United States|Comprehensive Cancer Care and Research Institute of Colorado LLC, Englewood, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|Mountain Blue Cancer Care Center, Golden, Colorado, United States|North Colorado Medical Center, Greeley, Colorado, United States|Rocky Mountain Cancer Centers-Greenwood Village, Greenwood Village, Colorado, United States|Rocky Mountain Cancer Centers-Lakewood, Lakewood, Colorado, United States|Saint Anthony Hospital, Lakewood, Colorado, United States|Rocky Mountain Cancer Centers-Littleton, Littleton, Colorado, United States|Littleton Adventist Hospital, Littleton, Colorado, United States|Rocky Mountain Cancer Centers-Sky Ridge, Lone Tree, Colorado, United States|Sky Ridge Medical Center, Lone Tree, Colorado, United States|Longmont United Hospital, Longmont, Colorado, United States|Rocky Mountain Cancer Centers-Longmont, Longmont, Colorado, United States|McKee Medical Center, Loveland, Colorado, United States|Parker Adventist Hospital, Parker, Colorado, United States|Rocky Mountain Cancer Centers-Parker, Parker, Colorado, United States|Saint Mary Corwin Medical Center, Pueblo, Colorado, United States|Rocky Mountain Cancer Centers - Pueblo, Pueblo, Colorado, United States|Rocky Mountain Cancer Centers-Thornton, Thornton, Colorado, United States|SCL Health Lutheran Medical Center, Wheat Ridge, Colorado, United States|Saint Vincent's Medical Center, Bridgeport, Connecticut, United States|Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States|Boca Raton Regional Hospital, Boca Raton, Florida, United States|Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States|Mount Sinai Medical Center, Miami Beach, Florida, United States|University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States|Memorial Hospital West, Pembroke Pines, Florida, United States|Emory University Hospital Midtown, Atlanta, Georgia, United States|Piedmont Hospital, Atlanta, Georgia, United States|Emory University/Winship Cancer Institute, Atlanta, Georgia, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States|Saint Luke's Mountain States Tumor Institute, Boise, Idaho, United States|Kootenai Medical Center, Coeur d'Alene, Idaho, United States|Saint Luke's Mountain States Tumor Institute - Fruitland, Fruitland, Idaho, United States|Saint Luke's Mountain States Tumor Institute - Meridian, Meridian, Idaho, United States|Saint Luke's Mountain States Tumor Institute - Nampa, Nampa, Idaho, United States|Kootenai Cancer Center, Post Falls, Idaho, United States|Kootenai Cancer Clinic, Sandpoint, Idaho, United States|Saint Luke's Mountain States Tumor Institute-Twin Falls, Twin Falls, Idaho, United States|Saint Joseph Medical Center, Bloomington, Illinois, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, United States|Illinois CancerCare-Canton, Canton, Illinois, United States|Memorial Hospital of Carbondale, Carbondale, Illinois, United States|Illinois CancerCare-Carthage, Carthage, Illinois, United States|Centralia Oncology Clinic, Centralia, Illinois, United States|Northwestern University, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Cancer Care Center of Decatur, Decatur, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Crossroads Cancer Center, Effingham, Illinois, United States|Illinois CancerCare-Eureka, Eureka, Illinois, United States|NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, United States|Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States|NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois, United States|NorthShore University HealthSystem-Highland Park Hospital, Highland Park, Illinois, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States|Illinois CancerCare-Macomb, Macomb, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Radiation Oncology of Northern Illinois, Ottawa, Illinois, United States|Illinois CancerCare-Pekin, Pekin, Illinois, United States|OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center, Pekin, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|OSF Saint Francis Radiation Oncology at Peoria Cancer Center, Peoria, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Illinois CancerCare-Peru, Peru, Illinois, United States|Valley Radiation Oncology, Peru, Illinois, United States|Illinois CancerCare-Princeton, Princeton, Illinois, United States|Central Illinois Hematology Oncology Center, Springfield, Illinois, United States|Southern Illinois University School of Medicine, Springfield, Illinois, United States|Springfield Clinic, Springfield, Illinois, United States|Memorial Medical Center, Springfield, Illinois, United States|Cancer Care Specialists of Illinois-Swansea, Swansea, Illinois, United States|Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States|Elkhart Clinic, Elkhart, Indiana, United States|Michiana Hematology Oncology PC-Elkhart, Elkhart, Indiana, United States|Elkhart General Hospital, Elkhart, Indiana, United States|Radiation Oncology Associates PC, Fort Wayne, Indiana, United States|Parkview Hospital Randallia, Fort Wayne, Indiana, United States|Franciscan Health Indianapolis, Indianapolis, Indiana, United States|Community Howard Regional Health, Kokomo, Indiana, United States|IU Health La Porte Hospital, La Porte, Indiana, United States|Memorial Regional Cancer Center Day Road, Mishawaka, Indiana, United States|Michiana Hematology Oncology PC-Mishawaka, Mishawaka, Indiana, United States|Saint Joseph Regional Medical Center-Mishawaka, Mishawaka, Indiana, United States|Michiana Hematology Oncology PC-Plymouth, Plymouth, Indiana, United States|Reid Health, Richmond, Indiana, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|Michiana Hematology Oncology PC-South Bend, South Bend, Indiana, United States|South Bend Clinic, South Bend, Indiana, United States|Northern Indiana Cancer Research Consortium, South Bend, Indiana, United States|Michiana Hematology Oncology PC-Westville, Westville, Indiana, United States|Medical Oncology and Hematology Associates-West Des Moines, Clive, Iowa, United States|Mercy Cancer Center-West Lakes, Clive, Iowa, United States|Alegent Health Mercy Hospital, Council Bluffs, Iowa, United States|Greater Regional Medical Center, Creston, Iowa, United States|Medical Oncology and Hematology Associates-Laurel, Des Moines, Iowa, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|Mercy Medical Center-West Lakes, West Des Moines, Iowa, United States|Kansas Institute of Medicine Cancer and Blood Center, Lenexa, Kansas, United States|Minimally Invasive Surgery Hospital, Lenexa, Kansas, United States|Menorah Medical Center, Overland Park, Kansas, United States|Saint Luke's South Hospital, Overland Park, Kansas, United States|Kansas City NCI Community Oncology Research Program, Prairie Village, Kansas, United States|Flaget Memorial Hospital, Bardstown, Kentucky, United States|Commonwealth Cancer Center-Corbin, Corbin, Kentucky, United States|Saint Joseph Radiation Oncology Resource Center, Lexington, Kentucky, United States|Saint Joseph Hospital East, Lexington, Kentucky, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|Jewish Hospital, Louisville, Kentucky, United States|Norton Hospital Pavilion and Medical Campus, Louisville, Kentucky, United States|Saints Mary and Elizabeth Hospital, Louisville, Kentucky, United States|Jewish Hospital Medical Center Northeast, Louisville, Kentucky, United States|Jewish Hospital Medical Center South, Shepherdsville, Kentucky, United States|Maine Medical Center- Scarborough Campus, Scarborough, Maine, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Northwest Hospital Center, Randallstown, Maryland, United States|Tufts Medical Center, Boston, Massachusetts, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Bixby Medical Center, Adrian, Michigan, United States|Hickman Cancer Center, Adrian, Michigan, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|Michigan Cancer Research Consortium NCORP, Ann Arbor, Michigan, United States|Beaumont Hospital-Dearborn, Dearborn, Michigan, United States|Saint John Hospital and Medical Center, Detroit, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Allegiance Health, Jackson, Michigan, United States|Sparrow Hospital, Lansing, Michigan, United States|Saint Mary Mercy Hospital, Livonia, Michigan, United States|Marquette General Hematology Oncology, Marquette, Michigan, United States|Marquette General Hospital, Marquette, Michigan, United States|Mercy Memorial Hospital, Monroe, Michigan, United States|Toledo Clinic Cancer Centers-Monroe, Monroe, Michigan, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, United States|Saint Mary's of Michigan, Saginaw, Michigan, United States|Lakeland Hospital, Saint Joseph, Michigan, United States|Marie Yeager Cancer Center, Saint Joseph, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Essentia Health Cancer Center, Duluth, Minnesota, United States|Essentia Health Saint Mary's Medical Center, Duluth, Minnesota, United States|Miller-Dwan Hospital, Duluth, Minnesota, United States|Fairview-Southdale Hospital, Edina, Minnesota, United States|Unity Hospital, Fridley, Minnesota, United States|Fairview Maple Grove Medical Center, Maple Grove, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|Health Partners Inc, Minneapolis, Minnesota, United States|New Ulm Medical Center, New Ulm, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, United States|Lakeview Hospital, Stillwater, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Rice Memorial Hospital, Willmar, Minnesota, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States|Fairview Lakes Medical Center, Wyoming, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Parkland Health Center-Bonne Terre, Bonne Terre, Missouri, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, United States|Southeast Cancer Center, Cape Girardeau, Missouri, United States|Centerpoint Medical Center LLC, Independence, Missouri, United States|Capital Region Medical Center-Goldschmidt Cancer Center, Jefferson City, Missouri, United States|Saint Luke's Hospital of Kansas City, Kansas City, Missouri, United States|North Kansas City Hospital, Kansas City, Missouri, United States|Heartland Hematology and Oncology Associates Incorporated, Kansas City, Missouri, United States|Research Medical Center, Kansas City, Missouri, United States|Saint Luke's East - Lee's Summit, Lee's Summit, Missouri, United States|Liberty Radiation Oncology Center, Liberty, Missouri, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, United States|Saint Joseph Oncology Inc, Saint Joseph, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Missouri Baptist Medical Center, Saint Louis, Missouri, United States|Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, United States|Missouri Baptist Sullivan Hospital, Sullivan, Missouri, United States|Missouri Baptist Outpatient Center-Sunset Hills, Sunset Hills, Missouri, United States|Community Hospital of Anaconda, Anaconda, Montana, United States|Billings Clinic Cancer Center, Billings, Montana, United States|Montana Cancer Consortium NCORP, Billings, Montana, United States|Saint Vincent Healthcare, Billings, Montana, United States|Frontier Cancer Center and Blood Institute-Billings, Billings, Montana, United States|Bozeman Deaconess Hospital, Bozeman, Montana, United States|Saint James Community Hospital and Cancer Treatment Center, Butte, Montana, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, United States|Great Falls Clinic, Great Falls, Montana, United States|Saint Peter's Community Hospital, Helena, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Montana Cancer Specialists, Missoula, Montana, United States|Saint Patrick Hospital - Community Hospital, Missoula, Montana, United States|Community Medical Hospital, Missoula, Montana, United States|CHI Health Saint Francis, Grand Island, Nebraska, United States|Heartland Hematology and Oncology, Kearney, Nebraska, United States|CHI Health Good Samaritan, Kearney, Nebraska, United States|Nebraska Cancer Research Center, Lincoln, Nebraska, United States|Saint Elizabeth Regional Medical Center, Lincoln, Nebraska, United States|Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|Alegent Health Immanuel Medical Center, Omaha, Nebraska, United States|Hemotology and Oncology Consultants PC, Omaha, Nebraska, United States|Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, United States|Alegent Health Lakeside Hospital, Omaha, Nebraska, United States|Creighton University Medical Center, Omaha, Nebraska, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Midlands Community Hospital, Papillion, Nebraska, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|The Valley Hospital-Luckow Pavilion, Paramus, New Jersey, United States|Neurosurgeons of New Jersey-Ridgewood, Ridgewood, New Jersey, United States|Valley Hospital, Ridgewood, New Jersey, United States|Valley Health System-Hematology/Oncology, Westwood, New Jersey, United States|Columbia University/Herbert Irving Cancer Center, New York, New York, United States|University of Rochester, Rochester, New York, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Altru Cancer Center, Grand Forks, North Dakota, United States|Toledo Clinic Cancer Centers-Bowling Green, Bowling Green, Ohio, United States|University of Cincinnati/Barrett Cancer Center, Cincinnati, Ohio, United States|Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio, United States|Bethesda North Hospital, Cincinnati, Ohio, United States|TriHealth Cancer Institute-Westside, Cincinnati, Ohio, United States|TriHealth Cancer Institute-Anderson, Cincinnati, Ohio, United States|Case Western Reserve University, Cleveland, Ohio, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|Grandview Hospital, Dayton, Ohio, United States|Good Samaritan Hospital - Dayton, Dayton, Ohio, United States|Miami Valley Hospital, Dayton, Ohio, United States|Samaritan North Health Center, Dayton, Ohio, United States|Blanchard Valley Hospital, Findlay, Ohio, United States|Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States|Wayne Hospital, Greenville, Ohio, United States|Kettering Medical Center, Kettering, Ohio, United States|Lima Memorial Hospital, Lima, Ohio, United States|Toledo Clinic Cancer Centers-Maumee, Maumee, Ohio, United States|Toledo Radiation Oncology at Northwest Ohio Onocolgy Center, Maumee, Ohio, United States|Saint Charles Hospital, Oregon, Ohio, United States|Toledo Clinic Cancer Centers-Oregon, Oregon, Ohio, United States|Flower Hospital, Sylvania, Ohio, United States|Mercy Hospital of Tiffin, Tiffin, Ohio, United States|The Toledo Hospital/Toledo Children's Hospital, Toledo, Ohio, United States|Saint Vincent Mercy Medical Center, Toledo, Ohio, United States|University of Toledo, Toledo, Ohio, United States|Mercy Saint Anne Hospital, Toledo, Ohio, United States|Toledo Clinic Cancer Centers-Toledo, Toledo, Ohio, United States|Upper Valley Medical Center, Troy, Ohio, United States|Fulton County Health Center, Wauseon, Ohio, United States|University Pointe, West Chester, Ohio, United States|Greene Memorial Hospital, Xenia, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa, Oklahoma, United States|Saint Charles Health System, Bend, Oregon, United States|Clackamas Radiation Oncology Center, Clackamas, Oregon, United States|Providence Oncology and Hematology Care Southeast, Clackamas, Oregon, United States|Bay Area Hospital, Coos Bay, Oregon, United States|Legacy Mount Hood Medical Center, Gresham, Oregon, United States|Providence Milwaukie Hospital, Milwaukie, Oregon, United States|Providence Newberg Medical Center, Newberg, Oregon, United States|Providence Willamette Falls Medical Center, Oregon City, Oregon, United States|Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|Legacy Meridian Park Hospital, Tualatin, Oregon, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States|Avera Cancer Institute, Sioux Falls, South Dakota, United States|Memorial Hospital, Chattanooga, Tennessee, United States|Pulmonary Medicine Center of Chattanooga-Hixson, Hixson, Tennessee, United States|Memorial GYN Plus, Ooltewah, Tennessee, United States|Saint Joseph Regional Cancer Center, Bryan, Texas, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|Inova Fairfax Hospital, Falls Church, Virginia, United States|Fredericksburg Oncology Inc, Fredericksburg, Virginia, United States|Sentara Norfolk General Hospital, Norfolk, Virginia, United States|Providence Regional Cancer System-Aberdeen, Aberdeen, Washington, United States|Cancer Care Center at Island Hospital, Anacortes, Washington, United States|Swedish Cancer Institute-Eastside Oncology Hematology, Bellevue, Washington, United States|PeaceHealth Saint Joseph Medical Center, Bellingham, Washington, United States|Harrison HealthPartners Hematology and Oncology-Bremerton, Bremerton, Washington, United States|Harrison Medical Center, Bremerton, Washington, United States|Highline Medical Center-Main Campus, Burien, Washington, United States|Providence Regional Cancer System-Centralia, Centralia, Washington, United States|Swedish Medical Center-Edmonds, Edmonds, Washington, United States|Saint Elizabeth Hospital, Enumclaw, Washington, United States|Providence Regional Cancer Partnership, Everett, Washington, United States|Saint Francis Hospital, Federal Way, Washington, United States|Swedish Cancer Institute-Issaquah, Issaquah, Washington, United States|Providence Regional Cancer System-Lacey, Lacey, Washington, United States|Saint Clare Hospital, Lakewood, Washington, United States|PeaceHealth Saint John Medical Center, Longview, Washington, United States|Harrison HealthPartners Hematology and Oncology-Poulsbo, Poulsbo, Washington, United States|Minor and James Medical PLLC, Seattle, Washington, United States|Pacific Gynecology Specialists, Seattle, Washington, United States|Swedish Medical Center-Ballard Campus, Seattle, Washington, United States|Group Health Cooperative-Seattle, Seattle, Washington, United States|Swedish Medical Center-First Hill, Seattle, Washington, United States|Providence Regional Cancer System-Shelton, Shelton, Washington, United States|Rockwood Clinic Cancer Treatment Center-Valley, Spokane Valley, Washington, United States|Rockwood Cancer Treatment Center-DHEC-Downtown, Spokane, Washington, United States|Evergreen Hematology and Oncology PS, Spokane, Washington, United States|Franciscan Research Center-Northwest Medical Plaza, Tacoma, Washington, United States|Northwest Medical Specialties PLLC, Tacoma, Washington, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, United States|Compass Oncology Vancouver, Vancouver, Washington, United States|Legacy Salmon Creek Hospital, Vancouver, Washington, United States|Providence Saint Mary Regional Cancer Center, Walla Walla, Washington, United States|North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington, United States|Providence Regional Cancer System-Yelm, Yelm, Washington, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin, United States|Aurora Cancer Care-Racine, Racine, Wisconsin, United States|Cheyenne Regional Medical Center-West, Cheyenne, Wyoming, United States|Big Horn Basin Cancer Center, Cody, Wyoming, United States|Billings Clinic-Cody, Cody, Wyoming, United States|Welch Cancer Center, Sheridan, Wyoming, United States","https://ClinicalTrials.gov/show/NCT01814813"
690,"Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma","Not yet recruiting","No Results Available","Glioblastoma|Gliosarcoma","Radiation: 3-Dimensional Conformal Radiation Therapy|Radiation: Intensity-Modulated Radiation Therapy (IMRT)|Drug: Temozolomide|Drug: Chloroquine|Procedure: Tumor Treating Fields Therapy (TTF)","Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States","https://ClinicalTrials.gov/show/NCT04397679"
691,"MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS","Unknown status","No Results Available","Glioblastoma","Drug: 5-aminolévulinique acid (5-ALA)|Drug: Placebo","Guyotat, Lyon, France","https://ClinicalTrials.gov/show/NCT01811121"
692,"Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma|Gliosarcoma","Radiation: Dose-Escalated Radiation Therapy|Procedure: Spectroscopic Magnetic Resonance Imaging|Drug: Temozolomide","University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States|Emory University/Winship Cancer Institute, Atlanta, Georgia, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT03137888"
693,"Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma|Recurrent Brain Neoplasm","Radiation: Palliative Radiation Therapy|Other: Questionnaire Administration|Radiation: Radiation Therapy Treatment Planning and Simulation","UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT02575027"
694,"Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma","Recruiting","No Results Available","Glioma|Glioblastoma","Drug: ruxolitinib|Radiation: radiation|Drug: temozolomide","Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT03514069"
695,"qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.","Completed","No Results Available","Glioblastoma|Hypoxia","Drug: Feraheme®","Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT02466828"
696,"New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma","Withdrawn","No Results Available","Glioblastoma|Sarcoma|Neuroblastoma","Biological: New Castle Disease Virus","Hadassah Medical Organization, Jerusalem, Israel","https://ClinicalTrials.gov/show/NCT01174537"
697,"Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers","Active, not recruiting","No Results Available","Brain Cancer|Glioblastoma","Behavioral: psychometric tests, questionnaires and neurocognitive assessments","Henry Ford Hospital, Detroit, Michigan, United States|Memoral Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States|Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States|Memorial Sloan Kettering Commack, Commack, New York, United States|Memorial Sloan Kettering Westchester, Harrison, New York, United States|Memoral Sloan Kettering Cancer Center, New York, New York, United States|University of Vermont Medical Center, Burlington, Vermont, United States","https://ClinicalTrials.gov/show/NCT02375841"
698,"18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy","Active, not recruiting","No Results Available","Glioblastoma|Malignant Glioma","Procedure: Computed Tomography|Other: Fluorodopa F 18|Procedure: Magnetic Resonance Imaging|Procedure: Positron Emission Tomography|Radiation: Proton Beam Radiation Therapy|Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Drug: Temozolomide","Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT03778294"
699,"Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma","Not yet recruiting","No Results Available","Recurrent Glioblastoma|Recurrent Gliosarcoma","Biological: Atezolizumab|Drug: Cabozantinib","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT05039281"
700,"Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma","Not yet recruiting","No Results Available","Recurrent Glioblastoma|Recurrent Gliosarcoma","Drug: Liothyronine|Drug: Lomustine|Drug: Methimazole","Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States","https://ClinicalTrials.gov/show/NCT05017610"
701,"Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients","Recruiting","No Results Available","Glioma, Malignant|Glioblastoma","Device: Magnetic Resonance guided Focused ultrasound (MRgFUS)","Fondazione IRCCS Neurologico Carlo Besta, Milano, Italy|CINAC-Hospital HM Puerta del Sur, Móstoles, Madrid, Spain","https://ClinicalTrials.gov/show/NCT04998864"
702,"Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma","Active, not recruiting","No Results Available","Astrocytoma, Grade III|Glioblastoma","Drug: TG02|Radiation: Radiation Therapy|Drug: Temozolomide","Universitaetskliniken der Uni Wien - Universitaetsklinikum Wien - AKH uniklinieken, Vienna, Austria|CHU de Lyon - CHU Lyon - Hopital neurologique Pierre Wertheimer, Bron, France|CHRU de Lille, Lille, France|Assistance Publique - Hopitaux de Marseille - Hôpital de La Timone, Marseille, France|Universitaetsklinikum Bonn, Bonn, Germany|Klinikum Der J.W. Goethe Universitaet-Klinik und Poliklinik fur Neurochirurgie, Frankfurt, Germany|Universitaetsklinikum Heidelberg - UniversitaetsKlinikum Heidelberg - Head Hospital, Heidelberg, Germany|Universitaetskliniken Regensburg - Universitaetsklinikum Regensburg, Regensburg, Germany|Erasmus MC Cancer Institute - location Daniel den Hoed, Rotterdam, Netherlands|UniversitaetsSpital Zurich, Zürich, Switzerland","https://ClinicalTrials.gov/show/NCT03224104"
703,"SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma","Active, not recruiting","Has Results","Glioblastoma|Gliosarcoma","Other: Laboratory Biomarker Analysis|Drug: Montanide ISA 51 VG|Biological: Sargramostim|Biological: SVN53-67/M57-KLH Peptide Vaccine|Drug: Temozolomide","Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Dana-Farber Harvard Cancer Center, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT02455557"
704,"Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide","Completed","No Results Available","Glioblastoma|Glioma","Procedure: Functional MRI imaging and tomotherapy","Cross Cancer Institute, Edmonton, Alberta, Canada","https://ClinicalTrials.gov/show/NCT00250211"
705,"Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma","Completed","Has Results","Glioblastoma Multiforme|Anaplastic Astrocytoma","Drug: Erlotinib","Lenox Hill Brain Tumor Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00301418"
706,"Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab","Completed","No Results Available","Malignant Glioma|Glioblastoma","Drug: MRZ|Drug: BEV","University of Californai, Irvine, Orange, California, United States|John Wayne Cancer Institute, Santa Monica, California, United States|Weill Cornell Medical College, New York, New York, United States|Duke Univ Medical Center, Durham, North Carolina, United States|Princess Margaret Hospital, Medical Oncology, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT02330562"
707,"Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma","Terminated","No Results Available","Glioblastoma|Gliosarcoma","Drug: Temozolomide|Radiation: Radiation|Drug: Sorafenib","University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00734526"
708,"The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors","Not yet recruiting","No Results Available","Glioblastoma Multiforme of Brain|Brain Cancer","Behavioral: Circuit-based resistance exercise (CRT)",,"https://ClinicalTrials.gov/show/NCT05116137"
709,"Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma","Terminated","No Results Available","Glioblastoma|Gliosarcoma","Drug: Temozolomide","H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States","https://ClinicalTrials.gov/show/NCT00365222"
710,"Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma","Recruiting","No Results Available","Glioblastoma|Gliosarcoma|Supratentorial Glioblastoma","Radiation: External Beam Radiation Therapy|Other: Laboratory Biomarker Analysis|Biological: Pembrolizumab|Radiation: Radiation Therapy|Drug: Temozolomide|Procedure: Therapeutic Conventional Surgery","Mayo Clinic in Rochester, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT03197506"
711,"Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Active, not recruiting","No Results Available","Glioblastoma|Gliosarcoma","Other: Laboratory Biomarker Analysis|Other: Placebo Administration|Other: Quality-of-Life Assessment|Drug: Temozolomide|Drug: Veliparib","University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States|Katmai Oncology Group, Anchorage, Alaska, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Banner University Medical Center - Tucson, Tucson, Arizona, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Kaiser Permanente-Deer Valley Medical Center, Antioch, California, United States|Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States|Mills-Peninsula Medical Center, Burlingame, California, United States|John Muir Medical Center-Concord Campus, Concord, California, United States|Kaiser Permanente-Fremont, Fremont, California, United States|Fresno Cancer Center, Fresno, California, United States|Kaiser Permanente-Fresno, Fresno, California, United States|Saint Jude Medical Center, Fullerton, California, United States|UC San Diego Moores Cancer Center, La Jolla, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|Los Angeles County-USC Medical Center, Los Angeles, California, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States|Kaiser Permanente-Modesto, Modesto, California, United States|USC Norris Oncology/Hematology-Newport Beach, Newport Beach, California, United States|Kaiser Permanente Oakland-Broadway, Oakland, California, United States|Kaiser Permanente-Oakland, Oakland, California, United States|Saint Joseph Hospital - Orange, Orange, California, United States|Kaiser Permanente-Rancho Cordova Cancer Center, Rancho Cordova, California, United States|Kaiser Permanente-Redwood City, Redwood City, California, United States|Kaiser Permanente-Richmond, Richmond, California, United States|Rohnert Park Cancer Center, Rohnert Park, California, United States|Kaiser Permanente-Roseville, Roseville, California, United States|Sutter Roseville Medical Center, Roseville, California, United States|The Permanente Medical Group-Roseville Radiation Oncology, Roseville, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|Kaiser Permanente-South Sacramento, Sacramento, California, United States|South Sacramento Cancer Center, Sacramento, California, United States|Kaiser Permanente - Sacramento, Sacramento, California, United States|UC San Diego Medical Center - Hillcrest, San Diego, California, United States|Kaiser Permanente-San Francisco, San Francisco, California, United States|UCSF Medical Center-Parnassus, San Francisco, California, United States|Kaiser Permanente-Santa Teresa-San Jose, San Jose, California, United States|Kaiser Permanente San Leandro, San Leandro, California, United States|Kaiser Permanente-San Rafael, San Rafael, California, United States|Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States|Palo Alto Medical Foundation-Santa Cruz, Santa Cruz, California, United States|Kaiser Permanente-Santa Rosa, Santa Rosa, California, United States|Kaiser Permanente Cancer Treatment Center, South San Francisco, California, United States|Kaiser Permanente-South San Francisco, South San Francisco, California, United States|Kaiser Permanente-Stockton, Stockton, California, United States|Northbay Cancer Center, Vacaville, California, United States|Kaiser Permanente Medical Center-Vacaville, Vacaville, California, United States|Kaiser Permanente-Vallejo, Vallejo, California, United States|Kaiser Permanente-Walnut Creek, Walnut Creek, California, United States|John Muir Medical Center-Walnut Creek, Walnut Creek, California, United States|University of Colorado Hospital, Aurora, Colorado, United States|Boulder Community Hospital, Boulder, Colorado, United States|Rocky Mountain Cancer Centers-Boulder, Boulder, Colorado, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, United States|Rocky Mountain Cancer Centers-Penrose, Colorado Springs, Colorado, United States|Kaiser Permanente-Franklin, Denver, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|Poudre Valley Hospital, Fort Collins, Colorado, United States|North Colorado Medical Center, Greeley, Colorado, United States|Kaiser Permanente-Rock Creek, Lafayette, Colorado, United States|Rocky Mountain Cancer Centers-Littleton, Littleton, Colorado, United States|Littleton Adventist Hospital, Littleton, Colorado, United States|Kaiser Permanente-Lone Tree, Lone Tree, Colorado, United States|Rocky Mountain Cancer Centers-Longmont, Longmont, Colorado, United States|McKee Medical Center, Loveland, Colorado, United States|SCL Health Lutheran Medical Center, Wheat Ridge, Colorado, United States|Hartford Hospital, Hartford, Connecticut, United States|Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States|Midstate Medical Center, Meriden, Connecticut, United States|The Hospital of Central Connecticut, New Britain, Connecticut, United States|Yale University, New Haven, Connecticut, United States|Boca Raton Regional Hospital, Boca Raton, Florida, United States|UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States|Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Lakeland Regional Health Hollis Cancer Center, Lakeland, Florida, United States|Mount Sinai Medical Center, Miami Beach, Florida, United States|University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States|AdventHealth Orlando, Orlando, Florida, United States|Orlando Health Cancer Institute, Orlando, Florida, United States|Memorial Hospital West, Pembroke Pines, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|Piedmont Hospital, Atlanta, Georgia, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|Northside Hospital, Atlanta, Georgia, United States|John B Amos Cancer Center, Columbus, Georgia, United States|Northeast Georgia Medical Center-Gainesville, Gainesville, Georgia, United States|Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu, Hawaii, United States|Queen's Cancer Cenrer - POB I, Honolulu, Hawaii, United States|Queen's Medical Center, Honolulu, Hawaii, United States|Straub Clinic and Hospital, Honolulu, Hawaii, United States|Hawaii Cancer Care Inc-Liliha, Honolulu, Hawaii, United States|Queen's Cancer Center - Kuakini, Honolulu, Hawaii, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States|Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, United States|Saint Joseph Medical Center, Bloomington, Illinois, United States|Northwestern University, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Crossroads Cancer Center, Effingham, Illinois, United States|NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, United States|Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States|NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois, United States|NorthShore University HealthSystem-Highland Park Hospital, Highland Park, Illinois, United States|Edward Hospital/Cancer Center, Naperville, Illinois, United States|Advocate Lutheran General Hospital, Park Ridge, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Edward Hospital/Cancer Center?Plainfield, Plainfield, Illinois, United States|Central Illinois Hematology Oncology Center, Springfield, Illinois, United States|Southern Illinois University School of Medicine, Springfield, Illinois, United States|Memorial Medical Center, Springfield, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States|Parkview Hospital Randallia, Fort Wayne, Indiana, United States|Franciscan Health Indianapolis, Indianapolis, Indiana, United States|Reid Health, Richmond, Indiana, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|Physicians' Clinic of Iowa PC, Cedar Rapids, Iowa, United States|Medical Oncology and Hematology Associates-West Des Moines, Clive, Iowa, United States|Mercy Cancer Center-West Lakes, Clive, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Laurel, Des Moines, Iowa, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|Mercy Medical Center - North Iowa, Mason City, Iowa, United States|Siouxland Regional Cancer Center, Sioux City, Iowa, United States|Mercy Medical Center-West Lakes, West Des Moines, Iowa, United States|Cancer Center of Kansas - Chanute, Chanute, Kansas, United States|Cancer Center of Kansas - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas - El Dorado, El Dorado, Kansas, United States|Cancer Center of Kansas - Fort Scott, Fort Scott, Kansas, United States|Cancer Center of Kansas-Independence, Independence, Kansas, United States|Cancer Center of Kansas-Kingman, Kingman, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|Cancer Center of Kansas-Liberal, Liberal, Kansas, United States|Cancer Center of Kansas - McPherson, McPherson, Kansas, United States|Cancer Center of Kansas - Newton, Newton, Kansas, United States|Menorah Medical Center, Overland Park, Kansas, United States|Cancer Center of Kansas - Parsons, Parsons, Kansas, United States|Cancer Center of Kansas - Pratt, Pratt, Kansas, United States|Cancer Center of Kansas - Salina, Salina, Kansas, United States|Cancer Center of Kansas - Wellington, Wellington, Kansas, United States|Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita, Kansas, United States|Ascension Via Christi Hospitals Wichita, Wichita, Kansas, United States|Cancer Center of Kansas - Wichita, Wichita, Kansas, United States|Cancer Center of Kansas - Winfield, Winfield, Kansas, United States|Baptist Health Corbin, Corbin, Kentucky, United States|Baptist Health Lexington, Lexington, Kentucky, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|Baptist Health Louisville, Louisville, Kentucky, United States|Baptist Health Madisonville/Merle Mahr Cancer Center, Madisonville, Kentucky, United States|Baptist Health Paducah, Paducah, Kentucky, United States|Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States|The NeuroMedical Center-Clinic, Baton Rouge, Louisiana, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|Eastern Maine Medical Center, Bangor, Maine, United States|Lafayette Family Cancer Center-EMMC, Brewer, Maine, United States|Maine Center for Cancer Medicine-Scarborough, Scarborough, Maine, United States|Maine Center for Cancer Medicine-Topsham, Topsham, Maine, United States|Anne Arundel Medical Center, Annapolis, Maryland, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, United States|Northwest Hospital Center, Randallstown, Maryland, United States|TidalHealth Peninsula Regional, Salisbury, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Simonds-Sinon Regional Cancer Center, Fitchburg, Massachusetts, United States|Lowell General Hospital, Lowell, Massachusetts, United States|UMass Memorial Medical Center - University Campus, Worcester, Massachusetts, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Ascension Saint John Hospital, Detroit, Michigan, United States|Green Bay Oncology - Escanaba, Escanaba, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, United States|Green Bay Oncology - Iron Mountain, Iron Mountain, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Sparrow Hospital, Lansing, Michigan, United States|Saint Mary Mercy Hospital, Livonia, Michigan, United States|Ascension Providence Hospitals - Novi, Novi, Michigan, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, United States|Spectrum Health Reed City Hospital, Reed City, Michigan, United States|William Beaumont Hospital-Royal Oak, Royal Oak, Michigan, United States|Ascension Saint Mary's Hospital, Saginaw, Michigan, United States|Lakeland Medical Center Saint Joseph, Saint Joseph, Michigan, United States|Marie Yeager Cancer Center, Saint Joseph, Michigan, United States|Ascension Providence Hospitals - Southfield, Southfield, Michigan, United States|Munson Medical Center, Traverse City, Michigan, United States|Metro Health Hospital, Wyoming, Michigan, United States|Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Essentia Health Cancer Center, Duluth, Minnesota, United States|Saint Luke's Hospital of Duluth, Duluth, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|Health Partners Inc, Minneapolis, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Rice Memorial Hospital, Willmar, Minnesota, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Southeast Cancer Center, Cape Girardeau, Missouri, United States|Saint Luke's Hospital, Chesterfield, Missouri, United States|Centerpoint Medical Center LLC, Independence, Missouri, United States|Saint Luke's Hospital of Kansas City, Kansas City, Missouri, United States|Saint Luke's East - Lee's Summit, Lee's Summit, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Missouri Baptist Medical Center, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Mercy Hospital Springfield, Springfield, Missouri, United States|CoxHealth South Hospital, Springfield, Missouri, United States|Billings Clinic Cancer Center, Billings, Montana, United States|Bozeman Deaconess Hospital, Bozeman, Montana, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, United States|CHI Health Saint Francis, Grand Island, Nebraska, United States|CHI Health Good Samaritan, Kearney, Nebraska, United States|Faith Regional Health Services Carson Cancer Center, Norfolk, Nebraska, United States|Nebraska Methodist Hospital, Omaha, Nebraska, United States|Alegent Health Immanuel Medical Center, Omaha, Nebraska, United States|Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, United States|Nebraska Cancer Specialists - Omaha, Omaha, Nebraska, United States|Creighton University Medical Center, Omaha, Nebraska, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Renown Regional Medical Center, Reno, Nevada, United States|New Hampshire Oncology Hematology PA-Concord, Concord, New Hampshire, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Solinsky Center for Cancer Care, Manchester, New Hampshire, United States|Portsmouth Regional Hospital, Portsmouth, New Hampshire, United States|John F Kennedy Medical Center, Edison, New Jersey, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Saint Barnabas Medical Center, Livingston, New Jersey, United States|Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|The Valley Hospital-Luckow Pavilion, Paramus, New Jersey, United States|Valley Hospital, Ridgewood, New Jersey, United States|Overlook Hospital, Summit, New Jersey, United States|Valley Health System-Hematology/Oncology, Westwood, New Jersey, United States|Montefiore Medical Center - Moses Campus, Bronx, New York, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Mary Imogene Bassett Hospital, Cooperstown, New York, United States|Mount Sinai Hospital, New York, New York, United States|University of Rochester, Rochester, New York, United States|State University of New York Upstate Medical University, Syracuse, New York, United States|Mission Hospital, Asheville, North Carolina, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|Vidant Oncology-Kinston, Kinston, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Sanford Clinic North-Fargo, Fargo, North Dakota, United States|Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States|Altru Cancer Center, Grand Forks, North Dakota, United States|Cleveland Clinic Akron General, Akron, Ohio, United States|Cleveland Clinic Mercy Hospital, Canton, Ohio, United States|Adena Regional Medical Center, Chillicothe, Ohio, United States|University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|Mount Carmel East Hospital, Columbus, Ohio, United States|Riverside Methodist Hospital, Columbus, Ohio, United States|Grant Medical Center, Columbus, Ohio, United States|Good Samaritan Hospital - Dayton, Dayton, Ohio, United States|Miami Valley Hospital, Dayton, Ohio, United States|Dayton Physician LLC-Miami Valley Hospital North, Dayton, Ohio, United States|Miami Valley Hospital North, Dayton, Ohio, United States|Armes Family Cancer Center, Findlay, Ohio, United States|Blanchard Valley Hospital, Findlay, Ohio, United States|Orion Cancer Care, Findlay, Ohio, United States|Wayne Hospital, Greenville, Ohio, United States|Toledo Clinic Cancer Centers-Maumee, Maumee, Ohio, United States|Saint Charles Hospital, Oregon, Ohio, United States|Mercy Health Perrysburg Cancer Center, Perrysburg, Ohio, United States|ProMedica Flower Hospital, Sylvania, Ohio, United States|Mercy Health - Saint Anne Hospital, Toledo, Ohio, United States|Toledo Clinic Cancer Centers-Toledo, Toledo, Ohio, United States|University of Cincinnati Cancer Center-West Chester, West Chester, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa, Oklahoma, United States|Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|Kaiser Permanente Northwest, Portland, Oregon, United States|Jefferson Abington Hospital, Abington, Pennsylvania, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Harrisburg, Pennsylvania, United States|Lancaster General Hospital, Lancaster, Pennsylvania, United States|Paoli Memorial Hospital, Paoli, Pennsylvania, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States|Guthrie Medical Group PC-Robert Packer Hospital, Sayre, Pennsylvania, United States|Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States|UPMC Susquehanna, Williamsport, Pennsylvania, United States|Lankenau Medical Center, Wynnewood, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Prisma Health Cancer Institute - Spartanburg, Boiling Springs, South Carolina, United States|Roper Hospital, Charleston, South Carolina, United States|Charleston Oncology - Roper, Charleston, South Carolina, United States|Lowcountry Hematology Oncology PA-North Charleston, Charleston, South Carolina, United States|Bon Secours Saint Francis Hospital, Charleston, South Carolina, United States|Charleston Oncology - Saint Francis, Charleston, South Carolina, United States|Lowcountry Hematology Oncology PA-West Ashley, Charleston, South Carolina, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Prisma Health Cancer Institute - Easley, Easley, South Carolina, United States|Gibbs Cancer Center-Gaffney, Gaffney, South Carolina, United States|Greenville Health System Cancer Institute-Andrews, Greenville, South Carolina, United States|Saint Francis Hospital, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Butternut, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Faris, Greenville, South Carolina, United States|Prisma Health Greenville Memorial Hospital, Greenville, South Carolina, United States|Saint Francis Cancer Center, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Eastside, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Greer, Greer, South Carolina, United States|Gibbs Cancer Center-Pelham, Greer, South Carolina, United States|Lowcountry Hematology Oncology PA-Mount Pleasant, Mount Pleasant, South Carolina, United States|Prisma Health Cancer Institute - Seneca, Seneca, South Carolina, United States|Spartanburg Medical Center, Spartanburg, South Carolina, United States|Avera Cancer Institute-Aberdeen, Aberdeen, South Dakota, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States|Avera Cancer Institute, Sioux Falls, South Dakota, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|Wellmont Holston Valley Hospital and Medical Center, Kingsport, Tennessee, United States|University of Tennessee - Knoxville, Knoxville, Tennessee, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States|Ben Taub General Hospital, Houston, Texas, United States|M D Anderson Cancer Center, Houston, Texas, United States|Memorial Hermann Texas Medical Center, Houston, Texas, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|University of Vermont and State Agricultural College, Burlington, Vermont, United States|University of Virginia Cancer Center, Charlottesville, Virginia, United States|Danville Regional Medical Center, Danville, Virginia, United States|Inova Fairfax Hospital, Falls Church, Virginia, United States|MultiCare Auburn Medical Center, Auburn, Washington, United States|PeaceHealth Saint Joseph Medical Center, Bellingham, Washington, United States|Highline Medical Center-Main Campus, Burien, Washington, United States|MultiCare Gig Harbor Medical Park, Gig Harbor, Washington, United States|Jefferson Healthcare, Port Townsend, Washington, United States|MultiCare Good Samaritan Hospital, Puyallup, Washington, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Franciscan Research Center-Northwest Medical Plaza, Tacoma, Washington, United States|MultiCare Tacoma General Hospital, Tacoma, Washington, United States|Northwest Medical Specialties PLLC, Tacoma, Washington, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, United States|Edwards Comprehensive Cancer Center, Huntington, West Virginia, United States|West Virginia University Healthcare, Morgantown, West Virginia, United States|Aurora Cancer Care-Southern Lakes VLCC, Burlington, Wisconsin, United States|HSHS Sacred Heart Hospital, Eau Claire, Wisconsin, United States|Marshfield Clinic Cancer Center at Sacred Heart, Eau Claire, Wisconsin, United States|Aurora Health Center-Fond du Lac, Fond Du Lac, Wisconsin, United States|Aurora Health Care Germantown Health Center, Germantown, Wisconsin, United States|Aurora Cancer Care-Grafton, Grafton, Wisconsin, United States|Green Bay Oncology at Saint Vincent Hospital, Green Bay, Wisconsin, United States|Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States|Green Bay Oncology Limited at Saint Mary's Hospital, Green Bay, Wisconsin, United States|Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, United States|Aurora BayCare Medical Center, Green Bay, Wisconsin, United States|Mercyhealth Hospital and Cancer Center - Janesville, Janesville, Wisconsin, United States|Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Aurora Bay Area Medical Group-Marinette, Marinette, Wisconsin, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States|Marshfield Medical Center, Marshfield, Wisconsin, United States|Aurora Cancer Care-Milwaukee, Milwaukee, Wisconsin, United States|Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Aurora Sinai Medical Center, Milwaukee, Wisconsin, United States|Marshfield Clinic-Minocqua Center, Minocqua, Wisconsin, United States|ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States|ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States|Saint Vincent Hospital Cancer Center at Oconto Falls, Oconto Falls, Wisconsin, United States|Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh, Wisconsin, United States|Aurora Cancer Care-Racine, Racine, Wisconsin, United States|Lakeview Medical Center-Marshfield Clinic, Rice Lake, Wisconsin, United States|Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin, United States|Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan, Wisconsin, United States|Saint Vincent Hospital Cancer Center at Sturgeon Bay, Sturgeon Bay, Wisconsin, United States|Green Bay Oncology - Sturgeon Bay, Sturgeon Bay, Wisconsin, United States|Aurora Medical Center in Summit, Summit, Wisconsin, United States|Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers, Wisconsin, United States|Aurora Cancer Care-Waukesha, Waukesha, Wisconsin, United States|ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States|UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States|Aurora Cancer Care-Milwaukee West, Wauwatosa, Wisconsin, United States|Aurora West Allis Medical Center, West Allis, Wisconsin, United States|Diagnostic and Treatment Center, Weston, Wisconsin, United States|Marshfield Medical Center - Weston, Weston, Wisconsin, United States|Fundacion De Investigacion de Diego, San Juan, Puerto Rico","https://ClinicalTrials.gov/show/NCT02152982"
712,"Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma","Recruiting","No Results Available","Recurrent Malignant Glioma|Brain Glioblastoma","Drug: OKN-007|Drug: Temozolomide (TMZ)","University of Alabama at Birmingham, Birmingham, Alabama, United States|St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|Providence Saint John's Health Center - John Wayne Cancer Institute, Santa Monica, California, United States|Swedish Medical Center, Englewood, Colorado, United States|AdventHealth Orlando, Orlando, Florida, United States|University of Iowa, Iowa City, Iowa, United States|Norton Healthcare, Louisville, Kentucky, United States|Henry Ford Health System, Detroit, Michigan, United States|Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|The University of Toledo, Toledo, Ohio, United States|The University of Oklahoma, Oklahoma City, Oklahoma, United States","https://ClinicalTrials.gov/show/NCT04388475"
713,"Testing Ramipril to Prevent Memory Loss in People With Glioblastoma","Recruiting","No Results Available","Glioblastoma|Radiotherapy; Complications|Cognitive Decline|Chemoradiation","Drug: Ramipril","Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|Porter Adventist Hospital, Denver, Colorado, United States|Littleton Adventist Hospital, Littleton, Colorado, United States|Parker Adventist Hospital, Parker, Colorado, United States|Regional Cancer Center-Lee Memorial Health System, Fort Myers, Florida, United States|Northside Hospital, Atlanta, Georgia, United States|Northside Hospital - Duluth, Duluth, Georgia, United States|Northside Hospital - Gwinnett, Lawrenceville, Georgia, United States|Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah, Georgia, United States|Suburban Hematology Oncology Associates - Snellville, Snellville, Georgia, United States|Hawaii Cancer Care - Savio, 'Aiea, Hawaii, United States|Pali Momi Medical Center, 'Aiea, Hawaii, United States|Queen's Cancer Center - Pearlridge, 'Aiea, Hawaii, United States|The Cancer Center of Hawaii-Pali Momi, 'Aiea, Hawaii, United States|Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu, Hawaii, United States|Queen's Cancer Cenrer - POB I, Honolulu, Hawaii, United States|Queen's Medical Center, Honolulu, Hawaii, United States|Straub Clinic and Hospital, Honolulu, Hawaii, United States|University of Hawaii Cancer Center, Honolulu, Hawaii, United States|Queen's Cancer Center - Kuakini, Honolulu, Hawaii, United States|The Cancer Center of Hawaii-Liliha, Honolulu, Hawaii, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, United States|Centralia Oncology Clinic, Centralia, Illinois, United States|Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Crossroads Cancer Center, Effingham, Illinois, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|Memorial Medical Center, Springfield, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|Saint Luke's Hospital, Cedar Rapids, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa, United States|Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita, Kansas, United States|Ascension Via Christi Hospitals Wichita, Wichita, Kansas, United States|Cancer Center of Kansas - Wichita, Wichita, Kansas, United States|Culicchia Neurological Clinic LLC, Marrero, Louisiana, United States|West Jefferson Medical Center, Marrero, Louisiana, United States|Louisiana State University Health Science Center, New Orleans, Louisiana, United States|University Medical Center New Orleans, New Orleans, Louisiana, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, United States|Mercy Health Mercy Campus, Muskegon, Michigan, United States|Metro Health Hospital, Wyoming, Michigan, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Essentia Health Cancer Center, Duluth, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Unity Hospital, Fridley, Minnesota, United States|Fairview Clinics and Surgery Center Maple Grove, Maple Grove, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|Health Partners Inc, Minneapolis, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Lakeview Hospital, Stillwater, Minnesota, United States|Rice Memorial Hospital, Willmar, Minnesota, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States|Fairview Lakes Medical Center, Wyoming, Minnesota, United States|Delbert Day Cancer Institute at PCRMC, Rolla, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|AtlantiCare Health Park-Cape May Court House, Cape May Court House, New Jersey, United States|AtlantiCare Surgery Center, Egg Harbor Township, New Jersey, United States|Lovelace Medical Center-Saint Joseph Square, Albuquerque, New Mexico, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, United States|Lovelace Radiation Oncology, Albuquerque, New Mexico, United States|Northwell Health Imbert Cancer Center, Bay Shore, New York, United States|Northwell Health/Center for Advanced Medicine, Lake Success, New York, United States|Randolph Hospital, Asheboro, North Carolina, United States|Mission Hospital, Asheville, North Carolina, United States|Cone Health Cancer Center at Alamance Regional, Burlington, North Carolina, United States|Cone Health Cancer Center, Greensboro, North Carolina, United States|Margaret R Pardee Memorial Hospital, Hendersonville, North Carolina, United States|Novant Health Cancer Institute - Kernersville, Kernersville, North Carolina, United States|Novant Health Forsyth Medical Center, Winston-Salem, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States|Riverside Methodist Hospital, Columbus, Ohio, United States|The Mark H Zangmeister Center, Columbus, Ohio, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Geisinger Medical Oncology-Lewisburg, Lewisburg, Pennsylvania, United States|Paoli Memorial Hospital, Paoli, Pennsylvania, United States|Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States|Lankenau Medical Center, Wynnewood, Pennsylvania, United States|Saint Joseph's/Candler - Bluffton Campus, Bluffton, South Carolina, United States|Prisma Health Cancer Institute - Spartanburg, Boiling Springs, South Carolina, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Prisma Health Cancer Institute - Easley, Easley, South Carolina, United States|Prisma Health Cancer Institute - Butternut, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Faris, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Eastside, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Greer, Greer, South Carolina, United States|Prisma Health Cancer Institute - Seneca, Seneca, South Carolina, United States|Duluth Clinic Ashland, Ashland, Wisconsin, United States|Marshfield Clinic-Chippewa Center, Chippewa Falls, Wisconsin, United States|Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, United States|Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States|Marshfield Clinic - Ladysmith Center, Ladysmith, Wisconsin, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States|Marshfield Clinic-Minocqua Center, Minocqua, Wisconsin, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin, United States|Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin, United States|Marshfield Clinic Stevens Point Center, Stevens Point, Wisconsin, United States|Marshfield Clinic-Wausau Center, Wausau, Wisconsin, United States|Diagnostic and Treatment Center, Weston, Wisconsin, United States|Marshfield Medical Center - Weston, Weston, Wisconsin, United States|Marshfield Clinic - Wisconsin Rapids Center, Wisconsin Rapids, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT03475186"
714,"Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme","Completed","No Results Available","Recurrent Glioblastoma Multiforme|Recurrent Gliosarcoma","Drug: temozolomide and bevacizumab","Center for Neurosciences, Tucson, Arizona, United States","https://ClinicalTrials.gov/show/NCT00883298"
715,"Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma","Completed","Has Results","Glioblastoma|Gliosarcoma","Drug: Bevacizumab|Drug: Tarceva|Drug: Temozolomide","University of California San Francisco, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT00525525"
716,"Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma","Completed","No Results Available","Glioma|Glioblastoma","Radiation: FDOPA PET/CT","UCLA, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT01813877"
717,"Surgically Induced Neurological Deficits in Glioblastomas (SIND Study)","Recruiting","No Results Available","Glioblastoma","Procedure: Maximal, safe resection of brain tumour","Stephen Price, Cambridge, United Kingdom","https://ClinicalTrials.gov/show/NCT04007185"
718,"Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma","Recruiting","No Results Available","Diffuse Astrocytoma, IDH-Wildtype|Recurrent Glioblastoma","Biological: Atezolizumab|Procedure: Conventional Surgery|Radiation: Fractionated Stereotactic Radiation Therapy|Biological: Tocilizumab","University of Colorado Hospital, Aurora, Colorado, United States|Poudre Valley Hospital, Fort Collins, Colorado, United States|Cancer Care and Hematology-Fort Collins, Fort Collins, Colorado, United States|UCHealth Greeley Hospital, Greeley, Colorado, United States|Medical Center of the Rockies, Loveland, Colorado, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, United States|Illinois CancerCare-Canton, Canton, Illinois, United States|Illinois CancerCare-Carthage, Carthage, Illinois, United States|Centralia Oncology Clinic, Centralia, Illinois, United States|Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Crossroads Cancer Center, Effingham, Illinois, United States|Illinois CancerCare-Eureka, Eureka, Illinois, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States|Illinois CancerCare-Macomb, Macomb, Illinois, United States|Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Illinois CancerCare-Pekin, Pekin, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Illinois CancerCare-Peru, Peru, Illinois, United States|Illinois CancerCare-Princeton, Princeton, Illinois, United States|Illinois CancerCare - Washington, Washington, Illinois, United States|Ascension Via Christi Hospitals Wichita, Wichita, Kansas, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, United States|Legacy Meridian Park Hospital, Tualatin, Oregon, United States|Reading Hospital, West Reading, Pennsylvania, United States|Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|Legacy Cancer Institute Medical Oncology and Day Treatment, Vancouver, Washington, United States|UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT04729959"
719,"Pembrolizumab in Treating Patients With Recurrent Glioblastoma","Active, not recruiting","No Results Available","Recurrent Glioblastoma|Recurrent Gliosarcoma","Other: Laboratory Biomarker Analysis|Biological: Pembrolizumab|Other: Pharmacological Study|Procedure: Therapeutic Conventional Surgery","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02337686"
720,"Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas","Unknown status","No Results Available","Solid Tumors, Glioblastoma, Recurrent Malignant Gliomas","Drug: CTO|Drug: CTO and Temodar®|Drug: CTO, Temodar®, Radiation therapy","New York University, New York, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Providence Cancer Center, Portland, Oregon, United States|Oregon Health and Sciences University, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT01107522"
721,"Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme","Completed","Has Results","Glioblastoma Multiforme|Gliosarcoma","Drug: Avastin|Drug: Temozolomide|Drug: Irinotecan","The Preston Robert Tisch Brain Tumor Center at Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00979017"
722,"Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients","Recruiting","No Results Available","Glioblastoma Multiforme|Glioblastoma|Glioma|Brain Tumor|Neoplasms|Neoplasms, Nerve Tissue","Device: NaviFUS System|Drug: Bevacizumab","Linkou Chang Gung Memorial Hospital, Taoyuan City, Taiwan","https://ClinicalTrials.gov/show/NCT04446416"
723,"Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma","Terminated","No Results Available","Glioma|Glioblastoma|Glioblastoma Multiforme","Drug: FDOPA PET","Houston Methodist Research Institute PET Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02176720"
724,"Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma","Terminated","Has Results","Anaplastic Astrocytoma|Glioblastoma","Drug: trabedersen|Drug: temozolomide|Device: Drug delivery system for administration of AP 12009|Procedure: Placement of Drug Delivery System|Drug: carmustine|Drug: lomustine","NJ Neuroscience Institute; JFK Medical Center, Edison, New Jersey, United States|Winthrop University Hospital, Mineola, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Hospital Británico, Ciudad Autónoma de Buenos Aires, Argentina|FLENI, Ciudad Autónoma de Buenos Aires, Argentina|Sanatorio Allende, Córdoba, Argentina|Universitätsklinik Innsbruck, Abteilung für Neurologie, Innsbruck, Austria|AKH Wien, Klinik für Neurochirurgie, Wien, Austria|Hospital de Câncer de Barretos, Barretos / SP, Brazil|Centro Goiano de Oncologia (CGO), Goiania, Brazil|Hospital Sao Vicente de Paulo, Passo Fundo, Brazil|Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil|Hospital Sao Lucas da PUCRS, Porto Alegre, Brazil|Hospital do Servidor Público Estadual, Sao Paulo, Brazil|ECOGENE-21 Centre d'études cliniques, Chicoutimi, Quebec, Canada|Foothills Medical Centre, Calgary, Canada|Montreal Neurological Institute and Hospital, Montreal, Canada|La Timone University Hospital, Marseille, France|Klinik und Poliklinik für Neurochirurgie, Frankfurt/M., Germany|Universitätsklinikum Freiburg, Freiburg, Germany|Neurochirurgische Klinik an der Universität Ulm am Bezirkskrankenhaus Günzburg, Günzburg, Germany|Universitätklinikum Hamburg-Eppendorf, Klinik für Neurochirurgie, Hamburg, Germany|Medizinische Hochschule Hannover Neurochirurgische Klinik, Hannover, Germany|Universitätsklinik Heidelberg Neurologische Klinik, Heidelberg, Germany|Universitätsklinikum Leipzig, Neurochirurgische Klinik, Leipzig, Germany|Otto-von-Guericke-Universität, Klinik für Neurochirurgie, Magdeburg, Germany|Klinik und Poliklinik für Neurochirurgie, Münster, Germany|Klinik und Poliklinik für Neurologie, Regensburg, Germany|Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ, Szeged, Hungary|Manipal Hospital & Manipal Institute for Neurological Disorders, Bangalore, India|NIMHANS, Bangalore, India|BGS Global Hospital, Bangalore, India|Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh, India|Apollo Speciality Hospitals, Chennai, India|Amrita Institute of Medical Sciences Research Center, Cochin, India|Care Hospitals, Hyderabaad, India|AMRI Hospitals, Kolkata, India|SGPGI of Medical Sciences, Lucknow, India|Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Mumbai, India|All India Institute of Medical Sciences (AIIMS), New Delhi, India|SCTIMST, Dept. of Neurosurgery, Thiruvananthapuram, India|Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of|Kangnam St. Mary's Hospital, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Hospital San Javier, Guadalajara, Mexico|Hospital General de Mexico, Mexico City, Mexico|Medica Sur, Mexico City, Mexico|Wojskowy Szpital Kliniczny, Klinika Neurochirurgii, Bydgoszcz, Poland|Akademickie Centrum Kliniczne, Gdańsk, Poland|Samodzielny Publiczny Szpital Kliniczny nr 4, Klinika Neurochirurgii i Neurochirurgii Dziecięcej, Lublin, Poland|Kliniczny Oddzial Neurochirurgii SUM w Sosnowcu Wojewódzki Szpital Specjalistyczny nr 5, Sosnowiec, Poland|Centrum Onkologii - Instytut Im. Marii Sklodowskiej-Curie, Warszawa, Poland|SP ZOZ Uniwersytecki Szpital Kliniczny nr 1, Klinika Neurochirurgii, Łódź, Poland|Chelyabinsk City Hospital #3; Department of Neurosurgery, Chelyabinsk, Russian Federation|State Institution Russian Oncology Research Center N.N. Blokhin, Moscow, Russian Federation|Samara Region Clinical Hospital M.I. Kalinin, Samara, Russian Federation|Russian Scientific Research Neurosurgical Institute A.L. Polenov, St. Petersburg, Russian Federation|Military Medical Academy, Neurosurgery Dept, St. Petersburg, Russian Federation|Hospital de Cruces, Baracaldo, Spain|Hospital Universitario Vall d'Hebron, Barcelona, Spain|Hospital Doce de Octubre, Madrid, Spain|Hospital Universitario Marqués de Valdecilla, Santander, Spain|Hospital Universitario Virgen del Rocío, Sevilla, Spain|China Medical University Hospital, Taichung, Taiwan|Taichung Veterans General Hospital, Taichung, Taiwan|Tri-Service General Hospital, Taipei City, Taiwan|Edinburgh Centre for Neuro-Oncology, Western General Hospital, Edinburgh, United Kingdom|The National Hospital for Neurology and Neurosurgery, London, United Kingdom","https://ClinicalTrials.gov/show/NCT00761280"
725,"Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma","Recruiting","No Results Available","Glioblastoma|Gliosarcoma|MGMT-Unmethylated Glioblastoma","Radiation: Radiation Therapy|Drug: Tinostamustine","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03452930"
726,"Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma","Terminated","No Results Available","Glioblastoma Multiforme|Astrocytoma, Grade IV","Biological: Personalized peptide vaccine|Drug: Poly-ICLC|Drug: Temozolomide","Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT02510950"
727,"Restrictive Use of Dexamethasone in Glioblastoma","Recruiting","No Results Available","Glioblastoma|Dexamethasone|Steroids","Drug: Dexamethasone","Department of Neurosurgery, Bern, Switzerland","https://ClinicalTrials.gov/show/NCT04266977"
728,"DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma","Recruiting","No Results Available","Gliosarcoma|Recurrent Glioblastoma","Diagnostic Test: Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging","Saint Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|Mayo Clinic Hospital, Phoenix, Arizona, United States|Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Eden Hospital Medical Center, Castro Valley, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States|UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States|VA Palo Alto Health Care System, Palo Alto, California, United States|Boca Raton Regional Hospital, Boca Raton, Florida, United States|Baptist MD Anderson Cancer Center, Jacksonville, Florida, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Moffitt Cancer Center-International Plaza, Tampa, Florida, United States|Moffitt Cancer Center - McKinley Campus, Tampa, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|Northside Hospital, Atlanta, Georgia, United States|Northside Hospital-Forsyth, Cumming, Georgia, United States|Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States|IU Health Methodist Hospital, Indianapolis, Indiana, United States|Baptist Health Lexington, Lexington, Kentucky, United States|Maryland Proton Treatment Center, Baltimore, Maryland, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States|Henry Ford Hospital, Detroit, Michigan, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States|University of Missouri - Ellis Fischel, Columbia, Missouri, United States|Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Siteman Cancer Center-South County, Saint Louis, Missouri, United States|Siteman Cancer Center at Saint Peters Hospital, Saint Peters, Missouri, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, United States|Memorial Sloan Kettering Commack, Commack, New York, United States|Memorial Sloan Kettering Westchester, Harrison, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States|Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|University of Cincinnati/Barrett Cancer Center, Cincinnati, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|Rhode Island Hospital, Providence, Rhode Island, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|Memorial Hermann Texas Medical Center, Houston, Texas, United States|University Hospital, San Antonio, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Froedtert Menomonee Falls Hospital, Menomonee Falls, Wisconsin, United States|Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States|ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States|ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States|UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States|Froedtert West Bend Hospital/Kraemer Cancer Center, West Bend, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT03115333"
729,"NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery","Completed","No Results Available","Gliosarcoma|Recurrent Glioblastoma","Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Targeted Molecular Therapy","Northwestern University, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT03020017"
730,"Vaccine Therapy in Treating Patients With Recurrent Glioblastoma","Active, not recruiting","No Results Available","Giant Cell Glioblastoma|Recurrent Glioblastoma|Recurrent Gliosarcoma","Other: Laboratory Biomarker Analysis|Biological: Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine","Mayo Clinic, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT03360708"
731,"Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection","Completed","No Results Available","Glioblastoma|Astrocytoma, Grade IV","Drug: XL765 (SAR245409)|Drug: XL147 (SAR245408)","Investigational Site Number 840001, Los Angeles, California, United States|Investigational Site Number 840003, San Francisco, California, United States|Investigational Site Number 840004, Boston, Massachusetts, United States|Investigational Site Number 840002, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01240460"
732,"A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma","Completed","No Results Available","Glioblastoma Multiforme|Anaplastic Oligoastrocytoma","Biological: Ad-RTS-hIL-12|Drug: veledimex","Cedars-Sinai, Los Angeles, California, United States|University of California - San Francisco, San Francisco, California, United States|Northwestern, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|Brigham & Women's, Boston, Massachusetts, United States|MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02026271"
733,"A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma","Not yet recruiting","No Results Available","Solid Tumor|Glioblastoma|Glioblastoma Multiforme|Glioblastoma Multiforme of Brain","Biological: C5252",,"https://ClinicalTrials.gov/show/NCT05095441"
734,"Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma","Active, not recruiting","No Results Available","Giant Cell Glioblastoma|Glioblastoma|Gliosarcoma","Other: Laboratory Biomarker Analysis|Biological: Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine|Drug: Temozolomide","Mayo Clinic, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT01957956"
735,"Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme","Completed","Has Results","Brain and Central Nervous System Tumors|Glioblastoma Multiforme","Drug: Celecoxib|Drug: Isotretinoin|Drug: Temozolomide|Drug: Thalidomide","Hembree Mercy Cancer Center at St. Edward Mercy Medical Center, Fort Smith, Arkansas, United States|University of Texas MD Anderson Cancer Center at Orlando, Orlando, Florida, United States|CCOP - Atlanta Regional, Atlanta, Georgia, United States|CCOP - Central Illinois, Decatur, Illinois, United States|CCOP - Wichita, Wichita, Kansas, United States|CCOP - Grand Rapids, Grand Rapids, Michigan, United States|CCOP - Kalamazoo, Kalamazoo, Michigan, United States|CCOP - Kansas City, Kansas City, Missouri, United States|Cancer Research for the Ozarks, Springfield, Missouri, United States|Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00112502"
736,"Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab","Withdrawn","No Results Available","Glioblastoma|Optic Neuropathy","Drug: Bevacizumab (Avastin)",,"https://ClinicalTrials.gov/show/NCT01331616"
737,"Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma","Active, not recruiting","No Results Available","Gliosarcoma|Supratentorial Glioblastoma","Biological: Ipilimumab|Other: Laboratory Biomarker Analysis|Biological: Nivolumab|Drug: Temozolomide","UCSF Medical Center-Parnassus, San Francisco, California, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Case Western Reserve University, Cleveland, Ohio, United States|Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02311920"
738,"Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma","Completed","No Results Available","Brain Stem Glioma|Glioblastoma","Biological: autologous dendritic cells","Cedars Sinai Medical Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT00576641"
739,"A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma","Completed","Has Results","Anaplastic Astrocytoma|Glioblastoma","Drug: Sunitinib Malate","H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States","https://ClinicalTrials.gov/show/NCT00606008"
740,"Patient-derived Glioma Stem Cell Organoids","Active, not recruiting","No Results Available","Glioblastoma","Procedure: Tumor biopsy","Maastricht UMC+, Maastricht, Limburg, Netherlands|Maastricht Radiation Oncology, Maastricht, Limburg, Netherlands","https://ClinicalTrials.gov/show/NCT04868396"
741,"A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)","Terminated","Has Results","Cancer of Brain and Nervous System","Device: NovoTTF100A|Drug: Bevacizumab|Drug: Temozolomide","Levine Cancer Institute, Charlotte, North Carolina, United States","https://ClinicalTrials.gov/show/NCT02343549"
742,"Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma","Completed","No Results Available","Brain Tumor|Recurring Glioblastoma","Biological: delta-24-RGD adenovirus","ERasmus Medical Center, Rotterdam, Netherlands","https://ClinicalTrials.gov/show/NCT01582516"
743,"Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery)","Recruiting","No Results Available","Recurrent Glioblastoma","Procedure: Skullremodeling surgery|Other: Control","Nikola Mikic, Aarhus, Denmark","https://ClinicalTrials.gov/show/NCT04223999"
744,"Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma","Recruiting","No Results Available","Gliosarcoma|MGMT-Unmethylated Glioblastoma","Biological: Ipilimumab|Biological: Nivolumab|Device: NovoTTF-100A Device|Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Radiation: Radiation Therapy|Drug: Temozolomide","University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Kaiser Permanente-Anaheim, Anaheim, California, United States|John Muir Medical Center-Concord Campus, Concord, California, United States|UC San Diego Moores Cancer Center, La Jolla, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|Kaiser Permanente-Ontario, Ontario, California, United States|UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States|Sutter Cancer Centers Radiation Oncology Services-Roseville, Roseville, California, United States|Sutter Roseville Medical Center, Roseville, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|Torrance Memorial Physician Network - Cancer Care, Torrance, California, United States|Torrance Memorial Medical Center, Torrance, California, United States|John Muir Medical Center-Walnut Creek, Walnut Creek, California, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, United States|Porter Adventist Hospital, Denver, Colorado, United States|Littleton Adventist Hospital, Littleton, Colorado, United States|Parker Adventist Hospital, Parker, Colorado, United States|Hartford Hospital, Hartford, Connecticut, United States|The Hospital of Central Connecticut, New Britain, Connecticut, United States|Beebe South Coastal Health Campus, Frankford, Delaware, United States|Beebe Medical Center, Lewes, Delaware, United States|Delaware Clinical and Laboratory Physicians PA, Newark, Delaware, United States|Helen F Graham Cancer Center, Newark, Delaware, United States|Medical Oncology Hematology Consultants PA, Newark, Delaware, United States|Christiana Care Health System-Christiana Hospital, Newark, Delaware, United States|Beebe Health Campus, Rehoboth Beach, Delaware, United States|Baptist MD Anderson Cancer Center, Jacksonville, Florida, United States|AdventHealth Orlando, Orlando, Florida, United States|Augusta University Medical Center, Augusta, Georgia, United States|Memorial Health University Medical Center, Savannah, Georgia, United States|Lewis Hall Singletary Oncology Center, Thomasville, Georgia, United States|Hawaii Cancer Care - Savio, 'Aiea, Hawaii, United States|Pali Momi Medical Center, 'Aiea, Hawaii, United States|Queen's Cancer Center - Pearlridge, 'Aiea, Hawaii, United States|The Cancer Center of Hawaii-Pali Momi, 'Aiea, Hawaii, United States|Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu, Hawaii, United States|Island Urology, Honolulu, Hawaii, United States|Queen's Cancer Cenrer - POB I, Honolulu, Hawaii, United States|Queen's Medical Center, Honolulu, Hawaii, United States|Straub Clinic and Hospital, Honolulu, Hawaii, United States|University of Hawaii Cancer Center, Honolulu, Hawaii, United States|Hawaii Cancer Care Inc-Liliha, Honolulu, Hawaii, United States|Queen's Cancer Center - Kuakini, Honolulu, Hawaii, United States|The Cancer Center of Hawaii-Liliha, Honolulu, Hawaii, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States|Castle Medical Center, Kailua, Hawaii, United States|Wilcox Memorial Hospital and Kauai Medical Clinic, Lihue, Hawaii, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States|Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, United States|Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho, United States|Saint Luke's Cancer Institute - Meridian, Meridian, Idaho, United States|Saint Alphonsus Medical Center-Nampa, Nampa, Idaho, United States|Saint Luke's Cancer Institute - Nampa, Nampa, Idaho, United States|Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, United States|Illinois CancerCare-Canton, Canton, Illinois, United States|Illinois CancerCare-Carthage, Carthage, Illinois, United States|Centralia Oncology Clinic, Centralia, Illinois, United States|Northwestern University, Chicago, Illinois, United States|University of Illinois, Chicago, Illinois, United States|Carle on Vermilion, Danville, Illinois, United States|Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States|Carle Physician Group-Effingham, Effingham, Illinois, United States|Crossroads Cancer Center, Effingham, Illinois, United States|Elmhurst Memorial Hospital, Elmhurst, Illinois, United States|Illinois CancerCare-Eureka, Eureka, Illinois, United States|NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, United States|Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States|NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois, United States|NorthShore University HealthSystem-Highland Park Hospital, Highland Park, Illinois, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States|Illinois CancerCare-Macomb, Macomb, Illinois, United States|Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States|Edward Hospital/Cancer Center, Naperville, Illinois, United States|Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Advocate Lutheran General Hospital, Park Ridge, Illinois, United States|Illinois CancerCare-Pekin, Pekin, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Illinois CancerCare-Peru, Peru, Illinois, United States|Illinois CancerCare-Princeton, Princeton, Illinois, United States|SwedishAmerican Regional Cancer Center/ACT, Rockford, Illinois, United States|Southern Illinois University School of Medicine, Springfield, Illinois, United States|Springfield Clinic, Springfield, Illinois, United States|Memorial Medical Center, Springfield, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|The Carle Foundation Hospital, Urbana, Illinois, United States|Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States|Illinois CancerCare - Washington, Washington, Illinois, United States|Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States|IU Health Methodist Hospital, Indianapolis, Indiana, United States|Mary Greeley Medical Center, Ames, Iowa, United States|McFarland Clinic PC - Ames, Ames, Iowa, United States|Medical Oncology and Hematology Associates-West Des Moines, Clive, Iowa, United States|Mercy Cancer Center-West Lakes, Clive, Iowa, United States|Jennie Edmundson Memorial Hospital, Council Bluffs, Iowa, United States|Heartland Oncology and Hematology LLP, Council Bluffs, Iowa, United States|Greater Regional Medical Center, Creston, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa, United States|Broadlawns Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Laurel, Des Moines, Iowa, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States|Mercy Medical Center-West Lakes, West Des Moines, Iowa, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|Tulane University Health Sciences Center, New Orleans, Louisiana, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|Eastern Maine Medical Center, Bangor, Maine, United States|MaineHealth Coastal Cancer Treatment Center, Bath, Maine, United States|Waldo County General Hospital, Belfast, Maine, United States|Lafayette Family Cancer Center-EMMC, Brewer, Maine, United States|Maine Medical Center-Bramhall Campus, Portland, Maine, United States|Penobscot Bay Medical Center, Rockport, Maine, United States|MaineHealth Cancer Care Center of York County, Sanford, Maine, United States|Maine Medical Center- Scarborough Campus, Scarborough, Maine, United States|Maine Medical Partners Neurology, Scarborough, Maine, United States|Maine Medical Partners - South Portland, South Portland, Maine, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States|UM Upper Chesapeake Medical Center, Bel Air, Maryland, United States|Central Maryland Radiation Oncology in Howard County, Columbia, Maryland, United States|UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie, Maryland, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|IHA Hematology Oncology Consultants-Brighton, Brighton, Michigan, United States|Saint Joseph Mercy Brighton, Brighton, Michigan, United States|IHA Hematology Oncology Consultants-Canton, Canton, Michigan, United States|Saint Joseph Mercy Canton, Canton, Michigan, United States|IHA Hematology Oncology Consultants-Chelsea, Chelsea, Michigan, United States|Saint Joseph Mercy Chelsea, Chelsea, Michigan, United States|Beaumont Hospital - Dearborn, Dearborn, Michigan, United States|Ascension Saint John Hospital, Detroit, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Borgess Medical Center, Kalamazoo, Michigan, United States|Saint Mary Mercy Hospital, Livonia, Michigan, United States|21st Century Oncology-Pontiac, Pontiac, Michigan, United States|William Beaumont Hospital-Royal Oak, Royal Oak, Michigan, United States|Ascension Saint Mary's Hospital, Saginaw, Michigan, United States|Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan, United States|Ascension Saint Joseph Hospital, Tawas City, Michigan, United States|William Beaumont Hospital - Troy, Troy, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan, United States|Metro Health Hospital, Wyoming, Michigan, United States|IHA Hematology Oncology Consultants-Ann Arbor, Ypsilanti, Michigan, United States|Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Minnesota Oncology - Burnsville, Burnsville, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Unity Hospital, Fridley, Minnesota, United States|Fairview Clinics and Surgery Center Maple Grove, Maple Grove, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Health Partners Inc, Minneapolis, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Lakeview Hospital, Stillwater, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, United States|Billings Clinic Cancer Center, Billings, Montana, United States|Bozeman Deaconess Hospital, Bozeman, Montana, United States|Saint James Community Hospital and Cancer Treatment Center, Butte, Montana, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Nebraska Medicine-Bellevue, Bellevue, Nebraska, United States|Cancer Partners of Nebraska - Pine Lake, Lincoln, Nebraska, United States|Southeast Nebraska Cancer Center - 68th Street Place, Lincoln, Nebraska, United States|Nebraska Methodist Hospital, Omaha, Nebraska, United States|Nebraska Medicine-Village Pointe, Omaha, Nebraska, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Morristown Medical Center, Morristown, New Jersey, United States|Capital Health Medical Center-Hopewell, Pennington, New Jersey, United States|Overlook Hospital, Summit, New Jersey, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States|NYP/Weill Cornell Medical Center, New York, New York, United States|University of Rochester, Rochester, New York, United States|State University of New York Upstate Medical University, Syracuse, New York, United States|Good Samaritan Hospital Medical Center, West Islip, New York, United States|Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States|Atrium Health Pineville/LCI-Pineville, Charlotte, North Carolina, United States|Atrium Health Cabarrus/LCI-Concord, Concord, North Carolina, United States|Sanford Bismarck Medical Center, Bismarck, North Dakota, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States|Summa Health System - Akron Campus, Akron, Ohio, United States|Case Western Reserve University, Cleveland, Ohio, United States|Riverside Methodist Hospital, Columbus, Ohio, United States|Dublin Methodist Hospital, Dublin, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Clackamas Radiation Oncology Center, Clackamas, Oregon, United States|Providence Cancer Institute Clackamas Clinic, Clackamas, Oregon, United States|Legacy Mount Hood Medical Center, Gresham, Oregon, United States|Providence Newberg Medical Center, Newberg, Oregon, United States|Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|Kaiser Permanente Northwest, Portland, Oregon, United States|Legacy Meridian Park Hospital, Tualatin, Oregon, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|Crozer-Keystone Regional Cancer Center at Broomall, Broomall, Pennsylvania, United States|Christiana Care Health System-Concord Health Center, Chadds Ford, Pennsylvania, United States|Lancaster General Ann B Barshinger Cancer Institute, Lancaster, Pennsylvania, United States|Lancaster General Hospital, Lancaster, Pennsylvania, United States|Forbes Hospital, Monroeville, Pennsylvania, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States|UPMC-Shadyside Hospital, Pittsburgh, Pennsylvania, United States|Reading Hospital, West Reading, Pennsylvania, United States|Wexford Health and Wellness Pavilion, Wexford, Pennsylvania, United States|Rock Hill Radiation Therapy Center, Rock Hill, South Carolina, United States|Avera Cancer Institute at Pierre, Pierre, South Dakota, United States|Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States|Avera Cancer Institute, Sioux Falls, South Dakota, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|Memorial Hermann Texas Medical Center, Houston, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Sandra L Maxwell Cancer Center, Cedar City, Utah, United States|Intermountain Medical Center, Murray, Utah, United States|McKay-Dee Hospital Center, Ogden, Utah, United States|Riverton Hospital, Riverton, Utah, United States|Dixie Medical Center Regional Cancer Center, Saint George, Utah, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|Central Vermont Medical Center/National Life Cancer Treatment, Berlin, Vermont, United States|University of Vermont Medical Center, Burlington, Vermont, United States|University of Vermont and State Agricultural College, Burlington, Vermont, United States|Inova Schar Cancer Institute, Fairfax, Virginia, United States|Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States|VCU Community Memorial Health Center, South Hill, Virginia, United States|Legacy Cancer Institute Medical Oncology and Day Treatment, Vancouver, Washington, United States|Legacy Salmon Creek Hospital, Vancouver, Washington, United States|Wheeling Hospital/Schiffler Cancer Center, Wheeling, West Virginia, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT04396860"
745,"Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform","Completed","Has Results","Glioblastoma|Cancer of Brain and Nervous System|Glioblastoma Multiforme","Drug: Temozolomide|Procedure: Stereotactic Radiosurgery (SRS)","Stanford University School of Medicine, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT01120639"
746,"Easing Psychosocial Burden for Informal Caregivers","Active, not recruiting","No Results Available","Glioblastoma","Behavioral: Focus Group|Behavioral: Meaning-Centered Psychotherapy for Cancer Caregivers / MCP-C|Behavioral: Enhanced Usual Care / EUC","Memorial Sloan Kettering Commack (Consent only), Commack, New York, United States|Memoral Sloan Kettering Westchester (Consent only), Harrison, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT03454295"
747,"Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy","Active, not recruiting","No Results Available","Glioblastoma|Gliosarcoma|Supratentorial Glioblastoma","Drug: Mefloquine|Drug: Memantine Hydrochloride|Drug: Metformin Hydrochloride|Drug: Temozolomide","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01430351"
748,"A Explorative Study to Evaluate the Clinical Feasibility of AVATAMED","Recruiting","No Results Available","Glioblastoma","Device: AVATAMED","Samsung Medical Center, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04313842"
749,"SurVaxM Expanded Access Protocol","No longer available","No Results Available","Glioblastoma","Drug: SurVaxM",,"https://ClinicalTrials.gov/show/NCT04802447"
750,"Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma","Drug: Tipifarnib|Radiation: External Beam Radiation Therapy|Drug: Temozolomide|Other: Laboratory Biomarker Analysis","Ronald Reagan UCLA Medical Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT02227901"
751,"Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma","Completed","Has Results","Glioblastoma Multiforme|Astrocytoma","Drug: Imatinib mesylate|Drug: Hydroxyurea","Novartis Investigative Site, Duelmen, Germany","https://ClinicalTrials.gov/show/NCT00154375"
752,"Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)","Completed","No Results Available","Glioblastoma|Astrocytoma","Drug: Temozolomide|Drug: Semustine",,"https://ClinicalTrials.gov/show/NCT00335075"
753,"Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma","Completed","Has Results","Glioblastoma|Gliomas","Drug: Temozolomide","Memorial Sloan-Kettering at Basking Ridge, Basking Ridge, New Jersey, United States|Memorial Sloan-Kettering Cancer Center at Commack, Commack, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00200161"
754,"LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma","Active, not recruiting","No Results Available","Glioblastoma|Recurrent Glioblastoma|Supratentorial Glioblastoma|Brain Tumor","Biological: lerapolturev|Biological: pembrolizumab","University of California San Francisco, San Francisco, California, United States|UConn Health, Farmington, Connecticut, United States|Baptist MD Anderson Cancer Center, Jacksonville, Florida, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Duke University Medical Center, Durham, North Carolina, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|The Ohio State University, Columbus, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT04479241"
755,"Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Adult Brain Glioblastoma|Adult Giant Cell Glioblastoma|Adult Gliosarcoma","Drug: Dimethyl Fumarate|Drug: Temozolomide|Radiation: Radiation Therapy","Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States","https://ClinicalTrials.gov/show/NCT02337426"
756,"Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma","Active, not recruiting","Has Results","Adult Glioblastoma|Adult Gliosarcoma","Radiation: 3-Dimensional Conformal Radiation Therapy|Drug: Cediranib Maleate|Radiation: Intensity-Modulated Radiation Therapy|Other: Laboratory Biomarker Analysis|Other: Placebo Administration|Drug: Temozolomide","University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States|The Kirklin Clinic at Acton Road, Birmingham, Alabama, United States|Arizona Oncology Services Foundation, Scottsdale, Arizona, United States|Banner University Medical Center - Tucson, Tucson, Arizona, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Saint Joseph Hospital - Orange, Orange, California, United States|Poudre Valley Hospital, Fort Collins, Colorado, United States|Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States|The Hospital of Central Connecticut, New Britain, Connecticut, United States|Yale University, New Haven, Connecticut, United States|Christiana Care Health System-Christiana Hospital, Newark, Delaware, United States|AdventHealth Orlando, Orlando, Florida, United States|Bay Medical Center, Panama City, Florida, United States|Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|Queen's Medical Center, Honolulu, Hawaii, United States|University of Hawaii Cancer Center, Honolulu, Hawaii, United States|The Cancer Center of Hawaii-Liliha, Honolulu, Hawaii, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States|Northwestern University, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|Radiation Oncology Associates PC, Fort Wayne, Indiana, United States|Parkview Hospital Randallia, Fort Wayne, Indiana, United States|IU Health Methodist Hospital, Indianapolis, Indiana, United States|University of Kansas Cancer Center, Kansas City, Kansas, United States|Kansas City NCI Community Oncology Research Program, Prairie Village, Kansas, United States|Baptist Health Lexington, Lexington, Kentucky, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|Maine Medical Center- Scarborough Campus, Scarborough, Maine, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|Henry Ford Macomb Hospital-Clinton Township, Clinton Township, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Ascension Saint John Hospital, Detroit, Michigan, United States|Genesys Regional Medical Center-West Flint Campus, Flint, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Sparrow Hospital, Lansing, Michigan, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, United States|Lake Huron Medical Center, Port Huron, Michigan, United States|Ascension Saint Mary's Hospital, Saginaw, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Saint Luke's Hospital of Kansas City, Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Nebraska Methodist Hospital, Omaha, Nebraska, United States|Sparta Cancer Treatment Center, Sparta, New Jersey, United States|University of Rochester, Rochester, New York, United States|Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States|Novant Health Forsyth Medical Center, Winston-Salem, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Summa Health System - Akron Campus, Akron, Ohio, United States|Cleveland Clinic Akron General, Akron, Ohio, United States|Summa Health System - Barberton Campus, Barberton, Ohio, United States|University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|University Hospitals Portage Medical Center, Ravenna, Ohio, United States|UH Seidman Cancer Center at Salem Regional Medical Center, Salem, Ohio, United States|University of Cincinnati Cancer Center-West Chester, West Chester, Ohio, United States|Cancer Treatment Center, Wooster, Ohio, United States|Natalie Warren Bryant Cancer Center at Saint Francis, Tulsa, Oklahoma, United States|Clackamas Radiation Oncology Center, Clackamas, Oregon, United States|Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|Jefferson Abington Hospital, Abington, Pennsylvania, United States|Saint Luke's University Hospital-Bethlehem Campus, Bethlehem, Pennsylvania, United States|Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, United States|Northeast Radiation Oncology Center, Dunmore, Pennsylvania, United States|UPMC Cancer Centers - Arnold Palmer Pavilion, Greensburg, Pennsylvania, United States|Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States|Paoli Memorial Hospital, Paoli, Pennsylvania, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|UPMC Washington Hospital Radiation Oncology, Washington, Pennsylvania, United States|Reading Hospital, West Reading, Pennsylvania, United States|Lankenau Medical Center, Wynnewood, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Spartanburg Medical Center, Spartanburg, South Carolina, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|University of Texas Medical Branch, Galveston, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Intermountain Medical Center, Murray, Utah, United States|McKay-Dee Hospital Center, Ogden, Utah, United States|Utah Valley Regional Medical Center, Provo, Utah, United States|Dixie Medical Center Regional Cancer Center, Saint George, Utah, United States|Utah Cancer Specialists-Salt Lake City, Salt Lake City, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|Inova Fairfax Hospital, Falls Church, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Swedish Medical Center-First Hill, Seattle, Washington, United States|University of Washington Medical Center - Montlake, Seattle, Washington, United States|Compass Oncology Vancouver, Vancouver, Washington, United States|Wheeling Hospital/Schiffler Cancer Center, Wheeling, West Virginia, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Aspirus Regional Cancer Center, Wausau, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01062425"
757,"Enhancing Optune Therapy With Targeted Craniectomy","Completed","No Results Available","Glioblastoma","Device: Optune|Procedure: Craniectomy","Aarhus University Hospital, Aarhus C, Aarhus, Denmark","https://ClinicalTrials.gov/show/NCT02893137"
758,"Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9","Active, not recruiting","No Results Available","Glioblastoma, Adult","Device: SonoCloud-9|Drug: Carboplatin","Northwestern University, Chicago, Illinois, United States|MD Anderson Cancer Center, Houston, Texas, United States|CHU, Angers, France|Hôpital Neurologique Pierre Wertheimer, Bron, France|Hôpital de La Timone, Marseille, France|Hôpital de la Pitié-Salpêtrière, Paris, France","https://ClinicalTrials.gov/show/NCT03744026"
759,"Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III","Recruiting","No Results Available","Glioblastoma|Recurrence|Progression","Drug: Temozolomide|Drug: Bevacizumab","Nagoya University Hospital, Nagoya, Aichi, Japan|Fujita Health University Hospital, Toyoake, Aichi, Japan|Hirosaki University School of Medicine, Hirosaki, Aomori, Japan|Ehime University Graduate School of Medicine, Shizukawa, Ehime, Japan|Kurume University Hospital, Kurume-shi, Fukuoka, Japan|Sapporo Medical University Hospital, Sapporo, Hokkaido, Japan|Kobe University Hospital, Kobe, Hyougo, Japan|University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan|Iwate Medical University, Morioka, Iwate, Japan|Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan|Nagasaki University Hospital, Nagasaki-shi, Nagasaki, Japan|Kansai Medical University, Hirakata, Osaka, Japan|Osaka University Graduate School of Medicine, Suita, Osaka, Japan|Saga University Hospital, Saga-shi, Saga, Japan|Saitama Medical University International Medical Center, Hidaka, Saitama, Japan|Dokkyo Medical University, Shimotsuge, Tochigi, Japan|Tokyo Medical And Dental University, Medical Hospital, Bunkyō-Ku, Tokyo, Japan|University of Yamanashi, Chuo-shi, Yamanashi, Japan|Chiba University Hospital, Chiba, Japan|Kusyu University Graduate School of Medical Sciences, Fukuoka, Japan|Hiroshima University Hospital, Hiroshima, Japan|Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan|Kitasato University School of Medicine, Kanagawa, Japan|Kumamoto University Hospital, Kumamoto, Japan|Kyoto University Graduate School of Medicine, Kyoto, Japan|Niigata University Medical & Dental Hospital, Niigata, Japan|Okayama University Hospital, Okayama, Japan|Osaka International Cancer Institute, Osaka, Japan|Nakamura Memorial Hospital, Sapporo, Japan|Hokkaido University Graduate School of Medicine, Sapporo, Japan|Shizuoka Canser Center Hospital, Shizuoka, Japan|National Cancer Center Hospital, Tokyo, Japan|The University of Tokyo Hospital, Tokyo, Japan|Keio University Hospital, Tokyo, Japan|Nihon University School of Medicine Itabashi Hospital, Tokyo, Japan|Kyorin University Faculty of Medicine, Department of Neurosurgery, Tokyo, Japan|Yamagata University Hospital, Yamagata, Japan","https://ClinicalTrials.gov/show/NCT02761070"
760,"Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma","Completed","Has Results","Glioblastoma|Gliosarcoma|Supratentorial Glioblastoma","Radiation: 3-Dimensional Conformal Radiation Therapy|Biological: Bevacizumab|Radiation: Intensity-Modulated Radiation Therapy|Other: Laboratory Biomarker Analysis|Other: Placebo|Other: Quality-of-Life Assessment|Drug: Temozolomide","Providence Hospital, Mobile, Alabama, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Arizona Oncology Services Foundation, Scottsdale, Arizona, United States|Arizona Oncology Associates-West Orange Grove, Tucson, Arizona, United States|Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, United States|Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States|Sutter Cancer Centers Radiation Oncology Services-Cameron Park, Cameron Park, California, United States|Mercy San Juan Medical Center, Carmichael, California, United States|John Muir Medical Center-Concord Campus, Concord, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|California Cancer Center - North Fresno, Fresno, California, United States|Cancer Care Associates of Fresno Medical Group Inc, Fresno, California, United States|Saint Jude Medical Center, Fullerton, California, United States|UC San Diego Moores Cancer Center, La Jolla, California, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States|Memorial Medical Center, Modesto, California, United States|Bay Area Tumor Institute, Oakland, California, United States|Kaiser Permanente Oakland-Broadway, Oakland, California, United States|Saint Joseph Hospital - Orange, Orange, California, United States|Pomona Valley Hospital Medical Center, Pomona, California, United States|Kaiser Permanente-Rancho Cordova Cancer Center, Rancho Cordova, California, United States|Rohnert Park Cancer Center, Rohnert Park, California, United States|Sutter Cancer Centers Radiation Oncology Services-Roseville, Roseville, California, United States|The Permanente Medical Group-Roseville Radiation Oncology, Roseville, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|Mercy General Hospital Radiation Oncology Center, Sacramento, California, United States|South Sacramento Cancer Center, Sacramento, California, United States|University of California San Diego, San Diego, California, United States|California Pacific Medical Center-Pacific Campus, San Francisco, California, United States|Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States|Kaiser Permanente Cancer Treatment Center, South San Francisco, California, United States|Sutter Cancer Centers Radiation Oncology Services-Vacaville, Vacaville, California, United States|John Muir Medical Center-Walnut Creek, Walnut Creek, California, United States|Rocky Mountain Cancer Centers-Aurora, Aurora, Colorado, United States|Boulder Community Hospital, Boulder, Colorado, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, United States|Porter Adventist Hospital, Denver, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|Poudre Valley Hospital, Fort Collins, Colorado, United States|Rocky Mountain Cancer Centers-Littleton, Littleton, Colorado, United States|North Suburban Medical Center, Thornton, Colorado, United States|SCL Health Lutheran Medical Center, Wheat Ridge, Colorado, United States|Saint Vincent's Medical Center, Bridgeport, Connecticut, United States|Hartford Hospital, Hartford, Connecticut, United States|The Hospital of Central Connecticut, New Britain, Connecticut, United States|Yale University, New Haven, Connecticut, United States|William Backus Hospital, Norwich, Connecticut, United States|Broward Health Medical Center, Fort Lauderdale, Florida, United States|Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States|Integrated Community Oncology Network-Florida Cancer Center Beaches, Jacksonville Beach, Florida, United States|Baptist MD Anderson Cancer Center, Jacksonville, Florida, United States|Integrated Community Oncology Network-Southside Cancer Center, Jacksonville, Florida, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Baptist Medical Center South, Jacksonville, Florida, United States|Mount Sinai Medical Center, Miami Beach, Florida, United States|Baptist Hospital of Miami, Miami, Florida, United States|21st Century Oncology-Orange Park, Orange Park, Florida, United States|Florida Hospital Orlando, Orlando, Florida, United States|UF Cancer Center at Orlando Health, Orlando, Florida, United States|21st Century Oncology-Palatka, Palatka, Florida, United States|Sacred Heart Hospital, Pensacola, Florida, United States|Integrated Community Oncology Network-Flager Cancer Center, Saint Augustine, Florida, United States|Robert and Carol Weissman Cancer Center at Martin Health, Stuart, Florida, United States|Piedmont Hospital, Atlanta, Georgia, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|John B Amos Cancer Center, Columbus, Georgia, United States|Dekalb Medical Center, Decatur, Georgia, United States|Northeast Georgia Medical Center-Gainesville, Gainesville, Georgia, United States|Southern Regional Medical Center, Riverdale, Georgia, United States|Memorial University Medical Center, Savannah, Georgia, United States|University of Hawaii Cancer Center, Honolulu, Hawaii, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States|Northwest Community Hospital, Arlington Heights, Illinois, United States|Northwestern University, Chicago, Illinois, United States|John H Stroger Jr Hospital of Cook County, Chicago, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Ingalls Memorial Hospital, Harvey, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Trinity Medical Center, Moline, Illinois, United States|Edward Hospital/Cancer Center, Naperville, Illinois, United States|Advocate Lutheran General Hospital, Park Ridge, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|Memorial Medical Center, Springfield, Illinois, United States|IU Health Bloomington, Bloomington, Indiana, United States|Radiation Oncology Associates PC, Fort Wayne, Indiana, United States|Parkview Hospital Randallia, Fort Wayne, Indiana, United States|IU Health Methodist Hospital, Indianapolis, Indiana, United States|Community Cancer Center East, Indianapolis, Indiana, United States|IU Health Central Indiana Cancer Centers-East, Indianapolis, Indiana, United States|Community Cancer Center North, Indianapolis, Indiana, United States|Saint Vincent Hospital and Health Care Center, Indianapolis, Indiana, United States|IU Health Ball Memorial Hospital, Muncie, Indiana, United States|Northern Indiana Cancer Research Consortium, South Bend, Indiana, United States|McFarland Clinic PC-William R Bliss Cancer Center, Ames, Iowa, United States|Physicians' Clinic of Iowa PC, Cedar Rapids, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States|Mercy Medical Center - North Iowa, Mason City, Iowa, United States|University of Kansas Cancer Center, Kansas City, Kansas, United States|University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States|Kansas City NCI Community Oncology Research Program, Prairie Village, Kansas, United States|Via Christi Regional Medical Center, Wichita, Kansas, United States|Wesley Medical Center, Wichita, Kansas, United States|The James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky, United States|Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, United States|Central Maine Medical Center, Lewiston, Maine, United States|Maine Medical Center- Scarborough Campus, Scarborough, Maine, United States|Anne Arundel Medical Center, Annapolis, Maryland, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States|Saint Agnes Hospital, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Saint Anne's Hospital, Fall River, Massachusetts, United States|Cape Cod Hospital, Hyannis, Massachusetts, United States|Lowell General Hospital, Lowell, Massachusetts, United States|D'Amour Center for Cancer Care, Springfield, Massachusetts, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|Beaumont Hospital-Dearborn, Dearborn, Michigan, United States|Saint John Hospital and Medical Center, Detroit, Michigan, United States|Genesys Regional Medical Center-West Flint Campus, Flint, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Sparrow Hospital, Lansing, Michigan, United States|William Beaumont Hospital-Royal Oak, Royal Oak, Michigan, United States|Saint Mary's of Michigan, Saginaw, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Sanford Clinic North-Bemidgi, Bemidji, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Saint Luke's Hospital of Duluth, Duluth, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Singing River Hospital, Pascagoula, Mississippi, United States|Cape Radiation Oncology, Cape Girardeau, Missouri, United States|Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States|Truman Medical Center, Kansas City, Missouri, United States|The University of Kansas Cancer Center-South, Kansas City, Missouri, United States|The University of Kansas Cancer Center-North, Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Siteman Cancer Center at Saint Peters Hospital, Saint Peters, Missouri, United States|Billings Clinic Cancer Center, Billings, Montana, United States|CHI Health Good Samaritan, Kearney, Nebraska, United States|Saint Elizabeth Regional Medical Center, Lincoln, Nebraska, United States|Nebraska Methodist Hospital, Omaha, Nebraska, United States|Alegent Health Immanuel Medical Center, Omaha, Nebraska, United States|Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Nevada Cancer Research Foundation CCOP, Las Vegas, Nevada, United States|Renown Regional Medical Center, Reno, Nevada, United States|Concord Hospital, Concord, New Hampshire, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Elliot Hospital, Manchester, New Hampshire, United States|Saint Barnabas Medical Center, Livingston, New Jersey, United States|Monmouth Medical Center, Long Branch, New Jersey, United States|Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|Riverview Medical Center/Booker Cancer Center, Red Bank, New Jersey, United States|Sparta Cancer Treatment Center, Sparta, New Jersey, United States|Lovelace Medical Center-Downtown, Albuquerque, New Mexico, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, United States|New Mexico Oncology Hematology Consultants, Albuquerque, New Mexico, United States|New York Oncology Hematology PC - Albany, Albany, New York, United States|Montefiore Medical Center - Moses Campus, Bronx, New York, United States|Maimonides Medical Center, Brooklyn, New York, United States|Sands Cancer Center, Canandaigua, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|South Nassau Communities, Oceanside, New York, United States|Hudson Valley Oncology Associates, Poughkeepsie, New York, United States|Highland Hospital, Rochester, New York, United States|University Radiation Oncology, Rochester, New York, United States|University of Rochester, Rochester, New York, United States|Stony Brook University Medical Center, Stony Brook, New York, United States|State University of New York Upstate Medical University, Syracuse, New York, United States|Mission Hospital-Memorial Campus, Asheville, North Carolina, United States|Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States|Novant Health Presbyterian Medical Center, Charlotte, North Carolina, United States|Margaret R Pardee Memorial Hospital, Hendersonville, North Carolina, United States|FirstHealth of the Carolinas-Moore Regional Hosiptal, Pinehurst, North Carolina, United States|Duke Women's Cancer Care Raleigh, Raleigh, North Carolina, United States|Novant Health Forsyth Medical Center, Winston-Salem, North Carolina, United States|Southeast Clinical Oncology Research (SCOR) Consortium NCORP, Winston-Salem, North Carolina, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Summa Akron City Hospital/Cooper Cancer Center, Akron, Ohio, United States|Akron General Medical Center, Akron, Ohio, United States|Summa Barberton Hospital, Barberton, Ohio, United States|UHHS-Chagrin Highlands Medical Center, Beachwood, Ohio, United States|Mercy Medical Center, Canton, Ohio, United States|Aultman Health Foundation, Canton, Ohio, United States|University of Cincinnati/Barrett Cancer Center, Cincinnati, Ohio, United States|Case Western Reserve University, Cleveland, Ohio, United States|MetroHealth Medical Center, Cleveland, Ohio, United States|Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|Riverside Methodist Hospital, Columbus, Ohio, United States|Grant Medical Center, Columbus, Ohio, United States|The Mark H Zangmeister Center, Columbus, Ohio, United States|Toledo Clinic Cancer Centers-Maumee, Maumee, Ohio, United States|Hillcrest Hospital Cancer Center, Mayfield Heights, Ohio, United States|Lake University Ireland Cancer Center, Mentor, Ohio, United States|Southwest General Health Center Ireland Cancer Center, Middleburg Heights, Ohio, United States|Saint Charles Hospital, Oregon, Ohio, United States|Cancer Care Center, Incorporated, Salem, Ohio, United States|North Coast Cancer Care, Sandusky, Ohio, United States|Trinity's Tony Teramana Cancer Center, Steubenville, Ohio, United States|Flower Hospital, Sylvania, Ohio, United States|Mercy Saint Anne Hospital, Toledo, Ohio, United States|University Pointe, West Chester, Ohio, United States|UHHS-Westlake Medical Center, Westlake, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Natalie Warren Bryant Cancer Center at Saint Francis, Tulsa, Oklahoma, United States|Willamette Valley Cancer Center, Eugene, Oregon, United States|Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|Salem Hospital, Salem, Oregon, United States|Abington Memorial Hospital, Abington, Pennsylvania, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|UPMC-Heritage Valley Health System Beaver, Beaver, Pennsylvania, United States|Saint Luke's University Hospital-Bethlehem Campus, Bethlehem, Pennsylvania, United States|Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Northeast Radiation Oncology Center, Dunmore, Pennsylvania, United States|Pocono Medical Center, East Stroudsburg, Pennsylvania, United States|The Regional Cancer Center, Erie, Pennsylvania, United States|Fox Chase Cancer Center Buckingham, Furlong, Pennsylvania, United States|Adams Cancer Center, Gettysburg, Pennsylvania, United States|UPMC Cancer Centers - Arnold Palmer Pavilion, Greensburg, Pennsylvania, United States|Cherry Tree Cancer Center, Hanover, Pennsylvania, United States|Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States|UPMC-Johnstown/John P. Murtha Regional Cancer Center, Johnstown, Pennsylvania, United States|Armstrong Center for Medicine and Health, Kittanning, Pennsylvania, United States|Lancaster General Hospital, Lancaster, Pennsylvania, United States|UPMC Cancer Center at UPMC McKeesport, McKeesport, Pennsylvania, United States|Intercommunity Cancer Center, Monroeville, Pennsylvania, United States|Allegheny Valley Hospital, Natrona Heights, Pennsylvania, United States|UPMC Jameson, New Castle, Pennsylvania, United States|Paoli Memorial Hospital, Paoli, Pennsylvania, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|Aria Health-Torresdale Campus, Philadelphia, Pennsylvania, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|UPMC-Shadyside Hospital, Pittsburgh, Pennsylvania, United States|UPMC Jefferson Regional Radiation Oncology, Pittsburgh, Pennsylvania, United States|UPMC-Passavant Hospital, Pittsburgh, Pennsylvania, United States|UPMC Cancer Center at UPMC Northwest, Seneca, Pennsylvania, United States|UPMC Washington Hospital Radiation Oncology, Washington, Pennsylvania, United States|Reading Hospital, West Reading, Pennsylvania, United States|Lankenau Medical Center, Wynnewood, Pennsylvania, United States|WellSpan Health-York Hospital, York, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Spartanburg Medical Center, Spartanburg, South Carolina, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Sanford Cancer Center-Oncology Clinic, Sioux Falls, South Dakota, United States|Erlanger Medical Center, Chattanooga, Tennessee, United States|Jackson-Madison County General Hospital, Jackson, Tennessee, United States|Thompson Cancer Survival Center, Knoxville, Tennessee, United States|Texas Oncology-Arlington South, Arlington, Texas, United States|Texas Oncology Bedford, Bedford, Texas, United States|Saint Joseph Regional Cancer Center, Bryan, Texas, United States|Texas Oncology Methodist Charlton Cancer Center, Dallas, Texas, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|Texas Oncology-Denton South, Denton, Texas, United States|The Klabzuba Cancer Center, Fort Worth, Texas, United States|University of Texas Medical Branch, Galveston, Texas, United States|M D Anderson Cancer Center, Houston, Texas, United States|Texas Oncology-Longview Cancer Center, Longview, Texas, United States|Covenant Medical Center-Lakeside, Lubbock, Texas, United States|West Texas Cancer Center, Odessa, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Texas Cancer Center-Sherman, Sherman, Texas, United States|Texas Oncology Cancer Center Sugar Land, Sugar Land, Texas, United States|Tyler Cancer Center, Tyler, Texas, United States|Intermountain Medical Center, Murray, Utah, United States|McKay-Dee Hospital Center, Ogden, Utah, United States|Utah Valley Regional Medical Center, Provo, Utah, United States|Dixie Medical Center Regional Cancer Center, Saint George, Utah, United States|Utah Cancer Specialists-Salt Lake City, Salt Lake City, Utah, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|University of Vermont Medical Center, Burlington, Vermont, United States|Inova Alexandria Hospital, Alexandria, Virginia, United States|Sentara Norfolk General Hospital, Norfolk, Virginia, United States|Naval Medical Center - Portsmouth, Portsmouth, Virginia, United States|PeaceHealth Saint Joseph Medical Center, Bellingham, Washington, United States|Harrison Medical Center, Bremerton, Washington, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Swedish Medical Center-First Hill, Seattle, Washington, United States|Cancer Care Northwest - Spokane South, Spokane, Washington, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, United States|Compass Oncology Vancouver, Vancouver, Washington, United States|North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington, United States|Wheeling Hospital/Schiffler Cancer Center, Wheeling, West Virginia, United States|Langlade Hospital and Cancer Center, Antigo, Wisconsin, United States|Radiology Associates of Appleton/ThedaCare Regional Medical Center, Appleton, Wisconsin, United States|Marshfield Clinic Cancer Center at Sacred Heart, Eau Claire, Wisconsin, United States|Sacred Heart Hospital, Eau Claire, Wisconsin, United States|Bellin Memorial Hospital, Green Bay, Wisconsin, United States|Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States|Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, United States|UW Cancer Center Johnson Creek, Johnson Creek, Wisconsin, United States|Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States|Dean Hematology and Oncology Clinic, Madison, Wisconsin, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Bay Area Medical Center, Marinette, Wisconsin, United States|Marshfield Clinic, Marshfield, Wisconsin, United States|Marshfield Medical Center, Marshfield, Wisconsin, United States|Froedtert and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Marshfield Clinic-Minocqua Center, Minocqua, Wisconsin, United States|Saint Michael's Hospital, Stevens Point, Wisconsin, United States|ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States|Aspirus Regional Cancer Center, Wausau, Wisconsin, United States|Diagnostic and Treatment Center, Weston, Wisconsin, United States|Marshfield Clinic - Weston Center, Weston, Wisconsin, United States|Aspirus UW Cancer Center, Wisconsin Rapids, Wisconsin, United States|Doctor H. Bliss Murphy Cancer Centre, St. John's, Newfoundland and Labrador, Canada|Health Sciences North, Sudbury, Ontario, Canada|CHUM - Hopital Notre-Dame, Montreal, Quebec, Canada|McGill University Department of Oncology, Montreal, Quebec, Canada|Allan Blair Cancer Centre, Regina, Saskatchewan, Canada|Tel Aviv Sourasky Medical Center, Tel Aviv, Israel","https://ClinicalTrials.gov/show/NCT00884741"
761,"Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma","Radiation: 3-dimensional conformal radiation therapy|Radiation: intensity-modulated radiation therapy|Radiation: photon beam radiation therapy|Radiation: proton beam radiation therapy|Drug: temozolomide|Other: laboratory biomarker analysis","University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States|Saint Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States|Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Arizona Oncology Associates-West Orange Grove, Tucson, Arizona, United States|Banner University Medical Center - Tucson, Tucson, Arizona, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, United States|AIS Cancer Center at San Joaquin Community Hospital, Bakersfield, California, United States|Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States|Sutter Cancer Centers Radiation Oncology Services-Cameron Park, Cameron Park, California, United States|Eden Hospital Medical Center, Castro Valley, California, United States|Fresno Cancer Center, Fresno, California, United States|Marin General Hospital, Greenbrae, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Los Angeles County-USC Medical Center, Los Angeles, California, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|Fremont - Rideout Cancer Center, Marysville, California, United States|Memorial Medical Center, Modesto, California, United States|Kaiser Permanente Oakland-Broadway, Oakland, California, United States|Saint Joseph Hospital - Orange, Orange, California, United States|UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States|Palo Alto Medical Foundation Health Care, Palo Alto, California, United States|Pomona Valley Hospital Medical Center, Pomona, California, United States|Kaiser Permanente-Rancho Cordova Cancer Center, Rancho Cordova, California, United States|Rohnert Park Cancer Center, Rohnert Park, California, United States|Sutter Cancer Centers Radiation Oncology Services-Roseville, Roseville, California, United States|The Permanente Medical Group-Roseville Radiation Oncology, Roseville, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|South Sacramento Cancer Center, Sacramento, California, United States|California Pacific Medical Center-Pacific Campus, San Francisco, California, United States|Palo Alto Medical Foundation-Santa Cruz, Santa Cruz, California, United States|Kaiser Permanente Cancer Treatment Center, South San Francisco, California, United States|Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California, United States|Sutter Cancer Centers Radiation Oncology Services-Vacaville, Vacaville, California, United States|John Muir Medical Center-Walnut Creek, Walnut Creek, California, United States|UCHealth Memorial Hospital Central, Colorado Springs, Colorado, United States|Poudre Valley Hospital, Fort Collins, Colorado, United States|Hartford Hospital, Hartford, Connecticut, United States|Boca Raton Regional Hospital, Boca Raton, Florida, United States|University of Florida Health Science Center - Gainesville, Gainesville, Florida, United States|Baptist MD Anderson Cancer Center, Jacksonville, Florida, United States|University of Florida Health Science Center - Jacksonville, Jacksonville, Florida, United States|Baptist Medical Center South, Jacksonville, Florida, United States|Miami Cancer Institute, Miami, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|Emory Proton Therapy Center, Atlanta, Georgia, United States|Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah, Georgia, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States|Northwestern University, Chicago, Illinois, United States|John H Stroger Jr Hospital of Cook County, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States|Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States|UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States|Advocate Lutheran General Hospital, Park Ridge, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Memorial Medical Center, Springfield, Illinois, United States|Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States|Radiation Oncology Associates PC, Fort Wayne, Indiana, United States|Parkview Hospital Randallia, Fort Wayne, Indiana, United States|Parkview Regional Medical Center, Fort Wayne, Indiana, United States|IU Health Methodist Hospital, Indianapolis, Indiana, United States|Community Cancer Center East, Indianapolis, Indiana, United States|Community Cancer Center South, Indianapolis, Indiana, United States|Community Cancer Center North, Indianapolis, Indiana, United States|IU Health Ball Memorial Hospital, Muncie, Indiana, United States|Mercy Hospital, Cedar Rapids, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|University of Kansas Cancer Center, Kansas City, Kansas, United States|University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States|Norton Hospital Pavilion and Medical Campus, Louisville, Kentucky, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|Willis-Knighton Medical and Cancer Center, Shreveport, Louisiana, United States|Maryland Proton Treatment Center, Baltimore, Maryland, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States|UM Upper Chesapeake Medical Center, Bel Air, Maryland, United States|Central Maryland Radiation Oncology in Howard County, Columbia, Maryland, United States|UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie, Maryland, United States|Tufts Medical Center, Boston, Massachusetts, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Boston Medical Center, Boston, Massachusetts, United States|Mass General/North Shore Cancer Center, Danvers, Massachusetts, United States|Lowell General Hospital, Lowell, Massachusetts, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|McLaren Cancer Institute-Bay City, Bay City, Michigan, United States|Beaumont Hospital - Dearborn, Dearborn, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|McLaren Cancer Institute-Flint, Flint, Michigan, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|McLaren Cancer Institute-Lapeer Region, Lapeer, Michigan, United States|Saint Mary Mercy Hospital, Livonia, Michigan, United States|McLaren Cancer Institute-Macomb, Mount Clemens, Michigan, United States|McLaren Cancer Institute-Central Michigan, Mount Pleasant, Michigan, United States|McLaren Cancer Institute-Owosso, Owosso, Michigan, United States|McLaren Cancer Institute-Northern Michigan, Petoskey, Michigan, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, United States|William Beaumont Hospital-Royal Oak, Royal Oak, Michigan, United States|Lakeland Medical Center Saint Joseph, Saint Joseph, Michigan, United States|William Beaumont Hospital - Troy, Troy, Michigan, United States|Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States|Saint Luke's Hospital of Duluth, Duluth, Minnesota, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|North Kansas City Hospital, Kansas City, Missouri, United States|University of Kansas Cancer Center - North, Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Billings Clinic Cancer Center, Billings, Montana, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States|Renown Regional Medical Center, Reno, Nevada, United States|Saint Mary's Regional Medical Center, Reno, Nevada, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States|Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|Capital Health Medical Center-Hopewell, Pennington, New Jersey, United States|ProCure Proton Therapy Center-Somerset, Somerset, New Jersey, United States|Virtua Voorhees, Voorhees, New Jersey, United States|Montefiore Medical Center - Moses Campus, Bronx, New York, United States|New York-Presbyterian/Brooklyn Methodist Hospital, Brooklyn, New York, United States|Memorial Sloan Kettering Commack, Commack, New York, United States|Memorial Sloan Kettering Westchester, Harrison, New York, United States|Northwell Health/Center for Advanced Medicine, Lake Success, New York, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Mission Hospital, Asheville, North Carolina, United States|Novant Health Forsyth Medical Center, Winston-Salem, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Sanford Bismarck Medical Center, Bismarck, North Dakota, United States|Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States|Cleveland Clinic Akron General, Akron, Ohio, United States|UHHS-Chagrin Highlands Medical Center, Beachwood, Ohio, United States|Geauga Hospital, Chardon, Ohio, United States|University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio, United States|Case Western Reserve University, Cleveland, Ohio, United States|Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|Riverside Methodist Hospital, Columbus, Ohio, United States|Mercy Cancer Center-Elyria, Elyria, Ohio, United States|Cleveland Clinic Cancer Center Independence, Independence, Ohio, United States|Hillcrest Hospital Cancer Center, Mayfield Heights, Ohio, United States|UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor, Ohio, United States|UH Seidman Cancer Center at Southwest General Hospital, Middleburg Heights, Ohio, United States|University Hospitals Parma Medical Center, Parma, Ohio, United States|North Coast Cancer Care, Sandusky, Ohio, United States|UH Seidman Cancer Center at Firelands Regional Medical Center, Sandusky, Ohio, United States|Cleveland Clinic Cancer Center Strongsville, Strongsville, Ohio, United States|University of Toledo, Toledo, Ohio, United States|University of Cincinnati Cancer Center-West Chester, West Chester, Ohio, United States|UHHS-Westlake Medical Center, Westlake, Ohio, United States|Cleveland Clinic Wooster Family Health and Surgery Center, Wooster, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Willamette Valley Cancer Center, Eugene, Oregon, United States|Legacy Mount Hood Medical Center, Gresham, Oregon, United States|Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, United States|Saint Luke's University Hospital-Bethlehem Campus, Bethlehem, Pennsylvania, United States|Northeast Radiation Oncology Center, Dunmore, Pennsylvania, United States|Ephrata Cancer Center, Ephrata, Pennsylvania, United States|Adams Cancer Center, Gettysburg, Pennsylvania, United States|UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Harrisburg, Pennsylvania, United States|Sechler Family Cancer Center, Lebanon, Pennsylvania, United States|University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Jefferson Torresdale Hospital, Philadelphia, Pennsylvania, United States|Reading Hospital, West Reading, Pennsylvania, United States|WellSpan Health-York Cancer Center, York, Pennsylvania, United States|Prisma Health Cancer Institute - Spartanburg, Boiling Springs, South Carolina, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Prisma Health Cancer Institute - Faris, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Eastside, Greenville, South Carolina, United States|Self Regional Healthcare, Greenwood, South Carolina, United States|Prisma Health Cancer Institute - Greer, Greer, South Carolina, United States|Prisma Health Cancer Institute - Seneca, Seneca, South Carolina, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|Tennessee Cancer Specialists-Dowell Springs, Knoxville, Tennessee, United States|Dell Seton Medical Center at The University of Texas, Austin, Texas, United States|Austin Cancer Centers-Central Austin, Austin, Texas, United States|Texas Oncology-Austin Midtown, Austin, Texas, United States|Texas Oncology - Central Austin Cancer Center, Austin, Texas, United States|Texas Oncology - South Austin Cancer Center, Austin, Texas, United States|Austin Cancer Centers-North, Austin, Texas, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|Texas Oncology - Denison Cancer Center, Denison, Texas, United States|Texas Oncology-Flower Mound, Flower Mound, Texas, United States|Texas Oncology - Fort Worth Cancer Center, Fort Worth, Texas, United States|University of Texas Medical Branch, Galveston, Texas, United States|Memorial Hermann Memorial City Medical Center, Houston, Texas, United States|M D Anderson Cancer Center, Houston, Texas, United States|UTMB Cancer Center at Victory Lakes, League City, Texas, United States|Covenant Medical Center-Lakeside, Lubbock, Texas, United States|Texas Oncology-Seton Williamson, Round Rock, Texas, United States|Texas Oncology - Round Rock Cancer Center, Round Rock, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Texas Oncology Cancer Center Sugar Land, Sugar Land, Texas, United States|Tyler Cancer Center, Tyler, Texas, United States|Logan Regional Hospital, Logan, Utah, United States|Intermountain Medical Center, Murray, Utah, United States|McKay-Dee Hospital Center, Ogden, Utah, United States|Utah Valley Regional Medical Center, Provo, Utah, United States|Dixie Medical Center Regional Cancer Center, Saint George, Utah, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|Central Vermont Medical Center/National Life Cancer Treatment, Berlin, Vermont, United States|University of Vermont Medical Center, Burlington, Vermont, United States|Norris Cotton Cancer Center-North, Saint Johnsbury, Vermont, United States|Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States|SCCA Proton Therapy Center, Seattle, Washington, United States|Seattle Cancer Care Alliance at Northwest Hospital, Seattle, Washington, United States|University of Washington Medical Center - Montlake, Seattle, Washington, United States|Compass Oncology Vancouver, Vancouver, Washington, United States|Legacy Salmon Creek Hospital, Vancouver, Washington, United States|Wheeling Hospital/Schiffler Cancer Center, Wheeling, West Virginia, United States|Langlade Hospital and Cancer Center, Antigo, Wisconsin, United States|Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Froedtert Menomonee Falls Hospital, Menomonee Falls, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States|Aspirus Regional Cancer Center, Wausau, Wisconsin, United States|BCCA-Vancouver Island Cancer Centre, Victoria, British Columbia, Canada|Ottawa Hospital and Cancer Center-General Campus, Ottawa, Ontario, Canada|Windsor Regional Cancer Centre, Windsor, Ontario, Canada|CHUM - Hopital Notre-Dame, Montreal, Quebec, Canada|McGill University Department of Oncology, Montreal, Quebec, Canada|CHUM - Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada|The Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec, Canada|CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ), Quebec City, Quebec, Canada|Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada","https://ClinicalTrials.gov/show/NCT02179086"
762,"Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors","Completed","No Results Available","Glioblastoma","Drug: TransMID","National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00088400"
763,"Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients","Completed","No Results Available","Glioblastoma Multiforme",,"Department of Stereotactic Neurosurgery, Freiburg, Baden Wuertemberg, Germany|University Hospital Munich, Department of Neurosurgery, Munich, Bavaria, Germany|University Hospital Bonn, Department of Neurosurgery, Bonn, North Rhine-Westphalia, Germany","https://ClinicalTrials.gov/show/NCT01089868"
764,"Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors","Completed","No Results Available","Glioblastoma Multiforme","Drug: TP-38",,"https://ClinicalTrials.gov/show/NCT00104091"
765,"Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy","Unknown status","No Results Available","Glioblastoma|Radiotherapy|Chemotherapy","Other: Analysis of spectroscopic biomarkers of proliferation for six-month survival","CHU Amiens Picardie, Amiens, Picardie, France","https://ClinicalTrials.gov/show/NCT03144167"
766,"Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.","Recruiting","No Results Available","Glioblastoma|Glioma|Neoplasms, Neuroepithelial|Neuroectodermal Tumors|Neoplasms|Neoplasms, Nerve Tissue|Vaccines|Immunologic Factors","Biological: Dendritic Cell/Tumor Fusion Vaccine|Drug: Interleukin-12|Drug: Temozolomide","The Second Affiliated hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China","https://ClinicalTrials.gov/show/NCT04388033"
767,"Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting","Active, not recruiting","No Results Available","Glioma|Glioblastoma|Glioblastoma Multiforme|GBM|Brain Cancer","Drug: VAL-083, Dianhydrogalactitol","University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02717962"
768,"EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma","Terminated","Has Results","Glioblastoma|Gliosarcoma","Biological: EGFRvIII CAR T cells","The Preston Robert Tisch Brain Tumor Center at Duke, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT02664363"
769,"Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme","Unknown status","No Results Available","Glioblastoma Multiforme","Radiation: Hypofractionated IMRT|Biological: Granulocyte-macrophage Colony-stimulating Factor|Drug: Temozolomide","Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China","https://ClinicalTrials.gov/show/NCT02663440"
770,"Niraparib Combined With Radiotherapy in rGBM","Recruiting","No Results Available","Recurrent Glioblastoma","Drug: Niraparib","Tianjin Huanhu Hosptal, Tianjin, Tianjin, China","https://ClinicalTrials.gov/show/NCT04715620"
771,"Radiosurgery for Glioblastoma Multiforme","Terminated","Has Results","Glioblastoma Multiforme","Procedure: CyberKnife","Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00456612"
772,"A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme","Recruiting","No Results Available","Glioblastoma Multiforme|Glioblastoma, Adult|Glioblastoma|Recurrent Brain Tumor|GBM","Drug: Sunitinib|Drug: Lomustine","VU University Medical Center, Amsterdam, Netherlands|University Medical Center Groningen, Groningen, Netherlands|Radboud UMC, Nijmegen, Netherlands","https://ClinicalTrials.gov/show/NCT03025893"
773,"Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Active, not recruiting","Has Results","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma","Radiation: 3-Dimensional Conformal Radiation Therapy|Procedure: Cognitive Assessment|Other: Laboratory Biomarker Analysis|Drug: Temozolomide|Drug: Vorinostat","Mayo Clinic in Arizona, Scottsdale, Arizona, United States|UCSF Medical Center-Parnassus, San Francisco, California, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|AdventHealth Orlando, Orlando, Florida, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|Pali Momi Medical Center, 'Aiea, Hawaii, United States|Queen's Cancer Center - Pearlridge, 'Aiea, Hawaii, United States|Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu, Hawaii, United States|Queen's Medical Center, Honolulu, Hawaii, United States|Straub Clinic and Hospital, Honolulu, Hawaii, United States|University of Hawaii Cancer Center, Honolulu, Hawaii, United States|Kuakini Medical Center, Honolulu, Hawaii, United States|Queen's Cancer Center - Kuakini, Honolulu, Hawaii, United States|The Cancer Center of Hawaii-Liliha, Honolulu, Hawaii, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States|Castle Medical Center, Kailua, Hawaii, United States|Wilcox Memorial Hospital and Kauai Medical Clinic, Lihue, Hawaii, United States|Rush University Medical Center, Chicago, Illinois, United States|Presence Resurrection Medical Center, Chicago, Illinois, United States|Garneau, Stewart C MD (UIA Investigator), Moline, Illinois, United States|Porubcin, Michael MD (UIA Investigator), Moline, Illinois, United States|Sharis, Christine M MD (UIA Investigator), Moline, Illinois, United States|Spector, David MD (UIA Investigator), Moline, Illinois, United States|Stoffel, Thomas J MD (UIA Investigator), Moline, Illinois, United States|Trinity Medical Center, Moline, Illinois, United States|McFarland Clinic PC - Ames, Ames, Iowa, United States|Constantinou, Costas L MD (UIA Investigator), Bettendorf, Iowa, United States|Medical Oncology and Hematology Associates-West Des Moines, Clive, Iowa, United States|Mercy Cancer Center-West Lakes, Clive, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|Iowa-Wide Oncology Research Coalition NCORP, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Laurel, Des Moines, Iowa, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|Iowa Lutheran Hospital, Des Moines, Iowa, United States|Siouxland Regional Cancer Center, Sioux City, Iowa, United States|Methodist West Hospital, West Des Moines, Iowa, United States|Mercy Medical Center-West Lakes, West Des Moines, Iowa, United States|Cancer Center of Kansas - Chanute, Chanute, Kansas, United States|Cancer Center of Kansas - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas - El Dorado, El Dorado, Kansas, United States|Cancer Center of Kansas - Fort Scott, Fort Scott, Kansas, United States|Cancer Center of Kansas-Independence, Independence, Kansas, United States|Cancer Center of Kansas-Kingman, Kingman, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|Cancer Center of Kansas-Liberal, Liberal, Kansas, United States|Cancer Center of Kansas - Newton, Newton, Kansas, United States|Cancer Center of Kansas - Parsons, Parsons, Kansas, United States|Cancer Center of Kansas - Pratt, Pratt, Kansas, United States|Cancer Center of Kansas - Salina, Salina, Kansas, United States|Cancer Center of Kansas - Wellington, Wellington, Kansas, United States|Associates In Womens Health, Wichita, Kansas, United States|Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita, Kansas, United States|Ascension Via Christi Hospitals Wichita, Wichita, Kansas, United States|Cancer Center of Kansas - Wichita, Wichita, Kansas, United States|Wichita NCI Community Oncology Research Program, Wichita, Kansas, United States|Cancer Center of Kansas - Winfield, Winfield, Kansas, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Cancer Trials Support Unit, Rockville, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Cancer Research Consortium of West Michigan NCORP, Grand Rapids, Michigan, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, United States|Munson Medical Center, Traverse City, Michigan, United States|Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Essentia Health Cancer Center, Duluth, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Unity Hospital, Fridley, Minnesota, United States|Hutchinson Area Health Care, Hutchinson, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, United States|Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, United States|Lakeview Hospital, Stillwater, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Rice Memorial Hospital, Willmar, Minnesota, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States|Billings Clinic Cancer Center, Billings, Montana, United States|Montana Cancer Consortium NCORP, Billings, Montana, United States|Nebraska Cancer Research Center, Lincoln, Nebraska, United States|Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|Alegent Health Immanuel Medical Center, Omaha, Nebraska, United States|Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, United States|Alegent Health Lakeside Hospital, Omaha, Nebraska, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Sanford Clinic North-Fargo, Fargo, North Dakota, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States|Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|University of Virginia Cancer Center, Charlottesville, Virginia, United States|Green Bay Oncology at Saint Vincent Hospital, Green Bay, Wisconsin, United States|Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States|Green Bay Oncology Limited at Saint Mary's Hospital, Green Bay, Wisconsin, United States|Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00731731"
774,"Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma","Completed","No Results Available","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma","Drug: Cediranib Maleate|Procedure: Diffusion Tensor Imaging|Procedure: Diffusion Weighted Imaging|Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging|Radiation: Fludeoxyglucose F-18|Radiation: Intensity-Modulated Radiation Therapy|Other: Laboratory Biomarker Analysis|Procedure: Perfusion Magnetic Resonance Imaging|Procedure: Positron Emission Tomography|Drug: Temozolomide","Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00662506"
775,"Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients","Recruiting","No Results Available","Recurrent Glioblastoma","Device: NaviFUS System","Chang Gung Medical Foundation, Taoyuan, Taiwan","https://ClinicalTrials.gov/show/NCT04988750"
776,"Oral ONC201 in Recurrent GBM, H3 K27M Glioma, and Midline Glioma","Recruiting","No Results Available","Glioblastoma|Diffuse Midline Glioma|H3 K27M Glioma|Thalamic Glioma|Infratentorial Glioma|Basal Ganglia Glioma","Drug: ONC201","University of California, Los Angeles, Los Angeles, California, United States|Miami Cancer Institute, Miami, Florida, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT02525692"
777,"Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM","Recruiting","No Results Available","Recurrent Glioblastoma","Device: Exablate BBBD|Drug: Carboplatin","Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Sheba Medical Center, Tel Hashomer, Israel|Fondazione IRCCS Neurologico Carlo Besta, Milano, Italy|Yonsei University Medical Center, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04440358"
778,"Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma","Other: pharmacological study|Procedure: adjuvant therapy|Radiation: 3-dimensional conformal radiation therapy|Radiation: intensity-modulated radiation therapy|Drug: temsirolimus|Drug: temozolomide","Mayo Clinic in Florida, Jacksonville, Florida, United States|Medical Oncology and Hematology Associates-West Des Moines, Clive, Iowa, United States|Mercy Capitol, Des Moines, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|Iowa Oncology Research Association CCOP, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates, Des Moines, Iowa, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|Iowa Lutheran Hospital, Des Moines, Iowa, United States|Mayo Clinic, Rochester, Minnesota, United States|Altru Cancer Center, Grand Forks, North Dakota, United States","https://ClinicalTrials.gov/show/NCT00316849"
779,"Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy","Recruiting","No Results Available","Recurrent Glioblastoma","Drug: Carboplatin|Device: Exablate BBBD","Stanford University, Palo Alto, California, United States|University of Maryland, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Cleveland Clinic, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT04417088"
780,"Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.","Recruiting","No Results Available","Initial Radiological Diagnosis Eligible for Tumor Resection|Initial Radiological Diagnosis Compatible With Newly Diagnosed Glioblastoma (IDH Wild-type)|Eligible for the Standard of Care Including Concurrent Temoradiation and Adjuvant Temozolomide","Device: SonoCloud-9 (SC9) device|Drug: Temozolomide according Stupp protocol","Katholieke Universiteit Leuven, Leuven, Belgium|Centre hospitalier Universitaire d'Angers, Angers, France|Groupe Hospitalier Saint-André, Bordeaux, France|Hospices Civils de Lyon, Hôpital Pierre Wertheimer, Bron, France|AP-HM, La Timone, Hôpital Universitaire, Marseille, France|APHP-Sorbonne, Pitié Salpêtrière Hospital, Paris, France|Centre hospitalier universitaire vaudois CHUV, Lausanne, Switzerland","https://ClinicalTrials.gov/show/NCT04614493"
781,"Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma Mutliforme","Radiation: IMRT Technique|Radiation: IMRT and accelerated hypofractionation technique|Radiation: neo-adjuvant TMZ followed by accelerated hypofractionated EBRT|Drug: Temozolomide and Accelerated Hypofractionation RT","McGill University Health Center, Montreal, Quebec, Canada","https://ClinicalTrials.gov/show/NCT01702610"
782,"INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme","Active, not recruiting","No Results Available","Glioblastoma Multiforme|Gliosarcoma|Colorectal Cancer|Renal Cell Carcinoma","Drug: INC280|Biological: bevacizumab","Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States|Yale School of Medicine, New Haven, Connecticut, United States|HCA Midwest - Kansas City, Kansas City, Missouri, United States|Oklahoma University Health Science Center, Oklahoma City, Oklahoma, United States|Tennessee Oncology PLLC, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT02386826"
783,"Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma","Completed","Has Results","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma","Radiation: 3-Dimensional Conformal Radiation Therapy|Drug: Motexafin Gadolinium|Drug: Temozolomide","Mobile Infirmary Medical Center, Mobile, Alabama, United States|Arizona Oncology Services Foundation, Scottsdale, Arizona, United States|The University of Arizona Medical Center-University Campus, Tucson, Arizona, United States|East Bay Radiation Oncology Center, Castro Valley, California, United States|Eden Hospital Medical Center, Castro Valley, California, United States|Valley Medical Oncology Consultants-Castro Valley, Castro Valley, California, United States|Bay Area Breast Surgeons Inc, Emeryville, California, United States|Valley Medical Oncology Consultants-Fremont, Fremont, California, United States|Saint Rose Hospital, Hayward, California, United States|Los Angeles County-USC Medical Center, Los Angeles, California, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States|Contra Costa Regional Medical Center, Martinez, California, United States|El Camino Hospital, Mountain View, California, United States|Highland General Hospital, Oakland, California, United States|Alta Bates Summit Medical Center - Summit Campus, Oakland, California, United States|Bay Area Tumor Institute, Oakland, California, United States|Hematology and Oncology Associates-Oakland, Oakland, California, United States|Tom K Lee Inc, Oakland, California, United States|Stanford Cancer Institute Palo Alto, Palo Alto, California, United States|Valley Care Health System - Pleasanton, Pleasanton, California, United States|Valley Medical Oncology Consultants, Pleasanton, California, United States|Doctors Medical Center- JC Robinson Regional Cancer Center, San Pablo, California, United States|Denver Veterans Administration Medical Center, Denver, Colorado, United States|University of Florida Health Science Center - Gainesville, Gainesville, Florida, United States|University of Florida Health Science Center - Jacksonville, Jacksonville, Florida, United States|University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States|Rush - Copley Medical Center, Aurora, Illinois, United States|Saint Joseph Medical Center, Bloomington, Illinois, United States|Graham Hospital Association, Canton, Illinois, United States|Memorial Hospital, Carthage, Illinois, United States|Heartland Cancer Research NCORP, Decatur, Illinois, United States|Eureka Hospital, Eureka, Illinois, United States|Galesburg Cottage Hospital, Galesburg, Illinois, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, United States|Mason District Hospital, Havana, Illinois, United States|Hopedale Medical Complex - Hospital, Hopedale, Illinois, United States|Joliet Oncology-Hematology Associates Limited, Joliet, Illinois, United States|Kewanee Hospital, Kewanee, Illinois, United States|Mcdonough District Hospital, Macomb, Illinois, United States|Bromenn Regional Medical Center, Normal, Illinois, United States|Community Cancer Center Foundation, Normal, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Ottawa Regional Hospital and Healthcare Center, Ottawa, Illinois, United States|OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center, Pekin, Illinois, United States|Pekin Hospital, Pekin, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|Proctor Hospital, Peoria, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|OSF Saint Francis Radiation Oncology at Peoria Cancer Center, Peoria, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Illinois Valley Hospital, Peru, Illinois, United States|Valley Radiation Oncology, Peru, Illinois, United States|Perry Memorial Hospital, Princeton, Illinois, United States|Saint Margaret's Hospital, Spring Valley, Illinois, United States|Franciscan Saint Margaret Health-Hammond Campus, Hammond, Indiana, United States|Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States|Franciscan Saint Anthony Health-Michigan City, Michigan City, Indiana, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States|Michigan Cancer Research Consortium NCORP, Ann Arbor, Michigan, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|Beaumont Hospital-Dearborn, Dearborn, Michigan, United States|Saint John Hospital and Medical Center, Detroit, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Genesys Regional Medical Center-West Flint Campus, Flint, Michigan, United States|McLaren Cancer Institute-Flint, Flint, Michigan, United States|Allegiance Health, Jackson, Michigan, United States|Sparrow Hospital, Lansing, Michigan, United States|Saint Mary Mercy Hospital, Livonia, Michigan, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, United States|Lake Huron Medical Center, Port Huron, Michigan, United States|Saint Mary's of Michigan, Saginaw, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Mercy Hospital-Joplin, Joplin, Missouri, United States|CHI Health Good Samaritan, Kearney, Nebraska, United States|John F Kennedy Medical Center, Edison, New Jersey, United States|Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|Rutgers New Jersey Medical School, Newark, New Jersey, United States|Duke Women's Cancer Care Raleigh, Raleigh, North Carolina, United States|Rex Cancer Center, Raleigh, North Carolina, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, United States|Paoli Memorial Hospital, Paoli, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Reading Hospital, West Reading, Pennsylvania, United States|Lankenau Medical Center, Wynnewood, Pennsylvania, United States|Main Line Health NCORP, Wynnewood, Pennsylvania, United States|Audie L Murphy Veterans Affairs Hospital, San Antonio, Texas, United States|Cancer Therapy and Research Center at The UT Health Science Center at San Antonio, San Antonio, Texas, United States|University Hospital, San Antonio, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|American Fork Hospital / Huntsman Intermountain Cancer Center, American Fork, Utah, United States|Sandra L Maxwell Cancer Center, Cedar City, Utah, United States|Cottonwood Hospital Medical Center, Murray, Utah, United States|Intermountain Medical Center, Murray, Utah, United States|McKay-Dee Hospital Center, Ogden, Utah, United States|Utah Valley Regional Medical Center, Provo, Utah, United States|Dixie Medical Center Regional Cancer Center, Saint George, Utah, United States|Intermountain Health Care, Salt Lake City, Utah, United States|Utah Cancer Specialists-Salt Lake City, Salt Lake City, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|University of Washington Medical Center, Seattle, Washington, United States|Wheeling Hospital/Schiffler Cancer Center, Wheeling, West Virginia, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Froedtert and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00305864"
784,"Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma","Recruiting","No Results Available","Astrocytoma, Grade IV|Giant Cell Glioblastoma|Glioblastoma Multiforme|Gliosarcoma","Radiation: Radiation","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT02709226"
785,"Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma","Recruiting","No Results Available","Glioblastoma|Glioblastoma With Primitive Neuronal Component|Gliosarcoma|Malignant Glioma|Oligodendroglial Component Present","Drug: Plerixafor|Drug: Temozolomide|Radiation: Whole-Brain Radiotherapy (WBRT)|Radiation: Radiation Therapy","Stanford Cancer Institute Palo Alto, Palo Alto, California, United States","https://ClinicalTrials.gov/show/NCT03746080"
786,"A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma","Completed","Has Results","Glioblastoma Multiforme","Drug: bevacizumab [Avastin]|Drug: irinotecan|Drug: temozolomide","Aachen, Germany|Berlin, Germany|Bochum, Germany|Bonn, Germany|Chemnitz, Germany|Dresden, Germany|Düsseldorf, Germany|Erfurt, Germany|Erlangen, Germany|Frankfurt am Main, Germany|Freiburg, Germany|Göttingen, Germany|Idar-Oberstein, Germany|Kiel, Germany|Köln, Germany|Leipzig, Germany|Mannheim, Germany|Marburg, Germany|Muenchen, Germany|München, Germany|Münster, Germany|Regensburg, Germany|Tübingen, Germany|Ulm, Germany","https://ClinicalTrials.gov/show/NCT00967330"
787,"Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma","Drug: gefitinib|Other: pharmacological study|Other: laboratory biomarker analysis|Other: questionnaire administration|Procedure: quality-of-life assessment","North Central Cancer Treatment Group, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT00014170"
788,"Evaluating Therapeutic Response to Novo-TTF","Recruiting","No Results Available","Glioblastoma Multiforme","Device: Novo-TTF","University Of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT02441322"
789,"Cancer Stem Cell High-Throughput Drug Screening Study","Unknown status","No Results Available","Glioblastoma Multiforme","Drug: Combination Drug Therapy","Swedish Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT02654964"
790,"Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma","Completed","No Results Available","Glioblastoma|Grade IV Astrocytoma|Glioblastoma Multiforme|Grade IV Glioma","Drug: MDNA55","University of California San Francisco, San Francisco, California, United States|John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, California, United States|Boca Raton Regional Hospital, Boca Raton, Florida, United States|Duke University Medical Center, Durham, North Carolina, United States|Oregon Health & Science University, Portland, Oregon, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Cancer Therapy and Research Center at The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT02858895"
791,"Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Terminated","No Results Available","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma","Drug: oxaliplatin|Other: pharmacological study","New Approaches to Brain Tumor Therapy Consortium, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00005856"
792,"Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma","Drug: tipifarnib|Radiation: radiation therapy","New Approaches to Brain Tumor Therapy Consortium, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00058097"
793,"Antisecretory Factor in Primary Glioblastoma 1","Completed","No Results Available","Glioblastoma|Cerebral Edema|Chemotherapy Effect","Dietary Supplement: Salovum","Department of Neurosurgery, Lund, Sweden","https://ClinicalTrials.gov/show/NCT04116138"
794,"Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816)","Completed","Has Results","Glioblastoma","Drug: Temozolomide|Radiation: Radiotherapy",,"https://ClinicalTrials.gov/show/NCT00725010"
795,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","Has Results","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma","Drug: cilengitide|Drug: temozolomide|Radiation: radiation therapy|Other: laboratory biomarker analysis|Other: pharmacological study","University of Alabama at Birmingham, Birmingham, Alabama, United States|Emory University, Atlanta, Georgia, United States|Johns Hopkins University, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00085254"
796,"Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme","Completed","No Results Available","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma","Drug: gefitinib|Radiation: radiation therapy|Other: laboratory biomarker analysis","Radiation Therapy Oncology Group, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00052208"
797,"Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors","Completed","No Results Available","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma","Drug: erlotinib hydrochloride|Radiation: 3-dimensional conformal radiation therapy|Drug: temozolomide","Mobile Infirmary Medical Center, Mobile, Alabama, United States|Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Northeast Georgia Cancer Care LLC, Athens, Georgia, United States|Rush - Copley Medical Center, Aurora, Illinois, United States|Saint Joseph Medical Center, Bloomington, Illinois, United States|Graham Hospital Association, Canton, Illinois, United States|Memorial Hospital, Carthage, Illinois, United States|Saint Anthony Memorial Hospital, Effingham, Illinois, United States|Eureka Hospital, Eureka, Illinois, United States|Galesburg Cottage Hospital, Galesburg, Illinois, United States|Illinois CancerCare Galesburg, Galesburg, Illinois, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, United States|Mason District Hospital, Havana, Illinois, United States|Hopedale Medical Complex - Hospital, Hopedale, Illinois, United States|Joliet Oncology-Hematology Associates Limited, Joliet, Illinois, United States|Kewanee Hospital, Kewanee, Illinois, United States|Mcdonough District Hospital, Macomb, Illinois, United States|Garneau, Stewart C MD (UIA Investigator), Moline, Illinois, United States|Porubcin, Michael MD (UIA Investigator), Moline, Illinois, United States|Sharis, Christine M MD (UIA Investigator), Moline, Illinois, United States|Stoffel, Thomas J MD (UIA Investigator), Moline, Illinois, United States|Vigliotti, Antonio, P.G. M.D. (UIA Investigator), Moline, Illinois, United States|Bromenn Regional Medical Center, Normal, Illinois, United States|Community Cancer Center Foundation, Normal, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Ottawa Regional Hospital and Healthcare Center, Ottawa, Illinois, United States|Pekin Cancer Treatment Center, Pekin, Illinois, United States|Pekin Hospital, Pekin, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|Proctor Hospital, Peoria, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|Illinois Oncology Research Association CCOP, Peoria, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Illinois Valley Hospital, Peru, Illinois, United States|Perry Memorial Hospital, Princeton, Illinois, United States|Saint Margaret's Hospital, Spring Valley, Illinois, United States|Valley Cancer Center, Spring Valley, Illinois, United States|Carle Clinic-Urbana Main, Urbana, Illinois, United States|Saint Anthony Memorial Health Center, Michigan City, Indiana, United States|McFarland Clinic, Ames, Iowa, United States|Constantinou, Costas L MD (UIA Investigator), Bettendorf, Iowa, United States|Saint Anthony Regional Hospital, Carroll, Iowa, United States|Saint Luke's Hospital, Cedar Rapids, Iowa, United States|Cedar Rapids Oncology Association, Cedar Rapids, Iowa, United States|Mercy Hospital, Cedar Rapids, Iowa, United States|Oncology Associates at Mercy Medical Center, Cedar Rapids, Iowa, United States|Medical Oncology and Hematology Associates-West Des Moines, Clive, Iowa, United States|Alegent Health Mercy Hospital, Council Bluffs, Iowa, United States|Mercy Capitol, Des Moines, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|Iowa Oncology Research Association CCOP, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates, Des Moines, Iowa, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|Iowa Lutheran Hospital, Des Moines, Iowa, United States|Community Memorial Hospital, Missouri Valley, Iowa, United States|Burgess Memorial Hospital, Onawa, Iowa, United States|Siouxland Regional Cancer Center, Sioux City, Iowa, United States|Siouxland Hematology Oncology Associates, Sioux City, Iowa, United States|Mercy Medical Center-Sioux City, Sioux City, Iowa, United States|Saint Luke's Regional Medical Center, Sioux City, Iowa, United States|Hospital District Sixth of Harper County, Anthony, Kansas, United States|Cancer Center of Kansas - Chanute, Chanute, Kansas, United States|Cancer Center of Kansas - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas - El Dorado, El Dorado, Kansas, United States|Cancer Center of Kansas - Fort Scott, Fort Scott, Kansas, United States|Cancer Center of Kansas-Independence, Independence, Kansas, United States|Cancer Center of Kansas-Kingman, Kingman, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|Cancer Center of Kansas - Newton, Newton, Kansas, United States|Cancer Center of Kansas - Parsons, Parsons, Kansas, United States|Cancer Center of Kansas - Pratt, Pratt, Kansas, United States|Cancer Center of Kansas - Salina, Salina, Kansas, United States|Cancer Center of Kansas - Wellington, Wellington, Kansas, United States|Associates In Womens Health, Wichita, Kansas, United States|Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita, Kansas, United States|Cancer Center of Kansas - Main Office, Wichita, Kansas, United States|Via Christi Regional Medical Center, Wichita, Kansas, United States|Wesley Medical Center, Wichita, Kansas, United States|Wichita CCOP, Wichita, Kansas, United States|Cancer Center of Kansas - Winfield, Winfield, Kansas, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|Michigan Cancer Research Consortium Community Clinical Oncology Program, Ann Arbor, Michigan, United States|Oakwood Hospital, Dearborn, Michigan, United States|Saint John Hospital and Medical Center, Detroit, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Genesys Regional Medical Center-West Flint Campus, Flint, Michigan, United States|Allegiance Health, Jackson, Michigan, United States|Sparrow Hospital, Lansing, Michigan, United States|Saint Mary's of Michigan, Saginaw, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Harris, John Gilbert MD (UIA Investigator), Alexandria, Minnesota, United States|Medini, Eitan MD (UIA Investigator), Alexandria, Minnesota, United States|Sanford Clinic North-Bemidgi, Bemidji, Minnesota, United States|Brainerd Medical Center Inc, Brainerd, Minnesota, United States|Essentia Health Saint Joseph's Medical Center, Brainerd, Minnesota, United States|Essentia Health Duluth Clinic CCOP, Duluth, Minnesota, United States|Essentia Health Saint Mary's Medical Center, Duluth, Minnesota, United States|Miller-Dwan Hospital, Duluth, Minnesota, United States|Etzell, Paul S MD (UIA Investigator), Fergus Falls, Minnesota, United States|Swenson, Wade II, MD (UIA Investigator), Fergus Falls, Minnesota, United States|Meeker County Memorial Hospital, Litchfield, Minnesota, United States|Virginia Piper Cancer Institute, Minneapolis, Minnesota, United States|Chippewa County - Montevideo Hospital, Montevideo, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|CentraCare Clinic, Saint Cloud, Minnesota, United States|Saint Cloud Hospital, Saint Cloud, Minnesota, United States|Saint Joseph's Hospital - Healtheast, Saint Paul, Minnesota, United States|Adult and Pediatric Urology PLLP, Sartell, Minnesota, United States|Woodwinds Health Campus, Woodbury, Minnesota, United States|Montana Cancer Consortium CCOP, Billings, Montana, United States|Northern Rockies Radiation Oncology Center, Billings, Montana, United States|Saint Vincent Healthcare, Billings, Montana, United States|Hematology-Oncology Centers of the Northern Rockies PC, Billings, Montana, United States|Billings Clinic, Billings, Montana, United States|Deaconess Medical Center, Billings, Montana, United States|Bozeman Deaconess Cancer Center, Bozeman, Montana, United States|Bozeman Deaconess Hospital, Bozeman, Montana, United States|Internal Medicine of Bozeman, Bozeman, Montana, United States|Saint James Community Hospital and Cancer Treatment Center, Butte, Montana, United States|Saint Peter's Community Hospital, Helena, Montana, United States|Glacier Oncology PLLC, Kalispell, Montana, United States|Community Medical Hospital, Missoula, Montana, United States|Montana Cancer Specialists, Missoula, Montana, United States|Saint Patrick Hospital - Community Hospital, Missoula, Montana, United States|Fremont Area Medical Center, Fremont, Nebraska, United States|Bryan LGH Medical Center West, Lincoln, Nebraska, United States|Bryan LGH Medical Center East, Lincoln, Nebraska, United States|Saint Elizabeth Regional Medical Center, Lincoln, Nebraska, United States|Midlands Community Hospital, Papillion, Nebraska, United States|Bismarck Cancer Center, Bismarck, North Dakota, United States|Mid Dakota Clinic, Bismarck, North Dakota, United States|Saint Alexius Medical Center, Bismarck, North Dakota, United States|Sanford Bismarck Medical Center, Bismarck, North Dakota, United States|Sanford Clinic North-Fargo, Fargo, North Dakota, United States|Sanford Medical Center-Fargo, Fargo, North Dakota, United States|University of Virginia, Charlottesville, Virginia, United States|Welch Cancer Center, Sheridan, Wyoming, United States","https://ClinicalTrials.gov/show/NCT00039494"
798,"Safety and Efficacy Study in Recurrent Grade IV Glioma","Recruiting","No Results Available","Glioblastoma Multiforme","Drug: Perillyl alcohol","University of Southern California, Los Angeles, California, United States|Cleveland Clinic, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT02704858"
799,"Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme","Completed","No Results Available","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma","Procedure: conventional surgery|Radiation: 3-dimensional conformal radiation therapy|Radiation: stereotactic radiosurgery|Drug: motexafin gadolinium|Procedure: magnetic resonance imaging|Procedure: spectroscopy","Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT00004262"
800,"Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma","Completed","No Results Available","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma","Drug: tipifarnib|Drug: temozolomide|Radiation: radiation therapy","Adult Brain Tumor Consortium, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00049387"
801,"Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma","Completed","Has Results","Adult Glioblastoma|Depression|Recurrent Adult Brain Tumor","Drug: vorinostat|Drug: temozolomide|Procedure: magnetic resonance spectroscopic imaging|Other: survey administration","Emory University, Atlanta, Georgia, United States","https://ClinicalTrials.gov/show/NCT01342757"
802,"Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma","Terminated","No Results Available","Grade IV Astrocytoma|Glioblastoma","Drug: Temozolomide|Drug: folinic acid at pharmacological dose is the escalated drug|Radiation: High voltage radiation therapy (linear accelerator)","Institut de Cacerologie de l'ouest - site Paul Papin, Angers, France|CHU de Lyon, Bron, France|ICO site Gauducheau, Nantes, France|CLCC Antoine Lacassagne, Nice, France","https://ClinicalTrials.gov/show/NCT01700569"
803,"NCT Neuro Master Match - N²M² (NOA-20)","Recruiting","No Results Available","Glioblastoma, Adult","Drug: APG101|Drug: Alectinib|Drug: Idasanutlin|Drug: Atezolizumab|Drug: Vismodegib|Drug: Temsirolimus|Drug: Palbociclib","Charité Berlin, Neurosurgery, Berlin, Germany|Knappschaftskrankenhaus Bochum GmbH, Neurology Clinic, Bochum, Germany|University Hospital Bonn, Neurology Clinic, Bonn, Germany|University Hospital Cologne, Neurosurgery, Cologne, Germany|University Hospital Dresden, Neurosurgery, Dresden, Germany|University Hospital Essen, Neurology Clinic, Essen, Germany|University Hospital Frankfurt, Neurooncology, Frankfurt am Main, Germany|University Hospital Heidelberg, Neurology Clinic, Heidelberg, Germany|University Hospital Saarland, Neurosurgery, Homburg, Germany|University Hospital Mainz, Neurosurgery, Mainz, Germany|University Hospital Mannheim, Neurology Clinic, Mannheim, Germany|University Hospital Regensburg, Neurology Clinic, Regensburg, Germany|University Hospital Tuebingen, Neurooncology, Tübingen, Germany","https://ClinicalTrials.gov/show/NCT03158389"
804,"Detection of Anti-glomerular Basement Membrane Antibodies (Anti-GBM): a Promising Biomarker for Lupus Nephritis (LN)?","Completed","No Results Available","Lupus Nephritis","Other: Detection of circulating anti-GBM antibodies (using chemiluminescence method and indirect immunofluorescence (IIF) method).","Damien JOLLY, Reims, France","https://ClinicalTrials.gov/show/NCT03664908"
805,"Radiosurgery Plus Bevacizumab in Glioblastoma","Terminated","No Results Available","Glioblastoma|Gliosarcoma|Brain Tumor","Radiation: radiosurgery|Biological: bevacizumab|Drug: irinotecan hydrochloride","Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT01086345"
806,"Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide","Completed","Has Results","Glioblastoma Multiforme","Radiation: Radiation|Drug: Chemotherapy","The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT01478854"
807,"Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection","Completed","No Results Available","Glioblastoma Multiforme|Cytomegalovirus Infection","Drug: Valganciclovir (Valcyte)|Other: Placebo","Department of neurosurgery, Karolinska University Hospital, Solna, Stockholm, Sweden|Department of Oncology, Norrland University Hospital, Umea, Sweden|Department of Oncology, Akademiska Hospital, Uppsala, Sweden","https://ClinicalTrials.gov/show/NCT00400322"
808,"Study of DC Vaccination Against Glioblastoma","Recruiting","No Results Available","Glioma|Glioblastoma Multiforme|Neoplasms","Procedure: Surgery|Drug: Chemotherapy|Radiation: Radiotherapy|Biological: DC vaccination|Drug: blank placebo","Huashan hospital, Fudan university, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT01567202"
809,"Effects of Steroid Tapering on Functional Capacity and Neurocognition","Withdrawn","No Results Available","Glioblastoma Multiforme","Drug: Dexamethasone acetate|Drug: Dexamethasone",,"https://ClinicalTrials.gov/show/NCT01169415"
810,"Dendritic Cell Cancer Vaccine for High-grade Glioma","Completed","No Results Available","Glioblastoma Multiforme","Drug: Trivax, Temozolomide, Surgery, Radiotherapy|Drug: Temozolomide, Surgery, Radiotherapy","Landesnervenklinik Wagner-Jauregg, Linz, Oberösterreich, Austria|Landeskrankenhaus Feldkirch, Feldkirch, Austria|Department of Neurosurgery, Medical University Graz, Graz, Austria|Clinical Department of Neurology, Medical University Innsbruck, Innsbruck, Austria|Department of Neurosurgery, Christian Doppler Klinik, Paracelsus Medizinische Privatuniversität, Salzburg, Austria|Neuroonkologisches Tumorboard KFJ-KA; Rudolfsstiftung, Vienna, Austria|Department of Paediatrics, Medical University Vienna, Vienna, Austria|Medical Department of Oncology, Donauspital, SMZ-Ost, Vienna, Austria","https://ClinicalTrials.gov/show/NCT01213407"
811,"Comparison of Standard Neuronavigation With Intraoperative Magnetic Resonance Imaging (MRI) for the Neurosurgical Treatment of Malignant Brain Tumors","Completed","No Results Available","Glioblastoma Multiforme","Device: Stealth Station|Device: PoleStar N20","Centre Hospitalier Universitaire de Liege, Liege, Belgium|Maastricht University Medical Center, Maastricht, Netherlands","https://ClinicalTrials.gov/show/NCT00943007"
812,"Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma","Withdrawn","No Results Available","Recurrent Glioblastoma|Gliosarcoma|Anaplastic Gliomas","Drug: Axitinib 1 MG|Drug: Sunitinib 5 MG|Drug: Pazopanib 5 MG","The Hong Kong Cancer Institute, Hong Kong, Hong Kong|National University Cancer Institute,, Singapore, Singapore","https://ClinicalTrials.gov/show/NCT03275558"
813,"A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma","Terminated","Has Results","Glioblastoma|Gliosarcoma|Anaplastic Astrocytoma","Drug: PD 0332991 (pre-surgery)|Drug: PD 0332991|Procedure: Resection as clinical care","University of California, San Francisco, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT01227434"
814,"Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma","Terminated","Has Results","Glioblastoma|Glioma|Gliosarcoma","Drug: Bevacizumab|Device: TTFields Therapy","University of California, San Diego, La Jolla, California, United States|University of California Irvine, Chao Family Comprehensive Cancer Center, Orange, California, United States|Miami Cancer Institute at Baptist Health, Miami, Florida, United States|UF Health Cancer Center at Orlando Health, Orlando, Florida, United States|Emory University, Atlanta, Georgia, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|University of Rochester, Rochester, New York, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT02743078"
815,"MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","Has Results","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma","Drug: FMISO|Other: MRI|Other: PET|Other: MRS","University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States|Moffitt Cancer Center, Tampa, Florida, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Mount Sinai Hospital, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States|American College of Radiology Imaging Network, Philadelphia, Pennsylvania, United States|University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States|University of Washington Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00902577"
816,"Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors","Completed","No Results Available","Brain Tumor|Glioblastoma","Drug: Dichloroacetate","University of Florida, Gainesville, Florida, United States","https://ClinicalTrials.gov/show/NCT01111097"
817,"Tryptophan Metabolism in Human Brain Tumors","Recruiting","No Results Available","Glioblastoma",,"Wayne State University, Detroit, Michigan, United States","https://ClinicalTrials.gov/show/NCT02367482"
818,"Trial of C134 in Patients With Recurrent GBM","Recruiting","No Results Available","Glioblastoma Multiforme of Brain|Anaplastic Astrocytoma of Brain|Gliosarcoma of Brain","Biological: C134","University of Alabama at Birmingham, Birmingham, Alabama, United States","https://ClinicalTrials.gov/show/NCT03657576"
819,"Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma","Terminated","No Results Available","Glioblastoma|CNS Disease|Brain Diseases","Drug: Dasatinib|Radiation: RT (Radiotherapy)|Drug: TMZ (Temozolomide)","UT MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00895960"
820,"Glioblastoma Platelet Activation Study","Completed","No Results Available","Glioblastoma|Circulating Platelet-monocyte Conjugates",,"Department of Neurosurgery, Greifswald, Germany","https://ClinicalTrials.gov/show/NCT02887417"
821,"CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan","Unknown status","No Results Available","Brain and Central Nervous System Tumors|Recurrent Glioblastoma Multiforme","Drug: CT-322|Drug: irinotecan hydrochloride","University of California, San Diego, La Jolla, California, United States|University of Kentucky, Lexington, Kentucky, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|SUNY Upstate Medical University, Syracuse, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Rhode Island Hospital, Providence, Rhode Island, United States|MD Anderson Cancer Center, Houston, Texas, United States|University of Virgina, Charlottesville, Virginia, United States|University of Wisconsin Hospital, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00562419"
822,"Engineered NK Cells Containing Deleted TGF-BetaR2 and NR3C1 for the Treatment of Recurrent Glioblastoma","Not yet recruiting","No Results Available","Recurrent Gliosarcoma|Recurrent Supratentorial Glioblastoma|Supratentorial Gliosarcoma","Biological: Cord Blood-derived Expanded Allogeneic Natural Killer Cells|Procedure: Resection","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04991870"
823,"RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas","Active, not recruiting","No Results Available","Glioblastoma|Oligodendroglioma|Anaplastic Oligodendroglioma","Drug: RRx-001 dose escalation with TMZ + RT|Radiation: Radiation|Drug: Fixed dose Temozolomide (75 mg/m2)|Drug: TMZ Maintenance","University of California San Francisco (UCSF), San Francisco, California, United States|The Cancer Institute of New Jersey (Rutgers University), New Brunswick, New Jersey, United States|Weill Cornell Brain Tumor Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT02871843"
824,"Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma","Terminated","No Results Available","IDH Family Wildtype|Recurrent Anaplastic Astrocytoma|Recurrent Glioblastoma","Procedure: Laser Interstitial Thermal Therapy|Drug: Lomustine","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03022578"
825,"Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme","Recruiting","No Results Available","Glioblastoma Multiforme|Glioblastoma|Malignant Glioma|Astrocytoma, Grade IV|GBM","Biological: pp65-shLAMP DC with GM-CSF|Biological: unpulsed PBMC and saline|Drug: Td|Drug: Saline|Biological: pp65-flLAMP DC with GM-CSF","University of Florida, Gainesville, Florida, United States|Orlando Health, Orlando, Florida, United States|Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT02465268"
826,"Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation","Suspended","No Results Available","Newly Diagnosed Glioblastoma in Patients ≥70 Years","Device: TTFields","University Hospital of Heidelberg, Radiation Oncology, Heidelberg, Germany","https://ClinicalTrials.gov/show/NCT04218019"
827,"Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma","Recruiting","No Results Available","Glioblastoma|Glioblastoma Multiforme|Glioma|GBM|Glioma, Malignant|Glioblastoma Multiforme of Brain","Drug: Niraparib|Radiation: Radiation therapy","St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|University of California San Francisco, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT05076513"
828,"Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)","Completed","No Results Available","Brain Cancer","Radiation: IMPT|Radiation: IMRT|Behavioral: Cognitive Tests|Behavioral: Questionnaires","University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01854554"
829,"Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel for Recurrent Glioblastoma","Recruiting","No Results Available","Glioblastoma|Gliosarcoma|GBM|Glioblastoma Multiforme|Glioblastoma, IDH-wildtype|Recurrent Glioblastoma","Device: Sonication for opening of blood-brain barrier|Drug: Chemotherapy, albumin-bound paclitaxel","Northwestern Memorial Hospital, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT04528680"
830,"Evaluating Tumor Pseudoprogression With FLT-PET and MRI","Terminated","No Results Available","Glioblastoma","Other: Radiologic exams","Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01105988"
831,"Study of Pamiparib in Newly Diagnosed and rGBM","Recruiting","No Results Available","Glioblastoma|Glioblastoma Multiforme|Glioblastoma Multiforme, Adult","Drug: Pamiparib|Drug: Olaparib|Radiation: Radiation therapy|Drug: Temozolomide","St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States","https://ClinicalTrials.gov/show/NCT04614909"
832,"Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma","Completed","Has Results","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Drug: dovitinib|Other: laboratory biomarker analysis","Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT01753713"
833,"Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma","Active, not recruiting","Has Results","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Biological: bevacizumab|Radiation: radiation therapy","University of Alabama at Birmingham, Birmingham, Alabama, United States|Arizona Oncology Services Foundation, Phoenix, Arizona, United States|Arizona Oncology-Deer Valley Center, Phoenix, Arizona, United States|John Muir Medical Center, Walnut Creek, California, United States|Yale University, New Haven, Connecticut, United States|University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States|Queen's Medical Center, Honolulu, Hawaii, United States|Radiation Oncology Associates PC, Fort Wayne, Indiana, United States|IU Health Methodist Hospital, Indianapolis, Indiana, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|Norton Health Care Pavilion - Downtown, Louisville, Kentucky, United States|Maine Medical Center- Scarborough Campus, Scarborough, Maine, United States|Lowell General Hospital, Lowell, Massachusetts, United States|University of Michigan University Hospital, Ann Arbor, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Nebraska Methodist Hospital, Omaha, Nebraska, United States|University of Rochester, Rochester, New York, United States|Cone Health Cancer Center, Greensboro, North Carolina, United States|Summa Akron City Hospital, Akron, Ohio, United States|Summa Barberton Hospital, Barberton, Ohio, United States|Lancaster General Hospital, Lancaster, Pennsylvania, United States|Radiation Therapy Oncology Group, Philadelphia, Pennsylvania, United States|Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|University of Texas Medical Branch, Galveston, Texas, United States|North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington, United States|Saint Vincent Hospital, Green Bay, Wisconsin, United States|Saint Mary's Hospital, Green Bay, Wisconsin, United States|Bay Area Medical Center, Marinette, Wisconsin, United States|Door County Cancer Center, Sturgeon Bay, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01730950"
834,"Comparison of ANCA and Anti-GBM Auto-antibodies Removal Kinetics Between Plasma Exchanges and Immunoadsorption in Patients With ANCA-associated Vasculitis or Anti-GBM Disease","Recruiting","No Results Available","Kidney Failure, Acute","Procedure: Apheresis technics","Assisatance Publique Hôpitaux de Marseille, Marseille, France","https://ClinicalTrials.gov/show/NCT03635385"
835,"Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma","Completed","No Results Available","Metastatic Colorectal Cancer|Glioblastoma|Bevacizumab|Capillaroscopy","Other: capillaroscopy|Other: blood pressure measurement","Centre Georges François Leclerc, Dijon, France","https://ClinicalTrials.gov/show/NCT01810744"
836,"Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme","Terminated","Has Results","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Drug: aminolevulinic acid|Procedure: therapeutic conventional surgery","Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT01575275"
837,"NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma","Completed","No Results Available","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Biological: Bevacizumab|Device: NovoTTF-l00A|Other: Quality of Life Assessment","University of Cincinnati, Cincinnati, Ohio, United States|University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT01894061"
838,"Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme","Completed","Has Results","Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Mixed Glioma|Recurrent Glioblastoma","Biological: Carcinoembryonic Antigen-Expressing Measles Virus|Other: Laboratory Biomarker Analysis|Procedure: Therapeutic Conventional Surgery","Mayo Clinic, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT00390299"
839,"GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery","Completed","Has Results","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Drug: vismodegib|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Other: pharmacological study","University of California at Los Angeles, Los Angeles, California, United States|University of California San Francisco, San Francisco, California, United States|Emory University/Winship Cancer Institute, Atlanta, Georgia, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|University Hospitals Case Medical Center, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00980343"
840,"Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma","Recruiting","No Results Available","Glioblastoma|Gliosarcoma|Malignant Glioma","Drug: TMZ|Drug: ipilimumab 3mg/kg|Drug: Nivolumab|Drug: ipilimumab 1mg/kg","National Institutes of Health Clinical Center, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT04817254"
841,"Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma","Terminated","Has Results","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097|Procedure: therapeutic conventional surgery|Other: pharmacological study|Other: laboratory biomarker analysis","Emory University/Winship Cancer Institute, Atlanta, Georgia, United States|Henry Ford Hospital, Detroit, Michigan, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01122901"
842,"Pazopanib in Treating Patients With Recurrent Glioblastoma","Completed","Has Results","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Drug: pazopanib hydrochloride|Other: laboratory biomarker analysis","University of California Los Angeles, Los Angeles, California, United States|University of California San Francisco, San Francisco, California, United States|National Cancer Institute Neuro-Oncology Branch, Bethesda, Maryland, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Duke University, Durham, North Carolina, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|MD Anderson Cancer Center, Houston, Texas, United States|University of Wisconsin, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00459381"
843,"AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme","Completed","No Results Available","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Drug: cediranib maleate","Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00305656"
844,"Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma","Active, not recruiting","No Results Available","Cytomegalovirus Positive|Glioblastoma|Gliosarcoma|Malignant Glioma|Recurrent Brain Neoplasm|Recurrent Glioblastoma","Biological: Autologous Cytomegalovirus-specific Cytotoxic T-lymphocytes|Other: Laboratory Biomarker Analysis|Drug: Temozolomide|Procedure: Therapeutic Conventional Surgery","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02661282"
845,"Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme","Completed","Has Results","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Drug: R-(-)-gossypol acetic acid|Other: laboratory biomarker analysis","University of Alabama at Birmingham, Birmingham, Alabama, United States|Moffitt Cancer Center, Tampa, Florida, United States|Johns Hopkins University, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00540722"
846,"Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Glioblastoma|Gliosarcoma|Malignant Gliomas","Drug: lenalidomide|Radiation: Radiation","Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|University of Virginia, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT00165477"
847,"Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma","Active, not recruiting","Has Results","Malignant Glioma|Glioblastoma|Gliosarcoma","Drug: Bevacizumab|Drug: Temozolomide|Radiation: Radiation Therapy (XRT)|Drug: Topotecan","The Preston Robert Tisch Brain Tumor Center at Duke, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01004874"
848,"Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme","Completed","Has Results","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Drug: vorinostat|Procedure: therapeutic conventional surgery|Drug: bortezomib","Mayo Clinic in Arizona, Scottsdale, Arizona, United States|The Medical Center of Aurora, Aurora, Colorado, United States|Boulder Community Hospital, Boulder, Colorado, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, United States|Porter Adventist Hospital, Denver, Colorado, United States|Exempla Saint Joseph Hospital, Denver, Colorado, United States|Presbyterian - Saint Lukes Medical Center - Health One, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|Colorado Cancer Research Program CCOP, Denver, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|Saint Mary's Hospital and Regional Medical Center, Grand Junction, Colorado, United States|North Colorado Medical Center, Greeley, Colorado, United States|Saint Anthony Hospital, Lakewood, Colorado, United States|Sky Ridge Medical Center, Lone Tree, Colorado, United States|Longmont United Hospital, Longmont, Colorado, United States|McKee Medical Center, Loveland, Colorado, United States|Saint Mary Corwin Medical Center, Pueblo, Colorado, United States|North Suburban Medical Center, Thornton, Colorado, United States|Exempla Lutheran Medical Center, Wheat Ridge, Colorado, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Rush - Copley Medical Center, Aurora, Illinois, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, United States|Saint Joseph Medical Center, Bloomington, Illinois, United States|Graham Hospital Association, Canton, Illinois, United States|Illinois CancerCare-Canton, Canton, Illinois, United States|Illinois CancerCare-Carthage, Carthage, Illinois, United States|Memorial Hospital, Carthage, Illinois, United States|Eureka Hospital, Eureka, Illinois, United States|Illinois CancerCare-Eureka, Eureka, Illinois, United States|Galesburg Cottage Hospital, Galesburg, Illinois, United States|Illinois CancerCare Galesburg, Galesburg, Illinois, United States|Illinois CancerCare-Cottage, Galesburg, Illinois, United States|Illinois CancerCare-Havana, Havana, Illinois, United States|Mason District Hospital, Havana, Illinois, United States|Hopedale Medical Complex - Hospital, Hopedale, Illinois, United States|Joliet Oncology-Hematology Associates Limited, Joliet, Illinois, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States|Illinois CancerCare-Macomb, Macomb, Illinois, United States|Mcdonough District Hospital, Macomb, Illinois, United States|Garneau, Stewart C MD (UIA Investigator), Moline, Illinois, United States|Porubcin, Michael MD (UIA Investigator), Moline, Illinois, United States|Sharis, Christine M MD (UIA Investigator), Moline, Illinois, United States|Stoffel, Thomas J MD (UIA Investigator), Moline, Illinois, United States|Holy Family Medical Center, Monmouth, Illinois, United States|Illinois CancerCare-Monmouth, Monmouth, Illinois, United States|Bromenn Regional Medical Center, Normal, Illinois, United States|Community Cancer Center Foundation, Normal, Illinois, United States|Illinois CancerCare-Community Cancer Center, Normal, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Ottawa Regional Hospital and Healthcare Center, Ottawa, Illinois, United States|Pekin Cancer Treatment Center, Pekin, Illinois, United States|Pekin Hospital, Pekin, Illinois, United States|Illinois CancerCare-Pekin, Pekin, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|Proctor Hospital, Peoria, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|Illinois Oncology Research Association CCOP, Peoria, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Illinois CancerCare-Peru, Peru, Illinois, United States|Illinois Valley Hospital, Peru, Illinois, United States|Illinois CancerCare-Princeton, Princeton, Illinois, United States|Perry Memorial Hospital, Princeton, Illinois, United States|Illinois CancerCare-Spring Valley, Spring Valley, Illinois, United States|Saint Margaret's Hospital, Spring Valley, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|Carle Clinic-Urbana Main, Urbana, Illinois, United States|Saint Francis Hospital and Health Centers, Beech Grove, Indiana, United States|Elkhart General Hospital, Elkhart, Indiana, United States|Community Howard Regional Health, Kokomo, Indiana, United States|IU Health La Porte Hospital, La Porte, Indiana, United States|Franciscan Saint Anthony Health-Michigan City, Michigan City, Indiana, United States|Saint Joseph Regional Medical Center-Mishawaka, Mishawaka, Indiana, United States|Reid Hospital and Health Care Services, Richmond, Indiana, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|South Bend Clinic, South Bend, Indiana, United States|Northern Indiana Cancer Research Consortium, South Bend, Indiana, United States|Constantinou, Costas L MD (UIA Investigator), Bettendorf, Iowa, United States|Cedar Rapids Oncology Association, Cedar Rapids, Iowa, United States|Mercy Hospital, Cedar Rapids, Iowa, United States|Oncology Associates at Mercy Medical Center, Cedar Rapids, Iowa, United States|Medical Oncology and Hematology Associates-West Des Moines, Clive, Iowa, United States|Mercy Capitol, Des Moines, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|Iowa Oncology Research Association CCOP, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Laurel, Des Moines, Iowa, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|Iowa Lutheran Hospital, Des Moines, Iowa, United States|Siouxland Hematology Oncology Associates, Sioux City, Iowa, United States|Mercy Medical Center-Sioux City, Sioux City, Iowa, United States|Saint Luke's Regional Medical Center, Sioux City, Iowa, United States|Hospital District Sixth of Harper County, Anthony, Kansas, United States|Bixby Medical Center, Adrian, Michigan, United States|Hickman Cancer Center, Adrian, Michigan, United States|Bronson Battle Creek, Battle Creek, Michigan, United States|Spectrum Health Big Rapids Hospital, Big Rapids, Michigan, United States|Grand Rapids Clinical Oncology Program, Grand Rapids, Michigan, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, United States|Community Cancer Center of Monroe, Monroe, Michigan, United States|Mercy Memorial Hospital, Monroe, Michigan, United States|Mercy Health Partners-Hackley Campus, Muskegon, Michigan, United States|Mercy Health Mercy Campus, Muskegon, Michigan, United States|Lakeland Hospital, St. Joseph, Michigan, United States|Munson Medical Center, Traverse City, Michigan, United States|Metro Health Hospital, Wyoming, Michigan, United States|Sanford Clinic North-Bemidgi, Bemidji, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Essentia Health Duluth Clinic CCOP, Duluth, Minnesota, United States|Essentia Health Saint Mary's Medical Center, Duluth, Minnesota, United States|Miller-Dwan Hospital, Duluth, Minnesota, United States|Fairview-Southdale Hospital, Edina, Minnesota, United States|Lake Region Healthcare Corporation-Cancer Care, Fergus Falls, Minnesota, United States|Unity Hospital, Fridley, Minnesota, United States|Hutchinson Area Health Care, Hutchinson, Minnesota, United States|Meeker County Memorial Hospital, Litchfield, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Virginia Piper Cancer Institute, Minneapolis, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Metro-Minnesota CCOP, Saint Louis Park, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Minnesota Oncology and Hematology PA-Woodbury, Woodbury, Minnesota, United States|Montana Cancer Consortium CCOP, Billings, Montana, United States|Northern Rockies Radiation Oncology Center, Billings, Montana, United States|Saint Vincent Healthcare, Billings, Montana, United States|Hematology-Oncology Centers of the Northern Rockies PC, Billings, Montana, United States|Billings Clinic, Billings, Montana, United States|Bozeman Deaconess Cancer Center, Bozeman, Montana, United States|Bozeman Deaconess Hospital, Bozeman, Montana, United States|Saint James Community Hospital and Cancer Treatment Center, Butte, Montana, United States|Berdeaux, Donald MD (UIA Investigator), Great Falls, Montana, United States|Great Falls Clinic, Great Falls, Montana, United States|Northern Montana Hospital, Havre, Montana, United States|Saint Peter's Community Hospital, Helena, Montana, United States|Glacier Oncology PLLC, Kalispell, Montana, United States|Kalispell Medical Oncology, Kalispell, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Community Medical Hospital, Missoula, Montana, United States|Montana Cancer Specialists, Missoula, Montana, United States|Saint Patrick Hospital - Community Hospital, Missoula, Montana, United States|Guardian Oncology and Center for Wellness, Missoula, Montana, United States|Rutherford Hospital, Rutherfordton, North Carolina, United States|Bismarck Cancer Center, Bismarck, North Dakota, United States|Mid Dakota Clinic, Bismarck, North Dakota, United States|Saint Alexius Medical Center, Bismarck, North Dakota, United States|Sanford Bismarck Medical Center, Bismarck, North Dakota, United States|Sanford Clinic North-Fargo, Fargo, North Dakota, United States|Sanford Medical Center-Fargo, Fargo, North Dakota, United States|Altru Cancer Center, Grand Forks, North Dakota, United States|Mary Rutan Hospital, Bellefontaine, Ohio, United States|Toledo Clinic Cancer Centers-Bowling Green, Bowling Green, Ohio, United States|North Coast Cancer Care-Clyde, Clyde, Ohio, United States|Riverside Methodist Hospital, Columbus, Ohio, United States|Grant Medical Center, Columbus, Ohio, United States|Mount Carmel Health Center West, Columbus, Ohio, United States|Doctors Hospital, Columbus, Ohio, United States|Grandview Hospital, Dayton, Ohio, United States|Good Samaritan Hospital - Dayton, Dayton, Ohio, United States|Miami Valley Hospital, Dayton, Ohio, United States|Samaritan North Health Center, Dayton, Ohio, United States|Dayton CCOP, Dayton, Ohio, United States|Grady Memorial Hospital, Delaware, Ohio, United States|Hematology Oncology Center Incorporated, Elyria, Ohio, United States|Blanchard Valley Hospital, Findlay, Ohio, United States|Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States|Wayne Hospital, Greenville, Ohio, United States|Kettering Medical Center, Kettering, Ohio, United States|Fairfield Medical Center, Lancaster, Ohio, United States|Lima Memorial Hospital, Lima, Ohio, United States|Marietta Memorial Hospital, Marietta, Ohio, United States|Saint Luke's Hospital, Maumee, Ohio, United States|Toledo Clinic Cancer Centers-Maumee, Maumee, Ohio, United States|Toledo Radiation Oncology at Northwest Ohio Onocolgy Center, Maumee, Ohio, United States|Licking Memorial Hospital, Newark, Ohio, United States|Saint Charles Hospital, Oregon, Ohio, United States|Toledo Clinic Cancer Centers-Oregon, Oregon, Ohio, United States|North Coast Cancer Care, Sandusky, Ohio, United States|Flower Hospital, Sylvania, Ohio, United States|Mercy Hospital of Tiffin, Tiffin, Ohio, United States|The Toledo Hospital/Toledo Children's Hospital, Toledo, Ohio, United States|Saint Vincent Mercy Medical Center, Toledo, Ohio, United States|University of Toledo, Toledo, Ohio, United States|Toledo Community Hospital Oncology Program CCOP, Toledo, Ohio, United States|Mercy Saint Anne Hospital, Toledo, Ohio, United States|Toledo Clinic Cancer Centers-Toledo, Toledo, Ohio, United States|Upper Valley Medical Center, Troy, Ohio, United States|Fulton County Health Center, Wauseon, Ohio, United States|Saint Ann's Hospital, Westerville, Ohio, United States|Clinton Memorial Hospital, Wilmington, Ohio, United States|Greene Memorial Hospital, Xenia, Ohio, United States|Genesis HealthCare System, Zanesville, Ohio, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Geisinger Medical Center-Cancer Center Hazleton, Hazleton, Pennsylvania, United States|Geisinger Medical Group, State College, Pennsylvania, United States|Geisinger Wyoming Valley, Wilkes-Barre, Pennsylvania, United States|AnMed Health Hospital, Anderson, South Carolina, United States|Spartanburg Regional Medical Center, Spartanburg, South Carolina, United States|Upstate Carolina CCOP, Spartanburg, South Carolina, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Fredericksburg Oncology Inc, Fredericksburg, Virginia, United States|Midelfort Clinic-Clairemont Campus, Eau Claire, Wisconsin, United States|Mayo Clinic Health System Eau Claire Hospital - Luther Campus, Eau Claire, Wisconsin, United States|Agnesian Cancer Center, Fond Du Lac, Wisconsin, United States|Rocky Mountain Oncology, Casper, Wyoming, United States|Welch Cancer Center, Sheridan, Wyoming, United States","https://ClinicalTrials.gov/show/NCT00641706"
849,"Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma","Completed","No Results Available","Glioblastoma|Small Cell Glioblastoma|Giant Cell Glioblastoma|Gliosarcoma|Glioblastoma With Oligodendroglial Component","Drug: Rindopepimut (CDX-110) with GM-CSF|Drug: Temozolomide|Drug: KLH","University of Alabama at Birmingham, Birmingham, Alabama, United States|University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, United States|Barrow Neurological Institute at St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|University of Arizona Health Network, Tucson, Arizona, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|City of Hope Cancer Center, Duarte, California, United States|UC San Diego Moores Cancer Center, La Jolla, California, United States|USC Norris Comprehensive Cancer Center, Los Angeles, California, United States|Chao Family Comprehensive Cancer Center, Orange, California, United States|Kaiser Permanente, Redwood City Medical Center, Redwood City, California, United States|University of California, Davis, Sacramento, California, United States|University of California, San Francisco, San Francisco, California, United States|Stanford Cancer Institute, Stanford University, Stanford, California, United States|Hartford Hospital, Hartford, Connecticut, United States|Yale University Medical Center, New Haven, Connecticut, United States|Christiana Care Health Services, Newark, Delaware, United States|University of Florida, Gainesville, Florida, United States|Mount Sinai Medical Center, Comprehensive Cancer Center, Miami Beach, Florida, United States|MD Anderson Cancer Center Orlando, Orlando, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|Atlanta Cancer Care, Atlanta, Georgia, United States|Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, United States|Georgia Regents University, Augusta, Georgia, United States|Kaiser Permanente Hawaii Moanalua Medical Center, Honolulu, Hawaii, United States|Northwestern University Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|North Shore University Health System, Evanston, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Covenant Clinic / Iowa Spine and Brain Institute, Waterloo, Iowa, United States|University of Kentucky, Lexington, Kentucky, United States|Norton Cancer Institute, Louisville, Kentucky, United States|Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States|LSU Health Sciences Center, Feist-Weiller Cancer Center, Shreveport, Louisiana, United States|Anne Arundel Medical Center, Annapolis, Maryland, United States|Johns Hopkins University School of Medicine, Baltimore, Maryland, United States|Center for Cancer and Blood Disorders, PC, Bethesda, Maryland, United States|Dana-Farber Cancer Institute and Mass General Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States|University of Michigan Health System, Ann Arbor, Michigan, United States|Edward W. Sparrow Hospital Association - Sparrow Regional Cancer Center, Lansing, Michigan, United States|St. Mary's of Michigan Medical Center/Field Neurosciences Institute, Saginaw, Michigan, United States|Allina Health, Abbott Northwestern Hospital, John Nasseff Neuroscience Institute, Minneapolis, Minnesota, United States|Ellis Fischel Cancer Center, Columbia, Missouri, United States|Washington University in St. Louis, Saint Louis, Missouri, United States|Southeast Nebraska Cancer Center, Lincoln, Nebraska, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|New Jersey Neuroscience Institute, JFK Medical Center, Edison, New Jersey, United States|John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States|Monmouth Medical Center, Long Branch, New Jersey, United States|Dent Neurosciences Research Institute, Amherst, New York, United States|Montefiore Medical Center, Bronx, New York, United States|New York Methodist Hospital, Brooklyn, New York, United States|The Long Island Brain Tumor Center at Neurology Surgery, P.C., Great Neck, New York, United States|North Shore University Hospital, Manhasset, New York, United States|Columbia University Medical Center - The Neurologic Institute of New York, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|SUNY Upstate Medical University, Syracuse, New York, United States|Brain and Spine Surgeons of New York, White Plains, New York, United States|The Preston Robert Tisch Brain Tumor Center at Duke University Medical Center, Durham, North Carolina, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States|University of Cincinnati Cancer Institute, Cincinnati, Ohio, United States|University Hospitals, Case Medical Center (Cleveland), Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University, Columbus, Ohio, United States|Providence Portland Medical Center, Oncology & Hematology Care, Portland, Oregon, United States|Pacific Neurosurgical, Portland, Oregon, United States|Lehigh Valley Physician Group-Hematology-Oncology Associates, Allentown, Pennsylvania, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|West Penn. Allegheny Health System, Pittsburgh, Pennsylvania, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina - Department of Neuroscience, Charleston, South Carolina, United States|University of Tennessee Medical Center - Knoxville, Knoxville, Tennessee, United States|Sarah Cannon Research Institute, Nashville, Tennessee, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States|Texas Oncology Midtwon, Austin, Texas, United States|Baylor Research Institute, Dallas, Texas, United States|The Methodist Neurological Institute, Houston, Texas, United States|University of Utah Department of Neurosurgery, Salt Lake City, Utah, United States|Fletcher Allen Health Care, Burlington, Vermont, United States|University of Virginia Healthcare System, Charlottesville, Virginia, United States|Swedish Neuroscience Institute, Seattle, Washington, United States|University of Washington Medical Center, Seattle, Washington, United States|University of Wisconsin Paul P Carbone Comprehensive Cancer Center, Madison, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Prince of Wales Hospital, Randwick, New South Wales, Australia|Royal North Shore Hospital, St Leonards, New South Wales, Australia|The Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia|Royal Brisbane and Women's Hospital, Herston, Queensland, Australia|Mater Adult Hospital, Mater Misericordiae Health Services Brisbane Limited, South Brisbane, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Calvary North Adelaide Hospital, North Adelaide, South Australia, Australia|Royal Hobart Hospital, Hobart, Tasmania, Australia|Launceston General Hospital, Launceston, Tasmania, Australia|Monash Medical Centre, Clayton, Victoria, Australia|Austin Health, Heidelberg, Victoria, Australia|Epworth Healthcare, Richmond, Victoria, Australia|Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia|Liverpool Hospital, Liverpool, Australia|Medical University Innsbruck, Dept of Neurology, Anichstrabe 35, Innsbruck, Austria|Medizinische Universität Wien, Innere Medizin I, Onkologie, Vienna, Austria|Universitair Ziekenhuis Antwerpen, Edegem, Antwerp, Belgium|ZNA Middelheim, Antwerpen, Belgium|Ghent University Hospital, Ghent, Belgium|Hospital Mae de Deus-Centro de Pesquisa em Oncologia Clinica, Porto Alegre, Rio Grande Do Sul, Brazil|Centro de Pesquisas Clinicas da Fundação Dr Amaral Carvalho, Jaú, São Paulo, Brazil|Fundação Faculdade Regional de Medicina de de São José do Rio Preto - Hospital de Base, São José do Rio Preto, São Paulo, Brazil|Instituto Nacional do Cancer (INCA), Rio de Janeiro, Brazil|Hospital Albert Einstein, Sao Paulo, Brazil|Instituto do Câncer do Estado de São Paulo - ICESP, São Paulo, Brazil|Real e Benemerita Associação Portuguesa de Beneficiência/ Hospital São José, São Paulo, Brazil|Hospital A C Camargo, São Paulo, Brazil|Foothills Hospital Medical Centre, Calgary, Alberta, Canada|British Columbia Cancer Agency, Vancouver Clinic, Vancouver, British Columbia, Canada|BC Cancer Agency - Vancouver Island Centre, Victoria, British Columbia, Canada|University of Manitoba-Cancer Care Manitoba, Winnipeg, Manitoba, Canada|QEII Health Sciences Centre, Halifax, Nova Scotia, Canada|Juravinski Cancer Centre, Hamilton, Ontario, Canada|London Regional Cancer Program, London Health Sciences Centre, London, Ontario, Canada|Ottawa Hospital, Regional Cancer Centre, Ottawa, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Centre Hospitalier de l'Universite de Montreal (CHUM) - Hopital Notre-Dame, Montreal, Quebec, Canada|Montreal Neurological Institute and Hospital, Montreal, Quebec, Canada|CHUS Hôpital Fleurimont, Shenbrooke, Quebec, Canada|CHUQ L'Hotel Dieu de Qujebec, Quebec, Canada|Fundacion Santa Fe, Bogota, Bogota D.C, Colombia|Hospital Ceske Budejovice, Ceske Budejovice, Czechia|Umiversity Hospital (Fakultni Nemocnice), Prague, Czechia|Hospital Na Homolce, Prague, Czechia|Multiscan s.r.o., Praha 5, Czechia|Masaryk´s Hospital Usti nad Labem, Usti nad Labem, Czechia|Institut de Cancerologie de I'Quest-Paul Papin, Angers, France|Institute Bergonie, Bordeaux, France|Centre Leon Berard de Lyon, Lyon, France|ICM Val d'Aurel Montpellier, Montpellier, France|Institut de Cancerologie de L'Quest-Center Rane Gauducheau, Nantes, France|Service de Neurologie-GH, Paris, France|Centre Eugene Marquis, Rennes, France|Institut de Cancerologie de l'ouest-Center Rene Gauducheau, St Herblain, France|Institut Gustave Roussy, Villejuif, France|Klinik und Poliklinik fur Neurologie der Universitat Regensburg, Regensburg, Bavaria, Germany|Strahlenklinik Universitatsklinikum Erlangen, Erlangen, Germany|Dr. Senchkenbergisches Institut fur Neuroonkologie, Frankfurt, Germany|University Hospital Hamburg Kopf und Neurozentrum, Hamburg, Germany|Universitaetsklinikum Heidelberg, Neurologische Klinik, IM Neuenheimer Feld 672, Heidelberg, Germany|University Medical Centre, Kiel, Germany|Universitaetsklinikum Muenster, Muenster, Germany|LMU Munich, Munich, Germany|NNA, Athens, Attiki, Greece|""HYGEIA"" Hospital, Marousi, District Of Attica, Greece|Országos Onkológiai Intézet Sugárterápiás Osztály, Budapest, Hungary|Debreceni Egyetem Orvos- és Egészségtudományi Centrum Onkológiai Intézet, Debrecen, Hungary|Borsod-Abaúj-Zemplén Megyei Kórház és Egyetemi Oktató Kórház, Sugárterápiás Osztály, Miskolc, Hungary|Pécsi Tudományegyetem Általános Orvostudományi Kar, Pécs, Hungary|Szegedi Tudományegyetem Onkoterápiás Klinika, Szeged, Hungary|Vas Megyei Markusovszky Lajos Általános Rehabilitációs és Gyógyfürdő Kórház, Egyetemi Oktatókórház Nonprofit Zrt, Szombathely, Hungary|City Cancer Centre, Vijayawada, Vijayawada, Andhra Pradesh, India|HCG - Bangalore Institute of Oncology, Bangalore, Bengaluru, Karnataka, India|Amrita Institute of Medical Sciences and Research Centre, Kochi, Kochi, Kerala, India|Sree Chitra Tirunal Institute for Medical Sciences & Technology, Thiruvananthapuram, Thiruvananthapuram, Kerala, India|Marathwada Regional Cancer Centre and Research Institute - Government, Aurangabad, Maharashtra, India|Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Andheri-West, Mumbai, India|Tata Memorial Hospital , Mumbai, Parel, Mumbai, India|Indraprastha Apollo Hospital, New Delhi, Jasola Viha, New Delhi, India|Sahyadri Hospitals Limited, Erandauame, Pune, India|Dr. Rai Memorial Medical Centre, Chennai, Chennai, Tamil Nadu, India|HCG Shanti Mukand Hospital - Curie Cancer Centre, Delhi, Delhi, India|Soroka University M.C., Beer-Sheva, Israel|Rambam Health Care Campus, Haifa, Israel|Hadassah Medical Center, Jerusalem, Israel|SHEBA Medical Center, Tel Hashomer, Israel|Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel|UO Oncologie Medica Dipartimento Oncologico, Bologna, Italy|Fondazione IRCCS Instituto Neurologico Carlo Besta, Milano, Italy|Sacred Heart Catholic University, Rome, Italy|Universita e AO Citta delia Scienza, Universita Di Torino, Torino, Italy|Grupo Médico Camino S.C., Mexico, D.F, Mexico|Hospital Civil de Guadalajara ""Fray Antonio Alcalde"", Guadalajara, Jalisco, Mexico|Ensayos Clínicos y Medicina de Alta Especialidad, S.C., Culiacán, Sinaloa, Mexico|Servicios Medicos de Investigacion Clinica Sc, Durango, Mexico|Hospital Central ""Ignacio Morones Prieto"", San Luis Potosí, Mexico|Medisch Centrum Haaglanden, The Hague, Zuid Holland, Netherlands|VUMC, Amsterdam, Netherlands|Radboud University Nijmegen Medical Center, Nijmegen, Netherlands|Christchurch Hospital, Christchurch Central, Christchurch, New Zealand|Palmerston North Hospital, Roslyn, Palmerston North, New Zealand|Waikato Hospital, Regional Cancer Centre, Hamilton, Waikato District, New Zealand|Waikato Hospital, Regional Cancer Center, Hamilton, Waikato Distric, New Zealand|Hospital Almanzor Aguinaga Asenjo, Chiclayo, Peru|Instituto Oncologico Miraflores, Lima, Peru|Clinica Anglo Americana, Lima, Peru|Clinica Ricardo Palma, Lima, Peru|Oncosalud, Lima, Peru|Institut Catala d Oncologia, LaHospitalet De Lubregat, Catalonia, Spain|Dra. Sonia Del Barco Berron, ICO Girona Avda,, Franca, Girona, Spain|Hospital Clinic, Barcelona, Spain|ICO Badalona-Hospital Germans Trias i Pujol, Barcelonia, Spain|Hospital 12 de Octubre, Madrid, Spain|Kantonsspital Aarau Medizinische Onkologie Tellstrasse, Aarau, AG, Switzerland|CHUV, Centre Hospitalier Universitaire Vaudois, Lausanne, VD, Switzerland|Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland|Inselspital, Universitatsspital Bern, Universitatsklinik fur Medizinische Onkologie, Freiburgstrasse, Bern, Switzerland|Hopitaux Universitaires de Geneve-HUG-Centre d'Oncologie, Geneva, Switzerland|Brain Tumor Center, University Hospital Zurich, Zurich, Switzerland|National Cheng Kung University Hospital, Tainan City, Bei District, Taiwan|Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan|Chang Gung Memorial Hospital Linkou Branch, Taichung, Taiwan|Taichung Veterans General Hospital, Taichung, Taiwan|Chi Mei Medical Center, Tainan City - Yongkang District, Taiwan|Tri-Service General Hospital, Taipei city - Neihu District, Taiwan|Siriraj Hospital, Bangkoknoi, Bangkok, Thailand|King Chulalongkorn Memorial Hospital, Patumwan, Bankok, Thailand|Maharaj Nakorn Chiang Mai Hospital, Amphoe Muang, Chiang Mai, Thailand|Songkhlanagarind Hospital, Hat Yai, Songkla, Thailand|Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom|The Bristol Haematology and Oncology Centre, Bristol, United Kingdom|Edinburgh Cancer Centre Western General Hospital, Edinburgh, United Kingdom|Beatson West of Scotland Cancer Centrel, Glasgow, United Kingdom|Guy's and St Thomas' NHS, Westminister Bridge Road, London, United Kingdom|Nottingham City Hospital, Nottingham, United Kingdom","https://ClinicalTrials.gov/show/NCT01480479"
850,"Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme","Completed","Has Results","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Drug: vorinostat|Procedure: conventional surgery","North Central Cancer Treatment Group, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT00238303"
851,"Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme","Completed","Has Results","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Drug: erlotinib hydrochloride|Drug: sorafenib tosylate|Other: pharmacological study","University of Alabama at Birmingham, Birmingham, Alabama, United States|Moffitt Cancer Center, Tampa, Florida, United States|Emory University, Atlanta, Georgia, United States|Johns Hopkins University, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Cleveland Clinic, Cleveland, Ohio, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00445588"
852,"Quality of Life of Patients With Glioblastoma (GBM) Treated With Tumor-Treating Fields","Completed","No Results Available","Malignant Glioma","Device: NovoTTF","The Preston Robert Tisch Brain Tumor Center at Duke, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT03501134"
853,"Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors","Completed","No Results Available","Glioblastoma","Biological: Dendritic Cell Immunotherapy","Cedars Sinai Medical center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT00576537"
854,"CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme","Completed","No Results Available","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Drug: temsirolimus|Other: laboratory biomarker analysis|Other: pharmacological study","North Central Cancer Treatment Group, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT00016328"
855,"A Prospective, Open-label, Single-arm Clinical Study","Recruiting","No Results Available","Recurrent Glioblastoma Multiforme","Combination Product: TTFields","Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China","https://ClinicalTrials.gov/show/NCT04689087"
856,"A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma","Terminated","Has Results","Glioblastoma Multiforme|Glioma|Astrocytoma|Brain Tumor","Drug: ITV DepoCyt + Temozolomide","Medical University of South Carolina, Charleston, South Carolina, United States","https://ClinicalTrials.gov/show/NCT01044966"
857,"Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies","Completed","No Results Available","Brain and Central Nervous System Tumors","Genetic: gene expression analysis|Genetic: microarray analysis|Genetic: protein expression analysis|Other: diagnostic laboratory biomarker analysis|Other: immunohistochemistry staining method","Mayo Clinic Scottsdale, Scottsdale, Arizona, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|Siouxland Hematology-Oncology Associates, LLP, Sioux City, Iowa, United States|Mercy Medical Center - Sioux City, Sioux City, Iowa, United States|St. Luke's Regional Medical Center, Sioux City, Iowa, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|Medcenter One Hospital Cancer Care Center, Bismarck, North Dakota, United States|Mid Dakota Clinic, PC, Bismarck, North Dakota, United States|St. Alexius Medical Center Cancer Center, Bismarck, North Dakota, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States","https://ClinicalTrials.gov/show/NCT00897663"
858,"Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme","Terminated","Has Results","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Drug: cilengitide|Procedure: therapeutic conventional surgery|Other: pharmacological study|Other: laboratory biomarker analysis","North American Brain Tumor Consortium, Watertown, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00112866"
859,"Interest of Fluorescein in Fluorescence-guided Resection of Gliomas (FLEGME)","Recruiting","No Results Available","Glioblastoma, Adult","Drug: Fluorescéine Sodique Faure|Procedure: White-light surgery","CHU Rennes, Rennes, France","https://ClinicalTrials.gov/show/NCT03291977"
860,"18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients With EGFR Activated Recurrent Glioblastoma","Active, not recruiting","No Results Available","EGFR Gene Amplification|EGFR Gene Mutation|Glioblastoma|Recurrent Glioblastoma|Supratentorial Glioblastoma|TP53 wt Allele","Other: Fludeoxyglucose F-18|Drug: Osimertinib|Procedure: Positron Emission Tomography","UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT03732352"
861,"A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas","Completed","No Results Available","Glioblastoma|Astrocytoma","Drug: Bevacizumab/Irinotecan","Seoul National University Hospital, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT00921167"
862,"Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma","Completed","Has Results","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Drug: sorafenib tosylate|Drug: erlotinib hydrochloride|Drug: tipifarnib|Drug: temsirolimus","University of California at Los Angeles, Los Angeles, California, United States|University of California San Francisco, San Francisco, California, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|M D Anderson Cancer Center, Houston, Texas, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00335764"
863,"EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma","Withdrawn","No Results Available","Adult Brain Glioblastoma|Adult Gliosarcoma|Recurrent Brain Neoplasm","Biological: EGFRBi-Armed Autologous T Cells|Other: Laboratory Biomarker Analysis",,"https://ClinicalTrials.gov/show/NCT02521090"
864,"Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma","Withdrawn","No Results Available","Anaplastic Astrocytoma|Glioblastoma|Oligodendroglioma|Supratentorial Glioblastoma","Drug: Extended Release Flucytosine|Device: NovoTTF-100A Device|Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Radiation: Radiation Therapy|Drug: Temozolomide|Procedure: Therapeutic Conventional Surgery|Biological: Vocimagene Amiretrorepvec",,"https://ClinicalTrials.gov/show/NCT04105374"
865,"Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme","Terminated","No Results Available","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Drug: fenretinide|Procedure: therapeutic conventional surgery|Other: pharmacological study|Other: laboratory biomarker analysis","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00075491"
866,"Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma","Terminated","No Results Available","Glioblastoma (GBM)|DIPG|Brainstem Glioma, Pediatric|Diffuse Spinal Glioma|Bilateral Thalamic Glioma|Gliomatosis Cerebri|Anaplastic Astrocytoma|Midline Diffuse Glioma","Drug: Doxorubicin","Meyer Children's Hospital, Florence, Italy","https://ClinicalTrials.gov/show/NCT02758366"
867,"Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","Has Results","Brain and Central Nervous System Tumors","Drug: dasatinib|Drug: temozolomide|Other: placebo|Radiation: radiation therapy","Helen and Harry Gray Cancer Center at Hartford Hospital, Hartford, Connecticut, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|John B. Amos Cancer Center, Columbus, Georgia, United States|Illinois CancerCare - Bloomington, Bloomington, Illinois, United States|St. Joseph Medical Center, Bloomington, Illinois, United States|Illinois CancerCare - Canton, Canton, Illinois, United States|Illinois CancerCare - Carthage, Carthage, Illinois, United States|Resurrection Medical Center, Chicago, Illinois, United States|Eureka Community Hospital, Eureka, Illinois, United States|Illinois CancerCare - Eureka, Eureka, Illinois, United States|Galesburg Clinic, PC, Galesburg, Illinois, United States|Illinois CancerCare - Havana, Havana, Illinois, United States|Illinois CancerCare - Kewanee Clinic, Kewanee, Illinois, United States|Illinois CancerCare - Macomb, Macomb, Illinois, United States|Illinois CancerCare - Monmouth, Monmouth, Illinois, United States|OSF Holy Family Medical Center, Monmouth, Illinois, United States|BroMenn Regional Medical Center, Normal, Illinois, United States|Community Cancer Center, Normal, Illinois, United States|Illinois CancerCare - Community Cancer Center, Normal, Illinois, United States|Community Hospital of Ottawa, Ottawa, Illinois, United States|Oncology Hematology Associates of Central Illinois, PC - Ottawa, Ottawa, Illinois, United States|Cancer Treatment Center at Pekin Hospital, Pekin, Illinois, United States|Illinois CancerCare - Pekin, Pekin, Illinois, United States|Proctor Hospital, Peoria, Illinois, United States|OSF St. Francis Medical Center, Peoria, Illinois, United States|CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States|Oncology Hematology Associates of Central Illinois, PC - Peoria, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|Illinois CancerCare - Peru, Peru, Illinois, United States|Illinois Valley Community Hospital, Peru, Illinois, United States|Illinois CancerCare - Princeton, Princeton, Illinois, United States|Illinois CancerCare - Spring Valley, Spring Valley, Illinois, United States|Valley Cancer Center, Spring Valley, Illinois, United States|CCOP - Carle Cancer Center, Urbana, Illinois, United States|Elkhart Clinic, LLC, Elkhart, Indiana, United States|Michiana Hematology-Oncology, PC - Elkhart, Elkhart, Indiana, United States|Elkhart General Hospital, Elkhart, Indiana, United States|St. Francis Hospital Cancer Care Services, Indianapolis, Indiana, United States|Howard Community Hospital, Kokomo, Indiana, United States|Center for Cancer Therapy at LaPorte Hospital and Health Services, La Porte, Indiana, United States|Michiana Hematology-Oncology, PC - South Bend, Mishawaka, Indiana, United States|Saint Joseph Regional Medical Center, Mishawaka, Indiana, United States|Michiana Hematology Oncology PC - Plymouth, Plymouth, Indiana, United States|Reid Hospital & Health Care Services, Richmond, Indiana, United States|CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|Michiana Hematology Oncology PC - La Porte, Westville, Indiana, United States|Cedar Rapids Oncology Associates, Cedar Rapids, Iowa, United States|Mercy Regional Cancer Center at Mercy Medical Center, Cedar Rapids, Iowa, United States|Medical Oncology and Hematology Associates - West Des Moines, Clive, Iowa, United States|Mercy Cancer Center - West Lakes, Clive, Iowa, United States|CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States|John Stoddard Cancer Center at Iowa Methodist Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates at John Stoddard Cancer Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates at Mercy Cancer Center, Des Moines, Iowa, United States|Mercy Cancer Center at Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|John Stoddard Cancer Center at Iowa Lutheran Hospital, Des Moines, Iowa, United States|Siouxland Hematology-Oncology Associates, LLP, Sioux City, Iowa, United States|Mercy Medical Center - Sioux City, Sioux City, Iowa, United States|St. Luke's Regional Medical Center, Sioux City, Iowa, United States|Methodist West Hospital, West Des Moines, Iowa, United States|Cancer Center of Kansas, PA - Chanute, Chanute, Kansas, United States|Cancer Center of Kansas, PA - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas, PA - El Dorado, El Dorado, Kansas, United States|Cancer Center of Kansas - Fort Scott, Fort Scott, Kansas, United States|Cancer Center of Kansas-Independence, Independence, Kansas, United States|Cancer Center of Kansas, PA - Kingman, Kingman, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|Cancer Center of Kansas, PA - Liberal, Liberal, Kansas, United States|Cancer Center of Kansas, PA - Newton, Newton, Kansas, United States|Cancer Center of Kansas, PA - Parsons, Parsons, Kansas, United States|Cancer Center of Kansas, PA - Pratt, Pratt, Kansas, United States|Cancer Center of Kansas, PA - Salina, Salina, Kansas, United States|Cancer Center of Kansas, PA - Wellington, Wellington, Kansas, United States|Associates in Womens Health, PA - North Review, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Medical Arts Tower, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Wichita, Wichita, Kansas, United States|CCOP - Wichita, Wichita, Kansas, United States|Via Christi Cancer Center at Via Christi Regional Medical Center, Wichita, Kansas, United States|Wesley Medical Center, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Winfield, Winfield, Kansas, United States|Hickman Cancer Center at Bixby Medical Center, Adrian, Michigan, United States|Community Cancer Center of Monroe, Monroe, Michigan, United States|Mercy Memorial Hospital - Monroe, Monroe, Michigan, United States|Lakeland Regional Cancer Care Center - St. Joseph, Saint Joseph, Michigan, United States|Lakeside Cancer Specialists, PLLC, Saint Joseph, Michigan, United States|MeritCare Bemidji, Bemidji, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy and Unity Cancer Center at Mercy Hospital, Coon Rapids, Minnesota, United States|Essentia Health - Duluth Clinic, Duluth, Minnesota, United States|CCOP - Duluth, Duluth, Minnesota, United States|Miller - Dwan Medical Center, Duluth, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Mercy and Unity Cancer Center at Unity Hospital, Fridley, Minnesota, United States|Hutchinson Area Health Care, Hutchinson, Minnesota, United States|HealthEast Cancer Care at St. John's Hospital, Maplewood, Minnesota, United States|Minnesota Oncology - Maplewood, Maplewood, Minnesota, United States|Virginia Piper Cancer Institute at Abbott - Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center - Minneapolis, Minneapolis, Minnesota, United States|Humphrey Cancer Center at North Memorial Outpatient Center, Robbinsdale, Minnesota, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CentraCare Clinic - River Campus, Saint Cloud, Minnesota, United States|Coborn Cancer Center, Saint Cloud, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|Park Nicollet Cancer Center, Saint Louis Park, Minnesota, United States|Regions Hospital Cancer Care Center, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|St. Francis Cancer Center at St. Francis Medical Center, Shakopee, Minnesota, United States|Lakeview Hospital, Stillwater, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Willmar Cancer Center at Rice Memorial Hospital, Willmar, Minnesota, United States|Minnesota Oncology - Woodbury, Woodbury, Minnesota, United States|Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, Saint Louis, Missouri, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|St. Vincent Healthcare Cancer Care Services, Billings, Montana, United States|Hematology-Oncology Centers of the Northern Rockies - Billings, Billings, Montana, United States|Billings Clinic - Downtown, Billings, Montana, United States|Bozeman Deaconess Cancer Center, Bozeman, Montana, United States|St. James Healthcare Cancer Care, Butte, Montana, United States|Benefis Sletten Cancer Institute, Great Falls, Montana, United States|St. Peter's Hospital, Helena, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Montana Cancer Specialists at Montana Cancer Center, Missoula, Montana, United States|Montana Cancer Center at St. Patrick Hospital and Health Sciences Center, Missoula, Montana, United States|New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care, Concord, New Hampshire, United States|New Hampshire Oncology - Hematology, PA - Hooksett, Hooksett, New Hampshire, United States|Lakes Region General Hospital, Laconia, New Hampshire, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, United States|CCOP - Hematology-Oncology Associates of Central New York, East Syracuse, New York, United States|Mission Hospitals - Memorial Campus, Asheville, North Carolina, United States|Wayne Memorial Hospital, Incorporated, Goldsboro, North Carolina, United States|Medcenter One Hospital Cancer Care Center, Bismarck, North Dakota, United States|Mid Dakota Clinic, PC, Bismarck, North Dakota, United States|St. Alexius Medical Center Cancer Center, Bismarck, North Dakota, United States|MeritCare Broadway, Fargo, North Dakota, United States|Altru Cancer Center at Altru Hospital, Grand Forks, North Dakota, United States|Wood County Oncology Center, Bowling Green, Ohio, United States|Adena Regional Medical Center, Chillicothe, Ohio, United States|Charles M. Barrett Cancer Center at University Hospital, Cincinnati, Ohio, United States|Riverside Methodist Hospital Cancer Care, Columbus, Ohio, United States|CCOP - Columbus, Columbus, Ohio, United States|Grant Medical Center Cancer Care, Columbus, Ohio, United States|Mount Carmel Health - West Hospital, Columbus, Ohio, United States|Doctors Hospital at Ohio Health, Columbus, Ohio, United States|Grandview Hospital, Dayton, Ohio, United States|Good Samaritan Hospital, Dayton, Ohio, United States|David L. Rike Cancer Center at Miami Valley Hospital, Dayton, Ohio, United States|Samaritan North Cancer Care Center, Dayton, Ohio, United States|CCOP - Dayton, Dayton, Ohio, United States|Grady Memorial Hospital, Delaware, Ohio, United States|Community Cancer Center, Elyria, Ohio, United States|Hematology Oncology Center, Elyria, Ohio, United States|Blanchard Valley Medical Associates, Findlay, Ohio, United States|Middletown Regional Hospital, Franklin, Ohio, United States|Wayne Hospital, Greenville, Ohio, United States|Charles F. Kettering Memorial Hospital, Kettering, Ohio, United States|Fairfield Medical Center, Lancaster, Ohio, United States|Lima Memorial Hospital, Lima, Ohio, United States|Strecker Cancer Center at Marietta Memorial Hospital, Marietta, Ohio, United States|Northwest Ohio Oncology Center, Maumee, Ohio, United States|Knox Community Hospital, Mount Vernon, Ohio, United States|Licking Memorial Cancer Care Program at Licking Memorial Hospital, Newark, Ohio, United States|St. Charles Mercy Hospital, Oregon, Ohio, United States|Toledo Clinic - Oregon, Oregon, Ohio, United States|Southern Ohio Medical Center Cancer Center, Portsmouth, Ohio, United States|Community Hospital of Springfield and Clark County, Springfield, Ohio, United States|Flower Hospital Cancer Center, Sylvania, Ohio, United States|Mercy Hospital of Tiffin, Tiffin, Ohio, United States|Toledo Hospital, Toledo, Ohio, United States|St. Vincent Mercy Medical Center, Toledo, Ohio, United States|Medical University of Ohio Cancer Center, Toledo, Ohio, United States|St. Anne Mercy Hospital, Toledo, Ohio, United States|Toledo Clinic, Incorporated - Main Clinic, Toledo, Ohio, United States|UVMC Cancer Care Center at Upper Valley Medical Center, Troy, Ohio, United States|Fulton County Health Center, Wauseon, Ohio, United States|Precision Radiotherapy at University Pointe, West Chester, Ohio, United States|Mount Carmel St. Ann's Cancer Center, Westerville, Ohio, United States|Ruth G. McMillan Cancer Center at Greene Memorial Hospital, Xenia, Ohio, United States|Genesis - Good Samaritan Hospital, Zanesville, Ohio, United States|Natalie Warren Bryant Cancer Center at St. Francis Hospital, Tulsa, Oklahoma, United States|Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest, Allentown, Pennsylvania, United States|Cancer Centers of the Carolinas - Easley, Easley, South Carolina, United States|Cancer Centers of the Carolinas - Faris Road, Greenville, South Carolina, United States|Cancer Centers of the Carolinas - Grove Commons, Greenville, South Carolina, United States|Greenville Hospital Cancer Center, Greenville, South Carolina, United States|Cancer Centers of the Carolinas - Eastside, Greenville, South Carolina, United States|CCOP - Greenville, Greenville, South Carolina, United States|Cancer Centers of the Carolinas - Greer Medical Oncology, Greer, South Carolina, United States|Cancer Centers of the Carolinas - Greer Radiation Oncology, Greer, South Carolina, United States|Cancer Centers of the Carolinas - Seneca, Seneca, South Carolina, United States|Cancer Centers of the Carolinas - Spartanburg, Spartanburg, South Carolina, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Avera Cancer Institute, Sioux Falls, South Dakota, United States|Sanford Cancer Center at Sanford USD Medical Center, Sioux Falls, South Dakota, United States|Fredericksburg Oncology, Incorporated, Fredericksburg, Virginia, United States|Center for Cancer Treatment & Prevention at Sacred Heart Hospital, Eau Claire, Wisconsin, United States|Marshfield Clinic Cancer Care at Regional Cancer Center, Eau Claire, Wisconsin, United States|Central Wisconsin Cancer Program at Agnesian HealthCare, Fond Du Lac, Wisconsin, United States|Gundersen Lutheran Center for Cancer and Blood, La Crosse, Wisconsin, United States|Marshfield Clinic - Marshfield Center, Marshfield, Wisconsin, United States|Saint Joseph's Hospital, Marshfield, Wisconsin, United States|Marshfield Clinic - Lakeland Center, Minocqua, Wisconsin, United States|Ministry Medical Group at Saint Mary's Hospital, Rhinelander, Wisconsin, United States|Marshfield Clinic - Indianhead Center, Rice Lake, Wisconsin, United States|Marshfield Clinic at Saint Michael's Hospital, Stevens Point, Wisconsin, United States|Saint Michael's Hospital Cancer Center, Stevens Point, Wisconsin, United States|Marshfield Clinic - Weston Center, Weston, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00869401"
868,"CD147-CART Cells in Patients With Recurrent Malignant Glioma.","Recruiting","No Results Available","Recurrent Glioblastoma|CD147 Positive","Biological: CD147-CART","National Translational Science Center for Molecular Medicine & Department of Cell Biology, Xi'an, Shaanxi, China","https://ClinicalTrials.gov/show/NCT04045847"
869,"Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MPP2+ Recurrent or Progressive Glioblastoma","Recruiting","No Results Available","Recurrent Glioblastoma|Recurrent Malignant Glioma|Recurrent WHO Grade II Glioma|Recurrent WHO Grade III Glioma","Biological: Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes","City of Hope Medical Center, Duarte, California, United States","https://ClinicalTrials.gov/show/NCT04214392"
870,"Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma","Completed","Has Results","Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Neoplasm","Procedure: Conventional Surgery|Other: Laboratory Biomarker Analysis|Drug: Sorafenib Tosylate|Drug: Temsirolimus","Providence Alaska Medical Center, Anchorage, Alaska, United States|Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States|Rush - Copley Medical Center, Aurora, Illinois, United States|Saint Joseph Medical Center, Bloomington, Illinois, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, United States|Graham Hospital Association, Canton, Illinois, United States|Illinois CancerCare-Canton, Canton, Illinois, United States|Illinois CancerCare-Carthage, Carthage, Illinois, United States|Memorial Hospital, Carthage, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|Heartland Cancer Research NCORP, Decatur, Illinois, United States|Saint Anthony Memorial Hospital, Effingham, Illinois, United States|Eureka Hospital, Eureka, Illinois, United States|Illinois CancerCare-Eureka, Eureka, Illinois, United States|Galesburg Cottage Hospital, Galesburg, Illinois, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, United States|Illinois CancerCare-Havana, Havana, Illinois, United States|Mason District Hospital, Havana, Illinois, United States|Hopedale Medical Complex - Hospital, Hopedale, Illinois, United States|Joliet Oncology-Hematology Associates Limited, Joliet, Illinois, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States|Kewanee Hospital, Kewanee, Illinois, United States|Illinois CancerCare-Macomb, Macomb, Illinois, United States|Mcdonough District Hospital, Macomb, Illinois, United States|Holy Family Medical Center, Monmouth, Illinois, United States|Illinois CancerCare-Monmouth, Monmouth, Illinois, United States|Bromenn Regional Medical Center, Normal, Illinois, United States|Community Cancer Center Foundation, Normal, Illinois, United States|Illinois CancerCare-Community Cancer Center, Normal, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Ottawa Regional Hospital and Healthcare Center, Ottawa, Illinois, United States|Illinois CancerCare-Pekin, Pekin, Illinois, United States|OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center, Pekin, Illinois, United States|Pekin Hospital, Pekin, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|Proctor Hospital, Peoria, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Illinois CancerCare-Peru, Peru, Illinois, United States|Illinois Valley Hospital, Peru, Illinois, United States|Illinois CancerCare-Princeton, Princeton, Illinois, United States|Perry Memorial Hospital, Princeton, Illinois, United States|Illinois CancerCare-Spring Valley, Spring Valley, Illinois, United States|Saint Margaret's Hospital, Spring Valley, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|The Carle Foundation Hospital, Urbana, Illinois, United States|Franciscan Saint Anthony Health-Michigan City, Michigan City, Indiana, United States|McFarland Clinic PC-William R Bliss Cancer Center, Ames, Iowa, United States|Mercy Hospital, Cedar Rapids, Iowa, United States|Oncology Associates at Mercy Medical Center, Cedar Rapids, Iowa, United States|Medical Oncology and Hematology Associates-West Des Moines, Clive, Iowa, United States|Mercy Capitol, Des Moines, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|Iowa-Wide Oncology Research Coalition NCORP, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Laurel, Des Moines, Iowa, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|Iowa Lutheran Hospital, Des Moines, Iowa, United States|Mercy Medical Center - North Iowa, Mason City, Iowa, United States|Siouxland Regional Cancer Center, Sioux City, Iowa, United States|Mercy Medical Center-Sioux City, Sioux City, Iowa, United States|Saint Luke's Regional Medical Center, Sioux City, Iowa, United States|Hospital District Sixth of Harper County, Anthony, Kansas, United States|Cancer Center of Kansas - Chanute, Chanute, Kansas, United States|Cancer Center of Kansas - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas - El Dorado, El Dorado, Kansas, United States|Cancer Center of Kansas - Fort Scott, Fort Scott, Kansas, United States|Cancer Center of Kansas-Independence, Independence, Kansas, United States|Cancer Center of Kansas-Kingman, Kingman, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|Southwest Medical Center, Liberal, Kansas, United States|Cancer Center of Kansas-Liberal, Liberal, Kansas, United States|Cancer Center of Kansas - McPherson, McPherson, Kansas, United States|Cancer Center of Kansas - Newton, Newton, Kansas, United States|Cancer Center of Kansas - Parsons, Parsons, Kansas, United States|Cancer Center of Kansas - Pratt, Pratt, Kansas, United States|Cancer Center of Kansas - Salina, Salina, Kansas, United States|Cancer Center of Kansas - Wellington, Wellington, Kansas, United States|Associates In Womens Health, Wichita, Kansas, United States|Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita, Kansas, United States|Cancer Center of Kansas - Wichita, Wichita, Kansas, United States|Via Christi Regional Medical Center, Wichita, Kansas, United States|Wichita NCI Community Oncology Research Program, Wichita, Kansas, United States|Cancer Center of Kansas - Winfield, Winfield, Kansas, United States|Michigan Cancer Research Consortium NCORP, Ann Arbor, Michigan, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|Bronson Battle Creek, Battle Creek, Michigan, United States|Spectrum Health Big Rapids Hospital, Big Rapids, Michigan, United States|Beaumont Hospital-Dearborn, Dearborn, Michigan, United States|Saint John Hospital and Medical Center, Detroit, Michigan, United States|Green Bay Oncology - Escanaba, Escanaba, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Genesys Regional Medical Center-West Flint Campus, Flint, Michigan, United States|Cancer Research Consortium of West Michigan NCORP, Grand Rapids, Michigan, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, United States|Green Bay Oncology - Iron Mountain, Iron Mountain, Michigan, United States|Allegiance Health, Jackson, Michigan, United States|Sparrow Hospital, Lansing, Michigan, United States|Saint Mary Mercy Hospital, Livonia, Michigan, United States|Mercy Health Mercy Campus, Muskegon, Michigan, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, United States|Lake Huron Medical Center, Port Huron, Michigan, United States|Saint Mary's of Michigan, Saginaw, Michigan, United States|Munson Medical Center, Traverse City, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Metro Health Hospital, Wyoming, Michigan, United States|Medini, Eitan MD (UIA Investigator), Alexandria, Minnesota, United States|Sanford Clinic North-Bemidgi, Bemidji, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Essentia Health Cancer Center, Duluth, Minnesota, United States|Essentia Health Saint Mary's Medical Center, Duluth, Minnesota, United States|Miller-Dwan Hospital, Duluth, Minnesota, United States|Fairview-Southdale Hospital, Edina, Minnesota, United States|Etzell, Paul S MD (UIA Investigator), Fergus Falls, Minnesota, United States|Lake Region Healthcare Corporation-Cancer Care, Fergus Falls, Minnesota, United States|Swenson, Wade II, MD (UIA Investigator), Fergus Falls, Minnesota, United States|Unity Hospital, Fridley, Minnesota, United States|Hutchinson Area Health Care, Hutchinson, Minnesota, United States|Meeker County Memorial Hospital, Litchfield, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Minnesota Cooperative Group Outreach Program, Minneapolis, Minnesota, United States|Virginia Piper Cancer Institute, Minneapolis, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|New Ulm Medical Center, New Ulm, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, United States|Saint Cloud Hospital, Saint Cloud, Minnesota, United States|Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|Saint Joseph's Hospital - Healtheast, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, United States|Lakeview Hospital, Stillwater, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Rice Memorial Hospital, Willmar, Minnesota, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States|Woodwinds Health Campus, Woodbury, Minnesota, United States|Nebraska Cancer Research Center, Lincoln, Nebraska, United States|Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|Alegent Health Immanuel Medical Center, Omaha, Nebraska, United States|Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, United States|Alegent Health Lakeside Hospital, Omaha, Nebraska, United States|Creighton University Medical Center, Omaha, Nebraska, United States|Rutherford Hospital, Rutherfordton, North Carolina, United States|Southeast Clinical Oncology Research (SCOR) Consortium NCORP, Winston-Salem, North Carolina, United States|Mid Dakota Clinic, Bismarck, North Dakota, United States|Saint Alexius Medical Center, Bismarck, North Dakota, United States|Sanford Bismarck Medical Center, Bismarck, North Dakota, United States|Roger Maris Cancer Center, Fargo, North Dakota, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Sanford Clinic North-Fargo, Fargo, North Dakota, United States|Altru Cancer Center, Grand Forks, North Dakota, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Geisinger Medical Center-Cancer Center Hazleton, Hazleton, Pennsylvania, United States|Geisinger Medical Group, State College, Pennsylvania, United States|Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States|AnMed Health Cancer Center, Anderson, South Carolina, United States|AnMed Health Hospital, Anderson, South Carolina, United States|Saint Francis Hospital, Greenville, South Carolina, United States|Spartanburg Medical Center, Spartanburg, South Carolina, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States|Avera Cancer Institute, Sioux Falls, South Dakota, United States|Avera McKennan Hospital and University Health Center, Sioux Falls, South Dakota, United States|Medical X-Ray Center, Sioux Falls, South Dakota, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|University of Virginia Cancer Center, Charlottesville, Virginia, United States|Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Green Bay Oncology at Saint Vincent Hospital, Green Bay, Wisconsin, United States|Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States|Green Bay Oncology Limited at Saint Mary's Hospital, Green Bay, Wisconsin, United States|Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, United States|Holy Family Memorial Hospital, Manitowoc, Wisconsin, United States|Bay Area Medical Center, Marinette, Wisconsin, United States|Green Bay Oncology - Oconto Falls, Oconto Falls, Wisconsin, United States|HSHS Saint Nicholas Hospital, Sheboygan, Wisconsin, United States|Green Bay Oncology - Sturgeon Bay, Sturgeon Bay, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00329719"
871,"Temozolomide in Elderly Patients With KPS < 70","Completed","No Results Available","Primary Brain Tumor|Glioblastoma","Drug: Temozolomide","Pitie salpetriere hospital, Paris, France","https://ClinicalTrials.gov/show/NCT01242566"
872,"Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: temozolomide|Drug: vatalanib|Procedure: adjuvant therapy|Radiation: radiation therapy","U.Z. Gasthuisberg, Leuven, Belgium|Klinikum der Universitaet Regensburg, Regensburg, Germany|Azienda Ospedaliera di Padova, Padova, Italy|Daniel Den Hoed Cancer Center at Erasmus Medical Center, Rotterdam, Netherlands|Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland","https://ClinicalTrials.gov/show/NCT00128700"
873,"ASP8374 + Cemiplimab in Recurrent Glioma","Recruiting","No Results Available","Glioblastoma|Recurrent Glioblastoma","Drug: ASP8374|Drug: cemiplimab|Drug: 89Zr-Df-IAB22M2C","Brigham and Women's Hospital, Boston, Massachusetts, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT04826393"
874,"Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme","Completed","No Results Available","Recurrent Central Nervous System Neoplasm","Biological: BTSC mRNA-loaded DCs","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00890032"
875,"Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: tamoxifen citrate|Radiation: radiation therapy","University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States|Huntsville Hospital System, Huntsville, Alabama, United States|Comprehensive Cancer Institute of Huntsville, Huntsville, Alabama, United States|MBCCOP - Gulf Coast, Mobile, Alabama, United States|Alabama Oncology, LLC, Montgomery, Alabama, United States|Radiation Oncology Associates of West Alabama, Tuscaloosa, Alabama, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Arizona Cancer Center, Tucson, Arizona, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Mount Diablo Medical Center, Concord, California, United States|Cancer Center and Beckman Research Institute, City of Hope, Duarte, California, United States|California Cancer Center, Fresno, California, United States|Saint Agnes Cancer Center, Fresno, California, United States|Glendale Memorial Hospital and Health Center, Glendale, California, United States|Sutter Health West Cancer Research Group, Greenbrae, California, United States|University of California San Diego Cancer Center, La Jolla, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Veterans Affairs Medical Center - Long Beach, Long Beach, California, United States|USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States|Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States|CCOP - Bay Area Tumor Institute, Oakland, California, United States|Huntington Cancer Center, Pasadena, California, United States|Cancer Care Center, Pomona, California, United States|Radiation Oncology Center - Sacramento, Sacramento, California, United States|Radiation Medical Group, Inc., San Diego, California, United States|UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States|O'Connor Hospital, San Jose, California, United States|CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California, United States|David Grant Medical Center, Travis Air Force Base, California, United States|Memorial Hospital Cancer Center, Colorado Springs, Colorado, United States|University of Colorado Cancer Center, Denver, Colorado, United States|Saint Mary's Hospital and Medical Center, Grand Junction, Colorado, United States|CCOP - Christiana Care Health Services, Wilmington, Delaware, United States|Walter Reed Army Medical Center, Washington, District of Columbia, United States|Lykes Center for Radiation Therapy, Clearwater, Florida, United States|Halifax Medical Center, Daytona Beach, Florida, United States|Radiation Therapy Associates - Fort Myers, Fort Myers, Florida, United States|University of Florida Health Science Center, Gainesville, Florida, United States|Health First Holmes Regional Medical Center, Melbourne, Florida, United States|CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States|Veterans Affairs Medical Center - Miami, Miami, Florida, United States|Sylvester Cancer Center, University of Miami, Miami, Florida, United States|Baptist Hospital of Miami, Miami, Florida, United States|Florida Radiation Oncology Group, Orange Park, Florida, United States|MD Anderson Cancer Center Orlando, Orlando, Florida, United States|Bay Medical Center, Panama City, Florida, United States|Gulf Coast Cancer Treatment Center, Panama City, Florida, United States|Sarasota Radiation and Medical Oncology Center, Sarasota, Florida, United States|Tallahassee Memorial Healthcare, Tallahassee, Florida, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Emory University Hospital - Atlanta, Atlanta, Georgia, United States|CCOP - Atlanta Regional, Atlanta, Georgia, United States|Medical Center/John B. Amos Community Cancer Center, Columbus, Georgia, United States|InterCommunity Cancer Center at Rome, Rome, Georgia, United States|Northwest Community Hospital, Arlington Heights, Illinois, United States|Northwestern Memorial Hospital, Chicago, Illinois, United States|University of Chicago Cancer Research Center, Chicago, Illinois, United States|CCOP - Central Illinois, Decatur, Illinois, United States|Provena St. Joseph Hospital- Regional Cancer Care Center, Elgin, Illinois, United States|Ingalls Memorial Hospital, Harvey, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Lutheran General Cancer Care Center, Park Ridge, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|St. John's Medical Center, Anderson, Indiana, United States|Bloomington Hospital, Bloomington, Indiana, United States|Veterans Affairs Medical Center - Indianapolis (Roudebush), Indianapolis, Indiana, United States|Clarion Health Partners Inc., Indianapolis, Indiana, United States|Community Hospitals of Indianapolis - Regional Cancer Center, Indianapolis, Indiana, United States|Ball Memorial Hospital, Muncie, Indiana, United States|Wendt Regional Cancer Center of Finley Hospital, Dubuque, Iowa, United States|Holden Comprehensive Cancer Center at The University of Iowa, Iowa City, Iowa, United States|Central Baptist Hospital, Lexington, Kentucky, United States|Veterans Affairs Medical Center - Lexington, Lexington, Kentucky, United States|Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky, United States|James Graham Brown Cancer Center, Louisville, Kentucky, United States|Louisville Radiation Oncology, Louisville, Kentucky, United States|Merle M. Mahr Cancer Center, Madisonville, Kentucky, United States|Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States|Romagosa Radiation Oncology Center, Lafayette, Louisiana, United States|MBCCOP - LSU Health Sciences Center, New Orleans, Louisiana, United States|Tulane University School of Medicine, New Orleans, Louisiana, United States|CCOP - Ochsner, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Anne Arundel Oncology Center, Annapolis, Maryland, United States|Greater Baltimore Medical Center and Cancer Center, Baltimore, Maryland, United States|Harbor Hospital Center, Baltimore, Maryland, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Radiation Oncology Affiliates of Maryland, P.A., Baltimore, Maryland, United States|Peninsula Regional Medical Center, Salisbury, Maryland, United States|Cape Cod Hospital, Hyannis, Massachusetts, United States|Veterans Affairs Medical Center - Boston (Jamaica Plain), Jamaica Plain, Massachusetts, United States|CCOP - Ann Arbor Regional, Ann Arbor, Michigan, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|McLaren Regional Cancer Center, Flint, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|CCOP - Kalamazoo, Kalamazoo, Michigan, United States|Marquette General Hospital, Marquette, Michigan, United States|MidMichigan Medical Center - Midland, Midland, Michigan, United States|William Beaumont Hospital, Royal Oak, Michigan, United States|St. Mary's Medical Center, Saginaw, Michigan, United States|William Beaumont Hospital - Troy, Troy, Michigan, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|North Mississippi Medical Center/Cancer Center, Tupelo, Mississippi, United States|Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, United States|CCOP - Kansas City, Kansas City, Missouri, United States|St. Louis University Health Sciences Center, Saint Louis, Missouri, United States|Mallinckrodt Institute of Radiology, Saint Louis, Missouri, United States|Cancer Research for the Ozarks, Springfield, Missouri, United States|CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|Nebraska Health System, Omaha, Nebraska, United States|Methodist Cancer Center - Omaha, Omaha, Nebraska, United States|CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, United States|Norris Cotton Cancer Center, Lebanon, New Hampshire, United States|Elliot Regional Cancer Center, Manchester, New Hampshire, United States|Veterans Affairs Medical Center - East Orange, East Orange, New Jersey, United States|John F. Kennedy Medical Center, Edison, New Jersey, United States|Trinitas Hospital - Jersey Street Campus, Elizabeth, New Jersey, United States|Monmouth Medical Center, Long Branch, New Jersey, United States|South Jersey Regional Cancer Center, Millville, New Jersey, United States|Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County, Mount Holly, New Jersey, United States|Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|Newark Beth Israel Medical Center, Newark, New Jersey, United States|Atlantic City Medical Center, Pomona, New Jersey, United States|Valley Hospital, Ridgewood, New Jersey, United States|Community Medical Center, Toms River, New Jersey, United States|St. Francis Medical Center, Trenton, New Jersey, United States|Associated Radiologists, P.A., Warren, New Jersey, United States|Saint Joseph Medical Center, Albuquerque, New Mexico, United States|Cancer Center of Albany Medical Center, Albany, New York, United States|Albert Einstein Comprehensive Cancer Center, Bronx, New York, United States|State University of New York Health Science Center at Brooklyn, Brooklyn, New York, United States|New York Methodist Hospital, Brooklyn, New York, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Finger Lakes Radiation Oncology, P.C., Clifton Springs, New York, United States|CCOP - North Shore University Hospital, Manhasset, New York, United States|Beth Israel Medical Center, New York, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Champlain Valley Physicians Hospital Medical Center, Plattsburgh, New York, United States|Vassar Brothers Hospital, Poughkeepsie, New York, United States|University of Rochester Cancer Center, Rochester, New York, United States|New York Medical College, Valhalla, New York, United States|Riverhill Radiation Oncology, Yonkers, New York, United States|Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, United States|Northeast Medical Center, Concord, North Carolina, United States|East Carolina University School of Medicine, Greenville, North Carolina, United States|Catawba Memorial Hospital, Hickory, North Carolina, United States|CCOP - Southeast Cancer Control Consortium, Winston-Salem, North Carolina, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|Meritcare Roger Maris Cancer Center, Fargo, North Dakota, United States|Trinity Cancer Care Center, Minot, North Dakota, United States|Akron General Medical Center, Akron, Ohio, United States|Akron City Hospital, Akron, Ohio, United States|Barrett Cancer Center, The University Hospital, Cincinnati, Ohio, United States|Christ Hospital, Cincinnati, Ohio, United States|Ireland Cancer Center, Cleveland, Ohio, United States|University Hospitals of Cleveland, Cleveland, Ohio, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|CCOP - Columbus, Columbus, Ohio, United States|Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States|CCOP - Dayton, Kettering, Ohio, United States|CCOP - Toledo Community Hospital Oncology Program, Toledo, Ohio, United States|St. Anthony Hospital, Oklahoma City, Oklahoma, United States|Oklahoma University Medical Center, Oklahoma City, Oklahoma, United States|St. John Health System, Tulsa, Oklahoma, United States|CCOP - Columbia River Program, Portland, Oregon, United States|Lehigh Valley Hospital, Allentown, Pennsylvania, United States|St. Luke's Hospital Regional Cancer Center, Bethlehem, Pennsylvania, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Fitzgerald Mercy Hospital, Darby, Pennsylvania, United States|Delaware County Memorial Hospital, Drexel Hill, Pennsylvania, United States|Pocono Cancer Center, East Stroudsburg, Pennsylvania, United States|Penn State Geisinger Cancer Center, Hershey, Pennsylvania, United States|Hahnemann University Hospital, Philadelphia, Pennsylvania, United States|University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States|Veterans Affairs Medical Center - Philadelphia, Philadelphia, Pennsylvania, United States|Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|Albert Einstein Cancer Center, Philadelphia, Pennsylvania, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|Mercy Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States|Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States|Reading Hospital and Medical Center, Reading, Pennsylvania, United States|Mercy Hospital Cancer Center - Scranton, Scranton, Pennsylvania, United States|Grand View Hospital, Sellersville, Pennsylvania, United States|Wilkes Barre General Hospital, Wilkes-Barre, Pennsylvania, United States|CCOP - MainLine Health, Wynnewood, Pennsylvania, United States|York Hospital, York, Pennsylvania, United States|Roger Williams Medical Center/BUSM, Providence, Rhode Island, United States|Medical University of South Carolina, Charleston, South Carolina, United States|CCOP - Greenville, Greenville, South Carolina, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Jackson-Madison County General Hospital, Jackson, Tennessee, United States|University of Tennessee, Memphis Cancer Center, Memphis, Tennessee, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States|Harrington Cancer Center, Amarillo, Texas, United States|Julie and Ben Rogers Cancer Institute, Beaumont, Texas, United States|University of Texas Medical Branch, Galveston, Texas, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|Wilford Hall - 59th Medical Wing, Lackland Air Force Base, Texas, United States|Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas, United States|Bayshore Medical Center, Pasadena, Texas, United States|East Texas Medical Center - Cancer Institute, Tyler, Texas, United States|Dixie Regional Medical Center, Saint George, Utah, United States|University of Utah Health Sciences Center, Salt Lake City, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|CCOP - Southwestern Vermont Regional Cancer Center, Bennington, Vermont, United States|Vermont Cancer Center, Burlington, Vermont, United States|Martha Jefferson Hospital, Charlottesville, Virginia, United States|Cancer Center at the University of Virginia, Charlottesville, Virginia, United States|RMH Regional Canter Center, Harrisonburg, Virginia, United States|Naval Medical Center, Portsmouth, Portsmouth, Virginia, United States|Bon-Secours - St. Mary's Hospital, Richmond, Virginia, United States|Massey Cancer Center, Richmond, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Deaconess Medical Center, Spokane, Washington, United States|Yakima Valley Memorial Hospital, Yakima, Washington, United States|Schiffler Cancer Center, Wheeling, West Virginia, United States|St. Vincent Hospital, Green Bay, Wisconsin, United States|Gundersen Lutheran Medical Foundation, La Crosse, Wisconsin, United States|Southern Wisconsin Radiotherapy Center, Madison, Wisconsin, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States|Marshfield Clinic, Marshfield, Wisconsin, United States|Community Memorial Hospital, Menomonee Falls, Wisconsin, United States|St. Joseph's Hospital, Milwaukee, Wisconsin, United States|Columbia Hospital, Milwaukee, Wisconsin, United States|St. Luke's Medical Center, Milwaukee, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Veterans Affairs Medical Center - Milwaukee (Zablocki), Milwaukee, Wisconsin, United States|Southeastern Wisconsin Regional Cancer Center, Racine, Wisconsin, United States|Waukesha Memorial Hospital, Waukesha, Wisconsin, United States|Tom Baker Cancer Center - Calgary, Calgary, Alberta, Canada|Cross Cancer Institute, Edmonton, Alberta, Canada|British Columbia Cancer Agency, Vancouver, British Columbia, Canada|Saint John Regional Hospital, Saint John, New Brunswick, Canada|Newfoundland Cancer Treatment and Research Foundation, St. Johns, Newfoundland and Labrador, Canada|Nova Scotia Cancer Centre, Halifax, Nova Scotia, Canada|Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada|Kingston Regional Cancer Centre, Kingston, Ontario, Canada|Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada|Ottawa Regional Cancer Centre - General Campus, Ottawa, Ontario, Canada|Northeastern Ontario Regional Cancer Centre, Sudbury, Sudbury, Ontario, Canada|Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay, Ontario, Canada|Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada|Princess Margaret Hospital, Toronto, Ontario, Canada|CHUS-Hopital Fleurimont, Fleurimont, Quebec, Canada|Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada|McGill University, Montreal, Quebec, Canada|CHU de Quebec - L'Hotel-Dieu de Quebec, Quebec City, Quebec, Canada|Allan Blair Cancer Centre, Regina, Saskatchewan, Canada|Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada","https://ClinicalTrials.gov/show/NCT00006388"
876,"Utility of Primary Glioblastoma Cell Lines","Recruiting","No Results Available","Tumor|Brain Tumor",,"Neuromed IRCCS, Pozzilli, IS, Italy","https://ClinicalTrials.gov/show/NCT04180046"
877,"Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme","Terminated","No Results Available","Brain and Central Nervous System Tumors","Drug: temozolomide|Procedure: adjuvant therapy|Procedure: chemotherapy|Procedure: radiation therapy","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00238277"
878,"Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma","Completed","Has Results","Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Neoplasm","Biological: Bevacizumab|Drug: Irinotecan Hydrochloride|Drug: Temozolomide","Mobile Infirmary Medical Center, Mobile, Alabama, United States|Fairbanks Memorial Hospital, Fairbanks, Alaska, United States|Arizona Oncology Services Foundation, Scottsdale, Arizona, United States|Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States|Mills-Peninsula Medical Center, Burlingame, California, United States|John Muir Medical Center-Concord Campus, Concord, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Marin General Hospital, Greenbrae, California, United States|Sutter Cancer Research Consortium, Novato, California, United States|California Pacific Medical Center-Pacific Campus, San Francisco, California, United States|Sutter Solano Medical Center/Cancer Center, Vallejo, California, United States|John Muir Medical Center-Walnut Creek, Walnut Creek, California, United States|Yale University, New Haven, Connecticut, United States|Boca Raton Regional Hospital, Boca Raton, Florida, United States|University of Florida Health Science Center - Gainesville, Gainesville, Florida, United States|Saint Luke's Mountain States Tumor Institute, Boise, Idaho, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Saint Vincent Anderson Regional Hospital/Cancer Center, Anderson, Indiana, United States|Franciscan Saint Francis Health-Beech Grove, Beech Grove, Indiana, United States|IU Health Methodist Hospital, Indianapolis, Indiana, United States|Reid Health, Richmond, Indiana, United States|University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States|Anne Arundel Medical Center, Annapolis, Maryland, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Borgess Medical Center, Kalamazoo, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|William Beaumont Hospital-Royal Oak, Royal Oak, Michigan, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Fairview-Southdale Hospital, Edina, Minnesota, United States|Unity Hospital, Fridley, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Northern Rockies Radiation Oncology Center, Billings, Montana, United States|Cheshire Medical Center-Dartmouth-Hitchcock Keene, Keene, New Hampshire, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|John F Kennedy Medical Center, Edison, New Jersey, United States|New Mexico Oncology Hematology Consultants, Albuquerque, New Mexico, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Highland Hospital, Rochester, New York, United States|University of Rochester, Rochester, New York, United States|Mission Hospital-Memorial Campus, Asheville, North Carolina, United States|Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States|Akron General Medical Center, Akron, Ohio, United States|Grandview Hospital, Dayton, Ohio, United States|Good Samaritan Hospital - Dayton, Dayton, Ohio, United States|Miami Valley Hospital, Dayton, Ohio, United States|Samaritan North Health Center, Dayton, Ohio, United States|Dayton NCI Community Oncology Research Program, Dayton, Ohio, United States|Veteran Affairs Medical Center, Dayton, Ohio, United States|Blanchard Valley Hospital, Findlay, Ohio, United States|Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States|Kettering Medical Center, Kettering, Ohio, United States|Upper Valley Medical Center, Troy, Ohio, United States|Greene Memorial Hospital, Xenia, Ohio, United States|Legacy Mount Hood Medical Center, Gresham, Oregon, United States|Providence Milwaukie Hospital, Milwaukie, Oregon, United States|Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Adventist Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|Legacy Emanuel Hospital and Health Center, Portland, Oregon, United States|Legacy Meridian Park Hospital, Tualatin, Oregon, United States|Radiation Therapy Oncology Group, Philadelphia, Pennsylvania, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|M D Anderson Cancer Center, Houston, Texas, United States|American Fork Hospital / Huntsman Intermountain Cancer Center, American Fork, Utah, United States|Sandra L Maxwell Cancer Center, Cedar City, Utah, United States|Cottonwood Hospital Medical Center, Murray, Utah, United States|Intermountain Medical Center, Murray, Utah, United States|McKay-Dee Hospital Center, Ogden, Utah, United States|Utah Valley Regional Medical Center, Provo, Utah, United States|Dixie Medical Center Regional Cancer Center, Saint George, Utah, United States|Intermountain Health Care, Salt Lake City, Utah, United States|Utah Cancer Specialists-Salt Lake City, Salt Lake City, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|Norris Cotton Cancer Center-North, Saint Johnsbury, Vermont, United States|Saint Francis Hospital, Federal Way, Washington, United States|EvergreenHealth Medical Center, Kirkland, Washington, United States|Virginia Mason Medical Center, Seattle, Washington, United States|University of Washington Medical Center, Seattle, Washington, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Froedtert and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00433381"
879,"The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation","Recruiting","No Results Available","Malignant Glioma|Glioblastoma","Drug: Evolocumab","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT04937413"
880,"Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma","Completed","No Results Available","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Neoplasm","Drug: Cediranib Maleate|Drug: Cilengitide|Other: Laboratory Biomarker Analysis","University of Alabama at Birmingham, Birmingham, Alabama, United States|Emory University/Winship Cancer Institute, Atlanta, Georgia, United States|Adult Brain Tumor Consortium, Baltimore, Maryland, United States|Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Massachusetts General Hospital, Charlestown, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00979862"
881,"Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA","Recruiting","No Results Available","Glioblastoma|Anaplastic Astrocytoma|Anaplastic Oligoastrocytoma|Glioma|Brain Neoplasm|Brain Cancer|Brain Tumor|Brain Tumor, Recurrent|Brain Neoplasm, Malignant","Drug: Intra-arterial Cetuximab|Drug: Intra-arterial Mannitol|Radiation: Hypofractionated re-irradiation","Lenox Hill Brain Tumor Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT02800486"
882,"An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)","Active, not recruiting","Has Results","Brain Neoplasms","Drug: Nivolumab|Drug: Temozolomide|Radiation: Radiotherapy|Other: Nivolumab Placebo","University of Alabama at Birmingham, Birmingham, Alabama, United States|St. Joseph Hospital And Medical Center, Phoenix, Arizona, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|UCLA Neuro-Oncology Program, Los Angeles, California, United States|Sutter Institute For Medical Research, Sacramento, California, United States|Sharp Memorial Hospital, San Diego, California, United States|The Regents of the University of California, San Francisco, San Francisco, California, United States|Yale University School Of Medicine, New Haven, Connecticut, United States|Georgetown University Medical Center, Washington, District of Columbia, United States|University Of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|Local Institution, Chicago, Illinois, United States|University Of Kansas Medical Center, Westwood, Kansas, United States|Norton Cancer Institute, Louisville, Kentucky, United States|Johns Hopkins University School Of Medicine, Baltimore, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|Washington University School OF Medicine-Siteman Cancer Center, Saint Louis, Missouri, United States|JFK Medical Center, Edison, New Jersey, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Columbia University, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Levine Cancer Institute, Charlotte, North Carolina, United States|Preston Robert Tisch Brain Tumor Center at Duke University, Durham, North Carolina, United States|Cleveland Clinic, Cleveland, Ohio, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Lehigh Valley Health Network, Allentown, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Medical University Of South Carolina, Charleston, South Carolina, United States|Erlanger Oncology & Hematology - Univ. of TN, Chattanooga, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University Of Texas Southwestern Medical Center, Dallas, Texas, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States|Swedish Neuroscience Institute, Seattle, Washington, United States|Local Institution, Liverpool, New South Wales, Australia|Royal North Shore Hospital, St. Leonards, New South Wales, Australia|Local Institution, Heidelberg, Victoria, Australia|Local Institution, Prahran, Victoria, Australia|Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia|Kepler Universitaetsklinikum, Linz, Austria|Medical University Of Vienna, Vienna, Austria|Universitair Ziekenhuis Brussel, Brussels, Belgium|Cliniques Universitaires Saint-Luc, Bruxelles, Belgium|Uz Leuven, Leuven, Belgium|BC Cancer - Vancouver, Vancouver, British Columbia, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, Canada|Montreal Neurological Institute and Hospital, Montreal, Quebec, Canada|Local Institution, Copenhagen, Denmark|Local Institution, Odense, Denmark|Local Institution, Lille Cedex, France|Hopital Neurologique Pierre Wertheimer, Lyon Cedex 03, France|Local Institution, Marseille, France|Local Institution, Nancy, France|Groupe Hospitalier Pitie-Salpetriere, Paris cedex 13, France|Hopital Saint Louis, Paris, France|Centre Eugene Marquis, Rennes Cedex, France|Institut Univ Cancer Toulouse, Toulouse, France|Universitaetsklinikum Bonn, Bonn, Germany|Uniklinik Erlangen, Erlangen, Germany|Klinikum Der J. W. Goethe-Universitaet Frankfurt/Main, Frankfurt Am Main, Germany|Universitaetsklinikum Freiburg, Freiburg, Germany|Universitaetsklinikum Hamburg, Hamburg, Germany|Universitaetsklinik Heidelberg, Heidelberg, Germany|Universitaetsklinikum Koeln, Koeln, Germany|Universitaetsklinikum Muenster, Muenster, Germany|Klinikum rechts der Isar der Technischen Universitat Munchen, Munich, Germany|Universitaetsklinikum Regensburg, Regensburg, Germany|Universitasklinikum Tubingen, Tuebingen, Germany|Local Institution, Petach Tikva, Israel|Local Institution, Tel Aviv, Israel|Local Institution, Bologna, Italy|Local Institution, Milano, Italy|Local Institution, Padova, Italy|Local Institution, Rozzano (milano), Italy|Local Institution, Siena, Italy|Azienda Ospedaliera Citta della Salute e della Scienza, Torino, Italy|Local Institution, Nagoya-shi, Aichi, Japan|Local Institution, Chiba-shi, Chiba, Japan|Local Institution, Hiroshima-Shi, Hiroshima, Japan|Local Institution, Sapporo-shi, Hokkaido, Japan|Local Institution, Kobe-shi, Hyogo, Japan|Local Institution, Tsukuba-shi, Ibaraki, Japan|Local Institution, Kanazawa-shi, Ishikawa, Japan|Local Institution, Kagoshima-shi, Kagoshima, Japan|Local Institution, Sagamihara-shi, Kanagawa, Japan|Local Institution, Kumamoto-shi, Kumamoto, Japan|Local Institution, Kyoto-shi, Kyoto, Japan|Local Institution, Okayama-shi, Okayama, Japan|Local Institution, Hirakata-shi, Osaka, Japan|Local Institution, Suita, Osaka, Japan|Local Institution, Hidaka-shi, Saitama, Japan|Local Institution, Bunkyo-ku, Tokyo, Japan|Local Institution, Chuo-ku, Tokyo, Japan|Local Institution, Mitaka-shi, Tokyo, Japan|Local Institution, Shinjuku-ku, Tokyo, Japan|Local Institution, Yamagata-shi, Yamagata, Japan|Local Institution, Kyoto, Japan|NKI AVL, Amsterdam, Netherlands|Universitair Medisch Centrum Groningen, Groningen, Netherlands|Erasmus Mc, Rotterdam, Netherlands|Universitair Medisch Centrum Utrecht, Utrecht, Netherlands|Local Institution, Oslo, Norway|Uniwersyteckie Centrum Kliniczne Klinika Onkologii I Radiote, Gdansk, Poland|Klinika Nowotworow Glowy i Szyi, Warszawa, Poland|Local Institution, Moscow, Russian Federation|Local Institution, Moscow, Russian Federation|Local Institution, Badalona-barcelona, Spain|Local Institution, Barcelona, Spain|Local Institution, Barcelona, Spain|Local Institution, Madrid, Spain|Local Institution, Madrid, Spain|Local Institution, Santiago Compostela, Spain|Local Institution, Valencia, Spain|Local Institution, Lund, Sweden|Local Institution, Solna, Sweden|University Hospital Geneva, Geneve, Switzerland|Centre hospitalier universitaire Vaudois (CHUV), Lausanne, Switzerland|UniversitaetsSpital Zurich, Zuerich, Switzerland|University College Hospital, London, Greater London, United Kingdom|Christie Hospital Nhs Found. Trust, Manchester, Greater Manchester, United Kingdom|Royal Marsden Hospital, Sutton, Surrey, United Kingdom|Beaston West of Scotland Cancer Centre, Glasgow, United Kingdom","https://ClinicalTrials.gov/show/NCT02667587"
883,"Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma","Completed","Has Results","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Neoplasm","Drug: Dasatinib|Other: Pharmacological Study","Mobile Infirmary Medical Center, Mobile, Alabama, United States|Arizona Oncology Services Foundation, Scottsdale, Arizona, United States|The University of Arizona Medical Center-University Campus, Tucson, Arizona, United States|Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, United States|Sutter Cancer Centers Radiation Oncology Services-Cameron Park, Cameron Park, California, United States|Mercy San Juan Medical Center, Carmichael, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Glendale Adventist Medical Center, Glendale, California, United States|UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States|Sutter Cancer Centers Radiation Oncology Services-Roseville, Roseville, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|Mercy General Hospital Radiation Oncology Center, Sacramento, California, United States|Sutter Cancer Centers Radiation Oncology Services-Vacaville, Vacaville, California, United States|Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States|Beebe Medical Center, Lewes, Delaware, United States|Christiana Care Health System-Christiana Hospital, Newark, Delaware, United States|Boca Raton Regional Hospital, Boca Raton, Florida, United States|Holy Cross Hospital, Fort Lauderdale, Florida, United States|University of Florida Health Science Center - Gainesville, Gainesville, Florida, United States|Integrated Community Oncology Network-Florida Cancer Center Beaches, Jacksonville Beach, Florida, United States|Baptist MD Anderson Cancer Center, Jacksonville, Florida, United States|Integrated Community Oncology Network-Southside Cancer Center, Jacksonville, Florida, United States|University of Florida Health Science Center - Jacksonville, Jacksonville, Florida, United States|Baptist Medical Center South, Jacksonville, Florida, United States|Jupiter Medical Center, Jupiter, Florida, United States|Mount Sinai Medical Center, Miami Beach, Florida, United States|21st Century Oncology-Orange Park, Orange Park, Florida, United States|21st Century Oncology-Palatka, Palatka, Florida, United States|Bay Medical Center, Panama City, Florida, United States|Integrated Community Oncology Network-Flager Cancer Center, Saint Augustine, Florida, United States|John B Amos Cancer Center, Columbus, Georgia, United States|Memorial Health University Medical Center, Savannah, Georgia, United States|Ingalls Memorial Hospital, Harvey, Illinois, United States|Saint John's Hospital, Springfield, Illinois, United States|Saint Vincent Anderson Regional Hospital/Cancer Center, Anderson, Indiana, United States|Franciscan Saint Francis Health-Beech Grove, Beech Grove, Indiana, United States|IU Health Methodist Hospital, Indianapolis, Indiana, United States|Reid Health, Richmond, Indiana, United States|Menorah Medical Center, Overland Park, Kansas, United States|Saint Luke's South Hospital, Overland Park, Kansas, United States|Kansas City NCI Community Oncology Research Program, Prairie Village, Kansas, United States|Shawnee Mission Medical Center-KCCC, Shawnee Mission, Kansas, United States|The James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky, United States|Union Hospital of Cecil County, Elkton, Maryland, United States|Boston Medical Center, Boston, Massachusetts, United States|Michigan Cancer Research Consortium NCORP, Ann Arbor, Michigan, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|Beaumont Hospital-Dearborn, Dearborn, Michigan, United States|Ascension Saint John Hospital, Detroit, Michigan, United States|Green Bay Oncology - Escanaba, Escanaba, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Genesys Regional Medical Center-West Flint Campus, Flint, Michigan, United States|Green Bay Oncology - Iron Mountain, Iron Mountain, Michigan, United States|Allegiance Health, Jackson, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Borgess Medical Center, Kalamazoo, Michigan, United States|Sparrow Hospital, Lansing, Michigan, United States|Saint Mary Mercy Hospital, Livonia, Michigan, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, United States|Lake Huron Medical Center, Port Huron, Michigan, United States|Saint Mary's of Michigan, Saginaw, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Fairview-Southdale Hospital, Edina, Minnesota, United States|Unity Hospital, Fridley, Minnesota, United States|Hutchinson Area Health Care, Hutchinson, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States|Singing River Hospital, Pascagoula, Mississippi, United States|Cape Radiation Oncology, Cape Girardeau, Missouri, United States|Centerpoint Medical Center LLC, Independence, Missouri, United States|Truman Medical Center, Kansas City, Missouri, United States|Saint Luke's Hospital of Kansas City, Kansas City, Missouri, United States|Saint Joseph Health Center, Kansas City, Missouri, United States|North Kansas City Hospital, Kansas City, Missouri, United States|Heartland Hematology and Oncology Associates Incorporated, Kansas City, Missouri, United States|Research Medical Center, Kansas City, Missouri, United States|Saint Luke's East - Lee's Summit, Lee's Summit, Missouri, United States|Liberty Radiation Oncology Center, Liberty, Missouri, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Siteman Cancer Center at Saint Peters Hospital, Saint Peters, Missouri, United States|Cancer Research for the Ozarks NCORP, Springfield, Missouri, United States|Mercy Hospital Springfield, Springfield, Missouri, United States|CoxHealth South Hospital, Springfield, Missouri, United States|Nebraska Methodist Hospital, Omaha, Nebraska, United States|Renown Regional Medical Center, Reno, Nevada, United States|Cheshire Medical Center-Dartmouth-Hitchcock Keene, Keene, New Hampshire, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Cooper Hospital University Medical Center, Camden, New Jersey, United States|Virtua Memorial, Mount Holly, New Jersey, United States|Sparta Cancer Treatment Center, Sparta, New Jersey, United States|Virtua Voorhees, Voorhees, New Jersey, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Highland Hospital, Rochester, New York, United States|University of Rochester, Rochester, New York, United States|Novant Health Presbyterian Medical Center, Charlotte, North Carolina, United States|Rutherford Hospital, Rutherfordton, North Carolina, United States|Summa Akron City Hospital/Cooper Cancer Center, Akron, Ohio, United States|Cleveland Clinic Akron General, Akron, Ohio, United States|Summa Barberton Hospital, Barberton, Ohio, United States|Aultman Health Foundation, Canton, Ohio, United States|University of Cincinnati/Barrett Cancer Center, Cincinnati, Ohio, United States|Grandview Hospital, Dayton, Ohio, United States|Good Samaritan Hospital - Dayton, Dayton, Ohio, United States|Miami Valley Hospital, Dayton, Ohio, United States|Samaritan North Health Center, Dayton, Ohio, United States|Veteran Affairs Medical Center, Dayton, Ohio, United States|Blanchard Valley Hospital, Findlay, Ohio, United States|Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States|Kettering Medical Center, Kettering, Ohio, United States|UH Seidman Cancer Center at Salem Regional Medical Center, Salem, Ohio, United States|Upper Valley Medical Center, Troy, Ohio, United States|University Pointe, West Chester, Ohio, United States|Cancer Treatment Center, Wooster, Ohio, United States|Greene Memorial Hospital, Xenia, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Salem Hospital, Salem, Oregon, United States|Abington Memorial Hospital, Abington, Pennsylvania, United States|Delaware County Memorial Hospital, Drexel Hill, Pennsylvania, United States|Northeast Radiation Oncology Center, Dunmore, Pennsylvania, United States|Adams Cancer Center, Gettysburg, Pennsylvania, United States|Cherry Tree Cancer Center, Hanover, Pennsylvania, United States|Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States|Upper Delaware Valley Cancer Center, Milford, Pennsylvania, United States|Reading Hospital, West Reading, Pennsylvania, United States|WellSpan Health-York Hospital, York, Pennsylvania, United States|AnMed Health Hospital, Anderson, South Carolina, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Saint Francis Hospital, Greenville, South Carolina, United States|Greenville Health System Cancer Institute-Eastside, Greenville, South Carolina, United States|Spartanburg Medical Center, Spartanburg, South Carolina, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Wellmont Holston Valley Hospital and Medical Center, Kingsport, Tennessee, United States|Thompson Cancer Survival Center, Knoxville, Tennessee, United States|Thompson Cancer Survival Center - West, Knoxville, Tennessee, United States|Thompson Cancer Survival Center at Methodist, Oak Ridge, Tennessee, United States|University of Texas Medical Branch, Galveston, Texas, United States|M D Anderson Cancer Center, Houston, Texas, United States|Covenant Medical Center-Lakeside, Lubbock, Texas, United States|American Fork Hospital / Huntsman Intermountain Cancer Center, American Fork, Utah, United States|Sandra L Maxwell Cancer Center, Cedar City, Utah, United States|Logan Regional Hospital, Logan, Utah, United States|Cottonwood Hospital Medical Center, Murray, Utah, United States|Intermountain Medical Center, Murray, Utah, United States|McKay-Dee Hospital Center, Ogden, Utah, United States|Utah Valley Regional Medical Center, Provo, Utah, United States|Dixie Medical Center Regional Cancer Center, Saint George, Utah, United States|Intermountain Health Care, Salt Lake City, Utah, United States|Utah Cancer Specialists-Salt Lake City, Salt Lake City, Utah, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|University of Vermont Medical Center, Burlington, Vermont, United States|University of Vermont College of Medicine, Burlington, Vermont, United States|Norris Cotton Cancer Center-North, Saint Johnsbury, Vermont, United States|Southwest VA Regional Cancer Center, Norton, Virginia, United States|Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States|North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington, United States|Wheeling Hospital/Schiffler Cancer Center, Wheeling, West Virginia, United States|Green Bay Oncology at Saint Vincent Hospital, Green Bay, Wisconsin, United States|Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States|Green Bay Oncology Limited at Saint Mary's Hospital, Green Bay, Wisconsin, United States|Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, United States|Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Bay Area Medical Center, Marinette, Wisconsin, United States|Froedtert and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States|ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States|Green Bay Oncology - Oconto Falls, Oconto Falls, Wisconsin, United States|Green Bay Oncology - Sturgeon Bay, Sturgeon Bay, Wisconsin, United States|ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States|London Regional Cancer Program, London, Ontario, Canada|CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ), Quebec City, Quebec, Canada|Allan Blair Cancer Centre, Regina, Saskatchewan, Canada|King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia","https://ClinicalTrials.gov/show/NCT00423735"
884,"Infigratinib in Recurrent High-Grade Glioma Patients","Recruiting","No Results Available","Glioma|Glioblastoma|GBM","Drug: Infigratinib","Chandler Regional Medical Center, Chandler, Arizona, United States|St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|HonorHealth Scottsdale Osborn Medical Center, Scottsdale, Arizona, United States","https://ClinicalTrials.gov/show/NCT04424966"
885,"An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)","Active, not recruiting","Has Results","Brain Cancer","Drug: Nivolumab|Drug: Temozolomide|Radiation: Radiotherapy","University of Alabama at Birmingham, Birmingham, Alabama, United States|St. Joseph Hospital And Medical Center, Phoenix, Arizona, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|UCLA Neuro-Oncology Program, Los Angeles, California, United States|Sutter Institute For Medical Research, Sacramento, California, United States|Sharp Memorial Hospital, San Diego, California, United States|The Regents of the University of California, San Francisco, San Francisco, California, United States|Yale Cancer Center, New Haven, Connecticut, United States|Georgetown University Medical Center, Washington, District of Columbia, United States|University Of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|Emory University - Winship Cancer Institute, Atlanta, Georgia, United States|The University Of Chicago, Chicago, Illinois, United States|University Of Kansas Medical Center, Westwood, Kansas, United States|Norton Cancer Institute, Louisville, Kentucky, United States|Johns Hopkins University School Of Medicine, Baltimore, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|Washington University School OF Medicine-Siteman Cancer Center, Saint Louis, Missouri, United States|JFK Medical Center, Edison, New Jersey, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Columbia University Medical Center (Cumc), New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Levine Cancer Institute, Charlotte, North Carolina, United States|Preston Robert Tisch Brain Tumor Center at Duke University, Durham, North Carolina, United States|Cleveland Clinic, Cleveland, Ohio, United States|The Ohio State University, Columbus, Ohio, United States|Lehigh Valley Health Network, Allentown, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Medical University Of South Carolina, Charleston, South Carolina, United States|Erlanger Oncology & Hematology - Univ. of TN, Chattanooga, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University Of Texas Southwestern Medical Center, Dallas, Texas, United States|University Of Texas Md Anderson Cancer Ctr, Houston, Texas, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States|Swedish Neuroscience Institute, Seattle, Washington, United States|Local Institution, Liverpool, New South Wales, Australia|Royal North Shore Hospital, St. Leonards, New South Wales, Australia|Local Institution, Heidelberg, Victoria, Australia|Local Institution, Prahran, Victoria, Australia|Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia|Kepler Universitaetsklinikum, Linz, Austria|Medical University Of Vienna, Vienna, Austria|Universitair Ziekenhuis Brussel, Brussels, Belgium|Cliniques Universitaires Saint-Luc, Bruxelles, Belgium|Uz Leuven, Leuven, Belgium|BC Cancer - Vancouver, Vancouver, British Columbia, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, Canada|Montreal Neurological Institute and Hospital, Montreal, Quebec, Canada|Local Institution, Copenhagen, Denmark|Local Institution, Odense, Denmark|Hopital Neurologique Pierre Wertheimer, Bron Cedex, France|Local Institution, Lille Cedex, France|Hopital La Timone, Marseille, France|Hopital Central, Nancy, France|Groupe Hospitalier Pitie-Salpetriere, Paris cedex 13, France|Local Institution, Paris, France|Centre Eugene Marquis, Rennes Cedex, France|Institut Univ Cancer Toulouse, Toulouse, France|Universitaetsklinikum Bonn, Bonn, Germany|Uniklinik Erlangen, Erlangen, Germany|Klinikum Der J. W. Goethe-Universitaet Frankfurt/Main, Frankfurt am Main, Germany|Medizinische Universitaetsklinik Freiburg, Freiburg, Germany|Universitaetsklinikum Hamburg, Hamburg, Germany|Universitaetsklinik Heidelberg, Heidelberg, Germany|Universitaetsklinikum Koeln, Koeln, Germany|Universitaetsklinikum Muenster, Muenster, Germany|Klinikum rechts der Isar der Technischen Universitat Munchen, Munich, Germany|Universitaetsklinikum Regensburg, Regensburg, Germany|Universitasklinikum Tubingen, Tuebingen, Germany|Local Institution, Petach Tikva, Israel|Local Institution, Tel Aviv, Israel|Local Institution, Bologna, Italy|Local Institution, Milano, Italy|Local Institution, Padova, Italy|Local Institution, Rozzano (milano), Italy|Local Institution, Siena, Italy|Azienda Ospedaliera Citta della Salute e della Scienza, Torino, Italy|Local Institution, Nagoya-shi, Aichi, Japan|Local Institution, Chiba-shi, Chiba, Japan|Local Institution, Hiroshima-Shi, Hiroshima, Japan|Local Institution, Sapporo-shi, Hokkaido, Japan|Local Institution, Kobe, Hyogo, Japan|Local Institution, Tsukuba-shi, Ibaraki, Japan|Local Institution, Kanazawa-shi, Ishikawa, Japan|Local Institution, Kagoshima-shi, Kagoshima, Japan|Local Institution, Sagamihara-shi, Kanagawa, Japan|Local Institution, Kumamoto-shi, Kumamoto, Japan|Local Institution, Kyoto-shi, Kyoto, Japan|Local Institution, Kyoto-shi, Kyoto, Japan|Local Institution, Okayama-shi, Okayama, Japan|Local Institution, Hirakata-shi, Osaka, Japan|Local Institution, Suita-shi, Osaka, Japan|Local Institution, Hidaka-shi, Saitama, Japan|Local Institution, Bunkyo-ku, Tokyo, Japan|Local Institution, Chuo-ku, Tokyo, Japan|Local Institution, Mitaka-shi, Tokyo, Japan|Local Institution, Yamagata-shi, Yamagata, Japan|Local Institution, Tokyo, Japan|NKI AVL, Amsterdam, Netherlands|Universitair Medisch Centrum Groningen, Groningen, Netherlands|Erasmus Mc, Rotterdam, Netherlands|Universitair Medisch Centrum Utrecht, Utrecht, Netherlands|Local Institution, Oslo, Norway|Uniwersyteckie Centrum Kliniczne Klinika Onkologii I Radiote, Gdansk, Poland|Local Institution, Warszawa, Poland|Local Institution, Moscow, Russian Federation|Local Institution, Moscow, Russian Federation|Local Institution, Badalona-Barcelona, Spain|Local Institution, Barcelona, Spain|Local Institution, Barcelona, Spain|Local Institution, Madrid, Spain|Local Institution, Madrid, Spain|Local Institution, Santiago De Compostela, Spain|Local Institution, Valencia, Spain|Local Institution, Lund, Sweden|Local Institution, Solna, Sweden|University Hospital Geneva, Geneve, Switzerland|Centre hospitalier universitaire Vaudois (CHUV), Lausanne, Switzerland|Universitaetsspital Zuerich, Zuerich, Switzerland|University College Hospital, London, Greater London, United Kingdom|Christie Hospital Nhs Found. Trust, Manchester, Greater Manchester, United Kingdom|Royal Marsden Hospital, Sutton, Surrey, United Kingdom|Beaston West of Scotland Cancer Centre, Glasgow, United Kingdom","https://ClinicalTrials.gov/show/NCT02617589"
886,"Lonafarnib and Temozolomide in Treating Patients With Glioblastoma Multiforme That Is Recurrent or Did Not Respond to Previous Treatment With Temozolomide","Active, not recruiting","No Results Available","Malignant Supratentorial Neoplasm|Recurrent Glioblastoma|Recurrent Gliosarcoma","Drug: Lonafarnib|Drug: Temozolomide","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00102648"
887,"Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas","Completed","Has Results","Brain Tumor|Glioblastoma","Drug: Vorinostst/Bevacizumab/Temozolomide","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00939991"
888,"Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma","Not yet recruiting","No Results Available","Glioma, Malignant","Drug: fb-PMT",,"https://ClinicalTrials.gov/show/NCT05226494"
889,"Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)","Completed","No Results Available","Glioblastoma Multiforme|Anaplastic Astrocytoma","Drug: Super-Selective Intraarterial Intracranial Infusion of BEVACIZUMAB","Lenox Hill Brain Tumor Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00968240"
890,"CT Perfusion in the Prognostication of Cerebral High Grade Glioma","Unknown status","No Results Available","Glioblastoma Multiforme","Radiation: CT Perfusion","QE II Health Sciences Centre, Halifax, Nova Scotia, Canada","https://ClinicalTrials.gov/show/NCT01923922"
891,"Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma","Completed","No Results Available","Glioblastoma","Drug: bsi-201 plus temozolomide","Research Site, Birmingham, Alabama, United States|Research Site, Tampa, Florida, United States|Research Site, Atlanta, Georgia, United States|Research Site, Baltimore, Maryland, United States|Research Site, Boston, Massachusetts, United States|Research Site, Detroit, Michigan, United States|Research Site, Winston Salem, North Carolina, United States|Research Site, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00687765"
892,"FDG and FDOPA PET Demonstration of Functional Brain Abnormalities","Recruiting","No Results Available","Glioblastoma","Procedure: Positron Emission Tomography|Procedure: Computed Tomography|Procedure: Multiparametric Magnetic Resonance Imaging Scan|Radiation: Fludeoxyglucose F-18|Radiation: fluorine F 18 fluorodopa","University of Virginia, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT04315584"
893,"Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma","Completed","No Results Available","Glioblastoma|Glioblastoma Multiforme|Glioma|Astrocytoma|Brain Tumor","Biological: Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy|Biological: Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab","Cedars-Sinai Medical Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT02010606"
894,"BNCT to Treat Glioma That Has Progressed Following Radiotherapy","Completed","No Results Available","Glioblastoma|Anaplastic Astrocytoma","Radiation: Bononophenylalanine (BPA)-based BNCT","Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland","https://ClinicalTrials.gov/show/NCT00115440"
895,"Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Radiation: iodine I 131 monoclonal antibody TNT-1/B","Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham, Birmingham, Alabama, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00128635"
896,"Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors","Completed","Has Results","Glioblastoma Multiforme|Gliosarcoma","Drug: Tarceva|Drug: Temodar|Procedure: Radiation Therapy","UCSF Department of Neurological Surgery, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT00187486"
897,"Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma","Suspended","No Results Available","Glioblastoma","Biological: Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF|Drug: Temozolomide|Biological: Tetanus-Diphtheria Toxoid (Td)|Biological: GM-CSF|Biological: 111-Indium-labeling of Cells for in vivo Trafficking Studies","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT03927222"
898,"A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma","Completed","No Results Available","Glioblastoma|Small Cell Glioblastoma|Giant Cell Glioblastoma|Gliosarcoma|Glioblastoma With Oligodendroglial Component|Recurrent Glioblastoma|Relapsed Glioblastoma","Drug: Bevacizumab|Drug: Rindopepimut (CDX-110) with GM-CSF|Drug: KLH","University of Alabama at Birmingham, Birmingham, Alabama, United States|St. Joseph's Hospital and Medical Center / Barrow Neurological Institute, Phoenix, Arizona, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|University of Southern California (USC) Norris Comprehensive Cancer Center, Los Angeles, California, United States|UC Irvine Chao Family Comprehensive Cancer Center, Orange, California, United States|University of California San Francisco, San Francisco, California, United States|Stanford Cancer Institute, Stanford University, Stanford, California, United States|University of Colorado, Denver, Aurora, Colorado, United States|Memorial Cancer Institute, Hollywood, Florida, United States|Orlando Health, Inc., Orlando, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|Piedmont Atlanta Hospital, Atlanta, Georgia, United States|Atlanta Cancer Care, Atlanta, Georgia, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|NorthShore University Health System, Evanston, Illinois, United States|The Johns Hopkins Hospital, Baltimore, Maryland, United States|Dana-Farber Cancer Institute and Mass General Hospital, Boston, Massachusetts, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Sparrow Cancer Center, Lansing, Michigan, United States|John Nasseff Neuroscience Institute, Abbott Northwestern Hospital, 800 e. 28th Str. MR, Minneapolis, Minnesota, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|New Jersey Neuroscience Institute JFK Medical Center, Edison, New Jersey, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Dent Neurologic Institute, 3980 Sheridan Dr, 3rd Flr Clinical Rsch, Amherst, New York, United States|The Long Island Brain Tumor Center at Neurology Surgery, P.C., Commack, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Stony Brook University Hospital, Stony Brook, New York, United States|The Preston Robert Tisch Brain Tumor Center; Duke University Medical Center, Durham, North Carolina, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States|University of Cincinnati Cancer Institute, Cincinnati, Ohio, United States|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States|Legacy Research Institute, Portland, Oregon, United States|Lehigh Valley Hospital-John and Dorothy Morgan Cancer Center, Allentown, Pennsylvania, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States|Texas Oncology Midtown, Austin, Texas, United States|Baylor Research Institute, Dallas, Texas, United States|UT Health Science Center, Houston Memorial Hermann Hospital, 6400 Fannin Street, #2800, Houston, Texas, United States|Utah Cancer Specialists, Salt Lake City, Utah, United States|Swedish Neuroscience Research, Seattle, Washington, United States|University of Washington Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT01498328"
899,"A Pilot Study to Determine Nutrition Status in Glioblastoma Multiforme Patients","Completed","No Results Available","Brain Cancer","Other: Nutrition","University of Alabama at Birmingham, Birmingham, Alabama, United States","https://ClinicalTrials.gov/show/NCT01770626"
900,"Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma","Completed","No Results Available","Glioma|Glioblastoma Multiforme|Anaplastic Astrocytoma","Drug: LS11 (talaporfin sodium)|Device: Light source (interstitial light emitting diodes)|Procedure: Intraoperative placement of device in glioma","Institute of Neurosurgery, Clinical Centre Serbia, Belgrade, Serbia","https://ClinicalTrials.gov/show/NCT00409214"
901,"Potentiation of Chemotherapy in Brain Tumors by Zinc","Recruiting","No Results Available","Newly Diagnosed Glioblastoma Who Underwent at Least Partial Resection of the Tumor Surgically","Dietary Supplement: zinc and ascorbate","Sheba Medical Center, Ramat Gan, Israel","https://ClinicalTrials.gov/show/NCT04488783"
902,"Ph I SU011248 + Irinotecan in Treatment of Pts w MG","Completed","No Results Available","Glioblastoma","Drug: SU011248 & Irinotecan","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00611728"
903,"Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics","Unknown status","No Results Available","Glioblastoma|Malignant Glioma",,"Nanfang Glioma Centre, Guangzhou, Guangdong, China","https://ClinicalTrials.gov/show/NCT02047058"
904,"Immunophenotyping From Blood of Patients With Malignant Gliomas","Active, not recruiting","No Results Available","Anaplastic Astrocytoma|Glioblastoma Multiforme","Other: Blood sample and life quality questionnaires","Departement of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität erlangen-Nürnberg, Erlangen, BAY, Germany","https://ClinicalTrials.gov/show/NCT02022384"
905,"Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)","Recruiting","No Results Available","Glioma|Glioma, Malignant|Glioblastoma|Glioblastoma Multiforme|Glioblastoma Multiforme of Brain|GBM|Brain Cancer","Procedure: Laparoscopically harvested omental free flap","Lenox Hill Brain Tumor Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT04222309"
906,"Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma","Enrolling by invitation","No Results Available","Astrocytoma, Grades II, III and IV|Glioblastoma Multiforme|Giant Cell Glioblastoma|Glioma|Oligodendrogliomas","Drug: LB-100","National Institutes of Health Clinical Center, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT03027388"
907,"Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients","Completed","No Results Available","Glioblastoma|Glioma","Drug: Bevacizumab standard of care","Hôpital Avicenne, Bobigny, France|Center Eugene Marquis, Rennes, France","https://ClinicalTrials.gov/show/NCT01836536"
908,"S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma","Completed","No Results Available","Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System","Drug: carmustine|Radiation: radiation therapy|Drug: O6-Benzylguanine","Alaska Regional Hospital Cancer Center, Anchorage, Alaska, United States|Banner Good Samaritan Medical Center, Phoenix, Arizona, United States|CCOP - Western Regional, Arizona, Phoenix, Arizona, United States|St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|Banner Thunderbird Medical Center, Phoenix, Arizona, United States|North Bay Cancer Center, Fairfield, California, United States|Memorial Hospital Cancer Center, Colorado Springs, Colorado, United States|St. Anthony Central Hospital, Denver, Colorado, United States|University of Colorado Cancer Center at University of Colorado Health Sciences Center, Denver, Colorado, United States|North Colorado Medical Center, Greeley, Colorado, United States|McKee Medical Center, Loveland, Colorado, United States|St. Anthony North Hospital, Westminster, Colorado, United States|Exempla Lutheran Medical Center, Wheat Ridge, Colorado, United States|West Florida Cancer Institute at West Florida Hospital - Pensacola, Pensacola, Florida, United States|Piedmont Hospital, Atlanta, Georgia, United States|CCOP - Atlanta Regional, Atlanta, Georgia, United States|Northside Hospital Cancer Center, Atlanta, Georgia, United States|Saint Joseph's Hospital of Atlanta, Atlanta, Georgia, United States|WellStar Cobb Hospital, Austell, Georgia, United States|Charles B. Eberhart Cancer Center at DeKalb Medical Center, Decatur, Georgia, United States|Northeast Georgia Medical Center, Gainesville, Georgia, United States|Gwinnett Medical Center, Lawrenceville, Georgia, United States|Kennestone Cancer Center at Wellstar Kennestone Hospital, Marietta, Georgia, United States|Southern Regional Medical Center, Riverdale, Georgia, United States|Hematology Oncology Associates of Eastern Idaho, Idaho Falls, Idaho, United States|Saint Anthony's Hospital at Saint Anthony's Health Center, Alton, Illinois, United States|University of Illinois at Chicago Cancer Center, Chicago, Illinois, United States|Veterans Affairs Medical Center - Chicago Westside Hospital, Chicago, Illinois, United States|Decatur Memorial Hospital Cancer Care Institute, Decatur, Illinois, United States|Good Samaritan Regional Health Center, Mt. Vernon, Illinois, United States|Regional Cancer Center at Memorial Medical Center, Springfield, Illinois, United States|St. Francis Hospital and Health Centers, Beech Grove, Indiana, United States|Genesis Regional Cancer Center at Genesis Medical Center, Davenport, Iowa, United States|Genesis Medical Center - West Campus, Davenport, Iowa, United States|Cancer Center of Kansas - Chanute, Chanute, Kansas, United States|Cancer Center of Kansas - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas, P.A. - El Dorado, El Dorado, Kansas, United States|Veterans Affairs Medical Center - Kansas City, Kansas City, Kansas, United States|Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center, Kansas City, Kansas, United States|Cancer Center of Kansas - Kingman, Kingman, Kansas, United States|Southwest Medical Center, Liberal, Kansas, United States|Cancer Center of Kansas - Newton, Newton, Kansas, United States|Cancer Center of Kansas, P.A. - Parsons, Parsons, Kansas, United States|Pratt Cancer Center of Kansas, Pratt, Kansas, United States|Cancer Center of Kansas - Salina, Salina, Kansas, United States|Salina Regional Health Center, Salina, Kansas, United States|Stormont-Vail Cancer Center, Topeka, Kansas, United States|St. Francis Comprehensive Cancer Center, Topeka, Kansas, United States|Cancer Center of Kansas - Wellington, Wellington, Kansas, United States|Associates in Womens Health, Wichita, Kansas, United States|Cancer Center of Kansas, P.A., Wichita, Kansas, United States|Cancer Center of Kansas, P.A. - Wichita, Wichita, Kansas, United States|CCOP - Wichita, Wichita, Kansas, United States|Via Christi Cancer Center at Via Christi Regional Medical Center, Wichita, Kansas, United States|Wesley Medical Center, Wichita, Kansas, United States|Cancer Center of Kansas - Winfield, Winfield, Kansas, United States|Baton Rouge General Regional Cancer Center, Baton Rouge, Louisiana, United States|Mary Bird Perkins Cancer Center - Baton Rouge, Baton Rouge, Louisiana, United States|MBCCOP - LSU Health Sciences Center, New Orleans, Louisiana, United States|Medical Center of Louisiana - New Orleans, New Orleans, Louisiana, United States|Battle Creek Health System Cancer Care Center, Battle Creek, Michigan, United States|Mecosta County General Hospital, Big Rapids, Michigan, United States|CCOP - Grand Rapids, Grand Rapids, Michigan, United States|Lacks Cancer Center at Saint Mary's Mercy Medical Center, Grand Rapids, Michigan, United States|Spectrum Health Cancer Care - Butterworth Campus, Grand Rapids, Michigan, United States|Metropolitan Hospital, Grand Rapids, Michigan, United States|Holland Community Hospital, Holland, Michigan, United States|Hackley Hospital, Muskegon, Michigan, United States|Northern Michigan Hospital, Petoskey, Michigan, United States|William Beaumont Hospital - Royal Oak Campus, Royal Oak, Michigan, United States|Munson Medical Center, Traverse City, Michigan, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|St. Francis Medical Center, Cape Girardeau, Missouri, United States|Southeast Missouri Regional Cancer Center at Southeast Missouri Hospital, Gape Girardeau, Missouri, United States|Freeman Cancer Institute at Freeman Health System, Joplin, Missouri, United States|CCOP - Kansas City, Kansas City, Missouri, United States|St. John's Regional Health Center, Springfield, Missouri, United States|Hulston Cancer Center at Cox Medical Center South, Springfield, Missouri, United States|CCOP - St. Louis-Cape Girardeau, St. Louis, Missouri, United States|David C. Pratt Cancer Center at St. John's Mercy, St. Louis, Missouri, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|Deaconess Billings Clinic - Downtown, Billings, Montana, United States|Hematology-Oncology Centers of the Northern Rockies - Billings, Billings, Montana, United States|Northern Rockies Radiation Oncology Center, Billings, Montana, United States|St. Vincent Healthcare, Billings, Montana, United States|Deaconess Billings Clinic Cancer Center, Billings, Montana, United States|Bozeman Deaconess Hospital, Bozeman, Montana, United States|Internal Medicine Associates of Bozeman, Bozeman, Montana, United States|St. James Community Hospital, Butte, Montana, United States|Great Falls Clinic, Great Falls, Montana, United States|Sletten Regional Cancer Institute, Great Falls, Montana, United States|St. Peter's Hospital, Helena, Montana, United States|Glacier Oncology, PLLC, Kalispell, Montana, United States|Kalispell Medical Oncology, Kalispell, Montana, United States|Eastern Montana Cancer Center, Miles City, Montana, United States|Community Medical Center, Missoula, Montana, United States|Montana Cancer Center at St. Patrick Hospital and Health Sciences Center, Missoula, Montana, United States|Montana Cancer Specialists at Montana Cancer Center, Missoula, Montana, United States|Good Samaritan Health Systems, Kearney, Nebraska, United States|James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York, United States|Presbyterian Cancer Center at Presbyterian Hospital, Charlotte, North Carolina, United States|Wayne Memorial Hospital, Incorporated, Goldsboro, North Carolina, United States|Adena Regional Medical Center, Chillicothe, Ohio, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|Riverside Methodist Hospital Cancer Care, Columbus, Ohio, United States|CCOP - Columbus, Columbus, Ohio, United States|Grant Riverside Cancer Services, Columbus, Ohio, United States|Mount Carmel West Hospital, Columbus, Ohio, United States|Doctors Hospital at Ohio Health, Columbus, Ohio, United States|Grandview Hospital, Dayton, Ohio, United States|Good Samaritan Hospital, Dayton, Ohio, United States|David L. Rike Cancer Center at Miami Valley Hospital, Dayton, Ohio, United States|Samaritan North Cancer Care Center, Dayton, Ohio, United States|Veterans Affairs Medical Center - Dayton, Dayton, Ohio, United States|CCOP - Dayton, Dayton, Ohio, United States|Grady Memorial Hospital, Delaware, Ohio, United States|Community Oncology Group - Independence, Independence, Ohio, United States|Charles F. Kettering Memorial Hospital, Kettering, Ohio, United States|Fairfield Medical Center, Lancaster, Ohio, United States|Strecker Cancer Center at Marietta Memorial Hospital, Marietta, Ohio, United States|Middletown Regional Hospital, Middletown, Ohio, United States|Licking Memorial Cancer Care Program at Licking Memorial Hospital, Newark, Ohio, United States|Mercy Medical Center Oncology Unit, Springfield, Ohio, United States|Community Hospital of Springfield and Clark County, Springfield, Ohio, United States|UVMC Cancer Care Center at Upper Valley Medical Center, Troy, Ohio, United States|Mount Carmel Cancer Services at Mount Carmel St. Ann's Hospital, Westerville, Ohio, United States|Cleveland Clinic - Wooster, Wooster, Ohio, United States|Ruth G. McMillan Cancer Center at Greene Memorial Hospital, Xenia, Ohio, United States|Genesis - Good Samaritan Hospital, Zanesville, Ohio, United States|Legacy Mount Hood Medical Center, Glesham, Oregon, United States|Providence Milwaukie Hospital, Milwaukie, Oregon, United States|Legacy Good Samaritan Hospital & Medical Center Comprehensive Cancer Center, Portland, Oregon, United States|Providence Cancer Center at Providence Portland Medical Center, Portland, Oregon, United States|CCOP - Columbia River Oncology Program, Portland, Oregon, United States|Providence St. Vincent Medical Center, Portland, Oregon, United States|Institute of Oncology at Vilnius University, Portland, Oregon, United States|Salem Hospital Regional Cancer Center, Salem, Oregon, United States|Legacy Meridian Park Hospital, Tualatin, Oregon, United States|Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center, Kingsport, Tennessee, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|Wilford Hall Medical Center, Lackland AFB, Texas, United States|CCOP - Scott and White Hospital, Temple, Texas, United States|Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah, United States|Danville Regional Medical Center, Danville, Virginia, United States|St. Joseph Hospital Community Cancer Center, Bellingham, Washington, United States|Olympic Hematology and Oncology, Bremerton, Washington, United States|St. Francis Hospital, Federal Way, Washington, United States|Skagit Valley Hospital Cancer Care Center, Mt. Vernon, Washington, United States|Capital Medical Center, Olympia, Washington, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, United States|Group Health Central Hospital, Seattle, Washington, United States|Harborview Medical Center, Seattle, Washington, United States|Swedish Cancer Institute at Swedish Medical Center - First Hill Campus, Seattle, Washington, United States|University Cancer Center at University of Washington Medical Center, Seattle, Washington, United States|North Puget Oncology at United General Hospital, Sedro-Wooley, Washington, United States|Cancer Care Northwest - Spokane South, Spokane, Washington, United States|Allenmore Hospital, Tacoma, Washington, United States|CCOP - Northwest, Tacoma, Washington, United States|St. Clare Hospital, Tacoma, Washington, United States|Southwest Washington Medical Center Cancer Center, Vancouver, Washington, United States|Central Washington Hospital, Wenatchee, Washington, United States|Wenatchee Valley Clinic, Wenatchee, Washington, United States|Welch Cancer Center, Sheridan, Wyoming, United States","https://ClinicalTrials.gov/show/NCT00017147"
909,"Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma","Withdrawn","No Results Available","Giant Cell Glioblastoma|Gliosarcoma|Oligodendroglioma|Recurrent Glioblastoma|Small Cell Glioblastoma","Biological: autologous dendritic cells pulsed with tumor lysate antigen Vaccine|Other: Laboratory Biomarker Analysis|Biological: Nivolumab|Other: Quality-of-Life Assessment|Other: Questionnaire Administration","UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT03014804"
910,"Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma","Active, not recruiting","No Results Available","Malignant Glioma|Glioblastoma Multiforme|Anaplastic Astrocytoma|High Grade Glioma","Biological: Dendritic Cell Vaccine|Biological: Tumor Lysate|Drug: Imiquimod|Procedure: Leukapheresis","University of Miami, Miami, Florida, United States","https://ClinicalTrials.gov/show/NCT01808820"
911,"Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma","Completed","No Results Available","CNS Tumor, Adult","Biological: IMA 950|Biological: Poly ICLC|Other: Immunomonitoring","Geneva University Hospitals, Centre of Oncology, Geneva, Switzerland","https://ClinicalTrials.gov/show/NCT01920191"
912,"Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas","Completed","Has Results","Glioblastoma Multiforme|Glioma","Drug: Thalidomide|Drug: CPT-11|Procedure: MRI Scan|Procedure: Quantitative Sensory Tests (QST)","U.T.M.D. Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00412542"
913,"Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue","Recruiting","No Results Available","Glioblastoma","Device: NICO Myriad and Tissue Preservation System (TPS)","Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT04545177"
914,"The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma","Terminated","No Results Available","Glioblastoma Multiforme|Anaplastic Astrocytoma","Biological: Toca 511|Drug: Toca FC|Drug: Lomustine|Drug: Temozolomide|Biological: Bevacizumab","Barrow Neurological Institute at Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|University of California, Irvine, Irvine, California, United States|University of California San Diego, La Jolla, California, United States|University of California, Los Angeles, Los Angeles, California, United States|St. Joseph Hospital, Orange, California, United States|University of California San Francisco, San Francisco, California, United States|Stanford University, Stanford, California, United States|University of Colorado Cancer Center, Aurora, Colorado, United States|Colorado Neurological Institute, Englewood, Colorado, United States|Associated Neurologists of Southern Connecticut, Fairfield, Connecticut, United States|Yale University/Yale Cancer Center, New Haven, Connecticut, United States|University of Florida McKnight Brain Institute, Gainesville, Florida, United States|University of Miami, Miami, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|NorthShore University Health System, Evanston, Illinois, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Johns Hopkins University School of Medicine, Baltimore, Maryland, United States|University of Michigan, Ann Arbor, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|Abbott Northwestern Hospital / Allina Health, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|HCA Midwest / Sarah Cannon, Kansas City, Missouri, United States|Washington University St. Louis, Saint Louis, Missouri, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|JFK Medical Center Neuroscience Institute, Edison, New Jersey, United States|John Theurer Cancer Center at Hackensack University, Hackensack, New Jersey, United States|Overlook Medical Center, Summit, New Jersey, United States|North Shore University Hospital, Lake Success, New York, United States|NYU Langone Medical Center, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|Columbia University, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Stony Brook University Hospital, Stony Brook, New York, United States|Cincinnati's Children's Hospital Medical Center, Cincinnati, Ohio, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Cleveland Clinic, Cleveland, Ohio, United States|Ohio State University, Columbus, Ohio, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Sanford Research, Sioux Falls, South Dakota, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Baylor University Medical Center, Dallas, Texas, United States|Houston Methodist Hospital Outpatient Center, Houston, Texas, United States|University of Texas Health Science Center at Houston (UTHealth), Houston, Texas, United States|University of Virginia Health System, Charlottesville, Virginia, United States|Inova Dwight and Martha Schar Cancer Institute, Fairfax, Virginia, United States|Sentara Neurosurgery Specialists, Norfolk, Virginia, United States|West Virginia University, Morgantown, West Virginia, United States|University of Wisconsin, Madison, Wisconsin, United States|University of Alberta, Edmonton, Alberta, Canada|University of British Columbia / Vancouver General Hospital, Vancouver, British Columbia, Canada|CancerCare Manitoba, Winnipeg, Manitoba, Canada|London Regional Cancer Centre, London, Ontario, Canada|Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, Canada|Sunnybrook Hospital / Sunnybrook Research Institute, Toronto, Ontario, Canada|Toronto Western Hospital, Toronto, Ontario, Canada|Montreal Neurological Institute, Montreal, Quebec, Canada|Jewish General Hospital, Montreal, Quebec, Canada|Sherbrooke Hospital University Centre (CHUS), Sherbrooke, Quebec, Canada|Rambam Health Care, Haifa, Israel|Hadassah Medical Center, Jerusalem, Israel|Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel|Seoul National University Hospital, Seoul, Korea, Republic of|Severance Hospital, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Seoul St. Mary's Hospital, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT02414165"
915,"Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma","Recruiting","No Results Available","Glioblastoma","Device: Focused Ultrasound (FUS) BBB Disruption","Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT03616860"
916,"Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas","Completed","No Results Available","Glioblastoma","Drug: C225-ILs-dox","Kantonsspital Aarau (KSA), Oncology, Aarau, Switzerland|Department of Oncology University Hospital Basel, Basel, Switzerland","https://ClinicalTrials.gov/show/NCT03603379"
917,"Safety of BBB Opening With the SonoCloud","Completed","No Results Available","Glioblastoma|Glioma|Brain Tumor","Device: SonoCloud|Drug: Carboplatin","Groupe Hospitalier Pitié Salpetriere - Neurosurgery Department, Paris, France","https://ClinicalTrials.gov/show/NCT02253212"
918,"Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Glioblastoma|Brain Cancer|Brain Neoplasm|Brain Tumor|Brain Neoplasm, Malignant|EGFR Gene Overexpression|GBM","Drug: Intra-arterial Cetuximab|Drug: Intra-arterial Mannitol","Lenox Hill Brain Tumor Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT02861898"
919,"MRI Detection of Microbleeds in Glioma Patients","Completed","No Results Available","Glioblastoma",,,"https://ClinicalTrials.gov/show/NCT02899663"
920,"Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma","Completed","No Results Available","Glioblastoma","Drug: Bevacizumab|Drug: Nimustine","Huashan hospital, Fudan University, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT02698280"
921,"HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM","Completed","Has Results","Brain and Central Nervous System Tumors","Biological: HSPPC-96|Drug: Temozolomide|Procedure: Standard Surgical Resection","University of California, San Francisco, San Francisco, California, United States|University of Miami, Miami, Florida, United States|Northwestern University, Chicago, Illinois, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States|The Valley Hospital, Paramus, New Jersey, United States|Northern Westchester Hospital, Mount Kisco, New York, United States|Columbia University, New York, New York, United States|University of Oklahoma, Oklahoma City, Oklahoma, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00905060"
922,"POSitron Emission Imaging Using 18F-FDOPA in Neurooncology","Completed","No Results Available","Glioblastoma","Other: impact of device 18F-FDOPA PET on treatment decisions","Centre Antoine Lacassagne, Nice, France","https://ClinicalTrials.gov/show/NCT02631655"
923,"Pilot Viability of 11C-MET-PET as a Post-surgery Baseline Scan in High-grade Gliomas","Unknown status","No Results Available","Glioblastoma",,,"https://ClinicalTrials.gov/show/NCT02585219"
924,"Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer","Completed","No Results Available","Glioblastoma","Biological: CMV-ALT + CMV-DCs|Biological: CMV-ALT + Saline","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00693095"
925,"Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients","Enrolling by invitation","No Results Available","Glioblastoma|Adult Gliosarcoma|Neoplasms, Brain|Neoplasms, Germ Cell and Embryonal|Recurrent Glioblastoma","Drug: MSC11FCD","Bundang CHA Medical Center, Seongnam, Kyunggido, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04657315"
926,"The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients","Terminated","No Results Available","Depression","Drug: duloxetine|Drug: PLACEBO",,"https://ClinicalTrials.gov/show/NCT02443194"
927,"Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas","Completed","No Results Available","Glioblastoma","Procedure: Lymphocyte harvesting & reinfusion","Johns Hopkins University, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT01653834"
928,"A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG)","Completed","No Results Available","Glioblastoma","Drug: Hydroxychloroquine|Radiation: Radiotherapy","St James's University Hospital, Leeds, West Yorkshire, United Kingdom|Glan Clwyd Hospital, Bodelwyddan, United Kingdom|Addenbrooke's Hospital, Cambridge, United Kingdom|Ninewells Hospital, Dundee, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom|Royal Surrey County Hospital, Guildford, United Kingdom|University College Hospital, London, United Kingdom|Guy's and St Thomas's Hospitals, London, United Kingdom|Charing Cross Hospital, London, United Kingdom|Christie Hospital, Manchester, United Kingdom|James Cook University Hospital, Middlesbrough, United Kingdom|Freeman Hospital, Newcastle, United Kingdom|Norfolk & Norwich University Hospitals, Norwich, United Kingdom|The Royal Preston Hospital, Preston, United Kingdom|Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom","https://ClinicalTrials.gov/show/NCT01602588"
929,"Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors","Completed","Has Results","Glioblastoma Multiforme|Gliosarcoma","Drug: ZD6474|Drug: temozolomide|Radiation: Radiation Therapy","Massachusetts General Hospital, Boston, Massachusetts, United States|Dana Farber / Brigham and Women's Cancer Center, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|University of Virginia, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT00441142"
930,"UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: A Phase 2 Trial","Recruiting","No Results Available","Glioblastoma Multiforme","Radiation: Reduced margin adaptive radiotherapy","Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT04726397"
931,"Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma","Completed","Has Results","Adult Brain Tumor|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Procedure: conventional surgery|Drug: tandutinib|Other: pharmacological study|Other: Tissue samples","University of Alabama at Birmingham, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Emory University, Atlanta, Georgia, United States|Johns Hopkins University, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00379080"
932,"Expanded Access for KHK2455","No longer available","No Results Available","Glioblastoma Multiforme","Drug: KHK2455",,"https://ClinicalTrials.gov/show/NCT04321694"
933,"Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide","Completed","No Results Available","Glioblastoma","Drug: Temodar and Irinotecan","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00616005"
934,"Automatic Segmentation MRI Cerebral Glioma","Not yet recruiting","No Results Available","Cerebral Glioblastoma","Device: MRI",,"https://ClinicalTrials.gov/show/NCT04674579"
935,"Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery","Completed","No Results Available","Glioblastoma","Drug: Aminolevulinic Acid","Allegheny General Hospital, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00961090"
936,"Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas","Completed","No Results Available","Malignant Gliomas","Drug: Cetuximab|Drug: Bevacizumab|Drug: Irinotecan","Aalborg University Hospital, Aalborg, Denmark|Rigshospitalet, Copenhagen, Denmark|Odense University Hospital, Odense, Denmark","https://ClinicalTrials.gov/show/NCT00463073"
937,"AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery","Recruiting","No Results Available","Brain and Central Nervous System Tumors","Drug: BGB 324 (before surgery)|Drug: BGB 324 (after surgery)","Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, Alabama, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Henry Ford Hospital, Detroit, Michigan, United States|Memorial Sloan Kettering, New York, New York, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT03965494"
938,"MRI Predictors of Response to Tumor Treating Fields","Recruiting","No Results Available","Glioblastoma Multiforme",,"New York Presbyterian - Brooklyn Methodist Hospital, Brooklyn, New York, United States","https://ClinicalTrials.gov/show/NCT03642080"
939,"The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.","Recruiting","No Results Available","Glioblastoma|Glioblastoma Multiforme|Glioblastoma Multiforme of Brain|Astrocytoma, Grade IV|Brain Tumor|Brain Cancer|Brain Neoplasms","Procedure: Awake craniotomy|Procedure: Craniotomy under general anesthesia","University Hospital Brussels, Brussels, Belgium|University Hospital Ghent, Ghent, Belgium|Elisabeth-Tweesteden Ziekenhuis, Tilburg, Noord-Brabant, Netherlands|Erasmus MC, Rotterdam, Zuid-Holland, Netherlands|Medical Center Haaglanden, The Hague, Zuid-Holland, Netherlands|University Medical Center Groningen, Groningen, Netherlands","https://ClinicalTrials.gov/show/NCT03861299"
940,"A Phase I/II Study of the Photon Radiosurgery System","Completed","No Results Available","Brain Tumor, Recurrent|Glioblastoma Multiforme","Procedure: Photon Radiosurgery System (Intrabeam)","Children's Memorial Hospital, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT00179907"
941,"Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG","Recruiting","No Results Available","Childhood Glioblastoma","Drug: depletion of regulatory T cells|Procedure: reoperation|Biological: cancer vaccine|Biological: checkpoint blockade","University Children's Hospital, Würzburg, Bavaria, Germany","https://ClinicalTrials.gov/show/NCT03879512"
942,"Prognostic Impact of Surgical Resection Extent for Supratentorial High Grade Gliomas.","Unknown status","No Results Available","Supratentorial Glioblastoma","Procedure: Supratentorial high grade gliomas resection.",,"https://ClinicalTrials.gov/show/NCT03997136"
943,"Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.","Unknown status","No Results Available","Glioblastoma Multiforme|Angiogenesis","Radiation: Chemoradiation with temozolomide","Taichung Veterans General Hospital, Taichung, Taiwan","https://ClinicalTrials.gov/show/NCT03225963"
944,"Low Dose Radiation Therapy for Glioblastoma Multiforme","Recruiting","No Results Available","High Grade Glioma","Radiation: Low Dose Fractionated Radiation Therapy (LDFRT)|Drug: Temozolomide","Sibley Memorial Hospital, Washington, District of Columbia, United States|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Suburban Hospital, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT01466686"
945,"Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma","Terminated","No Results Available","Glioblastoma","Procedure: Gamma Knife Radiosurgery","UCSF Department of Neurosurgery, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT01011231"
946,"Expanded Access for Pembrolizumab (MK-3475)","No longer available","No Results Available","Melanoma (Skin)|Melanoma Recurrent|Glioblastoma Multiforme|Glioblastoma by Gene Expression Profile|Glioma of Brain","Biological: pembrolizumab","N.N. Alexandrov National Cancer Centre, Minsk, Belarus|The Hong Kong Cancer Institute, Hong Kong, Hong Kong|""Cancer Research Center"" of the Ministry of Health of the Republic of Tajikistan, Dushanbe, Tajikistan|Republican Cancer Research Center of the Ministry of Health of the Republic of Uzbekistan (RENTC MH RUz), Tashkent, Uzbekistan","https://ClinicalTrials.gov/show/NCT03311542"
947,"Cilengitide Imaging Trial in Glioblastoma","Terminated","No Results Available","Supratentorial Newly Diagnosed Inoperable Gliobastoma","Drug: Drug (including placebo)|Other: Standard therapy","Merck KGaA Communication Center located in, Darmstadt, Germany","https://ClinicalTrials.gov/show/NCT01558687"
948,"Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT","Terminated","Has Results","Brain and Central Nervous System Tumors","Radiation: radiation therapy|Drug: Celecoxib","H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00068770"
949,"Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma","Completed","Has Results","Brain Tumor|Astrocytoma|Astroglioma|Glioblastoma|Gliosarcoma","Drug: Zotiraciclib (TG02)|Drug: Temozolomide (TMZ)","National Institutes of Health Clinical Center, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT02942264"
950,"Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","CNS Tumor, Adult","Drug: erlotinib hydrochloride|Drug: temozolomide|Radiation: radiation therapy","Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00274833"
951,"Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.","Withdrawn","No Results Available","Glioblastoma Multiforme|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma","Other: MRS Spectroscopy","Weill Cornell Medical College Department of Neurosurgery, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00645385"
952,"Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide","Not yet recruiting","No Results Available","Glioblastoma, IDH-wildtype","Drug: Metformin|Radiation: Radiation IMRT|Drug: Temozolomide","Foch Hospital, Suresnes, Hauts De Seine, France|Hôpital Neurologique Pierre Wertheimer, Bron, Lyon, France|Timone Hospital, Marseille, France|Saint Louis Hospital, Paris, France|Pitié Salpêtrière Hospital, Paris, France|Istituto Nazionale Carlo Besta, Milano, Italy","https://ClinicalTrials.gov/show/NCT04945148"
953,"Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma","Completed","Has Results","Glioblastoma|Malignant Glioma|Medulloblastoma Recurrent|Pediatric Glioblastoma Multiforme|Pediatric Brain Tumor, Recurrent|Pediatric Brain Tumor","Biological: CMV-DCs with GM-CSF|Biological: Td (tetanus toxoid)","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT03615404"
954,"Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma","Active, not recruiting","No Results Available","Glioblastoma","Other: Modified Atkins Ketogenic Diet","UC Health, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT03278249"
955,"Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI","Recruiting","No Results Available","Glioblastoma","Radiation: Avastin|Radiation: Lomustine|Radiation: Temozolomide|Device: MRI|Device: MRS|Device: DSC","Massachusetts general Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT02843230"
956,"Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas","Completed","No Results Available","Glioblastoma",,"Le Rhun, Lille, France","https://ClinicalTrials.gov/show/NCT02473484"
957,"Translational Study of Nivolumab in Combination With Bevacizumab for Recurrent Glioblastoma","Recruiting","No Results Available","Recurrent Adult Brain Tumor","Drug: Nivolumab|Drug: Bevacizumab","Rigshospitalet, Copenhagen, Denmark","https://ClinicalTrials.gov/show/NCT03890952"
958,"Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: temozolomide|Drug: temsirolimus","UZ Leuven, Leuven, Belgium|Institut de Cancerologie de l'Ouest (ICO) - Centre Rene Gauducheau, Nantes-Saint Herblain, France|CHU Pitie-Salpetriere AP-HP, Paris, France|Universitaetsklinikum Freiburg, Freiburg, Germany|Universitatsklinikum Heidelberg, Heidelberg, Germany|Ospedale Bellaria, Bologna, Italy|Medisch Centrum Haaglanden - Westeinde, Den Haag, Netherlands|Erasmus MC - Daniel den Hoed Cancer Center, Rotterdam, Netherlands|ICO Badalona - Hospital Germans Trias i Pujol, Badalona, Spain|Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland|UniversitaetsSpital Zuerich, Zurich, Switzerland|Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral, United Kingdom|Western General Hospital, Edinburgh, United Kingdom","https://ClinicalTrials.gov/show/NCT01019434"
959,"Disease Progression and Treatment-induced Alterations in Glioblastoma","Unknown status","No Results Available","Brain Tumor","Genetic: analyze systematically morphological and molecular changes associated with glioblastoma progression and therapy-resistance","Medical University of Vienna, Institute of Neurology, Vienna, Austria","https://ClinicalTrials.gov/show/NCT02152748"
960,"[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers","Recruiting","No Results Available","Healthy Subject|Intracranial Neoplasm|Glioblastoma","Drug: Fluorine F 18 DASA-23|Procedure: Positron Emission Tomography","Stanford University, School of Medicine, Palo Alto, California, United States","https://ClinicalTrials.gov/show/NCT03539731"
961,"A Phase 0 /II Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection","Recruiting","No Results Available","Glioblastoma Multiforme|Glioma of Brain","Drug: Ribociclib|Drug: Everolimus","Chandler Regional Medical Center, Chandler, Arizona, United States|St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|HonorHealth Scottsdale Osborn Medical Center, Scottsdale, Arizona, United States","https://ClinicalTrials.gov/show/NCT03834740"
962,"Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors","Active, not recruiting","No Results Available","Glioblastoma","Other: Energy restricted Ketogenic Diet (ERKD) (Metabolic Nutritional Therapy)","Michigan State University/Sparrow Hospital, East Lansing, Michigan, United States","https://ClinicalTrials.gov/show/NCT01535911"
963,"Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme","Completed","No Results Available","Recurrent Adult Brain Tumor","Drug: Gliadel wafers in combination with O6-benzylguanine","Duke Comprehensive Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00362921"
964,"Prospective Cohort of Patients With Newly Diagnosed Glioblastoma: Analysis of MMP2 and MMP9 Expression and Correlation to Neuro-imaging Features.","Recruiting","No Results Available","Brain Tumor","Biological: Blood sample|Biological: Tumor sample","Assistance Publique Hôpitaux de Marseille, Marseille, France","https://ClinicalTrials.gov/show/NCT03526822"
965,"Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma","Completed","Has Results","Glioblastoma Multiforme","Drug: Bevacizumab|Drug: Metronomic Temozolomide","Duke University Medical Center (Brain Tumor Center), Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00501891"
966,"Long-term Follow-up of Subjects Treated With CARv3-TEAM-E T Cells","Not yet recruiting","No Results Available","Glioblastoma Recurrent, EGFR vIII Mutant|Newly Diagnosed Glioblastoma, EGFRvIII Mutant|Recurrent Glioblastoma, EGFR vIII Negative","Diagnostic Test: Disease assessments|Procedure: Tumor Biopsy|Diagnostic Test: Blood test","Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT05024175"
967,"Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma","Completed","Has Results","Neoplasms","Drug: BAL101553|Drug: BAL101553 at MTD","Oncology Institute of Southern Switzerland; Ospedale Regionale San Giovanni Bellinzona e Valli, Bellinzona, Switzerland|Inselspital Bern, Bern, Switzerland|Cantonal Hospital of Grisons, Department of Oncology/ Haematology, Chur, Switzerland|Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland|Cantonal Hospital of St. Gallen, Dep. Medical Oncology & Hematology, St. Gallen, Switzerland|UniversitaetsSpital Zürich, Zürich, Switzerland","https://ClinicalTrials.gov/show/NCT02895360"
968,"A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma","Completed","Has Results","Glioma","Radiation: High Dose Radiation|Drug: Temozolomide","University of Michigan Hospital, Ann Arbor, Michigan, United States","https://ClinicalTrials.gov/show/NCT02805179"
969,"Autologous T Cells Redirected to EGFRVIII-With a Chimeric Antigen Receptor in Patients With EGFRVIII+ Glioblastoma","Terminated","No Results Available","Patients With Residual or Reccurent EGFRvIII+ Glioma","Biological: CART-EGFRvIII T cells","UCSF, San Francisco, California, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT02209376"
970,"Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Glioma","Recruiting","No Results Available","Neoplasms","Drug: Oral daily administration of BAL101553","UZ Leuven, Leuven, Belgium|Klinikum der Goethe-Universität Frankfurt, Frankfurt, Germany|Universitätsklinikum Heidelberg, Heidelberg, Germany|Universitätsklinikum Regensburg, Regensburg, Germany|Universitätsklinikum Tübingen, Tübingen, Germany|Universitätsspital Basel, Basel, Switzerland|Inselspital Universitätsspital Bern, Bern, Switzerland|Kantonsspital St. Gallen, St. Gallen, Switzerland|Universitätsspital Zürich, Zürich, Switzerland|Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom|University College London NHS Foundation Trust, London, United Kingdom|Sir Bobby Robson Cancer Trials Research Centre; Northern Centre for Cancer Care, Newcastle upon Tyne, United Kingdom|Royal Marsden Hospital, Sutton, United Kingdom","https://ClinicalTrials.gov/show/NCT02490800"
971,"Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma","Active, not recruiting","No Results Available","Recurrent Glioblastoma Multiforme|Progressive Glioblastoma Multiforme|Anaplastic Astrocytoma or Gliosarcoma","Biological: M032 (NSC 733972)","University of Alabama at Birmingham, Birmingham, Alabama, United States","https://ClinicalTrials.gov/show/NCT02062827"
972,"Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer","Recruiting","No Results Available","Glioblastoma|Gliosarcoma|MGMT-Unmethylated Glioblastoma|Recurrent Glioblastoma","Other: Laboratory Biomarker Analysis|Drug: Navtemadlin|Other: Pharmacological Study|Radiation: Radiation Therapy","University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States|UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT03107780"
973,"Study of Intraparenchymal Therapy as Adjunct Therapy in Patients With Recurrent, Resectable Glioblastoma Multiforme.","Terminated","No Results Available","Glioma","Procedure: CM-BC2","Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom","https://ClinicalTrials.gov/show/NCT02433392"
974,"A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma","Completed","No Results Available","Cancer","Drug: Sativex","The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral, United Kingdom|St James's Institute of Oncology, St James's University Hospital, Leeds, Yorkshire, United Kingdom|Bristol Haematology & Oncology Centre, Bristol, United Kingdom|Guy's and St Thomas NHS Foundation Trust, of St Thomas' Hospital, London, United Kingdom|The Christie NHS Foundation Trust, Manchester, United Kingdom","https://ClinicalTrials.gov/show/NCT01812603"
975,"Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas.","Completed","No Results Available","Glioblastoma Multiforme|Glioblastoma|Glioblastoma, Adult","Radiation: Hypofractionation guioded by dose painting","Radiotherapy Unit Ausl Irccs Reggio Emilia, Reggio Emilia, Italy","https://ClinicalTrials.gov/show/NCT04610229"
976,"A Safety Study of Sativex Compared With Placebo (Both With Dose-intense Temozolomide) in Recurrent Glioblastoma Patients","Completed","No Results Available","Cancer","Drug: Sativex|Drug: Placebo","Klinik für Onkologie, Hämatologie und Stammzelltransplantation, Universitätsklinikum Aachen RWTH, Aachen, Germany|Neurologie des Klinikums Altenburger Land, Altenburg, Germany|Zentrum für Neuroonkologie der Universität Duesseldorf, Duesseldorf, Germany|Strahlenklinik der Universität Erlangen, Erlangen, Germany|The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral, United Kingdom|St James's Institute of Oncology, St James's University Hospital, Leeds, Yorkshire, United Kingdom|Bristol Haematology & Oncology Centre, Bristol, United Kingdom|Queen's Centre for Haematology & Oncology, Castle Hill Hospital, Cottingham, United Kingdom|West of Scotland Beatson Cancer Centre, Glasgow, United Kingdom|Guy's & St Thomas' NHS Foundation Trust, of St Thomas' Hospital, London, United Kingdom|The Christie NHS Foundation Trust, Manchester, United Kingdom","https://ClinicalTrials.gov/show/NCT01812616"
977,"TPI 287 in Patients With Recurrent Glioblastoma Multiforme","Terminated","Has Results","Brain Cancer","Drug: TPI 287","UT MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01113463"
978,"Phase 2 Study of Sym004 for Adult Patients With Recurrent Glioblastoma","Completed","Has Results","Malignant Glioma","Drug: Sym004 - 18 mg/kg|Drug: Sym004 - 24 mg/kg","The Preston Robert Tisch Brain Tumor Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT02540161"
979,"AZD1390 in Recurrent Grade IV Glioma Patients","Not yet recruiting","No Results Available","Glioblastoma|Glioma|Glioblastoma Multiforme|Glioma, Malignant","Drug: AZD1390","St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States","https://ClinicalTrials.gov/show/NCT05182905"
980,"Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors","Completed","No Results Available","Recurrent Glioblastoma Multiforme","Drug: TP-38|Drug: TP38",,"https://ClinicalTrials.gov/show/NCT00071539"
981,"A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer","Recruiting","No Results Available","Recurrent Glioblastoma Multiforme|Primary Glioblastoma Multiforme|Brain Neoplasms, Malignant|Leptomeningeal Disease (LMD)","Radiation: Radiation Therapy|Drug: AZD1390","Research Site, Boston, Massachusetts, United States|Research Site, Boston, Massachusetts, United States|Research Site, New York, New York, United States|Research Site, Pittsburgh, Pennsylvania, United States|Research Site, Richmond, Virginia, United States|Research Site, Cambridge, United Kingdom|Research Site, Glasgow, United Kingdom|Research Site, Leeds, United Kingdom","https://ClinicalTrials.gov/show/NCT03423628"
982,"Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma","Recruiting","No Results Available","Leptomeningeal Metastases","Biological: IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes","City of Hope Medical Center, Duarte, California, United States","https://ClinicalTrials.gov/show/NCT04661384"
983,"Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab","Completed","Has Results","Glioblastoma|Glioblastoma Multiforme|Gliosarcoma|Brain Neoplasms|Central Nervous System Neoplasms","Drug: topotecan|Drug: pazopanib","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT01931098"
984,"ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: temozolomide|Drug: veliparib|Genetic: DNA methylation analysis|Genetic: gene expression analysis|Genetic: mutation analysis|Genetic: proteomic profiling|Other: high performance liquid chromatography|Other: immunoenzyme technique|Other: laboratory biomarker analysis|Other: mass spectrometry|Other: pharmacogenomic studies|Other: pharmacological study|Procedure: adjuvant therapy|Radiation: radiation therapy","UAB Comprehensive Cancer Center, Birmingham, Alabama, United States|UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|UPMC Cancer Centers, Pittsburgh, Pennsylvania, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00770471"
985,"Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: glioblastoma multiforme multipeptide vaccine IMA950|Biological: sargramostim|Drug: temozolomide|Other: laboratory biomarker analysis|Other: pharmacological study|Procedure: adjuvant therapy|Radiation: radiation therapy","Addenbrooke's Hospital, Cambridge, England, United Kingdom|UCL Cancer Institute, London, England, United Kingdom|Southampton General Hospital, Southampton, England, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, Scotland, United Kingdom|Western General Hospital, Edinburgh, United Kingdom|St James' University Hospital, Leeds, United Kingdom|The Christie NHS Foundation Trust, Manchester, United Kingdom","https://ClinicalTrials.gov/show/NCT01222221"
986,"Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Unknown status","Has Results","Brain and Central Nervous System Tumors","Drug: concurrent RAD001 10 mg/day|Drug: concurrent temozolomide|Radiation: Radiation therapy|Drug: concurrent RAD001 2.5 mg/day|Drug: concurrent RAD001 5 mg/day|Drug: post-radiation RAD001 10 mg/day|Drug: post-radiation temozolomide","CCOP - Christiana Care Health Services, Newark, Delaware, United States|University of Florida Shands Cancer Center, Gainesville, Florida, United States|Integrated Community Oncology Network, Jacksonville Beach, Florida, United States|Baptist Cancer Institute - Jacksonville, Jacksonville, Florida, United States|Integrated Community Oncology Network at Southside Cancer Center, Jacksonville, Florida, United States|Baptist Medical Center South, Jacksonville, Florida, United States|Integrated Community Oncology Network - Orange Park, Orange Park, Florida, United States|Florida Cancer Center - Palatka, Palatka, Florida, United States|Flagler Cancer Center, Saint Augustine, Florida, United States|H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa, Florida, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|St. Vincent Oncology Center, Indianapolis, Indiana, United States|St. Agnes Hospital Cancer Center, Baltimore, Maryland, United States|Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, United States|Regional Cancer Center at Singing River Hospital, Pascagoula, Mississippi, United States|St. Barnabas Medical Center Cancer Center, Livingston, New Jersey, United States|New York Oncology Hematology, PC at Albany Regional Cancer Care, Albany, New York, United States|University Radiation Oncology at Parkridge Hospital, Rochester, New York, United States|James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York, United States|Blumenthal Cancer Center at Carolinas Medical Center, Charlotte, North Carolina, United States|Summa Center for Cancer Care at Akron City Hospital, Akron, Ohio, United States|Barberton Citizens Hospital, Barberton, Ohio, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|Willamette Valley Cancer Center - Eugene, Eugene, Oregon, United States|Adams Cancer Center, Gettysburg, Pennsylvania, United States|Cherry Tree Cancer Center, Hanover, Pennsylvania, United States|McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center, Reading, Pennsylvania, United States|York Cancer Center at Apple Hill Medical Center, York, Pennsylvania, United States|Rhode Island Hospital Comprehensive Cancer Center, Providence, Rhode Island, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Tyler Cancer Center, Tyler, Texas, United States|Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah, United States|Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, United States|Waukesha Memorial Hospital Regional Cancer Center, Waukesha, Wisconsin, United States|Ottawa Hospital Regional Cancer Centre - General Campus, Ottawa, Ontario, Canada|Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel","https://ClinicalTrials.gov/show/NCT01062399"
987,"Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme","Terminated","No Results Available","Brain and Central Nervous System Tumors","Drug: nelfinavir mesylate|Drug: temozolomide|Procedure: adjuvant therapy|Radiation: radiation therapy","Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00915694"
988,"Expanded Access to ABT-414","No longer available","No Results Available","Glioblastoma or Solid Tumors, Epidermal Growth Factor Receptor (EGFR) Diagnosis","Drug: ABT-414",,"https://ClinicalTrials.gov/show/NCT03123952"
989,"Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: aldesleukin|Biological: therapeutic autologous lymphocytes|Procedure: adjuvant therapy|Procedure: conventional surgery","Hoag Cancer Center at Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States","https://ClinicalTrials.gov/show/NCT00331526"
990,"Boron Neutron Capture Therapy, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Radiation: BNCT(boron neutron capture therapy)|Radiation: XRT(X-ray radiation treatment)|Drug: TMZ(temozolomide)","Osaka Medical College, Takatsuki, Osaka, Japan","https://ClinicalTrials.gov/show/NCT00974987"
991,"Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Terminated","Has Results","Brain and Central Nervous System Tumors","Drug: poly ICLC","UCSF Comprehensive Cancer Center, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT00052715"
992,"Radiation Therapy in Treating Patients With Glioblastoma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: chemotherapy|Drug: hydroxyurea|Drug: pentoxifylline|Radiation: radiation therapy","Radiation Oncology Branch, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00019058"
993,"Neuradiab® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme","Unknown status","No Results Available","Brain Tumors","Drug: Neuradiab in combination with Bevacizumab (Avastin)","The Preston Robert Tisch Brain Tumor Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00906516"
994,"Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Active, not recruiting","No Results Available","Malignant Neoplasms of Brain","Biological: tetanus toxoid|Biological: therapeutic autologous dendritic cells|Biological: therapeutic autologous lymphocytes","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00639639"
995,"HSRT and IMRT Chemoradiotherapy for Newly Diagnosed GBM","Active, not recruiting","No Results Available","Glioma, Malignant","Device: Radiation|Drug: Temozolomide","CyberKnife Center, Department of Neurosurgery, Huashan Hospital, Shanghai, Shanghai, China","https://ClinicalTrials.gov/show/NCT04547621"
996,"Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: rubitecan","Universitair Ziekenhuis Antwerpen, Edegem, Belgium|Centre Jean Perrin, Clermont-Ferrand, France|Centre de Lute Contre le Cancer,Georges-Francois Leclerc, Dijon, France|Centre Leon Berard, Lyon, France|CRLCC Nantes - Atlantique, Nantes-Saint Herblain, France|Centre Eugene Marquis, Rennes, France|Centre Henri Becquerel, Rouen, France|Institut Gustave Roussy, Villejuif, France|Azienda Ospedaliera di Padova, Padua, Italy|Academisch Ziekenhuis der Vrije Universiteit, Amsterdam, Netherlands|Hospital Universitario 12 de Octubre, Madrid, Spain|Ospedale San Giovanni, Bellinzona, Switzerland|Clinique De Genolier, Genolier, Switzerland","https://ClinicalTrials.gov/show/NCT00005826"
997,"Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: suramin|Radiation: radiation therapy","University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Emory University Hospital - Atlanta, Atlanta, Georgia, United States|Johns Hopkins Oncology Center, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States|University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00004073"
998,"Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","Has Results","Brain and Central Nervous System Tumors","Drug: hydroxychloroquine|Drug: temozolomide|Other: pharmacological study|Radiation: Radiation","University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa, Florida, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|Case Comprehensive Cancer Center, Cleveland, Ohio, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00486603"
999,"Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: carboplatin|Drug: irinotecan hydrochloride|Radiation: radiation therapy","NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00010036"
1000,"Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: sodium borocaptate|Procedure: adjuvant therapy","Karl-Franzens-University Graz, Graz, Austria|Toronto Sunnybrook Regional Cancer Centre at Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Hopital Pasteur, Nice, France|Universitaetsklinikum Essen, Essen, Germany|Klinikum der Universitaet Muenchen - Grosshadern Campus, Munich, Germany|Ospedale Santa Chiara Pisa, Pisa, Italy|Vrije Universiteit Medisch Centrum, Amsterdam, Netherlands|EC Joint Research Centre - Institute for Energy, Petten, Netherlands","https://ClinicalTrials.gov/show/NCT00004015"
1001,"Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","Has Results","Brain and Central Nervous System Tumors","Drug: temozolomide|Genetic: DNA methylation analysis|Procedure: quality-of-life assessment|Radiation: Radiation","Tom Baker Cancer Centre, Calgary, Alberta, Canada|Cross Cancer Institute, Edmonton, Alberta, Canada|BCCA - Fraser Valley Cancer Centre, Surrey, British Columbia, Canada|BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada|BCCA - Vancouver Island Cancer Centre, Victoria, British Columbia, Canada|CancerCare Manitoba, Winnipeg, Manitoba, Canada|Atlantic Health Sciences Corporation, Saint John, New Brunswick, Canada|QEII Health Sciences Centre, Halifax, Nova Scotia, Canada|Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada|London Regional Cancer Program, London, Ontario, Canada|Odette Cancer Centre, Toronto, Ontario, Canada|Univ. Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada|CHUM - Hopital Notre-Dame, Montreal, Quebec, Canada|McGill University - Dept. Oncology, Montreal, Quebec, Canada|Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, Canada|Centre hospitalier regional de Trois-Rivieres, Trois-Rivieres, Quebec, Canada|Klinikum Der J.W. Goethe Universitaet, Frankfurt, Germany|Universitaetsklinikum Freiburg, Freiburg, Germany|Universitaetsklinikum Leipzig, Leipzig, Germany|Universitaetsklinikum Tuebingen, Tuebingen, Germany|Hiroshima University Hospital, Hiroshima, Japan|Maastro - Maastricht Radiation Oncology, Maastricht, Netherlands","https://ClinicalTrials.gov/show/NCT00482677"
1002,"Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: penicillamine|Radiation: radiation therapy","University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Emory University School of Medicine, Atlanta, Georgia, United States|Johns Hopkins Oncology Center, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States|University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00003751"
1003,"A Study of E7050 in Combination With E7080 in Participants With Advanced Solid Tumors (Dose Escalation) and in Participants With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2)","Terminated","Has Results","Advanced Solid Tumors","Drug: Golvatinib|Drug: Lenvatinib","Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Massachusetts General Hospital / Dana Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01433991"
1004,"Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: temozolomide|Radiation: radiation therapy","Duke Comprehensive Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00003464"
1005,"Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme","Completed","Has Results","Brain and Central Nervous System Tumors","Radiation: radiation therapy|Radiation: stereotactic radiosurgery","Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States|Southwest General Health Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00253448"
1006,"Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Unknown status","No Results Available","Brain and Central Nervous System Tumors","Drug: hyperbaric oxygen|Radiation: radiation therapy","Barrett Cancer Center, The University Hospital, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT00006460"
1007,"Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: R-(-)-gossypol acetic acid|Drug: temozolomide|Genetic: gene expression analysis|Genetic: mutation analysis|Genetic: protein expression analysis|Other: laboratory biomarker analysis|Other: pharmacological study|Procedure: adjuvant therapy|Radiation: radiation therapy","Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa, Florida, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00390403"
1008,"Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery","Withdrawn","No Results Available","Brain and Central Nervous System Tumors","Biological: lymphokine-activated killer cells|Drug: polifeprosan 20 with carmustine implant","Hoag Cancer Institute at Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States","https://ClinicalTrials.gov/show/NCT00814593"
1009,"High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: leucovorin calcium|Drug: methotrexate","Rush-Copley Cancer Care Center, Aurora, Illinois, United States|St. Joseph Medical Center, Bloomington, Illinois, United States|Graham Hospital, Canton, Illinois, United States|Memorial Hospital, Carthage, Illinois, United States|Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States|Hematology and Oncology Associates, Chicago, Illinois, United States|University of Illinois Cancer Center, Chicago, Illinois, United States|Veterans Affairs Medical Center - Chicago Westside Hospital, Chicago, Illinois, United States|Mercy Hospital and Medical Center, Chicago, Illinois, United States|Swedish Covenant Hospital, Chicago, Illinois, United States|Eureka Community Hospital, Eureka, Illinois, United States|Galesburg Clinic, Galesburg, Illinois, United States|Galesburg Cottage Hospital, Galesburg, Illinois, United States|Mason District Hospital, Havana, Illinois, United States|Hopedale Medical Complex, Hopedale, Illinois, United States|Midwest Center for Hematology/Oncology, Joliet, Illinois, United States|Joliet Oncology-Hematology Associates, Limited - West, Joliet, Illinois, United States|Kewanee Hospital, Kewanee, Illinois, United States|North Shore Oncology and Hematology Associates, Limited - Libertyville, Libertyville, Illinois, United States|McDonough District Hospital, Macomb, Illinois, United States|Northwest Medical Specialist, PC, Niles, Illinois, United States|BroMenn Regional Medical Center, Normal, Illinois, United States|Community Cancer Center, Normal, Illinois, United States|Community Hospital of Ottawa, Ottawa, Illinois, United States|Oncology Hematology Associates of Central Illinois, PC - Ottawa, Ottawa, Illinois, United States|Cancer Treatment Center at Pekin Hospital, Pekin, Illinois, United States|Proctor Hospital, Peoria, Illinois, United States|CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States|Oncology Hematology Associates of Central Illinois, PC - Peoria, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|OSF St. Francis Medical Center, Peoria, Illinois, United States|Illinois Valley Community Hospital, Peru, Illinois, United States|Perry Memorial Hospital, Princeton, Illinois, United States|Swedish-American Regional Cancer Center, Rockford, Illinois, United States|Hematology Oncology Associates - Skokie, Skokie, Illinois, United States|Hematology/Oncology of the North Shore at Gross Point Medical Center, Skokie, Illinois, United States|Midwest Cancer Research Group, Incorporated, Skokie, Illinois, United States|St. Margaret's Hospital, Spring Valley, Illinois, United States|Carle Cancer Center at Carle Foundation Hospital, Urbana, Illinois, United States|CCOP - Carle Cancer Center, Urbana, Illinois, United States|Saint Anthony Memorial Health Centers, Michigan City, Indiana, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Borgess Medical Center, Kalamazooaa, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy and Unity Cancer Center at Mercy Hospital, Coon Rapids, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Mercy and Unity Cancer Center at Unity Hospital, Fridley, Minnesota, United States|Minnesota Oncology Hematology, PA at Maplewood Cancer Center, Maplewood, Minnesota, United States|Virginia Piper Cancer Institute at Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hubert H. Humphrey Cancer Center at North Memorial Medical Center, Robbinsdale, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|Park Nicollet Health Services, St. Louis Park, Minnesota, United States|United Hospital, St. Paul, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Minnesota Oncology Hematology, PA - Woodbury, Woodbury, Minnesota, United States|Case Comprehensive Cancer Center, Cleveland, Ohio, United States|Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest, Allentown, Pennsylvania, United States|Avera Cancer Institute, Sioux Falls, South Dakota, United States|Medical X-Ray Center, PC, Sioux Falls, South Dakota, United States|Sioux Valley Hospital and University of South Dakota Medical Center, Sioux Falls, South Dakota, United States|West Virginia University - Robert C. Byrd Health Sciences Center - Charleston Division, Charleston, West Virginia, United States|Mary Babb Randolph Cancer Center at West Virginia University Hospitals, Morgantown, West Virginia, United States|Marshfield Clinic - Marshfield Center, Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00082797"
1010,"Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: irinotecan hydrochloride|Drug: temozolomide|Procedure: adjuvant therapy|Radiation: radiation therapy","Foundation for Cancer Research and Education, Phoenix, Arizona, United States|Providence Saint Joseph Medical Center - Burbank, Burbank, California, United States|Saint Agnes Medical Center, Fresno, California, United States|Loma Linda University Cancer Institute at Loma Linda University Medical Center, Loma Linda, California, United States|Providence Holy Cross Cancer Center, Mission Hills, California, United States|Pomona Valley Hospital Medical Center, Pomona, California, United States|Radiological Associates of Sacramento Medical Group, Inc., Sacramento, California, United States|Yale Comprehensive Cancer Center at Yale University School of Medicine, New Haven, Connecticut, United States|CCOP - Christiana Care Health Services, Newark, Delaware, United States|University of Florida Shands Cancer Center, Gainesville, Florida, United States|Baptist Cancer Institute - Jacksonville, Jacksonville, Florida, United States|John B. Amos Community Cancer Center, Columbus, Georgia, United States|Regional Radiation Oncology Center at Rome, Rome, Georgia, United States|Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center, Boise, Idaho, United States|Northwest Community Hospital, Arlington Heights, Illinois, United States|Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States|University of Chicago Cancer Research Center, Chicago, Illinois, United States|Ingalls Cancer Care Center at Ingalls Memorial Hospital, Harvey, Illinois, United States|Cardinal Bernardin Cancer Center at Loyola University Medical Center, Maywood, Illinois, United States|St. Francis Hospital and Health Centers, Beech Grove, Indiana, United States|Tulane Cancer Center, New Orleans, Louisiana, United States|CCOP - Ochsner, New Orleans, Louisiana, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Regional Cancer Center at Singing River Hospital, Pascagoula, Mississippi, United States|Cancer Institute of Cape Girardeau, Cape Girardeau, Missouri, United States|CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States|St. John's Regional Health Center, Springfield, Missouri, United States|Hulston Cancer Center at Cox Medical Center South, Springfield, Missouri, United States|Siteman Cancer Center at Barnes-Jewish Hospital, St Louis, Missouri, United States|Methodist Cancer Center at Methodist Hospital - Omaha, Omaha, Nebraska, United States|CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, United States|Dartmouth - Hitchcock Concord, Concord, New Hampshire, United States|Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|Cancer Institute of New Jersey at the Cooper University Hospital, Camden, New Jersey, United States|Cooper Cancer Institute, Camden, New Jersey, United States|John F. Kennedy Medical Center, Edison, New Jersey, United States|Monmouth Medical Center, Long Branch, New Jersey, United States|Community Medical Center, Toms River, New Jersey, United States|University of New Mexico Cancer Research and Treatment Center, Albuquerque, New Mexico, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Lipson Cancer and Blood Center at Rochester General Hospital, Rochester, New York, United States|James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York, United States|Randolph Hospital, Asheboro, North Carolina, United States|Mission Hospitals - Memorial Campus, Asheville, North Carolina, United States|John Smith, Jr./Dalton McMichael Cancer Center at Morehead Memorial Hospital, Eden, North Carolina, United States|Wayne Radiation Oncology, Goldsboro, North Carolina, United States|Moses Cone Regional Cancer Center at Wesley Long Community Hospital, Greensboro, North Carolina, United States|Annie Penn Cancer Center, Reidsville, North Carolina, United States|Akron City Hospital, Akron, Ohio, United States|McDowell Cancer Center at Akron General Medical Center, Akron, Ohio, United States|Radiation Oncology Center, Alliance, Ohio, United States|Aultman Hospital Cancer Center at Aultman Health Foundation, Canton, Ohio, United States|Charles M. Barrett Cancer Center at University Hospital, Cincinnati, Ohio, United States|CCOP - Columbus, Columbus, Ohio, United States|Grandview Hospital, Dayton, Ohio, United States|David L. Rike Cancer Center at Miami Valley Hospital, Dayton, Ohio, United States|Veterans Affairs Medical Center - Dayton, Dayton, Ohio, United States|Charles F. Kettering Memorial Hospital, Kettering, Ohio, United States|Middletown Regional Hospital, Middletown, Ohio, United States|Cancer Research UK Medical Oncology Unit at Churchill Hospital & Weatherall Institute of Molecular Medicine - Oxford, Salem, Ohio, United States|UVMC Cancer Care Center at Upper Valley Medical Center, Troy, Ohio, United States|Cancer Treatment Center, Wooster, Ohio, United States|Ruth G. McMillan Cancer Center at Greene Memorial Hospital, Xenia, Ohio, United States|Natalie Warren Bryant Cancer Center at St. Francis Hospital, Tulsa, Oklahoma, United States|Legacy Mount Hood Medical Center, Glesham, Oregon, United States|Providence Milwaukie Hospital, Milwaukie, Oregon, United States|Comprehensive Cancer Center at Legacy Good Samaritan Hospital & Medical Center, Portland, Oregon, United States|Providence Cancer Center at Providence Portland Medical Center, Portland, Oregon, United States|CCOP - Columbia River Oncology Program, Portland, Oregon, United States|Providence St. Vincent Medical Center, Portland, Oregon, United States|Institute of Oncology at Vilnius University, Portland, Oregon, United States|Legacy Meridian Park Hospital, Tualatin, Oregon, United States|Abington Memorial Hospital, Abington, Pennsylvania, United States|John and Dorothy Morgan Cancer Center at Lehigh Valley Hospital, Allentown, Pennsylvania, United States|St. Luke's Hospital Cancer Center, Bethlehem, Pennsylvania, United States|Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, United States|UPMC Cancer Center - Arnold Palmer Pavilion, Greensburg, Pennsylvania, United States|Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|UPMC McKeesport, McKeesport, Pennsylvania, United States|Paoli Memorial Hospital, Paoli, Pennsylvania, United States|Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States|Albert Einstein Cancer Center, Philadelphia, Pennsylvania, United States|Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|UPMC Cancer Center at Magee-Womens Hospital, Pittsburgh, Pennsylvania, United States|UPMC Cancer Center at UPMC Presbyterian, Pittsburgh, Pennsylvania, United States|UPMC St. Margaret, Pittsburgh, Pennsylvania, United States|Mercy Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States|UPMC - Shadyside, Pittsburgh, Pennsylvania, United States|UPMC - Passavant Hospital, Pittsburgh, Pennsylvania, United States|Cancer Center at St. Clair Memorial Hospital, Pittsburgh, Pennsylvania, United States|Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburg, Pennsylvania, United States|Reading Hospital and Medical Center, West Reading, Pennsylvania, United States|CCOP - MainLine Health, Wynnewood, Pennsylvania, United States|Lankenau Cancer Center at Lankenau Hospital, Wynnewood, Pennsylvania, United States|York Cancer Center at Wellspan Health, York, Pennsylvania, United States|Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Cottonwood Hospital Medical Center, Murray, Utah, United States|McKay-Dee Hospital Center, Ogden, Utah, United States|Utah Valley Regional Medical Center - Provo, Provo, Utah, United States|Utah Cancer Specialists at UCS Cancer Center, Salt Lake City, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|Dixie Regional Medical Center, St. George, Utah, United States|Green Mountain Oncology Group, Bennington, Vermont, United States|Fletcher Allen Health Care - University Health Center Campus, Burlington, Vermont, United States|Community Cancer Center at Rutland Regional Medical Center, Rutland, Vermont, United States|Massey Cancer Center at Virginia Commonwealth University, Richmond, Virginia, United States|CCOP - Virginia Mason Research Center, Seattle, Washington, United States|Southwest Washington Medical Center Cancer Center, Vancouver, Washington, United States|North Star Lodge Cancer Center, Yakima, Washington, United States|St. Vincent Hospital, Green Bay, Wisconsin, United States|Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States|Community Memorial Hospital, Menomonee Falls, Wisconsin, United States|Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00099125"
1011,"Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: temozolomide|Radiation: radiation therapy","Tom Baker Cancer Center - Calgary, Calgary, Alberta, Canada|Cross Cancer Institute, Edmonton, Alberta, Canada|British Columbia Cancer Agency - Fraser Valley Cancer Centre, Surrey, British Columbia, Canada|British Columbia Cancer Agency, Vancouver, British Columbia, Canada|British Columbia Cancer Agency - Vancouver Island Cancer Centre, Victoria, British Columbia, Canada|CancerCare Manitoba, Winnipeg, Manitoba, Canada|Doctor Leon Richard Oncology Centre, Moncton, New Brunswick, Canada|Saint John Regional Hospital, Saint John, New Brunswick, Canada|Newfoundland Cancer Treatment and Research Foundation, St. Johns, Newfoundland and Labrador, Canada|Nova Scotia Cancer Centre, Halifax, Nova Scotia, Canada|Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada|Ottawa Regional Cancer Centre - General Campus, Ottawa, Ontario, Canada|Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada|Princess Margaret Hospital, Toronto, Ontario, Canada|Cancer Care Ontario - Windsor Regional Cancer Centre, Windsor, Ontario, Canada|Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada","https://ClinicalTrials.gov/show/NCT00006353"
1012,"Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: carmustine|Drug: irinotecan hydrochloride|Radiation: radiation therapy",,"https://ClinicalTrials.gov/show/NCT00027612"
1013,"Study of Multiple Doses and Regimens of XL184 (Cabozantinib) in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse","Completed","No Results Available","Astrocytic Tumors","Drug: XL184","Birmingham, Alabama, United States|Encinitas, California, United States|Pleasant Hill, California, United States|Chicago, Illinois, United States|Chicago, Illinois, United States|Boston, Massachusetts, United States|Detroit, Michigan, United States|Minneapolis, Minnesota, United States|Amhearst, New York, United States|Rochester, New York, United States|Cleveland, Ohio, United States|Hershey, Pennsylvania, United States|Dallas, Texas, United States|Dallas, Texas, United States|San Antonio, Texas, United States|Charlottesville, Virginia, United States|Seattle, Washington, United States|Calgary, Alberta, Canada|Montreal, Quebec, Canada","https://ClinicalTrials.gov/show/NCT01068782"
1014,"Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: motexafin gadolinium|Radiation: radiation therapy",,"https://ClinicalTrials.gov/show/NCT00006452"
1015,"A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma","Completed","No Results Available","Glioblastoma, Glioma","Drug: GDC-0084","Los Angeles, California, United States|Boston, Massachusetts, United States|Boston, Massachusetts, United States|Houston, Texas, United States|Barcelona, Spain","https://ClinicalTrials.gov/show/NCT01547546"
1016,"Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: carmustine|Radiation: radiation therapy","University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States|Comprehensive Cancer Institute of Huntsville, Huntsville, Alabama, United States|Huntsville Hospital System, Huntsville, Alabama, United States|MBCCOP - Gulf Coast, Mobile, Alabama, United States|Alabama Oncology, LLC, Montgomery, Alabama, United States|DCH Cancer Treatment Center, Tuscaloosa, Alabama, United States|Foundation for Cancer Research and Education, Phoenix, Arizona, United States|Mount Diablo Medical Center, Concord, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Saint Agnes Cancer Center, Fresno, California, United States|California Cancer Center, Fresno, California, United States|Sutter Health Western Division Cancer Research Group, Greenbrae, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Veterans Affairs Medical Center - Long Beach, Long Beach, California, United States|Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States|USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States|CCOP - Bay Area Tumor Institute, Oakland, California, United States|Huntington Cancer Center, Pasadena, California, United States|Robert and Beverly Lewis Family Cancer Care Center, Pomona, California, United States|Radiation Oncology Center - Sacramento, Sacramento, California, United States|Radiation Medical Group, Incorporated, San Diego, California, United States|UCSF Comprehensive Cancer Center, San Francisco, California, United States|O'Connor Hospital, San Jose, California, United States|CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California, United States|David Grant Medical Center, Travis Air Force Base, California, United States|Memorial Hospital Cancer Center, Colorado Springs, Colorado, United States|University of Colorado Cancer Center, Denver, Colorado, United States|CCOP - Colorado Cancer Research Program, Incorporated, Denver, Colorado, United States|Saint Mary's Hospital and Medical Center, Grand Junction, Colorado, United States|CCOP - Christiana Care Health Services, Newark, Delaware, United States|University of Florida Health Science Center, Gainesville, Florida, United States|Florida Radiation Oncology Group, Jacksonville, Florida, United States|Holmes Regional Medical Center, Melbourne, Florida, United States|CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States|Veterans Affairs Medical Center - Miami, Miami, Florida, United States|Sylvester Cancer Center, University of Miami, Miami, Florida, United States|Baptist Hospital of Miami, Miami, Florida, United States|MD Anderson Cancer Center Orlando, Orlando, Florida, United States|Bay Medical Center, Panama City, Florida, United States|Gulf Coast Cancer Treatment Center, Panama City, Florida, United States|Sarasota Radiation and Medical Oncology Center, Sarasota, Florida, United States|Tallahassee Memorial Healthcare, Tallahassee, Florida, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Emory University Hospital - Atlanta, Atlanta, Georgia, United States|CCOP - Atlanta Regional, Atlanta, Georgia, United States|Medical Center/John B. Amos Community Cancer Center, Columbus, Georgia, United States|Regional Radiation Oncology Center at Rome, Rome, Georgia, United States|MBCCOP - Hawaii, Honolulu, Hawaii, United States|Northwest Community Hospital, Arlington Heights, Illinois, United States|Northwestern Memorial Hospital, Chicago, Illinois, United States|CCOP - Central Illinois, Decatur, Illinois, United States|Ingalls Memorial Hospital, Harvey, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Lutheran General Cancer Care Center, Park Ridge, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|St. John's Medical Center, Anderson, Indiana, United States|Bloomington Hospital, Bloomington, Indiana, United States|Veterans Affairs Medical Center - Indianapolis (Roudebush), Indianapolis, Indiana, United States|Clarian Health Partners Inc., Indianapolis, Indiana, United States|Community Regional Cancer Care, Indianapolis, Indiana, United States|Ball Memorial Hospital, Muncie, Indiana, United States|CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States|Wendt Regional Cancer Center of Finley Hospital, Dubuque, Iowa, United States|Central Baptist Hospital, Lexington, Kentucky, United States|Cancer Center at Lexington Clinic, Lexington, Kentucky, United States|Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky, United States|James Graham Brown Cancer Center, Louisville, Kentucky, United States|Louisville Radiation Oncology, Louisville, Kentucky, United States|Merle M. Mahr Cancer Center, Madisonville, Kentucky, United States|Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States|Tulane University School of Medicine, New Orleans, Louisiana, United States|MBCCOP - LSU Health Sciences Center, New Orleans, Louisiana, United States|CCOP - Ochsner, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Anne Arundel Oncology Center, Annapolis, Maryland, United States|Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States|Greater Baltimore Medical Center and Cancer Center, Baltimore, Maryland, United States|Harbor Hospital Center, Baltimore, Maryland, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Peninsula Regional Medical Center, Salisbury, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Cape Cod Hospital, Hyannis, Massachusetts, United States|Veterans Affairs Medical Center - Boston (Jamaica Plain), Jamaica Plain, Massachusetts, United States|CCOP - Michigan Cancer Research Consortium, Ann Arbor, Michigan, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|McLaren Regional Cancer Center, Flint, Michigan, United States|CCOP - Kalamazoo, Kalamazoo, Michigan, United States|Marquette General Hospital, Marquette, Michigan, United States|MidMichigan Medical Center - Midland, Midland, Michigan, United States|CCOP - Beaumont, Royal Oak, Michigan, United States|William Beaumont Hospital, Royal Oak, Michigan, United States|William Beaumont Hospital - Troy, Troy, Michigan, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, United States|CCOP - Kansas City, Kansas City, Missouri, United States|Mallinckrodt Institute of Radiology, Saint Louis, Missouri, United States|St. Louis University Health Sciences Center, Saint Louis, Missouri, United States|Cancer Research for the Ozarks, Springfield, Missouri, United States|CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|Methodist Hospital Cancer Center - Omaha, Omaha, Nebraska, United States|Nebraska Health System, Omaha, Nebraska, United States|CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, United States|Norris Cotton Cancer Center, Lebanon, New Hampshire, United States|Elliot Regional Cancer Center, Manchester, New Hampshire, United States|Veterans Affairs Medical Center - East Orange, East Orange, New Jersey, United States|John F. Kennedy Medical Center, Edison, New Jersey, United States|Trinitas Hospital - Jersey Street Campus, Elizabeth, New Jersey, United States|Monmouth Medical Center, Long Branch, New Jersey, United States|South Jersey Regional Cancer Center, Millville, New Jersey, United States|Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital, Mount Holly, New Jersey, United States|Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|Newark Beth Israel Medical Center, Newark, New Jersey, United States|Atlantic City Medical Center, Pomona, New Jersey, United States|Valley Hospital, Ridgewood, New Jersey, United States|Community Medical Center, Toms River, New Jersey, United States|St. Francis Medical Center, Trenton, New Jersey, United States|Associated Radiologists, P.A., Warren, New Jersey, United States|Radiation Oncology Associates of Albuquerque, Albuquerque, New Mexico, United States|Cancer Center of Albany Medical Center, Albany, New York, United States|State University of New York Health Science Center at Brooklyn, Brooklyn, New York, United States|New York Methodist Hospital, Brooklyn, New York, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Finger Lakes Radiation Oncology Center, Clifton Springs, New York, United States|CCOP - North Shore University Hospital, Manhasset, New York, United States|Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Champlain Valley Physicians Hospital Medical Center, Plattsburgh, New York, United States|Vassar Brothers Medical Center, Poughkeepsie, New York, United States|James P. Wilmot Cancer Center, Rochester, New York, United States|CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse, New York, United States|Riverhill Radiation Oncology, Yonkers, New York, United States|Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, United States|Northeast Medical Center, Concord, North Carolina, United States|East Carolina University School of Medicine, Greenville, North Carolina, United States|CCOP - Southeast Cancer Control Consortium, Winston-Salem, North Carolina, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|Trinity Cancer Care Center, Minot, North Dakota, United States|Akron General Medical Center, Akron, Ohio, United States|Akron City Hospital, Akron, Ohio, United States|Christ Hospital, Cincinnati, Ohio, United States|Barrett Cancer Center, Cincinnati, Ohio, United States|Ireland Cancer Center, Cleveland, Ohio, United States|University Hospitals of Cleveland, Cleveland, Ohio, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|CCOP - Columbus, Columbus, Ohio, United States|Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States|CCOP - Dayton, Dayton, Ohio, United States|CCOP - Toledo Community Hospital, Toledo, Ohio, United States|St. Anthony Hospital, Oklahoma City, Oklahoma, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|St. John Health System, Tulsa, Oklahoma, United States|CCOP - Oklahoma, Tulsa, Oklahoma, United States|CCOP - Columbia River Oncology Program, Portland, Oregon, United States|Lehigh Valley Hospital, Allentown, Pennsylvania, United States|St. Luke's Hospital Cancer Center, Bethlehem, Pennsylvania, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Mercy Fitzgerald Hospital, Darby, Pennsylvania, United States|Delaware County Memorial Hospital, Drexel Hill, Pennsylvania, United States|Pocono Cancer Center, East Stroudsburg, Pennsylvania, United States|Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Veterans Affairs Medical Center - Philadelphia, Philadelphia, Pennsylvania, United States|Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|Albert Einstein Cancer Center, Philadelphia, Pennsylvania, United States|Mercy Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States|Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|Reading Hospital and Medical Center, Reading, Pennsylvania, United States|Mercy Hospital Cancer Center - Scranton, Scranton, Pennsylvania, United States|Wilkes Barre General Hospital, Wilkes-Barre, Pennsylvania, United States|York Cancer Center, York, Pennsylvania, United States|Roger Williams Medical Center/BUSM, Providence, Rhode Island, United States|CCOP - Greenville, Greenville, South Carolina, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Jackson-Madison County General Hospital, Jackson, Tennessee, United States|University of Tennessee Cancer Institute, Memphis, Tennessee, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States|Harrington Cancer Center, Amarillo, Texas, United States|University of Texas Medical Branch, Galveston, Texas, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|Wilford Hall Medical Center, Lackland Air Force Base, Texas, United States|Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas, United States|Bayshore Medical Center, Pasadena, Texas, United States|Dixie Regional Medical Center, Saint George, Utah, United States|University of Utah Health Sciences Center, Salt Lake City, Utah, United States|Latter Day Saints Hospital, Salt Lake City, Utah, United States|Green Mountain Oncology Group, Burlington, Vermont, United States|Vermont Cancer Center, Burlington, Vermont, United States|Cancer Center at the University of Virginia, Charlottesville, Virginia, United States|RMH Regional Cancer Center, Harrisonburg, Virginia, United States|Naval Medical Center, Portsmouth, Portsmouth, Virginia, United States|Bon Secours - St. Mary's Hospital, Richmond, Virginia, United States|Massey Cancer Center, Richmond, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Deaconess Medical Center, Spokane, Washington, United States|Yakima Valley Memorial Hospital, Yakima, Washington, United States|Schiffler Cancer Center, Wheeling, West Virginia, United States|CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay, Wisconsin, United States|St. Vincent Hospital, Green Bay, Wisconsin, United States|Gundersen Lutheran Medical Foundation, La Crosse, Wisconsin, United States|Southern Wisconsin Radiotherapy Center, Madison, Wisconsin, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States|Marshfield Clinic, Marshfield, Wisconsin, United States|Community Memorial Hospital, Menomonee Falls, Wisconsin, United States|Columbia Hospital, Milwaukee, Wisconsin, United States|St. Luke's Medical Center, Milwaukee, Wisconsin, United States|Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, United States|Veterans Affairs Medical Center - Milwaukee (Zablocki), Milwaukee, Wisconsin, United States|All Saints Cancer Center, Racine, Wisconsin, United States|Waukesha Memorial Hospital Regional Cancer Center, Waukesha, Wisconsin, United States|Tom Baker Cancer Center - Calgary, Calgary, Alberta, Canada|Cross Cancer Institute, Edmonton, Alberta, Canada|Saint John Regional Hospital, Saint John, New Brunswick, Canada|Newfoundland Cancer Treatment and Research Foundation, St. Johns, Newfoundland and Labrador, Canada|Nova Scotia Cancer Centre, Halifax, Nova Scotia, Canada|Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada|Kingston Regional Cancer Centre, Kingston, Ontario, Canada|Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada|Ottawa Regional Cancer Centre, Ottawa, Ontario, Canada|Northeastern Ontario Regional Cancer Centre, Sudbury, Sudbury, Ontario, Canada|Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay, Ontario, Canada|Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada|Princess Margaret Hospital, Toronto, Ontario, Canada|CHUS-Hopital Fleurimont, Fleurimont, Quebec, Canada|Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada|McGill University, Montreal, Quebec, Canada|Centre Hospitalier Universitaire de Quebec, Quebec City, Quebec, Canada|Allan Blair Cancer Centre, Regina, Saskatchewan, Canada|Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada","https://ClinicalTrials.gov/show/NCT00003417"
1017,"Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: pyrazoloacridine|Procedure: adjuvant therapy|Radiation: radiation therapy","University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Josephine Ford Cancer Center at Henry Ford Health System, Detroit, Michigan, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00006355"
1018,"Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: carmustine|Radiation: low-LET photon therapy","Veterans Affairs Medical Center - Birmingham, Birmingham, Alabama, United States|University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States|Huntsville Hospital System, Huntsville, Alabama, United States|Urology Associates - Mobile AL, Mobile, Alabama, United States|MBCCOP - University of South Alabama, Mobile, Alabama, United States|Alabama Oncology, LLC, Montgomery, Alabama, United States|Radiation Oncology Associates of West Alabama, Tuscallosa, Alabama, United States|Providence Cancer Therapy Center, Anchorage, Alaska, United States|St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|Arizona Cancer Center, Tucson, Arizona, United States|Providence Saint Joseph Medical Center - Burbank, Burbank, California, United States|Mount Diablo Medical Center, Concord, California, United States|California Cancer Center, Fresno, California, United States|Saint Agnes Cancer Center, Fresno, California, United States|Glendale Memorial Hospital and Health Center, Glendale, California, United States|Sutter Health Western Division Cancer Research Group, Greenbrae, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Veterans Affairs Medical Center - Long Beach, Long Beach, California, United States|Kaiser Permanente Medical Center - Los Angeles, Los Angeles, California, United States|USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States|Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States|Beckman Research Institute, City of Hope, Los Angeles, California, United States|Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States|CCOP - Bay Area Tumor Institute, Oakland, California, United States|Cancer Care Center, Pomona, California, United States|Mercy Medical Center - Redding, Redding, California, United States|Radiation Oncology Center - Sacramento, Sacramento, California, United States|UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States|O'Connor Hospital, San Jose, California, United States|Santa Cruz Radiation Oncology Medical Group, Inc., Santa Cruz, California, United States|CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California, United States|Stanford University, Stanford, California, United States|David Grant Medical Center, Travis Air Force Base, California, United States|Radiation Oncology Center - Walnut Creek, Walnut Creek, California, United States|Memorial Hospital Cancer Center, Colorado Springs, Colorado, United States|University of Colorado Cancer Center, Denver, Colorado, United States|Bridgeport Hospital, Bridgeport, Connecticut, United States|Whittingham Cancer Center, Norwalk, Connecticut, United States|CCOP - Christiana Care Health Services, Wilmington, Delaware, United States|Walter Reed Army Medical Center, Washington, District of Columbia, United States|Lykes Center for Radiation Therapy, Clearwater, Florida, United States|Halifax Medical Center, Daytona Beach, Florida, United States|Radiation Therapy Associates - Fort Myers, Fort Myers, Florida, United States|University of Florida Health Science Center, Gainesville, Florida, United States|Health First Holmes Regional Medical Center, Melbourne, Florida, United States|CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States|Sylvester Cancer Center, University of Miami, Miami, Florida, United States|Baptist Hospital of Miami, Miami, Florida, United States|Florida Radiation Oncology Group, Orange Park, Florida, United States|MD Anderson Cancer Center Orlando, Orlando, Florida, United States|Gulf Coast Cancer Treatment Center, Panama City, Florida, United States|West Florida Cancer Institute - Pensacola, Pensacola, Florida, United States|Bayfront Medical Center, Saint Petersburg, Florida, United States|Sarasota Radiation and Medical Oncology Center, Sarasota, Florida, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Emory University Hospital - Atlanta, Atlanta, Georgia, United States|CCOP - Atlanta Regional, Atlanta, Georgia, United States|Medical Center/John B. Amos Community Cancer Center, Columbus, Georgia, United States|InterCommunity Cancer Center at Rome, Rome, Georgia, United States|South Georgia Medical Center, Valdosta, Georgia, United States|Northwest Community Hospital, Arlington Heights, Illinois, United States|Northwestern Memorial Hospital, Chicago, Illinois, United States|University of Chicago Cancer Research Center, Chicago, Illinois, United States|Ingalls Memorial Hospital, Harvey, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Lutheran General Cancer Care Center, Park Ridge, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|CCOP - Central Illinois, Springfield, Illinois, United States|CCOP - Carle Cancer Center, Urbana, Illinois, United States|St. John's Medical Center, Anderson, Indiana, United States|Clarion Health Partners Inc., Indianapolis, Indiana, United States|Community Hospitals of Indianapolis - Regional Cancer Center, Indianapolis, Indiana, United States|Ball Memorial Hospital, Muncie, Indiana, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|St. Joseph's Radiation Oncology Center, South Bend, Indiana, United States|Wendt Regional Cancer Center of Finley Hospital, Dubuque, Iowa, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|Medical Center at Bowling Green, Bowling Green, Kentucky, United States|Veterans Affairs Medical Center - Lexington, Lexington, Kentucky, United States|Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky, United States|James Graham Brown Cancer Center, Louisville, Kentucky, United States|Louisville Radiation Oncology, Louisville, Kentucky, United States|Merle M. Mahr Cancer Center, Madisonville, Kentucky, United States|Western Baptist Hospital, Paducah, Kentucky, United States|Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States|Romagosa Radiation Oncology Center, Lafayette, Louisiana, United States|East Jefferson General Hospital, Metairie, Louisiana, United States|MBCCOP - LSU Medical Center, New Orleans, Louisiana, United States|Tulane University School of Medicine, New Orleans, Louisiana, United States|CCOP - Ochsner, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Anne Arundel Oncology Center, Annapolis, Maryland, United States|Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States|Greater Baltimore Medical Center and Cancer Center, Baltimore, Maryland, United States|Harbor Hospital Center, Baltimore, Maryland, United States|Radiation Oncology Affiliates of Maryland, P.A., Baltimore, Maryland, United States|Johns Hopkins Oncology Center, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Joint Center for Radiation Therapy, Boston, Massachusetts, United States|Cape Cod Hospital, Hyannis, Massachusetts, United States|Veterans Affairs Medical Center - Boston (Jamaica Plain), Jamaica Plain, Massachusetts, United States|Veterans Affairs Medical Center - Ann Arbor, Ann Arbor, Michigan, United States|CCOP - Ann Arbor Regional, Ann Arbor, Michigan, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|McLaren Regional Cancer Center, Flint, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|CCOP - Kalamazoo, Kalamazoo, Michigan, United States|Sparrow Regional Cancer Center, Lansing, Michigan, United States|Marquette General Hospital, Marquette, Michigan, United States|MidMichigan Regional Medical Center, Midland, Michigan, United States|St. Mary's Medical Center, Saginaw, Michigan, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, United States|CCOP - Kansas City, Kansas City, Missouri, United States|Veterans Affairs Medical Center - Saint Louis, Saint Louis, Missouri, United States|St. Louis University Health Sciences Center, Saint Louis, Missouri, United States|Mallinckrodt Institute of Radiology, Saint Louis, Missouri, United States|Cancer Research for the Ozarks, Springfield, Missouri, United States|CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|Methodist Cancer Center - Omaha, Omaha, Nebraska, United States|CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, United States|Norris Cotton Cancer Center, Lebanon, New Hampshire, United States|Elliot Regional Cancer Center, Manchester, New Hampshire, United States|Veterans Affairs Medical Center - East Orange, East Orange, New Jersey, United States|John F. Kennedy Medical Center, Edison, New Jersey, United States|Trinitas Hosptial - Jersey Street Campus, Elizabeth, New Jersey, United States|South Jersey Hospital - Millville, Millville, New Jersey, United States|Fox Chase Cancer Center at Virtua-Memorial Hospital Burlington County, Mount Holly, New Jersey, United States|Newark Beth Israel Medical Center, Newark, New Jersey, United States|Community Medical Center, Toms River, New Jersey, United States|St. Francis Medical Center, Trenton, New Jersey, United States|Saint Joseph Medical Center, Albuquerque, New Mexico, United States|Cancer Center of Albany Medical Center, Albany, New York, United States|Veterans Affairs Medical Center - Albany, Albany, New York, United States|Albert Einstein Comprehensive Cancer Center, Bronx, New York, United States|State University of New York Health Science Center at Brooklyn, Brooklyn, New York, United States|New York Methodist Hospital, Brooklyn, New York, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Finger Lakes Radiation Oncology, P.C., Clifton Springs, New York, United States|CCOP - North Shore University Hospital, Manhasset, New York, United States|Beth Israel Medical Center, New York, New York, United States|Kaplan Cancer Center, New York, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Champlain Valley Physicians Hospital Medical Center, Plattsburgh, New York, United States|Vassar Brothers Hospital, Poughkeepsie, New York, United States|Genesee Hospital - Rochester, Rochester, New York, United States|University of Rochester Cancer Center, Rochester, New York, United States|New York Medical College, Valhalla, New York, United States|Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, United States|Northeast Medical Center, Concord, North Carolina, United States|East Carolina University School of Medicine, Greenville, North Carolina, United States|Catawba Memorial Hospital, Hickory, North Carolina, United States|CCOP - Southeast Cancer Control Consortium, Winston-Salem, North Carolina, United States|Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States|Meritcare Roger Maris Cancer Center, Fargo, North Dakota, United States|UNI-MED Medical Center, Minot, North Dakota, United States|Akron General Medical Center, Akron, Ohio, United States|Akron City Hospital, Akron, Ohio, United States|Christ Hospital, Cincinnati, Ohio, United States|Ireland Cancer Center, Cleveland, Ohio, United States|University Hospitals of Cleveland, Cleveland, Ohio, United States|Cleveland Clinic Cancer Center, Cleveland, Ohio, United States|CCOP - Columbus, Columbus, Ohio, United States|Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States|Veterans Affairs Medical Center - Dayton, Dayton, Ohio, United States|CCOP - Dayton, Kettering, Ohio, United States|CCOP - Toledo Community Hospital Oncology Program, Toledo, Ohio, United States|St. John Medical Center, Tulsa, Oklahoma, United States|Samaritan Regional Cancer Center, Corvallis, Oregon, United States|CCOP - Columbia River Program, Portland, Oregon, United States|Lehigh Valley Hospital, Allentown, Pennsylvania, United States|St. Luke's Hospital Regional Cancer Center, Bethlehem, Pennsylvania, United States|Penn State Geisinger Medical Center, Danville, Pennsylvania, United States|Mercy Catholic Medical Center, Mercy Fitzgerald Divison, Darby, Pennsylvania, United States|Delaware County Memorial Hospital, Drexel Hill, Pennsylvania, United States|Penn State Geisinger Cancer Center, Hershey, Pennsylvania, United States|Allegheny University Hospitals- Hahnemann, Philadelphia, Pennsylvania, United States|University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States|Veterans Affairs Medical Center - Philadelphia, Philadelphia, Pennsylvania, United States|Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|Albert Einstein Cancer Center, Philadelphia, Pennsylvania, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|Mercy Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States|Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States|Reading Hospital and Medical Center, Reading, Pennsylvania, United States|Mercy Hospital Cancer Center - Scranton, Scranton, Pennsylvania, United States|Grand View Hospital, Sellersville, Pennsylvania, United States|Wilkes Barre General Hospital, Wilkes-Barre, Pennsylvania, United States|CCOP - MainLine Health, Wynnewood, Pennsylvania, United States|York Hospital, York, Pennsylvania, United States|Roger Williams Medical Center/BUSM, Providence, Rhode Island, United States|Medical University of South Carolina, Charleston, South Carolina, United States|CCOP - Greenville, Greenville, South Carolina, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States|Jackson-Madison County General Hospital, Jackson, Tennessee, United States|Baptist Regional Cancer Center - Knoxville, Knoxville, Tennessee, United States|CCOP - Baptist Cancer Institute, Memphis, Tennessee, United States|University of Tennessee, Memphis Cancer Center, Memphis, Tennessee, United States|Vanderbilt Cancer Center, Nashville, Tennessee, United States|Harrington Cancer Center, Amarillo, Texas, United States|Julie and Ben Rogers Cancer Institute, Beaumont, Texas, United States|University of Texas Medical Branch, Galveston, Texas, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|Wilford Hall - 59th Medical Wing, Lackland Air Force Base, Texas, United States|Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas, United States|Bayshore Medical Center, Pasadena, Texas, United States|East Texas Medical Center - Cancer Institute, Tyler, Texas, United States|Dixie Regional Medical Center, Saint George, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|CCOP - Southwestern Vermont Regional Cancer Center, Bennington, Vermont, United States|Vermont Cancer Center, Burlington, Vermont, United States|Green Mountain Oncology Group, Rutland, Vermont, United States|Veterans Affairs Medical Center - White River Junction, White River Junction, Vermont, United States|Martha Jefferson Hospital, Charlottesville, Virginia, United States|Cancer Center, University of Virginia HSC, Charlottesville, Virginia, United States|Virginia Baptist Hospital, Lynchburg, Virginia, United States|Naval Medical Center, Portsmouth, Portsmouth, Virginia, United States|Massey Cancer Center, Richmond, Virginia, United States|Swedish Cancer Institute, Seattle, Washington, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Deaconess Medical Center, Spokane, Washington, United States|Yakima Valley Memorial Hospital, Yakima, Washington, United States|Schiffler Oncology Center, Wheeling, West Virginia, United States|St. Vincent Hospital, Green Bay, Wisconsin, United States|Gundersen Lutheran Medical Foundation, La Crosse, Wisconsin, United States|Veterans Affairs Medical Center - Madison, Madison, Wisconsin, United States|Southern Wisconsin Radiotherapy Center, Madison, Wisconsin, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States|Marshfield Clinic, Marshfield, Wisconsin, United States|Community Memorial Hospital, Menomonee Falls, Wisconsin, United States|St. Joseph's Hospital, Milwaukee, Wisconsin, United States|Columbia Hospital, Milwaukee, Wisconsin, United States|St. Luke's Medical Center, Milwaukee, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Veterans Affairs Medical Center - Milwaukee (Zablocki), Milwaukee, Wisconsin, United States|Southeastern Wisconsin Regional Cancer Center, Racine, Wisconsin, United States|Waukesha Memorial Hospital, Waukesha, Wisconsin, United States|Tom Baker Cancer Center - Calgary, Calgary, Alberta, Canada|Cross Cancer Institute, Edmonton, Alberta, Canada|British Columbia Cancer Agency - Vancouver Island Cancer Centre, Victoria, British Columbia, Canada|Doctor Leon Richard Oncology Centre, Moncton, New Brunswick, Canada|Saint John Regional Hospital, Saint John, New Brunswick, Canada|Nova Scotia Cancer Centre, Halifax, Nova Scotia, Canada|Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada|Kingston Regional Cancer Centre, Kingston, Ontario, Canada|Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada|Ottawa Regional Cancer Centre - Civic Campus, Ottawa, Ontario, Canada|Northeastern Ontario Regional Cancer Centre, Sudbury, Sudbury, Ontario, Canada|Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay, Ontario, Canada|Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada|Princess Margaret Hospital, Toronto, Ontario, Canada|Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada|McGill University Department of Oncology, Montreal, Quebec, Canada|Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada","https://ClinicalTrials.gov/show/NCT00002545"
1019,"Carmustine and O(6)-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme","Withdrawn","No Results Available","Brain and Central Nervous System Tumors","Drug: O6-benzylguanine|Drug: carmustine",,"https://ClinicalTrials.gov/show/NCT00046878"
1020,"Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: carmustine|Radiation: radiation therapy|Radiation: stereotactic radiosurgery","University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States|Comprehensive Cancer Institute of Huntsville, Huntsville, Alabama, United States|Huntsville Hospital System, Huntsville, Alabama, United States|MBCCOP - Gulf Coast, Mobile, Alabama, United States|Alabama Oncology, LLC, Montgomery, Alabama, United States|DCH Cancer Treatment Center, Tuscaloosa, Alabama, United States|Foundation for Cancer Research and Education, Phoenix, Arizona, United States|Mount Diablo Medical Center, Concord, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Saint Agnes Cancer Center, Fresno, California, United States|California Cancer Center, Fresno, California, United States|Sutter Health West Cancer Research Group, Greenbrae, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Veterans Affairs Medical Center - Long Beach, Long Beach, California, United States|Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States|USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States|CCOP - Bay Area Tumor Institute, Oakland, California, United States|Huntington Cancer Center, Pasadena, California, United States|Robert and Beverly Lewis Family Cancer Care Center, Pomona, California, United States|Radiation Oncology Center - Sacramento, Sacramento, California, United States|Radiation Medical Group, Incorporated, San Diego, California, United States|UCSF Comprehensive Cancer Center, San Francisco, California, United States|O'Connor Hospital, San Jose, California, United States|CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California, United States|David Grant Medical Center, Travis Air Force Base, California, United States|Memorial Hospital Cancer Center, Colorado Springs, Colorado, United States|University of Colorado Cancer Center, Denver, Colorado, United States|Saint Mary's Hospital and Medical Center, Grand Junction, Colorado, United States|Hospital of St. Raphael, New Haven, Connecticut, United States|CCOP - Christiana Care Health Services, Newark, Delaware, United States|University of Florida Health Science Center, Gainesville, Florida, United States|Florida Radiation Oncology Group, Jacksonville, Florida, United States|Health First Holmes Regional Medical Center, Melbourne, Florida, United States|CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States|Veterans Affairs Medical Center - Miami, Miami, Florida, United States|Sylvester Cancer Center, University of Miami, Miami, Florida, United States|Baptist Hospital of Miami, Miami, Florida, United States|MD Anderson Cancer Center Orlando, Orlando, Florida, United States|Bay Medical Center, Panama City, Florida, United States|Gulf Coast Cancer Treatment Center, Panama City, Florida, United States|Sarasota Radiation and Medical Oncology Center, Sarasota, Florida, United States|Tallahassee Memorial Healthcare, Tallahassee, Florida, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Emory University Hospital - Atlanta, Atlanta, Georgia, United States|CCOP - Atlanta Regional, Atlanta, Georgia, United States|Medical Center/John B. Amos Community Cancer Center, Columbus, Georgia, United States|Regional Radiation Oncology Center at Rome, Rome, Georgia, United States|MBCCOP - Hawaii, Honolulu, Hawaii, United States|Northwest Community Hospital, Arlington Heights, Illinois, United States|Northwestern Memorial Hospital, Chicago, Illinois, United States|CCOP - Central Illinois, Decatur, Illinois, United States|Ingalls Memorial Hospital, Harvey, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Lutheran General Cancer Care Center, Park Ridge, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|St. John's Medical Center, Anderson, Indiana, United States|Bloomington Hospital, Bloomington, Indiana, United States|Veterans Affairs Medical Center - Indianapolis (Roudebush), Indianapolis, Indiana, United States|Clarian Health Partners Inc., Indianapolis, Indiana, United States|Regional Cancer Center, Indianapolis, Indiana, United States|Ball Memorial Hospital, Muncie, Indiana, United States|CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States|Wendt Regional Cancer Center of Finley Hospital, Dubuque, Iowa, United States|Central Baptist Hospital, Lexington, Kentucky, United States|Cancer Center at Lexington Clinic, Lexington, Kentucky, United States|Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky, United States|James Graham Brown Cancer Center, Louisville, Kentucky, United States|Louisville Radiation Oncology, Louisville, Kentucky, United States|Merle M. Mahr Cancer Center, Madisonville, Kentucky, United States|Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States|Tulane University School of Medicine, New Orleans, Louisiana, United States|MBCCOP - LSU Medical Center, New Orleans, Louisiana, United States|CCOP - Ochsner, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Anne Arundel Oncology Center, Annapolis, Maryland, United States|Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States|Greater Baltimore Medical Center and Cancer Center, Baltimore, Maryland, United States|Harbor Hospital Center, Baltimore, Maryland, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Peninsula Regional Medical Center, Salisbury, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Cape Cod Hospital, Hyannis, Massachusetts, United States|Veterans Affairs Medical Center - Boston (Jamaica Plain), Jamaica Plain, Massachusetts, United States|CCOP - Ann Arbor Regional, Ann Arbor, Michigan, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|McLaren Regional Cancer Center, Flint, Michigan, United States|CCOP - Kalamazoo, Kalamazoo, Michigan, United States|Marquette General Hospital, Marquette, Michigan, United States|MidMichigan Medical Center - Midland, Midland, Michigan, United States|CCOP - Beaumont, Royal Oak, Michigan, United States|William Beaumont Hospital, Royal Oak, Michigan, United States|William Beaumont Hospital - Troy, Troy, Michigan, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, United States|CCOP - Kansas City, Kansas City, Missouri, United States|Mallinckrodt Institute of Radiology, Saint Louis, Missouri, United States|St. Louis University Health Sciences Center, Saint Louis, Missouri, United States|Cancer Research for the Ozarks, Springfield, Missouri, United States|CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|Methodist Hospital Cancer Center - Omaha, Omaha, Nebraska, United States|Nebraska Health System, Omaha, Nebraska, United States|CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, United States|Norris Cotton Cancer Center, Lebanon, New Hampshire, United States|Elliot Regional Cancer Center, Manchester, New Hampshire, United States|Veterans Affairs Medical Center - East Orange, East Orange, New Jersey, United States|John F. Kennedy Medical Center, Edison, New Jersey, United States|Trinitas Hospital - Jersey Street Campus, Elizabeth, New Jersey, United States|Monmouth Medical Center, Long Branch, New Jersey, United States|South Jersey Regional Cancer Center, Millville, New Jersey, United States|Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital, Mount Holly, New Jersey, United States|Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|Newark Beth Israel Medical Center, Newark, New Jersey, United States|Atlantic City Medical Center, Pomona, New Jersey, United States|Valley Hospital, Ridgewood, New Jersey, United States|Community Medical Center, Toms River, New Jersey, United States|St. Francis Medical Center, Trenton, New Jersey, United States|Associated Radiologists, P.A., Warren, New Jersey, United States|Radiation Oncology Associates of Albuquerque, Albuquerque, New Mexico, United States|Cancer Center of Albany Medical Center, Albany, New York, United States|State University of New York Health Science Center at Brooklyn, Brooklyn, New York, United States|New York Methodist Hospital, Brooklyn, New York, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Finger Lakes Radiation Oncology Center, Clifton Springs, New York, United States|CCOP - North Shore University Hospital, Manhasset, New York, United States|Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Champlain Valley Physicians Hospital Medical Center, Plattsburgh, New York, United States|Vassar Brothers Medical Center, Poughkeepsie, New York, United States|James P. Wilmot Cancer Center, Rochester, New York, United States|CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse, New York, United States|Riverhill Radiation Oncology, Yonkers, New York, United States|Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, United States|Northeast Medical Center, Concord, North Carolina, United States|East Carolina University School of Medicine, Greenville, North Carolina, United States|CCOP - Southeast Cancer Control Consortium, Winston-Salem, North Carolina, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|Trinity Cancer Care Center, Minot, North Dakota, United States|Akron General Medical Center, Akron, Ohio, United States|Akron City Hospital, Akron, Ohio, United States|Christ Hospital, Cincinnati, Ohio, United States|Barrett Cancer Center, Cincinnati, Ohio, United States|Ireland Cancer Center, Cleveland, Ohio, United States|University Hospitals of Cleveland, Cleveland, Ohio, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|CCOP - Columbus, Columbus, Ohio, United States|Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States|CCOP - Dayton, Dayton, Ohio, United States|CCOP - Toledo Community Hospital, Toledo, Ohio, United States|St. Anthony Hospital, Oklahoma City, Oklahoma, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|St. John Health System, Tulsa, Oklahoma, United States|CCOP - Oklahoma, Tulsa, Oklahoma, United States|CCOP - Columbia River Program, Portland, Oregon, United States|Lehigh Valley Hospital, Allentown, Pennsylvania, United States|St. Luke's Hospital Cancer Center, Bethlehem, Pennsylvania, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Mercy Fitzgerald Hospital, Darby, Pennsylvania, United States|Delaware County Memorial Hospital, Drexel Hill, Pennsylvania, United States|Pocono Cancer Center, East Stroudsburg, Pennsylvania, United States|Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Veterans Affairs Medical Center - Philadelphia, Philadelphia, Pennsylvania, United States|Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|Albert Einstein Cancer Center, Philadelphia, Pennsylvania, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|Mercy Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States|Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States|Reading Hospital and Medical Center, Reading, Pennsylvania, United States|Mercy Hospital Cancer Center - Scranton, Scranton, Pennsylvania, United States|Wilkes Barre General Hospital, Wilkes-Barre, Pennsylvania, United States|York Cancer Center, York, Pennsylvania, United States|Roger Williams Medical Center/BUSM, Providence, Rhode Island, United States|CCOP - Greenville, Greenville, South Carolina, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Jackson-Madison County General Hospital, Jackson, Tennessee, United States|University of Tennessee Cancer Institute, Memphis, Tennessee, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States|Harrington Cancer Center, Amarillo, Texas, United States|University of Texas Medical Branch, Galveston, Texas, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|Wilford Hall Medical Center, Lackland Air Force Base, Texas, United States|Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas, United States|Bayshore Medical Center, Pasadena, Texas, United States|Dixie Regional Medical Center, Saint George, Utah, United States|University of Utah Health Sciences Center, Salt Lake City, Utah, United States|Latter Day Saints Hospital, Salt Lake City, Utah, United States|Vermont Cancer Center, Burlington, Vermont, United States|Cancer Center at the University of Virginia, Charlottesville, Virginia, United States|RMH Regional Cancer Center, Harrisonburg, Virginia, United States|Naval Medical Center, Portsmouth, Portsmouth, Virginia, United States|Bon Secours - St. Mary's Hospital, Richmond, Virginia, United States|Massey Cancer Center, Richmond, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Deaconess Medical Center, Spokane, Washington, United States|Yakima Valley Memorial Hospital, Yakima, Washington, United States|Schiffler Cancer Center, Wheeling, West Virginia, United States|CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay, Wisconsin, United States|St. Vincent Hospital, Green Bay, Wisconsin, United States|Gundersen Lutheran Medical Foundation, La Crosse, Wisconsin, United States|Southern Wisconsin Radiotherapy Center, Madison, Wisconsin, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States|Marshfield Clinic, Marshfield, Wisconsin, United States|Community Memorial Hospital, Menomonee Falls, Wisconsin, United States|Columbia Hospital, Milwaukee, Wisconsin, United States|St. Luke's Medical Center, Milwaukee, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Veterans Affairs Medical Center - Milwaukee (Zablocki), Milwaukee, Wisconsin, United States|All Saints Cancer Center, Racine, Wisconsin, United States|Waukesha Memorial Hospital Regional Cancer Center, Waukesha, Wisconsin, United States|Tom Baker Cancer Center - Calgary, Calgary, Alberta, Canada|Cross Cancer Institute, Edmonton, Alberta, Canada|Saint John Regional Hospital, Saint John, New Brunswick, Canada|Newfoundland Cancer Treatment and Research Foundation, St. Johns, Newfoundland and Labrador, Canada|Nova Scotia Cancer Centre, Halifax, Nova Scotia, Canada|Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada|Kingston Regional Cancer Centre, Kingston, Ontario, Canada|Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada|Ottawa Regional Cancer Centre, Ottawa, Ontario, Canada|Northeastern Ontario Regional Cancer Centre, Sudbury, Sudbury, Ontario, Canada|Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay, Ontario, Canada|Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada|Princess Margaret Hospital, Toronto, Ontario, Canada|CHUS-Hopital Fleurimont, Fleurimont, Quebec, Canada|Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada|McGill University, Montreal, Quebec, Canada|Centre Hospitalier Universitaire de Quebec, Quebec City, Quebec, Canada|Allan Blair Cancer Centre, Regina, Saskatchewan, Canada|Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada","https://ClinicalTrials.gov/show/NCT00006386"
1021,"Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: carmustine|Drug: chemotherapy|Drug: cisplatin|Drug: etoposide|Radiation: radiation therapy","CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States|CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States|CCOP - Carle Cancer Center, Urbana, Illinois, United States|CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States|CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States|Siouxland Hematology-Oncology, Sioux City, Iowa, United States|CCOP - Wichita, Wichita, Kansas, United States|CCOP - Ochsner, New Orleans, Louisiana, United States|CCOP - Duluth, Duluth, Minnesota, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CentraCare Clinic, Saint Cloud, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|Quain & Ramstad Clinic, P.C., Bismarck, North Dakota, United States|Altru Health Systems, Grand Forks, North Dakota, United States|CCOP - Toledo Community Hospital Oncology Program, Toledo, Ohio, United States|CCOP - Geisinger Clinical and Medical Center, Danville, Pennsylvania, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|CCOP - Sioux Community Cancer Consortium, Sioux Falls, South Dakota, United States","https://ClinicalTrials.gov/show/NCT00003996"
1022,"Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: motexafin gadolinium|Radiation: radiation therapy","Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States|University of California Davis Cancer Center, Sacramento, California, United States","https://ClinicalTrials.gov/show/NCT00003409"
1023,"Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia","Completed","No Results Available","Malignant Neoplasms Brain","Biological: RNA-loaded dendritic cell vaccine|Drug: basiliximab","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00626483"
1024,"Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: bispecific antibody MDX447|Biological: lymphokine-activated killer cells|Procedure: conventional surgery","Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States","https://ClinicalTrials.gov/show/NCT00005813"
1025,"Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Procedure: conventional surgery|Radiation: brachytherapy|Radiation: radiation therapy","University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|Abramson Cancer Center at University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00053183"
1026,"Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: motexafin gadolinium|Radiation: radiation therapy","Memorial Sloan-Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00022256"
1027,"Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: motexafin gadolinium|Radiation: radiation therapy","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00032097"
1028,"Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas","Completed","Has Results","Recurrent Glioblastoma","Drug: enzastaurin|Drug: bevacizumab|Drug: Enzyme-inducing antiepileptic drugs (EIAED)|Drug: Non-enzyme inducing antiepileptic drugs (NEIAED)","For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00586508"
1029,"Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: prinomastat|Drug: temozolomide","Agouron Pharmaceuticals, Inc., La Jolla, California, United States","https://ClinicalTrials.gov/show/NCT00004200"
1030,"Multi-parametric MRI/Fluorine-18 Fluciclovine PET-CT in Glioblastoma","Unknown status","No Results Available","Tumor, Brain","Radiation: Fluciclovine PET/CT","Department of Nuclear Medicine, St James's University Hospitals, Leeds, United Kingdom","https://ClinicalTrials.gov/show/NCT03409549"
1031,"Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: dalteparin|Radiation: radiation therapy","H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|CCOP - Carle Cancer Center, Urbana, Illinois, United States|CCOP - Kalamazoo, Kalamazoo, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|CCOP - Oklahoma, Tulsa, Oklahoma, United States|Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center, Nashville, Tennessee, United States|CCOP - Scott and White Hospital, Temple, Texas, United States|CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay, Wisconsin, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00028678"
1032,"Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: olaparib|Drug: temozolomide|Genetic: gene expression analysis|Genetic: protein expression analysis|Other: laboratory biomarker analysis|Other: pharmacological study|Procedure: diffusion-weighted magnetic resonance imaging|Procedure: dynamic contrast-enhanced magnetic resonance imaging|Procedure: therapeutic conventional surgery","Bristol Haematology and Oncology Centre, Bristol, England, United Kingdom|Addenbrooke's Hospital, Cambridge, England, United Kingdom|Christie Hospital, Manchester, England, United Kingdom|Royal Marsden Hospital, Sutton, England, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, Scotland, United Kingdom|Queen Elizabeth Hospital, Birmingham, United Kingdom|Western General Hospital, Edinburgh, United Kingdom","https://ClinicalTrials.gov/show/NCT01390571"
1033,"Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: sagopilone|Genetic: fluorescence in situ hybridization|Genetic: gene expression analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Other: pharmacological study","Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland","https://ClinicalTrials.gov/show/NCT00424060"
1034,"Radiation Therapy Followed by Bleomycin in Treating Adult Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme","Terminated","Has Results","Brain and Central Nervous System Tumors","Biological: bleomycin|Device: Ommaya reservoir|Radiation: radiation therapy","Foundation for Cancer Research and Education, Phoenix, Arizona, United States|Markey Cancer Center at University of Kentucky Chandler Medical Center, Lexington, Kentucky, United States|Methodist Hospital Cancer Center at Nebraska Methodist Hospital - Omaha, Omaha, Nebraska, United States|South Jersey Regional Cancer Center, Millville, New Jersey, United States|Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital, Mount Holly, New Jersey, United States|Cancer Treatment Center, Wooster, Ohio, United States|St. John Health System, Tulsa, Oklahoma, United States|Cottonwood Hospital Medical Center, Murray, Utah, United States|Utah Valley Regional Medical Center - Provo, Provo, Utah, United States|Dixie Regional Medical Center, Saint George, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|CCOP - Marshfield Clinic Research Foundation, Marshfield, Wisconsin, United States|Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00006916"
1035,"Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme","Completed","Has Results","Brain and Central Nervous System Tumors","Biological: bevacizumab|Drug: sorafenib tosylate","Mayo Clinic Scottsdale, Scottsdale, Arizona, United States|Cancer Care Associates, Fresno, California, United States|Front Range Cancer Specialists, Fort Collins, Colorado, United States|Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center, Hartford, Connecticut, United States|Baptist Cancer Institute - Jacksonville, Jacksonville, Florida, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|Rush-Copley Cancer Care Center, Aurora, Illinois, United States|Carle Cancer Center at Carle Foundation Hospital, Urbana, Illinois, United States|CCOP - Carle Cancer Center, Urbana, Illinois, United States|St. Francis Hospital and Health Centers - Beech Grove Campus, Beech Grove, Indiana, United States|Reid Hospital & Health Care Services, Richmond, Indiana, United States|McFarland Clinic, PC, Ames, Iowa, United States|Cedar Rapids Oncology Associates, Cedar Rapids, Iowa, United States|Mercy Regional Cancer Center at Mercy Medical Center, Cedar Rapids, Iowa, United States|Medical Oncology and Hematology Associates - West Des Moines, Clive, Iowa, United States|Mercy Capitol Hospital, Des Moines, Iowa, United States|CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States|John Stoddard Cancer Center at Iowa Methodist Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates at John Stoddard Cancer Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates at Mercy Cancer Center, Des Moines, Iowa, United States|Mercy Cancer Center at Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|John Stoddard Cancer Center at Iowa Lutheran Hospital, Des Moines, Iowa, United States|McCreery Cancer Center at Ottumwa Regional, Ottumwa, Iowa, United States|Siouxland Hematology-Oncology Associates, LLP, Sioux City, Iowa, United States|Mercy Medical Center - Sioux City, Sioux City, Iowa, United States|St. Luke's Regional Medical Center, Sioux City, Iowa, United States|Cancer Center of Kansas, PA - Chanute, Chanute, Kansas, United States|Cancer Center of Kansas, PA - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas, PA - El Dorado, El Dorado, Kansas, United States|Cancer Center of Kansas - Fort Scott, Fort Scott, Kansas, United States|Cancer Center of Kansas-Independence, Independence, Kansas, United States|Cancer Center of Kansas, PA - Kingman, Kingman, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|Southwest Medical Center, Liberal, Kansas, United States|Cancer Center of Kansas, PA - Newton, Newton, Kansas, United States|Cancer Center of Kansas, PA - Parsons, Parsons, Kansas, United States|Cancer Center of Kansas, PA - Pratt, Pratt, Kansas, United States|Cancer Center of Kansas, PA - Salina, Salina, Kansas, United States|Cancer Center of Kansas, PA - Wellington, Wellington, Kansas, United States|Associates in Womens Health, PA - North Review, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Medical Arts Tower, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Wichita, Wichita, Kansas, United States|CCOP - Wichita, Wichita, Kansas, United States|Via Christi Cancer Center at Via Christi Regional Medical Center, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Winfield, Winfield, Kansas, United States|Drs. Carrol, Sheth, Raghavan, Louisville, Kentucky, United States|Hickman Cancer Center at Bixby Medical Center, Adrian, Michigan, United States|Saint Joseph Mercy Cancer Center, Ann Arbor, Michigan, United States|CCOP - Michigan Cancer Research Consortium, Ann Arbor, Michigan, United States|Oakwood Cancer Center at Oakwood Hospital and Medical Center, Dearborn, Michigan, United States|Green Bay Oncology, Limited - Escanaba, Escanaba, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Van Elslander Cancer Center at St. John Hospital and Medical Center, Grosse Pointe Woods, Michigan, United States|Dickinson County Healthcare System, Iron Mountain, Michigan, United States|Foote Memorial Hospital, Jackson, Michigan, United States|Haematology-Oncology Associates of Ohio and Michigan, PC, Lambertville, Michigan, United States|Sparrow Regional Cancer Center, Lansing, Michigan, United States|St. Mary Mercy Hospital, Livonia, Michigan, United States|Community Cancer Center of Monroe, Monroe, Michigan, United States|Mercy Memorial Hospital - Monroe, Monroe, Michigan, United States|St. Joseph Mercy Oakland, Pontiac, Michigan, United States|Mercy Regional Cancer Center at Mercy Hospital, Port Huron, Michigan, United States|Seton Cancer Institute at Saint Mary's - Saginaw, Saginaw, Michigan, United States|St. John Macomb Hospital, Warren, Michigan, United States|Alexandria, Minnesota, United States|MeritCare Bemidji, Bemidji, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy and Unity Cancer Center at Mercy Hospital, Coon Rapids, Minnesota, United States|Duluth Clinic Cancer Center - Duluth, Duluth, Minnesota, United States|CCOP - Duluth, Duluth, Minnesota, United States|Miller - Dwan Medical Center, Duluth, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Fergus Falls Medical Group, PA, Fergus Falls, Minnesota, United States|Mercy and Unity Cancer Center at Unity Hospital, Fridley, Minnesota, United States|Hutchinson Area Health Care, Hutchinson, Minnesota, United States|HealthEast Cancer Care at St. John's Hospital, Maplewood, Minnesota, United States|Minnesota Oncology Hematology, PA - Maplewood, Maplewood, Minnesota, United States|Virginia Piper Cancer Institute at Abbott - Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center - Minneapolis, Minneapolis, Minnesota, United States|Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center, Robbinsdale, Minnesota, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CentraCare Clinic - River Campus, Saint Cloud, Minnesota, United States|Coborn Cancer Center, Saint Cloud, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|Park Nicollet Cancer Center, Saint Louis Park, Minnesota, United States|Regions Hospital Cancer Care Center, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|St. Francis Cancer Center at St. Francis Medical Center, Shakopee, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Minnesota Oncology Hematology, PA - Woodbury, Woodbury, Minnesota, United States|CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States|St. John's Regional Health Center, Springfield, Missouri, United States|Hulston Cancer Center at Cox Medical Center South, Springfield, Missouri, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|Hematology-Oncology Centers of the Northern Rockies - Billings, Billings, Montana, United States|Northern Rockies Radiation Oncology Center, Billings, Montana, United States|St. Vincent Healthcare Cancer Care Services, Billings, Montana, United States|Billings Clinic - Downtown, Billings, Montana, United States|Bozeman Deaconess Cancer Center, Bozeman, Montana, United States|St. James Healthcare Cancer Care, Butte, Montana, United States|Great Falls Clinic - Main Facility, Great Falls, Montana, United States|Great Falls, Montana, United States|Northern Montana Hospital, Havre, Montana, United States|St. Peter's Hospital, Helena, Montana, United States|Glacier Oncology, PLLC, Kalispell, Montana, United States|Kalispell Medical Oncology at KRMC, Kalispell, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Community Medical Center, Missoula, Montana, United States|Guardian Oncology and Center for Wellness, Missoula, Montana, United States|Montana Cancer Specialists at Montana Cancer Center, Missoula, Montana, United States|Montana Cancer Center at St. Patrick Hospital and Health Sciences Center, Missoula, Montana, United States|Cancer Resource Center - Lincoln, Lincoln, Nebraska, United States|CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|Immanuel Medical Center, Omaha, Nebraska, United States|Alegant Health Cancer Center at Bergan Mercy Medical Center, Omaha, Nebraska, United States|Creighton University Medical Center, Omaha, Nebraska, United States|Rutherford Hospital, Rutherfordton, North Carolina, United States|Bismarck Cancer Center, Bismarck, North Dakota, United States|Medcenter One Hospital Cancer Care Center, Bismarck, North Dakota, United States|Mid Dakota Clinic, PC, Bismarck, North Dakota, United States|St. Alexius Medical Center Cancer Center, Bismarck, North Dakota, United States|CCOP - MeritCare Hospital, Fargo, North Dakota, United States|MeritCare Broadway, Fargo, North Dakota, United States|Mary Rutan Hospital, Bellefontaine, Ohio, United States|Wood County Oncology Center, Bowling Green, Ohio, United States|Adena Regional Medical Center, Chillicothe, Ohio, United States|Charles M. Barrett Cancer Center at University Hospital, Cincinnati, Ohio, United States|North Coast Cancer Care - Clyde, Clyde, Ohio, United States|Riverside Methodist Hospital Cancer Care, Columbus, Ohio, United States|CCOP - Columbus, Columbus, Ohio, United States|Grant Medical Center Cancer Care, Columbus, Ohio, United States|Mount Carmel Health - West Hospital, Columbus, Ohio, United States|Doctors Hospital at Ohio Health, Columbus, Ohio, United States|Grandview Hospital, Dayton, Ohio, United States|Good Samaritan Hospital, Dayton, Ohio, United States|David L. Rike Cancer Center at Miami Valley Hospital, Dayton, Ohio, United States|Samaritan North Cancer Care Center, Dayton, Ohio, United States|CCOP - Dayton, Dayton, Ohio, United States|Grady Memorial Hospital, Delaware, Ohio, United States|Hematology Oncology Center, Elyria, Ohio, United States|Blanchard Valley Medical Associates, Findlay, Ohio, United States|Middletown Regional Hospital, Franklin, Ohio, United States|Wayne Hospital, Greenville, Ohio, United States|Charles F. Kettering Memorial Hospital, Kettering, Ohio, United States|Fairfield Medical Center, Lancaster, Ohio, United States|Lima Memorial Hospital, Lima, Ohio, United States|Strecker Cancer Center at Marietta Memorial Hospital, Marietta, Ohio, United States|Northwest Ohio Oncology Center, Maumee, Ohio, United States|St. Luke's Hospital, Maumee, Ohio, United States|Licking Memorial Cancer Care Program at Licking Memorial Hospital, Newark, Ohio, United States|Fisher-Titus Medical Center, Norwalk, Ohio, United States|St. Charles Mercy Hospital, Oregon, Ohio, United States|Toledo Clinic - Oregon, Oregon, Ohio, United States|North Coast Cancer Care, Incorporated, Sandusky, Ohio, United States|Mercy Medical Center, Springfield, Ohio, United States|Community Hospital of Springfield and Clark County, Springfield, Ohio, United States|Flower Hospital Cancer Center, Sylvania, Ohio, United States|Mercy Hospital of Tiffin, Tiffin, Ohio, United States|Toledo Hospital, Toledo, Ohio, United States|St. Vincent Mercy Medical Center, Toledo, Ohio, United States|Medical University of Ohio Cancer Center, Toledo, Ohio, United States|CCOP - Toledo Community Hospital, Toledo, Ohio, United States|St. Anne Mercy Hospital, Toledo, Ohio, United States|Toledo Clinic, Incorporated - Main Clinic, Toledo, Ohio, United States|UVMC Cancer Care Center at Upper Valley Medical Center, Troy, Ohio, United States|Fulton County Health Center, Wauseon, Ohio, United States|Precision Radiotherapy at University Pointe, West Chester, Ohio, United States|Mount Carmel St. Ann's Cancer Center, Westerville, Ohio, United States|Clinton Memorial Hospital, Wilmington, Ohio, United States|Ruth G. McMillan Cancer Center at Greene Memorial Hospital, Xenia, Ohio, United States|Genesis - Good Samaritan Hospital, Zanesville, Ohio, United States|Providence Milwaukie Hospital, Milwaukie, Oregon, United States|Legacy Good Samaritan Hospital & Comprehensive Cancer Center, Portland, Oregon, United States|Providence Cancer Center at Providence Portland Medical Center, Portland, Oregon, United States|Adventist Medical Center, Portland, Oregon, United States|CCOP - Columbia River Oncology Program, Portland, Oregon, United States|Providence St. Vincent Medical Center, Portland, Oregon, United States|Northwest Cancer Specialists at Rose Quarter Cancer Center, Portland, Oregon, United States|Knight Cancer Institute at Oregon Health and Science University, Portland, Oregon, United States|Geisinger Cancer Institute at Geisinger Health, Danville, Pennsylvania, United States|Geisinger Hazleton Cancer Center, Hazleton, Pennsylvania, United States|Geisinger Medical Group - Scenery Park, State College, Pennsylvania, United States|Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center, Wilkes-Barre, Pennsylvania, United States|AnMed Cancer Center, Anderson, South Carolina, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States|Gibbs Regional Cancer Center at Spartanburg Regional Medical Center, Spartanburg, South Carolina, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Medical X-Ray Center, PC, Sioux Falls, South Dakota, United States|Sanford Cancer Center at Sanford USD Medical Center, Sioux Falls, South Dakota, United States|Fredericksburg Oncology, Incorporated, Fredericksburg, Virginia, United States|Southwest Washington Medical Center Cancer Center, Vancouver, Washington, United States|Luther Midlelfort Hospital, Eau Claire, Wisconsin, United States|Midelfort Clinic - Luther, Eau Claire, Wisconsin, United States|Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center, Green Bay, Wisconsin, United States|Green Bay Oncology, Limited at St. Mary's Hospital, Green Bay, Wisconsin, United States|St. Mary's Hospital Medical Center - Green Bay, Green Bay, Wisconsin, United States|St. Vincent Hospital Regional Cancer Center, Green Bay, Wisconsin, United States|Holy Family Memorial Medical Center Cancer Care Center, Manitowoc, Wisconsin, United States|Bay Area Cancer Care Center at Bay Area Medical Center, Marinette, Wisconsin, United States|Green Bay Oncology, Limited - Oconto Falls, Oconto Falls, Wisconsin, United States|Green Bay Oncology, Limited - Sturgeon Bay, Sturgeon Bay, Wisconsin, United States|Rocky Mountain Oncology, Casper, Wyoming, United States|Welch Cancer Center at Sheridan Memorial Hospital, Sheridan, Wyoming, United States","https://ClinicalTrials.gov/show/NCT00621686"
1036,"Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I","Terminated","No Results Available","Malignant Gliomas","Drug: Irinotecan|Drug: Lenalidomide","UT MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00671801"
1037,"Targeting Potassium Channels to Reprogram Glioblastoma Microenvironment: in Vitro and in Vivo Studies","Unknown status","No Results Available","Cancer of Head and Neck","Other: brain tumor-immune cells communication","Cristina Limatola, Pozzilli, Is, Italy|Cristina Limatola, Pozzilli, Italy","https://ClinicalTrials.gov/show/NCT03954691"
1038,"A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96","Recruiting","No Results Available","Glioma of Brain","Biological: gp96|Drug: Temozolomide|Radiation: radiotherapy","Beijing Tiantan Hospital Affiliated to Capital Medical University, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT03650257"
1039,"Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma","Terminated","Has Results","Adult Brain Tumors","Drug: erlotinib hydrochloride","UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT00387894"
1040,"Biological Therapy in Treating Patients With Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: autologous tumor cell vaccine|Biological: sargramostim|Biological: tumor-draining lymph node lymphocyte therapy|Drug: cyclophosphamide|Procedure: conventional surgery","Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00003185"
1041,"Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96","Completed","No Results Available","Glioma","Biological: gp96","Beijing Tiantan Hospital Affiliated to Capital Medical University, Beijing, China","https://ClinicalTrials.gov/show/NCT02122822"
1042,"Simultaneous Integrated Boost in Malignant Glioma Patients Treated With Chemoradiation","Unknown status","No Results Available","Glioblastoma Multiforme|Chemoradiation","Radiation: Simultaneous integrated boost","Taichung Veterans General Hospital, Taichung, Taiwan","https://ClinicalTrials.gov/show/NCT03225300"
1043,"Sirolimus in Treating Patients With Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: Rapamycin|Procedure: Surgery|Procedure: Supportive Care","Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT00047073"
1044,"Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: everolimus|Drug: temozolomide|Genetic: microarray analysis|Other: immunohistochemistry staining method","Tom Baker Cancer Centre, Calgary, Alberta, Canada|Cross Cancer Institute, Edmonton, Alberta, Canada|BCCA - Cancer Centre for the Southern Interior, Kelowna, British Columbia, Canada|BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada|QEII Health Sciences Center, Halifax, Nova Scotia, Canada|London Regional Cancer Program, London, Ontario, Canada|Univ. Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada|CHUM - Hopital Notre-Dame, Montreal, Quebec, Canada|McGill University - Dept. Oncology, Montreal, Quebec, Canada","https://ClinicalTrials.gov/show/NCT00387400"
1045,"Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients With Newly Diagnosed Glioblastoma","Recruiting","No Results Available","Brain Tumor Adult","Biological: DRI cell therapy","University of Alabama at Birmingham, Birmingham, Alabama, United States","https://ClinicalTrials.gov/show/NCT04165941"
1046,"Differentiation Between Healthy Cerebral Tissue and Tumor Tissue Using a Tissue Sensing Instrument","Active, not recruiting","No Results Available","Glioblastoma|Surgical Margin","Procedure: Diffuse Reflectance Spectroscopy","Karolinska University Hospital, Stockholm, Sweden","https://ClinicalTrials.gov/show/NCT05171127"
1047,"Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme","Terminated","No Results Available","Brain and Central Nervous System Tumors","Drug: erlotinib hydrochloride","Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00227032"
1048,"Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme","Unknown status","No Results Available","Brain and Central Nervous System Tumors","Drug: carboplatin|Drug: temozolomide","Overlook Hospital, Summit, New Jersey, United States","https://ClinicalTrials.gov/show/NCT00014105"
1049,"Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: acridine carboxamide","Beatson Oncology Centre, Glasgow, Scotland, United Kingdom","https://ClinicalTrials.gov/show/NCT00004937"
1050,"Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme","Withdrawn","No Results Available","Brain and Central Nervous System Tumors","Drug: carboplatin|Drug: temozolomide",,"https://ClinicalTrials.gov/show/NCT00021307"
1051,"Imaging Study of Glioblastomas Treated With Avastin","Terminated","Has Results","Malignant Gliomas","Device: DECT|Device: MR spectroscopy","London Regional Cancer Centre, London, Ontario, Canada","https://ClinicalTrials.gov/show/NCT01549392"
1052,"Personalized Functional Profiling in Metastatic Gastrointestinal Cancer or Recurrent Glioblastoma Patients in Luxembourg.","Recruiting","No Results Available","Oncology","Diagnostic Test: Personalized Functional Profiling","Centre hospitalier de Luxembourg, Luxembourg, Luxembourg|Hôpitaux Robert Schmuan, Luxembourg, Luxembourg","https://ClinicalTrials.gov/show/NCT03997617"
1053,"ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: gefitinib","Duke Comprehensive Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00016991"
1054,"SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: leflunomide|Drug: procarbazine hydrochloride","St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|Arizona Cancer Center, Tucson, Arizona, United States|USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States|Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States|Beckman Research Institute, City of Hope, Los Angeles, California, United States|St. Francis Hospital, San Francisco, California, United States|University of Colorado Cancer Center, Denver, Colorado, United States|Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Medical College of Georgia Hospital and Clinics, Augusta, Georgia, United States|Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States|Indiana University Cancer Center, Indianapolis, Indiana, United States|University of Iowa College of Medicine, Iowa City, Iowa, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Cancer Center of Albany Medical Center, Albany, New York, United States|Albert Einstein Comprehensive Cancer Center, Bronx, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, United States|Barrett Cancer Center, The University Hospital, Cincinnati, Ohio, United States|Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States|Western Pennsylvania Cancer Institute, Pittsburgh, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Vanderbilt Cancer Center, Nashville, Tennessee, United States|Simmons Cancer Center - Dallas, Dallas, Texas, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|University of Washington Medical Center, Seattle, Washington, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Cross Cancer Institute, Edmonton, Alberta, Canada|Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada|Princess Margaret Hospital, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT00003293"
1055,"Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: glufosfamide","Kaiser Franz Josef Hospital, Vienna (Wien), Austria|Centre Jean Perrin, Clermont-Ferrand, France|Centre de Lute Contre le Cancer,Georges-Francois Leclerc, Dijon, France|Centre Leon Berard, Lyon, France|CRLCC Nantes - Atlantique, Nantes-Saint Herblain, France|Centre Antoine Lacassagne, Nice, France|CHU Pitie-Salpetriere, Paris, France|Centre Eugene Marquis, Rennes, France|Institut Gustave Roussy, Villejuif, France|University of Ioannina, Ioannina, Greece|Schneider Children's Medical Center of Israel, Petah-Tikva, Israel|Azienda Ospedaliera di Padova, Padova (Padua), Italy|Istituti Fisioterapici Ospitalieri - Roma, Rome, Italy|Rotterdam Cancer Institute, Rotterdam, Netherlands|Academisch Ziekenhuis Utrecht, Utrecht, Netherlands|Instituto Portugues de Oncologia de Francisco Gentil, Lisbon, Portugal|Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland|Kantonsspital - St. Gallen, St. Gallen, Switzerland","https://ClinicalTrials.gov/show/NCT00014300"
1056,"Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme","Unknown status","No Results Available","Brain and Central Nervous System Tumors","Drug: erlotinib hydrochloride","Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00054496"
1057,"Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: carmustine|Drug: erlotinib hydrochloride|Drug: temozolomide","U.Z. Gasthuisberg, Leuven, Belgium|Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon, France|Centre Regional Rene Gauducheau, Nantes-Saint Herblain, France|Centre Antoine Lacassagne, Nice, France|CHU Pitie-Salpetriere, Paris, France|Institut Gustave Roussy, Villejuif, France|Azienda Ospedaliera di Padova, Padova, Italy|Medisch Centrum Haaglanden, 's-Gravenhage, Netherlands|University Medical Center Rotterdam at Erasmus Medical Center, Rotterdam, Netherlands|Western Infirmary, Glasgow, Scotland, United Kingdom","https://ClinicalTrials.gov/show/NCT00086879"
1058,"Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme","Unknown status","No Results Available","Brain and Central Nervous System Tumors","Drug: carmustine in ethanol|Procedure: conventional surgery","USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States|UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States|Stanford University Medical Center, Stanford, California, United States|University of Colorado Cancer Center, Denver, Colorado, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Emory University Hospital - Atlanta, Atlanta, Georgia, United States|Evanston Northwestern Health Care, Evanston, Illinois, United States|John F. Kennedy Medical Center, Edison, New Jersey, United States|Barrett Cancer Center, Cincinnati, Ohio, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|Massey Cancer Center, Richmond, Virginia, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00006656"
1059,"Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas","Recruiting","No Results Available","Anaplastic Astrocytoma, IDH-Wildtype|Anaplastic Oligoastrocytoma|Anaplastic Oligodendroglioma|Diffuse Astrocytoma, IDH-Wildtype|Glioblastoma|Oligoastrocytoma|Oligodendroglioma|WHO Grade II Glioma|WHO Grade III Glioma","Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Radiation: Radiation Therapy|Drug: Temozolomide","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04623931"
1060,"Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: irinotecan hydrochloride|Drug: thalidomide","Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT00039468"
1061,"Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas","Unknown status","No Results Available","Glioma|Anaplastic Oligoastrocytoma|Glioblastomas (GBM)","Procedure: Structural Image Guidance|Procedure: Metabolic Image Guidance",,"https://ClinicalTrials.gov/show/NCT02795364"
1062,"AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: AEE788|Drug: everolimus","Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States|Duke Univaersity Medical Center, Durham, North Carolina, United States|MD Anderson Cancer Center/University of Texas, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00107237"
1063,"Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma","Completed","No Results Available","Malignant Glioma|Glioblastoma Multiforme","Radiation: Whole Brain Radiation|Drug: Temozolomide|Drug: ABT-414","Nagoya University Hospital /ID# 138559, Nagoya-shi, Aichi, Japan|Hiroshima University Hospital /ID# 139399, Hiroshima-shi, Hiroshima, Japan|Hokkaido University Hospital /ID# 150589, Sapporo-shi, Hokkaido, Japan|University of Tsukuba Hospital /ID# 140433, Tsukuba-shi, Ibaraki, Japan|Iwate Medical University Hospital /ID# 149145, Shiwa-gun, Iwate, Japan|Kitasato University Hospital /ID# 148493, Sagamihara-shi, Kanagawa, Japan|Kumamoto University Hospital /ID# 138558, Kumamoto-shi, Kumamoto, Japan|Kyoto Prefect Univ Med /ID# 149093, Kyoto-shi, Kyoto, Japan|Kyoto University Hospital /ID# 163206, Kyoto-shi, Kyoto, Japan|Tohoku University Hospital /ID# 138464, Sendai-shi, Miyagi, Japan|Okayama University Hospital /ID# 148674, Okayama-shi, Okayama, Japan|Osaka University Hospital /ID# 140438, Suita-shi, Osaka, Japan|Saitama Medical University International Medical Center /ID# 140361, Hidaka-shi, Saitama, Japan|Shizuoka Cancer Center /ID# 148673, Sunto-gun, Shizuoka, Japan|Dokkyo Medical University Hospital /ID# 150990, Shimotsuga-gun, Tochigi, Japan|National Cancer Center Hospital /ID# 140435, Chuo-ku, Tokyo, Japan|Nihon University Itabashi Hospital /ID# 149385, Itabashi-ku, Tokyo, Japan|Kyorin University Hospital /ID# 140360, Mitaka-shi, Tokyo, Japan|Tokyo Women's Medical University Hospital /ID# 140436, Shinjuku-ku, Tokyo, Japan|Chiba Cancer Center /ID# 164375, Chiba, Japan|NHO Kyoto Medical Center /ID# 140437, Kyoto, Japan|Osaka International Cancer Institute /ID# 148494, Osaka, Japan","https://ClinicalTrials.gov/show/NCT02590263"
1064,"O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy","Terminated","Has Results","Brain and Central Nervous System Tumors","Drug: O6-benzylguanine|Drug: temozolomide","Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda, Maryland, United States|NCI - Neuro-Oncology Branch, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00436436"
1065,"Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma","Completed","Has Results","Brain and Central Nervous System Tumors","Drug: bevacizumab|Drug: erlotinib hydrochloride","Cedars-Sinai Medical Center, Los Angeles, California, United States|M.D. Anderson Cancer Center at Orlando, Orlando, Florida, United States|Northwestern University, Northwestern Medical Faculty Foundation, Chicago, Illinois, United States|Evanston Hospital, Evanston, Illinois, United States|Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina, United States|Neuro-Oncology Associates at Baylor University Medical Center, Dallas, Dallas, Texas, United States|M.D. Anderson Cancer Center at University of Texas, Houston, Texas, United States|The Methodist Hospital Neurological Institute, Houston, Texas, United States|Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00720356"
1066,"NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: interleukin-4 PE38KDEL cytotoxin|Procedure: conventional surgery","UCSD Thornton Hospital, La Jolla, California, United States|Emory University Hospital - Atlanta, Atlanta, Georgia, United States|St. Louis University Health Sciences Center, Saint Louis, Missouri, United States|Charlotte Neurosurgical Associates, Charlotte, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00014677"
1067,"Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma","Completed","Has Results","Brain and Central Nervous System Tumors","Drug: bortezomib + temozolomide+ radiation therapy","University of California Los Angeles, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT00998010"
1068,"Study of Neurological Complication After Radiotherapy for High Grade Glioblastoma","Unknown status","No Results Available","Leukoencephalopathy","Radiation: brain radiotherapy","Hopital Pitié Salpétriere, Paris, France|Centre paul Strauss, Strasbourg, France","https://ClinicalTrials.gov/show/NCT02544178"
1069,"Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: celecoxib|Drug: temozolomide|Drug: thalidomide|Procedure: adjuvant therapy","Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States|Cancer Center at the University of Virginia, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT00047294"
1070,"Activity of Seviteronel in Patients With Androgen Receptor (AR)-Positive Glioblastoma","Terminated","No Results Available","Solid Tumor|Androgen Receptor Gene Overexpression","Drug: SEVI-D (Seviteronel in combination with dexamthasone)","St Vincent's Hospital, Darlinghurst, New South Wales, Australia","https://ClinicalTrials.gov/show/NCT03600467"
1071,"Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas","Terminated","Has Results","Glioblastoma|Glioma","Drug: Selinexor","Massachusetts General Hospital, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Center for Neuro-Oncology, Boston, Massachusetts, United States|Columbia University, Herbert Irving Comprehensive Cancer Center, New York, New York, United States|The Phase I Unit, Dept. of Oncology, Rigshospitalet, Copenhagen, Denmark|University of Groningen Faculty of Medical Sciences, Medical Oncology, Groningen, Netherlands|Erasmus MC-Daniel den Hoed Cancer Center- Neuro-Oncology Unit, Rotterdam, Netherlands","https://ClinicalTrials.gov/show/NCT01986348"
1072,"Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma","Completed","Has Results","Brain and Central Nervous System Tumors","Biological: bevacizumab|Drug: temozolomide|Radiation: external beam radiation therapy","Jonsson Comprehensive Cancer Center, University of California, Los Angeles (UCLA), Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT01013285"
1073,"Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma","Completed","Has Results","Brain and Central Nervous System Tumors","Drug: Concurrent temozolomide|Radiation: Concurrent radiation therapy|Drug: 100mg/m2 adjuvant temozolomide days 1 to 5 of 28 day cycle|Drug: 75mg/m2 adjuvant temozolomide days 1-21 of 28 day cycle","Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital, Fairbanks, Alaska, United States|Arizona Oncology Services Foundation, Phoenix, Arizona, United States|Mayo Clinic Scottsdale, Scottsdale, Arizona, United States|Arizona Oncology - Tucson, Tucson, Arizona, United States|Auburn Radiation Oncology, Auburn, California, United States|Providence Saint Joseph Medical Center - Burbank, Burbank, California, United States|Radiation Oncology Centers - Cameron Park, Cameron Park, California, United States|Mercy Cancer Center at Mercy San Juan Medical Center, Carmichael, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Kaiser Permanente Medical Center - Los Angeles, Los Angeles, California, United States|Radiation Oncology Center - Roseville, Roseville, California, United States|Radiological Associates of Sacramento Medical Group, Incorporated, Sacramento, California, United States|Mercy General Hospital, Sacramento, California, United States|UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States|Solano Radiation Oncology Center, Vacaville, California, United States|Penrose Cancer Center at Penrose Hospital, Colorado Springs, Colorado, United States|Poudre Valley Radiation Oncology, Fort Collins, Colorado, United States|Yale Cancer Center, New Haven, Connecticut, United States|Tunnell Cancer Center at Beebe Medical Center, Lewes, Delaware, United States|CCOP - Christiana Care Health Services, Newark, Delaware, United States|Eugene M. and Christine E. Lynn Cancer Institute at Boca Raton Community Hospital - Main Campus, Boca Raton, Florida, United States|University of Florida Shands Cancer Center, Gainesville, Florida, United States|Integrated Community Oncology Network, Jacksonville Beach, Florida, United States|Baptist Cancer Institute - Jacksonville, Jacksonville, Florida, United States|Integrated Community Oncology Network at Southside Cancer Center, Jacksonville, Florida, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|Baptist Medical Center South, Jacksonville, Florida, United States|Baptist-South Miami Regional Cancer Program, Miami, Florida, United States|Integrated Community Oncology Network - Orange Park, Orange Park, Florida, United States|Florida Cancer Center - Palatka, Palatka, Florida, United States|Flagler Cancer Center, Saint Augustine, Florida, United States|H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa, Florida, United States|Piedmont Hospital, Atlanta, Georgia, United States|John B. Amos Cancer Center, Columbus, Georgia, United States|Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center, Boise, Idaho, United States|Northwest Community Hospital, Arlington Heights, Illinois, United States|Rush-Copley Cancer Care Center, Aurora, Illinois, United States|St. Joseph Medical Center, Bloomington, Illinois, United States|Graham Hospital, Canton, Illinois, United States|Memorial Hospital, Carthage, Illinois, United States|John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, United States|University of Chicago Cancer Research Center, Chicago, Illinois, United States|Eureka Community Hospital, Eureka, Illinois, United States|Galesburg Clinic, PC, Galesburg, Illinois, United States|Galesburg Cottage Hospital, Galesburg, Illinois, United States|InterCommunity Cancer Center of Western Illinois, Galesburg, Illinois, United States|Mason District Hospital, Havana, Illinois, United States|Hopedale Medical Complex, Hopedale, Illinois, United States|Joliet Oncology-Hematology Associates, Limited - West, Joliet, Illinois, United States|McDonough District Hospital, Macomb, Illinois, United States|Cardinal Bernardin Cancer Center at Loyola University Medical Center, Maywood, Illinois, United States|BroMenn Regional Medical Center, Normal, Illinois, United States|Community Cancer Center, Normal, Illinois, United States|Community Hospital of Ottawa, Ottawa, Illinois, United States|Oncology Hematology Associates of Central Illinois, PC - Ottawa, Ottawa, Illinois, United States|Cancer Treatment Center at Pekin Hospital, Pekin, Illinois, United States|Proctor Hospital, Peoria, Illinois, United States|OSF St. Francis Medical Center, Peoria, Illinois, United States|CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States|Oncology Hematology Associates of Central Illinois, PC - Peoria, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|Illinois Valley Community Hospital, Peru, Illinois, United States|Perry Memorial Hospital, Princeton, Illinois, United States|St. Margaret's Hospital, Spring Valley, Illinois, United States|Valley Cancer Center, Spring Valley, Illinois, United States|Carle Cancer Center at Carle Foundation Hospital, Urbana, Illinois, United States|CCOP - Carle Cancer Center, Urbana, Illinois, United States|Elkhart General Hospital, Elkhart, Indiana, United States|Radiation Oncology Associates Southwest, Fort Wayne, Indiana, United States|Parkview Regional Cancer Center at Parkview Health, Fort Wayne, Indiana, United States|Central Indiana Cancer Centers - East, Indianapolis, Indiana, United States|Howard Community Hospital, Kokomo, Indiana, United States|Center for Cancer Therapy at LaPorte Hospital and Health Services, La Porte, Indiana, United States|Saint Anthony Memorial Health Centers, Michigan City, Indiana, United States|CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|Saint Joseph Regional Medical Center, South Bend, Indiana, United States|South Bend Clinic, South Bend, Indiana, United States|McFarland Clinic, PC, Ames, Iowa, United States|Mercy Capitol Hospital, Des Moines, Iowa, United States|CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States|John Stoddard Cancer Center at Iowa Methodist Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates at John Stoddard Cancer Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates at Mercy Cancer Center, Des Moines, Iowa, United States|Mercy Cancer Center at Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|John Stoddard Cancer Center at Iowa Lutheran Hospital, Des Moines, Iowa, United States|Mercy Cancer Center at Mercy Medical Center - North Iowa, Mason City, Iowa, United States|Cancer Center of Kansas, PA - Chanute, Chanute, Kansas, United States|Cancer Center of Kansas, PA - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas, PA - El Dorado, El Dorado, Kansas, United States|Cancer Center of Kansas-Independence, Independence, Kansas, United States|Cancer Center of Kansas, PA - Kingman, Kingman, Kansas, United States|Southwest Medical Center, Liberal, Kansas, United States|Cancer Center of Kansas, PA - Newton, Newton, Kansas, United States|Menorah Medical Center, Overland Park, Kansas, United States|Kansas City Cancer Centers - Southwest, Overland Park, Kansas, United States|Cancer Center of Kansas, PA - Parsons, Parsons, Kansas, United States|Cancer Center of Kansas, PA - Pratt, Pratt, Kansas, United States|Cancer Center of Kansas, PA - Salina, Salina, Kansas, United States|Shawnee Mission Medical Center, Shawnee Mission, Kansas, United States|Cancer Center of Kansas, PA - Wellington, Wellington, Kansas, United States|Associates in Womens Health, PA - North Review, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Medical Arts Tower, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Wichita, Wichita, Kansas, United States|CCOP - Wichita, Wichita, Kansas, United States|Via Christi Cancer Center at Via Christi Regional Medical Center, Wichita, Kansas, United States|Wesley Medical Center, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Winfield, Winfield, Kansas, United States|DeCesaris Cancer Institute at Anne Arundel Medical Center, Annapolis, Maryland, United States|St. Agnes Hospital Cancer Center, Baltimore, Maryland, United States|Union Hospital Cancer Program at Union Hospital, Elkton, Maryland, United States|Hickman Cancer Center at Bixby Medical Center, Adrian, Michigan, United States|Saint Joseph Mercy Cancer Center, Ann Arbor, Michigan, United States|CCOP - Michigan Cancer Research Consortium, Ann Arbor, Michigan, United States|Oakwood Cancer Center at Oakwood Hospital and Medical Center, Dearborn, Michigan, United States|Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States|Green Bay Oncology, Limited - Escanaba, Escanaba, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Van Elslander Cancer Center at St. John Hospital and Medical Center, Grosse Pointe Woods, Michigan, United States|Dickinson County Healthcare System, Iron Mountain, Michigan, United States|Foote Memorial Hospital, Jackson, Michigan, United States|Borgess Medical Center, Kalamazoo, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|Haematology-Oncology Associates of Ohio and Michigan, PC, Lambertville, Michigan, United States|Sparrow Regional Cancer Center, Lansing, Michigan, United States|St. Mary Mercy Hospital, Livonia, Michigan, United States|Community Cancer Center of Monroe, Monroe, Michigan, United States|Mercy Memorial Hospital - Monroe, Monroe, Michigan, United States|St. Joseph Mercy Oakland, Pontiac, Michigan, United States|Mercy Regional Cancer Center at Mercy Hospital, Port Huron, Michigan, United States|William Beaumont Hospital - Royal Oak Campus, Royal Oak, Michigan, United States|Seton Cancer Institute at Saint Mary's - Saginaw, Saginaw, Michigan, United States|Lakeland Regional Cancer Care Center - St. Joseph, Saint Joseph, Michigan, United States|Providence Cancer Institute at Providence Hospital - Southfield Campus, Southfield, Michigan, United States|St. John Macomb Hospital, Warren, Michigan, United States|Alexandria, Minnesota, United States|MeritCare Bemidji, Bemidji, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy and Unity Cancer Center at Mercy Hospital, Coon Rapids, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Fergus Falls, Minnesota, United States|Mercy and Unity Cancer Center at Unity Hospital, Fridley, Minnesota, United States|Minnesota Oncology Hematology, PA - Maplewood, Maplewood, Minnesota, United States|Virginia Piper Cancer Institute at Abbott - Northwestern Hospital, Minneapolis, Minnesota, United States|Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center, Robbinsdale, Minnesota, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CentraCare Clinic - River Campus, Saint Cloud, Minnesota, United States|Coborn Cancer Center, Saint Cloud, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|Park Nicollet Cancer Center, Saint Louis Park, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Minnesota Oncology Hematology, PA - Woodbury, Woodbury, Minnesota, United States|Independence Regional Health Center, Independence, Missouri, United States|St. John's Regional Medical Center, Joplin, Missouri, United States|Truman Medical Center - Hospital Hill, Kansas City, Missouri, United States|Saint Luke's Cancer Institute at Saint Luke's Hospital, Kansas City, Missouri, United States|St. Joseph Medical Center, Kansas City, Missouri, United States|North Kansas City Hospital, Kansas City, Missouri, United States|Parvin Radiation Oncology, Kansas City, Missouri, United States|CCOP - Kansas City, Kansas City, Missouri, United States|Kansas City Cancer Centers - South, Kansas City, Missouri, United States|Research Medical Center, Kansas City, Missouri, United States|Liberty Hospital, Liberty, Missouri, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, United States|CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States|St. John's Regional Health Center, Springfield, Missouri, United States|Hulston Cancer Center at Cox Medical Center South, Springfield, Missouri, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|Hematology-Oncology Centers of the Northern Rockies - Billings, Billings, Montana, United States|Northern Rockies Radiation Oncology Center, Billings, Montana, United States|St. Vincent Healthcare Cancer Care Services, Billings, Montana, United States|Billings Clinic - Downtown, Billings, Montana, United States|St. James Healthcare Cancer Care, Butte, Montana, United States|Great Falls Clinic - Main Facility, Great Falls, Montana, United States|Great Falls, Montana, United States|Northern Montana Hospital, Havre, Montana, United States|Glacier Oncology, PLLC, Kalispell, Montana, United States|Kalispell Medical Oncology at KRMC, Kalispell, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Community Medical Center, Missoula, Montana, United States|Guardian Oncology and Center for Wellness, Missoula, Montana, United States|Montana Cancer Specialists at Montana Cancer Center, Missoula, Montana, United States|Montana Cancer Center at St. Patrick Hospital and Health Sciences Center, Missoula, Montana, United States|Good Samaritan Cancer Center at Good Samaritan Hospital, Kearney, Nebraska, United States|Cancer Resource Center - Lincoln, Lincoln, Nebraska, United States|CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|Methodist Estabrook Cancer Center, Omaha, Nebraska, United States|Immanuel Medical Center, Omaha, Nebraska, United States|Alegant Health Cancer Center at Bergan Mercy Medical Center, Omaha, Nebraska, United States|Creighton University Medical Center, Omaha, Nebraska, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|CCOP - Nevada Cancer Research Foundation, Las Vegas, Nevada, United States|Dartmouth - Hitchcock Concord, Concord, New Hampshire, United States|Kingsbury Center for Cancer Care at Cheshire Medical Center, Keene, New Hampshire, United States|Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|St. Barnabas Medical Center Cancer Center, Livingston, New Jersey, United States|Frederick R. and Betty M. Smith Cancer Treatment Center, Sparta, New Jersey, United States|Cancer Institute of New Jersey at Cooper - Voorhees, Voorhees, New Jersey, United States|New York Methodist Hospital, Brooklyn, New York, United States|Monter Cancer Center of the North Shore-LIJ Health System, Lake Success, New York, United States|CCOP - North Shore University Hospital, Manhasset, New York, United States|Don Monti Comprehensive Cancer Center at North Shore University Hospital, Manhasset, New York, United States|Long Island Jewish Medical Center, New Hyde Park, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Hudson Valley Oncology Associates, Poughkeepsie, New York, United States|Lipson Cancer and Blood Center at Rochester General Hospital, Rochester, New York, United States|Mission Hospitals - Memorial Campus, Asheville, North Carolina, United States|Wayne Memorial Hospital, Incorporated, Goldsboro, North Carolina, United States|Wayne Radiation Oncology, Goldsboro, North Carolina, United States|Rutherford Hospital, Rutherfordton, North Carolina, United States|Wilmed Radiation Oncology Services, Wilson, North Carolina, United States|CCOP - MeritCare Hospital, Fargo, North Dakota, United States|MeritCare Broadway, Fargo, North Dakota, United States|McDowell Cancer Center at Akron General Medical Center, Akron, Ohio, United States|Summa Center for Cancer Care at Akron City Hospital, Akron, Ohio, United States|Mary Rutan Hospital, Bellefontaine, Ohio, United States|Wood County Oncology Center, Bowling Green, Ohio, United States|Aultman Cancer Center at Aultman Hospital, Canton, Ohio, United States|Adena Regional Medical Center, Chillicothe, Ohio, United States|Cleveland Clinic Cancer Center at Fairview Hospital, Cleveland, Ohio, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|Riverside Methodist Hospital Cancer Care, Columbus, Ohio, United States|CCOP - Columbus, Columbus, Ohio, United States|Grant Medical Center Cancer Care, Columbus, Ohio, United States|Mount Carmel Health - West Hospital, Columbus, Ohio, United States|Doctors Hospital at Ohio Health, Columbus, Ohio, United States|Grady Memorial Hospital, Delaware, Ohio, United States|Cleveland Clinic Cancer Center, Independence, Ohio, United States|Fairfield Medical Center, Lancaster, Ohio, United States|Lima Memorial Hospital, Lima, Ohio, United States|Strecker Cancer Center at Marietta Memorial Hospital, Marietta, Ohio, United States|Northwest Ohio Oncology Center, Maumee, Ohio, United States|St. Luke's Hospital, Maumee, Ohio, United States|Licking Memorial Cancer Care Program at Licking Memorial Hospital, Newark, Ohio, United States|St. Charles Mercy Hospital, Oregon, Ohio, United States|Toledo Clinic - Oregon, Oregon, Ohio, United States|Cancer Research UK Medical Oncology Unit at Churchill Hospital & Weatherall Institute of Molecular Medicine - Oxford, Salem, Ohio, United States|North Coast Cancer Care, Incorporated, Sandusky, Ohio, United States|Mercy Medical Center, Springfield, Ohio, United States|Community Hospital of Springfield and Clark County, Springfield, Ohio, United States|Flower Hospital Cancer Center, Sylvania, Ohio, United States|Mercy Hospital of Tiffin, Tiffin, Ohio, United States|Toledo Hospital, Toledo, Ohio, United States|St. Vincent Mercy Medical Center, Toledo, Ohio, United States|Medical University of Ohio Cancer Center, Toledo, Ohio, United States|CCOP - Toledo Community Hospital, Toledo, Ohio, United States|Toledo Clinic, Incorporated - Main Clinic, Toledo, Ohio, United States|Fulton County Health Center, Wauseon, Ohio, United States|Mount Carmel St. Ann's Cancer Center, Westerville, Ohio, United States|Cancer Treatment Center, Wooster, Ohio, United States|Genesis - Good Samaritan Hospital, Zanesville, Ohio, United States|Oklahoma University Cancer Institute, Oklahoma City, Oklahoma, United States|Natalie Warren Bryant Cancer Center at St. Francis Hospital, Tulsa, Oklahoma, United States|Willamette Valley Cancer Center - Eugene, Eugene, Oregon, United States|Legacy Mount Hood Medical Center, Gresham, Oregon, United States|Providence Milwaukie Hospital, Milwaukie, Oregon, United States|Legacy Good Samaritan Hospital & Comprehensive Cancer Center, Portland, Oregon, United States|Providence Cancer Center at Providence Portland Medical Center, Portland, Oregon, United States|Adventist Medical Center, Portland, Oregon, United States|CCOP - Columbia River Oncology Program, Portland, Oregon, United States|Providence St. Vincent Medical Center, Portland, Oregon, United States|Legacy Emanuel Hospital and Health Center and Children's Hospital, Portland, Oregon, United States|Salem Hospital Regional Cancer Care Services, Salem, Oregon, United States|Legacy Meridian Park Hospital, Tualatin, Oregon, United States|Rosenfeld Cancer Center at Abington Memorial Hospital, Abington, Pennsylvania, United States|Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest, Allentown, Pennsylvania, United States|Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, United States|Geisinger Cancer Institute at Geisinger Health, Danville, Pennsylvania, United States|Northeast Radiation Oncology Center, Dunmore, Pennsylvania, United States|Dale and Frances Hughes Cancer Center at Pocono Medical Center, East Stroudsburg, Pennsylvania, United States|Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Riddle Memorial Hospital Cancer Center, Media, Pennsylvania, United States|Upper Delaware Valley Cancer Center, Milford, Pennsylvania, United States|Intercommunity Cancer Center, Monroeville, Pennsylvania, United States|Alle-Kiski Medical Center, Natrona Heights, Pennsylvania, United States|Cancer Center of Paoli Memorial Hospital, Paoli, Pennsylvania, United States|Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States|Frankford Hospital Cancer Center - Torresdale Campus, Philadelphia, Pennsylvania, United States|Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center, Reading, Pennsylvania, United States|Somerset Oncology Center, Somerset, Pennsylvania, United States|Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center, Wilkes-Barre, Pennsylvania, United States|CCOP - Main Line Health, Wynnewood, Pennsylvania, United States|Lankenau Cancer Center at Lankenau Hospital, Wynnewood, Pennsylvania, United States|AnMed Cancer Center, Anderson, South Carolina, United States|Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States|Gibbs Regional Cancer Center at Spartanburg Regional Medical Center, Spartanburg, South Carolina, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Avera Cancer Institute, Sioux Falls, South Dakota, United States|Medical X-Ray Center, PC, Sioux Falls, South Dakota, United States|Sanford Cancer Center at Sanford USD Medical Center, Sioux Falls, South Dakota, United States|Thompson Cancer Survival Center West, Knoxville, Tennessee, United States|Thompson Cancer Survival Center, Knoxville, Tennessee, United States|Thompson Cancer Survival Center at Methodist, Oak Ridge, Tennessee, United States|Medical City Dallas Hospital, Dallas, Texas, United States|Texas Oncology, PA at Texas Cancer Center Dallas Southwest, Dallas, Texas, United States|Klabzuba Cancer Center at Harris Methodist Fort Worth Hospital, Fort Worth, Texas, United States|M. D. Anderson Cancer Center at University of Texas, Houston, Texas, United States|Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas, United States|Texas Oncology, PA at Texas Cancer Center - Sherman, Sherman, Texas, United States|Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land, Sugar Land, Texas, United States|American Fork Hospital, American Fork, Utah, United States|Sandra L. Maxwell Cancer Center, Cedar City, Utah, United States|Jon and Karen Huntsman Cancer Center at Intermountain Medical Center, Murray, Utah, United States|Val and Ann Browning Cancer Center at McKay-Dee Hospital Center, Ogden, Utah, United States|Utah Valley Regional Medical Center - Provo, Provo, Utah, United States|Dixie Regional Medical Center - East Campus, Saint George, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|Utah Cancer Specialists at UCS Cancer Center, Salt Lake City, Utah, United States|Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah, United States|Fletcher Allen Health Care - University Health Center Campus, Burlington, Vermont, United States|Norris Cotton Cancer Center - North, Saint Johnsbury, Vermont, United States|Fredericksburg Oncology, Incorporated, Fredericksburg, Virginia, United States|Sentara Cancer Institute at Sentara Norfolk General Hospital, Norfolk, Virginia, United States|Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia, United States|St. Joseph Cancer Center, Bellingham, Washington, United States|St. Francis Hospital, Federal Way, Washington, United States|Cascade Cancer Center at Evergreen Hospital Medical Center, Kirkland, Washington, United States|CCOP - Virginia Mason Research Center, Seattle, Washington, United States|University Cancer Center at University of Washington Medical Center, Seattle, Washington, United States|Southwest Washington Medical Center Cancer Center, Vancouver, Washington, United States|North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington, United States|Theda Care Cancer Institute, Appleton, Wisconsin, United States|Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center, Green Bay, Wisconsin, United States|Green Bay Oncology, Limited at St. Mary's Hospital, Green Bay, Wisconsin, United States|St. Mary's Hospital Medical Center - Green Bay, Green Bay, Wisconsin, United States|St. Vincent Hospital Regional Cancer Center, Green Bay, Wisconsin, United States|Gundersen Lutheran Center for Cancer and Blood, La Crosse, Wisconsin, United States|University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, Wisconsin, United States|Bay Area Cancer Care Center at Bay Area Medical Center, Marinette, Wisconsin, United States|Community Memorial Hospital Cancer Care Center, Menomonee Falls, Wisconsin, United States|Regional Cancer Center at Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States|Green Bay Oncology, Limited - Oconto Falls, Oconto Falls, Wisconsin, United States|Door County Cancer Center at Door County Memorial Hospital, Sturgeon Bay, Wisconsin, United States|Green Bay Oncology, Limited - Sturgeon Bay, Sturgeon Bay, Wisconsin, United States|Waukesha Memorial Hospital Regional Cancer Center, Waukesha, Wisconsin, United States|Tom Baker Cancer Centre - Calgary, Calgary, Alberta, Canada|CancerCare Manitoba, Winnipeg, Manitoba, Canada|Saint John Regional Hospital, Saint John, New Brunswick, Canada|Margaret and Charles Juravinski Cancer Centre, Hamilton, Ontario, Canada|Ottawa Hospital Regional Cancer Centre - General Campus, Ottawa, Ontario, Canada|Cancer Care Program at Thunder Bay Regional Health Sciences, Thunder Bay, Ontario, Canada|Princess Margaret Hospital, Toronto, Ontario, Canada|McGill Cancer Centre at McGill University, Montreal, Quebec, Canada|Centre Hospitalier Universitaire de Quebec, Quebec City, Quebec, Canada|Allan Blair Cancer Centre at Pasqua Hospital, Regina, Saskatchewan, Canada","https://ClinicalTrials.gov/show/NCT00304031"
1074,"A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma","Completed","No Results Available","Brain Cancer","Drug: MK-3475","University of California, Los Angeles, Los Angeles, California, United States|University of California, San Francisco, San Francisco, California, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Memorial Sloan-Kettering Cancer, New York, New York, United States|UT, MD Anderson Cancer Center, Houston, Texas, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT02852655"
1075,"A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas","Completed","No Results Available","Mixed Gliomas|Malignant Gliomas|Glioblastoma Multiforme","Drug: XL765 (SAR245409)|Drug: Temozolomide","Investigational Site Number, Birmingham, Alabama, United States|Investigational Site Number, Los Angeles, California, United States|Investigational Site Number, Boston, Massachusetts, United States|Investigational Site Number, New York, New York, United States|Investigational Site Number, Rochester, New York, United States|Investigational Site Number, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00704080"
1076,"A Phase I Study of ABT 510 for Newly Diagnosed Glioblastoma Multiforme","Completed","No Results Available","Brain Tumor","Drug: ABT 510","University of Alabama at Birmingham, Birmingham, Alabama, United States","https://ClinicalTrials.gov/show/NCT00584883"
1077,"A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma","Completed","No Results Available","Glioma","Drug: Nelfinavir","Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01020292"
1078,"Feasibility of the LUM Imaging System for Detection of Cancer to the Brain","Active, not recruiting","No Results Available","Low Grade Glioma of Brain|Glioblastoma|Metastasis to Brain","Combination Product: LUM Imaging System","Brigham and Women's Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT03717142"
1079,"Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG","Completed","No Results Available","Glioblastoma|Gliosarcoma","Drug: Gleevec, RAD001, and Hydroxyurea","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00613132"
1080,"Ph II Bevacizumab + Etoposide for Pts w Recurrent MG","Completed","Has Results","Glioblastoma|Gliosarcoma","Drug: Bevacizumab and Etoposide","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00612430"
1081,"Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme","Completed","No Results Available","Malignant Glioma","Drug: CDX-110 with GM-CSF|Drug: Temozolomide","Celldex Investigational Site, Orange, California, United States|Celldex Investigational Site, San Francisco, California, United States|Celldex Investigational Site, San Francisco, California, United States|Celldex Investigational Site, Stanford, California, United States|Celldex Investigational Site, Stanford, California, United States|Celldex Investigational Site, New Haven, Connecticut, United States|Celldex Investigational Site, New Haven, Connecticut, United States|Celldex Investigational Site, New Haven, Connecticut, United States|Celldex Investigational Site, Gainesville, Florida, United States|Celldex Investigational Site, Chicago, Illinois, United States|Celldex Investigational Site, Evanston, Illinois, United States|Celldex Investigational Site, Boston, Massachusetts, United States|Celldex Investigational Site, Lansing, Michigan, United States|Celldex Investigational Site, Saginaw, Michigan, United States|Celldex Investigational Site, Saginaw, Michigan, United States|Celldex Investigational Site, Hackensack, New Jersey, United States|Celldex Investigational Site, Amherst, New York, United States|Celldex Investigational Site, New York, New York, United States|Celldex Investigational Site, New York, New York, United States|Celldex Investigational Site, Durham, North Carolina, United States|Celldex Investigational Site, Cincinnati, Ohio, United States|Celldex Investigational Site, Cincinnati, Ohio, United States|Celldex Investigational Site, Cincinnati, Ohio, United States|Celldex Investigational Site, Cleveland, Ohio, United States|Celldex Investigational Site, Cleveland, Ohio, United States|Celldex Investigational Site, Orange Village, Ohio, United States|Celldex Investigational Site, West Chester, Ohio, United States|Celldex Investigational Site, Westlake, Ohio, United States|Celldex Investigational Site, Philadelphia, Pennsylvania, United States|Celldex Investigational Site, Houston, Texas, United States|Celldex Investigational Site, San Antonio, Texas, United States|Celldex Investigational Site, Salt Lake City, Utah, United States|Celldex Investigational Site, Charlottesville, Virginia, United States|Celldex Investigational Site, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00458601"
1082,"Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)","Completed","Has Results","Glioblastoma|Gliosarcoma","Drug: Imatinib Mesylate & Hydroxyurea","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00615927"
1083,"Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor","Completed","No Results Available","Astrocytoma|Glioblastoma|Glioma",,"National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00001148"
1084,"Study of Pembrolizumab and M032 (NSC 733972)","Not yet recruiting","No Results Available","Glioblastoma Multiforme|Anaplastic Astrocytoma|Gliosarcoma","Drug: M032|Drug: Pembrolizumab","University of Alabama at Birmingham, Birmingham, Alabama, United States","https://ClinicalTrials.gov/show/NCT05084430"
1085,"Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVA","Completed","No Results Available","Glioblastoma Multiform (Grade IV Astrocytoma)","Drug: PolyMVA","Stony Brook University Medical Center, Stony Brook, New York, United States","https://ClinicalTrials.gov/show/NCT01833273"
1086,"Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme","Completed","No Results Available","Malignant Glioma","Drug: NPC-08","The Tazuke Kofukai Foundation Medical Research Kitano Hospital, Osaka, Japan","https://ClinicalTrials.gov/show/NCT00919737"
1087,"Neuro-pharmacological Study of Ketoconazole for High-grade Gliomas","Not yet recruiting","No Results Available","Glioblastoma|Glioblastoma Multiforme|Glioblastoma Multiforme of Brain|Glioblastoma Multiforme, Adult","Drug: Ketoconazole","Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT04869449"
1088,"6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients","Completed","Has Results","Anaplastic Glioma of Brain|Glioblastoma Multiforme|Brain Cancer","Drug: Capecitabine|Drug: Celecoxib (Celebrex)|Drug: Temozolomide|Drug: Lomustine|Drug: 6-Thioguanine","UT MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00504660"
1089,"Ph I Dasatinib + Erlotinib in Recurrent MG","Completed","No Results Available","Glioblastoma|Gliosarcoma","Drug: Erlotinib and Dasatinib","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00609999"
1090,"Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma","Completed","Has Results","Brain and Central Nervous System Tumors","Drug: temozolomide 60 mg x 21 days|Drug: temozolomide 75 mg x 21 days|Drug: ABT-888 20 mg x 21 days|Drug: ABT-888 40 mg x 21 days|Drug: Temozolomide 150 mg x 5 days|Drug: ABT-888 40 mg x 5 days","Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|Leeward Radiation Oncology, 'Ewa Beach, Hawaii, United States|Cancer Research Center of Hawaii, Honolulu, Hawaii, United States|Queen's Cancer Institute at Queen's Medical Center, Honolulu, Hawaii, United States|Hawaii Medical Center - East, Honolulu, Hawaii, United States|University of Chicago Cancer Research Center, Chicago, Illinois, United States|CCOP - Kansas City, Prairie Village, Kansas, United States|Central Baptist Hospital, Lexington, Kentucky, United States|Louisville Oncology at Norton Cancer Institute - Louisville, Louisville, Kentucky, United States|Regional Cancer Center at Singing River Hospital, Pascagoula, Mississippi, United States|Renown Institute for Cancer at Renown Regional Medical Center, Reno, Nevada, United States|Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States|Highland Hospital of Rochester, Rochester, New York, United States|James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York, United States|Legacy Good Samaritan Hospital & Comprehensive Cancer Center, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT01026493"
1091,"A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: Pamiparib|Drug: TMZ|Radiation: Radiation","Center for Neurosciences, Tucson, Arizona, United States|UCLA Neuro-Oncology, Los Angeles, California, United States|University of California at San Francisco, San Francisco, California, United States|Sarah Cannon Research Institute at Health One, Denver, Colorado, United States|Massachusetts General Hospital Pappas Center for Neuro-Oncology, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Health Systems, Detroit, Michigan, United States|Health Midwest Ventures Group, LLC, Kansas City, Missouri, United States|Washington University, Saint Louis, Missouri, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Cleveland Clinic, Cleveland, Ohio, United States|The Ohio State University, Columbus, Ohio, United States|University of Oklahoma Health Sciences Center (Stephenson Cancer Center), Oklahoma City, Oklahoma, United States|Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|SCRI / Tennessee Oncology, Nashville, Tennessee, United States|Huntsman Cancer Center, Salt Lake City, Utah, United States|University of Virginia Health Systems, Charlottesville, Virginia, United States|Institut Gustave Roussy, Villejuif, France|Erasmus University Medical Center, Rotterdam, Netherlands|Universitätsspital Zuerich - Klinik fur Neurologie, Zurich, Switzerland","https://ClinicalTrials.gov/show/NCT03150862"
1092,"LITT Palliative Treatment for Patients With Malignant Gliomas","Withdrawn","No Results Available","Malignant Glioma of Brain|Glioblastoma","Other: Palliative regimen consisting of LITT","The Preston Robert Tisch Brain Tumor Center at Duke, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT03176160"
1093,"Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors","Completed","No Results Available","Brain Tumor|Glioblastoma Multiforme",,"University of Miami, Miami, Florida, United States","https://ClinicalTrials.gov/show/NCT02006563"
1094,"MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma","Terminated","Has Results","Brain and Central Nervous System Tumors","Drug: temozolomide|Other: Imaging biomarker analysis|Radiation: Photon Radiation Therapy","Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00756106"
1095,"Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma","Completed","Has Results","Brain and Central Nervous System Tumors","Drug: everolimus|Drug: temozolomide|Radiation: radiation","Mayo Clinic Scottsdale, Scottsdale, Arizona, United States|Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center, Hartford, Connecticut, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center, Boise, Idaho, United States|Illinois CancerCare - Bloomington, Bloomington, Illinois, United States|St. Joseph Medical Center, Bloomington, Illinois, United States|Graham Hospital, Canton, Illinois, United States|Illinois CancerCare - Canton, Canton, Illinois, United States|Illinois CancerCare - Carthage, Carthage, Illinois, United States|Memorial Hospital, Carthage, Illinois, United States|Eureka Community Hospital, Eureka, Illinois, United States|Illinois CancerCare - Eureka, Eureka, Illinois, United States|Galesburg Clinic, PC, Galesburg, Illinois, United States|Illinois CancerCare - Galesburg, Galesburg, Illinois, United States|Illinois CancerCare - Havana, Havana, Illinois, United States|Mason District Hospital, Havana, Illinois, United States|Illinois CancerCare - Kewanee Clinic, Kewanee, Illinois, United States|Illinois CancerCare - Macomb, Macomb, Illinois, United States|McDonough District Hospital, Macomb, Illinois, United States|Trinity Cancer Center at Trinity Medical Center - 7th Street Campus, Moline, Illinois, United States|Moline, Illinois, United States|Illinois CancerCare - Monmouth, Monmouth, Illinois, United States|OSF Holy Family Medical Center, Monmouth, Illinois, United States|BroMenn Regional Medical Center, Normal, Illinois, United States|Community Cancer Center, Normal, Illinois, United States|Illinois CancerCare - Community Cancer Center, Normal, Illinois, United States|Community Hospital of Ottawa, Ottawa, Illinois, United States|Oncology Hematology Associates of Central Illinois, PC - Ottawa, Ottawa, Illinois, United States|Cancer Treatment Center at Pekin Hospital, Pekin, Illinois, United States|Illinois CancerCare - Pekin, Pekin, Illinois, United States|CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States|Oncology Hematology Associates of Central Illinois, PC - Peoria, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|OSF St. Francis Medical Center, Peoria, Illinois, United States|Illinois CancerCare - Peru, Peru, Illinois, United States|Illinois Valley Community Hospital, Peru, Illinois, United States|Illinois CancerCare - Princeton, Princeton, Illinois, United States|Perry Memorial Hospital, Princeton, Illinois, United States|Illinois CancerCare - Spring Valley, Spring Valley, Illinois, United States|St. Francis Hospital and Health Centers - Beech Grove Campus, Beech Grove, Indiana, United States|Reid Hospital & Health Care Services, Richmond, Indiana, United States|McFarland Clinic, PC, Ames, Iowa, United States|Bettendorf, Iowa, United States|Cedar Rapids Oncology Associates, Cedar Rapids, Iowa, United States|Mercy Regional Cancer Center at Mercy Medical Center, Cedar Rapids, Iowa, United States|Siouxland Hematology-Oncology Associates, LLP, Sioux City, Iowa, United States|Mercy Medical Center - Sioux City, Sioux City, Iowa, United States|St. Luke's Regional Medical Center, Sioux City, Iowa, United States|Cancer Center of Kansas, PA - Chanute, Chanute, Kansas, United States|Cancer Center of Kansas, PA - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas, PA - El Dorado, El Dorado, Kansas, United States|Cancer Center of Kansas - Fort Scott, Fort Scott, Kansas, United States|Cancer Center of Kansas-Independence, Independence, Kansas, United States|Cancer Center of Kansas, PA - Kingman, Kingman, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|Cancer Center of Kansas, PA - Liberal, Liberal, Kansas, United States|Cancer Center of Kansas, PA - McPherson, McPherson, Kansas, United States|Cancer Center of Kansas, PA - Newton, Newton, Kansas, United States|Cancer Center of Kansas, PA - Parsons, Parsons, Kansas, United States|Cancer Center of Kansas, PA - Pratt, Pratt, Kansas, United States|Cancer Center of Kansas, PA - Salina, Salina, Kansas, United States|Cancer Center of Kansas, PA - Wellington, Wellington, Kansas, United States|Associates in Womens Health, PA - North Review, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Wichita, Wichita, Kansas, United States|CCOP - Wichita, Wichita, Kansas, United States|Via Christi Cancer Center at Via Christi Regional Medical Center, Wichita, Kansas, United States|Wesley Medical Center, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Winfield, Winfield, Kansas, United States|Saint Joseph Mercy Cancer Center, Ann Arbor, Michigan, United States|CCOP - Michigan Cancer Research Consortium, Ann Arbor, Michigan, United States|Oakwood Cancer Center at Oakwood Hospital and Medical Center, Dearborn, Michigan, United States|Green Bay Oncology, Limited - Escanaba, Escanaba, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Genesys Regional Medical Center, Grand Blanc, Michigan, United States|Van Elslander Cancer Center at St. John Hospital and Medical Center, Grosse Pointe Woods, Michigan, United States|Dickinson County Healthcare System, Iron Mountain, Michigan, United States|Foote Memorial Hospital, Jackson, Michigan, United States|Sparrow Regional Cancer Center, Lansing, Michigan, United States|St. Mary Mercy Hospital, Livonia, Michigan, United States|St. Joseph Mercy Oakland, Pontiac, Michigan, United States|Mercy Regional Cancer Center at Mercy Hospital, Port Huron, Michigan, United States|Seton Cancer Institute at Saint Mary's - Saginaw, Saginaw, Michigan, United States|St. John Macomb Hospital, Warren, Michigan, United States|MeritCare Bemidji, Bemidji, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy and Unity Cancer Center at Mercy Hospital, Coon Rapids, Minnesota, United States|Duluth Clinic Cancer Center - Duluth, Duluth, Minnesota, United States|CCOP - Duluth, Duluth, Minnesota, United States|Miller - Dwan Medical Center, Duluth, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Mercy and Unity Cancer Center at Unity Hospital, Fridley, Minnesota, United States|Hutchinson Area Health Care, Hutchinson, Minnesota, United States|HealthEast Cancer Care at St. John's Hospital, Maplewood, Minnesota, United States|Minnesota Oncology - Maplewood, Maplewood, Minnesota, United States|Virginia Piper Cancer Institute at Abbott - Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center - Minneapolis, Minneapolis, Minnesota, United States|New Ulm Medical Center, New Ulm, Minnesota, United States|Humphrey Cancer Center at North Memorial Outpatient Center, Robbinsdale, Minnesota, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|Park Nicollet Cancer Center, Saint Louis Park, Minnesota, United States|Regions Hospital Cancer Care Center, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|St. Francis Cancer Center at St. Francis Medical Center, Shakopee, Minnesota, United States|Lakeview Hospital, Stillwater, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Willmar Cancer Center at Rice Memorial Hospital, Willmar, Minnesota, United States|Minnesota Oncology - Woodbury, Woodbury, Minnesota, United States|Mercy Clinic Cancer and Hematology - Rolla, Rolla, Missouri, United States|CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States|St. John's Regional Health Center, Springfield, Missouri, United States|Hulston Cancer Center at Cox Medical Center South, Springfield, Missouri, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|St. Vincent Healthcare Cancer Care Services, Billings, Montana, United States|Hematology-Oncology Centers of the Northern Rockies - Billings, Billings, Montana, United States|Billings Clinic - Downtown, Billings, Montana, United States|Bozeman Deaconess Cancer Center, Bozeman, Montana, United States|St. James Healthcare Cancer Care, Butte, Montana, United States|Great Falls Clinic - Main Facility, Great Falls, Montana, United States|Sletten Cancer Institute at Benefis Healthcare, Great Falls, Montana, United States|Northern Montana Hospital, Havre, Montana, United States|St. Peter's Hospital, Helena, Montana, United States|Glacier Oncology, PLLC, Kalispell, Montana, United States|Kalispell Medical Oncology at KRMC, Kalispell, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Montana Cancer Specialists at Montana Cancer Center, Missoula, Montana, United States|Montana Cancer Center at St. Patrick Hospital and Health Sciences Center, Missoula, Montana, United States|Cancer Resource Center - Lincoln, Lincoln, Nebraska, United States|CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|Immanuel Medical Center, Omaha, Nebraska, United States|Alegant Health Cancer Center at Bergan Mercy Medical Center, Omaha, Nebraska, United States|Lakeside Hospital, Omaha, Nebraska, United States|Creighton University Medical Center, Omaha, Nebraska, United States|MeritCare Broadway, Fargo, North Dakota, United States|CCOP - MeritCare Hospital, Fargo, North Dakota, United States|Roger Maris Cancer Center at MeritCare Hospital, Fargo, North Dakota, United States|Altru Cancer Center at Altru Hospital, Grand Forks, North Dakota, United States|Adena Regional Medical Center, Chillicothe, Ohio, United States|Charles M. Barrett Cancer Center at University Hospital, Cincinnati, Ohio, United States|Riverside Methodist Hospital Cancer Care, Columbus, Ohio, United States|CCOP - Columbus, Columbus, Ohio, United States|Grant Medical Center Cancer Care, Columbus, Ohio, United States|Mount Carmel Health - West Hospital, Columbus, Ohio, United States|Doctors Hospital at Ohio Health, Columbus, Ohio, United States|Grandview Hospital, Dayton, Ohio, United States|Good Samaritan Hospital, Dayton, Ohio, United States|David L. Rike Cancer Center at Miami Valley Hospital, Dayton, Ohio, United States|Samaritan North Cancer Care Center, Dayton, Ohio, United States|CCOP - Dayton, Dayton, Ohio, United States|Grady Memorial Hospital, Delaware, Ohio, United States|Blanchard Valley Medical Associates, Findlay, Ohio, United States|Middletown Regional Hospital, Franklin, Ohio, United States|Wayne Hospital, Greenville, Ohio, United States|Charles F. Kettering Memorial Hospital, Kettering, Ohio, United States|Fairfield Medical Center, Lancaster, Ohio, United States|Strecker Cancer Center at Marietta Memorial Hospital, Marietta, Ohio, United States|Knox Community Hospital, Mount Vernon, Ohio, United States|Licking Memorial Cancer Care Program at Licking Memorial Hospital, Newark, Ohio, United States|Community Hospital of Springfield and Clark County, Springfield, Ohio, United States|UVMC Cancer Care Center at Upper Valley Medical Center, Troy, Ohio, United States|Precision Radiotherapy at University Pointe, West Chester, Ohio, United States|Mount Carmel St. Ann's Cancer Center, Westerville, Ohio, United States|Ruth G. McMillan Cancer Center at Greene Memorial Hospital, Xenia, Ohio, United States|Genesis - Good Samaritan Hospital, Zanesville, Ohio, United States|Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest, Allentown, Pennsylvania, United States|Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Medical X-Ray Center, PC, Sioux Falls, South Dakota, United States|Sanford Cancer Center at Sanford USD Medical Center, Sioux Falls, South Dakota, United States|Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center, Green Bay, Wisconsin, United States|Green Bay Oncology, Limited at St. Mary's Hospital, Green Bay, Wisconsin, United States|St. Mary's Hospital Medical Center - Green Bay, Green Bay, Wisconsin, United States|St. Vincent Hospital Regional Cancer Center, Green Bay, Wisconsin, United States|Bay Area Cancer Care Center at Bay Area Medical Center, Marinette, Wisconsin, United States|Green Bay Oncology, Limited - Oconto Falls, Oconto Falls, Wisconsin, United States|Green Bay Oncology, Limited - Sturgeon Bay, Sturgeon Bay, Wisconsin, United States|Welch Cancer Center at Sheridan Memorial Hospital, Sheridan, Wyoming, United States","https://ClinicalTrials.gov/show/NCT00553150"
1096,"Study of DSP-0390 in Patients With Recurrent High-Grade Glioma","Recruiting","No Results Available","High Grade Glioma|Glioblastoma Multiforme","Drug: DSP-0390","Washington University School of Medicine, Saint Louis, Missouri, United States|John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States|Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States|Kyoto University Hospital, Kyoto, Sakyo-ku, Japan|National Cancer Center Hospital, Chuo Ku, Tokyo, Japan","https://ClinicalTrials.gov/show/NCT05023551"
1097,"Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma","Unknown status","No Results Available","Glioblastoma Multiforme of Brain|Anaplastic Astrocytoma of Brain","Drug: Temozolomide","Radiation ward of Emam Reza Hospital, Mashhad, Razavi Khorasan, Iran, Islamic Republic of|Omid Hospital, Mashhad, Razavi Khorasan, Iran, Islamic Republic of","https://ClinicalTrials.gov/show/NCT03633552"
1098,"Evaluation of GLR2007 for Advanced Solid Tumors","Active, not recruiting","No Results Available","Non-small Cell Lung Cancer|Glioblastoma Multiforme","Drug: GLR2007","USA002, Lafayette, Indiana, United States|USA005, Omaha, Nebraska, United States|USA001, Philadelphia, Pennsylvania, United States|USA004, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT04444427"
1099,"Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme","Completed","Has Results","Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Recurrent Adult Brain Neoplasm","Biological: Anti-Endoglin Chimeric Monoclonal Antibody TRC105|Biological: Bevacizumab|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Other: Quality-of-Life Assessment","University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Saint Jude Medical Center, Fullerton, California, United States|Saint Joseph Hospital - Orange, Orange, California, United States|Sharp Memorial Hospital, San Diego, California, United States|UCSF Medical Center-Mount Zion, San Francisco, California, United States|UCSF Medical Center-Parnassus, San Francisco, California, United States|Greenwich Hospital, Greenwich, Connecticut, United States|Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States|Stamford Hospital/Bennett Cancer Center, Stamford, Connecticut, United States|Beebe Medical Center, Lewes, Delaware, United States|Christiana Gynecologic Oncology LLC, Newark, Delaware, United States|Delaware Clinical and Laboratory Physicians PA, Newark, Delaware, United States|Helen F Graham Cancer Center, Newark, Delaware, United States|Medical Oncology Hematology Consultants PA, Newark, Delaware, United States|Regional Hematology and Oncology PA, Newark, Delaware, United States|Christiana Care Health System-Christiana Hospital, Newark, Delaware, United States|Beebe Health Campus, Rehoboth Beach, Delaware, United States|Nanticoke Memorial Hospital, Seaford, Delaware, United States|Christiana Care Health System-Wilmington Hospital, Wilmington, Delaware, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Mount Sinai Medical Center, Miami Beach, Florida, United States|Florida Hospital Orlando, Orlando, Florida, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States|Kootenai Medical Center, Coeur d'Alene, Idaho, United States|Kootenai Cancer Center, Post Falls, Idaho, United States|Kootenai Cancer Clinic, Sandpoint, Idaho, United States|Saint Joseph Medical Center, Bloomington, Illinois, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, United States|Illinois CancerCare-Canton, Canton, Illinois, United States|Memorial Hospital of Carbondale, Carbondale, Illinois, United States|Illinois CancerCare-Carthage, Carthage, Illinois, United States|Centralia Oncology Clinic, Centralia, Illinois, United States|Northwestern University, Chicago, Illinois, United States|Cancer Care Center of Decatur, Decatur, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Crossroads Cancer Center, Effingham, Illinois, United States|Illinois CancerCare-Eureka, Eureka, Illinois, United States|NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, United States|NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois, United States|Hematology Oncology Associates of Illinois-Highland Park, Highland Park, Illinois, United States|NorthShore University HealthSystem-Highland Park Hospital, Highland Park, Illinois, United States|Presence Saint Mary's Hospital, Kankakee, Illinois, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States|NorthShore Hematology Oncology-Libertyville, Libertyville, Illinois, United States|Illinois CancerCare-Macomb, Macomb, Illinois, United States|Garneau, Stewart C MD (UIA Investigator), Moline, Illinois, United States|Spector, David MD (UIA Investigator), Moline, Illinois, United States|Trinity Medical Center, Moline, Illinois, United States|Illinois Cancer Specialists-Niles, Niles, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Radiation Oncology of Northern Illinois, Ottawa, Illinois, United States|Illinois CancerCare-Pekin, Pekin, Illinois, United States|OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center, Pekin, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|OSF Saint Francis Radiation Oncology at Peoria Cancer Center, Peoria, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Illinois CancerCare-Peru, Peru, Illinois, United States|Valley Radiation Oncology, Peru, Illinois, United States|Illinois CancerCare-Princeton, Princeton, Illinois, United States|Hematology Oncology Associates of Illinois - Skokie, Skokie, Illinois, United States|Central Illinois Hematology Oncology Center, Springfield, Illinois, United States|Southern Illinois University School of Medicine, Springfield, Illinois, United States|Springfield Clinic, Springfield, Illinois, United States|Memorial Medical Center, Springfield, Illinois, United States|Cancer Care Specialists of Illinois-Swansea, Swansea, Illinois, United States|Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States|Michiana Hematology Oncology PC-Crown Point, Crown Point, Indiana, United States|Elkhart Clinic, Elkhart, Indiana, United States|Michiana Hematology Oncology PC-Elkhart, Elkhart, Indiana, United States|Elkhart General Hospital, Elkhart, Indiana, United States|Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States|Community Howard Regional Health, Kokomo, Indiana, United States|IU Health La Porte Hospital, La Porte, Indiana, United States|Memorial Regional Cancer Center Day Road, Mishawaka, Indiana, United States|Michiana Hematology Oncology PC-Mishawaka, Mishawaka, Indiana, United States|Saint Joseph Regional Medical Center-Mishawaka, Mishawaka, Indiana, United States|Michiana Hematology Oncology PC-Plymouth, Plymouth, Indiana, United States|Reid Health, Richmond, Indiana, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|Michiana Hematology Oncology PC-South Bend, South Bend, Indiana, United States|South Bend Clinic, South Bend, Indiana, United States|Northern Indiana Cancer Research Consortium, South Bend, Indiana, United States|Michiana Hematology Oncology PC-Westville, Westville, Indiana, United States|Mary Greeley Medical Center, Ames, Iowa, United States|McFarland Clinic PC-William R Bliss Cancer Center, Ames, Iowa, United States|Constantinou, Costas L MD (UIA Investigator), Bettendorf, Iowa, United States|McFarland Clinic PC-Boone, Boone, Iowa, United States|Mercy Hospital, Cedar Rapids, Iowa, United States|Oncology Associates at Mercy Medical Center, Cedar Rapids, Iowa, United States|McFarland Clinic PC-Trinity Cancer Center, Fort Dodge, Iowa, United States|University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States|McFarland Clinic PC-Jefferson, Jefferson, Iowa, United States|McFarland Clinic PC-Marshalltown, Marshalltown, Iowa, United States|Siouxland Regional Cancer Center, Sioux City, Iowa, United States|Mercy Medical Center-Sioux City, Sioux City, Iowa, United States|Saint Luke's Regional Medical Center, Sioux City, Iowa, United States|Cancer Center of Kansas - Chanute, Chanute, Kansas, United States|Cancer Center of Kansas - Dodge City, Dodge City, Kansas, United States|Cancer Center of Kansas - El Dorado, El Dorado, Kansas, United States|Cancer Center of Kansas - Fort Scott, Fort Scott, Kansas, United States|Cancer Center of Kansas-Independence, Independence, Kansas, United States|Cancer Center of Kansas-Kingman, Kingman, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|Cancer Center of Kansas-Liberal, Liberal, Kansas, United States|Cancer Center of Kansas-Manhattan, Manhattan, Kansas, United States|Cancer Center of Kansas - McPherson, McPherson, Kansas, United States|Cancer Center of Kansas - Newton, Newton, Kansas, United States|Cancer Center of Kansas - Parsons, Parsons, Kansas, United States|Cancer Center of Kansas - Pratt, Pratt, Kansas, United States|Cancer Center of Kansas - Salina, Salina, Kansas, United States|Cancer Center of Kansas - Wellington, Wellington, Kansas, United States|Associates In Womens Health, Wichita, Kansas, United States|Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita, Kansas, United States|Cancer Center of Kansas - Wichita, Wichita, Kansas, United States|Via Christi Regional Medical Center, Wichita, Kansas, United States|Wichita NCI Community Oncology Research Program, Wichita, Kansas, United States|Cancer Center of Kansas - Winfield, Winfield, Kansas, United States|Baptist Health Corbin, Corbin, Kentucky, United States|Oncology Hematology Care Inc-Crestview, Crestview Hills, Kentucky, United States|Hardin Memorial Hospital, Elizabethtown, Kentucky, United States|Baptist Health Lexington, Lexington, Kentucky, United States|Baptist Health Madisonville/Merle Mahr Cancer Center, Madisonville, Kentucky, United States|Baptist Health Paducah, Paducah, Kentucky, United States|Eastern Maine Medical Center, Bangor, Maine, United States|Lafayette Family Cancer Center-EMMC, Brewer, Maine, United States|Maine Center for Cancer Medicine-Scarborough, Scarborough, Maine, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Massachusetts General Hospital, Charlestown, Massachusetts, United States|Bixby Medical Center, Adrian, Michigan, United States|Hickman Cancer Center, Adrian, Michigan, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|Bronson Battle Creek, Battle Creek, Michigan, United States|Beaumont Hospital-Dearborn, Dearborn, Michigan, United States|Saint John Hospital and Medical Center, Detroit, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, United States|Allegiance Health, Jackson, Michigan, United States|Borgess Medical Center, Kalamazoo, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Sparrow Hospital, Lansing, Michigan, United States|Saint Mary Mercy Hospital, Livonia, Michigan, United States|Mercy Memorial Hospital, Monroe, Michigan, United States|Toledo Clinic Cancer Centers-Monroe, Monroe, Michigan, United States|Mercy Health Mercy Campus, Muskegon, Michigan, United States|Lakeland Community Hospital, Niles, Michigan, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, United States|Lake Huron Medical Center, Port Huron, Michigan, United States|Spectrum Health Reed City Hospital, Reed City, Michigan, United States|Saint Mary's of Michigan, Saginaw, Michigan, United States|Lakeland Hospital, Saint Joseph, Michigan, United States|Marie Yeager Cancer Center, Saint Joseph, Michigan, United States|Munson Medical Center, Traverse City, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Ann Arbor Hematology -Oncology Associates, Ypsilanti, Michigan, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Essentia Health Cancer Center, Duluth, Minnesota, United States|Essentia Health Saint Mary's Medical Center, Duluth, Minnesota, United States|Miller-Dwan Hospital, Duluth, Minnesota, United States|Saint Luke's Hospital of Duluth, Duluth, Minnesota, United States|Fairview-Southdale Hospital, Edina, Minnesota, United States|Unity Hospital, Fridley, Minnesota, United States|Hutchinson Area Health Care, Hutchinson, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|Health Partners Inc, Minneapolis, Minnesota, United States|New Ulm Medical Center, New Ulm, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, United States|Saint Cloud Hospital, Saint Cloud, Minnesota, United States|Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, United States|Lakeview Hospital, Stillwater, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Rice Memorial Hospital, Willmar, Minnesota, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States|Parkland Health Center-Bonne Terre, Bonne Terre, Missouri, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, United States|Southeast Cancer Center, Cape Girardeau, Missouri, United States|Capital Region Medical Center-Goldschmidt Cancer Center, Jefferson City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Missouri Baptist Medical Center, Saint Louis, Missouri, United States|Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, United States|Missouri Baptist Sullivan Hospital, Sullivan, Missouri, United States|Missouri Baptist Outpatient Center-Sunset Hills, Sunset Hills, Missouri, United States|Billings Clinic Cancer Center, Billings, Montana, United States|Montana Cancer Consortium NCORP, Billings, Montana, United States|Saint Vincent Healthcare, Billings, Montana, United States|Bozeman Deaconess Hospital, Bozeman, Montana, United States|Saint James Community Hospital and Cancer Treatment Center, Butte, Montana, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, United States|Saint Peter's Community Hospital, Helena, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Saint Patrick Hospital - Community Hospital, Missoula, Montana, United States|Community Medical Hospital, Missoula, Montana, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|New Hampshire Oncology Hematology PA-Concord, Concord, New Hampshire, United States|New Hampshire Oncology Hematology PA-Hooksett, Hooksett, New Hampshire, United States|LRGHealthcare-Lakes Region General Hospital, Laconia, New Hampshire, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Cooper Hospital University Medical Center, Camden, New Jersey, United States|MD Anderson Cancer Center at Cooper-Voorhees, Voorhees, New Jersey, United States|Hematology Oncology Associates of Central New York-Auburn, Auburn, New York, United States|Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse, New York, United States|Mount Sinai Hospital, New York, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|State University of New York Upstate Medical University, Syracuse, New York, United States|Hematology Oncology Associates of Central New York-Onondaga Hill, Syracuse, New York, United States|Wayne Memorial Hospital, Goldsboro, North Carolina, United States|Kinston Medical Specialists PA, Kinston, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Altru Cancer Center, Grand Forks, North Dakota, United States|Strecker Cancer Center-Belpre, Belpre, Ohio, United States|Toledo Clinic Cancer Centers-Bowling Green, Bowling Green, Ohio, United States|Adena Regional Medical Center, Chillicothe, Ohio, United States|Oncology Hematology Care Inc-Eden Park, Cincinnati, Ohio, United States|Oncology Hematology Care Inc-Mercy West, Cincinnati, Ohio, United States|Oncology Hematology Care Inc - Anderson, Cincinnati, Ohio, United States|Oncology Hematology Care Inc-Kenwood, Cincinnati, Ohio, United States|Oncology Hematology Care Inc-Blue Ash, Cincinnati, Ohio, United States|Columbus Oncology and Hematology Associates Inc, Columbus, Ohio, United States|Riverside Methodist Hospital, Columbus, Ohio, United States|Columbus NCI Community Oncology Research Program, Columbus, Ohio, United States|Grant Medical Center, Columbus, Ohio, United States|The Mark H Zangmeister Center, Columbus, Ohio, United States|Mount Carmel Health Center West, Columbus, Ohio, United States|Doctors Hospital, Columbus, Ohio, United States|Good Samaritan Hospital - Dayton, Dayton, Ohio, United States|Miami Valley Hospital, Dayton, Ohio, United States|Samaritan North Health Center, Dayton, Ohio, United States|Delaware Health Center-Grady Cancer Center, Delaware, Ohio, United States|Delaware Radiation Oncology, Delaware, Ohio, United States|Grady Memorial Hospital, Delaware, Ohio, United States|Oncology Hematology Care Inc-Healthplex, Fairfield, Ohio, United States|Blanchard Valley Hospital, Findlay, Ohio, United States|Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States|Wayne Hospital, Greenville, Ohio, United States|Kettering Medical Center, Kettering, Ohio, United States|Fairfield Medical Center, Lancaster, Ohio, United States|Lima Memorial Hospital, Lima, Ohio, United States|Marietta Memorial Hospital, Marietta, Ohio, United States|OneHealth Marion General Hospital, Marion, Ohio, United States|Toledo Clinic Cancer Centers-Maumee, Maumee, Ohio, United States|Toledo Radiation Oncology at Northwest Ohio Onocolgy Center, Maumee, Ohio, United States|Knox Community Hospital, Mount Vernon, Ohio, United States|Licking Memorial Hospital, Newark, Ohio, United States|Newark Radiation Oncology, Newark, Ohio, United States|Saint Charles Hospital, Oregon, Ohio, United States|Toledo Clinic Cancer Centers-Oregon, Oregon, Ohio, United States|Southern Ohio Medical Center, Portsmouth, Ohio, United States|Springfield Regional Medical Center, Springfield, Ohio, United States|Flower Hospital, Sylvania, Ohio, United States|Mercy Hospital of Tiffin, Tiffin, Ohio, United States|Saint Vincent Mercy Medical Center, Toledo, Ohio, United States|University of Toledo, Toledo, Ohio, United States|Toledo Community Hospital Oncology Program CCOP, Toledo, Ohio, United States|Mercy Saint Anne Hospital, Toledo, Ohio, United States|Toledo Clinic Cancer Centers-Toledo, Toledo, Ohio, United States|Upper Valley Medical Center, Troy, Ohio, United States|Fulton County Health Center, Wauseon, Ohio, United States|Saint Ann's Hospital, Westerville, Ohio, United States|Genesis Healthcare System Cancer Care Center, Zanesville, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa, Oklahoma, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, United States|PinnacleHealth Cancer Center-Community Campus, Harrisburg, Pennsylvania, United States|Reading Hospital, West Reading, Pennsylvania, United States|Greenville Health System Cancer Institute-Easley, Easley, South Carolina, United States|Greenville Health System Cancer Institute-Andrews, Greenville, South Carolina, United States|Greenville Health System Cancer Institute-Butternut, Greenville, South Carolina, United States|Greenville Health System Cancer Institute-Faris, Greenville, South Carolina, United States|Greenville Memorial Hospital, Greenville, South Carolina, United States|Greenville Health System Cancer Institute-Eastside, Greenville, South Carolina, United States|Greenville Health System Cancer Institute-Greer, Greer, South Carolina, United States|Greenville Health System Cancer Institute-Seneca, Seneca, South Carolina, United States|Greenville Health System Cancer Institute-Spartanburg, Spartanburg, South Carolina, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|University Medical Center Brackenridge, Austin, Texas, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|University of Virginia Cancer Center, Charlottesville, Virginia, United States|Fredericksburg Oncology Inc, Fredericksburg, Virginia, United States|Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Community Memorial Hospital, Menomonee Falls, Wisconsin, United States|Froedtert and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States|ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin, United States|ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States|ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States|Rocky Mountain Oncology, Casper, Wyoming, United States|Big Horn Basin Cancer Center, Cody, Wyoming, United States|Billings Clinic-Cody, Cody, Wyoming, United States|Welch Cancer Center, Sheridan, Wyoming, United States","https://ClinicalTrials.gov/show/NCT01648348"
1100,"Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: filgrastim|Drug: carboplatin|Drug: thiotepa|Procedure: autologous bone marrow transplantation|Procedure: peripheral blood stem cell transplantation","Kaplan Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00002619"
1101,"Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas","Completed","No Results Available","Glioblastoma|Malignant Gliomas","Drug: CC-8490","Neuro Oncology BranchNational Cancer Institute, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00074646"
1102,"Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma","Completed","No Results Available","Glioblastoma|Anaplastic Astrocytoma","Drug: AP 12009 10 µM|Drug: AP 12009 80 µM|Drug: temozolomide or PCV|Device: Drug delivery system for administration of AP 12009|Procedure: Placement of Drug Delivery System","Universitätsklinik Innsbruck; Abteilung für Neurochirurgie, Innsbruck, Austria|Landes-Nervenklinik Wagner-Jauregg, Linz, Austria|Kaiser Franz Josef Spital, Abteilung für Neurologie, Wien, Austria|Sarajishvili Institute of Clinical Neurology and Neurosurgery, Tbilisi, Georgia|Medizinische Klinik und Poliklinik mit Schwerpunkt Onkologie und Hämatologie, Charité Campus Mitte, Berlin, Germany|Klinik und Poliklinik für Neurologie, Cottbus, Germany|Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Germany|Universitätsklinikum Gießen, Neurochirurgische Universitätsklinik, Gießen, Germany|Universitätsklinikum Kiel, Klinik für Neurochirurgie, Kiel, Germany|Universitätsklinikum Leipzig, Klinik und Poliklinik für Neurochirurgie, Leipzig, Germany|Universitätsklinik Magdeburg, Klinik für Neurochirurgie, Magdeburg, Germany|Universitätskliniken Mainz, Neurochirurgische Klinik und Poliklinik, Mainz, Germany|Universitätsklinikum Münster, Klinik und Poliklinik für Neurochirurgie, Münster, Germany|Klinikum und Poliklinik für Neurologie, Universität Regensburg, Regensburg, Germany|Klinikum Saarbrücken, Neurochirurgie, Saarbrücken, Germany|Neurologische Universitätsklinik Tübingen, Tübingen, Germany|Department of Neurosurgery, Amrita Institute of Medical Sciences & Research Centre, Cochin, Kerala, India|Sree Chitra Tirunal Institute for Medical Sciences & Technology, Department of Neurosurgery, Trivandrum, Kerala, India|Manipal Hospital; Manipal Institute for Neurological Disorders, Bangalore, India|Department of Neurosurgery, National Institute of Mental Health and Neurosciences, Bangalore, India|Department of Medical Oncology, Nizam's Institute of Medical Sciences, Hyderabad, India|Department of Neurosurgery, LTMG Hospital & LTM Medical College, Mumbai, India|Department of Neurosurgery, Neurosciences Center, New Dehli, India|Department of Neurological Sciences, Christian Medical College & Hospital, Vellore, India|Soroka Medical Center, Neurosurgery Department, Beer Sheva, Israel|Rambam Medical Center, Neurosurgery Department, Haifa, Israel|Rabin Medical Center, Neurosurgery Department, Petach Tikva, Israel|Sverdlovsk Regional Oncological Clinic, Ekaterinburg, Russian Federation|Republican Clinical Hospital of Ministry of Health of Tatarstan Republic, Kazan, Russian Federation|Burdenko Neurosurgery Research Institute, Moscow, Russian Federation|Omsk State Medical Academy; State Educational Institution of Higher Professional Education, Omsk, Russian Federation|State Institution of Healthcare, Samara Regional Clinical Hospital in the name of M.I. Kalinin, Samara, Russian Federation|Polenov Neurosurgery Research Institute, St. Petersburg, Russian Federation|Military Medical Academy named after I.S.M. Kirov, Neurosurgery Department, St. Petersburg, Russian Federation|Medical Center ""XXI century"", St. Petersburg, Russian Federation|Tcheliabinsk Regional Clinical Hospital; State Medical Institution for Prophylaxis and Treatment, Tcheliabinsk, Russian Federation","https://ClinicalTrials.gov/show/NCT00431561"
1103,"Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study","Recruiting","No Results Available","Glioblastoma|Brain Metastases","Drug: Losartan","Oslo University Hospital, Oslo, Norway","https://ClinicalTrials.gov/show/NCT03951142"
1104,"Bispecific T Cell Engager BRiTE for Patients With Grade IV Malignant Glioma","Not yet recruiting","No Results Available","Malignant Glioma|Glioblastoma","Drug: hEGFRvIII-CD3 (BRiTE)|Biological: Activated Cell Therapy","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT04903795"
1105,"Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour","Completed","No Results Available","Recurrent Glioblastoma|Brain Tumor","Drug: Cediranib|Drug: Lomustine","Research Site, Boston, Massachusetts, United States|Research Site, Sutton, United Kingdom","https://ClinicalTrials.gov/show/NCT00503204"
1106,"Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer","Completed","No Results Available","Glioblastoma|Malignant Glioma","Drug: MRZ|Drug: TMZ|Radiation: RT|Device: Optune","University of California San Diego Medical Center, La Jolla, California, United States|UC Irvine, Orange, California, United States|John Wayne Cancer Center Outpatient Clinic, Santa Monica, California, United States|Northwestern Center For Clinical Research, Chicago, Illinois, United States|Duke Cancer Center, Durham, North Carolina, United States|Pennsylvania State University College of Medicine, Hershey, Pennsylvania, United States|Princess Margaret Cancer Centre, Toronto, Ontario, Canada|University of Zurich Hospital, Zurich, Switzerland","https://ClinicalTrials.gov/show/NCT02903069"
1107,"Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain","Completed","No Results Available","Brain and Central Nervous System Tumors|Melanoma (Skin)|Metastatic Cancer","Drug: boronophenylalanine-fructose complex","Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Massachusetts Institute of Technology, Cambridge, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00039572"
1108,"Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma","Terminated","No Results Available","Glioblastoma|Glioma","Dietary Supplement: Ascorbic Acid|Biological: Bevacizumab|Other: Laboratory Biomarker Analysis|Other: Quality-of-Life Assessment","University of Nebraska Medical Center, Omaha, Nebraska, United States","https://ClinicalTrials.gov/show/NCT02833701"
1109,"Validation of Readiband™ Actigraph and Associated Sleep/Wake Classification Algorithms","Completed","No Results Available","Glioma|Glioblastoma","Device: Readiband Sleep Tracking","Abbott Northwestern Hospital, Minneapolis, Minnesota, United States","https://ClinicalTrials.gov/show/NCT03877861"
1110,"Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma","Recruiting","No Results Available","Glioma|Glioblastoma","Drug: Soliramfetol","Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT03868943"
1111,"A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma","Completed","No Results Available","Glioblastoma|Anaplastic Astrocytoma","Drug: Fingolimod","The Johns Hopkins University, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT02490930"
1112,"Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma","Completed","Has Results","Anaplastic Astrocytomas|Anaplastic Oligodendrogliomas|Glioblastomas (GBM)","Drug: Etirinotecan pegol","Stanford University School of Medicine, Palo Alto, California, United States","https://ClinicalTrials.gov/show/NCT01663012"
1113,"Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption","Recruiting","No Results Available","Glioma|Glioblastoma","Device: Focused ultrasound (FUS)","University of Maryland, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|University of Virginia, Charlottesville, Virginia, United States|West Virginia University, Morgantown, West Virginia, United States","https://ClinicalTrials.gov/show/NCT03551249"
1114,"INCMGA00012 and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas","Recruiting","No Results Available","Glioma|Glioblastoma","Drug: Epacadostat|Drug: Bevacizumab|Radiation: Radiation therapy|Procedure: Peripheral blood draw","Mayo Clinic, Phoenix, Arizona, United States|Mayo Clinic, Rochester, Minnesota, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT03532295"
1115,"Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma","Completed","Has Results","Glioblastoma|Gliosarcoma","Drug: Avastin|Drug: Bortezomib","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00611325"
1116,"Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma","Terminated","Has Results","Brain Neoplasms|Central Nervous System Neoplasms","Drug: TPI287|Drug: Bevacizumab","University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01582152"
1117,"Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)","Completed","Has Results","Glioblastoma|Gliosarcoma","Drug: Bevacizumab and Erlotinib","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00671970"
1118,"TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors","Active, not recruiting","No Results Available","Adult Glioblastoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Recurrent Uterine Corpus Cancer|Solid Neoplasm|Stage IIIA Fallopian Tube Cancer AJCC v7|Stage IIIA Ovarian Cancer AJCC v6 and v7|Stage IIIA Primary Peritoneal Cancer AJCC v7|Stage IIIB Fallopian Tube Cancer AJCC v7|Stage IIIB Ovarian Cancer AJCC v6 and v7|Stage IIIB Primary Peritoneal Cancer AJCC v7|Stage IIIC Fallopian Tube Cancer AJCC v7|Stage IIIC Ovarian Cancer AJCC v6 and v7|Stage IIIC Primary Peritoneal Cancer AJCC v7|Stage IV Fallopian Tube Cancer AJCC v6 and v7|Stage IV Ovarian Cancer AJCC v6 and v7|Stage IV Primary Peritoneal Cancer AJCC v7","Biological: Bevacizumab|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Sapanisertib","Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Massachusetts General Hospital, Charlestown, Massachusetts, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT02142803"
1119,"Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme","Completed","Has Results","Glioblastoma|Gliosarcoma","Drug: Erlotinib + sirolimus","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00672243"
1120,"PET/CT Imaging of Malignant Brain Tumors With 124I-NM404","Completed","No Results Available","Glioblastoma|Brain Metastases","Drug: NM404","University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01516905"
1121,"Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly","Completed","No Results Available","Glioblastoma|Anaplastic Astrocytoma","Drug: Temozolomide|Radiation: Radiotherapy of the partial brain.","University of Heidelberg, Heidelberg, Baden-Württemberg, Germany|University of Frankfurt, Frankfurt, Hessen, Germany|Charite Berlin, Berlin, Germany|University of Bochum, Bochum, Germany|University of Bonn, Bonn, Germany|University of Dresden, Dresden, Germany|University of Düsseldorf, Düsseldorf, Germany|University of Erlangen, Erlangen, Germany|University of Essen, Essen, Germany|University of Freiburg, Freiburg, Germany|University of Hamburg, Hamburg, Germany|University of Hannover II, Hannover, Germany|University of Hannover, Hannover, Germany|University of Homburg, Homburg, Germany|University of Kiel, Kiel, Germany|University of Leipzig, Leipzig, Germany|University of Mainz, Mainz, Germany|University of Heidelberg, Mannheim, Germany|University of Marburg, Marburg, Germany|University of Regensburg, Regensburg, Germany|University of Tübingen, Tübingen, Germany|University of Ulm, Ulm, Germany|University of Zurich, Zurich, Switzerland","https://ClinicalTrials.gov/show/NCT01502241"
1122,"Loupe-Based Intraoperative Fluorescence Imaging","Recruiting","No Results Available","Glioblastoma Multiforme|Anaplastic Astrocytoma",,"University of Kentucky, Lexington, Kentucky, United States","https://ClinicalTrials.gov/show/NCT04780009"
1123,"Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma","Completed","No Results Available","Glioblastoma Multiforme|Anaplastic Glioma","Drug: Temodar and O6-Benzylguanine (BG)","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00613093"
1124,"Image Guided Reirradiation of High-grade Glioma","Terminated","No Results Available","Malignant Glioma|Glioblastoma","Radiation: External beam radiotherapy","Department of Radiation Oncology, Rigshospitalet, Copenhagen, Denmark|Skånes universitetssjukhus, Lund, Sweden","https://ClinicalTrials.gov/show/NCT02025231"
1125,"A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies","Unknown status","No Results Available","Cancer of Pancreas|Cancer of Liver|Cancer of Rectum|Cancer of Colon|Cancer, Gall Bladder|Myeloma Multiple|Glioblastoma Multiforme","Drug: Cannabidiol|Drug: Bortezomib|Drug: Leucovorin|Drug: 5-FU|Drug: Oxaliplatin|Drug: Bevacizumab|Drug: Irinotecan|Drug: Gemcitabine|Drug: Temozolomide","Southwest Cancer Center, Orlando, Florida, United States","https://ClinicalTrials.gov/show/NCT03607643"
1126,"Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma","Completed","No Results Available","Glioblastoma|Gliosarcoma","Drug: Zactima, Gleevec, Hydroxyurea","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00613054"
1127,"A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm","Completed","No Results Available","Solid Tumors|Glioblastoma","Drug: CBL0137","Roswell Park Cancer Institute, Buffalo, New York, United States|University Hospital of Cleveland, Cleveland, Ohio, United States|Cleveland Clinic, Cleveland, Ohio, United States|CTRC at The University of Texas Healh Science Center at San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT01905228"
1128,"Multi-site Validation and Application of a Consensus DSC-MRI Protocol","Unknown status","No Results Available","Glioblastoma Multiforme|Gliosarcoma","Diagnostic Test: DSC-MRI","Mayo Clinic, Scottsdale, Arizona, United States|Brown University, Providence, Rhode Island, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT03401866"
1129,"Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients","Recruiting","No Results Available","Glioblastoma Multiforme|Meningioma","Drug: Ribociclib","Barrow Brain and Spine, Phoenix, Arizona, United States","https://ClinicalTrials.gov/show/NCT02933736"
1130,"Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer","Completed","Has Results","Brain and Central Nervous System Tumors|Prostate Cancer","Drug: everolimus|Drug: gefitinib","Memorial Sloan Kettering Cancer Center, New York, New York, United States|Vall d'Hebron University Hospital, Barcelona, Spain","https://ClinicalTrials.gov/show/NCT00085566"
1131,"Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients","Recruiting","No Results Available","Glioma|Glioblastoma Multiforme","Other: Non- interventional","Novosibirsk State University, Novosibirsk, Novosibirskaya Oblast', Russian Federation","https://ClinicalTrials.gov/show/NCT03865355"
1132,"ADV-TK Improves Outcome of Recurrent High-Grade Glioma","Completed","No Results Available","Malignant Glioma of Brain|Glioblastoma","Biological: ADV-TK/GCV|Procedure: Surgery|Drug: systemic chemotherapy","Beijing YouAn Hospital, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT00870181"
1133,"Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas","Completed","No Results Available","Gliosarcoma|Glioblastoma","Drug: Vandetanib and Etoposide","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00613223"
1134,"Borderzone Sampling","Completed","No Results Available","High Grade Glioma|Glioblastoma","Device: PoleStar N20 intraoperative MRI","Maastricht University Medical Center, Maastricht, Limburg, Netherlands","https://ClinicalTrials.gov/show/NCT00780819"
1135,"Study of Recombinant Human Endostatin Combined With Temozolomide and Irinotecan in Recurrent Gliomas","Recruiting","No Results Available","Glioblastoma, Recurrent|Lower Grade Glioma, Recurrent","Drug: recombinant human endostatin,temozolomide,irinotecan","Beijing Sanbo Brain Hospital, Beijing, China","https://ClinicalTrials.gov/show/NCT04267978"
1136,"Temozolomide Chronotherapy for High Grade Glioma","Active, not recruiting","No Results Available","Glioma|Glioblastoma Multiforme","Drug: Temozolomide|Other: Functional Assessment of Cancer Therapy - Brain|Other: ActTrust Condor Instrument Watch","Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT02781792"
1137,"Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma","Unknown status","No Results Available","Glioma, Malignant|Gliosarcoma|Astrocytoma of Brain","Drug: Intranasal Modified Temozolomide","Central Contact, Banja Luka, Bosnia and Herzegovina|Central Contact, Plovdiv,, Bulgaria|Central Contact, Tbilisi, Georgia","https://ClinicalTrials.gov/show/NCT04091503"
1138,"PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404","Completed","Has Results","Glioblastoma Multiforme|Brain Metastases","Drug: NM404","University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01540513"
1139,"Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma","Unknown status","No Results Available","Malignant Glioma|Recurrent Glioblastoma","Biological: Durvalumab|Other: Laboratory Biomarker Analysis|Procedure: Surgical Procedure|Biological: Tremelimumab","Northwestern University, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT02794883"
1140,"BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain Tumor","Completed","No Results Available","GLIOBLASTOMA MULTIFORME|Brain Neoplasm",,"Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT01124461"
1141,"Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma","Completed","No Results Available","Malignant Glioma|Glioblastoma Multiforme","Biological: Dose Escalation of Ad-hCMV-TK and Ad-hCMV-Flt3L","University of Michigan Health System Department of Neurosurgery, Ann Arbor, Michigan, United States","https://ClinicalTrials.gov/show/NCT01811992"
1142,"Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma","Completed","Has Results","Glioblastoma|Gliosarcoma","Drug: hydroxyurea|Drug: imatinib mesylate","Duke Cancer Institute, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00354913"
1143,"A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy","Completed","Has Results","Intracranial Tumors|Glioblastoma|Melanoma","Other: PBR PET|Biological: Cancer Immunotherapy|Radiation: Radiation and chemotherapy","Dana Farber Cancer Institute, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT02431572"
1144,"Social Determinants of Health in Glioblastoma Population","Recruiting","No Results Available","Glioma|Astrocytoma|Oligodendroglioma|Ependymoma|Ganglioglioma|Pleomorphic Xanthoastrocytoma","Other: Part 1 Survey Group|Other: Part 2 Focus Group","Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT03900689"
1145,"Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2","Suspended","No Results Available","Glioblastoma Multiforme|Anaplastic Astrocytoma","Drug: PAC-1 Compound","University of Illinois at Chicago, Chicago, Illinois, United States|Johns Hopkins Cancer Center, Baltimore, Maryland, United States|Regions Hospital, Saint Paul, Minnesota, United States","https://ClinicalTrials.gov/show/NCT03332355"
1146,"A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas","Completed","No Results Available","Glioblastoma|Diffuse Intrinsic Pontine Glioma","Drug: DSP-7888","National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, Japan|Kanagawa Children's Medical Center, Yokohama, Kanagawa, Japan|Osaka University Hospital, Suita, Osaka, Japan|National Center for Child Health and Development, Setagaya, Tokyo, Japan|Hiroshima University Hospital, Hiroshima, Japan|Osaka City General Hospital, Osaka, Japan","https://ClinicalTrials.gov/show/NCT02750891"
1147,"Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma","Completed","Has Results","Adult Ependymoblastoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Medulloblastoma|Adult Mixed Glioma|Adult Oligodendroglial Tumors|Adult Pineoblastoma|Adult Supratentorial Primitive Neuroectodermal Tumor (PNET)","Radiation: radiation therapy|Drug: temozolomide|Drug: plerixafor|Other: laboratory biomarker analysis|Other: pharmacological study","Stanford University, School of Medicine, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT01977677"
1148,"AMG 102 and Avastin for Recurrent Malignant Glioma","Completed","Has Results","Glioblastoma Multiforme|Gliosarcoma","Drug: AMG 102|Drug: Avastin","The Preston Robert Tisch Brain Tumor Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01113398"
1149,"3D Printed Mask for GBM and Brain Mets","Recruiting","No Results Available","Brain Cancer","Device: 3D-printed mask|Device: Thermoplastic mask","Princess Margaret Cancer Centre, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT04114786"
1150,"Brain Tumor Intraoperative Ultrasound Database","Not yet recruiting","No Results Available","Brain Tumor|Brain Neoplasms|Brain Cancer|Glioma|Glioblastoma","Diagnostic Test: Ultrasound","University Hospital Rio Hortega, Valladolid, Spain","https://ClinicalTrials.gov/show/NCT05062772"
1151,"Upfront Bevacizumab/témozolomide for Gliomastomas With Neurological Impairment","Completed","No Results Available","Chemoradiotherapy","Other: TMZ and BEV induction before chemoradiotherapy",,"https://ClinicalTrials.gov/show/NCT03623347"
1152,"Immunotoxin Therapy in Treating Children With Progressive or Recurrent Glioblastoma Multiforme or Anaplastic Astrocytoma","Unknown status","No Results Available","Brain and Central Nervous System Tumors","Biological: transferrin-CRM107","Children's Hospital of Orange County, Orange, California, United States|Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina, United States","https://ClinicalTrials.gov/show/NCT00052624"
1153,"A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma","Terminated","Has Results","Glioblastoma Multiforme|Brain Neoplasms","Drug: OncoGel (ReGel/Paclitaxel)","The University of Chicago Brain Tumor Center, Chicago, Illinois, United States|The Johns Hopkins University, Baltimore, Maryland, United States|University of Rochester Medical Center, Rochester, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00479765"
1154,"Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma","Completed","No Results Available","Grade IV Glioma|Grade IV Astrocytoma|Glioblastoma Multiforme","Biological: TVI-Brain-1","Saint Luke's Hospital, Kansas City, Missouri, United States|Washington University, Saint Louis, Missouri, United States|Baylor University Medical Center, Dallas, Texas, United States|Aurora BayCare Medical Center, Green Bay, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01290692"
1155,"O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas","Completed","Has Results","Glioblastoma|Gliosarcoma","Radiation: 3-Dimensional Conformal Radiation Therapy|Procedure: Autologous Hematopoietic Stem Cell Transplantation|Drug: Carmustine|Biological: Filgrastim|Procedure: In Vitro-Treated Peripheral Blood Stem Cell Transplantation|Radiation: Intensity-Modulated Radiation Therapy|Other: Laboratory Biomarker Analysis|Drug: O6-Benzylguanine|Drug: Plerixafor|Radiation: Proton Beam Radiation Therapy|Drug: Temozolomide","Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00669669"
1156,"Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas","Completed","No Results Available","Glioblastoma|Gliosarcoma","Drug: Temodar, O6-BG, and Irinotecan","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00612638"
1157,"Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy","Terminated","No Results Available","Glioblastoma Multiforme (WHO Grade IV)|Anaplastic Astrocytoma (WHO Grade III)","Drug: 06Benzylguanine|Genetic: MGMT P140K|Device: Meltenyi CliniMacs","Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT00272870"
1158,"Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma","Completed","No Results Available","Glioma|Glioblastoma|Glioblastoma Multiforme|GBM|Brain Cancer","Drug: VAL-083 (Dianhydrogalactitol)","University of California, San Francisco, Division of Neuro-Oncology, San Francisco, California, United States|Sarah Cannon Research Institute, Denver, Colorado, United States|Florida Cancer Specialists, Sarasota, Florida, United States|Mayo Clinic, Rochester, Minnesota, United States|Sarah Cannon Research Institute, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT01478178"
1159,"Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant Glioma","Recruiting","No Results Available","Recurrent Glioblastoma Multiforme (GBM)|Grade 3 Isocitrate Dehydrogenase (IDH) Wildtype Astrocytoma|Grade 3 or 4 Astrocytoma|Glioblastoma Surgery","Drug: Icapamespib","University of California, Las Angeles Medical Center, Los Angeles, California, United States|University of California San Diego, San Diego, California, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|MD Anderson Cancer Center, Houston, Texas, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT04782609"
1160,"A Trial of Ipatasertib in Combination With Atezolizumab","Recruiting","No Results Available","Solid Tumor|Glioblastoma Multiforme|Prostate Cancer Metastatic","Drug: ipatasertib|Drug: Atezolizumab","Royal Marsden Hospital NHS Foundation Trust, Sutton, Surrey, United Kingdom","https://ClinicalTrials.gov/show/NCT03673787"
1161,"Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme","Terminated","No Results Available","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Solid Neoplasm|Recurrent Adult Brain Neoplasm","Drug: Cilengitide|Other: Clinical Observation|Other: Laboratory Biomarker Analysis","University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT01122888"
1162,"Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas","Unknown status","No Results Available","Glioblastoma Multiforme|Astrocytoma Anaplastic Foci","Drug: MAB-425 radiolabeled with I-125",,"https://ClinicalTrials.gov/show/NCT01317888"
1163,"Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma","Completed","No Results Available","Glioma|Glioblastoma Multiforme|Astrocytoma","Radiation: Conventional RT|Radiation: Hyperfractionated RT|Drug: Carmustine",,"https://ClinicalTrials.gov/show/NCT03722355"
1164,"Sunitinib to Treat Recurrent Brain Cancer","Terminated","Has Results","Glioblastoma Multiforme|Malignant Gliomas|Anaplastic Gliomas","Drug: Sutent (sunitinib)","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00923117"
1165,"Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers","Completed","No Results Available","Glioblastoma|Malignant Glioma|WHO Grade III Glioma","Other: Palliative Therapy|Other: Quality-of-Life Assessment|Other: Supportive Care|Other: Survey Administration","Mayo Clinic in Arizona, Scottsdale, Arizona, United States","https://ClinicalTrials.gov/show/NCT04630379"
1166,"Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors","Recruiting","No Results Available","Glioblastoma|WHO Grade II Glioma|WHO Grade III Glioma","Other: Educational Intervention|Other: Questionnaire Administration|Other: Survey Administration|Other: Video","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04479696"
1167,"Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme","Terminated","No Results Available","Brain and Central Nervous System Tumors","Drug: boron phenylalanine|Drug: mannitol|Other: biologic sample preservation procedure|Radiation: radiation therapy treatment planning/simulation","Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham, England, United Kingdom|Cancer Research UK Clinical Trials Unit - Birmingham, Birmingham, England, United Kingdom","https://ClinicalTrials.gov/show/NCT01233492"
1168,"Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma","Completed","No Results Available","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma","Drug: arsenic trioxide|Radiation: radiation therapy","New Approaches to Brain Tumor Therapy Consortium, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00045565"
1169,"Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma","Recruiting","No Results Available","Glioblastoma|WHO Grade II Glioma|WHO Grade III Glioma","Radiation: Intensity-Modulated Radiation Therapy|Other: Quality-of-Life","Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT03251027"
1170,"A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511","Terminated","No Results Available","Glioblastoma Multiforme|Astrocytoma|Gliomas, Malignant","Biological: Toca 511 vector|Drug: Toca FC • Flucytosine • 5-FC • 5-Fluorocytosine","University of California, Los Angeles, Los Angeles, California, United States|UCSD, San Diego, California, United States|UCSF, San Francisco, California, United States|Henry Ford Health System, Detroit, Michigan, United States|JFK Medical Center Neuroscience Institute, Edison, New Jersey, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|John Theurer Cancer Center at Hackensack University, Hackensack, New Jersey, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University, Columbus, Ohio, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Swedish Neuroscience Institute, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT04327011"
1171,"Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","Completed","Has Results","Malignant Neoplasms of Brain","Biological: PEP-3 vaccine|Biological: sargramostim|Drug: Temozolomide","Duke University Medical Center, Durham, North Carolina, United States|M. D. Anderson Cancer Center at University of Texas, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00643097"
1172,"Standard Radiation Therapy, Higher-Dose Radiation Therapy, or Chemotherapy in Treating Older Patients With Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: temozolomide|Radiation: hypofractionated radiation therapy|Radiation: radiation therapy","Centre Leon Berard, Lyon, France","https://ClinicalTrials.gov/show/NCT00820963"
1173,"Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas","Completed","Has Results","Brain Tumor|Glioblastoma|Anaplastic Glioma","Drug: everolimus|Drug: sorafenib","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT01434602"
1174,"Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma","Completed","Has Results","Advanced Cancers|Lymphoma","Drug: Azacitidine|Drug: Vorinostat|Drug: Gemcitabine|Drug: Busulfan|Drug: Melphalan|Drug: Dexamethasone|Other: Caphosol|Drug: Glutamine|Drug: Pyridoxine|Drug: Rituximab","University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01983969"
1175,"Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors","Active, not recruiting","Has Results","Giant Cell Glioblastoma|Glioblastoma|Gliosarcoma|Oligodendroglioma|Recurrent Brain Neoplasm|Recurrent Glioblastoma","Biological: Bevacizumab|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Other: Placebo Administration|Biological: Trebananib","Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States|Alaska Women's Cancer Care, Anchorage, Alaska, United States|Anchorage Oncology Centre, Anchorage, Alaska, United States|Katmai Oncology Group, Anchorage, Alaska, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Arizona Oncology-Deer Valley Center, Phoenix, Arizona, United States|Arizona Oncology Services Foundation, Scottsdale, Arizona, United States|Arizona Oncology Associates-West Orange Grove, Tucson, Arizona, United States|Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States|Mills-Peninsula Medical Center, Burlingame, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|Los Angeles County-USC Medical Center, Los Angeles, California, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States|Sutter Cancer Research Consortium, Novato, California, United States|Saint Joseph Hospital - Orange, Orange, California, United States|UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States|California Pacific Medical Center-Pacific Campus, San Francisco, California, United States|Sutter Solano Medical Center/Cancer Center, Vallejo, California, United States|Poudre Valley Hospital, Fort Collins, Colorado, United States|Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States|The Hospital of Central Connecticut, New Britain, Connecticut, United States|Eastern Connecticut Hematology and Oncology Associates, Norwich, Connecticut, United States|William Backus Hospital, Norwich, Connecticut, United States|Broward Health Medical Center, Fort Lauderdale, Florida, United States|Piedmont Hospital, Atlanta, Georgia, United States|Piedmont Fayette Hospital, Fayetteville, Georgia, United States|Northeast Georgia Medical Center-Gainesville, Gainesville, Georgia, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States|Rush - Copley Medical Center, Aurora, Illinois, United States|Northwestern University, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Carle on Vermilion, Danville, Illinois, United States|Heartland Cancer Research NCORP, Decatur, Illinois, United States|Carle Physician Group-Effingham, Effingham, Illinois, United States|NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, United States|NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois, United States|Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, United States|Carle Cancer Institute Normal, Normal, Illinois, United States|OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center, Pekin, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|OSF Saint Francis Radiation Oncology at Peoria Cancer Center, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|The Carle Foundation Hospital, Urbana, Illinois, United States|Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States|Rush-Copley Healthcare Center, Yorkville, Illinois, United States|Menorah Medical Center, Overland Park, Kansas, United States|Saint Luke's South Hospital, Overland Park, Kansas, United States|Kansas City NCI Community Oncology Research Program, Prairie Village, Kansas, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|Maine Medical Center- Scarborough Campus, Scarborough, Maine, United States|Michigan Cancer Research Consortium NCORP, Ann Arbor, Michigan, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|Beaumont Hospital - Dearborn, Dearborn, Michigan, United States|Ascension Saint John Hospital, Detroit, Michigan, United States|Green Bay Oncology - Escanaba, Escanaba, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Green Bay Oncology - Iron Mountain, Iron Mountain, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Borgess Medical Center, Kalamazoo, Michigan, United States|Sparrow Hospital, Lansing, Michigan, United States|Saint Mary Mercy Hospital, Livonia, Michigan, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, United States|Lake Huron Medical Center, Port Huron, Michigan, United States|William Beaumont Hospital-Royal Oak, Royal Oak, Michigan, United States|Ascension Saint Mary's Hospital, Saginaw, Michigan, United States|William Beaumont Hospital - Troy, Troy, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Unity Hospital, Fridley, Minnesota, United States|Hutchinson Area Health Care, Hutchinson, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|Health Partners Inc, Minneapolis, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Rice Memorial Hospital, Willmar, Minnesota, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Singing River Hospital, Pascagoula, Mississippi, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, United States|Centerpoint Medical Center LLC, Independence, Missouri, United States|Freeman Health System, Joplin, Missouri, United States|Mercy Hospital Joplin, Joplin, Missouri, United States|Saint Luke's Hospital of Kansas City, Kansas City, Missouri, United States|North Kansas City Hospital, Kansas City, Missouri, United States|Heartland Hematology and Oncology Associates Incorporated, Kansas City, Missouri, United States|Research Medical Center, Kansas City, Missouri, United States|Saint Luke's East - Lee's Summit, Lee's Summit, Missouri, United States|Liberty Radiation Oncology Center, Liberty, Missouri, United States|Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, United States|Saint Joseph Oncology Inc, Saint Joseph, Missouri, United States|Saint Louis Cancer and Breast Institute-South City, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Cancer Research for the Ozarks NCORP, Springfield, Missouri, United States|Mercy Hospital Springfield, Springfield, Missouri, United States|CoxHealth South Hospital, Springfield, Missouri, United States|Nebraska Methodist Hospital, Omaha, Nebraska, United States|New York Oncology Hematology PC - Albany, Albany, New York, United States|New York Oncology Hematology PC - Albany Medical Center, Albany, New York, United States|Hematology Oncology Associates of Central New York-Auburn, Auburn, New York, United States|Montefiore Medical Center - Moses Campus, Bronx, New York, United States|Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse, New York, United States|Hematology Oncology Associates of Central New York-Liverpool, Liverpool, New York, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Hematology Oncology Associates of Central New York-Rome, Rome, New York, United States|Hematology Oncology Associates of Central New York-Onondaga Hill, Syracuse, New York, United States|Mission Hospital, Asheville, North Carolina, United States|Mountain Radiation Oncology PA, Asheville, North Carolina, United States|AdventHealth Infusion Center Asheville, Asheville, North Carolina, United States|Messino Cancer Centers, Asheville, North Carolina, United States|AdventHealth Hendersonville, Hendersonville, North Carolina, United States|Rutherford Hospital, Rutherfordton, North Carolina, United States|Southeast Clinical Oncology Research Consortium NCORP, Winston-Salem, North Carolina, United States|Summa Health System - Akron Campus, Akron, Ohio, United States|Cleveland Clinic Akron General, Akron, Ohio, United States|Summa Health System - Barberton Campus, Barberton, Ohio, United States|Strecker Cancer Center-Belpre, Belpre, Ohio, United States|Adena Regional Medical Center, Chillicothe, Ohio, United States|University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio, United States|Columbus Oncology and Hematology Associates Inc, Columbus, Ohio, United States|Riverside Methodist Hospital, Columbus, Ohio, United States|Columbus NCI Community Oncology Research Program, Columbus, Ohio, United States|Grant Medical Center, Columbus, Ohio, United States|The Mark H Zangmeister Center, Columbus, Ohio, United States|Mount Carmel Health Center West, Columbus, Ohio, United States|Doctors Hospital, Columbus, Ohio, United States|Delaware Health Center-Grady Cancer Center, Delaware, Ohio, United States|Delaware Radiation Oncology, Delaware, Ohio, United States|Grady Memorial Hospital, Delaware, Ohio, United States|Fairfield Medical Center, Lancaster, Ohio, United States|Lancaster Radiation Oncology, Lancaster, Ohio, United States|Marietta Memorial Hospital, Marietta, Ohio, United States|Summa Health Medina Medical Center, Medina, Ohio, United States|Knox Community Hospital, Mount Vernon, Ohio, United States|Licking Memorial Hospital, Newark, Ohio, United States|Newark Radiation Oncology, Newark, Ohio, United States|Southern Ohio Medical Center, Portsmouth, Ohio, United States|University Hospitals Portage Medical Center, Ravenna, Ohio, United States|Springfield Regional Medical Center, Springfield, Ohio, United States|University of Cincinnati Cancer Center-West Chester, West Chester, Ohio, United States|Saint Ann's Hospital, Westerville, Ohio, United States|Genesis Healthcare System Cancer Care Center, Zanesville, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Natalie Warren Bryant Cancer Center at Saint Francis, Tulsa, Oklahoma, United States|Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa, Oklahoma, United States|Warren Clinic Oncology-Tulsa, Tulsa, Oklahoma, United States|Clackamas Radiation Oncology Center, Clackamas, Oregon, United States|Willamette Valley Cancer Center, Eugene, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|UPMC-Heritage Valley Health System Beaver, Beaver, Pennsylvania, United States|Saint Luke's University Hospital-Bethlehem Campus, Bethlehem, Pennsylvania, United States|Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, United States|UPMC Cancer Center at UPMC Horizon, Farrell, Pennsylvania, United States|Adams Cancer Center, Gettysburg, Pennsylvania, United States|UPMC Cancer Centers - Arnold Palmer Pavilion, Greensburg, Pennsylvania, United States|Cherry Tree Cancer Center, Hanover, Pennsylvania, United States|UPMC-Johnstown/John P. Murtha Regional Cancer Center, Johnstown, Pennsylvania, United States|Lancaster General Hospital, Lancaster, Pennsylvania, United States|UPMC Cancer Center at UPMC McKeesport, McKeesport, Pennsylvania, United States|UPMC Cancer Center-Natrona Heights, Natrona Heights, Pennsylvania, United States|UPMC Jameson, New Castle, Pennsylvania, United States|Paoli Memorial Hospital, Paoli, Pennsylvania, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|UPMC-Presbyterian Hospital, Pittsburgh, Pennsylvania, United States|UPMC-Saint Margaret, Pittsburgh, Pennsylvania, United States|UPMC-Shadyside Hospital, Pittsburgh, Pennsylvania, United States|UPMC Jefferson Regional Radiation Oncology, Pittsburgh, Pennsylvania, United States|UPMC-Passavant Hospital, Pittsburgh, Pennsylvania, United States|UPMC-Saint Clair Hospital Cancer Center, Pittsburgh, Pennsylvania, United States|UPMC Cancer Center at UPMC Northwest, Seneca, Pennsylvania, United States|UPMC Uniontown Hospital Radiation Oncology, Uniontown, Pennsylvania, United States|UPMC Washington Hospital Radiation Oncology, Washington, Pennsylvania, United States|Reading Hospital, West Reading, Pennsylvania, United States|Lankenau Medical Center, Wynnewood, Pennsylvania, United States|Main Line Health NCORP, Wynnewood, Pennsylvania, United States|WellSpan Health-York Hospital, York, Pennsylvania, United States|AnMed Health Cancer Center, Anderson, South Carolina, United States|Gibbs Cancer Center-Pelham, Greer, South Carolina, United States|Spartanburg Medical Center, Spartanburg, South Carolina, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Texas Oncology-Austin Midtown, Austin, Texas, United States|Texas Oncology - Central Austin Cancer Center, Austin, Texas, United States|Texas Oncology - South Austin Cancer Center, Austin, Texas, United States|Texas Oncology Bedford, Bedford, Texas, United States|Texas Oncology at Baylor Charles A Sammons Cancer Center, Dallas, Texas, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|Texas Oncology - Fort Worth Cancer Center, Fort Worth, Texas, United States|Texas Oncology-Grapevine, Grapevine, Texas, United States|Texas Oncology-Longview Cancer Center, Longview, Texas, United States|Texas Oncology-Seton Williamson, Round Rock, Texas, United States|Texas Oncology - Round Rock Cancer Center, Round Rock, Texas, United States|Texas Oncology Cancer Center Sugar Land, Sugar Land, Texas, United States|Tyler Cancer Center, Tyler, Texas, United States|American Fork Hospital / Huntsman Intermountain Cancer Center, American Fork, Utah, United States|Sandra L Maxwell Cancer Center, Cedar City, Utah, United States|Logan Regional Hospital, Logan, Utah, United States|Intermountain Medical Center, Murray, Utah, United States|McKay-Dee Hospital Center, Ogden, Utah, United States|Utah Valley Regional Medical Center, Provo, Utah, United States|Dixie Medical Center Regional Cancer Center, Saint George, Utah, United States|Utah Cancer Specialists-Salt Lake City, Salt Lake City, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|Cancer Care Northwest - Spokane South, Spokane, Washington, United States|Cancer Care Northwest-North Spokane, Spokane, Washington, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, United States|Compass Oncology Vancouver, Vancouver, Washington, United States|Langlade Hospital and Cancer Center, Antigo, Wisconsin, United States|Green Bay Oncology at Saint Vincent Hospital, Green Bay, Wisconsin, United States|Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States|Green Bay Oncology Limited at Saint Mary's Hospital, Green Bay, Wisconsin, United States|Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Holy Family Memorial Hospital, Manitowoc, Wisconsin, United States|Bay Area Medical Center, Marinette, Wisconsin, United States|Froedtert Menomonee Falls Hospital, Menomonee Falls, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin, United States|ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States|Saint Vincent Hospital Cancer Center at Oconto Falls, Oconto Falls, Wisconsin, United States|Saint Vincent Hospital Cancer Center at Sturgeon Bay, Sturgeon Bay, Wisconsin, United States|Green Bay Oncology - Sturgeon Bay, Sturgeon Bay, Wisconsin, United States|ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States|Aspirus Regional Cancer Center, Wausau, Wisconsin, United States|Allan Blair Cancer Centre, Regina, Saskatchewan, Canada","https://ClinicalTrials.gov/show/NCT01609790"
1176,"FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy","Unknown status","No Results Available","Glioblastoma Multiforme|Anaplastic Astrocytoma|Radiotherapy",,"CHRU de Brest, Brest, France","https://ClinicalTrials.gov/show/NCT03370926"
1177,"Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)","Completed","Has Results","Glioblastoma|Glioma|Astrocytoma","Drug: Temozolomide|Radiation: Radiotherapy",,"https://ClinicalTrials.gov/show/NCT00723827"
1178,"ANG1005 in Patients With Recurrent High-Grade Glioma","Completed","No Results Available","Glioma|Glioblastoma|Brain Tumor, Recurrent","Drug: ANG1005|Drug: Bevacizumab","Moores UC San Diego Cancer Center, La Jolla, California, United States|Northwestern University, Chicago, Illinois, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Norris Cotton Cancer Center, Lebanon, New Hampshire, United States|Cleveland Clinic, Cleveland, Ohio, United States|UPMC Cancer Center, Pittsburgh, Pennsylvania, United States|Univeristy of Texas Health Science Center in San Antonio, San Antonio, Texas, United States|Emily Couric Clinical Cancer Center, Charlottesville, Virginia, United States|Seattle Cancer Care Alliance, Seattle, Washington, United States|University of Washington Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT01967810"
1179,"LITT Followed by Hypofractionated RT for Recurrent Gliomas","Recruiting","No Results Available","Glioblastoma|Brain Tumor|Glioma|Neoplasms","Device: Procedure: LITT|Radiation: Hypo-Fractionated Radiation Therapy","University of Maryland Greenebaum Cancer Center, Baltimore, Maryland, United States|UCH Kaufman Cancer Center, Bel Air, Maryland, United States|Central Maryland Radiation Oncology, Columbia, Maryland, United States|Baltimore Washington Medical Center, Glen Burnie, Maryland, United States","https://ClinicalTrials.gov/show/NCT04181684"
1180,"Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)","Completed","No Results Available","Recurrence of Solid Tumor|Glioblastoma Multiforme|Melanoma","Drug: MK-4827|Drug: Temozolomide",,"https://ClinicalTrials.gov/show/NCT01294735"
1181,"A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer","Recruiting","No Results Available","Solid Tumor|Glioblastoma|Non-small Cell Lung Cancer|Breast Cancer","Drug: TAS2940","Tennessee Oncology, Nashville, Tennessee, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, United States|CLCC Gustave Roussy, Villejuif, Cedex, France","https://ClinicalTrials.gov/show/NCT04982926"
1182,"IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma","Completed","No Results Available","Glioblastoma Multiforme|Anaplastic Astrocytoma|Oligoastrocytoma","Drug: IL13-PE38QQR|Procedure: Surgery for placement|Procedure: Radiation therapy|Drug: Temozolomide with radiation therapy","University of California San Francisco - Dept. of Neurological Surgery, San Francisco, California, United States|Carolina Neurosurgery & Spine Assoc., Charlotte, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|Cleveland Clinic Foundation Department of Neurological Surgery, Cleveland, Ohio, United States|University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States|University of Virginia Health Systems - Department of Neurological Surgery, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT00089427"
1183,"Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients","Completed","Has Results","Recurrent Glioblastoma Multiforme|Malignant Glioma|Adult Brain Tumor","Drug: Vorinostat|Drug: Bevacizumab","Duke Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01738646"
1184,"The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas","Terminated","No Results Available","Anaplastic Astrocytoma|Glioblastoma Multiforme|Tumor Angiogenesis","Device: Functional MRI (DCE-MRI)|Procedure: Blood sample|Procedure: Tumor sample","Dept. of Oncology & Dept. of Radiology, Haukeland University Hospital, Bergen, Norway, Hordaland, Norway","https://ClinicalTrials.gov/show/NCT00473408"
1185,"Phosphorus 32 in Treating Patients With Glioblastoma Multiforme","Unknown status","No Results Available","Brain and Central Nervous System Tumors","Radiation: brachytherapy|Radiation: phosphorus P32","Center for Molecular Medicine, Garden City, New York, United States","https://ClinicalTrials.gov/show/NCT00004129"
1186,"WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases","Recruiting","No Results Available","Anaplastic Astrocytoma, IDH-Wildtype|Glioblastoma, IDH-Wildtype|Lung Non-Small Cell Carcinoma|Metastatic Malignant Neoplasm in the Central Nervous System|Metastatic Malignant Neoplasm in the Leptomeninges","Drug: EGFR/EGFRvIII Inhibitor WSD0922-FU|Procedure: Therapeutic Conventional Surgery","Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT04197934"
1187,"Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery","Completed","No Results Available","Malignant Neoplasms of Brain","Biological: PEP-3-KLH conjugate vaccine|Biological: daclizumab|Drug: temozolomide|Other: placebo|Biological: PEP-3-KLH","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00626015"
1188,"Individual Patient Compassionate Use of GX-I7","Available","No Results Available","Glioblastoma|High Grade Glioma|Recurrent Glioblastoma|Melanoma|Advanced Cancer","Drug: GX-I7","Kangnam St. Mary's Hospital, Seoul, Korea, Republic of","https://ClinicalTrials.gov/show/NCT04289155"
1189,"A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma","Unknown status","No Results Available","Malignant Glioma|Glioblastoma Multiforme|GBM|Astrocytoma|Oligodendroglioma","Drug: 131I-TM601","University of Chicago, Chicago, Illinois, United States|Johns Hopkins University, Baltimore, Maryland, United States|St. Mary's Health Care, Grand Rapids, Michigan, United States|University of Virginia, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT00683761"
1190,"Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma","Unknown status","No Results Available","Malignant Glioma|Glioblastoma Multiforme|GBM|Astrocytoma|Oligodendroglioma","Drug: TM-601","University of Alabama, Birmingham, Alabama, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|Northwestern University, Chicago, Illinois, United States|Washington University, St. Louis, Missouri, United States|Columbia University, New York, New York, United States|Wake Forest University, Winston-Salem, North Carolina, United States|University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00591058"
1191,"Phase I Newly Diagnosed GBM With Temozolomide, Radiation, and Minocycline Followed by Adjuvant Minocycline/Temozolomide (D-TERMINED)","Completed","No Results Available","Newly Diagnosed High Grade Glioma","Drug: Minocycline with chemoradiation (temozolomide and radiation therapy)","Huntsman Cancer Institute, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT02272270"
1192,"Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)","Completed","No Results Available","High-grade Glioma|Astrocytoma|Glioblastoma","Radiation: 18F Fluorothymidine PET CT","Hôpital St André, CHU de Bordeaux, Bordeaux, France|Hôpital Pellegrin-tripode , CHU de Bordeaux, Bordeaux, France","https://ClinicalTrials.gov/show/NCT00624728"
1193,"Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2","Suspended","No Results Available","Breast Cancer|Non-Small-Cell Lung Cancer|Glioblastoma|Other Cancers","Drug: FPPRGD2","Stanford University School of Medicine, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT01383135"
1194,"Re-irradiation of High Grade Gliomas: a Quality of Life Study","Withdrawn","No Results Available","Anaplastic Astrocytoma|Glioblastoma Multiforme|Anaplastic Oligoastrocytoma","Other: EORTC QLQ-C30|Other: EORTC QLQ-BN20|Other: Hopkins Verbal Learning Test-Revised (HVLT-R)|Other: Stroop color-word test|Other: Controlled oral word association test (COWA)|Other: Jamar hand dynamometer|Other: EORTC QLQ- FA13|Other: Trail Making Test (TMT)","Maastricht Radiation Oncology, Maastricht, Netherlands","https://ClinicalTrials.gov/show/NCT01711580"
1195,"Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases","Completed","No Results Available","Adult Anaplastic Astrocytoma|Adult Anaplastic Ependymoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Recurrent Adult Brain Tumor|Tumors Metastatic to Brain|Adult Anaplastic Oligoastrocytoma","Drug: bafetinib|Procedure: microdialysis|Other: pharmacological study|Other: liquid chromatography|Other: mass spectrometry|Other: laboratory biomarker analysis|Genetic: protein expression analysis|Genetic: western blotting|Other: immunohistochemistry staining method|Procedure: therapeutic conventional surgery","City of Hope Medical Center, Duarte, California, United States|South Pasadena Cancer Center, South Pasadena, California, United States","https://ClinicalTrials.gov/show/NCT01234740"
1196,"Comparison of Hypertonic Saline and Mannitol on Brain Relaxation During Supratentorial Tumors Resection","Not yet recruiting","No Results Available","Brain Tumor - Metastatic|Brain Tumor, Adult: Glioblastoma","Drug: %3 HS bolus|Drug: %3 HS infusion 20 ml/h|Drug: 20% mannitol",,"https://ClinicalTrials.gov/show/NCT04314674"
1197,"Establishment of a Brain and Spinal Tumor Tissue Bank","Unknown status","No Results Available","Glioblastoma Multiforme|Glioma|Neuroectodermal Tumors",,"Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan","https://ClinicalTrials.gov/show/NCT00686387"
1198,"The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function","Completed","No Results Available","Colorectal Cancer|Lung Cancer|Breast Cancer|Glioblastoma",,"Cedars-Sinai Medical Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT00973557"
1199,"Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas","Completed","No Results Available","Glioblastoma|Gliosarcoma|Anaplastic Astrocytoma","Drug: Oral Topotecan and Temodar","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00610571"
1200,"Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET)","Recruiting","No Results Available","Advanced / Metastic Solid Tumors|Glioblastoma|Chronic Leukemia Lymphocytic","Biological: Blood and tumor samples","HOPITAL Pierre WERTHEIMER - HCL, Bron, France|Centre Léon Bérard, Lyon, France","https://ClinicalTrials.gov/show/NCT05099068"
1201,"LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)","Recruiting","No Results Available","Glioma|Glioblastoma|Brain Tumor","Procedure: LITT|Radiation: Hypofractionated Radiation Therapy","Maryland Proton Treatment Center, Baltimore, Maryland, United States|University of Maryland Greenebaum Cancer Center, Baltimore, Maryland, United States|UCH Kaufman Cancer Center, Bel Air, Maryland, United States|Central Maryland Radiation Oncology, Columbia, Maryland, United States|Baltimore Washington Medical Center, Glen Burnie, Maryland, United States","https://ClinicalTrials.gov/show/NCT04699773"
1202,"PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas","Completed","No Results Available","Gliosarcoma|Glioblastoma|Anaplastic Astrocytoma","Drug: Temodar and SCH 66336","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00612651"
1203,"AMG 595 First-in-Human in Recurrent Gliomas","Completed","No Results Available","Advanced Malignant Glioma|Anaplastic Astrocytomas|Glioblastoma Multiforme","Drug: AMG 595","Research Site, Los Angeles, California, United States|Research Site, Boston, Massachusetts, United States|Research Site, Cincinnati, Ohio, United States|Research Site, Parkville, Victoria, Australia","https://ClinicalTrials.gov/show/NCT01475006"
1204,"Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations","Active, not recruiting","No Results Available","Anaplastic Astrocytoma|Glioblastoma|Malignant Glioma","Radiation: Radiation Therapy|Drug: Temozolomide|Drug: Veliparib","Children's Hospital of Alabama, Birmingham, Alabama, United States|USA Health Strada Patient Care Center, Mobile, Alabama, United States|Banner Children's at Desert, Mesa, Arizona, United States|Phoenix Childrens Hospital, Phoenix, Arizona, United States|Arkansas Children's Hospital, Little Rock, Arkansas, United States|Kaiser Permanente Downey Medical Center, Downey, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Miller Children's and Women's Hospital Long Beach, Long Beach, California, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|Mattel Children's Hospital UCLA, Los Angeles, California, United States|Valley Children's Hospital, Madera, California, United States|UCSF Benioff Children's Hospital Oakland, Oakland, California, United States|Kaiser Permanente-Oakland, Oakland, California, United States|Children's Hospital of Orange County, Orange, California, United States|Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|Yale University, New Haven, Connecticut, United States|Alfred I duPont Hospital for Children, Wilmington, Delaware, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Children's National Medical Center, Washington, District of Columbia, United States|Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida, United States|Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States|Nemours Children's Clinic-Jacksonville, Jacksonville, Florida, United States|University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States|Nicklaus Children's Hospital, Miami, Florida, United States|AdventHealth Orlando, Orlando, Florida, United States|Arnold Palmer Hospital for Children, Orlando, Florida, United States|Nemours Children's Hospital, Orlando, Florida, United States|Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa, Florida, United States|Saint Mary's Hospital, West Palm Beach, Florida, United States|Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, United States|Memorial Health University Medical Center, Savannah, Georgia, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, United States|University of Illinois, Chicago, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Saint Jude Midwest Affiliate, Peoria, Illinois, United States|Riley Hospital for Children, Indianapolis, Indiana, United States|Saint Vincent Hospital and Health Care Center, Indianapolis, Indiana, United States|Blank Children's Hospital, Des Moines, Iowa, United States|University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|Norton Children's Hospital, Louisville, Kentucky, United States|Children's Hospital New Orleans, New Orleans, Louisiana, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|Eastern Maine Medical Center, Bangor, Maine, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|UMass Memorial Medical Center - University Campus, Worcester, Massachusetts, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States|Ascension Saint John Hospital, Detroit, Michigan, United States|Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|Beaumont Children's Hospital-Royal Oak, Royal Oak, Michigan, United States|Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis, Minnesota, United States|University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States|Cardinal Glennon Children's Medical Center, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Children's Hospital and Medical Center of Omaha, Omaha, Nebraska, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|Sunrise Hospital and Medical Center, Las Vegas, Nevada, United States|Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, United States|Renown Regional Medical Center, Reno, Nevada, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Morristown Medical Center, Morristown, New Jersey, United States|Saint Peter's University Hospital, New Brunswick, New Jersey, United States|Albany Medical Center, Albany, New York, United States|Montefiore Medical Center - Moses Campus, Bronx, New York, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|University of Rochester, Rochester, New York, United States|State University of New York Upstate Medical University, Syracuse, New York, United States|New York Medical College, Valhalla, New York, United States|Mission Hospital, Asheville, North Carolina, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States|Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Children's Hospital Medical Center of Akron, Akron, Ohio, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Rainbow Babies and Childrens Hospital, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Dayton Children's Hospital, Dayton, Ohio, United States|ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Legacy Emanuel Children's Hospital, Portland, Oregon, United States|Oregon Health and Science University, Portland, Oregon, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Prisma Health Richland Hospital, Columbia, South Carolina, United States|BI-LO Charities Children's Cancer Center, Greenville, South Carolina, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|T C Thompson Children's Hospital, Chattanooga, Tennessee, United States|East Tennessee Childrens Hospital, Knoxville, Tennessee, United States|Saint Jude Children's Research Hospital, Memphis, Tennessee, United States|The Children's Hospital at TriStar Centennial, Nashville, Tennessee, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States|Dell Children's Medical Center of Central Texas, Austin, Texas, United States|Driscoll Children's Hospital, Corpus Christi, Texas, United States|Medical City Dallas Hospital, Dallas, Texas, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|Cook Children's Medical Center, Fort Worth, Texas, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States|M D Anderson Cancer Center, Houston, Texas, United States|Children's Hospital of San Antonio, San Antonio, Texas, United States|Methodist Children's Hospital of South Texas, San Antonio, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Scott and White Memorial Hospital, Temple, Texas, United States|Primary Children's Hospital, Salt Lake City, Utah, United States|Children's Hospital of The King's Daughters, Norfolk, Virginia, United States|Naval Medical Center - Portsmouth, Portsmouth, Virginia, United States|Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States|Seattle Children's Hospital, Seattle, Washington, United States|Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington, United States|Mary Bridge Children's Hospital and Health Center, Tacoma, Washington, United States|Madigan Army Medical Center, Tacoma, Washington, United States|West Virginia University Healthcare, Morgantown, West Virginia, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States|John Hunter Children's Hospital, Hunter Regional Mail Centre, New South Wales, Australia|Sydney Children's Hospital, Randwick, New South Wales, Australia|The Children's Hospital at Westmead, Westmead, New South Wales, Australia|Queensland Children's Hospital, South Brisbane, Queensland, Australia|Monash Medical Center-Clayton Campus, Clayton, Victoria, Australia|Royal Children's Hospital, Parkville, Victoria, Australia|Perth Children's Hospital, Perth, Western Australia, Australia|Alberta Children's Hospital, Calgary, Alberta, Canada|British Columbia Children's Hospital, Vancouver, British Columbia, Canada|Janeway Child Health Centre, Saint John's, Newfoundland and Labrador, Canada|IWK Health Centre, Halifax, Nova Scotia, Canada|McMaster Children's Hospital at Hamilton Health Sciences, Hamilton, Ontario, Canada|The Montreal Children's Hospital of the MUHC, Montreal, Quebec, Canada|Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada|Centre Hospitalier Universitaire de Quebec, Quebec, Canada|Starship Children's Hospital, Grafton, Auckland, New Zealand|Christchurch Hospital, Christchurch, New Zealand|HIMA San Pablo Oncologic Hospital, Caguas, Puerto Rico","https://ClinicalTrials.gov/show/NCT03581292"
1205,"Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma","Completed","No Results Available","Glioma|High Grade Astrocytoma|Glioblastoma Multiforme","Biological: Cancer vaccine plus immune adjuvant, plus activated white blood cells","Saint Luke's Hospital, Kansas City, Missouri, United States","https://ClinicalTrials.gov/show/NCT01081223"
1206,"Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: arsenic trioxide|Drug: temozolomide|Procedure: adjuvant therapy|Radiation: intensity-modulated radiation therapy|Radiation: radiation therapy","City of Hope Comprehensive Cancer Center, Duarte, California, United States","https://ClinicalTrials.gov/show/NCT00720564"
1207,"Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients","Unknown status","No Results Available","Glioblastoma|Nervous System Neoplasms|Central Nervous System Neoplasms|Astrocytoma|Glioma|Neoplasms, Neuroepithelial|Neuroectodermal Tumors|Neoplasms by Histologic Type|Neoplasms, Nerve Tissue",,"University of Munich, Dep. of Radiation Oncology, Munich, Bavaria, Germany","https://ClinicalTrials.gov/show/NCT01579253"
1208,"Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001","Active, not recruiting","No Results Available","High Grade Glioma|Astrocytoma, Grade III|Glioblastoma","Drug: BMX-001|Radiation: Radiation Therapy|Drug: Temozolomide","University of Alabama- Birmingham, Birmingham, Alabama, United States|University of California San Francisco, San Francisco, California, United States|University of Kentucky, Lexington, Kentucky, United States|St. Luke's Hospital, Kansas City, Missouri, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Duke Cancer Institute, Durham, North Carolina, United States|Ohio State University, Columbus, Ohio, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States|University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT02655601"
1209,"A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas","Recruiting","No Results Available","Anaplastic Oligoastrocytoma|Anaplastic Astrocytoma|Glioblastoma","Drug: β-elemene","Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China","https://ClinicalTrials.gov/show/NCT02629757"
1210,"Nivolumab With DC Vaccines for Recurrent Brain Tumors","Completed","Has Results","Malignant Glioma|Astrocytoma|Glioblastoma","Drug: nivolumab|Biological: DC","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT02529072"
1211,"Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma","Completed","Has Results","Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Neoplasm","Drug: Bendamustine Hydrochloride|Other: Quality-of-Life Assessment","Northwestern University, Chicago, Illinois, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00823797"
1212,"A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas","Unknown status","No Results Available","Anaplastic Oligoastrocytoma|Anaplastic Astrocytoma|Glioblastoma","Drug: Temozolomide|Drug: α-IFN","Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China","https://ClinicalTrials.gov/show/NCT01765088"
1213,"Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma","Completed","No Results Available","Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Recurrent Adult Brain Tumor","Drug: ziv-aflibercept|Procedure: radiation therapy|Drug: temozolomide|Procedure: pharmacological study|Procedure: laboratory biomarker analysis","University of California at Los Angeles (UCLA ), Los Angeles, California, United States|UCSF-Mount Zion, San Francisco, California, United States|University of California San Francisco Medical Center-Parnassus, San Francisco, California, United States|Adult Brain Tumor Consortium, Baltimore, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Massachusetts General Hospital, Charlestown, Massachusetts, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00650923"
1214,"Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED)","Completed","No Results Available","Malignant Glioma|Glioblastoma|Gliosarcoma","Drug: AP23573","Center For Neuro-Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, United States|The Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina, United States|Brain Tumor Institute, The Cleveland Clinic, Cleveland, Ohio, United States|M.D. Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00087451"
1215,"BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab","Completed","No Results Available","Gliosarcoma|Recurrent Glioblastoma|Astrocytoma of Brain|Glioblastoma","Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Ubidecarenone Injectable Nanosuspension","Stanford University, School of Medicine, Palo Alto, California, United States","https://ClinicalTrials.gov/show/NCT03020602"
1216,"Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas","Completed","No Results Available","Malignant Glioma|Glioblastoma Multiforme|Anaplastic Astrocytoma","Biological: AdV-tk|Drug: Valacyclovir","The Ohio State University Medical Center, Dept Neurosurgery, Columbus, Ohio, United States|The Methodist Hosptial, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00751270"
1217,"Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer","Completed","No Results Available","Glioma|Astrocytoma|Glioblastoma","Drug: G207, an oncolytic virus",,"https://ClinicalTrials.gov/show/NCT00028158"
1218,"Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma (BrTK02)","Completed","No Results Available","Malignant Glioma|Glioblastoma Multiforme|Anaplastic Astrocytoma","Biological: AdV-tk|Drug: Valacyclovir","City of Hope Medical Center, Duarte, California, United States|The University of Chicago, Chicago, Illinois, United States|The Ohio State University Medical Center, Dept. Neurological Surgery, Columbus, Ohio, United States|The Methodist Hospital Neurological Institute, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00589875"
1219,"Memory Perception Assessment in Central/Non-central Nervous System Cancers","Recruiting","No Results Available","Glioblastoma|Glioma|Breast Cancer|Healthy","Other: QMRP questionnaire","Icm Val D'Aurelle, Montpellier, Herault, France|CHU D'amiens, Amiens, Nord, France|UFR de Psychologie Université de Lille, Villeneuve-d'Ascq, Nord, France|Hôpital d'Instruction des Armées, Clamart, France|Hopital saint Louis, Paris, France|CHU Lyon, Saint-Genis-Laval, France","https://ClinicalTrials.gov/show/NCT03975959"
1220,"NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors","Recruiting","No Results Available","Hepatocellular Carcinoma|Glioblastoma|Medulloblastoma|Colon Cancer","Biological: NKG2D-based CAR T-cells","Xunyang Changchun Shihua Hospital, Jiujiang, Jiangxi, China","https://ClinicalTrials.gov/show/NCT05131763"
1221,"NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors","Withdrawn","No Results Available","Hepatocellular Carcinoma|Glioblastoma|Medulloblastoma|Colon Cancer","Biological: NKG2D-based CAR T-cells","Affiliated hospital of jiujiang university, Jiujiang, Jiangxi, China","https://ClinicalTrials.gov/show/NCT04270461"
1222,"Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma","Withdrawn","No Results Available","High Grade Malignant Neoplasm|Glioblastoma Multiforme|Anaplastic Astrocytoma","Other: fluorescein|Other: intraoperative MRI","University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States","https://ClinicalTrials.gov/show/NCT02540135"
1223,"Radiotherapy for Malignant Astrocytomas in the Elderly","Completed","No Results Available","Primary Brain Tumor|Anaplastic Astrocytoma|Glioblastoma Multiforme","Drug: Radiotherapy","Hôpital de la Salpêtrière, Paris, Ile de France, France","https://ClinicalTrials.gov/show/NCT00430911"
1224,"Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)","Unknown status","No Results Available","High Grade Glioma|Glioblastoma|Glioma of Brainstem|Glioma, Malignant","Combination Product: Combined immune adjuvants and radiation","Beijing Tiantan Hospital, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT03392545"
1225,"Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.","Recruiting","No Results Available","Glioblastoma Multiforme|Brain Neoplasms|Gastroesophageal Adenocarcinoma|Pancreatic Ductal Adenocarcinoma","Drug: 68Ga-FF58","Novartis Investigative Site, Lyon Cedex, France","https://ClinicalTrials.gov/show/NCT04712721"
1226,"Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR","Not yet recruiting","No Results Available","Brain Metastases|Cancer|Gliomas|Glioblastoma","Drug: F18 Fluciclovine|Other: Standard of Care","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT05054400"
1227,"An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)","Completed","No Results Available","Breast Cancer|Colorectal Cancer|Non-Small Cell Lung Cancer|Glioblastoma|Renal Cell Cancer",,"Many locations, Alabama, United States|Many locations, Alaska, United States|Many locations, Arizona, United States|Many locations, Arkansas, United States|Many locations, California, United States|Many locations, Colorado, United States|Many locations, Connecticut, United States|Many locations, Delaware, United States|Many locations, Florida, United States|Many locations, Georgia, United States|Many locations, Hawaii, United States|Many locations, Idaho, United States|Many locations, Illinois, United States|Many locations, Indiana, United States|Many locations, Iowa, United States|Many locations, Kansas, United States|Many locations, Kentucky, United States|Many locations, Louisiana, United States|Many locations, Maine, United States|Many locations, Maryland, United States|Many locations, Massachusetts, United States|Many locations, Michigan, United States|Many locations, Minnesota, United States|Many locations, Mississippi, United States|Many locations, Missouri, United States|Many locations, Montana, United States|Many locations, Nebraska, United States|Many locations, Nevada, United States|Many locations, New Hampshire, United States|Many locations, New Jersey, United States|Many locations, New Mexico, United States|Many locations, New York, United States|Many locations, North Carolina, United States|Many locations, North Dakota, United States|Many locations, Ohio, United States|Many locations, Oklahoma, United States|Many locations, Oregon, United States|Many locations, Pennsylvania, United States|Many locations, Rhode Island, United States|Many locations, South Carolina, United States|Many locations, South Dakota, United States|Many locations, Tennessee, United States|Many locations, Texas, United States|Many locations, Utah, United States|Many locations, Vermont, United States|Many locations, Virginia, United States|Many locations, Washington, United States|Many locations, West Virginia, United States|Many locations, Wisconsin, United States|Many locations, Wyoming, United States","https://ClinicalTrials.gov/show/NCT01598597"
1228,"Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: filgrastim|Biological: sargramostim|Drug: cyclophosphamide|Drug: thiotepa|Procedure: autologous bone marrow transplantation|Procedure: bone marrow ablation with stem cell support|Procedure: peripheral blood stem cell transplantation","St. Joseph's Hospital and Medical Center, Paterson, New Jersey, United States|Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00008008"
1229,"Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma","Recruiting","No Results Available","Grade III Astrocytoma|Grade IV Astrocytoma|Astrocytoma, Grade IV|Astrocytoma, Grade III","Drug: Tadalafil","Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT04757662"
1230,"Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor","Completed","No Results Available","Glioblastoma Multiforme|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Anaplastic Oligoastrocytoma","Biological: Toca 511|Drug: Toca FC","UC Irivine, Irvine, California, United States|UCLA, Los Angeles, California, United States|UC San Diego, Moores Cancer Center, San Diego, California, United States|Henry Ford Hospital, Detroit, Michigan, United States|JFK Medical Center New Jersery, Edison, New Jersey, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT01985256"
1231,"Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor","Completed","No Results Available","Glioblastoma Multiforme|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Anaplastic Oligoastrocytoma","Biological: Toca 511 vector|Drug: Toca FC","UCLA, Los Angeles, California, United States|University of California at San Diego, San Diego, California, United States|Henry Ford Hospital, Detroit, Michigan, United States|JFK Medical Center, Edison, New Jersey, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University, Columbus, Ohio, United States|Swedish Neuroscience Institute, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT01470794"
1232,"Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants","Not yet recruiting","No Results Available","Glioblastoma|Astrocytoma|Oligodendroglioma","Drug: OKN-007",,"https://ClinicalTrials.gov/show/NCT03649464"
1233,"Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma","Completed","No Results Available","Brain and Central Nervous System Tumors","Procedure: conventional surgery|Radiation: iodine I 131 monoclonal antibody TNT-1/B","Carolina Neurosurgery and Spine Associates, Charlotte, North Carolina, United States|Temple University, Philadelphia, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT00004017"
1234,"3D Prediction of Patient-Specific Response","Recruiting","No Results Available","Advanced Cancer|Ovarian Cancer|Glioblastoma Multiforme|Anaplastic Astrocytoma","Diagnostic Test: EV3D Assay","University of Arkansas for Medical Sciences, Winthrop P. Rockefeller Cancer Institute, Little Rock, Arkansas, United States|University of California, San Francisco, San Francisco, California, United States|Capital Health Institute for Neurosciences, Trenton, New Jersey, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Oregon Health & Science University, Portland, Oregon, United States|Veterans Administration Portland Health Care System, Portland, Oregon, United States|Penn State Health, Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Prisma Health, Greenville, South Carolina, United States|Inova Fairfax Hospital, Falls Church, Virginia, United States","https://ClinicalTrials.gov/show/NCT03561207"
1235,"A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors","Terminated","No Results Available","Malignant Glioma|Glioma|Glioblastoma|Glioblastoma Multiforme|Astrocytoma","Drug: Aminolevulinic Acid","MultiCare Health System Research Institute, Tacoma, Washington, United States","https://ClinicalTrials.gov/show/NCT01351519"
1236,"A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer","Withdrawn","No Results Available","Advanced Glioblastoma|Advanced Colorectal Cancer|Advanced Triple-negative Breast Cancer|Advanced Non-small Cell Lung Cancer","Drug: ONC201","Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT02038699"
1237,"Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme","Terminated","Has Results","Brain and Central Nervous System Tumors|Cerebral Edema","Drug: Boswellia serrata extract|Dietary Supplement: cyanocobalamin","Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00243022"
1238,"A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.","Withdrawn","No Results Available","Carcinoma, Renal Cell|Glioblastoma|Carcinoma, Hepatocellular","Drug: Crizotinib plus VEGF inhibitor combinations|Drug: Crizotinib plus axitinib|Drug: Crizotinib plus sunitinib|Drug: Crizotinib plus bevacizumab|Drug: Crizotinib plus sorafenib",,"https://ClinicalTrials.gov/show/NCT01441388"
1239,"Bevacizumab Beyond Progression (BBP)","Completed","Has Results","Malignant Glioma|Grade 4 Malignant Glioma|Glioblastoma|Gliosarcoma","Radiation: Radiation Therapy|Drug: Temozolomide|Drug: Bevacizumab","Duke Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01740258"
1240,"Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection","Recruiting","No Results Available","Glioma, Malignant|High Grade Glioma|Glioblastoma|Glioblastoma Multiforme|Anaplastic Astrocytoma","Drug: OS2966|Drug: Gadoteridol","Moffitt Cancer Center, Tampa, Florida, United States","https://ClinicalTrials.gov/show/NCT04608812"
1241,"Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas","Active, not recruiting","No Results Available","Glioblastoma|Astrocytoma, Grade III|Astrocytoma, Grade IV|Malignant Glioma","Radiation: Stereotactic Radiosurgery","Northwell Health Brain Tumor Center, Lake Success, New York, United States","https://ClinicalTrials.gov/show/NCT03956706"
1242,"Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma","Completed","Has Results","Brain and Central Nervous System Tumors","Drug: temozolomide|Genetic: protein expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: diagnostic laboratory biomarker analysis|Other: immunoenzyme technique","Memorial Sloan-Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00498927"
1243,"Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma","Terminated","Has Results","Glioblastoma|Malignant Glioma|Brain Tumors|Anaplastic Astrocytoma","Radiation: Stem Cell Radiotherapy (ScRT) and Temozolomide","Roosevelt Hospital, New York, New York, United States","https://ClinicalTrials.gov/show/NCT02039778"
1244,"A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas","Completed","No Results Available","Glioma","Drug: RTA 744|Drug: RTA 744 injection","UCLA School of Medicine, Department of Neurology, Los Angeles, California, United States|Baylor University Medical Center: Neuro-Oncology Associates, Dallas, Texas, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00526812"
1245,"GW572016 to Treat Recurrent Malignant Brain Tumors","Completed","No Results Available","Glioma|Brain Tumor|Glioblastoma Multiforme|GBM|Gliosarcoma|GS","Drug: lapatinib ditosylate|Procedure: Adjuvant therapy|Procedure: Conventional surgery|Procedure: Neoadjuvant therapy","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00107003"
1246,"Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRd","Recruiting","No Results Available","Recurrent Glioma|Recurrent Glioblastoma|Poly ADP Ribose Polymerase (PARP) Inhibitor|PTEN Gene Inactivation|IDH Mutation","Drug: Talazoparib","Department of Clinical Oncology, Hong Kong, Hong Kong","https://ClinicalTrials.gov/show/NCT04740190"
1247,"A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma","Completed","No Results Available","Glioblastoma|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Anaplastic Oligoastrocytoma","Biological: Toca 511 vector|Drug: Toca FC","City of Hope, Duarte, California, United States|UCLA, Los Angeles, California, United States|UCSD, San Diego, California, United States|UCSF, San Francisco, California, United States|Henry Ford Hospital, Detroit, Michigan, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|The Ohio State University, Columbus, Ohio, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|The Methodist Hospital Research Institute, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01156584"
1248,"131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma","Unknown status","No Results Available","Malignant Glioma|Glioblastoma Multiforme|GBM|Anaplastic Astrocytoma|Oligo-Astrocytoma|Gliosarcoma","Drug: 131-I-TM-601|Drug: 131I-TM601","University of Alabama at Birmingham, Birmingham, Alabama, United States|City of Hope, Duarte, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|Florida Hospital Cancer Institute, Orlando, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|Emory University, Atlanta, Georgia, United States|Northwestern University, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|Johns Hopkins Medical Center, Baltimore, Maryland, United States|Tufts-New England Medical Center, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Lacks Cancer Center at St. Mary's Health Care, Grand Rapids, Michigan, United States|St. Louis Hospital, St. Louis, Missouri, United States|Washington University Medical Center, St. Louis, Missouri, United States|Columbia University Medical Center, New York, New York, United States|Carolina Neurosurgery and Spine, Charlotte, North Carolina, United States|Mary Crowley Medical Research Center, Dallas, Texas, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States|University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00114309"
1249,"Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors","Completed","No Results Available","Glioblastoma Multiforme|Glioma|Gliosarcoma|Malignant Brain Tumor","Drug: Indoximod|Drug: Temozolomide|Drug: Bevacizumab|Radiation: Stereotactic Radiation","Eden Medical Center, Castro Valley, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|UC Irvine Chao Family Comprehensive Cancer Center, Orange, California, United States|Moffitt Cancer Center, Tampa, Florida, United States|University Cancer and Blood Center, Athens, Georgia, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Augusta University, Augusta, Georgia, United States|University of Chicago, Chicago, Illinois, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|University of Kentucy, Lexington, Kentucky, United States|John Nasseff Neuroscience Institute, Minneapolis, Minnesota, United States|University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, United States|Wake Forest Baptist Health Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|Penn State Hershey Medical Center, Hershey, Pennsylvania, United States|Texas Oncology, Austin, Texas, United States|Huntsman Cancer Center, Salt Lake City, Utah, United States|Virginia Cancer Specialists, Fairfax, Virginia, United States","https://ClinicalTrials.gov/show/NCT02052648"
1250,"Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects","Completed","No Results Available","Brain Cancer|Brain Neoplasm|Glioma|Glioblastoma|Gliosarcoma|Malignant Brain Tumor|Neoplasm, Neuroepithelial|Neuroectodermal Tumors|Neoplasm by Histologic Type|Neoplasm, Nerve Tissue|Nervous System Diseases","Biological: DNX-2401|Biological: pembrolizumab","University of Arkansas for Medical Sciences (UAMS), Little Rock, Arkansas, United States|UCLA Medical Center, Los Angeles, California, United States|Northwestern University, Chicago, Illinois, United States|University of Minnesota Neurosurgery, Minneapolis, Minnesota, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Weill-Cornell Medicine New York-Presbyterian, New York, New York, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States|Cleveland Clinic, Cleveland, Ohio, United States|Ohio State University James Cancer Center, Columbus, Ohio, United States|Lehigh Valley Health Network, Allentown, Pennsylvania, United States|Texas Oncology Austin-Midtown, Austin, Texas, United States|MD Anderson Cancer Center, Houston, Texas, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States|University Health Network, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT02798406"
1251,"Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma","Active, not recruiting","Has Results","Glioblastoma|Recurrent Adult Brain Neoplasm|Malignant Glioma|WHO Grade III Glioma","Drug: sorafenib tosylate|Drug: valproic acid|Drug: sildenafil citrate","Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States","https://ClinicalTrials.gov/show/NCT01817751"
1252,"Immunotherapy (Nivolumab and Ipilimumab) Before and After Surgery for the Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults","Recruiting","No Results Available","Glioblastoma|Malignant Glioma|Recurrent Glioblastoma|Recurrent Malignant Glioma|Recurrent Grade III Glioma|Grade III Glioma","Biological: Ipilimumab|Biological: Nivolumab|Drug: Placebo Administration|Other: Quality-of-Life Assessment|Other: Questionnaire Administration","Children's Hospital of Los Angeles, Los Angeles, California, United States|Rady Children's Hospital, San Diego, California, United States|University of California, San Francisco, San Francisco, California, United States|Children's National Medical Center, Washington, District of Columbia, United States|University of Florida, Gainesville, Florida, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Doernbecher Children's Hospital Oregon Health & Science University, Portland, Oregon, United States|Sydney Children's Hospital, Sydney, New South Wales, Australia|The Children's Hospital at Westmead, Westmead, New South Wales, Australia|Queensland Children's Hospital, South Brisbane, Queensland, Australia|Women's and Children's Hospital, North Adelaide, South Australia, Australia|Royal Children's Hospital, Parkville, Victoria, Australia|Perth Children's' Hospital, Perth, Western Australia, Australia|Sheba Medical Center, Ramat Gan, Israel|The University Children's Hospital in Zurich, Zurich, Switzerland","https://ClinicalTrials.gov/show/NCT04323046"
1253,"SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue","Recruiting","No Results Available","Brain Tumour|High Grade Glioma|Low-grade Glioma|Glioblastoma","Device: SonoClear ACF","University Hospital Bratislava, Bratislava, Slovakia","https://ClinicalTrials.gov/show/NCT04734444"
1254,"Non-Viral TCR Gene Therapy","Recruiting","No Results Available","Glioblastoma|Non-Small Cell Lung Cancer|Breast Cancer|Gastrointestinal/Genitourinary Cancer|Ovarian Cancer","Drug: Fludarabine|Drug: Cyclophosphamide|Drug: Aldesleukin|Biological: Sleeping Beauty Transposed PBL","National Institutes of Health Clinical Center, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT04102436"
1255,"Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma","Recruiting","No Results Available","Glioblastoma|Malignant Glioma|Recurrent Glioma|Refractory Glioma|WHO Grade III Glioma","Biological: HER2(EQ)BBζ/CD19t+ T cells|Other: Laboratory Biomarker Analysis|Procedure: Leukapheresis","City of Hope Medical Center, Duarte, California, United States","https://ClinicalTrials.gov/show/NCT03389230"
1256,"A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas","Recruiting","No Results Available","Glioma|BRAF V600E|Pleomorphic Xantho-Astrocytoma|Glioblastoma","Procedure: Surgical Cohort","Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States|Massachusettes General Hospital, Boston, Massachusetts, United States|Washington University Siteman Cancer Center, Saint Louis, Missouri, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|Penn State Hershey Medical Center, Hershey, Pennsylvania, United States|University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT03593993"
1257,"Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype","Recruiting","No Results Available","Glioma|Glioblastoma|High Grage Glioma|Low Grade Glioma|Malignant Glioma","Drug: Nivolumab","National Institutes of Health Clinical Center, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT03718767"
1258,"A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)","Completed","No Results Available","B-cell Malignancies|Colorectal Cancer (CRC)|Head and Neck Cancer|Lung Cancer|Lymphoma|Melanoma|Ovarian Cancer|Glioblastoma","Drug: Nivolumab (Phase 1)|Drug: Epacadostat (Phase 1)|Drug: Chemotherapy (Phase 1)|Drug: Nivolumab (Phase 2)|Drug: Epacadostat (Phase 2)","UAB Comprehensive Cancer Center, Birmingham, Alabama, United States|The Angeles Clinic and Research Institute, Los Angeles, California, United States|USC Norris Cancer Center, Los Angeles, California, United States|UCSF - University of California San Francisco, San Francisco, California, United States|University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States|The University of Kansas Clinical Research Center, Fairway, Kansas, United States|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Lahey Hospital & Medical Center, Burlington, Massachusetts, United States|NYU Cancer Center, New York, New York, United States|Columbia University, Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Wake Forest Medical Center Boulevard, Winston-Salem, North Carolina, United States|Sanford Research, Fargo, North Dakota, United States|University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States|Sanford Research, North Sioux City, South Dakota, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Texas Oncology Research, Austin, Texas, United States|MD Anderson Cancer Center, Houston, Texas, United States|Utah Cancer Specialists, Salt Lake City, Utah, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|The Christie NHS Foundation Trust, Manchester, United Kingdom|Oxford University Hospitals NHS Trust, Oxford, United Kingdom","https://ClinicalTrials.gov/show/NCT02327078"
1259,"BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations","Recruiting","No Results Available","IDH1 Mutation|IDH2 Mutation|Recurrent Glioblastoma|Recurrent WHO Grade II Glioma|Recurrent WHO Grade III Glioma","Drug: PARP Inhibitor BGB-290|Drug: Temozolomide|Procedure: Therapeutic Conventional Surgery","UAB Comprehensive Cancer Center, Birmingham, Alabama, United States|University of California, Los Angeles, Los Angeles, California, United States|Yale University, New Haven, Connecticut, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States|Washington University, Saint Louis, Missouri, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|University Hospital, Cleveland, Ohio, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|University of Virginia, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT03914742"
1260,"CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII","Completed","Has Results","Malignant Glioma|Glioblastoma|Brain Cancer|Gliosarcoma","Biological: Epidermal growth factor receptor(EGFRv)III Chimeric antigen receptor (CAR) transduced PBL|Drug: Aldesleukin|Drug: Fludarabine|Drug: Cyclophosphamide","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT01454596"
1261,"Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors","Terminated","No Results Available","Glioma|Brain Cancer|Brain Tumor|Glioblastoma Multiforme|High Grade Glioma","Biological: Dendritic Cell Vaccine|Biological: Tumor Lysate|Other: Imiquimod|Procedure: Leukapheresis","University of Miami, Miami, Florida, United States","https://ClinicalTrials.gov/show/NCT01902771"
1262,"A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas","Completed","No Results Available","Glioblastoma|Gliosarcoma|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma","Drug: Nanoliposomal CPT-11","University of California, San Francisco, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT00734682"
1263,"Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas","Terminated","No Results Available","Glioblastoma Multiforme|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Anaplastic Mixed Oligoastrocytoma","Drug: Talampanel",,"https://ClinicalTrials.gov/show/NCT00062504"
1264,"Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children","Recruiting","No Results Available","Glioblastoma Multiforme|Anaplastic Astrocytoma|Malignant Brain Tumor|High Grade Glioma","Drug: Cabozantinib","Riley Hospital for Children at IU Health, Indianapolis, Indiana, United States|Riley Hospital for Children at IU Health, Indianapolis, Indiana, United States|Riley Hospital for Children at IU Health, Indianapolis, Indiana, United States","https://ClinicalTrials.gov/show/NCT02885324"
1265,"A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies","Recruiting","No Results Available","Advanced Malignant Solid Neoplasm|RAS Mutation|Lung Cancer|Colon Cancer|Glioblastoma|Pancreatic Cancer","Drug: RSC-1255 Dose Escalation|Drug: RSC-1255 Dose Expansion","University of California, Los Angles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles, California, United States|UC Davis Comprehensive Cancer Center, Sacramento, California, United States|Anschutz Cancer Pavilion - University of Colorado Hospital, Aurora, Colorado, United States|Sarah Cannon Research Institute - Health One, Denver, Colorado, United States|Sidney Kimmel Cancer Center - Thomas Jefferson Hospital, Philadelphia, Pennsylvania, United States|Sarah Cannon Tennessee Oncology, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT04678648"
1266,"Phase I Study of Safety and Immunogenicity of ADU-623","Completed","No Results Available","Astrocytic Tumors|Glioblastoma Multiforme|Anaplastic Astrocytoma|Brain Tumor","Biological: Cohort 1|Biological: Cohort 2|Biological: Cohort 3|Drug: Antibiotics","Providence Cancer Center, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT01967758"
1267,"Ceritinib Rare Indications Study in ALK+ Tumors","Terminated","Has Results","Tumors With Aberrations in ALK|Anaplastic Large Cell Lymphoma|Inflammatory Myofibroblastic Tumor|Glioblastoma","Drug: Ceritinib (LDK378)","Novartis Investigative Site, Brno, Czech Republic, Czechia|Novartis Investigative Site, Copenhagen, Denmark|Novartis Investigative Site, Lyon Cedex, France|Novartis Investigative Site, Saint-Herblain Cédex, France|Novartis Investigative Site, Strasbourg, France|Novartis Investigative Site, Tel Aviv, Israel|Novartis Investigative Site, Milano, MI, Italy|Novartis Investigative Site, Seoul, Korea, Republic of|Novartis Investigative Site, Seoul, Korea, Republic of|Novartis Investigative Site, Seoul, Korea, Republic of|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Bangkok, Thailand|Novartis Investigative Site, Bangkok, Thailand","https://ClinicalTrials.gov/show/NCT02465528"
1268,"Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma","Completed","No Results Available","Malignant Glioma|Glioblastoma Multiforme|Anaplastic Astrocytoma|Mixed Oligoastrocytoma","Drug: IL13-PE38QQR|Procedure: targeted fusion protein therapy|Procedure: surgery","University of Colorado Health Sciences Center, Denver, Colorado, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University Hospital Eppendorf, Hamburg, Germany|University Hospital Kiel, Department of Neurosurgery, Kiel, Germany|Sourasky Medical Center, Tel Aviv, Israel|Chaim Sheba Medical Center, Tel Hashomer, Israel","https://ClinicalTrials.gov/show/NCT00041587"
1269,"Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma","Completed","No Results Available","Malignant Glioma|Glioblastoma Multiforme|Anaplastic Astrocytoma|Mixed Oligoastrocytoma","Drug: IL13-PE38QQR|Procedure: targeted fusion protein therapy|Procedure: surgery","University of Alabama at Birmingham, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center, Tampa, Florida, United States|Emory University, Atlanta, Georgia, United States|The Johns Hopkins University, Baltimore, Maryland, United States|Henry Ford Health Systems, Detroit, Michigan, United States|Wake Forest University, Winston-Salem, North Carolina, United States|Cleveland Clinic, Cleveland, Ohio, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00024570"
1270,"Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: lapatinib ditosylate","Tom Baker Cancer Centre - Calgary, Calgary, Alberta, Canada|British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna, British Columbia, Canada|British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada|Margaret and Charles Juravinski Cancer Centre, Hamilton, Ontario, Canada|Princess Margaret Hospital, Toronto, Ontario, Canada|Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada","https://ClinicalTrials.gov/show/NCT00099060"
1271,"BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas","Recruiting","No Results Available","Glioblastoma|IDH1 Gene Mutation|IDH2 Gene Mutation|Low Grade Glioma|Malignant Glioma|Recurrent Glioblastoma|Recurrent WHO Grade II Glioma|Recurrent WHO Grade III Glioma|WHO Grade II Glioma|WHO Grade III Glioma","Drug: PARP Inhibitor BGB-290|Drug: Temozolomide","Children's Hospital Los Angeles, Los Angeles, California, United States|Rady Children's Hospital - San Diego, San Diego, California, United States|University of California, San Francisco, San Francisco, California, United States|Yale University, New Haven, Connecticut, United States|Children's National Medical Center, Washington, District of Columbia, United States|University of Florida Health Science Center - Gainesville, Gainesville, Florida, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT03749187"
1272,"Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer","Suspended","No Results Available","Metastatic Colorectal Cancer|Progressive Glioblastoma|Metastatic Pancreatic Cancer|Metastatic Ovarian Cancer|Metastatic Breast Carcinoma","Biological: Young TIL|Drug: Aldesleukin|Drug: Cyclophosphamide|Drug: Fludarabine|Drug: Pembrolizumab (Keytruda)","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT01174121"
1273,"A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas","Completed","Has Results","Adult Anaplastic Astrocytoma|Adult Giant Cell Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Drug: ixabepilone|Other: pharmacological study|Drug: Anticonvulsant","Emory University, Atlanta, Georgia, United States|Johns Hopkins University, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Wake Forest University, Winston-Salem, North Carolina, United States|Cleveland Clinic, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00045708"
1274,"Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma","Recruiting","No Results Available","Recurrent Glioblastoma|Recurrent Malignant Glioma|Recurrent WHO Grade II Glioma|Recurrent WHO Grade III Glioma|Refractory Glioblastoma|Refractory Malignant Glioma|Refractory WHO Grade II Glioma|Refractory WHO Grade III Glioma","Biological: IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells|Biological: IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes|Other: Laboratory Biomarker Analysis|Procedure: Magnetic Resonance Imaging|Procedure: Magnetic Resonance Spectroscopic Imaging|Other: Quality-of-Life Assessment","City of Hope Comprehensive Cancer Center, Duarte, California, United States","https://ClinicalTrials.gov/show/NCT02208362"
1275,"Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas","Recruiting","No Results Available","Astrocytoma|Oligodendroglioma|Oligoastrocytoma|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Anaplastic Oligoastrocytoma|Glioblastoma|Brain Tumors|Brain Cancer",,"Tufts Medical Center, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|University of Vermont, Burlington, Vermont, United States","https://ClinicalTrials.gov/show/NCT01849952"
1276,"Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG","Recruiting","No Results Available","Glioblastoma|Medulloblastoma|Ependymoma|Diffuse Intrinsic Pontine Glioma","Drug: Indoximod|Radiation: Partial Radiation|Radiation: Full-dose Radiation|Drug: Temozolomide|Drug: Cyclophosphamide|Drug: Etoposide|Drug: Lomustine","Augusta University, Georgia Cancer Center, Augusta, Georgia, United States|Emory University, Children's Heathcare of Atlanta, Druid Hills, Georgia, United States","https://ClinicalTrials.gov/show/NCT04049669"
1277,"A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors","Completed","No Results Available","Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Ovarian Carcinoma-Enrollment Completed|Colorectal Cancer (CRC)-Enrollment Completed|Renal Cell Carcinoma (RCC) (Phase ll Only)|Glioblastoma (GBM) (Phase ll Only)-Enrollment Completed","Drug: Combination of varlilumab and nivolumab","University of Arizona Cancer Center, Tucson, Arizona, United States|The Stanford Center for Clinical and Translational Education and Research, Palo Alto, California, United States|UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States|University of Colorado Medical Center, Aurora, Colorado, United States|Smilow Cancer Hospital at Yale University Cancer Center, New Haven, Connecticut, United States|Georgetown University, Washington, District of Columbia, United States|George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States|Mount Sinai Medical Center, Miami Beach, Florida, United States|Northwest Georgia Oncology Centers PC, Marietta, Georgia, United States|Parkview Research Center, Fort Wayne, Indiana, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States|Laura and Isaac Perlmutter Cancer Center, New York, New York, United States|Columbia University Medical Center, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States|Cleveland Clinic, Cleveland, Ohio, United States|Providence Health & Services, Portland, Oregon, United States|Inova Schar Cancer Institute Research, Fairfax, Virginia, United States","https://ClinicalTrials.gov/show/NCT02335918"
1278,"Ex VIvo DEtermiNed Cancer Therapy","Recruiting","No Results Available","Bladder Cancer|Kidney Cancer|Melanoma|Sarcoma|Glioblastoma|Head and Neck Cancer","Diagnostic Test: Functional drug screen","Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, South Yorkshire, United Kingdom","https://ClinicalTrials.gov/show/NCT05231655"
1279,"Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas","Recruiting","No Results Available","High Grade Glioma|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Glioblastoma","Drug: Regadenoson 0.05mg|Drug: Regadensoson 0.1mg|Drug: Regadensoson 0.2mg|Drug: Regadensoson 0.4mg|Drug: Regadensoson 0.7mg|Drug: Regadensoson 1.0mg|Drug: Regadensoson 1.4mg","UAB Comprehensive Cancer Center, Birmingham, Alabama, United States|Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|Abrams Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT03971734"
1280,"Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma","Completed","Has Results","Glioblastoma|Astrocytoma|Oligodendroglioma|Brain Tumor, Recurrent","Drug: Temozolomide","Marmara University Hospital, Istanbul, Turkey","https://ClinicalTrials.gov/show/NCT00575887"
1281,"Evaluation of Factors in Human Brain Tumors","Completed","No Results Available","Brain Neoplasm|Glioblastoma|Glioma|Pituitary Neoplasm",,"National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00001171"
1282,"ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors","Completed","No Results Available","Glioblastoma|Rhabdomyosarcomas|Neuroblastoma|Osteosarcoma","Drug: Irinotecan (Camptosar), Gefitinib (Iressa)","St. Jude Children's Research Hospital, Memphis, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00132158"
1283,"Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma","Unknown status","No Results Available","Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Anaplastic Oligoastrocytoma|Glioblastoma","Drug: Carmustine|Procedure: tumor resection surgery","Beijing Tiantan Hospital Affiliated to Capital Medical University, Beijing, Beijing, China","https://ClinicalTrials.gov/show/NCT01656980"
1284,"Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma","Unknown status","No Results Available","Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Anaplastic Oligoastrocytoma|Glioblastoma","Drug: Carmustine(BCNU)|Procedure: Surgery","Sun Yat-Sen University Cancer Center, Guangzhou, Guangzhou, China","https://ClinicalTrials.gov/show/NCT01637753"
1285,"Dendritic Cell Vaccine for Patients With Brain Tumors","Active, not recruiting","No Results Available","Glioma|Anaplastic Astrocytoma|Anaplastic Astro-oligodendroglioma|Glioblastoma","Biological: autologous tumor lysate-pulsed DC vaccination|Biological: Tumor lysate-pulsed DC vaccination+0.2% resiquimod|Biological: Tumor-lysate pulsed DC vaccination +adjuvant polyICLC","University of Los Angeles, California, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT01204684"
1286,"Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors","Completed","No Results Available","Brain Tumor|Brain Tumor, Recurrent|Brain Neoplasm|Brain Cancer|Glioblastoma Multiforme|Recurrent Glioblastoma Multiforme","Device: AutoLITT system","University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00747253"
1287,"The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)","Completed","Has Results","Glioma|Astrocytoma|Oligodendroglioma|Glioblastoma","Drug: Temozolomide",,"https://ClinicalTrials.gov/show/NCT00392171"
1288,"Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG","Recruiting","No Results Available","High Grade Glioma|BRAF V600E|BRAF V600K|Anaplastic Astrocytoma|Anaplastic Pleomorphic Xanthoastrocytoma|Gliosarcoma|Glioblastoma","Drug: Encorafenib|Drug: Binimetinib|Biological: Research Bloods|Biological: Tumor Tissue","UAB Comprehensive Cancer Center, Birmingham, Alabama, United States|Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Henry Ford Hospital, Detroit, Michigan, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|Abrams Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT03973918"
1289,"Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: temozolomide|Drug: thalidomide","Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States|UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States|Neuro-Oncology Branch, Bethesda, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|Simmons Cancer Center - Dallas, Dallas, Texas, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00006358"
1290,"Quality of Life and Patient Needs in Advanced High Grade Gliomas","Active, not recruiting","No Results Available","Quality of Life|Brain Tumor|Glioblastoma|Glioma|Anaplastic Astrocytoma","Other: Phone interviews",,"https://ClinicalTrials.gov/show/NCT05039346"
1291,"Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas","Completed","No Results Available","Glioblastoma Multiforme|Anaplastic Astrocytoma|Oligoastrocytoma, Mixed|Gliosarcoma","Genetic: Interferon-beta","University of Alabama at Birmingham, Birmingham, Alabama, United States|University of Arizona at Tucson, Tucson, Arizona, United States|University of Colorado Health Sciences Center, Denver, Colorado, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00031083"
1292,"Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine","Terminated","No Results Available","Glioblastoma Multiforme|Astrocytoma, Grade III|Anaplastic Ependymoma|Clear Cell Ependymoma|Ependymoma","Biological: Heat Shock Protein Peptide Complex-96 (HSPPC-96)|Procedure: Tumor Resection|Radiation: Radiation","Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT02722512"
1293,"Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma","Terminated","No Results Available","High Grade Glioma: Glioblastoma (GBM)|High Grade Glioma: Gliosarcoma|Anaplastic Astrocytoma (AA)|Anaplastic Oligodendroglioma (AO)|Mixed Anaplastic Oligoastrocytoma (AOA)","Drug: Plerixafor|Drug: Bevacizumab|Procedure: Surgery","Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01339039"
1294,"Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas","Terminated","Has Results","Adult Anaplastic Astrocytoma|Adult Anaplastic Ependymoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma","Drug: Temozolomide|Radiation: hypofractionated radiation therapy|Biological: bevacizumab|Other: questionnaire administration","Northwestern University, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|Northwestern Lake Forest Hospital, Lake Forest, Illinois, United States|Edward Cancer Center, Naperville, Illinois, United States|Central Dupage Hospital, Warrenville, Illinois, United States","https://ClinicalTrials.gov/show/NCT01478321"
1295,"A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies","Completed","No Results Available","Acute Myeloid Leukemia|Myelodysplastic Syndromes|Glioblastoma Multiforme|Melanoma|Non-Small Cell Lung Cancer|Ovarian Cancer|Pancreatic Cancer|Sarcoma|Renal Cell Carcinoma","Drug: DSP-7888 Dosing Emulsion","USOR - Rocky Mountain Cancer Center, Denver, Colorado, United States|Emory University Winship Cancer Institute, Atlanta, Georgia, United States|Horizon Oncology Research, Lafayette, Indiana, United States|USOR - TX Oncology Austin, Austin, Texas, United States|USOR -TX Oncology Dallas, Dallas, Texas, United States|USOR - TX Oncology Tyler, Tyler, Texas, United States|USOR - VA Cancer Specialists, Fairfax, Virginia, United States|USOR - VA Oncology Associates, Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT02498665"
1296,"Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer","Not yet recruiting","No Results Available","Ependymoma|Medulloblastoma|Glioblastoma|Primitive Neuroectodermal Tumor (PNET)","Drug: Ibrutinib|Drug: Indoximod|Drug: Cyclophosphamide|Drug: Etoposide","Augusta University, Georgia Cancer Center, Augusta, Georgia, United States","https://ClinicalTrials.gov/show/NCT05106296"
1297,"Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors","Completed","Has Results","Glioblastoma|Gliosarcoma|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Anaplastic Mixed Oligoastrocytoma","Biological: Bevacizumab|Drug: MLN-518 (Tandutinib)|Procedure: Quality-of-life assessment","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00667394"
1298,"Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery","Unknown status","No Results Available","Primary Malignant Neoplasm of Nervous System|Glioma|Glioblastoma|Metastasis","Procedure: Interventional arm|Procedure: Control arm","Klinik für Neurochirurgie Johann Wolfgang Goethe University, Frankfurt am Main, Hessen, Germany","https://ClinicalTrials.gov/show/NCT01798771"
1299,"Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients","Completed","No Results Available","Malignant Glioma|Glioblastoma Multiforme|Anaplastic Astrocytoma|Mixed Oligoastrocytoma|Malignant Astrocytoma","Drug: IL13-PE38QQR|Procedure: targeted fusion protein therapy|Procedure: surgery","University of California San Francisco, San Francisco, California, United States|Yale University, New Haven, Connecticut, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00024557"
1300,"Combination Chemotherapy for Patients With Brain Cancer","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: filgrastim|Drug: paclitaxel|Drug: topotecan hydrochloride","Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States","https://ClinicalTrials.gov/show/NCT00002814"
1301,"Valproic Acid in Childhood Progressive Brain Tumors","Withdrawn","No Results Available","Pediatric Brain Tumor|Glioma|Anaplastic Astrocytoma|Medulloblastoma|Glioblastoma","Drug: Valproic Acid","Medical University of South Carolina, Charleston, South Carolina, United States","https://ClinicalTrials.gov/show/NCT01861990"
1302,"A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas","Completed","No Results Available","Glioma|Glioblastoma|Astrocytoma|Oligodendroglioma|Brain Neoplasm","Drug: Motexafin Gadolinium Injection","Barrow Neurological Institute, Phoenix, Arizona, United States","https://ClinicalTrials.gov/show/NCT00080054"
1303,"AZD8055 for Adults With Recurrent Gliomas","Completed","No Results Available","Glioblastoma Multiforme|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Malignant Glioma|Brainstem Glioma","Drug: AZD8055","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT01316809"
1304,"(11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas","Terminated","No Results Available","Low Grade Glioma|Glioblastoma Multiforme|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Oligoastrocytoma",,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT01281982"
1305,"Natural History of Patients With Brain and Spinal Cord Tumors","Completed","No Results Available","Astrocytoma|Oligodendroglioma|Glioblastoma|Glioma|Anaplastic Glioma",,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00009035"
1306,"Serial MRI Scans During Radiation Therapy","Recruiting","No Results Available","Glioblastoma|Esophageal Cancer|Radiotherapy|Magnetic Resonance Imaging|MRI|Prostate Cancer|Vulvar Cancer|Pediatric Glioblastoma Multiforme","Diagnostic Test: MRI IMAGING","Brigham and Women Hospital, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT04188535"
1307,"HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma","Not yet recruiting","No Results Available","Neoplasms|High Grade Glioma|Glioblastoma Multiforme|Malignant Glioma of Brain|Anaplastic Astrocytoma of Brain|High-grade Glioma|Anaplastic Glioma|Giant Cell Glioblastoma","Drug: Biological G207","Children's of Alabama, Birmingham, Alabama, United States","https://ClinicalTrials.gov/show/NCT04482933"
1308,"A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas","Withdrawn","No Results Available","Ependymoma|Brainstem Glioma|Astrocytoma|Glioblastoma Multiforme|PNET",,,"https://ClinicalTrials.gov/show/NCT01117155"
1309,"Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer","Terminated","Has Results","Advanced Breast Cancer (Parts 1 and 2)|Advanced Pancreatic Cancer (Part 1)|Advanced Colorectal Cancer (Part 1)|Advanced Cholangiocarcinoma (Part 1)|Advanced Glioblastoma Multiforme (Part 1)","Drug: Bosutinib|Drug: Capecitabine","Pfizer Investigational Site, Boston, Massachusetts, United States|Pfizer Investigational Site, Detroit, Michigan, United States|Pfizer Investigational Site, Adelaide, South Australia, Australia|Pfizer Investigational Site, Edegem, Belgium|Pfizer Investigational Site, Saint Herblain, France|Pfizer Investigational Site, Hong Kong, Hong Kong|Pfizer Investigational Site, Madrid, Spain","https://ClinicalTrials.gov/show/NCT00959946"
1310,"Mind-Body Intervention in Glioma Couples","Completed","No Results Available","Glioblastoma|Low Grade Glioma|Malignant Glioma|Metastatic Malignant Neoplasm in the Brain|Partner|WHO Grade III Glioma","Procedure: Mind-Body Intervention Procedure|Other: Quality-of-Life Assessment|Other: Questionnaire Administration","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03244995"
1311,"A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)","Active, not recruiting","No Results Available","Advanced Solid Tumors|Solid Tumor|Solid Carcinoma|Solid Tumor, Adult|ccRCC|RCC, Clear Cell Adenocarcinoma|RCC|Kidney Cancer|Clear Cell Renal Cell Carcinoma|Renal Cell Carcinoma, Metastatic|Renal Cell Carcinoma Recurrent|Renal Cell Carcinoma, Clear Cell Adenocarcinoma|Glioblastoma|Glioblastoma, Adult|GBM|Glioblastoma Multiforme","Drug: Belzutifan",,"https://ClinicalTrials.gov/show/NCT02974738"
1312,"Multimodal MR Imaging in Patients With Glioblastoma Treated With Dendritic Cell Therapy","Unknown status","No Results Available","Malignant Gliomas","Other: MR imaging","University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium|University Hospitals of Leuven, Leuven, Vlaams-Brabant, Belgium","https://ClinicalTrials.gov/show/NCT01657734"
1313,"Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers","Recruiting","No Results Available","Glioblastomas|Sarcoma|Astrocytoma|Brain Cancer|Leukemia","Behavioral: Enhanced Mindfulness Intervention|Behavioral: Psychoeducation","National Institutes of Health Clinical Center, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT03538587"
1314,"A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma and H3 K27M-Mutant High-Grade Glioma","Not yet recruiting","No Results Available","Anaplastic Astrocytoma|Diffuse Intrinsic Pontine Glioma|Diffuse Midline Glioma, H3 K27M-Mutant|Glioblastoma|Malignant Glioma","Radiation: Radiation Therapy|Drug: Selinexor",,"https://ClinicalTrials.gov/show/NCT05099003"
1315,"BIBF 1120 for Recurrent High-Grade Gliomas","Completed","Has Results","Glioblastoma|Gliosarcoma|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Anaplastic Oligoastrocytoma","Drug: BIBF 1120","Massachusetts General Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Cleveland Clinic, Cleveland, Ohio, United States|University of Virginia, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT01380782"
1316,"A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2","Recruiting","No Results Available","Malignant Glioma of Brain|Astrocytoma|Malignant Astrocytoma|Oligodendroglioma|Anaplastic Oligodendroglioma of Brain (Diagnosis)|Mixed Oligo-Astrocytoma|Ependymoma|Ganglioglioma|Pylocytic/Pylomyxoid Astrocytoma|Brain Tumor|Glioma|Brain Cancer|Glioblastoma|Glioblastoma Multiforme","Drug: rQNestin|Drug: Cyclophosphamide|Procedure: Stereotactic biopsy","Dana Farber Cancer Institute, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT03152318"
1317,"Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas","Active, not recruiting","No Results Available","Brain Tumor, Recurrent|Glioblastoma|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Mixed Glioma","Procedure: Cytoreductive surgery|Drug: Perifosine|Drug: Temsirolimus","Columbia University Medical Center, New York, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT02238496"
1318,"Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: gefitinib","Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States|UCSF Comprehensive Cancer Center, San Francisco, California, United States|Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda, Maryland, United States|NCI - Neuro-Oncology Branch, Bethesda, Maryland, United States|Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States|M.D. Anderson Cancer Center at University of Texas, Houston, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00025675"
1319,"Sorafenib in Newly Diagnosed High Grade Glioma","Completed","No Results Available","Glioblastoma|Gliosarcoma|Anaplastic Astrocytoma|Anaplastic Oligoastrocytoma|Anaplastic Oligodendroglioma","Drug: Sorafenib dose escalation","Geneva University Hospital (Hopitaux Universitaires de Geneve), Department of Oncology, Geneva, GE, Switzerland","https://ClinicalTrials.gov/show/NCT00884416"
1320,"Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma","Terminated","Has Results","Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Anaplastic Oligoastrocytoma|Glioblastoma|Gliosarcoma","Dietary Supplement: ascorbic acid|Drug: temozolomide|Other: quality-of-life assessment|Other: laboratory biomarker analysis","University of Nebraska Medical Center, Omaha, Nebraska, United States","https://ClinicalTrials.gov/show/NCT02168270"
1321,"Oncolytic Adenovirus DNX-2401 in Treating Patients With Recurrent High-Grade Glioma","Recruiting","No Results Available","IDH1 wt Allele|Recurrent Anaplastic Astrocytoma|Recurrent Glioblastoma|Recurrent Gliosarcoma|Recurrent Malignant Glioma","Biological: Oncolytic Adenovirus Ad5-DNX-2401|Procedure: Therapeutic Conventional Surgery","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03896568"
1322,"Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors","Completed","No Results Available","Glioblastoma|Astrocytoma|Pineoblastoma|Rhabdoid Tumor|Supratentorial Neoplasms","Procedure: Stem Cell Transplant","Children's Memorial Hospital, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT00179803"
1323,"Fluoroethyltyrosine in Detecting Tumors in Participants With Recurrent Intracranial Tumors","Recruiting","No Results Available","Intracranial Neoplasm|Low Grade Glioma|Recurrent Glioblastoma|Recurrent World Health Organization (WHO) Grade II Glioma|Recurrent WHO Grade III Glioma","Drug: F-18 Fluoroethyltyrosine (FET)|Procedure: Positron Emission Tomography (PET)","University of California, San Francisco, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT04044937"
1324,"Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma","Completed","No Results Available","Adult Grade III Lymphomatoid Granulomatosis|Adult Nasal Type Extranodal NK/T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Childhood Burkitt Lymphoma|Childhood Diffuse Large Cell Lymphoma|Childhood Grade III Lymphomatoid Granulomatosis|Childhood Immunoblastic Large Cell Lymphoma|Childhood Nasal Type Extranodal NK/T-cell Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Progressive Hairy Cell Leukemia, Initial Treatment|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia/Lymphoma|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Recurrent/Refractory Childhood Hodgkin Lymphoma|Refractory Hairy Cell Leukemia|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Hodgkin Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Adult T-cell Leukemia/Lymphoma|Stage IV Childhood Anaplastic Large Cell Lymphoma|Stage IV Childhood Hodgkin Lymphoma|Stage IV Childhood Large Cell Lymphoma|Stage IV Childhood Lymphoblastic Lymphoma|Stage IV Childhood Small Noncleaved Cell Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IVA Mycosis Fungoides/Sezary Syndrome|Stage IVB Mycosis Fungoides/Sezary Syndrome|T-cell Large Granular Lymphocyte Leukemia|Testicular Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific|Unspecified Childhood Solid Tumor, Protocol Specific|Waldenström Macroglobulinemia","Biological: bevacizumab|Drug: cediranib maleate","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00458731"
1325,"Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas","Withdrawn","No Results Available","Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Biological: carboxylesterase-expressing allogeneic neural stem cells|Drug: irinotecan hydrochloride|Other: laboratory biomarker analysis","City of Hope Medical Center, Duarte, California, United States","https://ClinicalTrials.gov/show/NCT02055196"
1326,"International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)","Recruiting","No Results Available","Glioblastoma WHO Grade IV|Diffuse Midline Glioma Histone 3 K27M WHO Grade IV|Anaplastic Astrocytoma WHO Grade III|Diffuse Intrinsic Pontine Glioma|Gliomatosis Cerebri","Drug: Temozolomide + Valproic Acid","Universitätsklinik RWTH Aachen, Aachen, Germany|Klinikum Augsburg, Augsburg, Germany|Charité Universitätsmedizin Berlin, Berlin, Germany|HELIOS Klinikum Berlin Buch, Berlin, Germany|Evangelisches Krankenhaus Bielefeld, Bielefeld, Germany|Universitätsklinikum Bonn, Bonn, Germany|Städtisches Klinikum Braunschweig gGmbH, Braunschweig, Germany|Klinikum Bremen-Mitte gGmbH, Bremen, Germany|Carl-Thiem-Klinikum Cottbus gGmbH, Cottbus, Germany|Klinikum Dortmund gGmbH, Dortmund, Germany|Universitätsklinikum Carl Gustav Carus Dresden, Dresden, Germany|Sana Kliniken Duisburg GmbH - Wedau Kliniken, Duisburg, Germany|HELIOS Klinikum Erfurt GmbH, Erfurt, Germany|Universitätsklinikum Erlangen, Erlangen, Germany|Universitätsklinikum Essen, Essen, Germany|Universitätsklinikum Frankfurt, Frankfurt, Germany|Universitätsklinikum Freiburg, Freiburg, Germany|Universitätsklinikum Gießen und Marburg GmbH, Gießen, Germany|Universitätsmedizin Greifswald, Greifswald, Germany|Universitätsmedizin Göttingen, Göttingen, Germany|Universitätsklinikum Halle, Halle, Germany|Universitätsklinikum Hamburg, Hamburg, Germany|Angelika-Lautenschläger-Klinik, Heidelberg, Germany|SLK-Kliniken Heilbronn GmbH, Heilbronn, Germany|Gemeinschaftskrankenhaus Herdecke, Herdecke, Germany|Universitätsklinikum des Saarlandes, Homburg, Germany|Universitätsklinikum Jena, Jena, Germany|Städtisches Klinikum Karlsruhe, Karlsruhe, Germany|Gesundheit Nordhessen - Klinikum Kassel, Kassel, Germany|UKSH Kiel, Kiel, Germany|Gemeinschaftsklinikum Mittelrhein gGmbH, Koblenz, Germany|HELIOS Klinikum Krefeld, Krefeld, Germany|Kliniken der Stadt KölngGmbH, Köln, Germany|Universitätsklinikum Leipzig, Leipzig, Germany|UKSH Campus Lübeck, Lübeck, Germany|Universitätsklinikum Magdeburg A. ö. R., Magdeburg, Germany|Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany|UMM Universitätsmedizin Mannheim, Mannheim, Germany|Johannes Wesling Klinikum Minden, Minden, Germany|Technische Universität München / Klinikum Schwabing, München, Germany|Universitätsklinikum Münster, Münster, Germany|Klinikum Oldenburg gGmbH, Oldenburg, Germany|Universitätsklinikum Regensburg, Regensburg, Germany|Universitäts-Kinder- und Jugendklinik Rostock, Rostock, Germany|ASKLEPIOS Klinik St. Augustin, Sankt Augustin, Germany|Klinikum Stuttgart - Olgahospital, Stuttgart, Germany|Universitätsklinikum Tübingen, Tübingen, Germany|Universitätsklinikum Ulm, Ulm, Germany|Universitätsklinik Würzburg, Würzburg, Germany","https://ClinicalTrials.gov/show/NCT03243461"
1327,"A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas","Completed","Has Results","Glioblastoma Multiforme|Gliosarcoma|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Anaplastic Mixed Oligoastrocytoma","Drug: ZD6474 (Vandetanib)|Drug: Carboplatin","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00995007"
1328,"Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: temozolomide|Procedure: adjuvant therapy|Radiation: radiation therapy","Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, Alabama, United States|University of South Alabama Cancer Research Institute, Mobile, Alabama, United States|Phoenix Children's Hospital, Phoenix, Arizona, United States|Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States|Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Southern California Permanente Medical Group, Downey, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States|Loma Linda University Cancer Institute at Loma Linda University Medical Center, Loma Linda, California, United States|Jonathan Jaques Children's Cancer Center at Miller Children's Hospital, Long Beach, California, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angeles, California, United States|Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States|Children's Hospital Central California, Madera, California, United States|Children's Hospital and Research Center at Oakland, Oakland, California, United States|Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center, Orange, California, United States|Children's Hospital of Orange County, Orange, California, United States|Lucile Packard Children's Hospital at Stanford University Medical Center, Palo Alto, California, United States|Sutter Cancer Center, Sacramento, California, United States|University of California Davis Cancer Center, Sacramento, California, United States|Kaiser Permanente Medical Center - Sacramento, Sacramento, California, United States|Kaiser Permanente Medical Center/Kaiser Foundation Hospital - San Diego, San Diego, California, United States|Children's Hospital and Health Center - San Diego, San Diego, California, United States|UCSF Comprehensive Cancer Center, San Francisco, California, United States|Santa Barbara Cottage Hospital, Santa Barbara, California, United States|Kaiser Permanente Medical Center - Santa Clara Kiely Campus, Santa Clara, California, United States|General Robert Huyser Cancer Center at David Grant Medical Center, Travis Air Force Base, California, United States|Children's Hospital Cancer Center, Denver, Colorado, United States|Presbyterian - St. Luke's Medical Center, Denver, Colorado, United States|Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center, Farmington, Connecticut, United States|Yale Comprehensive Cancer Center, New Haven, Connecticut, United States|Alfred I. duPont Hospital for Children, Wilmington, Delaware, United States|Lombardi Cancer Center at Georgetown University Medical Center, Washington, District of Columbia, United States|Children's National Medical Center, Washington, District of Columbia, United States|Broward General Medical Center, Fort Lauderdale, Florida, United States|Children's Hospital of Southwest Florida, Fort Myers, Florida, United States|University of Florida Shands Cancer Center, Gainesville, Florida, United States|Joe DiMaggio Children's Hospital at Memorial, Hollywood, Florida, United States|Nemours Children's Clinic, Jacksonville, Florida, United States|Jackson Memorial Hospital, Miami, Florida, United States|Miami Children's Hospital, Miami, Florida, United States|Baptist-South Miami Regional Cancer Program, Miami, Florida, United States|Florida Hospital Cancer Institute, Orlando, Florida, United States|Nemours Children's Clinic-Orlando, Orlando, Florida, United States|Sacred Heart Children's Hospital, Pensacola, Florida, United States|All Children's Hospital, St. Petersburg, Florida, United States|St. Joseph's Children's Hospital of Tampa, Tampa, Florida, United States|Kaplan Cancer Center at St. Mary's Medical Center, West Palm Beach, Florida, United States|AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Scottish Rite Campus, Atlanta, Georgia, United States|MBCCOP-Medical College of Georgia Cancer Center, Augusta, Georgia, United States|Medical Center of Central Georgia, Macon, Georgia, United States|Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center, Savannah, Georgia, United States|Cancer Research Center of Hawaii, Honolulu, Hawaii, United States|Tripler Army Medical Center, Honolulu, Hawaii, United States|St. Luke's Mountain States Tumor Institute - Boise, Boise, Idaho, United States|University of Chicago Cancer Research Center, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Illinois Medical Center, Chicago, Illinois, United States|Children's Memorial Hospital - Chicago, Chicago, Illinois, United States|Advocate Hope Children's Hospital, Oak Lawn, Illinois, United States|Lutheran General Cancer Care Center, Park Ridge, Illinois, United States|Saint Jude Midwest Affiliate, Peoria, Illinois, United States|Southern Illinois University School of Medicine, Springfield, Illinois, United States|Riley Children Cancer Center at Riley Hospital for Children, Indianapolis, Indiana, United States|St. Vincent Hospitals and Health Care Centers, Indianapolis, Indiana, United States|Blank Children's Hospital, Des Moines, Iowa, United States|Holden Comprehensive Cancer Center at University of Iowa, Iowa City, Iowa, United States|Wesley Medical Center, Wichita, Kansas, United States|Markey Cancer Center at University of Kentucky Chandler Medical Center, Lexington, Kentucky, United States|Kosair Children's Hospital, Louisville, Kentucky, United States|MBCCOP - LSU Health Sciences Center, New Orleans, Louisiana, United States|Tulane Cancer Center at Tulane University Hospital and Clinic, New Orleans, Louisiana, United States|Children's Hospital of New Orleans, New Orleans, Louisiana, United States|Ochsner Cancer Institute at Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Pediatric Specialty Clinic at Eastern Maine Medical Center, Bangor, Maine, United States|Maine Children's Cancer Program, Scarborough, Maine, United States|Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States|Alvin and Lois Lapidus Cancer Institute at Sinai Hospital, Baltimore, Maryland, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Walter Reed Army Medical Center, Silver Spring, Maryland, United States|Floating Hospital for Children, Boston, Massachusetts, United States|Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States|Baystate Regional Cancer Program at D'Amour Center for Cancer Care, Springfield, Massachusetts, United States|UMASS Memorial Cancer Center - University Campus, Worcester, Massachusetts, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Children's Hospital of Michigan, Detroit, Michigan, United States|Van Elslander Cancer Center at St. John Hospital and Medical Center, Detroit, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|DeVos Children's Hospital, Grand Rapids, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|Breslin Cancer Center at Ingham Regional Medical Center, Lansing, Michigan, United States|William Beaumont Hospital - Royal Oak Campus, Royal Oak, Michigan, United States|St. Mary's - Duluth Clinic Cancer Center, Duluth, Minnesota, United States|Children's Hospitals and Clinics - Minneapolis/St. Paul, Minneapolis, Minnesota, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|University of Missouri - Columbia, Columbia, Missouri, United States|Children's Mercy Hospital, Kansas City, Missouri, United States|Cardinal Glennon Children's Hospital, Saint Louis, Missouri, United States|St. Louis Children's Hospital, Saint Louis, Missouri, United States|Children's Hospital of Omaha, Omaha, Nebraska, United States|UNMC Eppley Cancer Center at the University of Nebraska Medical Center, Omaha, Nebraska, United States|Nevada Cancer Research Foundation, Las Vegas, Nevada, United States|Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States|Newark Beth Israel Medical Center, Newark, New Jersey, United States|St. Joseph's Hospital and Medical Center, Paterson, New Jersey, United States|Valerie Fund Children's Center at Atlantic Health, Summit, New Jersey, United States|University of New Mexico Cancer Research and Treatment Center, Albuquerque, New Mexico, United States|Children's Hospital at Albany Medical Center, Albany, New York, United States|Albert Einstein Cancer Center at Albert Einstein College of Medicine, Bronx, New York, United States|Brooklyn Hospital Center, Brooklyn, New York, United States|SUNY Downstate Medical Center, Brooklyn, New York, United States|Brookdale University Hospital and Medical Center, Brooklyn, New York, United States|Comprehensive Cancer Center at Maimonides Medical Center, Brooklyn, New York, United States|Schneider Children's Hospital, New Hyde Park, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|New York Weill Cornell Cancer Center at Cornell University, New York, New York, United States|Mount Sinai Medical Center, New York, New York, United States|Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York, United States|James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York, United States|Long Island Cancer Center at Stony Brook University Hospital, Stony Brook, New York, United States|SUNY Upstate Medical University Hospital, Syracuse, New York, United States|New York Medical College, Valhalla, New York, United States|Mission Hospitals - Memorial Campus, Asheville, North Carolina, United States|Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States|Blumenthal Cancer Center at Carolinas Medical Center, Charlotte, North Carolina, United States|Presbyterian Cancer Center at Presbyterian Hospital, Charlotte, North Carolina, United States|Duke Comprehensive Cancer Center, Durham, North Carolina, United States|Leo W. Jenkins Cancer Center at Pitt County Memorial Hospital, Greenville, North Carolina, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|Dakota Cancer Institute at Innovis Health - Dakota Clinic, Fargo, North Dakota, United States|Children's Hospital Medical Center of Akron, Akron, Ohio, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University, Cleveland, Ohio, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|Columbus Children's Hospital, Columbus, Ohio, United States|Children's Medical Center - Dayton, Dayton, Ohio, United States|Toledo Children's Hospital, Toledo, Ohio, United States|St. Vincent Mercy Medical Center, Toledo, Ohio, United States|Tod Children's Hospital - Forum Health, Youngstown, Ohio, United States|Children's Hospital at Oklahoma University Medical Center, Oklahoma City, Oklahoma, United States|Natalie Warren Bryant Cancer Center at St. Francis Hospital, Tulsa, Oklahoma, United States|CCOP - Columbia River Oncology Program, Portland, Oregon, United States|Legacy Emanuel Hospital and Health Center & Children's Hospital, Portland, Oregon, United States|Doernbecher Children's Hospital at Oregon Health & Science University, Portland, Oregon, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Penn State Children's Hospital, Hershey, Pennsylvania, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|St. Christopher's Hospital for Children, Philadelphia, Pennsylvania, United States|Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina, United States|Palmetto Health South Carolina Cancer Center, Columbia, South Carolina, United States|Children's Hospital of Greenville Hospital System, Greenville, South Carolina, United States|Avera Cancer Institute, Sioux Falls, South Dakota, United States|Sioux Valley Hospital and University of South Dakota Medical Center, Sioux Falls, South Dakota, United States|East Tennessee State University Cancer Center at Johnson City Medical Center, Johnson City, Tennessee, United States|East Tennessee Children's Hospital, Knoxville, Tennessee, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, United States|Vanderbilt Children's Hospital, Nashville, Tennessee, United States|Texas Tech University Health Sciences Center School of Medicine, Amarillo, Texas, United States|Children's Hospital of Austin, Austin, Texas, United States|Medical City Dallas Hospital, Dallas, Texas, United States|Simmons Cancer Center at University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States|Cook Children's Medical Center - Fort Worth, Fort Worth, Texas, United States|University of Texas Medical Branch, Galveston, Texas, United States|M.D. Anderson Cancer Center at University of Texas, Houston, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|San Antonio Military Pediatric Cancer and Blood Disorders Center, Lackland Air Force Base, Texas, United States|Covenant Children's Hospital, Lubbock, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|MBCCOP - South Texas Pediatrics, San Antonio, Texas, United States|Methodist Cancer Center at Methodist Specialty and Transplant Hospital, San Antonio, Texas, United States|CCOP - Scott and White Hospital, Temple, Texas, United States|Center for Cancer Prevention and Care at Scott and White Clinic, Temple, Texas, United States|Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah, United States|Vermont Cancer Center at University of Vermont, Burlington, Vermont, United States|University of Virginia Cancer Center, Charlottesville, Virginia, United States|INOVA Fairfax Hospital, Falls Church, Virginia, United States|Children's Hospital of the King's Daughters, Norfolk, Virginia, United States|Naval Medical Center - Portsmouth, Portsmouth, Virginia, United States|Massey Cancer Center at Virginia Commonwealth University, Richmond, Virginia, United States|Carilion Medical Center for Children at Roanoke Community Hospital, Roanoke, Virginia, United States|Children's Hospital and Regional Medical Center - Seattle, Seattle, Washington, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, United States|Group Health Central Hospital, Seattle, Washington, United States|Deaconess Medical Center, Spokane, Washington, United States|Mary Bridge Children's Hospital and Health Center - Tacoma, Tacoma, Washington, United States|Madigan Army Medical Center, Tacoma, Washington, United States|West Virginia University - Robert C. Byrd Health Sciences Center - Charleston Division, Charleston, West Virginia, United States|Cabell Huntington Hospital, Huntington, West Virginia, United States|Mary Babb Randolph Cancer Center at West Virginia University Hospitals, Morgantown, West Virginia, United States|Bellin Memorial Hospital, Green Bay, Wisconsin, United States|CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay, Wisconsin, United States|St. Vincent Hospital, Green Bay, Wisconsin, United States|Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States|Marshfield Clinic - Marshfield Center, Marshfield, Wisconsin, United States|CCOP - Marshfield Clinic Research Foundation, Marshfield, Wisconsin, United States|Midwest Children's Cancer Center, Milwaukee, Wisconsin, United States|Sydney Children's Hospital, Randwick, New South Wales, Australia|Children's Hospital at Westmead, Westmead, New South Wales, Australia|Royal Children's Hospital, Brisbane, Queensland, Australia|Women's and Children's Hospital, North Adelaide, South Australia, Australia|Royal Children's Hospital, Parkville, Victoria, Australia|Princess Margaret Hospital for Children, Perth, Western Australia, Australia|Alberta Children's Hospital, Calgary, Alberta, Canada|Cross Cancer Institute at University of Alberta, Edmonton, Alberta, Canada|British Columbia Children's Hospital, Vancouver, British Columbia, Canada|CancerCare Manitoba, Winnipeg, Manitoba, Canada|Janeway Children's Health and Rehabilitation Centre, St. John's, Newfoundland and Labrador, Canada|IWK Health Centre, Halifax, Nova Scotia, Canada|McMaster Children's Hospital at Hamilton Health Sciences, Hamilton, Ontario, Canada|Children's Hospital of Western Ontario, London, Ontario, Canada|Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada|Hospital for Sick Children, Toronto, Ontario, Canada|Montreal Children's Hospital at McGill University Health Center, Montreal, Quebec, Canada|Hopital Sainte Justine, Montreal, Quebec, Canada|Centre de Recherche du Centre Hospitalier de l'Universite Laval, Sainte Foy, Quebec, Canada|Allan Blair Cancer Centre at Pasqua Hospital, Regina, Saskatchewan, Canada|Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada|University Medical Center Groningen, Groningen, Netherlands|Starship Children's Health, Auckland, New Zealand|Puerto Rico Cancer Center at University of Puerto Rico - Medical Sciences Campus, San Juan, Puerto Rico|San Jorge Children's Hospital, Santurce, Puerto Rico|Swiss Pediatric Oncology Group Bern, Bern, Switzerland|Swiss Pediatric Oncology Group Geneva, Geneva, Switzerland|Swiss Pediatric Oncology Group Lausanne, Lausanne, Switzerland","https://ClinicalTrials.gov/show/NCT00028795"
1329,"Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma","Withdrawn","No Results Available","Glioblastoma Multiforme|Gliosarcoma|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Glioma","Drug: enzyme-inducing anti-epileptic drugs","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00734864"
1330,"Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma","Completed","No Results Available","Malignant Glioma|Glioblastoma Multiforme|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Mixed Oligoastrocytoma","Drug: IL13-PE38QQR|Procedure: targeted fusion protein therapy|Procedure: surgery","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00064779"
1331,"Genetic Analysis of Brain Tumors","Terminated","No Results Available","Glioma|Glioblastoma Multiforme|Anaplastic Astrocytoma|Oligodendroglioma|Astrocytoma",,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States|Columbia University, New York, New York, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00031538"
1332,"Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas","Completed","Has Results","Anaplastic Astrocytoma|Brain Stem Glioma|Childhood Mixed Glioma|Fibrillary Astrocytoma|Giant Cell Glioblastoma|Glioblastoma|Gliosarcoma|Untreated Childhood Anaplastic Astrocytoma|Untreated Childhood Brain Stem Glioma|Untreated Childhood Fibrillary Astrocytoma|Untreated Childhood Giant Cell Glioblastoma|Untreated Childhood Glioblastoma|Untreated Childhood Gliosarcoma","Radiation: 3-Dimensional Conformal Radiation Therapy|Radiation: Intensity-Modulated Radiation Therapy|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Temozolomide|Drug: Veliparib","Children's Hospital Los Angeles, Los Angeles, California, United States|Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States|Children's National Medical Center, Washington, District of Columbia, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States|Pediatric Brain Tumor Consortium, Memphis, Tennessee, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, United States|Texas Children's Hospital, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01514201"
1333,"Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies","Available","No Results Available","Pancreatic Cancer|Small Bowel Cancer|Colorectal Cancer|Melanoma|Non Small Cell Lung Cancer|Thyroid Cancer|Bladder Cancer|Head and Neck Cancer|Gastric Cancer|Esophageal Cancer|Cholangiocarcinoma|Ovarian Cancer|Hepatocellular Carcinoma|Glioblastoma|MAPK Gene Mutation|KRAS Activating Mutation|BRAF Gene Mutation|NRAS Gene Mutation|HRAS Gene Mutation|MEK Mutation|ERK Mutation","Drug: Ulixertinib (BVD-523)","University of Alabama at Birmingham, Birmingham, Alabama, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States|xCures Inc., San Francisco, California, United States|Providence Saint John's Health Center, Santa Monica, California, United States|University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Franciscan Health, Indianapolis, Indiana, United States|Harold Alfond Center for Cancer Care, Augusta, Maine, United States|Cancer and Leukemia Center, Sterling Heights, Michigan, United States|Nebraska Cancer Specialists, Omaha, Nebraska, United States|Monmouth Medical Center, Long Branch, New Jersey, United States|Duke Health, Durham, North Carolina, United States|Lehigh Valley Health Network, Allentown, Pennsylvania, United States|Texas Oncology - Denton, Denton, Texas, United States|Seattle Cancer Care Alliance, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT04566393"
1334,"Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)","Active, not recruiting","No Results Available","Advanced Solid Tumors|Triple Negative Breast Cancer|Ovarian Cancer|Gastric Cancer|Colorectal Cancer|Glioblastoma|Biliary Tract Cancers|Pancreatic Cancer","Biological: Pembrolizumab|Drug: Lenvatinib","City of Hope ( Site 0002), Duarte, California, United States|Cedars Sinai Medical Center ( Site 0003), Los Angeles, California, United States|University of California Davis Comprehensive Cancer Center ( Site 0005), Sacramento, California, United States|University of Colorado, Anschutz Cancer Pavilion ( Site 0007), Aurora, Colorado, United States|University of Florida-Health Cancer Center-Orlando ( Site 0015), Orlando, Florida, United States|Rutgers Cancer Institute of New Jersey ( Site 0009), New Brunswick, New Jersey, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0023), New York, New York, United States|Sanford Fargo Medical Center ( Site 0059), Fargo, North Dakota, United States|Lehigh Valley Hospital- Cedar Crest ( Site 0047), Allentown, Pennsylvania, United States|Sanford Cancer Center ( Site 0058), Sioux Falls, South Dakota, United States|West Cancer Center - East Campus ( Site 0018), Germantown, Tennessee, United States|Mary Crowley Cancer Research Centers - Medical City Hospital ( Site 0049), Dallas, Texas, United States|Swedish Medical Center ( Site 0021), Seattle, Washington, United States|University of Wisconsin Carbone Cancer Center ( Site 0017), Madison, Wisconsin, United States|Fundacion Favaloro para la Docencia e Investigacion Medica ( Site 2106), Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina|Hospital Aleman ( Site 2100), Buenos Aires, Caba, Argentina|Hospital Britanico de Buenos Aires ( Site 2109), Ciudad de Buenos Aires, Caba, Argentina|Instituto de Oncologia de Rosario ( Site 2105), Rosario, Santa Fe, Argentina|CEMIC ( Site 2104), Buenos Aires, Argentina|IDIM Instituto de Diagnostico e Investigaciones Metabolicas ( Site 2101), Caba, Argentina|Royal Brisbane and Women s Hospital ( Site 0901), Herston, Queensland, Australia|Alfred Health ( Site 0902), Melbourne, Victoria, Australia|Sir Charles Gairdner Hospital ( Site 0903), Nedlands, Western Australia, Australia|BC Cancer - Abbotsford ( Site 0200), Abbotsford, British Columbia, Canada|CancerCare Manitoba ( Site 0201), Winnipeg, Manitoba, Canada|Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0208), Hamilton, Ontario, Canada|Sunnybrook Research Institute ( Site 0207), Toronto, Ontario, Canada|Princess Margaret Cancer Centre ( Site 0202), Toronto, Ontario, Canada|Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0210), Montreal, Quebec, Canada|CHU de Quebec Universite de Laval ( Site 0206), Quebec, Canada|Centro Investigación del Cáncer James Lind ( Site 1203), Temuco, Araucania, Chile|Fundacion Arturo Lopez Perez ( Site 1201), Santiago, Region M. De Santiago, Chile|Pontificia Universidad Catolica de Chile ( Site 1202), Santiago, Region M. De Santiago, Chile|Hospital Clinico Universidad de Chile ( Site 1200), Santiago, Region M. De Santiago, Chile|Fundacion Colombiana de Cancerologia Clinica Vida ( Site 1105), Medellin, Antioquia, Colombia|Instituto Nacional de Cancerologia E.S.E ( Site 1102), Bogota, Distrito Capital De Bogota, Colombia|Oncologos del Occidente S.A. ( Site 1106), Pereira, Risaralda, Colombia|Fundacion Valle del Lili ( Site 1101), Cali, Valle Del Cauca, Colombia|Centre Antoine Lacassagne ( Site 0404), Nice, Alpes-Maritimes, France|Centre Leon Berard ( Site 0405), Lyon, Auvergne, France|Institut Claudius Regaud IUCT Oncopole ( Site 0403), Toulouse, Haute-Garonne, France|Centre Oscar Lambret ( Site 0401), Lille, Nord, France|Institut de Cancerologie de l Ouest Centre Rene Gauducheau ( Site 0402), Saint-Herblain, Val-de-Marne, France|Institut Gustave Roussy ( Site 0400), Villejuif, Val-de-Marne, France|Robert Bosch GmbH ( Site 0307), Stuttgart, Baden-Wurttemberg, Germany|Universitaetsklinikum Regensburg ( Site 0304), Regensburg, Bayern, Germany|Universitaetsklinikum Frankfurt ( Site 0306), Frankfurt am Main, Hessen, Germany|HELIOS Dr. Horst Schmidt Kliniken Wiesbaden ( Site 0301), Wiesbaden, Hessen, Germany|SRH Wald-Klinikum Gera GmbH ( Site 0309), Gera, Thuringen, Germany|Universitaetsklinikum Jena ( Site 0302), Jena, Thuringen, Germany|Soroka Medical Center ( Site 0601), Beer Sheva, Israel|Rambam Medical Center ( Site 0602), Haifa, Israel|Hadassah Ein Kerem Medical Center ( Site 0604), Jerusalem, Israel|Chaim Sheba Medical Center ( Site 0600), Ramat Gan, Israel|Sourasky Medical Center ( Site 0603), Tel Aviv, Israel|Istituto Clinico Humanitas Research Hospital ( Site 1402), Rozzano, Milano, Italy|Policlinico Le Scotte - A.O. Senese ( Site 1401), Siena, Toscana, Italy|Istituto Nazionale Tumori Fondazione Pascale ( Site 1400), Napoli, Italy|Fondazione Policlinico Universitario A. Gemelli ( Site 1403), Roma, Italy|Asan Medical Center ( Site 1002), Songpagu, Seoul, Korea, Republic of|Seoul National University Hospital ( Site 1000), Seoul, Korea, Republic of|Severance Hospital Yonsei University Health System ( Site 1001), Seoul, Korea, Republic of|Arkhangelsk Clinical Oncological Dispensary ( Site 1600), Arkhangelsk, Arkhangel Skaya Oblast, Russian Federation|Russian Oncological Research Center n.a. N.N. Blokhin ( Site 1604), Moscow, Moskva, Russian Federation|Leningrad Regional Oncology Center ( Site 1609), Saint-Petersburg, Sankt-Peterburg, Russian Federation|Scientific Research Oncology Institute n.a. N.N.Petrov ( Site 1610), Saint-Petersburg, Sankt-Peterburg, Russian Federation|City Clinical Oncology Center ( Site 1608), Saint-Petersburg, Sankt-Peterburg, Russian Federation|Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1603), Kazan, Tatarstan, Respublika, Russian Federation|Hospital Clinic i Provincial ( Site 0703), Barcelona, Spain|Hospital Universitario Gregorio Maranon ( Site 0701), Madrid, Spain|Clinica Universitaria de Navarra ( Site 0704), Madrid, Spain|Hospital Ramon y Cajal ( Site 0702), Madrid, Spain|Inselspital Universitaetsspital Bern ( Site 1705), Bern, Berne, Switzerland|Kantonsspital Graubuenden ( Site 1704), Chur, Grisons, Switzerland|Kantonsspital St. Gallen ( Site 1702), St. Gallen, Sankt Gallen, Switzerland|Ospedale Regionale di Bellinzona e Valli ( Site 1703), Bellinzona, Ticino, Switzerland|Hopitaux Universitaires de Geneve HUG ( Site 1701), Geneve, Switzerland|Universitaetsspital Zurich ( Site 1700), Zurich, Switzerland|National Cheng Kung University Hospital ( Site 3003), Tainan, Taiwan|National Taiwan University Hospital ( Site 3000), Taipei, Taiwan|Chulalongkorn University ( Site 5001), Bangkok, Krung Thep Maha Nakhon, Thailand|Ramathibodi Hospital. ( Site 5002), Bangkok, Krung Thep Maha Nakhon, Thailand|Siriraj Hospital ( Site 5003), Bangkok, Krung Thep Maha Nakhon, Thailand|Cambridge University Hospitals NHS Trust ( Site 0803), Cambridge, Cambridgeshire, United Kingdom|Leicester Royal Infirmary. Univ. Hosp. of Leicester NHS Trust ( Site 0804), Leicester, Leicestershire, United Kingdom|Guy's Hospital ( Site 0806), London, London, City Of, United Kingdom|Royal Marsden Hospital (Sutton) ( Site 0800), London, Surrey, United Kingdom|Christie NHS Foundation Trust ( Site 0805), Manchester, United Kingdom","https://ClinicalTrials.gov/show/NCT03797326"
1335,"Bortezomib in Treating Patients With Recurrent Glioma","Terminated","No Results Available","Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Drug: bortezomib","New Approaches to Brain Tumor Therapy Consortium, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00006773"
1336,"Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma","Recruiting","No Results Available","Glioma|Glioma of Brain|Cancer|Pediatric Cancer|Pediatric Brain Tumor|Astrocytoma|Glioblastoma|Hemispheric","Other: Specialized tumor board recommendation","University of California, San Diego Rady Children's Hospital, San Diego, California, United States|University of California, San Francisco, San Francisco, California, United States|Children's National Medical Center, Washington, District of Columbia, United States|University of Florida, Gainesville, Florida, United States|Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States|Johns Hopkins University, Baltimore, Maryland, United States|Children's Hospitals and Clinics of Minneapolis, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|Washington University, Saint Louis, Missouri, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|The Children's Hospital Of Philadelphia, Philadelphia, Pennsylvania, United States|University of Utah, Salt Lake City, Utah, United States|Seattle Children's Hospital, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT03739372"
1337,"Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors","Completed","No Results Available","Efficacy and Safety","Drug: apatinib|Drug: temodar","Neurosurgery, Shandong Cancer Hospital and Institute, Jinan, Shandong, China","https://ClinicalTrials.gov/show/NCT03660761"
1338,"Restricted Calorie Ketogenic Diet as a Treatment in Malignant Tumors","Unknown status","No Results Available","Malignant Tumors","Other: ketogenic diet","the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China","https://ClinicalTrials.gov/show/NCT03160599"
1339,"Improving Goals of Care Discussion in Advanced Cancer Patients","Completed","Has Results","Primary Stage IV Hepatobiliary|Esophageal|Colorectal Cancer|Glioblastoma|Cancer of Stomach|Cancer of Pancreas|Melanoma|Head or Neck Cancer|Stage III|Stage IV|Lung Cancers|Pancreatic Cancers","Behavioral: GoC intervention","Smilow Cancer Hospital, Yale Cancer Center, Yale University, New Haven, Connecticut, United States|Mount Sinai Beth Israel, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Kings County Hospital Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT02374255"
1340,"Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms","Completed","No Results Available","Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Mixed Gliomas|Glioblastoma Multiforme|Recurrent Brain Tumor","Drug: carmustine|Drug: mercaptopurine|Drug: streptozocin",,"https://ClinicalTrials.gov/show/NCT00004688"
1341,"FR901228 in Treating Patients With Recurrent High-Grade Gliomas","Completed","Has Results","Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Drug: depsipeptide","University of California Los Angeles, Los Angeles, California, United States|University of California San Francisco, San Francisco, California, United States|National Cancer Institute Neuro-Oncology Branch, Bethesda, Maryland, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|MD Anderson Cancer Center, Houston, Texas, United States|University of Wisconsin, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00085540"
1342,"Study of Acetazolamide With Temozolomide in Adults With Newly Diagnosed or Recurrent Malignant Glioma","Recruiting","No Results Available","Malignant Glioma of Brain","Drug: Acetazolamide|Drug: Temozolomide","University of Chicago Medical Center, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT03011671"
1343,"BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma","Completed","Has Results","Glioma","Drug: BIBW 2992|Drug: TMZ|Drug: BIBW 2992 plus TMZ","1200.36.0016 Boehringer Ingelheim Investigational Site, Birmingham, Alabama, United States|1200.36.0012 Boehringer Ingelheim Investigational Site, Phoenix, Arizona, United States|1200.36.0005 Boehringer Ingelheim Investigational Site, Duarte, California, United States|1200.36.0014 Boehringer Ingelheim Investigational Site, Los Angeles, California, United States|1200.36.0019 Boehringer Ingelheim Investigational Site, Orlando, Florida, United States|1200.36.0023 Boehringer Ingelheim Investigational Site, Atlanta, Georgia, United States|1200.36.0008 Boehringer Ingelheim Investigational Site, Louisville, Kentucky, United States|1200.36.0002 Boehringer Ingelheim Investigational Site, Boston, Massachusetts, United States|1200.36.0003 Boehringer Ingelheim Investigational Site, Detroit, Michigan, United States|1200.36.0009 Boehringer Ingelheim Investigational Site, New York, New York, United States|1200.36.0001 Boehringer Ingelheim Investigational Site, Durham, North Carolina, United States|1200.36.0007 Boehringer Ingelheim Investigational Site, Charleston, South Carolina, United States|1200.36.0020 Boehringer Ingelheim Investigational Site, Memphis, Tennessee, United States|1200.36.0017 Boehringer Ingelheim Investigational Site, Dallas, Texas, United States|1200.36.0010 Boehringer Ingelheim Investigational Site, Houston, Texas, United States|1200.36.0011 Boehringer Ingelheim Investigational Site, Charlottesville, Virginia, United States|1200.36.0022 Boehringer Ingelheim Investigational Site, Seattle, Washington, United States|1200.36.1005 Boehringer Ingelheim Investigational Site, Calgary, Alberta, Canada|1200.36.1010 Boehringer Ingelheim Investigational Site, Winnipeg, Manitoba, Canada|1200.36.1009 Boehringer Ingelheim Investigational Site, Moncton, New Brunswick, Canada|1200.36.1011 Boehringer Ingelheim Investigational Site, Halifax, Nova Scotia, Canada|1200.36.1008 Boehringer Ingelheim Investigational Site, Hamilton, Ontario, Canada|1200.36.1001 Boehringer Ingelheim Investigational Site, Kingston, Ontario, Canada|1200.36.1003 Boehringer Ingelheim Investigational Site, Toronto, Ontario, Canada|1200.36.1004 Boehringer Ingelheim Investigational Site, Toronto, Ontario, Canada|1200.36.1007 Boehringer Ingelheim Investigational Site, Fleurimont, Quebec, Canada|1200.36.1002 Boehringer Ingelheim Investigational Site, Montreal, Quebec, Canada|1200.36.1006 Boehringer Ingelheim Investigational Site, Quebec, Canada","https://ClinicalTrials.gov/show/NCT00727506"
1344,"Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22","Recruiting","No Results Available","Glioblastoma Multiforme|Fibrillary Astrocytoma of Brain|Glioma of Brainstem|Anaplastic Astrocytoma|Pilomyxoid Astrocytoma|Mixed Oligodendroglioma-Astrocytoma|Brain Stem Glioma|Diffuse Intrinsic Pontine Glioma","Drug: SIACI of Erbitux and Bevacizumab","Weill Cornell Medical College/New York Presbyterian Hospital, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01884740"
1345,"Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor","Completed","No Results Available","Brain Tumor|Glioblastoma|Medulloblastoma|Ependymoma|Anaplastic Astrocytoma","Biological: Dendritic Cells|Drug: Imiquimod","Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States","https://ClinicalTrials.gov/show/NCT01171469"
1346,"Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas","Completed","Has Results","Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor|Anaplastic Oligoastrocytoma","Biological: E. coli CD-expressing genetically modified neural stem cells|Drug: flucytosine|Drug: leucovorin calcium|Other: pharmacological study|Other: laboratory biomarker analysis","City of Hope Medical Center, Duarte, California, United States","https://ClinicalTrials.gov/show/NCT02015819"
1347,"A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer","Not yet recruiting","No Results Available","Non-small Cell Lung Cancer|Metastatic Colorectal Cancer|Metastatic Breast Cancer|Metastatic Kidney Cancer|Cervical Cancer|Epithelial Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer","Drug: Zirabev",,"https://ClinicalTrials.gov/show/NCT04889495"
1348,"Afatinib (BIBW 2992) QTcF Trial in Patients With Relapsed or Refractory Solid Tumours","Completed","Has Results","Neoplasms","Drug: BIBW 2992","1200.24.4403 Boehringer Ingelheim Investigational Site, Guildford, United Kingdom|1200.24.4402 Boehringer Ingelheim Investigational Site, London, United Kingdom|1200.24.4404 Boehringer Ingelheim Investigational Site, London, United Kingdom|1200.24.4401 Boehringer Ingelheim Investigational Site, Sutton, United Kingdom","https://ClinicalTrials.gov/show/NCT00875433"
1349,"Fimepinostat in Treating Brain Tumors in Children and Young Adults","Recruiting","No Results Available","Diffuse Intrinsic Pontine Glioma|Recurrent Anaplastic Astrocytoma|Recurrent Glioblastoma|Recurrent Malignant Glioma|Recurrent Medulloblastoma","Drug: Fimepinostat|Procedure: Therapeutic Conventional Surgery","Rady Children's Hospital, San Diego, California, United States|University of California, San Francisco, San Francisco, California, United States|Children's National Medical Center, Washington, District of Columbia, United States|University of Florida, Gainesville, Florida, United States|Lurie Children's Hospital of Chicago, Chicago, Illinois, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|University of Michigan Hospital, Ann Arbor, Michigan, United States|Children's Minnesota Research Institute, Minneapolis, Minnesota, United States|Washington University in St Louis, Saint Louis, Missouri, United States|Nationwide Children's, Columbus, Ohio, United States|Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, United States|Texas Children's Hospital, Houston, Texas, United States|University of Utah, Children's Primary, Salt Lake City, Utah, United States|Seattle Children's Hospital, Seattle, Washington, United States|The University Children's Hospital in Zurich, Zürich, Zurich, Switzerland","https://ClinicalTrials.gov/show/NCT03893487"
1350,"More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery","Withdrawn","No Results Available","Benign Neoplasms, Brain|Brain Cancer|Brain Neoplasms, Benign|Brain Neoplasms, Malignant|Brain Tumor, Primary|Brain Tumor, Recurrent|Brain Tumors|Intracranial Neoplasms|Neoplasms, Brain|Neoplasms, Intracranial|Primary Brain Neoplasms|Primary Malignant Brain Neoplasms|Primary Malignant Brain Tumors|Gliomas|Glioblastoma","Drug: 5-ALA (Gliolan)","Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University Winship Cancer Institute, Atlanta, Georgia, United States|Emory Saint Joseph's Hospital, Atlanta, Georgia, United States|University of Michigan, Ann Arbor, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT01445691"
1351,"INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas","Recruiting","No Results Available","Glioblastoma Multiforme|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|DIPG|High-grade Astrocytoma NOS|CNS Primary Tumor, NOS (Malignant Glioma)","Drug: INCB7839","Children's Hospital Los Angeles, Los Angeles, California, United States|Lucile Packard Children Hospital Stanford University, Palo Alto, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Children's National Medical Center, Washington, District of Columbia, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Lurie Childrens Hospital-Chicago, Chicago, Illinois, United States|National Cancer Institute Pediatric Oncology Branch, Bethesda, Maryland, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Cincinnati Children Hospital Medical Center, Cincinnati, Ohio, United States|Children Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States|St. Jude Children Research Hospital, Memphis, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04295759"
1352,"Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma","Suspended","No Results Available","Anaplastic Astrocytoma|Anaplastic Ganglioglioma|Anaplastic Pleomorphic Xanthoastrocytoma|Glioblastoma|Malignant Glioma|WHO Grade 3 Glioma","Drug: Dabrafenib Mesylate|Radiation: Radiation Therapy|Drug: Trametinib Dimethyl Sulfoxide","Children's Hospital of Alabama, Birmingham, Alabama, United States|Phoenix Childrens Hospital, Phoenix, Arizona, United States|Arkansas Children's Hospital, Little Rock, Arkansas, United States|Kaiser Permanente Downey Medical Center, Downey, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Miller Children's and Women's Hospital Long Beach, Long Beach, California, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|Kaiser Permanente-Oakland, Oakland, California, United States|Children's Hospital of Orange County, Orange, California, United States|Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|UCSF Medical Center-Mission Bay, San Francisco, California, United States|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|Yale University, New Haven, Connecticut, United States|Alfred I duPont Hospital for Children, Wilmington, Delaware, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida, United States|University of Florida Health Science Center - Gainesville, Gainesville, Florida, United States|Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States|Nemours Children's Clinic-Jacksonville, Jacksonville, Florida, United States|University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States|Nicklaus Children's Hospital, Miami, Florida, United States|AdventHealth Orlando, Orlando, Florida, United States|Arnold Palmer Hospital for Children, Orlando, Florida, United States|Nemours Children's Hospital, Orlando, Florida, United States|Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa, Florida, United States|Saint Mary's Hospital, West Palm Beach, Florida, United States|Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, United States|Memorial Health University Medical Center, Savannah, Georgia, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, United States|University of Illinois, Chicago, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Saint Jude Midwest Affiliate, Peoria, Illinois, United States|Riley Hospital for Children, Indianapolis, Indiana, United States|Saint Vincent Hospital and Health Care Center, Indianapolis, Indiana, United States|University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|Norton Children's Hospital, Louisville, Kentucky, United States|Children's Hospital New Orleans, New Orleans, Louisiana, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|Eastern Maine Medical Center, Bangor, Maine, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, United States|Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|Beaumont Children's Hospital-Royal Oak, Royal Oak, Michigan, United States|Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis, Minnesota, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States|Cardinal Glennon Children's Medical Center, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Children's Hospital and Medical Center of Omaha, Omaha, Nebraska, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Morristown Medical Center, Morristown, New Jersey, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, United States|Albany Medical Center, Albany, New York, United States|Montefiore Medical Center - Moses Campus, Bronx, New York, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|State University of New York Upstate Medical University, Syracuse, New York, United States|Mission Hospital, Asheville, North Carolina, United States|Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Children's Hospital Medical Center of Akron, Akron, Ohio, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Rainbow Babies and Childrens Hospital, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Dayton Children's Hospital, Dayton, Ohio, United States|ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Legacy Emanuel Children's Hospital, Portland, Oregon, United States|Oregon Health and Science University, Portland, Oregon, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|Penn State Children's Hospital, Hershey, Pennsylvania, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Prisma Health Richland Hospital, Columbia, South Carolina, United States|BI-LO Charities Children's Cancer Center, Greenville, South Carolina, United States|East Tennessee Childrens Hospital, Knoxville, Tennessee, United States|Saint Jude Children's Research Hospital, Memphis, Tennessee, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States|Dell Children's Medical Center of Central Texas, Austin, Texas, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|Cook Children's Medical Center, Fort Worth, Texas, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States|Children's Hospital of San Antonio, San Antonio, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Scott and White Memorial Hospital, Temple, Texas, United States|Primary Children's Hospital, Salt Lake City, Utah, United States|Children's Hospital of The King's Daughters, Norfolk, Virginia, United States|Seattle Children's Hospital, Seattle, Washington, United States|Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington, United States|Mary Bridge Children's Hospital and Health Center, Tacoma, Washington, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States|HIMA San Pablo Oncologic Hospital, Caguas, Puerto Rico","https://ClinicalTrials.gov/show/NCT03919071"
1353,"[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours","Terminated","No Results Available","Renal Cell Carcinoma|Neuroendocrine Tumours","Drug: 18F-FAZA PET Imaging","Cross Cancer Institute, Edmonton, Alberta, Canada","https://ClinicalTrials.gov/show/NCT00323076"
1354,"HYPONCO - Hypoxia in Brain Tumors","Completed","No Results Available","Anaplastic Glioma","Other: 18F-FMISO PET-scanning","Caen University Hospital, Caen, France","https://ClinicalTrials.gov/show/NCT01200134"
1355,"Phase I/II Trial of Safety and Anti-tumor Efficacy of AXL1717(Picropodophyllin) in the Treatment of Recurrent Malignant Astrocytomas","Unknown status","No Results Available","Glioblastoma|Gliosarcoma|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Anaplastic Oligoastrocytoma|Anaplastic Ependymoma","Drug: AXL1717","Rush University Medical Center, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT01721577"
1356,"Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors","Withdrawn","No Results Available","Malignant Intracranial Tumors|Glioblastoma Multiforme|Anaplastic Astrocytomas|Anaplastic Oligodendrogliomas|Anaplastic Ependymoma","Procedure: Photodynamic therapy using Photosan and LumaCare™ Lamp Model LC-122M","National Taiwan University Hospital, Taipei, Taiwan","https://ClinicalTrials.gov/show/NCT00243490"
1357,"RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma","Terminated","Has Results","Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097|Biological: bevacizumab|Other: laboratory biomarker analysis|Other: pharmacological study","University of California at Los Angeles (UCLA ), Los Angeles, California, United States|University of California San Francisco Medical Center-Parnassus, San Francisco, California, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01189240"
1358,"A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor","Terminated","No Results Available","Head and Neck Squamous Cell Carcinoma|Non-small Cell Lung Cancer|Triple Negative Breast Cancer|Colorectal Carcinoma|Glioblastoma Multiforme","Drug: ABBV-221","Massachusetts General Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|South Texas Accelerated Research Therapeutics, San Antonio, Texas, United States|Fundacion Jimenez Diaz, Madrid, Spain|Hosp Univ Madrid Sanchinarro, Madrid, Spain","https://ClinicalTrials.gov/show/NCT02365662"
1359,"STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain","Active, not recruiting","No Results Available","Metastatic Malignant Neoplasm in the Brain|Metastatic Melanoma|Recurrent Brain Neoplasm|Recurrent Glioblastoma|Recurrent Malignant Glioma","Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: STAT3 Inhibitor WP1066","M D Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01904123"
1360,"Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors","Completed","No Results Available","Astrocytoma, Oligoastrocytoma, Mixed|Ganglioneuroma|Glioma|Ganglioglioma|Glioblastoma Multiforme Glioma","Drug: Irinotecan|Drug: Bevacizumab|Device: FDOPA-PET/MRI imaging","Washington University School of Medicine, St. Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT01999270"
1361,"MK-2206 for Recurrent Malignant Glioma","Withdrawn","No Results Available","Malignant Glioma","Drug: MK-2206","UCLA Medical Center, Los Angeles, California, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Memorial Sloan Kettering, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01249105"
1362,"Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma","Active, not recruiting","No Results Available","Multiple Myeloma|Lymphoma, Large B-Cell, Diffuse|Pleiotropic Pathway Modifier|Glioblastoma|Lymphoma|Primary Central Nervous System Lymphoma","Drug: CC-122","City of Hope Cancer Center, Duarte, California, United States|UCLA Neuro-Oncology Program, Los Angeles, California, United States|University of California, San Francisco, San Francisco, California, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Henry Ford Medical Center - New Center One, Detroit, Michigan, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States|Rutgers Cancer Institute of New Jersey University, New Brunswick, New Jersey, United States|Mount Sinai Hospital, New York, New York, United States|Weill Medical College of Cornell University, New York, New York, United States|MUSC Rheumatology and Immunology Dept., Charleston, South Carolina, United States|Greenville Hospital System, Greenville, South Carolina, United States|Sarah Cannon Research Institute Drug Development Unit, Nashville, Tennessee, United States|Texas Oncology, PA - Dallas 75246, Dallas, Texas, United States|South Texas Accelerated Research Therapeutics, San Antonio, Texas, United States|Swedish Medical Center Cancer Institute Research, Seattle, Washington, United States|Yakima Valley Memorial Hospital/ North Star Lodge, Yakima, Washington, United States|Cliniques Universitaires Saint-Luc, Bruxelles, Belgium|UZ Leuven, Leuven, Belgium|CU CHU Clemenceau, Caen Cedex, France|Paoli CalmettesHematology, Marseille le Cedex, France|Centre Hospitalier Lyon Sud, Pierre Bénite, France|Institut universitaire du cancer de Toulouse (IUCT) - Oncopole, Toulouse CEDEX 9, France|Institut Gustave Roussy, Villejuif Cedex, France|A.O.U. di Bologna Policlinico S.Orsola-Malpighi, Bologna, Italy|U.O.C. Ospedale Bellaria, Bologna, Italy|Istituto Nazionale Tumori, Milan, Italy|Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Fondazione Giovanni Pascale, Napoli, Campania, Italy|Istituto Nazionale Tumori Regina Elena, Struttura Complessa Ematologia ed Unita di Cellule Staminali, Roma, Italy|Istituto Clinico Humanitas, Rozzano (MI), Italy|Hospital Universitari Germans Trias i Pujol, Badalona (Barcelona), Spain|Hospital del Mar, Barcelona, Spain|Vall d´Hebron University Hospital, Barcelona, Spain|Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain|Hospital 12 de Octubre, Madrid, Spain|Clinica Universidad de Navarra, Pamplona, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital Virgen del Rocio, Sevilla, Spain|Hospital Universitario Clinico de Valencia, Valencia, Spain","https://ClinicalTrials.gov/show/NCT01421524"
1363,"HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors","Recruiting","No Results Available","Neoplasms, Brain|Glioblastoma Multiforme|Glioblastoma of Cerebellum|Neoplasms|Astrocytoma|Astrocytoma, Cerebellar|Neuroectodermal Tumors|Neuroectodermal Tumors, Primitive|Cerebellar PNET, Childhood|Cerebellar Neoplasms|Cerebellar Neoplasms, Primary|Cerebellar Neoplasm, Malignant|Cerebellar Neoplasm Malignant Primary|Neoplasm Metastases|Neoplasm Malignant|Neoplasms, Neuroepithelial|Neoplasms, Germ Cell and Embryonal|Neoplasms by Histologic Type|Neoplasms, Glandular and Epithelial|Neoplasms, Nerve Tissue|Central Nervous System Neoplasms, Primary|Central Nervous System Neoplasms, Malignant|Nervous System Neoplasms|Neoplasms by Site|Brain Diseases|Central Nervous System Diseases|Nervous System Diseases|Medulloblastoma Recurrent|HSV|Virus|Pediatric Brain Tumor|Nervous System Cancer|Primitive Neuroectodermal Tumor (PNET) of Cerebellum","Biological: G207","Children's of Alabama, Birmingham, Alabama, United States","https://ClinicalTrials.gov/show/NCT03911388"
1364,"Cellular Immunotherapy Study for Brain Cancer","Completed","No Results Available","Gliomas|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Anaplastic Mixed Glioma|Glioblastoma Multiforme|Malignant Meningioma","Drug: alloreactive CTL","University of California, Los Angeles, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT01144247"
1365,"VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide","Completed","Has Results","Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Biological: ziv-aflibercept|Other: pharmacological study|Other: laboratory biomarker analysis","University of California Los Angeles, Los Angeles, California, United States|University of California San Francisco, San Francisco, California, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|M D Anderson Cancer Center, Houston, Texas, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00369590"
1366,"Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma","Completed","No Results Available","Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Drug: sorafenib tosylate|Other: pharmacological study","University of Alabama at Birmingham, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Emory University/Winship Cancer Institute, Atlanta, Georgia, United States|Adult Brain Tumor Consortium, Baltimore, Maryland, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00093613"
1367,"ONC206 for Treatment of Newly Diagnosed, or Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant Brain Tumors (PNOC 023)","Recruiting","No Results Available","Diffuse Midline Glioma (DMG)|Malignant Brain Tumors|Glioblastoma|Recurrent Ependymoma|Recurrent Malignant Brain Neoplasm|Spinal Cord Glioma|WHO Grade III Glioma","Drug: ONC206|Radiation: Standard of Care Radiation Therapy","University of California, San Francisco, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT04732065"
1368,"Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)","Recruiting","No Results Available","Brain Tumor, Recurrent|Brain Tumor|Brain Tumor, Primary|Brain Tumor - Metastatic|Brain Tumor, Adult: Glioblastoma|Brain Tumor, Adult Meningioma","Device: GammaTile","HonorHealth Research Institute, Phoenix, Arizona, United States|Miami Cancer Institute, Baptist Health South Florida, Miami, Florida, United States|Piedmont Healthcare, Atlanta, Georgia, United States|Abbott Northwestern Hospital, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|University of North Carolina Health, Chapel Hill, North Carolina, United States|Vidant, Greenville, North Carolina, United States|UT Southwestern Medical Center, Dallas, Texas, United States|Univertity of Texas Healthy Science Center of San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT04427384"
1369,"ALBATROSS Study: International Multicenter Study for Prospective Validation of Imaging Biomarkers Calculated at Vascular Habitats of High-grade Gliomas","Recruiting","No Results Available","Astrocytoma, Grade IV",,"Universitat Politècnica de València, Valencia, Spain","https://ClinicalTrials.gov/show/NCT05229198"
1370,"Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma","Terminated","Has Results","Brain Tumor|Anaplastic Astrocytoma|Anaplastic Ependymoma|Anaplastic Oligodendroglioma|Brain Stem Glioma|Giant Cell Glioblastoma|Glioblastoma|Gliosarcoma|Mixed Glioma","Drug: ritonavir|Drug: lopinavir","Cleveland Clinic Taussig Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT01095094"
1371,"Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2","Completed","No Results Available","Anaplastic Astrocytoma|Anaplastic Ependymoma|Anaplastic Meningioma|Anaplastic Oligodendroglioma|Brain Stem Glioma|Ependymoblastoma|Giant Cell Glioblastoma|Glioblastoma|Gliosarcoma|Grade III Meningioma|Meningeal Hemangiopericytoma|Mixed Glioma|Pineal Gland Astrocytoma|Brain Tumor","Biological: therapeutic allogeneic lymphocytes|Biological: aldesleukin|Other: laboratory biomarker analysis|Procedure: positron emission tomography","City of Hope, Duarte, California, United States","https://ClinicalTrials.gov/show/NCT01082926"
1372,"Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations","Recruiting","No Results Available","Advanced Malignant Solid Neoplasm|Glioblastoma|Recurrent Cholangiocarcinoma|Recurrent Glioma|Recurrent Malignant Solid Neoplasm|WHO Grade 2 Glioma|WHO Grade 3 Glioma","Drug: Olaparib","UC Irvine Health Cancer Center-Newport, Costa Mesa, California, United States|Los Angeles County-USC Medical Center, Los Angeles, California, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States|USC Norris Oncology/Hematology-Newport Beach, Newport Beach, California, United States|UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States|Stanford Cancer Institute Palo Alto, Palo Alto, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|Smilow Cancer Center/Yale-New Haven Hospital, New Haven, Connecticut, United States|Yale University, New Haven, Connecticut, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States|UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States|University of Florida Health Science Center - Gainesville, Gainesville, Florida, United States|University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States|Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|Emory Saint Joseph's Hospital, Atlanta, Georgia, United States|University of Kansas Clinical Research Center, Fairway, Kansas, United States|University of Kansas Cancer Center, Kansas City, Kansas, United States|University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States|University of Kansas Hospital-Indian Creek Campus, Overland Park, Kansas, United States|University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States|University of Kansas Cancer Center - North, Kansas City, Missouri, United States|University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States|University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Siteman Cancer Center-South County, Saint Louis, Missouri, United States|Siteman Cancer Center at Christian Hospital, Saint Louis, Missouri, United States|Siteman Cancer Center at Saint Peters Hospital, Saint Peters, Missouri, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States|Vanderbilt Breast Center at One Hundred Oaks, Nashville, Tennessee, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States|M D Anderson Cancer Center, Houston, Texas, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT03212274"
1373,"A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)","Active, not recruiting","No Results Available","Diffuse Intrinsic Pontine Glioma|Malignant Glioma of Brain|High Grade Glioma|Bithalamic High Grade Glioma|Brainstem Glioma|Glioblastoma|Anaplastic Astrocytoma","Drug: ribociclib|Drug: Everolimus","Children's National Medical Center, Washington, District of Columbia, United States|Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States|Levine Cancer Institute, Charlotte, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Texas Children's Hospital, Houston, Texas, United States|Seattle Children's Hospital, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT03355794"
1374,"Implantable Microdevice In Primary Brain Tumors","Recruiting","No Results Available","Grade II Glioma|Grade III Glioma|Grade IV Glioma|Astrocytoma|Oligodendroglioma of Brain|Anaplastic Astrocytoma of Brain|Anaplastic Oligodendroglioma|Glioblastoma","Combination Product: Microdevice","Brigham and Women's Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT04135807"
1375,"Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors","Completed","No Results Available","Brain Neoplasms, Malignant|Brain Neoplasms, Benign|Malignant Meningioma|Glioblastoma Multiforme|Anaplastic Astrocytoma","Drug: pioglitazone|Drug: Pioglitazone","Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01151670"
1376,"3T MRI Biomarkers of Glioma Treatment Response","Terminated","No Results Available","Adult Anaplastic Astrocytoma|Adult Anaplastic Ependymoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor","Device: 3-Tesla magnetic resonance imaging|Device: CEST-MRI|Device: DW-MRI|Device: DCE-MRI|Device: DSC-MRI|Drug: IV administration of gadolinium-containing contrast agent","Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT01996527"
1377,"Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma","Completed","No Results Available","Glioma|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Anaplastic Oligoastrocytoma|Glioblastoma Multiforme|Astrocytoma, Grade III|Astrocytoma, Grade IV|Brain Cancer","Biological: Neural stem cells loaded with an oncolytic adenovirus","City of Hope, Duarte, California, United States|Northwestern Memorial Hospital, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT03072134"
1378,"RO4929097 in Treating Patients With Recurrent Invasive Gliomas","Terminated","No Results Available","Adult Anaplastic Oligodendroglioma|Adult Brain Stem Glioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Recurrent Adult Brain Tumor","Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097|Procedure: therapeutic conventional surgery|Other: pharmacological study|Other: laboratory biomarker analysis","University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT01269411"
1379,"A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma","Completed","No Results Available","Advanced Malignancy|Advanced Solid Tumors|Cancer|Oncology|Oncology Patients|Tumors|Glioblastoma|Multiple Myeloma","Drug: AMG 232","Research Site, Santa Monica, California, United States|Research Site, Norwalk, Connecticut, United States|Research Site, Boston, Massachusetts, United States|Research Site, Boston, Massachusetts, United States|Research Site, Hackensack, New Jersey, United States|Research Site, New Brunswick, New Jersey, United States|Research Site, New York, New York, United States|Greenville Hospital System, Greenville, South Carolina, United States|Research Site, Greenville, South Carolina, United States|Research Site, Lyon CEDEX 08, France|Research Site, Villejuif, France|Research Site, Amsterdam, Netherlands|Research Site, Rotterdam, Netherlands|Research Site, Utrecht, Netherlands","https://ClinicalTrials.gov/show/NCT01723020"
1380,"APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors","Recruiting","No Results Available","Solid Tumor|Advanced Cancer|Renal Cancer|Gastric Cancer|Gastroesophageal Junction Adenocarcinoma|NSCLC|Lung Cancer|Brain Tumor|Glioblastoma Multiforme","Drug: APL-101 Oral Capsules","Banner MD Anderson, Gilbert, Arizona, United States|Mayo Clinic, Phoenix, Arizona, United States|Loma Linda University Medical Center, Loma Linda, California, United States|University of Southern California / Norris Comprehensive Cancer Center, Los Angeles, California, United States|Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, United States|University of California, Los Angeles (UCLA) Ronald Reagan Medical Center, Los Angeles, California, United States|Kaiser Permanente - CA, Riverside, California, United States|St. Joseph Health, Santa Rosa, California, United States|Kaiser Permanente - Vallejo, Vallejo, California, United States|Christiana Hospital, Newark, Delaware, United States|Florida Cancer Specialists - South, Fort Myers, Florida, United States|Mayo Clinic, Jacksonville, Florida, United States|Florida Hospital Cancer Institute, Orlando, Florida, United States|Florida Cancer Specialists - North, Saint Petersburg, Florida, United States|Florida Cancer Specialists, Tallahassee, Florida, United States|Moffitt, Tampa, Florida, United States|Florida Cancer Specialists, West Palm Beach, Florida, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Maryland Oncology Hematology, Silver Spring, Maryland, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Mayo Clinic, Rochester, Minnesota, United States|Park Nicollet Institute - Frauenshuh Cancer Center, Saint Louis Park, Minnesota, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Cleveland Clinic, Cleveland, Ohio, United States|The Ohio State University (OSU), Columbus, Ohio, United States|Kettering Health Network, Kettering, Ohio, United States|Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|St. Francis Cancer Center, Greenville, South Carolina, United States|Sarah Cannon and HCA Research Institute, Nashville, Tennessee, United States|The Don & Sybil Harrington Cancer Center, Amarillo, Texas, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States|MultiCare Health System, Tacoma, Washington, United States|West Virginia University Cancer Institute, Morgantown, West Virginia, United States|University of Wisconsin, Madison, Wisconsin, United States|Flinders Medical Centre, Bedford Park, South Australia, Australia|Border Medical Oncology, Albury, Australia|St Vincents Hospital Melbourne, Melbourne, Australia|Sir Charles Gairdner Hospital, Nedlands, Australia|Calvary Central Districts Hospita, North Adelaide, Australia|Lady Davis Institute for Medical Research Jewish General Hospital, Montreal, Quebec, Canada|Cross Cancer Institute, Edmonton, Canada|McGill University Health Center - Research Institute, Montréal, Canada|Princess Margaret Hospital, Toronto, Canada|Cancer Care Manitoba, Winnipeg, Canada|Helsinki University Central Hospita, Helsinki, Finland|Tampere University Hospital, Tampere, Finland|CHRU de Brest - Hôpital Morvan, Brest, France|CHRU de Lille, Lille, France|Centre Leon Berard, Lyon, France|Hopital Bichat - Claude Bernard - AP-HP, Paris, France|CHU Rennes - Hopital Pontchaillou, Rennes, France|Gustave Roussy, Villejuif, France|Szent Borbala Korhaz, Tatabanya, Hungary|Torokbalinti Tudogyogyintezet, Torokbalint, Hungary|Azienda Ospedaliero Universitaria Policlinico G. Rodolico-San Marco - Presidio Ospedaliero G. Rodolico, Catania, Italy|Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy|Istituto Europeo di Oncologia, Milano, Italy|IRCCS Ospedale San Raffaele, Milan, Italy|PanOncology Trials, LLC, Rio Piedras, Puerto Rico|Arkhangelsk Clinical Oncological Dispensary, Arkhangelsk, Russian Federation|Private Medical Institution Euromedservice, Saint Petersburg, Russian Federation|Saint-Petersburg Clinical Research Center of Specialized Types of Medical Care (Oncology), Saint Petersburg, Russian Federation|Ogarev Mordovia State University, Saransk, Russian Federation|JSC Current Medical Technologies, St. Petersburg, Russian Federation|Volgograd Regional Clinical Oncology Dispensary, Volgograd, Russian Federation|National Cancer Centre Singapore, Singapore, Singapore|Oncocare Cancer Centre, Singapore, Singapore|Tan Tock Seng Hospital, Singapore, Singapore|Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Clinic Barcelona, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Institut Catala d'Oncologia - L'Hospitalet, Barcelona, Spain|Hospital General Universitario Gregorio Maranon, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Universitario Central de Asturias, Oviedo, Spain|Hospital Universitario Donostia, San Sebastián, Spain|Hospital Universitario Virgen del Rocio, Sevilla, Spain|Instituto Valenciano de Oncologia, Valencia, Spain|Taipei Medical University - Shuang Ho Hospital, New Taipei City, Taiwan|Chi-Mei Hospital - Liouying Branch, Tainan, Taiwan|National Taiwan University Hospital, Taipei City, Taiwan|Taipei Medical University Hospital, Taipei, Taiwan|Linkou Chang Gung Memorial Hospital (CGMHLK), Taoyuan City, Taiwan|City Hematology Center of Municipal Non-Profit Enterprise ""City Clinical Hospital #4"" DCC, Dnipropetrovs'k, Ukraine|Communal Non-commercial Enterprise of Kharkiv Regional Council Regional Clinical Specialized Dispensary of Radiation Protection of Population, Department of Surger, Kharkiv, Ukraine|State Institution V.T.Zaitsev Institute of General and Urgent Surgery of National Academy of Medical Sciences of Ukraine, Department of Purulent Surgery, Kharkiv, Ukraine|Kyiv Municipal Clinical Oncology Center, Kyiv, Ukraine|Imperial College Healthcare NHS Trust, London, United Kingdom|The Christie NHS Foundation Trust, Manchester, United Kingdom|Royal Marsden Hospital - Surrey, Surrey Quays, United Kingdom","https://ClinicalTrials.gov/show/NCT03175224"
1381,"Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma","Terminated","No Results Available","Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Diffuse Astrocytoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Adult Oligodendroglioma|Recurrent Adult Brain Tumor","Drug: erlotinib hydrochloride|Drug: isotretinoin|Other: laboratory biomarker analysis|Genetic: protein expression analysis","Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01103375"
1382,"Sunitinib in Treating Patients With Recurrent Malignant Gliomas","Completed","Has Results","Adult Anaplastic Astrocytoma|Adult Diffuse Astrocytoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Adult Oligodendroglioma|Adult Pineal Gland Astrocytoma","Drug: sunitinib malate|Other: pharmacological study","Ohio State University Medical Center, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT00499473"
1383,"Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma","Completed","Has Results","Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Diffuse Astrocytoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Adult Pilocytic Astrocytoma|Adult Pineal Gland Astrocytoma|Adult Subependymal Giant Cell Astrocytoma|Recurrent Adult Brain Tumor","Drug: erlotinib|Drug: temsirolimus|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Other: pharmacological study","University of California Los Angeles, Los Angeles, California, United States|University of California San Francisco, San Francisco, California, United States|National Cancer Institute Neuro-Oncology Branch, Bethesda, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|M D Anderson Cancer Center, Houston, Texas, United States|University of Texas Health Science Center, San Antonio, Texas, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00112736"
1384,"Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms","Recruiting","No Results Available","Central Nervous System Neoplasms|Glioblastoma|Gliosarcoma, Adult|Anaplastic Oligodendroglioma|Anaplastic Astrocytoma|Pilocytic Astrocytoma|Oligodendroglioma|Gliomatosis Cerebri|Pleomorphic Xanthoastrocytoma|Anaplastic Pleomorphic Xanthoastrocytoma|Diffuse Midline Glioma, H3 K27M-Mutant|Ependymoma|Ependymoma, Anaplastic|Medulloblastoma|Teratoid Rhabdoid Tumor|Neuroectodermal Tumors, Primitive|Neuroectodermal Tumors|Anaplastic Meningioma|Atypical Meningioma|Choroid Plexus Neoplasms|Pineal Tumor|Diffuse Astrocytoma|Glial Tumor","Drug: ONC206","National Institutes of Health, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT04541082"
1385,"Dendritic Cell Vaccination for Patients With Solid Tumors","Unknown status","No Results Available","Glioblastoma|Renal Cell Carcinoma|Sarcomas|Breast Cancers|Malignant Mesothelioma|Colorectal Tumors","Biological: autologous dendritic cell vaccination","Antwerp University Hospital, Center for Cellular Therapy and Regenerative Medicine, Edegem, Antwerp, Belgium","https://ClinicalTrials.gov/show/NCT01291420"
1386,"Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery","Terminated","No Results Available","Recurrent Childhood Anaplastic Astrocytoma|Recurrent Childhood Anaplastic Oligoastrocytoma|Recurrent Childhood Anaplastic Oligodendroglioma|Recurrent Childhood Giant Cell Glioblastoma|Recurrent Childhood Glioblastoma|Recurrent Childhood Gliomatosis Cerebri|Recurrent Childhood Gliosarcoma","Biological: oncolytic HSV-1716|Drug: dexamethasone|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis","Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT02031965"
1387,"Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies","Completed","No Results Available","Hematological Neoplasms|Non-Hodgkin's Lymphoma|Hodgkin's Lymphoma|Lymphoma|Multiple Myeloma|Acute Myeloid Leukemia|Leukemia|Myelodysplastic Syndromes|Neoplasms|Melanoma|Breast Cancer|Metastatic Breast Cancer|Non-Small Cell Lung Cancer|Small Cell Lung Cancer|Renal Cell Carcinoma|Glioblastoma Multiforme|Osteosarcoma|Sarcoma|Thyroid Cancer|Genitourinary","Drug: CC-486|Drug: Vidaza","Scottsdale Healthcare Research Institute, Scottsdale, Arizona, United States|Mayo Clinic - Arizona, Scottsdale, Arizona, United States|University of Arizona Cancer Center, Tucson, Arizona, United States|University of Iowa, Iowa City, Iowa, United States|Henry Ford Health System, Detroit, Michigan, United States|Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Greenville Hospital System, Greenville, South Carolina, United States|Vanderbilt- Ingram Cancer Center, Nashville, Tennessee, United States|The Methodist Hospital Research Institute l, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02223052"
1388,"A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors","Recruiting","No Results Available","Basal Cell Carcinoma|Medulloblastoma|Adenocarcinoma of Esophagogastric Junction|Small Cell Lung Cancer|Neuroendocrine Neoplasm|Glioblastoma","Drug: ZSP1602","Jilin Cancer Hospital, Chang Chun, Jilin, China","https://ClinicalTrials.gov/show/NCT03734913"
1389,"Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy","Completed","Has Results","Childhood High-grade Cerebellar Astrocytoma|Childhood High-grade Cerebral Astrocytoma|Recurrent Childhood Anaplastic Astrocytoma|Recurrent Childhood Anaplastic Oligoastrocytoma|Recurrent Childhood Anaplastic Oligodendroglioma|Recurrent Childhood Brain Tumor|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Glioblastoma|Recurrent Childhood Visual Pathway and Hypothalamic Glioma","Drug: cilengitide|Other: laboratory biomarker analysis|Other: pharmacological study","Kaiser Permanente-Oakland, Oakland, California, United States|University of California San Francisco Medical Center-Parnassus, San Francisco, California, United States|Lombardi Comprehensive Cancer Center at Georgetown University, Washington, District of Columbia, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States|Newark Beth Israel Medical Center, Newark, New Jersey, United States|Montefiore Medical Center, Bronx, New York, United States|New York University Langone Medical Center, New York, New York, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Children's Hospital Medical Center of Akron, Akron, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Palmetto Health Richland, Columbia, South Carolina, United States|T C Thompson Children's Hospital, Chattanooga, Tennessee, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, United States|Seattle Children's Hospital, Seattle, Washington, United States|Midwest Children's Cancer Center, Milwaukee, Wisconsin, United States|CancerCare Manitoba, Winnipeg, Manitoba, Canada","https://ClinicalTrials.gov/show/NCT00679354"
1390,"Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas","Active, not recruiting","No Results Available","Anaplastic Astrocytoma|Anaplastic Oligoastrocytoma|Diffuse Intrinsic Pontine Glioma|Diffuse Midline Glioma, H3 K27M-Mutant|Glioblastoma|Gliosarcoma","Drug: Adavosertib|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Radiation: Radiation Therapy","Children's Hospital of Alabama, Birmingham, Alabama, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Children's Hospital of Orange County, Orange, California, United States|UCSF Medical Center-Parnassus, San Francisco, California, United States|UCSF Medical Center-Mission Bay, San Francisco, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Children's National Medical Center, Washington, District of Columbia, United States|Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, United States|Riley Hospital for Children, Indianapolis, Indiana, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, United States|University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States|Saint Jude Children's Research Hospital, Memphis, Tennessee, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States|Seattle Children's Hospital, Seattle, Washington, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States|Hospital for Sick Children, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT01922076"
1391,"Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors","Recruiting","No Results Available","Medulloblastoma|Astrocytoma, Grade III|Glioblastoma|Anaplastic Astrocytoma|Brain Stem Neoplasms, Malignant|Oligodendroblastoma|Anaplastic Oligodendroglioma|Malignant Glioma","Drug: Mebendazole","Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States|Johns Hopkins University School of Medicine, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT02644291"
1392,"18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas","Terminated","Has Results","Adult Anaplastic Ependymoma|Adult Anaplastic Oligodendroglioma|Adult Brain Stem Glioma|Adult Diffuse Astrocytoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Adult Oligodendroglioma|Adult Pilocytic Astrocytoma|Adult Pineal Gland Astrocytoma|Adult Subependymal Giant Cell Astrocytoma|Childhood High-grade Cerebellar Astrocytoma|Childhood High-grade Cerebral Astrocytoma|Childhood Low-grade Cerebellar Astrocytoma|Childhood Low-grade Cerebral Astrocytoma|Recurrent Adult Brain Tumor|Recurrent Childhood Anaplastic Astrocytoma|Recurrent Childhood Anaplastic Oligoastrocytoma|Recurrent Childhood Anaplastic Oligodendroglioma|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Diffuse Astrocytoma|Recurrent Childhood Fibrillary Astrocytoma|Recurrent Childhood Gemistocytic Astrocytoma|Recurrent Childhood Giant Cell Glioblastoma|Recurrent Childhood Glioblastoma|Recurrent Childhood Gliomatosis Cerebri|Recurrent Childhood Gliosarcoma|Recurrent Childhood Oligoastrocytoma|Recurrent Childhood Oligodendroglioma|Recurrent Childhood Pilomyxoid Astrocytoma|Recurrent Childhood Protoplasmic Astrocytoma|Recurrent Childhood Subependymal Giant Cell Astrocytoma|Recurrent Childhood Visual Pathway and Hypothalamic Glioma|Recurrent Childhood Visual Pathway Glioma|Untreated Childhood Anaplastic Astrocytoma|Untreated Childhood Anaplastic Oligoastrocytoma|Untreated Childhood Anaplastic Oligodendroglioma|Untreated Childhood Brain Stem Glioma|Untreated Childhood Cerebellar Astrocytoma|Untreated Childhood Cerebral Astrocytoma|Untreated Childhood Diffuse Astrocytoma|Untreated Childhood Fibrillary Astrocytoma|Untreated Childhood Gemistocytic Astrocytoma|Untreated Childhood Giant Cell Glioblastoma|Untreated Childhood Glioblastoma|Untreated Childhood Gliomatosis Cerebri|Untreated Childhood Gliosarcoma|Untreated Childhood Oligoastrocytoma|Untreated Childhood Oligodendroglioma|Untreated Childhood Pilomyxoid Astrocytoma|Untreated Childhood Protoplasmic Astrocytoma|Untreated Childhood Subependymal Giant Cell Astrocytoma|Untreated Childhood Visual Pathway and Hypothalamic Glioma|Untreated Childhood Visual Pathway Glioma","Drug: 18F-fluoro-dihydroxyphenylalanine|Procedure: Positron emission tomography (PET)|Procedure: Computed tomography (CT)|Procedure: Magnetic resonance imaging","Stanford University Hospitals and Clinics, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT02175745"
1393,"Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors","Withdrawn","No Results Available","Acoustic Schwannoma|Adult Anaplastic Astrocytoma|Adult Anaplastic Ependymoma|Adult Anaplastic Meningioma|Adult Anaplastic Oligodendroglioma|Adult Brain Stem Glioma|Adult Choroid Plexus Tumor|Adult Craniopharyngioma|Adult Diffuse Astrocytoma|Adult Ependymoblastoma|Adult Ependymoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Grade I Meningioma|Adult Grade II Meningioma|Adult Medulloblastoma|Adult Meningeal Hemangiopericytoma|Adult Mixed Glioma|Adult Myxopapillary Ependymoma|Adult Oligodendroglioma|Adult Papillary Meningioma|Adult Pilocytic Astrocytoma|Adult Pineal Gland Astrocytoma|Adult Pineoblastoma|Adult Pineocytoma|Adult Subependymal Giant Cell Astrocytoma|Adult Subependymoma|Adult Supratentorial Primitive Neuroectodermal Tumor (PNET)|Childhood Choroid Plexus Tumor|Childhood Craniopharyngioma|Childhood Ependymoblastoma|Childhood Grade I Meningioma|Childhood Grade II Meningioma|Childhood Grade III Meningioma|Childhood High-grade Cerebellar Astrocytoma|Childhood High-grade Cerebral Astrocytoma|Childhood Infratentorial Ependymoma|Childhood Low-grade Cerebellar Astrocytoma|Childhood Low-grade Cerebral Astrocytoma|Childhood Medulloepithelioma|Childhood Supratentorial Ependymoma|Meningeal Melanocytoma|Newly Diagnosed Childhood Ependymoma|Recurrent Adult Brain Tumor|Recurrent Childhood Anaplastic Astrocytoma|Recurrent Childhood Anaplastic Oligoastrocytoma|Recurrent Childhood Anaplastic Oligodendroglioma|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Diffuse Astrocytoma|Recurrent Childhood Ependymoma|Recurrent Childhood Fibrillary Astrocytoma|Recurrent Childhood Gemistocytic Astrocytoma|Recurrent Childhood Giant Cell Glioblastoma|Recurrent Childhood Glioblastoma|Recurrent Childhood Gliomatosis Cerebri|Recurrent Childhood Gliosarcoma|Recurrent Childhood Medulloblastoma|Recurrent Childhood Oligoastrocytoma|Recurrent Childhood Oligodendroglioma|Recurrent Childhood Pilocytic Astrocytoma|Recurrent Childhood Pilomyxoid Astrocytoma|Recurrent Childhood Pineoblastoma|Recurrent Childhood Pleomorphic Xanthoastrocytoma|Recurrent Childhood Protoplasmic Astrocytoma|Recurrent Childhood Subependymal Giant Cell Astrocytoma|Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor|Recurrent Childhood Visual Pathway and Hypothalamic Glioma|Recurrent Childhood Visual Pathway Glioma|Untreated Childhood Anaplastic Astrocytoma|Untreated Childhood Anaplastic Oligodendroglioma|Untreated Childhood Brain Stem Glioma|Untreated Childhood Cerebellar Astrocytoma|Untreated Childhood Cerebral Astrocytoma|Untreated Childhood Diffuse Astrocytoma|Untreated Childhood Fibrillary Astrocytoma|Untreated Childhood Gemistocytic Astrocytoma|Untreated Childhood Giant Cell Glioblastoma|Untreated Childhood Glioblastoma|Untreated Childhood Gliomatosis Cerebri|Untreated Childhood Gliosarcoma|Untreated Childhood Medulloblastoma|Untreated Childhood Oligoastrocytoma|Untreated Childhood Oligodendroglioma|Untreated Childhood Pilocytic Astrocytoma|Untreated Childhood Pilomyxoid Astrocytoma|Untreated Childhood Pineoblastoma|Untreated Childhood Pleomorphic Xanthoastrocytoma|Untreated Childhood Protoplasmic Astrocytoma|Untreated Childhood Subependymal Giant Cell Astrocytoma|Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor|Untreated Childhood Visual Pathway and Hypothalamic Glioma|Untreated Childhood Visual Pathway Glioma","Radiation: gallium Ga 68-edotreotide|Procedure: positron emission tomography|Procedure: computed tomography|Other: laboratory biomarker analysis","University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States","https://ClinicalTrials.gov/show/NCT02194452"
1394,"SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors","Recruiting","No Results Available","Anaplastic Astrocytoma|Anaplastic Ependymoma|Anaplastic Ganglioglioma|Anaplastic Meningioma|Anaplastic Oligodendroglioma|Pleomorphic Xanthoastrocytoma, Anaplastic|Atypical Teratoid/Rhabdoid Tumor|Brain Cancer|Brain Tumor|Central Nervous System Neoplasms|Choroid Plexus Carcinoma|CNS Embryonal Tumor With Rhabdoid Features|Ganglioneuroblastoma of Central Nervous System|CNS Tumor|Embryonal Tumor of CNS|Ependymoma|Glioblastoma|Glioma|Glioma, Malignant|Medulloblastoma|Medulloblastoma; Unspecified Site|Medulloepithelioma|Neuroepithelial Tumor|Neoplasms|Neoplasms, Neuroepithelial|Papillary Tumor of the Pineal Region (High-grade Only)|Pediatric Brain Tumor|Pineal Parenchymal Tumor of Intermediate Differentiation (High-grade Only)|Pineoblastoma|Primitive Neuroectodermal Tumor|Recurrent Medulloblastoma|Refractory Brain Tumor|Neuroblastoma. CNS|Glioblastoma, IDH-mutant|Glioblastoma, IDH-wildtype|Medulloblastoma, Group 3|Medulloblastoma, Group 4|Glioma, High Grade|Neuroepithelial Tumor, High Grade|Medulloblastoma, SHH-activated and TP53 Mutant|Medulloblastoma, SHH-activated and TP53 Wildtype|Medulloblastoma, Chromosome 9q Loss|Medulloblastoma, Non-WNT Non-SHH, NOS|Medulloblastoma, Non-WNT/Non-SHH|Medulloblastoma, PTCH1 Mutation|Medulloblastoma, WNT-activated|Ependymoma, Recurrent|Glioma, Recurrent High Grade|Glioma, Recurrent Malignant|Embryonal Tumor, NOS|Glioma, Diffuse Midline, H3K27M-mutant|Embryonal Tumor With Multilayered Rosettes (ETMR)|Ependymoma, NOS, WHO Grade III|Ependymoma, NOS, WHO Grade II|Medulloblastoma, G3/G4|Ependymoma, RELA Fusion Positive","Drug: Gemcitabine|Drug: ribociclib|Drug: sonidegib|Drug: trametinib|Biological: filgrastim","St. Jude Children's Research Hospital, Memphis, Tennessee, United States","https://ClinicalTrials.gov/show/NCT03434262"
1395,"Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors","Completed","No Results Available","Dose Escalation|Safety|Preliminary Efficacy|Advanced Solid Tumors|Metastatic Breast Cancer|Advanced Pancreatic Adenocarcinoma|Metastatic Colorectal Cancer|Recurrent Glioblastoma Multiforme|Gastric Cancer|Gastroesophageal Junction Cancer|Triple Negative Metastatic Breast Cancer|Hormone Receptor Positive (ER+/PR+, and Her2-) Metastatic Breast Cancer","Drug: LDE225|Drug: BKM120","Cedars Sinai Medical Center SC, Los Angeles, California, United States|University of California San Francisco UCSF (SC), San Francisco, California, United States|H. Lee Moffitt Cancer Center & Research Institute Moffitt 4, Tampa, Florida, United States|Dana Farber Cancer Institute Dana SC, Boston, Massachusetts, United States|Mayo Clinic - Rochester Division of Hematology, Rochester, Minnesota, United States|Duke University Medical Center Duke - Baker, Durham, North Carolina, United States|Willamette Valley Clinical Studies Williamette Valley Cancer, Eugene, Oregon, United States|Northwest Cancer Specialists Northwest Cancer, Portland, Oregon, United States|Fox Chase Cancer Center FCCC, Philadelphia, Pennsylvania, United States|Texas Oncology Midtown Texas Oncology, Dallas, Texas, United States|Sammons Cancer Center - Texas Oncology SC-2, Dallas, Texas, United States|University of Texas/MD Anderson Cancer Center SC-3, Houston, Texas, United States|University of Utah / Huntsman Cancer Institute Huntsman, Salt Lake City, Utah, United States|Novartis Investigative Site, Parkville, Victoria, Australia|Novartis Investigative Site, Wilrijk, Belgium|Novartis Investigative Site, Edmonton, Alberta, Canada|Novartis Investigative Site, Essen, Germany|Novartis Investigative Site, Ancona, AN, Italy|Novartis Investigative Site, Milano, MI, Italy|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, Glasgow, United Kingdom|Novartis Investigative Site, Sutton, United Kingdom","https://ClinicalTrials.gov/show/NCT01576666"
1396,"Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors","Terminated","Has Results","Anaplastic Astrocytoma|Anaplastic Ependymoma|Astrocytoma, Grade II|Ependymoma|Giant Cell Glioblastoma|Glioblastoma|Gliosarcoma|Oligodendroglioma|Brainstem Tumors","Drug: imetelstat sodium","Childrens Hospital Los Angeles, Los Angeles, California, United States|Lucile Packard Children's Hospital at Stanford University Medical Center, Palo Alto, California, United States|Children's National Medical Center, Washington, District of Columbia, United States|Lurie Children's Hospital- Chicago, Chicago, Illinois, United States|NCI - Pediatric Oncology Branch, Bethesda, Maryland, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Duke Comprehensive Cancer Center, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States|Saint Jude Children's Research Hospital, Memphis, Tennessee, United States|Texas Children's Cancer Center and Hematology Service at Texas Children's Hospital, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01836549"
1397,"Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma","Completed","No Results Available","Anaplastic Astrocytoma|Anaplastic Oligoastrocytoma|Anaplastic Oligodendroglioma|Giant Cell Glioblastoma|Glioblastoma|Gliosarcoma|Mixed Glioma|Recurrent Brain Neoplasm","Other: Laboratory Biomarker Analysis|Drug: Montanide ISA-51/Survivin Peptide Vaccine|Biological: Sargramostim","Roswell Park Cancer Institute, Buffalo, New York, United States","https://ClinicalTrials.gov/show/NCT01250470"
1398,"High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma","Terminated","No Results Available","Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Recurrent Adult Brain Neoplasm","Drug: Vorinostat|Radiation: Stereotactic Radiosurgery|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Procedure: Therapeutic Conventional Surgery","Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01378481"
1399,"Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors","Terminated","No Results Available","Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Recurrent Adult Brain Tumor","Drug: aminolevulinic acid|Other: laboratory biomarker analysis|Procedure: therapeutic conventional surgery","Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT01148966"
1400,"Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas","Completed","Has Results","Adult Anaplastic Astrocytoma|Adult Anaplastic Ependymoma|Adult Anaplastic Oligodendroglioma|Adult Brain Stem Glioma|Adult Diffuse Astrocytoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Adult Oligodendroglioma|Adult Pilocytic Astrocytoma|Adult Pineal Gland Astrocytoma|Adult Subependymal Giant Cell Astrocytoma|Recurrent Adult Brain Tumor","Radiation: Hyperfractionated radiation therapy|Radiation: Stereotactic radiosurgery|Drug: Alisertib|Procedure: Quality-of-life assessment","Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT02186509"
1401,"Evaluation of the CONVIVO System","Not yet recruiting","No Results Available","Glioblastoma|Glial Tumor|Brain Metastases|Meningioma|Schwannoma|Pituitary Tumor","Diagnostic Test: CONVIVO system|Other: Conventional histologic evaluation",,"https://ClinicalTrials.gov/show/NCT05139277"
1402,"A Study of FT 2102 in Participants With Advanced Solid Tumors and Gliomas With an IDH1 Mutation","Active, not recruiting","No Results Available","Cohort 1a and 1b: Glioma|Cohort 1a and 1b: Glioblastoma Multiforme|Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas)|Cohort 3a and 3b: Chondrosarcoma|Cohort 4a and 4b: Intrahepatic Cholangiocarcinoma|Cohort 5a: Other Solid Tumors With IDH1 Mutations","Drug: FT-2102|Drug: Azacitidine|Biological: Nivolumab|Drug: Gemcitabine and Cisplatin","Banner MD Anderson, Gilbert, Arizona, United States|University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States|University of Miami, Sylvester Comprehensive Cancer Center, Miami, Florida, United States|Northwestern University, Lurie Comprehensive Cancer Center, Chicago, Illinois, United States|Univerity of Iowa, Holden Comprehesive Cancer Institute, Iowa City, Iowa, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|Columbia University Medical Center, New York, New York, United States|Baylor Scott and White Medical Center, Temple, Texas, United States|University of Utah, Huntsman Cancer Hospital, Salt Lake City, Utah, United States|Medical College of Wisconsin, Froedtert Hospital, Milwaukee, Wisconsin, United States|Austin Hospital, Heidelberg, Victoria, Australia|Peter MacCallum Cancer Centre, Melbourne, Australia|Centre de Lutte Contre Cancre (CLCC) - Institute Bergonie, Bordeaux, France|Centre de Lutte Cancre (CLCC) - Lyon, Lyon, France|Hospital de la Timone, Marseille, France|Institut Gustave Roussy Cancer Campus, Villejuif, France|Seoul National University Hospital, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Vall D'Hebron University Hospital, Barcelona, Spain|Cancer Research Beatson Institute, Glasgow, United Kingdom|The Royal Marsden Hospital, London, United Kingdom","https://ClinicalTrials.gov/show/NCT03684811"
1403,"Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma","Completed","Has Results","Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Diffuse Astrocytoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Adult Oligodendroglioma|Recurrent Adult Brain Neoplasm","Other: Laboratory Biomarker Analysis|Drug: Perifosine|Drug: Temsirolimus|Procedure: Therapeutic Conventional Surgery","Memorial Sloan Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01051557"
1404,"Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies","Recruiting","No Results Available","Mesothelioma|Glioblastoma|Renal Cell Carcinoma|Non Small Cell Lung Cancer|Melanoma|Pancreatic Ductal Adenocarcinoma|Gastric Cancer|Squamous Cell Carcinoma of Head and Neck|Cholangiocarcinoma|Breast Cancer|Ovarian Cancer|Cervical Cancer|Endocervical Cancer|Colorectal Cancer|Esophageal Cancer","Drug: NGM707|Drug: NGM707 plus pembrolizumab","Florida Cancer Specialists & Research Institute, Sarasota, Florida, United States|START Midwest, LLC, Grand Rapids, Michigan, United States|Nebraska Cancer Specialists, Omaha, Nebraska, United States|MD Anderson Cancer Center, Houston, Texas, United States|NEXT Oncology, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT04913337"
1405,"Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models","Recruiting","No Results Available","Brain Tumor|Glioma|Glioblastoma|Astrocytoma|Neoplasm, Brain|Oligodendroglioma|Patient Education as Topic|Decision Making, Shared","Device: Three-dimensional printed model","Radboud University Medical Center, Nijmegen, Gelderland, Netherlands","https://ClinicalTrials.gov/show/NCT04970615"
1406,"A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas","Completed","No Results Available","Adult Anaplastic Astrocytoma|Recurrent Grade III Glioma|Recurrent Grade IV Glioma|Adult Anaplastic Oligodendroglioma|Adult Brain Tumor|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Recurrent Adult Brain Tumor|Adult Anaplastic Oligoastrocytoma|Recurrent High Grade Glioma","Drug: flucytosine|Other: polymerase chain reaction|Other: immunohistochemistry staining method|Biological: gene therapy|Other: pharmacological study|Other: 3-Tesla magnetic resonance imaging|Other: laboratory biomarker analysis|Procedure: therapeutic conventional surgery|Biological: E. coli CD-expressing genetically modified neural stem cells","City of Hope, Duarte, California, United States","https://ClinicalTrials.gov/show/NCT01172964"
1407,"Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas","Active, not recruiting","No Results Available","Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Recurrent Adult Brain Neoplasm","Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Temozolomide|Drug: Vorinostat","University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States|UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States|UCSF Medical Center-Mount Zion, San Francisco, California, United States|Moffitt Cancer Center, Tampa, Florida, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|National Cancer Institute Neuro-Oncology Branch, Bethesda, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States|M D Anderson Cancer Center, Houston, Texas, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00268385"
1408,"Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors","Completed","No Results Available","Glioblastoma Multiforme|Glioma|Gliosarcoma|Malignant Brain Tumor|Ependymoma|Medulloblastoma|Diffuse Intrinsic Pontine Glioma|Primary CNS Tumor","Drug: Indoximod|Drug: Temozolomide|Radiation: Conformal Radiation|Drug: Cyclophosphamide|Drug: Etoposide","Children's Hospital Colorado, Aurora, Colorado, United States|Arnold Palmer Hospital for Children, Orlando, Florida, United States|Children's Heathcare of Atlanta, Atlanta, Georgia, United States|Augusta University, Augusta, Georgia, United States|Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota, United States","https://ClinicalTrials.gov/show/NCT02502708"
1409,"Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma","Completed","Has Results","Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Grade I Meningioma|Adult Grade II Meningioma|Adult Grade III Meningioma|Recurrent Adult Brain Tumor","Drug: erlotinib hydrochloride|Other: laboratory biomarker analysis|Other: pharmacological study","University of California Los Angeles, Los Angeles, California, United States|University of California San Francisco, San Francisco, California, United States|National Cancer Institute Neuro-Oncology Branch, Bethesda, Maryland, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|University of Wisconsin, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00045110"
1410,"Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors","Recruiting","No Results Available","Glioma|Glioma, Malignant|Glioma, Mixed|Glial Cell Tumors|Breast Cancer|Breast Carcinoma|Cancer of Breast|Cancer of the Breast|Breast Tumor|Malignant Tumor of Breast|Advanced Breast Cancer|Advanced Breast Carcinoma|Metastatic Breast Cancer|Metastatic Breast Carcinoma|Prostate Cancer|Prostatic Cancer|Cancer of Prostate|Cancer of the Prostate|Prostate Neoplasm|Castrate Resistant Prostate Cancer|Castration-resistant Prostate Cancer|Castration Resistant Prostatic Neoplasms|Glioblastoma|Recurrent Glioblastoma","Drug: NUV-422","Arizona Oncology Associates, Tucson, Arizona, United States|Miami Cancer Institute, Miami, Florida, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Carolina BioOncology Institute, Huntersville, North Carolina, United States|Prisma Health Cancer Institute, Greenville, South Carolina, United States|Texas Oncology P.A. Austin, Austin, Texas, United States|Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, United States|Texas Oncology, Tyler, Texas, United States|University of Utah Huntsman Cancer Institute, Salt Lake City, Utah, United States|Virginia Cancer Specialists, Fairfax, Virginia, United States","https://ClinicalTrials.gov/show/NCT04541225"
1411,"A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas","Recruiting","No Results Available","Pilomyxoid Astrocytoma|Pilocytic Astrocytoma|Glioma, Astrocytic|Optic Nerve Glioma|Pleomorphic Xanthoastrocytoma|Glioblastoma Multiforme|Anaplastic Astrocytoma|Gliosarcoma|Diffuse Intrinsic Pontine Glioma|DIPG|Low-grade Glioma|Brainstem Glioma","Drug: Mebendazole|Drug: Vincristine|Drug: Carboplatin|Drug: Temozolomide|Drug: Bevacizumab|Drug: Irinotecan","Cohen Children's Medical Center of New York, New Hyde Park, New York, United States","https://ClinicalTrials.gov/show/NCT01837862"
1412,"Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients","Recruiting","No Results Available","Cancer|Breast Cancer|Gastric Cancer|Renal Cancer|Prostate Cancer|Melanoma|Lung Cancer|Hepatocellular Cancer|Colorectal Cancer|Head and Neck Cancer|Pancreatic Cancer|Ovarian Cancer|Glioblastoma|Endometrial Cancer|Bladder Cancer|Esophageal Cancer|B-cell Lymphoma","Other: Blood draws","Service de NEURO-ONCOLOGIE du Groupement Hospitalier EST, Bron, France|Service d'ONCOLOGIE DIGESTIVE et HEPATOLOGIE de l'hôpital de la Croix-Rousse, Lyon, France|Service d'ONCOLOGIE DIGESTIVE et HEPATOLOGIE de l'Hôpital E. Herriot, Lyon, France|Service d'Oto-Rhino-Laryngologie de l'Hôpital de la Croix-Rousse, Lyon, France|Service d'Urologie de l'Hôpital E. Herriot, Lyon, France|Service de Gynécologie de l'hôpital de la Croix-Rousse, Lyon, France|Service de Gynécologie du Groupement Hospitalier Est, Lyon, France|Service de Pneumologie de l'hôpital de la Croix-Rousse, Lyon, France|Service de Pneumologie du Groupement Hospitalier Est, Lyon, France|Service d'Hématologie de l'Hôpital Lyon Sud, Pierre-Bénite, France|Service d'ONCOLOGIE DIGESTIVE et HEPATOLOGIE du Centre Hospitalier Lyon Sud, Pierre-Bénite, France|Service d'Oncologie médicale du Centre hospitalier Lyon Sud, Pierre-Bénite, France|Service d'Urologie de l'hôpital Lyon Sud, Pierre-Bénite, France|Service de Chirurgie de l'hôpital Lyon Sud, Pierre-Bénite, France|Service de Dermatologie de l'hôpital Lyon Sud, Pierre-Bénite, France|Service de Gynécologie de l'hôpital Lyon Sud, Pierre-Bénite, France|Service de Pneumologie de l'Hôpital Lyon Sud, Pierre-Bénite, France","https://ClinicalTrials.gov/show/NCT03787056"
1413,"Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors","Recruiting","No Results Available","Glioma|Pilocytic Astrocytoma|Anaplastic Astrocytoma|Glioblastoma|Mixed Oligoastrocytoma|Mixed Glioma|Oligodendroglioma|Optic Glioma|Astrocytoma","Device: MRI-guided laser ablation|Drug: Doxorubicin|Drug: Etoposide|Device: Dynamic contrast-enhanced (DCE) MRI|Device: Dynamic susceptibility contrast (DSC) MRI","Washington University School of Medicine, Saint Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT02372409"
1414,"Phase I Study of APX005M in Pediatric CNS Tumors","Recruiting","No Results Available","Glioblastoma Multiforme|High-grade Astrocytoma NOS|CNS Primary Tumor, Nos|Ependymoma, NOS|Diffuse Intrinsic Pontine Gliomas (DIPG)|Medulloblastoma","Biological: APX005M treatment for recurrent or refractory primary malignant CNS tumor patients|Biological: APX005M treatment for newly diagnosed DIPG patients","Children's Hospital Los Angeles, Los Angeles, California, United States|Lucile Packard Children Hospital Stanford University, Palo Alto, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Childrens National Medical Center, Washington, District of Columbia, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Lurie Childrens Hospital-Chicago, Chicago, Illinois, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Cincinnati Children Hospital Medical Center, Cincinnati, Ohio, United States|Children Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States|St. Jude Children Research Hospital, Memphis, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT03389802"
1415,"Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors","Terminated","Has Results","Malignant Melanoma|Medullary Thyroid Cancer|Glioblastoma|Large-Cell Neuroendocrine Carcinoma|Neuroendocrine Prostate Cancer|High Grade Gastroenteropancreatic Neuroendocrine Carcinoma|Other Neuroendocrine Carcinoma|Other Solid Tumors","Drug: Rovalpituzumab tesirine|Drug: Dexamethasone","Banner MD Anderson Cancer Ctr /ID# 155424, Gilbert, Arizona, United States|Mayo Clinic - Scottsdale /ID# 155419, Scottsdale, Arizona, United States|University of California, Los Angeles /ID# 155429, Los Angeles, California, United States|Univ California, San Francisco /ID# 155409, San Francisco, California, United States|Cedars-Sinai Medical Center - West Hollywood /ID# 155428, West Hollywood, California, United States|Univ of Colorado Cancer Center /ID# 155415, Aurora, Colorado, United States|Sarah Cannon Research Institute at HealthONE - Denver /ID# 155420, Denver, Colorado, United States|University of Florida - Archer /ID# 155414, Gainesville, Florida, United States|Moffitt Cancer Center /ID# 170220, Tampa, Florida, United States|Emory University Hospital /ID# 155417, Atlanta, Georgia, United States|University of Kentucky Chandler Medical Center /ID# 155423, Lexington, Kentucky, United States|Johns Hopkins University /ID# 155412, Baltimore, Maryland, United States|Massachusetts General Hospital /ID# 155411, Boston, Massachusetts, United States|Dana-Farber Cancer Institute /ID# 171044, Boston, Massachusetts, United States|Mayo Clinic - Rochester /ID# 155416, Rochester, Minnesota, United States|Washington University-School of Medicine /ID# 155425, Saint Louis, Missouri, United States|Rutgers Cancer Institute of NJ /ID# 162010, New Brunswick, New Jersey, United States|University of New Mexico /ID# 205054, Albuquerque, New Mexico, United States|Roswell Park Comprehensive Cancer Center /ID# 162015, Buffalo, New York, United States|Weill Cornell Medical College /ID# 155418, New York, New York, United States|Duke University Medical Center /ID# 155421, Durham, North Carolina, United States|Univ Hosp Cleveland /ID# 155410, Cleveland, Ohio, United States|Oregon Health and Science University /ID# 162011, Portland, Oregon, United States|Greenville Hospital System /ID# 155427, Greenville, South Carolina, United States|Mary Crowley Cancer Research /ID# 162014, Dallas, Texas, United States|Texas Oncology - Forth Worth /ID# 162045, Fort Worth, Texas, United States|University of Texas MD Anderson Cancer Center /ID# 155413, Houston, Texas, United States|University of Utah /ID# 155426, Salt Lake City, Utah, United States|Virginia Cancer Specialists /ID# 162006, Fairfax, Virginia, United States|Northwest Cancer Specialists, P.C. /ID# 155431, Vancouver, Washington, United States","https://ClinicalTrials.gov/show/NCT02709889"
1416,"Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma","Completed","No Results Available","Brain Cancer|MALIGNANT GLIOMA|Glioblastoma|Anaplastic Astrocytoma (AA)|Anaplastic Oligodendroglioma (AO)|Anaplastic Oligo-astrocytoma (AOA)|Anaplastic Mixed Gliomas|Malignant Glioma NOS","Other: Bevacizumab & Stereotactic Radiotherapy","University of California San Francisco, San Francisco, California, United States|Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States|Memorial Sloan Kettering Commack, Commack, New York, United States|Memorial Sloan Kettering Westchester, Harrison, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01392209"
1417,"p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors","Completed","No Results Available","Teratoid Tumor, Atypical|Choroid Plexus Neoplasms|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Brainstem Tumors|Giant Cell Glioblastoma|Glioblastoma|Gliosarcoma|Medulloblastoma|Neuroectodermal Tumor, Primitive","Drug: azurin-derived cell-penetrating peptide p28","Children's Hospital Los Angeles, Los Angeles, California, United States|Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States|Children's National Medical Center, Washington, D.C., District of Columbia, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, United States|National Cancer Institute Pediatric Oncology Branch, Bethesda, Maryland, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01975116"
1418,"HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors","Active, not recruiting","No Results Available","Supratentorial Neoplasms, Malignant|Malignant Glioma|Glioblastoma|Anaplastic Astrocytoma|PNET|Cerebral Primitive Neuroectodermal Tumor|Embryonal Tumor","Biological: G207","Children's of Alabama, Birmingham, Alabama, United States|Nationwide Children's Hospital, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT02457845"
1419,"Multiple Doses of Neural Stem Cell Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas","Not yet recruiting","No Results Available","Recurrent Anaplastic Astrocytoma|Recurrent Anaplastic Oligoastrocytoma|Recurrent Anaplastic Oligodendroglioma|Recurrent Glioblastoma|Recurrent Gliosarcoma|Recurrent Malignant Glioma|Recurrent WHO Grade II Glioma|Recurrent WHO Grade III Glioma","Biological: Neural Stem Cells-expressing CRAd-S-pk7|Procedure: Resection","City of Hope Medical Center, Duarte, California, United States","https://ClinicalTrials.gov/show/NCT05139056"
1420,"18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy","Completed","Has Results","Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Male Breast Cancer|Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma|Recurrent Adenoid Cystic Carcinoma of the Oral Cavity|Recurrent Adult Brain Tumor|Recurrent Basal Cell Carcinoma of the Lip|Recurrent Colon Cancer|Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity|Recurrent Hypopharyngeal Cancer|Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity|Recurrent Laryngeal Cancer|Recurrent Lip and Oral Cavity Cancer|Recurrent Lymphoepithelioma of the Nasopharynx|Recurrent Lymphoepithelioma of the Oropharynx|Recurrent Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity|Recurrent Mucoepidermoid Carcinoma of the Oral Cavity|Recurrent Nasopharyngeal Cancer|Recurrent Non-small Cell Lung Cancer|Recurrent Oropharyngeal Cancer|Recurrent Pancreatic Cancer|Recurrent Paranasal Sinus and Nasal Cavity Cancer|Recurrent Rectal Cancer|Recurrent Renal Cell Cancer|Recurrent Salivary Gland Cancer|Stage IIIA Breast Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Breast Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Stage IV Non-small Cell Lung Cancer|Stage IV Pancreatic Cancer|Stage IV Renal Cell Cancer|Stage IVA Colon Cancer|Stage IVA Rectal Cancer|Stage IVA Salivary Gland Cancer|Stage IVB Colon Cancer|Stage IVB Salivary Gland Cancer|Stage IVC Salivary Gland Cancer|Tongue Cancer|Unspecified Adult Solid Tumor, Protocol Specific","Drug: 18F-fludeoxyglucose (18F-FDG)|Drug: 18F-FPPRGD2","Stanford University, School of Medicine, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT01806675"
1421,"Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas","Completed","Has Results","Untreated Childhood Anaplastic Astrocytoma|Untreated Childhood Anaplastic Oligodendroglioma|Untreated Childhood Brain Stem Glioma|Untreated Childhood Giant Cell Glioblastoma|Untreated Childhood Glioblastoma|Untreated Childhood Gliomatosis Cerebri|Untreated Childhood Gliosarcoma|Untreated Childhood Oligodendroglioma","Drug: gefitinib|Radiation: radiation therapy|Other: pharmacological study|Other: laboratory biomarker analysis","Pediatric Brain Tumor Consortium, Memphis, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00042991"
1422,"Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases","Terminated","No Results Available","Adult Anaplastic (Malignant) Meningioma|Adult Anaplastic Astrocytoma|Adult Anaplastic Ependymoma|Adult Anaplastic Oligodendroglioma|Adult Brain Stem Glioma|Adult Choroid Plexus Neoplasm|Adult Diffuse Astrocytoma|Adult Ependymoblastoma|Adult Ependymoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Grade II Meningioma|Adult Medulloblastoma|Adult Mixed Glioma|Adult Oligodendroglioma|Adult Papillary Meningioma|Adult Pineal Gland Astrocytoma|Adult Pineoblastoma|Adult Primary Melanocytic Lesion of Meninges|Adult Supratentorial Primitive Neuroectodermal Tumor|Malignant Adult Intracranial Hemangiopericytoma|Metastatic Malignant Neoplasm in the Brain|Multiple Sclerosis|Recurrent Adult Brain Neoplasm","Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging|Drug: Gadobenate Dimeglumine|Drug: Gadobutrol|Radiation: Gadopentetate Dimeglumine","USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT02967380"
1423,"Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas","Recruiting","No Results Available","Recurrent Anaplastic Astrocytoma|Recurrent Anaplastic Oligoastrocytoma|Recurrent Anaplastic Oligodendroglioma|Recurrent Glioblastoma|Recurrent Gliosarcoma|Recurrent Malignant Glioma|Recurrent WHO Grade III Glioma","Biological: Carboxylesterase-expressing Allogeneic Neural Stem Cells|Drug: Irinotecan|Drug: Irinotecan Hydrochloride|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study","City of Hope Medical Center, Duarte, California, United States","https://ClinicalTrials.gov/show/NCT02192359"
1424,"Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma","Active, not recruiting","No Results Available","Adult Anaplastic Astrocytoma|Adult Anaplastic Ependymoma|Adult Anaplastic Oligodendroglioma|Adult Brain Stem Glioma|Adult Diffuse Astrocytoma|Adult Ependymoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Adult Myxopapillary Ependymoma|Adult Oligodendroglioma|Adult Pilocytic Astrocytoma|Adult Pineal Gland Astrocytoma|Adult Subependymal Giant Cell Astrocytoma|Adult Subependymoma","Procedure: biopsy|Procedure: computed tomography|Procedure: therapeutic conventional surgery|Radiation: radiation therapy treatment planning/simulation|Radiation: radiation therapy|Procedure: magnetic resonance imaging|Procedure: positron emission tomography|Drug: fluorine F 18 fluorodopa","Mayo Clinic, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT01165632"
1425,"RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma","Completed","No Results Available","Acoustic Schwannoma|Adult Anaplastic (Malignant) Meningioma|Adult Anaplastic Astrocytoma|Adult Anaplastic Ependymoma|Adult Brain Stem Glioma|Adult Choroid Plexus Neoplasm|Adult Craniopharyngioma|Adult Diffuse Astrocytoma|Adult Ependymoblastoma|Adult Ependymoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Grade I Meningioma|Adult Grade II Meningioma|Adult Medulloblastoma|Adult Mixed Glioma|Adult Myxopapillary Ependymoma|Adult Oligodendroglioma|Adult Papillary Meningioma|Adult Pilocytic Astrocytoma|Adult Pineal Gland Astrocytoma|Adult Pineoblastoma|Adult Pineocytoma|Adult Primary Melanocytic Lesion of Meninges|Adult Subependymal Giant Cell Astrocytoma|Adult Subependymoma|Adult Supratentorial Primitive Neuroectodermal Tumor|Malignant Adult Intracranial Hemangiopericytoma","Radiation: 3-Dimensional Conformal Radiation Therapy|Drug: Gamma-Secretase Inhibitor RO4929097|Radiation: Intensity-Modulated Radiation Therapy|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Temozolomide|Procedure: Therapeutic Conventional Surgery","Memorial Sloan-Kettering Cancer Center, New York, New York, United States|University of Virginia Cancer Center, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT01119599"
1426,"Yoga Therapy in Treating Patients With Malignant Brain Tumors","Terminated","No Results Available","Adult Anaplastic Astrocytoma|Adult Anaplastic Ependymoma|Adult Anaplastic Meningioma|Adult Anaplastic Oligodendroglioma|Adult Brain Stem Glioma|Adult Choroid Plexus Tumor|Adult Diffuse Astrocytoma|Adult Ependymoblastoma|Adult Ependymoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Grade II Meningioma|Adult Medulloblastoma|Adult Meningeal Hemangiopericytoma|Adult Mixed Glioma|Adult Oligodendroglioma|Adult Papillary Meningioma|Adult Pineal Gland Astrocytoma|Adult Pineoblastoma|Adult Pineocytoma|Adult Supratentorial Primitive Neuroectodermal Tumor (PNET)|Recurrent Adult Brain Tumor","Procedure: yoga therapy|Other: questionnaire administration|Procedure: quality-of-life assessment","Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01234805"
1427,"Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma","Terminated","No Results Available","Adult Anaplastic Astrocytoma|Adult Anaplastic Ependymoma|Adult Anaplastic Oligodendroglioma|Adult Diffuse Astrocytoma|Adult Ependymoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Adult Myxopapillary Ependymoma|Adult Oligodendroglioma|Adult Pilocytic Astrocytoma|Adult Pineal Gland Astrocytoma|Adult Subependymoma","Drug: etanidazole|Procedure: conventional surgery|Other: pharmacological study|Other: laboratory biomarker analysis","Abramson Cancer Center of The University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00430079"
1428,"Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors","Completed","No Results Available","Adult Anaplastic Astrocytoma|Adult Anaplastic Ependymoma|Adult Anaplastic Oligodendroglioma|Adult Brain Stem Glioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Adult Solid Neoplasm|Male Breast Carcinoma|Recurrent Adult Brain Neoplasm|Recurrent Breast Carcinoma|Recurrent Colon Carcinoma|Recurrent Melanoma|Recurrent Non-Small Cell Lung Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Ovarian Germ Cell Tumor|Recurrent Pancreatic Carcinoma|Recurrent Rectal Carcinoma|Recurrent Renal Cell Carcinoma|Stage III Pancreatic Cancer|Stage III Renal Cell Cancer|Stage IIIA Colon Cancer|Stage IIIA Non-Small Cell Lung Cancer|Stage IIIA Ovarian Cancer|Stage IIIA Ovarian Germ Cell Tumor|Stage IIIA Rectal Cancer|Stage IIIA Skin Melanoma|Stage IIIB Breast Cancer|Stage IIIB Colon Cancer|Stage IIIB Non-Small Cell Lung Cancer|Stage IIIB Ovarian Cancer|Stage IIIB Ovarian Germ Cell Tumor|Stage IIIB Rectal Cancer|Stage IIIB Skin Melanoma|Stage IIIC Breast Cancer|Stage IIIC Colon Cancer|Stage IIIC Ovarian Cancer|Stage IIIC Ovarian Germ Cell Tumor|Stage IIIC Rectal Cancer|Stage IIIC Skin Melanoma|Stage IV Breast Cancer|Stage IV Non-Small Cell Lung Cancer|Stage IV Ovarian Cancer|Stage IV Ovarian Germ Cell Tumor|Stage IV Pancreatic Cancer|Stage IV Renal Cell Cancer|Stage IV Skin Melanoma|Stage IVA Colon Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Rectal Cancer","Drug: Gamma-Secretase Inhibitor RO4929097|Drug: Cediranib Maleate|Other: Pharmacological Study|Other: Laboratory Biomarker Analysis","Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada|University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT01131234"
1429,"Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors","Terminated","No Results Available","Adult Anaplastic Astrocytoma|Adult Anaplastic Ependymoma|Adult Anaplastic Oligodendroglioma|Adult Brain Stem Glioma|Adult Central Nervous System Germ Cell Tumor|Adult Choroid Plexus Tumor|Adult Craniopharyngioma|Adult Diffuse Astrocytoma|Adult Ependymoblastoma|Adult Ependymoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Grade I Meningioma|Adult Grade II Meningioma|Adult Grade III Meningioma|Adult Medulloblastoma|Adult Meningeal Hemangiopericytoma|Adult Mixed Glioma|Adult Myxopapillary Ependymoma|Adult Oligodendroglioma|Adult Pilocytic Astrocytoma|Adult Pineoblastoma|Adult Pineocytoma|Adult Subependymoma|Adult Supratentorial Primitive Neuroectodermal Tumor (PNET)|Meningeal Melanocytoma","Drug: EF5|Procedure: conventional surgery|Procedure: positron emission tomography|Radiation: fluorine F 18 EF5|Other: pharmacological study","Abramson Cancer Center of The University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00110032"
1430,"Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors","Terminated","Has Results","Childhood Choroid Plexus Tumor|Childhood Ependymoblastoma|Childhood Grade III Meningioma|Childhood High-grade Cerebellar Astrocytoma|Childhood High-grade Cerebral Astrocytoma|Childhood Medulloepithelioma|Recurrent Childhood Anaplastic Astrocytoma|Recurrent Childhood Anaplastic Oligoastrocytoma|Recurrent Childhood Anaplastic Oligodendroglioma|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Giant Cell Glioblastoma|Recurrent Childhood Glioblastoma|Recurrent Childhood Gliomatosis Cerebri|Recurrent Childhood Gliosarcoma|Recurrent Childhood Medulloblastoma|Recurrent Childhood Pineoblastoma|Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor","Drug: palbociclib isethionate|Other: pharmacological study|Other: laboratory biomarker analysis","Childrens Hospital Los Angeles, Los Angeles, California, United States|Lucile Packard Children Hospital Stanford University, Palo Alto, California, United States|Childrens National Medical Center, Washington, District of Columbia, United States|Lurie Childrens Hospital-Chicago, Chicago, Illinois, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Cincinnati Children Hospital Medical Center, Cincinnati, Ohio, United States|Children Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States|St. Jude Children Research Hospital, Memphis, Tennessee, United States|Texas Childrens Hospital, Houston, Texas, United States|Seattle Children Hospital, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT02255461"
1431,"Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction","Completed","No Results Available","Adult Anaplastic Astrocytoma|Adult Anaplastic Ependymoma|Adult Anaplastic Oligodendroglioma|Adult Brain Stem Glioma|Adult Diffuse Astrocytoma|Adult Ependymoblastoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Adult Myxopapillary Ependymoma|Adult Oligodendroglioma|Adult Pilocytic Astrocytoma|Adult Primary Hepatocellular Carcinoma|Adult Subependymoma|Advanced Adult Primary Liver Cancer|Advanced Malignant Mesothelioma|Male Breast Cancer|Recurrent Adenoid Cystic Carcinoma of the Oral Cavity|Recurrent Adult Brain Tumor|Recurrent Adult Primary Liver Cancer|Recurrent Anal Cancer|Recurrent Basal Cell Carcinoma of the Lip|Recurrent Bladder Cancer|Recurrent Breast Cancer|Recurrent Cervical Cancer|Recurrent Colon Cancer|Recurrent Esophageal Cancer|Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity|Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity|Recurrent Lymphoepithelioma of the Nasopharynx|Recurrent Lymphoepithelioma of the Oropharynx|Recurrent Malignant Mesothelioma|Recurrent Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity|Recurrent Mucoepidermoid Carcinoma of the Oral Cavity|Recurrent Non-small Cell Lung Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Pancreatic Cancer|Recurrent Prostate Cancer|Recurrent Rectal Cancer|Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Recurrent Verrucous Carcinoma of the Larynx|Recurrent Verrucous Carcinoma of the Oral Cavity|Stage II Esophageal Cancer|Stage II Pancreatic Cancer|Stage III Esophageal Cancer|Stage III Pancreatic Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Adenoid Cystic Carcinoma of the Oral Cavity|Stage IV Anal Cancer|Stage IV Basal Cell Carcinoma of the Lip|Stage IV Bladder Cancer|Stage IV Breast Cancer|Stage IV Colon Cancer|Stage IV Esophageal Cancer|Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity|Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity|Stage IV Lymphoepithelioma of the Nasopharynx|Stage IV Lymphoepithelioma of the Oropharynx|Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity|Stage IV Mucoepidermoid Carcinoma of the Oral Cavity|Stage IV Non-small Cell Lung Cancer|Stage IV Ovarian Epithelial Cancer|Stage IV Pancreatic Cancer|Stage IV Prostate Cancer|Stage IV Rectal Cancer|Stage IV Salivary Gland Cancer|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squamous Cell Carcinoma of the Larynx|Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IV Squamous Cell Carcinoma of the Nasopharynx|Stage IV Squamous Cell Carcinoma of the Oropharynx|Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage IV Verrucous Carcinoma of the Larynx|Stage IV Verrucous Carcinoma of the Oral Cavity|Stage IVA Cervical Cancer|Stage IVB Cervical Cancer|Unspecified Adult Solid Tumor, Protocol Specific|Untreated Metastatic Squamous Neck Cancer With Occult Primary","Drug: erlotinib hydrochloride|Other: laboratory biomarker analysis","Cancer and Leukemia Group B, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT00030498"
1432,"Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors","Completed","Has Results","Recurrent Childhood Anaplastic Astrocytoma|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Ependymoma|Recurrent Childhood Giant Cell Glioblastoma|Recurrent Childhood Glioblastoma|Recurrent Childhood Gliosarcoma|Recurrent Childhood Medulloblastoma|Recurrent Childhood Oligodendroglioma","Drug: lapatinib ditosylate|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Other: pharmacological study|Procedure: positron emission tomography|Procedure: magnetic resonance imaging","Pediatric Brain Tumor Consortium, Memphis, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00095940"
1433,"Deciphering Mechanisms Underlying Cancer Immunogenicity","Recruiting","No Results Available","Head and Neck Cancer|Ovarian Cancer|Cervical Cancer|Cervical Intraepithelial Neoplasia 3|Glioblastoma Multiforme of Brain Stem|Non Small Cell Lung Cancer|Anal Cancer","Other: Blood samples, tumor biopsy specimens and ascites samples will be collected.","Hopital Larrey, Toulouse, France|Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France","https://ClinicalTrials.gov/show/NCT03958240"
1434,"Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.","Completed","No Results Available","Glioblastoma Multiforme|Squamous Cell Carcinoma of Head and Neck|Prostate Cancer|Ewing's Osteosarcoma|Chronic Lymphocytic Leukemia|Neoplasm Metastasis","Drug: CC-115","Cedars-Sinai Medical Center, Los Angeles, California, United States|UCLA, Los Angeles, California, United States|University of California, San Francisco Comprehensive Cancer Center and Cancer Research Institiute, San Francisco, California, United States|Moffitt Cancer Center, Tampa, Florida, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Henry Ford Medical Center - New Center One, Detroit, Michigan, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Sarah Cannon Research Institute Drug Development Unit, Nashville, Tennessee, United States|Mary Crowley Medical Research Center, Dallas, Texas, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, United States|Gustave Roussy, Villejuif Cedex, France|Uniklinik Koln, Koeln, Germany|Universitatsklinikum Wurzburg, Würzburg, Germany|Hospital Val d'Hebron, Barcelona, Spain|Hospital Universitario Madrid Sanchinarro, Madrid, Spain|Hospital de Donosti, San Sebastián (Guipuzcoa), Spain|Hospital Virgen del Rocio, Sevilla, Spain","https://ClinicalTrials.gov/show/NCT01353625"
1435,"A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma","Unknown status","No Results Available","Glioma","Drug: Temozolomide and Bevacizumab","Kentuckiana Cancer Institute, Louisville, Kentucky, United States","https://ClinicalTrials.gov/show/NCT00660621"
1436,"Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients","Recruiting","No Results Available","Cancer|Cancer Metastatic|Neoplasms|Breast Cancer|Lung Cancer|Glioblastoma|Prostate Cancer|Gynecologic Cancer|Colorectal Cancer|Sarcoma|Kidney Cancer|Bladder Cancer|Lymphoma|Leukemia|Head and Neck Cancer|Pancreas Cancer|Multiple Myeloma|Anxiety|Social Isolation|Stress|Loneliness|Melanoma|Uterine Cancer","Behavioral: Elly Mobile Phone Application","Cedars Sinai Medical Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT04604158"
1437,"HYPAZ: Hypertension Induced by Pazopanib","Terminated","No Results Available","Renal Cell Carcinoma|Soft Tissue Sarcoma|Glioblastoma|Ovarian Cancer|Cervical Cancer|Breast Cancer|Non-small Cell Lung Cancer|Small Cell Lung Cancer|Pancreatic Cancer|Melanoma|Gastrointestinal Cancer","Drug: Pazopanib","Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom","https://ClinicalTrials.gov/show/NCT01392352"
1438,"Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma","Completed","Has Results","Glial Cell Tumors|Malignant Gliomas|Glioblastoma Multiforme|Anaplastic Astrocytoma|Gliomatosis Cerebri|Gliosarcoma|Brainstem Glioma|Diffuse Intrinsic Pontine Glioma","Drug: Valproic acid|Drug: Bevacizumab|Radiation: Radiation therapy","University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Children's Medical Center Dallas, Center for Cancer and Blood Disorders, Dallas, Texas, United States|Cook Children's Medical Center, Fort Worth, Texas, United States|MD Anderson Cancer Center, Houston, Texas, United States|Texas Children's Hospital, Houston, Texas, United States|University of Texas Health Science Center, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00879437"
1439,"A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma","Not yet recruiting","No Results Available","Medulloblastoma|Glioblastoma Multiforme|Anaplastic Astrocytoma|High-grade Astrocytoma NOS|Anaplastic Oligodendroglioma|Anaplastic Ependymoma|Ependymoma|Diffuse Intrinsic Pontine Glioma","Biological: SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years|Biological: SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥1 and <10 years|Biological: SurVaxM for patients with non-relapsed DIPG post radiation-therapy ages ≥1 and ≤21 years",,"https://ClinicalTrials.gov/show/NCT04978727"
1440,"Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors","Recruiting","No Results Available","Advanced Solid Tumors|Glioblastoma|Soft Tissue Sarcoma (Excluding GIST)|Endometrial Carcinoma|Epithelial Ovarian Carcinoma|Mesothelioma|Gastroenteropancreatic Neuroendocrine Tumor|SCLC|Gastric Carcinoma|Pancreatic Adenocarcinoma|Colorectal Carcinoma|Neuroendocrine Tumors","Drug: Lurbinectedin|Drug: Irinotecan","Massachusetts General Hospital -, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Virgen Del Rocio, Sevilla, Spain","https://ClinicalTrials.gov/show/NCT02611024"
1441,"Pediatric Long-Term Follow-up and Rollover Study","Recruiting","No Results Available","Diffuse Astrocytoma|Anaplastic Astrocytoma|Astrocytoma|Oligodendroglioma, Childhood|Anaplastic Oligodendroglioma|Glioblastoma|Pilocytic Astrocytoma|Giant Cell Astrocytoma|Pleomorphic Xanthoastrocytoma|Anaplastic Pleomorphic Xanthoastrocytoma|Angiocentric Glioma|Chordoid Glioma of Third Ventricle|Gangliocytoma|Ganglioglioma|Anaplastic Ganglioglioma|Dysplastic Gangliocytoma of Cerebrellum|Desmoplastic Infantile Astrocytoma and Ganglioglioma|Papillary Glioneuronal Tumor|Rosette-forming Glioneurona Tumor|Central Neurocytoma|Extraventricular Neurocytoma|Cerebellar Liponeurocytoma|Neurofibromatosis Type 1","Drug: dabrafenib|Drug: trametinib","Phoenix Childrens Hospital, Phoenix, Arizona, United States|Children s National Hospital CQTI571A2306, Washington, District of Columbia, United States|Johns Hopkins University IDS Pharmacy, Baltimore, Maryland, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|University of Minnesota, Minneapolis, Minnesota, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio, United States|St Jude Children's Research Hospital, Memphis, Tennessee, United States|Novartis Investigative Site, Toronto, Ontario, Canada|Novartis Investigative Site, Rennes, Bretagne, France|Novartis Investigative Site, Marseille Cedex 5, France|Novartis Investigative Site, Paris, France|Novartis Investigative Site, Vandoeuvre Les Nancy, France|Novartis Investigative Site, Villejuif Cedex, France|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Sutton, Surrey, United Kingdom|Novartis Investigative Site, London, United Kingdom","https://ClinicalTrials.gov/show/NCT03975829"
1442,"Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children","Active, not recruiting","No Results Available","Malignant Glioma|Anaplastic Astrocytoma|Anaplastic Oligoastrocytoma|Anaplastic Oligodendroglioma|Glioblastoma|Gliosarcoma|Atypical Teratoid/Rhabdoid Tumor of Brain|Medulloblastoma|Ependymoma|Pleomorphic Xanthoastrocytoma of Brain|Embryonal Tumor of Brain","Biological: Polio/Rhinovirus Recombinant (PVSRIPO)","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT03043391"
1443,"The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors","Not yet recruiting","No Results Available","Cancer|Cancer Metastatic|Neoplasms|Breast Cancer|Lung Cancer|Thyroid Cancer|Lymphoma|Lymphoma, Non-Hodgkin|Hodgkin Lymphoma|Leukemia|Sarcoma|Skin Cancer|Bone Cancer|Gynecologic Cancer|Pancreas Cancer|Multiple Myeloma|Colorectal Cancer|Gastrointestinal Cancer|Prostate Cancer|Glioblastoma|Brain Cancer|Head and Neck Cancer","Behavioral: Virtual group based physical activity (BurnAlong) and Social Media Discussion Board",,"https://ClinicalTrials.gov/show/NCT05131815"
1444,"Phase II Pediatric Study With Dabrafenib in Combination With Trametinib in Patients With HGG and LGG","Active, not recruiting","No Results Available","Diffuse Astrocytoma|Anaplastic Astrocytoma|Astrocytoma|Oligodendroglioma, Childhood|Anaplastic Oligodendroglioma|Glioblastoma|Pilocytic Astrocytoma|Giant Cell Astrocytoma|Pleomorphic Xanthoastrocytoma|Anaplastic Pleomorphic Xanthoastrocytoma|Angiocentric Glioma|Chordoid Glioma of Third Ventricle|Gangliocytoma|Ganglioglioma|Anaplastic Ganglioglioma|Dysplastic Gangliocytoma of Cerebrellum|Desmoplastic Infantile Astrocytoma and Ganglioglioma|Papillary Glioneuronal Tumor|Rosette-forming Glioneurona Tumor|Central Neurocytoma|Extraventricular Neurocytoma|Cerebellar Iponeurocytoma","Drug: dabrafenib|Drug: trametinib|Drug: Carboplatin with vincristine","Children's Hospital of Orange County, Orange, California, United States|Childrens National Hospital, Washington, District of Columbia, United States|Nicklaus Childrens Hospital, Miami, Florida, United States|Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago, Illinois, United States|Indiana University School of Medicine, Indianapolis, Indiana, United States|Johns Hopkins University IDS Pharmacy John Hopkins Hospital, Baltimore, Maryland, United States|Washington University School of Medicine SC, Saint Louis, Missouri, United States|Cincinnati Children's Hospital Medical Center Cancer & Blood Disease Inst., Cincinnati, Ohio, United States|St Jude Children's Research Hospital, Memphis, Tennessee, United States|Texas Children s Hospital Baylor College of Medicine, Houston, Texas, United States|Novartis Investigative Site, Caba, Buenos Aires, Argentina|Novartis Investigative Site, Randwick, New South Wales, Australia|Novartis Investigative Site, Parkville, Victoria, Australia|Novartis Investigative Site, Brussels, Belgium|Novartis Investigative Site, Barretos, SP, Brazil|Novartis Investigative Site, Sao Paulo, SP, Brazil|Novartis Investigative Site, Sao Paulo, SP, Brazil|Novartis Investigative Site, Vancouver, British Colombia, Canada|Novartis Investigative Site, Toronto, Ontario, Canada|Novartis Investigative Site, Montreal, Quebec, Canada|Novartis Investigative Site, Brno, Czechia|Novartis Investigative Site, Praha 5, Czechia|Novartis Investigative Site, Copenhagen, Denmark|Novartis Investigative Site, Tampere, Finland|Novartis Investigative Site, Villejuif Cedex, Villejuif, France|Novartis Investigative Site, Lille Cedex, France|Novartis Investigative Site, Lyon Cedex, France|Novartis Investigative Site, Paris, France|Novartis Investigative Site, Strasbourg Cedex, France|Novartis Investigative Site, Toulouse Cedex 9, France|Novartis Investigative Site, Augsburg, Germany|Novartis Investigative Site, Berlin, Germany|Novartis Investigative Site, Essen, Germany|Novartis Investigative Site, Gottingen, Germany|Novartis Investigative Site, Hamburg, Germany|Novartis Investigative Site, Heidelberg, Germany|Novartis Investigative Site, Koeln, Germany|Novartis Investigative Site, Petach-Tikva, Israel|Novartis Investigative Site, Tel-Hashomer, Israel|Novartis Investigative Site, Firenze, FI, Italy|Novartis Investigative Site, Genova, GE, Italy|Novartis Investigative Site, Milano, MI, Italy|Novartis Investigative Site, Roma, RM, Italy|Novartis Investigative Site, Torino, TO, Italy|Novartis Investigative Site, Fukuoka city, Fukuoka, Japan|Novartis Investigative Site, Setagaya-ku, Tokyo, Japan|Novartis Investigative Site, Osaka, Japan|Novartis Investigative Site, Utrecht, CS, Netherlands|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Valencia, Spain|Novartis Investigative Site, Stockholm, Sweden|Novartis Investigative Site, Zuerich, Switzerland|Novartis Investigative Site, Leeds, United Kingdom|Novartis Investigative Site, Liverpool, United Kingdom|Novartis Investigative Site, London, United Kingdom","https://ClinicalTrials.gov/show/NCT02684058"
1445,"A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)","Terminated","No Results Available","Colorectal Cancer|Triple Negative Breast Cancer|Pancreatic Cancer|Non-Small Cell Lung Cancer|Head and Neck Cancer|Ovarian Cancer|Lymphoma|Sarcoma|Bladder Cancer|Melanoma|IDH1 Mutated Solid Tumors|IDH1 Mutated or MGMT Methylated Recurrent HGG (Not Recruiting)","Biological: Toca 511|Drug: Toca FC","Sarah Cannon Research Institute, Denver, Colorado, United States|University of Miami, Miami, Florida, United States|MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02576665"
1446,"SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry","Recruiting","No Results Available","Cancer, Metastatic|Cancer|Cancer of Pancreas|Cancer of Liver|Cancer of Stomach|Cancer Liver|Cancer of Rectum|Cancer of Kidney|Cancer of Esophagus|Cancer of Cervix|Cancer of Colon|Cancer of Larynx|Cancer, Lung|Cancer, Breast|Cancer, Advanced|Cancer Prostate|Cancer of Neck|Cancer of Skin|Neuroendocrine Tumors|Carcinoma|Mismatch Repair Deficiency|BRCA Gene Rearrangement|Non Hodgkin Lymphoma|Leukemia|Non Small Cell Lung Cancer|Cholangiocarcinoma|Glioblastoma|Central Nervous System Tumor|Melanoma|Urothelial Carcinoma|Bladder Cancer|Ovarian Cancer|Endometrial Cancer|Testicular Cancer|Breast Cancer|COVID|Myelofibrosis|Myeloproliferative Neoplasm|Myeloproliferative Disorders|Follicular Lymphoma|Mantle Cell Lymphoma|Marginal Zone Lymphoma|Myelodysplastic Syndromes","Other: Clinical Trial Matching","Massive Bio, Inc, New York, New York, United States","https://ClinicalTrials.gov/show/NCT03452774"
1447,"The Registry of Oncology Outcomes Associated With Testing and Treatment","Recruiting","No Results Available","Adenocarcinoma|Adenocystic Carcinoma|Anal Cancer|Appendix Cancer|Brain Tumor|Glioblastoma|Astrocytoma|Bile Duct Cancer|Cholangiocarcinoma|Bladder Cancer|Bone Cancer|Synovial Sarcoma|Chondrosarcoma|Liposarcoma|Sarcoma, Kaposi|Sarcoma,Soft Tissue|Sarcoma|Osteosarcoma|CNS Cancer|Brain Stem Neoplasms|Breast Cancer|Cervical Cancer|Colorectal Cancer|Rectal Cancer|Colon Cancer|Esophageal Cancer|Esophagus Cancer|Cancer of Colon|Pancreatic Cancer|Cancer of Pancreas|Testis Cancer|Testicular Cancer|Ureter Cancer|Renal Cell Carcinoma|Kidney Cancer|Gestational Trophoblastic Tumor|Head and Neck Neoplasms|Parotid Tumor|Larynx Cancer|Tongue Cancer|Pharynx Cancer|Salivary Gland Cancer|Acute Myeloid Leukemia|Chronic Myeloid Leukemia|Acute Lymphoblastic Leukemia|Multiple Myeloma|Non Hodgkin Lymphoma|Carcinoid Tumor|Lung Cancer|Neuroendocrine Tumors|Mesothelioma|Thyroid Cancer|Parathyroid Neoplasms|Adrenal Cancer|Small Bowel Cancer|Stomach Cancer|Liver Cancer|Hepatic Cancer|Melanoma|Skin Cancer|Unknown Primary Tumors|Uterine Cancer|Fallopian Tube Cancer|Ovarian Cancer|Prostate Cancer|Vaginal Cancer|Penile Cancer|Vulvar Cancer|Waldenstrom Macroglobulinemia|Cancer, Advanced|Thymus Cancer|Nasopharyngeal Carcinoma|Multiple Endocrine Neoplasia|Pheochromocytoma|Small Cell Carcinoma|Pulmonary Carcinoma","Diagnostic Test: Biomarker Testing (L)|Drug: Systemic Treatment (T)|Other: Patient Reported Outcomes (P)","Teton Cancer Institute, Idaho Falls, Idaho, United States","https://ClinicalTrials.gov/show/NCT04028479"
1448,"GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas","Active, not recruiting","No Results Available","Glioma, Malignant","Biological: AdV-tk|Drug: Valacyclovir|Radiation: Radiation|Drug: Temozolomide|Biological: Nivolumab|Other: Laboratory Biomarker Analysis","Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|Abrams Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT03576612"
1449,"PPX, Temozolomide, and Concurrent Radiation for Newly Diagnosed Brain Tumors","Completed","Has Results","Brain Tumor","Drug: PPX +TMZ+XRT","Lifespan Hospitals, Providence, Rhode Island, United States","https://ClinicalTrials.gov/show/NCT00763750"
1450,"Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer","Active, not recruiting","No Results Available","Acute Myeloid Leukemia|Brain Glioblastoma|Estrogen Receptor Negative|Extensive Stage Small Cell Lung Carcinoma|Head and Neck Carcinoma|HER2/Neu Negative|Hormone-Resistant Prostate Cancer|Limited Stage Small Cell Lung Carcinoma|Myelodysplastic Syndrome|Progesterone Receptor Negative|Progressive Disease|Recurrent Carcinoma|Stage II Pancreatic Cancer|Stage II Rectal Cancer|Stage IIA Pancreatic Cancer|Stage IIA Rectal Cancer|Stage IIB Pancreatic Cancer|Stage IIB Rectal Cancer|Stage IIC Rectal Cancer|Stage III Colon Cancer|Stage III Esophageal Cancer|Stage III Gastric Cancer|Stage III Non-Small Cell Lung Cancer|Stage III Ovarian Cancer|Stage III Pancreatic Cancer|Stage III Rectal Cancer|Stage III Skin Melanoma|Stage IIIA Colon Cancer|Stage IIIA Esophageal Cancer|Stage IIIA Gastric Cancer|Stage IIIA Non-Small Cell Lung Cancer|Stage IIIA Ovarian Cancer|Stage IIIA Rectal Cancer|Stage IIIA Skin Melanoma|Stage IIIB Colon Cancer|Stage IIIB Esophageal Cancer|Stage IIIB Gastric Cancer|Stage IIIB Non-Small Cell Lung Cancer|Stage IIIB Ovarian Cancer|Stage IIIB Rectal Cancer|Stage IIIB Skin Melanoma|Stage IIIC Colon Cancer|Stage IIIC Esophageal Cancer|Stage IIIC Gastric Cancer|Stage IIIC Ovarian Cancer|Stage IIIC Rectal Cancer|Stage IIIC Skin Melanoma|Stage IV Bladder Cancer|Stage IV Bone Sarcoma|Stage IV Breast Cancer|Stage IV Colon Cancer|Stage IV Esophageal Cancer|Stage IV Gastric Cancer|Stage IV Non-Small Cell Lung Cancer|Stage IV Ovarian Cancer|Stage IV Pancreatic Cancer|Stage IV Rectal Cancer|Stage IV Renal Cell Cancer|Stage IV Skin Melanoma|Stage IV Soft Tissue Sarcoma|Stage IVA Bone Sarcoma|Stage IVA Colon Cancer|Stage IVA Rectal Cancer|Stage IVB Bone Sarcoma|Stage IVB Colon Cancer|Stage IVB Rectal Cancer|Triple-Negative Breast Carcinoma","Other: Best Practice|Other: Laboratory Biomarker Analysis|Procedure: Supportive Care|Other: Survey Administration","Virginia K Crosson Cancer Center, Fullerton, California, United States","https://ClinicalTrials.gov/show/NCT03154190"
1451,"Engagement of Patients With Advanced Cancer","Completed","Has Results","End of Life|Advanced Cancer|Lung Neoplasm|Gastric Cancer|Colon Cancer|Glioblastoma Multiforme|Head and Neck Neoplasms|Rectum Cancer|Melanoma|Kidney Cancer|Prostate Cancer|Testicular Neoplasms|Liver Cancer|Cancer of Unknown Origin","Behavioral: EPAC",,"https://ClinicalTrials.gov/show/NCT02966509"
1452,"Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors","Completed","No Results Available","Anaplastic Astrocytoma|Anaplastic Oligoastrocytoma|Anaplastic Oligodendroglioma|Estrogen Receptor Negative|Estrogen Receptor Positive|Glioblastoma|Hormone-Resistant Prostate Cancer|Metastatic Prostate Carcinoma|Metastatic Renal Cell Cancer|Recurrent Adult Brain Neoplasm|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Hepatocellular Carcinoma|Recurrent Lung Carcinoma|Recurrent Melanoma|Recurrent Ovarian Carcinoma|Recurrent Prostate Carcinoma|Recurrent Renal Cell Carcinoma|Recurrent Uterine Corpus Carcinoma|Resectable Hepatocellular Carcinoma|Sarcoma|Stage IA Breast Cancer|Stage IA Ovarian Cancer|Stage IA Uterine Corpus Cancer|Stage IB Breast Cancer|Stage IB Ovarian Cancer|Stage IB Uterine Corpus Cancer|Stage IC Ovarian Cancer|Stage II Uterine Corpus Cancer|Stage IIA Breast Cancer|Stage IIA Lung Carcinoma|Stage IIA Ovarian Cancer|Stage IIB Breast Cancer|Stage IIB Esophageal Cancer|Stage IIB Lung Carcinoma|Stage IIB Ovarian Cancer|Stage IIB Skin Melanoma|Stage IIC Ovarian Cancer|Stage IIC Skin Melanoma|Stage IIIA Breast Cancer|Stage IIIA Esophageal Cancer|Stage IIIA Lung Carcinoma|Stage IIIA Ovarian Cancer|Stage IIIA Skin Melanoma|Stage IIIA Uterine Corpus Cancer|Stage IIIB Breast Cancer|Stage IIIB Esophageal Cancer|Stage IIIB Ovarian Cancer|Stage IIIB Skin Melanoma|Stage IIIB Uterine Corpus Cancer|Stage IIIC Breast Cancer|Stage IIIC Esophageal Cancer|Stage IIIC Ovarian Cancer|Stage IIIC Skin Melanoma|Stage IIIC Uterine Corpus Cancer|Stage IV Bladder Urothelial Carcinoma|Stage IV Esophageal Cancer|Stage IV Ovarian Cancer|Stage IV Prostate Cancer|Stage IV Skin Melanoma|Stage IVA Uterine Corpus Cancer|Stage IVB Uterine Corpus Cancer","Biological: DEC-205/NY-ESO-1 Fusion Protein CDX-1401|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Sirolimus","Roswell Park Cancer Institute, Buffalo, New York, United States","https://ClinicalTrials.gov/show/NCT01522820"
1453,"The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)","Recruiting","No Results Available","Cancer, All Types|Cancer of Liver|Cancer of Stomach|Cancer of Head and Neck|Cancer of Rectum|Cancer of Kidney|Cancer of Esophagus|Cancer of Colon|Cancer Skin|Cancer of Cervix|Cancer, Metastatic|Cancer of Larynx|Cancer of Neck|Cancer of Lung|Cancer of Brain and Nervous System|Cancer of Vulva, Disseminated|Cancer of Pancreas|Sarcoma|GIST|Small-cell Lung Cancer|Adenocarcinoma Lung|Cancer of Prostate|Cancer, Advanced|Adrenal Cancer|Testicular Cancer|Uterine Cancer|Bronchoalveolar Cell Lung Cancer|Cancer Unknown Primary|Glioblastoma Multiforme|Oligodendroglioma|Breast Cancer|Renal Cell Carcinoma|Hepatocellular Carcinoma|Cholangiocarcinoma|Squamous Cell Carcinoma|Transitional Cell Carcinoma|Cancer, Other|Cancer, Anal|Melanoma|Cancer, Bile Duct|Cancer, Bladder|Cancer Cords Vocal|Cancers Cell Neuroendocrine|Cancer Differentiated Poorly|Cancer, Anaplastic Thyroid",,"Specicare, Gainesville, Georgia, United States","https://ClinicalTrials.gov/show/NCT03896958"
1454,"Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma","Active, not recruiting","No Results Available","Anaplastic Astrocytoma|Anaplastic Ependymoma|Anaplastic Oligodendroglioma|Gliosarcoma|Mixed Glioma|Recurrent Adult Brain Neoplasm|Recurrent Glioblastoma","Other: Laboratory Biomarker Analysis|Drug: Lapatinib|Drug: Lapatinib Ditosylate|Other: Pharmacological Study|Procedure: Therapeutic Conventional Surgery","UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States|Memorial Sloan Kettering Commack, Commack, New York, United States|Memorial Sloan Kettering Westchester, Harrison, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT02101905"
1455,"Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors","Completed","No Results Available","Anxiety Disorder|Worry|Uncertainty|Sleep Disorders|Insomnia|Fatigue|Pain|Depression|Cognitive-behavioral Therapy|Psychological Intervention|Esophageal Cancer|Pancreatic Cancer|Leukemia|Lung Cancer|Multiple Myeloma|Ovarian Neoplasm|Stage III or IV Cervical or Uterine Cancer|Stage IIIB, IIIC, or IV Breast Cancer|Glioblastoma Multiforme|Relapsed Lymphoma|Stage III or IV Colorectal Cancer|Stage IIIC or IV Melanoma","Behavioral: Cognitive-behavioral therapy for worry, uncertainty & insomnia","Wexner Medical Center at The Ohio State University Department of Psychiatry, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT01929720"
1456,"Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma","Completed","No Results Available","Multiple Myeloma|Diffuse Large B-Cell Lymphoma|Glioblastoma Multiforme|Hepatocellular Carcinoma|Non-Small Cell Lung Cancer|Neuroendocrine Tumors of Non-Pancreatic Origin|Hormone Receptor-Positive Breast Cancer","Drug: CC-223","Cedars-Sinai Medical Center, Los Angeles, California, United States|UCLA Neuro-Oncology Program, Los Angeles, California, United States|University of California, San Francisco Hellen Diller Family Comprehensive Cancer Center, San Francisco, California, United States|Moffitt Cancer Center, Tampa, Florida, United States|Mayo Clinic Cancer Clinical Studies Unit, Rochester, Minnesota, United States|Billings Clinic, Billings, Montana, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|NYU Cancer Institute - Bellevue Hospital, New York, New York, United States|Sarah Cannon Research Institute Drug Development Unit, Nashville, Tennessee, United States|Mary Crowley Medical Research Center, Dallas, Texas, United States|Institut Claudius Regaud, Toulouse Cedex, France|Institut Gustave Roussy Faculte de Medecine Paris Sud Service de pneumologie, Villejuif, France|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital Universitario Virgen Del Rocio, Sevilla, Spain|Sarah Cannon Research Institute UK, London, United Kingdom|UCL Cancer Institute, London, United Kingdom","https://ClinicalTrials.gov/show/NCT01177397"
1457,"Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer","Completed","Has Results","Gastric Adenocarcinoma|Esophageal Cancer|Hepatocellular Carcinoma|Non-small Cell Lung Cancer|Small Cell Lung Cancer|Ovarian Epithelial Cancer|Carcinoma Breast Stage IV|Hormone-refractory Prostate Cancer|Head and Neck Cancers- Squamous Cell|Renal Cell Cancer|Urinary Bladder Neoplasms|Cervical Cancer|Endometrial Cancer|Glioblastoma Multiforme|Triple Negative Breast Cancer|Pancreatic Cancer","Drug: Sacituzumab Govitecan-hziy (SG)","University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States|Yale University School of Medicine, New Haven, Connecticut, United States|Helen F. Graham Cancer Center, Newark, Delaware, United States|MD Anderson Cancer Center Orlando (UF Health Cancer Center), Orlando, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|IU Health Goshen Cancer Center, Goshen, Indiana, United States|Massachusettes General Hospital, Boston, Massachusetts, United States|Weill Cornell/New York Presbyterian Hospital, New York, New York, United States|Columbia University Herbert Irving Cancer Center, New York, New York, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States|Texas Oncology Sammons Cancer Center, Dallas, Texas, United States|Virginia Mason Cancer Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT01631552"
1458,"Nimotuzumab in Children With HGG","Completed","No Results Available","High Grade Glioma",,"University Bonn, Children's Medical Hospital, Bonn, Germany","https://ClinicalTrials.gov/show/NCT00561873"
1459,"Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas","Active, not recruiting","No Results Available","Malignant Glioma|Recurrent Brain Neoplasm|Recurrent Childhood Central Nervous System Neoplasm|Recurrent Childhood Glioblastoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Primary Central Nervous System Neoplasm|WHO Grade III Glioma","Other: Pharmacological Study|Drug: Selinexor","Children's Hospital of Alabama, Birmingham, Alabama, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Children's Hospital of Orange County, Orange, California, United States|UCSF Medical Center-Mission Bay, San Francisco, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Children's National Medical Center, Washington, District of Columbia, United States|Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, United States|Riley Hospital for Children, Indianapolis, Indiana, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, United States|University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States|Saint Jude Children's Research Hospital, Memphis, Tennessee, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States|Seattle Children's Hospital, Seattle, Washington, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT02323880"
1460,"Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors","Active, not recruiting","No Results Available","Childhood Astrocytoma|Childhood Atypical Teratoid/Rhabdoid Tumor|Diffuse Intrinsic Pontine Glioma|Glioma|Recurrent Childhood Anaplastic Oligodendroglioma|Recurrent Childhood Brain Neoplasm|Recurrent Childhood Glioblastoma|Recurrent Childhood Medulloblastoma|Recurrent Primitive Neuroectodermal Tumor|Refractory Brain Neoplasm","Other: Laboratory Biomarker Analysis|Biological: Sargramostim|Biological: Wild-type Reovirus","Mayo Clinic, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT02444546"
1461,"Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water","Recruiting","No Results Available","Brain Cancer",,"Huntsman Cancer Institute, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT01246869"
1462,"A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab","Recruiting","No Results Available","Glioma","Drug: Bevacizumab|Radiation: PRDR","University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01743950"
1463,"A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma","Completed","No Results Available","Glioma","Drug: LY2157299|Drug: Radiation|Drug: Temozolomide","For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., La Jolla, California, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., San Francisco, California, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tampa, Florida, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Chicago, Illinois, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Indianapolis, Indiana, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Durham, North Carolina, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Frankfurt, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Heidelberg, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Barcelona, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madrid, Spain","https://ClinicalTrials.gov/show/NCT01220271"
1464,"Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)","Completed","No Results Available","Malignant Glioma","Other: No intervention","Osaka, Japan|Tokyo, Japan","https://ClinicalTrials.gov/show/NCT02300532"
1465,"Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma","Completed","No Results Available","Malignant Glioma","Other: No intervention","Osaka, Japan|Tokyo, Japan","https://ClinicalTrials.gov/show/NCT02300506"
1466,"GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma","Completed","Has Results","Brain and Central Nervous System Tumors","Biological: HSPPC-96|Procedure: Standard Surgical Resection","University of California, San Francisco, San Francisco, California, United States|Columbia University, New York, New York, United States|University Hospitals Case Medical Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00293423"
1467,"Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: motexafin gadolinium|Procedure: magnetic resonance imaging|Procedure: surgical procedure","Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT00003410"
1468,"Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma","Terminated","Has Results","High Grade Glioma","Drug: Antineoplaston therapy (Atengenal + Astugenal)","Burzynski Clinic, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00003535"
1469,"Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation","Unknown status","No Results Available","Humoral Rejection|Guillain-Barre Syndrome|Miller Fisher Syndrome|CIDP|Good Pasture Syndrome|Hyperviscosity Syndrome","Drug: Fibrinogen concentrate|Other: Fresh Frozen Plasma","University Medical Centre Ljubljana, Ljubljana, Gorenjska, Slovenia","https://ClinicalTrials.gov/show/NCT03801135"
1470,"Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors","Terminated","No Results Available","Cancer","Drug: BEZ235|Drug: Everolimus","University of Cincinnati, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT01508104"
1471,"A Patient-Centric Platform Trial for Precision Oncology","Recruiting","No Results Available","Oncology",,"Cancer Commons, Los Altos, California, United States","https://ClinicalTrials.gov/show/NCT03793088"
1472,"Continued Treatment for Participants Enrolled in Studies of BXQ-350","Enrolling by invitation","No Results Available","Neoplasms","Drug: BXQ-350","University of Kentucky Markey Cancer Center, Lexington, Kentucky, United States|University of Cincinnati Barrett Center, Cincinnati, Ohio, United States|The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT04404569"
1473,"Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide","Completed","No Results Available","Newly Diagnosed High-Grade Glioma","Drug: Mebendazole","The Johs Hopkins Hospital, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT01729260"
1474,"Glioma Microenvironment an Exploratory Study","Active, not recruiting","No Results Available","Glioma of Brain","Procedure: Tumor resection","Hospital Sirio Libanes, São Paulo, Sao, Brazil","https://ClinicalTrials.gov/show/NCT03189420"
1475,"Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors","Completed","No Results Available","Neoplasms","Drug: BXQ-350","University of Kentucky Markey Cancer Center, Lexington, Kentucky, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, United States|University of Cincinnati Barrett Center, Cincinnati, Ohio, United States|The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT02859857"
1476,"Personalized Translational Platform for Biomarker Discovery in Brain Tumors","Completed","No Results Available","High Grade Glioma","Drug: FLT-PET/CT: (3'deoxy-3'-[(18)F] fluorothymidine) PET/CT","University of California at San Diego, San Diego, California, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01240161"
1477,"A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma","Completed","No Results Available","Recurrent or Progressive Malignant Glioma","Drug: ANG1005","Dana Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, United States|University of Texas, MD Anderson Cancer Center, Houston, Texas, United States|UT Health Science Center at the Cancer Therapy and Research Center (CTRC), San Antonio, Texas, United States|University of Virginia Health System, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT00539344"
1478,"Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors","Completed","Has Results","Malignant Brain Tumors","Drug: Antineoplaston therapy (Atengenal + Astugenal)","Burzynski Clinic, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00003475"
1479,"Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: aminolevulinic acid|Procedure: Surgical Resection","University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00752323"
1480,"A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, Followed By Dose Dense Therapy With Temozolomide For Newly Diagnosed Malignant High Grade Glioma","Unknown status","No Results Available","Glioma","Drug: Temozolomide","Kentuckiana Cancer Institute, Louisville, Kentucky, United States","https://ClinicalTrials.gov/show/NCT00660283"
1481,"Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: chemotherapy|Drug: cladribine|Radiation: radiation therapy","Radiation Oncology Branch, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00019071"
1482,"Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Radiation: radiation therapy|Radiation: stereotactic radiosurgery","Alfred Hospital, Melbourne, Victoria, Australia|Centre Antoine Lacassagne, Nice, France|Medizinische Klinik I, Dresden, Germany|Universitaet Wuerzburg/Hautkrankheiten, Wuerzburg, Germany|Vrije Universiteit Medisch Centrum, Amsterdam, Netherlands|Institut Catala d'Oncologia - Hospital Duran i Reynals, Barcelona, Spain|Universitaetsspital, Zurich, Switzerland|Royal Marsden Hospital, Sutton, England, United Kingdom","https://ClinicalTrials.gov/show/NCT00003916"
1483,"Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: tipifarnib","Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States|UCSF Comprehensive Cancer Center, San Francisco, California, United States|Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda, Maryland, United States|Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00005859"
1484,"Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas","Unknown status","No Results Available","Brain and Central Nervous System Tumors","Drug: carboplatin|Drug: tamoxifen citrate|Drug: temozolomide|Procedure: adjuvant therapy|Radiation: radiation therapy","San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas, Encinitas, California, United States","https://ClinicalTrials.gov/show/NCT00492687"
1485,"EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas","Completed","No Results Available","Brain Cancer","Drug: erlotinib|Procedure: Cytoreductive Surgery","Memorial Sloan-Kettering at Basking Ridge, Basking Ridge, New Jersey, United States|Memorial Sloan-Kettering Cancer Center at Commack, Commack, New York, United States|Columbia University Medical Center, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01257594"
1486,"Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas","Terminated","Has Results","Brain Tumor, Recurrent","Drug: Photofrin photodynamic therapy.","Medical College of Wisconsin/ Froedtert Hospital, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01966809"
1487,"Complementary/Integrative Medicine for Brain Cancer Patients","Withdrawn","No Results Available","Quality of Life|Chemotherapeutic Toxicity|Radiation Toxicity","Other: Acupuncture",,"https://ClinicalTrials.gov/show/NCT03185780"
1488,"Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)","Recruiting","No Results Available","Glioma","Drug: Rhenium Liposome Treatment","UT Southwestern Medical Center, Dallas, Texas, United States|MD Anderson Cancer Center, Houston, Texas, United States|The Cancer Therapy and Research Center at UTHSCSA, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT01906385"
1489,"Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S","Recruiting","No Results Available","Astrocytoma|Brain Cancer|Brain Metastases|Bladder Cancer|Breast Cancer|Cervical Cancer|Cholangiocarcinoma|Colorectal Cancer|Esophagus Cancer|Gastric Cancer|Head and Neck Cancer|Kidney Cancer|Liver Cancer|Lung Cancer|Melanoma|Ovarian Cancer|Pancreatic Cancer|Pleural Mesothelioma|Prostate Cancer|Sarcoma|Tongue Cancer|Thymic Carcinoma|Urinary Tract Cancer","Drug: QBS10072S","St George Private Hospital, Kogarah, New South Wales, Australia|Sydney Southwest Private Hospital, Liverpool, New South Wales, Australia","https://ClinicalTrials.gov/show/NCT04430842"
1490,"Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma","Completed","Has Results","Glioma","Drug: pazopanib|Drug: lapatinib",,"https://ClinicalTrials.gov/show/NCT00350727"
1491,"Low Dose Naltrexone for Glioma Patients","Completed","Has Results","Malignant Glioma","Drug: LDN|Drug: Placebo","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01303835"
1492,"A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade Glioma","Recruiting","No Results Available","Recurrent High Grade Glioma","Drug: Cerebraca wafer","Hualien Tzu Chi Hospital, Hualien City, Taiwan|Taichung Veterans General Hospital, Taichung, Taiwan|Tri-Service General Hospital, Taipei, Taiwan","https://ClinicalTrials.gov/show/NCT03234595"
1493,"Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors","Completed","Has Results","High Grade Gliomas|Brain Tumors","Procedure: adjuvant therapy|Drug: Temozolomide|Drug: Valproic Acid|Radiation: Radiation therapy","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Virginia Commonwealth University, Richmond, Virginia, United States","https://ClinicalTrials.gov/show/NCT00302159"
1494,"PVSRIPO in Recurrent Malignant Glioma","Active, not recruiting","No Results Available","Malignant Glioma","Biological: PVSRIPO","UCSF Neurological Surgery, San Francisco, California, United States|Baptist MD Anderson Cancer Center, Jacksonville, Florida, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Preston Robert Tisch Brain Tumor Center at Duke University, Durham, North Carolina, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT02986178"
1495,"Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: O6-benzylguanine|Drug: busulfan|Drug: temozolomide|Procedure: adjuvant therapy|Procedure: autologous bone marrow transplantation|Procedure: conventional surgery|Procedure: peripheral blood stem cell transplantation|Radiation: radiation therapy",,"https://ClinicalTrials.gov/show/NCT00253487"
1496,"Bevacizumab in Treating Patients With Recurrent or Progressive Glioma","Completed","Has Results","Brain and Central Nervous System Tumors","Biological: bevacizumab","Hematology-Oncology Associates of Illinois, Chicago, Illinois, United States|Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT00337207"
1497,"Study of LBH589 (Panobinostat) to Treat Malignant Brain Tumors","Terminated","No Results Available","Recurrent Malignant Gliomas","Drug: Panobinostat","Long Island Brain Tumor Center at Neurological Surgery PC / Long Island Neuro-Oncology Associates, Commack, New York, United States|Long Island Brain Tumor Center at Neurological Surgery PC / Long Island Neuro-Oncology Associates, Great Neck, New York, United States","https://ClinicalTrials.gov/show/NCT00848523"
1498,"Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: lomustine|Drug: procarbazine hydrochloride|Drug: temozolomide|Drug: vincristine sulfate","Medical Research Council Clinical Trials Unit, London, England, United Kingdom","https://ClinicalTrials.gov/show/NCT00052455"
1499,"IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma","Unknown status","No Results Available","Brain and Central Nervous System Tumors","Biological: interleukin-4 PE38KDEL cytotoxin|Drug: isolated perfusion|Procedure: surgical procedure","University of Southern California, Healthcare Consultation Center, Los Angeles, California, United States|UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States|Neuro-Oncology Service, San Francisco, California, United States|John Wayne Cancer Institute, Santa Monica, California, United States|Laboratory of Molecular Biology, Bethesda, Maryland, United States|Food and Drug Administration, Rockville, Maryland, United States|St. Louis University Health Sciences Center, Saint Louis, Missouri, United States|Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Charlotte Neurosurgical Associates, Charlotte, North Carolina, United States|Barrett Cancer Center, The University Hospital, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT00003842"
1500,"Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: O6-benzylguanine|Drug: carmustine","Duke Comprehensive Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00003348"
1501,"Gene Therapy in Treating Patients With Primary Brain Tumors","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: gene therapy|Drug: chemotherapy|Drug: ganciclovir|Procedure: conventional surgery","University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00002824"
1502,"G207 Followed by Radiation Therapy in Malignant Glioma","Completed","No Results Available","Malignant Glioma","Drug: G207","University of Alabama at Birmingham, Birmingham, Alabama, United States","https://ClinicalTrials.gov/show/NCT00157703"
1503,"Irinotecan in Treating Patients With Recurrent Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: irinotecan hydrochloride","University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Emory University Hospital - Atlanta, Atlanta, Georgia, United States|Johns Hopkins Oncology Center, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States|University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00003301"
1504,"Taurolidine in Treating Patients With Recurrent or Progressive Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: taurolidine","Memorial Sloan-Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00022360"
1505,"SarCNU in Treating Patients With Recurrent Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: SarCNU","Tom Baker Cancer Center - Calgary, Calgary, Alberta, Canada|Ottawa Regional Cancer Centre, Ottawa, Ontario, Canada|Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada|Toronto General Hospital, Toronto, Ontario, Canada|McGill University, Montreal, Quebec, Canada","https://ClinicalTrials.gov/show/NCT00036660"
1506,"O(6)-Benzylguanine in Treating Patients With Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: O6-benzylguanine","Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States|UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|Simmons Cancer Center - Dallas, Dallas, Texas, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00002971"
1507,"Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma","Unknown status","No Results Available","Brain and Central Nervous System Tumors","Drug: thalidomide|Drug: topotecan hydrochloride","Rush Cancer Institute at Rush University Medical Center, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT00014443"
1508,"Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas","Unknown status","No Results Available","Brain and Central Nervous System Tumors","Drug: carmustine|Drug: lomustine|Drug: porfimer sodium|Drug: procarbazine hydrochloride|Procedure: neoadjuvant therapy|Procedure: surgical procedure|Radiation: radiation therapy","Rocky Mountain Neurological Associates, Englewood, Colorado, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States|St. Michael's Hospital-Annex, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT00003788"
1509,"Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors","Completed","No Results Available","Brain Tumor, Recurrent","Drug: Photofrin (porfimer sodium) & photodynamic therapy.","Children's Hospital of Wisconsin, Wauwatosa, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01682746"
1510,"Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma","Completed","Has Results","Brain Cancer|Malignant Glioma","Other: radiotherapy (RT) in combination with temozolomide and bevacizumab","Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States|Memorial Sloan-Kettering Cancer Center at Commack, Commack, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00782756"
1511,"Study of Capecitabine to Treat Recurrent High Grade Gliomas","Completed","Has Results","Malignant Glioma","Drug: Capecitabine","University of Florida, Gainesville, Florida, United States","https://ClinicalTrials.gov/show/NCT00717197"
1512,"First in Patient Study for PF-06840003 in Malignant Gliomas","Terminated","Has Results","Oligodendroglioma|Astrocytoma|Malignant Glioma","Drug: PF-06840003","Ronald Reagan UCLA Medical Center, Los Angeles, California, United States|UCLA Clinical & Translational Research Center, Los Angeles, California, United States|UCLA Oncology Center, Los Angeles, California, United States|UCLA School of Medicine, Los Angeles, California, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham & Women's Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, United States|Columbia University Medical Center, New York, New York, United States|Columbia University Medical Center, New York, New York, United States|CUMC Research Pharmacy, New York, New York, United States|Columbia Doctors Tarrytown, Tarrytown, New York, United States|Duke Cancer Center, Durham, North Carolina, United States|Duke University Medical Center, Duke Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT02764151"
1513,"Study of Immunotoxin, MR1-1","Terminated","No Results Available","Supratentorial Malignant Brain Tumor","Biological: MR1-1","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01009866"
1514,"Establishment of a Signature of Circulating microRNA as a Tool to Aid Diagnosis of Primary Brain Tumors in Adults","Completed","No Results Available","Brain Tumors",,"Groupe Hospitalier Pitié-Salpêtrière, Paris, France","https://ClinicalTrials.gov/show/NCT03630861"
1515,"A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG","Terminated","No Results Available","Pediatric Brain Tumor|Diffuse Intrinsic Pontine Glioma","Biological: Ad-RTS-hIL-12|Drug: Oral Veledimex - Arm 1 (Pediatric Brain Tumor)|Drug: Oral Veledimex - Arm 2 (DIPG)","University of California San Francisco, Benioff Children's Hospital, San Francisco, California, United States|Lurie Children's Hospital of Chicago, Chicago, Illinois, United States|Dana- Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT03330197"
1516,"Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors","Completed","No Results Available","Childhood Atypical Teratoid/Rhabdoid Tumor|Childhood Central Nervous System Choriocarcinoma|Childhood Central Nervous System Embryonal Tumor|Childhood Central Nervous System Germinoma|Childhood Central Nervous System Mixed Germ Cell Tumor|Childhood Central Nervous System Teratoma|Childhood Central Nervous System Yolk Sac Tumor|Childhood Choroid Plexus Tumor|Childhood Craniopharyngioma|Childhood Ependymoblastoma|Childhood Grade I Meningioma|Childhood Grade II Meningioma|Childhood Grade III Meningioma|Childhood High-grade Cerebellar Astrocytoma|Childhood High-grade Cerebral Astrocytoma|Childhood Infratentorial Ependymoma|Childhood Low-grade Cerebellar Astrocytoma|Childhood Low-grade Cerebral Astrocytoma|Childhood Medulloepithelioma|Childhood Mixed Glioma|Childhood Oligodendroglioma|Childhood Supratentorial Ependymoma|Extra-adrenal Paraganglioma|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Central Nervous System Embryonal Tumor|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Ependymoma|Recurrent Childhood Medulloblastoma|Recurrent Childhood Pineoblastoma|Recurrent Childhood Spinal Cord Neoplasm|Recurrent Childhood Subependymal Giant Cell Astrocytoma|Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor|Recurrent Childhood Visual Pathway and Hypothalamic Glioma","Drug: vorinostat|Drug: temozolomide|Other: diagnostic laboratory biomarker analysis|Other: pharmacological study","Childrens Memorial Hospital, Chicago, Illinois, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, United States|University of Minnesota Medical Center-Fairview, Minneapolis, Minnesota, United States|Oregon Health and Science University, Portland, Oregon, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States|Seattle Children's Hospital, Seattle, Washington, United States|Hospital for Sick Children, Toronto, Ontario, Canada|Hospital Sainte-Justine, Montreal, Quebec, Canada","https://ClinicalTrials.gov/show/NCT01076530"
1517,"ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors","Completed","No Results Available","Childhood Atypical Teratoid/Rhabdoid Tumor|Childhood Central Nervous System Germ Cell Tumor|Childhood Choroid Plexus Tumor|Childhood Craniopharyngioma|Childhood Ependymoblastoma|Childhood Grade I Meningioma|Childhood Grade II Meningioma|Childhood Grade III Meningioma|Childhood High-grade Cerebellar Astrocytoma|Childhood High-grade Cerebral Astrocytoma|Childhood Infratentorial Ependymoma|Childhood Low-grade Cerebellar Astrocytoma|Childhood Low-grade Cerebral Astrocytoma|Childhood Medulloepithelioma|Childhood Mixed Glioma|Childhood Oligodendroglioma|Childhood Supratentorial Ependymoma|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Brain Tumor|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Ependymoma|Recurrent Childhood Medulloblastoma|Recurrent Childhood Pineoblastoma|Recurrent Childhood Spinal Cord Neoplasm|Recurrent Childhood Subependymal Giant Cell Astrocytoma|Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor|Recurrent Childhood Visual Pathway and Hypothalamic Glioma","Drug: veliparib|Drug: temozolomide|Other: pharmacological study|Other: laboratory biomarker analysis","Pediatric Brain Tumor Consortium, Memphis, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00946335"
1518,"Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma","Completed","No Results Available","Childhood Burkitt Lymphoma|Childhood Central Nervous System Germ Cell Tumor|Childhood Choroid Plexus Tumor|Childhood Craniopharyngioma|Childhood Grade I Meningioma|Childhood Grade II Meningioma|Childhood Grade III Meningioma|Childhood High-grade Cerebral Astrocytoma|Childhood Infratentorial Ependymoma|Childhood Low-grade Cerebral Astrocytoma|Childhood Spinal Cord Neoplasm|Childhood Supratentorial Ependymoma|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Brain Tumor|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Ependymoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Medulloblastoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor|Recurrent Childhood Visual Pathway and Hypothalamic Glioma|Unspecified Childhood Solid Tumor, Protocol Specific","Drug: ispinesib|Other: laboratory biomarker analysis|Other: pharmacological study","Children's Oncology Group, Arcadia, California, United States","https://ClinicalTrials.gov/show/NCT00363272"
1519,"Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer","Completed","No Results Available","Advanced Cancer|Brain Involvement","Drug: DM-CHOC-PEN","Tulane University Medical School, New Orleans, Louisiana, United States","https://ClinicalTrials.gov/show/NCT01048008"
1520,"Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors","Completed","No Results Available","Childhood Atypical Teratoid/Rhabdoid Tumor|Childhood Central Nervous System Germ Cell Tumor|Childhood Choroid Plexus Tumor|Childhood Craniopharyngioma|Childhood Ependymoblastoma|Childhood Grade I Meningioma|Childhood Grade II Meningioma|Childhood Grade III Meningioma|Childhood High-grade Cerebellar Astrocytoma|Childhood High-grade Cerebral Astrocytoma|Childhood Infratentorial Ependymoma|Childhood Low-grade Cerebellar Astrocytoma|Childhood Low-grade Cerebral Astrocytoma|Childhood Medulloepithelioma|Childhood Mixed Glioma|Childhood Oligodendroglioma|Childhood Supratentorial Ependymoma|Recurrent Childhood Brain Tumor|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Ependymoma|Recurrent Childhood Medulloblastoma|Recurrent Childhood Pineoblastoma|Recurrent Childhood Subependymal Giant Cell Astrocytoma|Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor|Recurrent Childhood Visual Pathway and Hypothalamic Glioma","Drug: lenalidomide|Procedure: perfusion-weighted magnetic resonance imaging|Procedure: diffusion-weighted magnetic resonance imaging|Other: laboratory biomarker analysis","Pediatric Brain Tumor Consortium, Memphis, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00100880"
1521,"Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment","Completed","No Results Available","Childhood Central Nervous System Germ Cell Tumor|Childhood Extragonadal Germ Cell Tumor|Childhood Hepatoblastoma|Childhood Hepatocellular Carcinoma|Childhood High-grade Cerebral Astrocytoma|Childhood Low-grade Cerebral Astrocytoma|Childhood Malignant Ovarian Germ Cell Tumor|Childhood Malignant Testicular Germ Cell Tumor|Childhood Teratoma|Recurrent Adrenocortical Carcinoma|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Ependymoma|Recurrent Childhood Liver Cancer|Recurrent Childhood Malignant Germ Cell Tumor|Recurrent Childhood Rhabdomyosarcoma|Recurrent Childhood Soft Tissue Sarcoma|Recurrent Childhood Visual Pathway and Hypothalamic Glioma|Recurrent Colon Cancer|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Nasopharyngeal Cancer|Recurrent Neuroblastoma|Recurrent Osteosarcoma|Recurrent Rectal Cancer|Recurrent Renal Cell Cancer","Drug: oxaliplatin","Children's Oncology Group, Arcadia, California, United States","https://ClinicalTrials.gov/show/NCT00091182"
1522,"Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma","Completed","No Results Available","Childhood High-grade Cerebral Astrocytoma|Childhood Oligodendroglioma|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Medulloblastoma|Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor|Recurrent Childhood Visual Pathway and Hypothalamic Glioma","Drug: tipifarnib","Children's Oncology Group, Arcadia, California, United States","https://ClinicalTrials.gov/show/NCT00070525"
1523,"Cilengitide in Treating Children With Refractory Primary Brain Tumors","Completed","No Results Available","Childhood Central Nervous System Germ Cell Tumor|Childhood Choroid Plexus Tumor|Childhood Craniopharyngioma|Childhood Ependymoblastoma|Childhood Grade I Meningioma|Childhood Grade II Meningioma|Childhood Grade III Meningioma|Childhood High-grade Cerebellar Astrocytoma|Childhood High-grade Cerebral Astrocytoma|Childhood Infratentorial Ependymoma|Childhood Low-grade Cerebellar Astrocytoma|Childhood Low-grade Cerebral Astrocytoma|Childhood Medulloepithelioma|Childhood Mixed Glioma|Childhood Oligodendroglioma|Childhood Supratentorial Ependymoma|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Brain Tumor|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Ependymoma|Recurrent Childhood Medulloblastoma|Recurrent Childhood Pineoblastoma|Recurrent Childhood Subependymal Giant Cell Astrocytoma|Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor|Recurrent Childhood Visual Pathway and Hypothalamic Glioma","Drug: cilengitide|Other: laboratory biomarker analysis","Pediatric Brain Tumor Consortium, Memphis, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00063973"
1524,"FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia","Completed","No Results Available","Blastic Phase Chronic Myelogenous Leukemia|Childhood Central Nervous System Germ Cell Tumor|Childhood Choroid Plexus Tumor|Childhood Chronic Myelogenous Leukemia|Childhood Craniopharyngioma|Childhood Grade I Meningioma|Childhood Grade II Meningioma|Childhood Grade III Meningioma|Childhood High-grade Cerebral Astrocytoma|Childhood Infratentorial Ependymoma|Childhood Low-grade Cerebral Astrocytoma|Childhood Spinal Cord Neoplasm|Childhood Supratentorial Ependymoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Ependymoma|Recurrent Childhood Medulloblastoma|Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor|Recurrent Childhood Visual Pathway and Hypothalamic Glioma|Refractory Chronic Lymphocytic Leukemia|Relapsing Chronic Myelogenous Leukemia|Unspecified Childhood Solid Tumor, Protocol Specific","Drug: romidepsin","Children's Oncology Group, Arcadia, California, United States","https://ClinicalTrials.gov/show/NCT00053963"
1525,"Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors","Completed","No Results Available","Childhood Central Nervous System Germ Cell Tumor|Childhood Choroid Plexus Tumor|Childhood Craniopharyngioma|Childhood Ependymoblastoma|Childhood Grade I Meningioma|Childhood Grade II Meningioma|Childhood Grade III Meningioma|Childhood High-grade Cerebellar Astrocytoma|Childhood High-grade Cerebral Astrocytoma|Childhood Infratentorial Ependymoma|Childhood Low-grade Cerebellar Astrocytoma|Childhood Low-grade Cerebral Astrocytoma|Childhood Medulloepithelioma|Childhood Mixed Glioma|Childhood Oligodendroglioma|Childhood Supratentorial Ependymoma|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Ependymoma|Recurrent Childhood Medulloblastoma|Recurrent Childhood Pineoblastoma|Recurrent Childhood Subependymal Giant Cell Astrocytoma|Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor|Recurrent Childhood Visual Pathway and Hypothalamic Glioma","Drug: O6-benzylguanine|Drug: temozolomide|Biological: filgrastim|Other: pharmacological study|Other: laboratory biomarker analysis","Pediatric Brain Tumor Consortium, Memphis, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00052780"
1526,"VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma","Terminated","No Results Available","Brain and Central Nervous System Tumors","Drug: CLORETAZINE|Drug: temozolomide","Hematology-Oncology Associates of Illinois, Chicago, Illinois, United States|Northwestern University, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT00516282"
1527,"Diffusion Tensor MRI to Distinguish Brain Tumor Recurrence From Radiation Necrosis","Completed","No Results Available","Glioma Tumor Recurrence|Radiation Necrosis|Primary Brain Tumor",,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00285324"
1528,"Vaccine Therapy in Treating Patients With Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: therapeutic autologous dendritic cells","Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT00068510"
1529,"Trial of IDH305 in IDH1 Mutant Grade II or III Glioma","Withdrawn","No Results Available","Glioma","Drug: IDH305","Laura & Isaac Perlmutter Cancer Center & NYU Langone Medical Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT02977689"
1530,"Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: carmustine|Drug: efaproxiral","University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa, Florida, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00005855"
1531,"Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: recombinant adenovirus-p53 SCH-58500|Procedure: conventional surgery",,"https://ClinicalTrials.gov/show/NCT00004080"
1532,"A Study Evaluating the Safety, Pharmacokinetics, and Anti-tumor Activity of ABBV-321 in Subjects With Advanced Solid Tumors Associated With Overexpression of the Epidermal Growth Factor Receptor (EGFR)","Completed","No Results Available","Advanced Solid Tumors Cancer","Drug: ABBV-321","Highlands Oncology Group /ID# 166132, Springdale, Arkansas, United States|The Angeles Clinic and Researc /ID# 166133, Los Angeles, California, United States|University of California, Davis Comprehensive Cancer Center /ID# 215012, Sacramento, California, United States|Northwestern University Feinberg School of Medicine /ID# 165191, Chicago, Illinois, United States|University of Chicago /ID# 166064, Chicago, Illinois, United States|Northshore University Health System Dermatology Clinical Trials Unit /ID# 201095, Skokie, Illinois, United States|University of Kentucky Markey Cancer Center /ID# 217665, Lexington, Kentucky, United States|Dana-Farber Cancer Institute /ID# 212920, Boston, Massachusetts, United States|Washington University-School of Medicine /ID# 214955, Saint Louis, Missouri, United States|Columbia Univ Medical Center /ID# 167184, New York, New York, United States|Stony Brook University Hospital /ID# 216976, Stony Brook, New York, United States|Duke University Medical Center /ID# 166135, Durham, North Carolina, United States|Lifespan Cancer Institute at Rhode Island Hospital /ID# 168600, Providence, Rhode Island, United States|South Texas Accelerated Research Therapeutics /ID# 166134, San Antonio, Texas, United States|Northern Cancer Institute /ID# 166138, St Leonards, New South Wales, Australia|Monash Health /ID# 217435, Clayton, Victoria, Australia|Austin Hospital /ID# 166137, Heidelberg, Victoria, Australia|Sheba Medical Center /ID# 166398, Ramat Gan, Israel","https://ClinicalTrials.gov/show/NCT03234712"
1533,"Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors","Completed","No Results Available","Brain and Central Nervous System Tumors","Procedure: surgical procedure|Radiation: brachytherapy|Radiation: intraoperative radiation therapy|Radiation: iodine I 125","University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Emory University Hospital - Atlanta, Atlanta, Georgia, United States|Johns Hopkins Oncology Center, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States|University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00003574"
1534,"Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: O6-benzylguanine|Drug: carmustine","Duke Comprehensive Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00005081"
1535,"Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: carmustine|Drug: temozolomide","Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States|UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|Simmons Cancer Center - Dallas, Dallas, Texas, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00003176"
1536,"Procarbazine in Treating Patients With Recurrent Brain Tumor","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: procarbazine hydrochloride","University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Emory University Hospital - Atlanta, Atlanta, Georgia, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00004004"
1537,"Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: cintredekin besudotox|Procedure: adjuvant therapy|Procedure: conventional surgery|Procedure: neoadjuvant therapy","Memorial Sloan-Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00036972"
1538,"Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: atrasentan hydrochloride","University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|Abramson Cancer Center at University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00017264"
1539,"Karenitecin in Treating Patients With Recurrent Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: karenitecin","University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Josephine Ford Cancer Center at Henry Ford Health System, Detroit, Michigan, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00014521"
1540,"Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: irofulven","University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Emory University Hospital - Atlanta, Atlanta, Georgia, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00012038"
1541,"Immunotoxin Therapy in Treating Patients With Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: cintredekin besudotox|Drug: isolated perfusion|Procedure: conventional surgery","University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa, Florida, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda, Maryland, United States|National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Josephine Ford Cancer Center at Henry Ford Health System, Detroit, Michigan, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00006268"
1542,"EMD 121974 in Treating Patients With Progressive or Recurrent Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: cilengitide","University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Emory University Hospital - Atlanta, Atlanta, Georgia, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00006093"
1543,"COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: incyclinide","University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Emory University Hospital - Atlanta, Atlanta, Georgia, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00004147"
1544,"Biological Therapy in Treating Patients With Primary or Advanced Glioma","Suspended","No Results Available","Brain and Central Nervous System Tumors","Biological: aldesleukin|Biological: lymphokine-activated killer cells","Staten Island University Hospital, Staten Island, New York, United States","https://ClinicalTrials.gov/show/NCT00003067"
1545,"Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: methotrexate|Other: pharmacological study",,"https://ClinicalTrials.gov/show/NCT00463008"
1546,"Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma","Completed","No Results Available","High Grade Glioma","Procedure: DNA methylation analysis|Procedure: polymerase chain reaction|Procedure: computed tomography|Procedure: magnetic resonance imaging",,"https://ClinicalTrials.gov/show/NCT00897611"
1547,"Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: bevacizumab|Drug: irinotecan hydrochloride","Duke Comprehensive Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00268359"
1548,"MRI in Evaluating the Effect of Efaproxiral on the Brain in Patients With Recurrent or Progressive Glioma Enrolled on Clinical Trial NABTT-9806","Withdrawn","No Results Available","Brain and Central Nervous System Tumors","Device: magnetic resonance imaging (MRI)",,"https://ClinicalTrials.gov/show/NCT00433472"
1549,"Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: gimatecan","Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT00087061"
1550,"Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: L-alanosine","H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa, Florida, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00075894"
1551,"Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With Glioma","Terminated","Has Results","Brain and Central Nervous System Tumors|Musculoskeletal Complications","Drug: testosterone gel applied to skin|Dietary Supplement: whey powder protein","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00631137"
1552,"Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma","Completed","Has Results","Brain and Central Nervous System Tumors","Drug: terameprocol|Other: pharmacological study","UAB Comprehensive Cancer Center, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa, Florida, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00404248"
1553,"Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5","Completed","No Results Available","Sarcoma|Melanoma|Lung Cancer|Breast Cancer|High Grade Gliomas","Drug: F-18 RGD-K5","Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00743353"
1554,"Brachytherapy in Treating Patients With Recurrent Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Procedure: adjuvant therapy|Radiation: iodine I 125","University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|Abramson Cancer Center at University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00045474"
1555,"Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas","Completed","No Results Available","Brain and Central Nervous System Tumors|Thromboembolism","Other: laboratory biomarker analysis|Other: physiologic testing|Procedure: management of therapy complications","Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa, Florida, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00253669"
1556,"Clinical Study of WT2725 in Patients With Advanced Malignancies","Completed","Has Results","Cancer","Biological: WT2725","The University of Arizona Cancer Center - North Campus, Tucson, Arizona, United States|UC San Diego Moores Cancer Center, La Jolla, California, United States|The University of Chicago Medical Center, Chicago, Illinois, United States|Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, United States|The University of Texas, MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01621542"
1557,"A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors","Recruiting","No Results Available","Solid Tumors","Drug: Regorafenib, (Stivarga, BAY73-4506)|Drug: Nivolumab (Opdivo)","City of Hope National Medical Center, Duarte, California, United States|Rocky Mountain Cancer Centers, Aurora, Colorado, United States|H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|Oncology Associates of Oregon, Eugene, Oregon, United States|Sarah Cannon Cancer Center, Nashville, Tennessee, United States|Baylor Charles A. Sammons Cancer Center at Dallas, Dallas, Texas, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, United States|Hôpital Erasme/Erasmus Ziekenhuis, Bruxelles - Brussel, Belgium|UZ Antwerpen, Edegem, Belgium|CHU de Liège, Liege, Belgium|Institut Bergonié - Unicancer Nouvelle Aquitaine, Bordeaux Cedex, France|Centre Léon Bérard, Lyon Cedex, France|Hôpital de la Pitié-Salpétrière, Paris, France|Institut de Cancérologie de l'Ouest - Saint Herblain, Saint Herblain, France|Institut Claudius Regaud - iUCT Oncopole, Toulouse Cedex 9, France|Institut Gustave Roussy, Villejuif Cedex, France|AUSL di Bologna - IRCCS Istituto Scienze Neurologiche, Bologna, Emilia-Romagna, Italy|Istituto Clinico Humanitas - Humanitas Mirasole S.p.A., Milano, Lombardia, Italy|Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Lombardia, Italy|ASST Grande Ospedale Metropolitano Niguarda, Milano, Lombardia, Italy|Istituto Oncologico Veneto IRCCS (IOV), Padova, Veneto, Italy|Aichi Cancer Center Hospital, Nagoya, Aichi, Japan|Kobe University Hospital, Kobe, Hyogo, Japan|Tohoku University Hospital, Sendai, Miyagi, Japan|Saitama Cancer Center, Kita-Adachigun, Saitama, Japan|National Cancer Center Hospital, Chuo-ku, Tokyo, Japan|The Cancer Institute Hospital of JFCR, Koto-ku, Tokyo, Japan|Seoul National University Hospital, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of|China Medical University Hospital, Taichung, Taiwan|Chi-Mei Medical Center, Liouyine, Tainan, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan|Royal Marsden NHS Trust (Surrey), Sutton, Surrey, United Kingdom|University Hospitals Coventry and Warwickshire NHS Trust, Coventry, West Midlands, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom|Royal Marsden Hospital (London), London, United Kingdom","https://ClinicalTrials.gov/show/NCT04704154"
1558,"Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer","Active, not recruiting","No Results Available","Brain and Central Nervous System Tumors|Intraocular Melanoma|Lung Cancer|Melanoma (Skin)|Metastatic Cancer|Neuroblastoma|Ovarian Cancer|Retinoblastoma|Sarcoma|Small Intestine Cancer","Genetic: DNA analysis|Other: immunologic technique|Other: pharmacological study|Radiation: iodine I 131 monoclonal antibody 3F8|Radiation: 131I-3F8","Memorial Sloan Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00445965"
1559,"Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies","Terminated","No Results Available","Solid Tumors","Drug: INCB057643|Drug: Gemcitabine|Drug: Paclitaxel|Drug: Rucaparib|Drug: Abiraterone|Drug: Ruxolitinib|Drug: Azacitidine","University of Alabama, Birmingham, Alabama, United States|University of California, La Jolla, California, United States|Sarah Cannon Research Institute at Health One, Denver, Colorado, United States|Yale University, New Haven, Connecticut, United States|Sylvester Comprehensive Cancer Center, Miami, Florida, United States|Hematology - Oncology Associates of Treasure Coast, Port Saint Lucie, Florida, United States|University of Michigan, Ann Arbor, Michigan, United States|University of Minnesota, Minneapolis, Minnesota, United States|Washington University, Saint Louis, Missouri, United States|University of Rochester, Wilmot Cancer Center, Rochester, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States|Oncology Consultants, P.A., Houston, Texas, United States|The Methodist Hospital, Houston, Texas, United States|Huntsman Cancer Institute, Salt Lake City, Utah, United States|MultiCare Institute for Research and Innovation, Tacoma, Washington, United States|Institut Jules Bordet, Clinical Trial Conduct Unit, Brussels, Belgium|HÔPITAL SAINT-LOUIS, Service Hématologie Adultes, Paris, France","https://ClinicalTrials.gov/show/NCT02711137"
1560,"Study of Tissue and Blood Samples From Patients With High-Grade Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Other: diagnostic laboratory biomarker analysis","Mayo Clinic Scottsdale, Scottsdale, Arizona, United States|Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center, Hartford, Connecticut, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center, Boise, Idaho, United States|Illinois CancerCare - Bloomington, Bloomington, Illinois, United States|St. Joseph Medical Center, Bloomington, Illinois, United States|Graham Hospital, Canton, Illinois, United States|Illinois CancerCare - Canton, Canton, Illinois, United States|Illinois CancerCare - Carthage, Carthage, Illinois, United States|Memorial Hospital, Carthage, Illinois, United States|Eureka Community Hospital, Eureka, Illinois, United States|Illinois CancerCare - Eureka, Eureka, Illinois, United States|Galesburg Clinic, PC, Galesburg, Illinois, United States|Illinois CancerCare - Galesburg, Galesburg, Illinois, United States|Illinois CancerCare - Havana, Havana, Illinois, United States|Mason District Hospital, Havana, Illinois, United States|Illinois CancerCare - Kewanee Clinic, Kewanee, Illinois, United States|Illinois CancerCare - Macomb, Macomb, Illinois, United States|McDonough District Hospital, Macomb, Illinois, United States|Trinity Cancer Center at Trinity Medical Center - 7th Street Campus, Moline, Illinois, United States|Moline, Illinois, United States|Illinois CancerCare - Monmouth, Monmouth, Illinois, United States|OSF Holy Family Medical Center, Monmouth, Illinois, United States|BroMenn Regional Medical Center, Normal, Illinois, United States|Community Cancer Center, Normal, Illinois, United States|Illinois CancerCare - Community Cancer Center, Normal, Illinois, United States|Community Hospital of Ottawa, Ottawa, Illinois, United States|Oncology Hematology Associates of Central Illinois, PC - Ottawa, Ottawa, Illinois, United States|Cancer Treatment Center at Pekin Hospital, Pekin, Illinois, United States|Illinois CancerCare - Pekin, Pekin, Illinois, United States|CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States|Oncology Hematology Associates of Central Illinois, PC - Peoria, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|OSF St. Francis Medical Center, Peoria, Illinois, United States|Illinois CancerCare - Peru, Peru, Illinois, United States|Illinois Valley Community Hospital, Peru, Illinois, United States|Illinois CancerCare - Princeton, Princeton, Illinois, United States|Perry Memorial Hospital, Princeton, Illinois, United States|Illinois CancerCare - Spring Valley, Spring Valley, Illinois, United States|Bettendorf, Iowa, United States|Cedar Rapids Oncology Associates, Cedar Rapids, Iowa, United States|Mercy Regional Cancer Center at Mercy Medical Center, Cedar Rapids, Iowa, United States|Siouxland Hematology-Oncology Associates, LLP, Sioux City, Iowa, United States|Mercy Medical Center - Sioux City, Sioux City, Iowa, United States|St. Luke's Regional Medical Center, Sioux City, Iowa, United States|Hickman Cancer Center at Bixby Medical Center, Adrian, Michigan, United States|Saint Joseph Mercy Cancer Center, Ann Arbor, Michigan, United States|CCOP - Michigan Cancer Research Consortium, Ann Arbor, Michigan, United States|Oakwood Cancer Center at Oakwood Hospital and Medical Center, Dearborn, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Van Elslander Cancer Center at St. John Hospital and Medical Center, Grosse Pointe Woods, Michigan, United States|Foote Memorial Hospital, Jackson, Michigan, United States|Sparrow Regional Cancer Center, Lansing, Michigan, United States|St. Mary Mercy Hospital, Livonia, Michigan, United States|Community Cancer Center of Monroe, Monroe, Michigan, United States|Mercy Memorial Hospital - Monroe, Monroe, Michigan, United States|St. Joseph Mercy Oakland, Pontiac, Michigan, United States|Mercy Regional Cancer Center at Mercy Hospital, Port Huron, Michigan, United States|Seton Cancer Institute at Saint Mary's - Saginaw, Saginaw, Michigan, United States|St. John Macomb Hospital, Warren, Michigan, United States|MeritCare Bemidji, Bemidji, Minnesota, United States|Duluth Clinic Cancer Center - Duluth, Duluth, Minnesota, United States|CCOP - Duluth, Duluth, Minnesota, United States|Miller - Dwan Medical Center, Duluth, Minnesota, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CentraCare Clinic - River Campus, Saint Cloud, Minnesota, United States|Coborn Cancer Center, Saint Cloud, Minnesota, United States|Mount Sinai Medical Center, New York, New York, United States|Bismarck Cancer Center, Bismarck, North Dakota, United States|Medcenter One Hospital Cancer Care Center, Bismarck, North Dakota, United States|Mid Dakota Clinic, PC, Bismarck, North Dakota, United States|St. Alexius Medical Center Cancer Center, Bismarck, North Dakota, United States|MeritCare Broadway, Fargo, North Dakota, United States|CCOP - MeritCare Hospital, Fargo, North Dakota, United States|Roger Maris Cancer Center at MeritCare Hospital, Fargo, North Dakota, United States|Wood County Oncology Center, Bowling Green, Ohio, United States|Adena Regional Medical Center, Chillicothe, Ohio, United States|Riverside Methodist Hospital Cancer Care, Columbus, Ohio, United States|CCOP - Columbus, Columbus, Ohio, United States|Grant Medical Center Cancer Care, Columbus, Ohio, United States|Mount Carmel Health - West Hospital, Columbus, Ohio, United States|Doctors Hospital at Ohio Health, Columbus, Ohio, United States|Grady Memorial Hospital, Delaware, Ohio, United States|Community Cancer Center, Elyria, Ohio, United States|Hematology Oncology Center, Elyria, Ohio, United States|Fairfield Medical Center, Lancaster, Ohio, United States|Lima Memorial Hospital, Lima, Ohio, United States|Strecker Cancer Center at Marietta Memorial Hospital, Marietta, Ohio, United States|Northwest Ohio Oncology Center, Maumee, Ohio, United States|Knox Community Hospital, Mount Vernon, Ohio, United States|Licking Memorial Cancer Care Program at Licking Memorial Hospital, Newark, Ohio, United States|St. Charles Mercy Hospital, Oregon, Ohio, United States|Toledo Clinic - Oregon, Oregon, Ohio, United States|Southern Ohio Medical Center Cancer Center, Portsmouth, Ohio, United States|North Coast Cancer Care, Incorporated, Sandusky, Ohio, United States|Community Hospital of Springfield and Clark County, Springfield, Ohio, United States|Flower Hospital Cancer Center, Sylvania, Ohio, United States|Mercy Hospital of Tiffin, Tiffin, Ohio, United States|Toledo Hospital, Toledo, Ohio, United States|St. Vincent Mercy Medical Center, Toledo, Ohio, United States|Medical University of Ohio Cancer Center, Toledo, Ohio, United States|CCOP - Toledo Community Hospital, Toledo, Ohio, United States|St. Anne Mercy Hospital, Toledo, Ohio, United States|Toledo Clinic, Incorporated - Main Clinic, Toledo, Ohio, United States|Fulton County Health Center, Wauseon, Ohio, United States|Mount Carmel St. Ann's Cancer Center, Westerville, Ohio, United States|Genesis - Good Samaritan Hospital, Zanesville, Ohio, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Fredericksburg Oncology, Incorporated, Fredericksburg, Virginia, United States","https://ClinicalTrials.gov/show/NCT01004887"
1561,"Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors","Unknown status","No Results Available","Brain and Central Nervous System Tumors|Metastatic Cancer","Drug: verteporfin|Procedure: conventional surgery","Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, United States|Midwest Children's Cancer Center at Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00002647"
1562,"High Light and Low Light Dose PDT in Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: porfimer sodium|Procedure: adjuvant therapy|Procedure: conventional surgery","Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00118222"
1563,"Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer","Terminated","Has Results","Cancer","Drug: cyproheptadine hydrochloride|Other: placebo","Miller Children's Hospital, Long Beach, California, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|A.I. duPont Hospital for Children, Wilmington, Delaware, United States|Children's National Medical Center, Washington, District of Columbia, United States|Children's Hospital of Southwest Florida at Lee Memorial, Fort Myers, Florida, United States|Nemours Children's Clinic - Jacksonville, Jacksonville, Florida, United States|Arnold Palmer Hospital for Children, Orlando, Florida, United States|Nemours Children's Clinic - Orlando, Orlando, Florida, United States|Nemours Children's Hospital Pensacola, Pensacola, Florida, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Columbia University Medical Center, New York, New York, United States|CHRISTUS Santa Rosa Children's Hospital, San Antonio, Texas, United States|Children's Hospital of The King's Daughters, Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT01132547"
1564,"A Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain","Unknown status","No Results Available","Glioma","Drug: 5-Aminolevuline Acid","Legacy Health System, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT01403311"
1565,"Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: temozolomide|Other: 3'-deoxy-3'-[18F]fluorothymidine|Other: pharmacological study|Drug: Mibefradil","UAB Comprehensive Cancer Center, Birmingham, Alabama, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|Johns Hopkins University, Baltimore, Maryland, United States|Henry Ford Hospital, Detroit, Michigan, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01480050"
1566,"Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment","Completed","No Results Available","Brain and Central Nervous System Tumors|Lymphoma|Metastatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific","Drug: bortezomib|Drug: temozolomide|Other: pharmacological study","City of Hope Comprehensive Cancer Center, Duarte, California, United States|City of Hope Medical Group, Pasadena, California, United States","https://ClinicalTrials.gov/show/NCT00544284"
1567,"Vaccine Therapy in Treating Patients With Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine","Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT00612001"
1568,"Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma","Completed","Has Results","Glioma","Drug: bevacizumab|Drug: carmustine","University of California Davis Cancer Center, Sacramento, California, United States","https://ClinicalTrials.gov/show/NCT00795665"
1569,"Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors","Withdrawn","No Results Available","Brain and Central Nervous System Tumors","Procedure: conventional surgery|Procedure: magnetic resonance imaging|Procedure: magnetic resonance spectroscopic imaging",,"https://ClinicalTrials.gov/show/NCT00005083"
1570,"Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: carmustine|Drug: temozolomide","Memorial Sloan-Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00005637"
1571,"Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor","Completed","No Results Available","Brain and Central Nervous System Tumors|Gastrointestinal Stromal Tumor|Sarcoma","Biological: sargramostim|Biological: telomerase: 540-548 peptide vaccine","Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00069940"
1572,"Study of Tissue Samples From Patients With Glioma or Other Brain Tumors","Completed","No Results Available","Central Nervous System Lymphoma","Other: laboratory biomarker analysis|Other: pharmacogenomic studies","CHU Montpellier, Montpellier, France|Clinique Gui de Chauliac, Montpellier, France","https://ClinicalTrials.gov/show/NCT00967200"
1573,"Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm","Unknown status","No Results Available","Brain and Central Nervous System Tumors|Metastatic Cancer","Drug: carmustine in ethanol|Procedure: conventional surgery","UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States|Massey Cancer Center, Richmond, Virginia, United States","https://ClinicalTrials.gov/show/NCT00009854"
1574,"Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: hydroxyurea|Drug: imatinib mesylate|Drug: vatalanib","Duke Comprehensive Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00387933"
1575,"Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors","Completed","Has Results","Brain Tumors|Nervous System Tumors|Cognition Disorders|Fatigue","Drug: Armodafinil|Other: placebo","Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01032200"
1576,"Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas","Withdrawn","No Results Available","Brain and Central Nervous System Tumors","Drug: Isotretinoin|Drug: Procarbazine Hydrochloride",,"https://ClinicalTrials.gov/show/NCT00003564"
1577,"Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: aldesleukin|Biological: muromonab-CD3|Biological: therapeutic tumor infiltrating lymphocytes|Procedure: conventional surgery","Children's Health Center, Denver, Colorado, United States|Veterans Affairs Medical Center - Denver, Denver, Colorado, United States|University of Colorado Cancer Center, Denver, Colorado, United States","https://ClinicalTrials.gov/show/NCT00002572"
1578,"Gene Therapy in Treating Patients With Recurrent Malignant Gliomas","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: Ad5CMV-p53 gene|Procedure: conventional surgery","UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|Simmons Cancer Center - Dallas, Dallas, Texas, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00004041"
1579,"Suramin in Treating Patients With Recurrent Primary Brain Tumors","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: chemotherapy|Drug: suramin","Department of Neurosurgery - Emory, Atlanta, Georgia, United States","https://ClinicalTrials.gov/show/NCT00002639"
1580,"Temozolomide in Treating Patients With Recurrent Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: temozolomide","Memorial Sloan-Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00004113"
1581,"Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors","Completed","No Results Available","Brain and Central Nervous System Tumors|Melanoma (Skin)|Metastatic Cancer","Biological: monoclonal antibody Me1-14 F(ab')2","Duke Comprehensive Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00002754"
1582,"Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Procedure: biopsy|Procedure: magnetic resonance imaging","Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT00005082"
1583,"Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: chemotherapy|Procedure: conventional surgery|Procedure: magnetic resonance imaging|Procedure: magnetic resonance spectroscopic imaging|Radiation: radiation therapy","UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT00274755"
1584,"Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma","Completed","Has Results","Brain and Central Nervous System Tumors","Drug: Erlotinib hydrochloride","University of California San Diego, San Diego, California, United States|Duke Children's Hospital and Health Center, Durham, North Carolina, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00124657"
1585,"Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: gefitinib|Drug: temozolomide","Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States|UCSF Comprehensive Cancer Center, San Francisco, California, United States|Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda, Maryland, United States|Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|Simmons Cancer Center - Dallas, Dallas, Texas, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00027625"
1586,"CCI-779 in Treating Patients With Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: temsirolimus","Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States|UCSF Comprehensive Cancer Center, San Francisco, California, United States|Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda, Maryland, United States|Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|M.D. Anderson Cancer Center at University of Texas, Houston, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00022724"
1587,"Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma","Withdrawn","No Results Available","Brain and Central Nervous System Tumors","Biological: filgrastim|Drug: carboplatin|Drug: temozolomide","NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00006263"
1588,"Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: irinotecan hydrochloride|Drug: temozolomide","Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States|UCSF Comprehensive Cancer Center, San Francisco, California, United States|Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda, Maryland, United States|Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00006025"
1589,"Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: irinotecan hydrochloride|Drug: temozolomide","Duke Comprehensive Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00005951"
1590,"Imatinib Mesylate in Treating Patients With Gliomas","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: imatinib mesylate","Kaiser Franz Josef Hospital, Vienna, Austria|U.Z. Gasthuisberg, Leuven, Belgium|Centre de Lutte Contre le Cancer, Georges-Francois Leclerc, Dijon, France|CRLCC Nantes - Atlantique, Nantes-Saint Herblain, France|Centre Antoine Lacassagne, Nice, France|Institut Gustave Roussy, Villejuif, France|Azienda Ospedaliera di Padova, Padova, Italy|Daniel Den Hoed Cancer Center at Erasmus Medical Center, Rotterdam, Netherlands|Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland|Beatson Oncology Centre, Glasgow, Scotland, United Kingdom","https://ClinicalTrials.gov/show/NCT00039364"
1591,"CC-5013 in Treating Patients With Recurrent Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: lenalidomide","Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00036894"
1592,"Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: O6-benzylguanine|Drug: temozolomide|Procedure: conventional surgery","Duke Comprehensive Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00006474"
1593,"Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: carboplatin|Drug: pyrazoloacridine","CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States|Mayo Clinic, Jacksonville, Florida, United States|CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States|CCOP - Carle Cancer Center, Urbana, Illinois, United States|CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States|CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States|Siouxland Hematology-Oncology, Sioux City, Iowa, United States|CCOP - Wichita, Wichita, Kansas, United States|CCOP - Ochsner, New Orleans, Louisiana, United States|CCOP - Duluth, Duluth, Minnesota, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CentraCare Health Plaza, Saint Cloud, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|Medcenter One Health System, Bismarck, North Dakota, United States|CCOP - Merit Care Hospital, Fargo, North Dakota, United States|Altru Cancer Center, Grand Forks, North Dakota, United States|CCOP - Toledo Community Hospital, Toledo, Ohio, United States|CCOP - Geisinger Clinic and Medical Center, Danville, Pennsylvania, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|CCOP - Sioux Community Cancer Consortium, Sioux Falls, South Dakota, United States|CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay, Wisconsin, United States|Allan Blair Cancer Centre, Regina, Saskatchewan, Canada","https://ClinicalTrials.gov/show/NCT00005976"
1594,"Carmustine in Treating Patients With Recurrent Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: carmustine|Procedure: conventional surgery","University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Emory University Hospital - Atlanta, Atlanta, Georgia, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00004028"
1595,"Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: aldesleukin|Biological: autologous tumor cell vaccine|Biological: muromonab-CD3|Biological: sargramostim|Biological: therapeutic autologous lymphocytes|Procedure: surgical procedure|Radiation: radiation therapy","Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States","https://ClinicalTrials.gov/show/NCT00004024"
1596,"Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: Erlotinib + Sirolimus","Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT00509431"
1597,"Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers","Completed","No Results Available","Stage IV Melanoma","Biological: recombinant interferon alfa-2b|Drug: cisplatin|Drug: sodium stibogluconate|Drug: dacarbazine|Drug: vinblastine","Cleveland Clinic Taussig Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00498979"
1598,"Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: polifeprosan 20 with carmustine implant|Procedure: surgical procedure|Radiation: iodine I 125","Barrett Cancer Center, The University Hospital, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT00003876"
1599,"Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: carmustine|Drug: irinotecan hydrochloride|Drug: polifeprosan 20 with carmustine implant|Procedure: surgical procedure","Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States|Duke Comprehensive Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00003463"
1600,"CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: CC-8490","Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00074243"
1601,"Talampanel in Treating Patients With Recurrent High-Grade Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: talampanel","Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00064363"
1602,"Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma","Completed","No Results Available","Brain and Central Nervous System Tumors|Infection","Other: laboratory biomarker analysis|Other: questionnaire administration",,"https://ClinicalTrials.gov/show/NCT00999622"
1603,"SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: semaxanib","Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States|UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States|Neuro-Oncology Branch, Bethesda, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States|Simmons Cancer Center - Dallas, Dallas, Texas, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00004868"
1604,"Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: celecoxib|Drug: cyclophosphamide|Drug: etoposide|Drug: thalidomide","Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00047281"
1605,"Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: imatinib mesylate","Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States|UCSF Comprehensive Cancer Center, San Francisco, California, United States|Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda, Maryland, United States|Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00010049"
1606,"Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: imatinib mesylate|Drug: temozolomide|Other: pharmacological study","Duke Cancer Institute, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00354068"
1607,"Bevacizumab in Recurrent Grade II and III Glioma","Completed","No Results Available","Central Nervous System Tumors","Biological: Bevacizumab|Drug: Temozolomide","Landesnervenklinik Wagner Jauregg, Linz, Austria|Medical University Vienna - General Hospital AKH, Vienna, Austria|Universitair Ziekenhuis Brussel, Brussel, Belgium|U.Z. Leuven - Campus Gasthuisberg, Leuven, Belgium|CHRU de Lille, Lille, France|CHU de Lyon - CHU Lyon - Hopital neurologique Pierre Wertheimer, Lyon, France|Assistance Publique - Hôpitaux de Marseille - Hôpital de La Timone, Marseille, France|CHU de Nice - Hopital Pasteur, Nice, France|CHU Pitie-Salpetriere, Paris, France|Institut Gustave Roussy, Paris, France|Centre Eugene Marquis, Rennes, France|Institut de Cancerologie de l'Ouest (ICO) - Centre Rene Gauducheau, Saint - Herblain, France|Centre Paul Strauss, Strasbourg, France|Universitaetsklinikum Bonn, Bonn, Germany|Universitaetsklinikum - Essen, Essen, Germany|Klinikum Der J.W. Goethe Universitaet, Frankfurt am Main, Germany|Universitaetsklinikum Heidelberg - UniversitaetsKlinikum Heidelberg - Head Hospital, Heidelberg, Germany|Universitaetskliniken Regensburg, Regensburg, Germany|Ospedale Bellaria, Bologna, Italy|Medisch Centrum Haaglanden - Westeinde, Den Haag, Netherlands|University Medical Center Groningen, Groningen, Netherlands|Academisch Ziekenhuis Maastricht, Maastricht, Netherlands|Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands|Daniel Den Hoed Cancer Center at Erasmus Medical Center, Rotterdam, Netherlands|Universitair Medisch Centrum - Academisch Ziekenhuis, Utrecht, Netherlands|Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland|UniversitaetsSpital Zurich - Division of Oncology, Zurich, Switzerland|University Hospitals Bristol NHS Foundation Trust - Bristol Haematology And Oncology Centre, Bristol, United Kingdom|University Of Dundee - Ninewells Hospital, Dundee, United Kingdom|NHS Lothian - Western General Hospital, Edinburgh, United Kingdom|NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital, Glasgow, United Kingdom|Leeds Teaching Hospitals NHS Trust - St. James's University Hospital, Leeds, United Kingdom|Imperial College Healthcare NHS Trust - Charing Cross Hospital, London, United Kingdom|University College Hospital, London, United Kingdom|The Christie NHS Foundation Trust, Manchester, United Kingdom|Freeman Hospital, Northern Centre For Cancer Care, Newcastle upon Tyne, United Kingdom|Nottingham University Hospitals NHS Trust - City Hospital, Nottingham, United Kingdom|Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital, Sheffield, United Kingdom|Royal Marsden Hospital - Sutton, Surrey, Sutton, United Kingdom","https://ClinicalTrials.gov/show/NCT01164189"
1608,"Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors","Completed","No Results Available","Brain and Central Nervous System Tumors|Seizure","Drug: levetiracetam|Drug: pregabalin","Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland|USZ, Zürich, Switzerland","https://ClinicalTrials.gov/show/NCT00629889"
1609,"Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: bevacizumab|Drug: irinotecan|Procedure: dynamic contrast-enhanced magnetic resonance imaging","Duke Comprehensive Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00352521"
1610,"Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas","Unknown status","No Results Available","Brain and Central Nervous System Tumors","Drug: enzastaurin hydrochloride|Drug: temozolomide|Other: pharmacological study","Beatson West of Scotland Cancer Centre, Glasgow, Scotland, United Kingdom","https://ClinicalTrials.gov/show/NCT00516607"
1611,"Study of Blood and Cheek Cell Samples From Patients With Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Genetic: polymorphism analysis|Other: laboratory biomarker analysis|Other: medical chart review","UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT01009307"
1612,"ExAblate Blood Brain Barrier Disruption (BBBD) for Planned Surgery in Suspected Infiltrating Glioma","Active, not recruiting","No Results Available","Glioma","Device: ExAblate 4000 - Type 2","University of Maryland Medical System, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT03322813"
1613,"Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas","Completed","No Results Available","Brain and Central Nervous System Tumors","Radiation: iodine I 131 monoclonal antibody 81C6","Duke Comprehensive Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00002753"
1614,"Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: procarbazine hydrochloride|Drug: thalidomide","CCOP - Central Illinois, Decatur, Illinois, United States|CCOP - Southeast Cancer Control Consortium, Goldsboro, North Carolina, United States|Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|CCOP - Greenville, Greenville, South Carolina, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States","https://ClinicalTrials.gov/show/NCT00079092"
1615,"O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: O6-benzylguanine|Drug: polifeprosan 20 with carmustine implant|Procedure: conventional surgery","University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Emory University Hospital - Atlanta, Atlanta, Georgia, United States|Johns Hopkins Oncology Center, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States|University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00004892"
1616,"Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma","Completed","Has Results","Brain Tumors|Osteoporosis|Central Nervous System(CNS)Malignancies","Drug: IV Zometa","Duke Comprehensive Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00301873"
1617,"Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas","Completed","No Results Available","Brain and Central Nervous System Tumors","Other: fluorine F 18 fluorothymidine|Procedure: positron emission tomography","University Cancer Center at University of Washington Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00276770"
1618,"Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery","Unknown status","No Results Available","Brain and Central Nervous System Tumors","Drug: arsenic trioxide|Drug: temozolomide|Radiation: radiation therapy","Hematology-Oncology Associates of Illinois, Chicago, Illinois, United States|Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States|Edward Cancer Center, Naperville, Illinois, United States","https://ClinicalTrials.gov/show/NCT00275067"
1619,"Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: therapeutic autologous lymphocytes|Genetic: gene expression analysis|Other: laboratory biomarker analysis",,"https://ClinicalTrials.gov/show/NCT00730613"
1620,"Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: imatinib mesylate|Other: pharmacological study|Procedure: conventional surgery","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00401024"
1621,"Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy","Terminated","No Results Available","Brain and Central Nervous System Tumors|Thrombocytopenia","Drug: temozolomide|Genetic: comparative genomic hybridization|Genetic: polymorphism analysis|Other: laboratory biomarker analysis|Other: pharmacological study|Radiation: radiation therapy","City of Hope Comprehensive Cancer Center, Duarte, California, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00471653"
1622,"Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain","Completed","Has Results","Cancer","Drug: Fentanyl sublingual spray|Drug: Placebo","InSys Therapeutics, Incorporated, Chandler, Arizona, United States","https://ClinicalTrials.gov/show/NCT00538850"
1623,"Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: filgrastim|Drug: carboplatin|Drug: temozolomide|Drug: thiotepa|Procedure: autologous bone marrow transplantation|Procedure: peripheral blood stem cell transplantation","NYU Cancer Institute at New York University Medical Center, New York, New York, United States|Columbus Children's Hospital, Columbus, Ohio, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Princess Margaret Hospital for Children, Perth, Western Australia, Australia","https://ClinicalTrials.gov/show/NCT00025558"
1624,"Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors","Completed","No Results Available","Brain and Central Nervous System Tumors","Procedure: conventional surgery|Radiation: iodine I 131 monoclonal antibody 81C6|Radiation: radiation therapy","Duke Comprehensive Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00003478"
1625,"Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases","Active, not recruiting","No Results Available","Brain and Central Nervous System Tumors|Lymphoma|Metastatic Cancer","Drug: pemetrexed","Hematology-Oncology Associates of Illinois, Chicago, Illinois, United States|Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States","https://ClinicalTrials.gov/show/NCT00276783"
1626,"E-MOSAIC Electronic Tool to Monitor Symptoms","Completed","No Results Available","Cancer",,"Universitaetsspital-Basel, Basel, Switzerland|Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni, Bellinzona, Switzerland|Inselspital Bern, Bern, Switzerland|Spital Buelach, Bulach, Switzerland|Kantonsspital Graubuenden, Chur, Switzerland|Kantonsspital Freiburg, Freiburg, Switzerland|Kantonsspital - St. Gallen, St. Gallen, Switzerland","https://ClinicalTrials.gov/show/NCT00477919"
1627,"Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers","Completed","No Results Available","Brain and Central Nervous System Tumors|Psychosocial Effects of Cancer and Its Treatment","Behavioral: exercise intervention|Other: educational intervention|Other: physiologic testing|Other: management of therapy complications|Behavioral: mind-body intervention procedure|Procedure: Measurement of stress-related hormones","Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00376818"
1628,"ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma","Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: ATN-161|Drug: carboplatin","Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00352313"
1629,"Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas","Unknown status","No Results Available","Brain and Central Nervous System Tumors","Drug: lonafarnib|Drug: temozolomide","Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon, France|Centre Regional Rene Gauducheau, Nantes-Saint Herblain, France|Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland","https://ClinicalTrials.gov/show/NCT00083096"
1630,"Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors","Completed","Has Results","Brain Tumors|Metastatic Disease","Drug: donepezil hydrochloride|Drug: Placebo","Associates in Womens Health, PA - North Review, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Medical Arts Tower, Wichita, Kansas, United States|Cancer Center of Kansas, PA - Wichita, Wichita, Kansas, United States|CCOP - Wichita, Wichita, Kansas, United States|Via Christi Cancer Center at Via Christi Regional Medical Center, Wichita, Kansas, United States|Central Maine Comprehensive Cancer Center at Central Maine Medical Center, Lewiston, Maine, United States|New Hampshire Oncology - Hematology, PA - Hooksett, Hooksett, New Hampshire, United States|Lakes Region General Hospital, Laconia, New Hampshire, United States|Don Monti Comprehensive Cancer Center at North Shore University Hospital, Manhasset, New York, United States|CCOP - MeritCare Hospital, Fargo, North Dakota, United States|Trinity CancerCare Center, Minot, North Dakota, United States|Summa Center for Cancer Care at Akron City Hospital, Akron, Ohio, United States|MetroHealth Cancer Care Center at MetroHealth Medical Center, Cleveland, Ohio, United States|United States Air Force Medical Center - Wright-Patterson, Wright-Patterson Air Force Base, Ohio, United States|Thompson Cancer Survival Center, Knoxville, Tennessee, United States|Gundersen Lutheran Center for Cancer and Blood, La Crosse, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00369785"
1631,"Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors","Completed","No Results Available","Bone Marrow Suppression|Brain and Central Nervous System Tumors|Drug/Agent Toxicity by Tissue/Organ","Procedure: filgrastim|Biological: gene therapy|Drug: lomustine|Drug: procarbazine hydrochloride|Drug: vincristine sulfate|Procedure: in vitro-treated peripheral blood stem cell transplantation","Indiana University Cancer Center, Indianapolis, Indiana, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00005796"
1632,"Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders","Completed","No Results Available","Brain and Central Nervous System Tumors|Metastatic Cancer|Radiation Toxicity","Other: Questionnaire","Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00255671"
1633,"Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers","Completed","No Results Available","Brain and Central Nervous System Tumors|Metastatic Cancer","Radiation: iodine I 131 monoclonal antibody 81C6","Duke Comprehensive Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00002752"
1634,"Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors","Withdrawn","No Results Available","Brain and Central Nervous System Tumors","Other: laboratory biomarker analysis|Procedure: biopsy|Procedure: magnetic resonance imaging|Radiation: gadopentetate dimeglumine",,"https://ClinicalTrials.gov/show/NCT00005790"
1635,"Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors","Completed","No Results Available","Brain and Central Nervous System Tumors|Unspecified Adult Solid Tumor, Protocol Specific","Dietary Supplement: calcitriol|Drug: carboplatin","University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00008086"
1636,"Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer","Completed","No Results Available","Brain and Central Nervous System Tumors","Biological: aldesleukin|Biological: autologous tumor cell vaccine|Biological: filgrastim|Biological: sargramostim|Biological: therapeutic autologous lymphocytes|Drug: carmustine|Drug: cisplatin|Drug: cyclophosphamide|Drug: paclitaxel|Procedure: autologous bone marrow transplantation|Procedure: conventional surgery|Procedure: peripheral blood stem cell transplantation","Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States","https://ClinicalTrials.gov/show/NCT00014573"
1637,"Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer","Completed","No Results Available","Brain and Central Nervous System Tumors|Breast Cancer|Gastrointestinal Carcinoid Tumor|Islet Cell Tumor|Lung Cancer|Lymphoma|Melanoma (Skin)|Neoplastic Syndrome","Radiation: yttrium Y 90-edotreotide","H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States","https://ClinicalTrials.gov/show/NCT00006368"
1638,"Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors","Completed","No Results Available","Brain and Central Nervous System Tumors|Neuroblastoma","Drug: carmustine|Drug: irinotecan hydrochloride|Procedure: surgical procedure|Radiation: iodine I 131 monoclonal antibody 81C6","Duke Comprehensive Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00003484"
1639,"BCX-1777 in Treating Patients With Refractory Cancer","Completed","No Results Available","Cancer","Drug: forodesine hydrochloride","Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00073944"
1640,"Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor","Completed","No Results Available","Brain and Central Nervous System Tumors|Radiation Toxicity","Dietary Supplement: EGb761|Drug: donepezil hydrochloride|Procedure: cognitive assessment","CCOP - Western Regional, Arizona, Phoenix, Arizona, United States|Regional Radiation Oncology Center at Rome, Rome, Georgia, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States","https://ClinicalTrials.gov/show/NCT00070161"
1641,"Thalidomide and Docetaxel in Treating Patients With Advanced Cancer","Completed","No Results Available","Cancer","Drug: docetaxel|Drug: thalidomide","Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00049296"
1642,"Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors","Terminated","No Results Available","Brain and Central Nervous System Tumors|Cognitive/Functional Effects|Depression|Fatigue|Quality of Life","Drug: methylphenidate hydrochloride|Procedure: quality-of-life assessment|Radiation: radiation therapy","CCOP - Western Regional, Arizona, Phoenix, Arizona, United States|CCOP - Central Illinois, Decatur, Illinois, United States|MBCCOP - LSU Health Sciences Center, New Orleans, Louisiana, United States|CCOP - Southeast Cancer Control Consortium, Goldsboro, North Carolina, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|CCOP - Columbus, Columbus, Ohio, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States","https://ClinicalTrials.gov/show/NCT00031798"
1643,"Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas","Completed","No Results Available","Brain and Central Nervous System Tumors|Breast Cancer|Kidney Cancer|Lung Cancer|Lymphoma|Melanoma (Skin)|Ovarian Cancer|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol Specific","Drug: carboxyamidotriazole|Drug: paclitaxel","Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda, Maryland, United States|NCI - Medical Oncology Clinical Research Unit, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00019019"
1644,"Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma","Terminated","No Results Available","Brain and Central Nervous System Tumors|Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific","Biological: filgrastim|Biological: sargramostim|Biological: therapeutic autologous lymphocytes|Drug: O6-benzylguanine|Drug: carmustine|Drug: temozolomide|Procedure: in vitro-treated peripheral blood stem cell transplantation","Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT00003567"
1645,"Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors","Completed","No Results Available","Brain and Central Nervous System Tumors|Metastatic Cancer|Neuroblastoma","Procedure: surgical procedure|Radiation: astatine At 211 monoclonal antibody 81C6","Duke Comprehensive Cancer Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00003461"
1646,"Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer","Completed","No Results Available","Brain and Central Nervous System Tumors|Intraocular Melanoma|Lung Cancer|Melanoma (Skin)|Neuroblastoma|Retinoblastoma|Sarcoma","Radiation: iodine I 131 monoclonal antibody 3F8","Memorial Sloan-Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00003022"
1647,"Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors","Completed","No Results Available","Adrenocortical Carcinoma|Brain and Central Nervous System Tumors|Head and Neck Cancer|Liver Cancer|Malignant Mesothelioma|Pheochromocytoma|Sarcoma","Drug: cisplatin|Drug: doxorubicin hydrochloride|Drug: tamoxifen citrate|Procedure: conventional surgery|Radiation: radiation therapy","Ottawa Regional Cancer Centre at Ottawa Hospital - General Campus, Ottawa, Ontario, Canada","https://ClinicalTrials.gov/show/NCT00002608"
1648,"Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors","Terminated","Has Results","Childhood Brain Tumor","Drug: Antineoplaston therapy (Atengenal + Astugenal)","Burzynski Clinic, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00003476"
1649,"HUMC 1612: Optune NovoTTF-200A System","Recruiting","No Results Available","High Grade Glioma|Ependymoma","Device: Optune NovoTTF-200A System","Arnold Palmer Hospital for Children, Orlando, Florida, United States|Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center, Hackensack, New Jersey, United States","https://ClinicalTrials.gov/show/NCT03128047"
1650,"Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma","Completed","No Results Available","Brain and Central Nervous System Tumors|Lymphoma|Lymphoproliferative Disorder|Small Intestine Cancer|Unspecified Childhood Solid Tumor, Protocol Specific","Drug: imetelstat sodium|Other: laboratory biomarker analysis|Other: pharmacological study","UAB Comprehensive Cancer Center, Birmingham, Alabama, United States|Children's Hospital of Orange County, Orange, California, United States|UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States|Children's National Medical Center, Washington, District of Columbia, United States|AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus, Atlanta, Georgia, United States|Children's Memorial Hospital - Chicago, Chicago, Illinois, United States|Riley's Children Cancer Center at Riley Hospital for Children, Indianapolis, Indiana, United States|Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda, Maryland, United States|Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute, Boston, Massachusetts, United States|C.S. Mott Children's Hospital at University of Michigan Medical Center, Ann Arbor, Michigan, United States|Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St. Louis, Missouri, United States|Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Knight Cancer Institute at Oregon Health and Science University, Portland, Oregon, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, United States|Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States|Baylor University Medical Center - Houston, Houston, Texas, United States|Children's Hospital and Regional Medical Center - Seattle, Seattle, Washington, United States|Midwest Children's Cancer Center at Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States|Hospital for Sick Children, Toronto, Ontario, Canada|Hopital Sainte Justine, Montreal, Quebec, Canada","https://ClinicalTrials.gov/show/NCT01273090"
1651,"Temozolomide in Treating Patients With Recurrent High-Grade Glioma","Completed","Has Results","Recurrent Central Nervous System Neoplasm","Drug: temozolomide","UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States","https://ClinicalTrials.gov/show/NCT00619112"
1652,"A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors","Completed","No Results Available","Malignant Glioma|Recurrent Ependymoma","Biological: AdV-tk|Drug: valacyclovir|Radiation: Radiation","Ann & Robert H. Lurie Children's Hospital of Chicago (Formerly Children's Memorial Hospital), Chicago, Illinois, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT00634231"
1653,"Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049)","Completed","No Results Available","Advanced Cancer","Drug: ridaforolimus|Drug: MK-0752|Drug: MK-2206",,"https://ClinicalTrials.gov/show/NCT01295632"
1654,"Safety Study of Afatinib for Brain Cancer","Active, not recruiting","No Results Available","Brain Cancer","Drug: Afatinib","John Wayne Cancer Institute, Santa Monica, California, United States","https://ClinicalTrials.gov/show/NCT02423525"
1655,"C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression","Withdrawn","No Results Available","Gliomas","Drug: Sodium Acetate C11 PET/CT Imaging","Phoenix Molecular Imaging, Phoenix, Arizona, United States","https://ClinicalTrials.gov/show/NCT01961934"
1656,"Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma","Recruiting","No Results Available","Glioma, Malignant","Drug: D2C7-IT|Drug: 2141-V11","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT04547777"
1657,"Safety of ABM-1310 in Patients With Advanced Solid Tumors","Recruiting","No Results Available","Advanced Solid Tumor|BRAF V600 Mutation","Drug: ABM-1310|Drug: Cobimetinib","Henry Ford Cancer Institute, Detroit, Michigan, United States|Comprehensive Cancer Centers of Nevada (CCCN), Las Vegas, Nevada, United States|MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT04190628"
1658,"Combination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant Glioma","Withdrawn","No Results Available","Malignant Glioma","Biological: PVSRIPO|Drug: Atezolizumab",,"https://ClinicalTrials.gov/show/NCT03973879"
1659,"Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma","Recruiting","No Results Available","Pediatric Solid Tumor|Pediatric Lymphoma|Pediatric Brain Tumor|DIPG|Neuroblastoma|Ewing Sarcoma|Rhabdomyosarcoma|Osteosarcoma","Drug: CLR 131","Lucile Packard Children's Hospital, Palo Alto, California, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Texas Children's Hospital, Houston, Texas, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Children's Hospital at Westmead, Westmead, New South Wales, Australia|Hospital for Sick Children, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT03478462"
1660,"Dexanabinol in Patients With Brain Cancer","Completed","No Results Available","Brain Cancer","Drug: Dexanabinol","Moores UCSD Cancer Center, La Jolla, California, United States","https://ClinicalTrials.gov/show/NCT01654497"
1661,"D2C7-IT With Atezolizumab for Recurrent Gliomas","Recruiting","No Results Available","Malignant Glioma","Drug: D2C7-IT (6920 ng/mL via convection-enhanced delivery)|Drug: Atezolizumab (1200 mg every three weeks)|Drug: D2C7-IT (4613.2 ng/mL via convection-enhanced delivery)","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT04160494"
1662,"A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas","Not yet recruiting","No Results Available","Newly Diagnosed H3-mutated Glioma","Drug: Tecentriq 1200 MG in 20 ML Injection|Biological: H3K27M peptide vaccine|Other: Imiquimod (5%)","Department of Neurology University Hospital, Mannheim, Bade-Württemberg, Germany|Department of Neurology and Polyclinic, Universitiy Clinic Heidelberg, Heidelberg, Baden-Württemberg, Germany|Neurological Clinic, Department of Neurology with an interdisciplinary focus on neurooncology, Neurological University Clinic Tübingen, Tübingen, Baden-Württemberg, Germany|Dr. Senckenberg Institute for Neurooncology, University Hospital Frankfurt, Frankfurt am Main, Hessen, Germany|Clinical Neuro-Oncology Section, University Hospital Bonn (UKB), Bonn, Nordrhein-Westfalen, Germany|Neurooncology Department, University Hospital Essen, Essen, Nordrhein-Westfalen, Germany|Clinic and Polyclinic for Neurosurgery, University Hospital Carl Gustav Carus Dresden, Dresden, Sachsen, Germany|Department of Neurosurgery with Pediatric Neurosurgery, Berlin, Germany","https://ClinicalTrials.gov/show/NCT04808245"
1663,"Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations","Recruiting","No Results Available","Cholangiocarcinoma|Chondrosarcoma|Glioma|Any Solid Tumor","Drug: LY3410738","Mayo Clinic of Scottsdale, Phoenix, Arizona, United States|The University of Arizona Cancer Center, Tucson, Arizona, United States|USC Norris Cancer Hospital, Los Angeles, California, United States|UCSF Medical Center at Mission Bay, San Francisco, California, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|University of Chicago Pritzker School of Medicine, Chicago, Illinois, United States|Indiana University School of Medicine, Indianapolis, Indiana, United States|The John Hopkins Hospital, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Mayo Clinic, Rochester, Minnesota, United States|Memorial Sloan Kettering Cancer Center, Middletown, New Jersey, United States|Memorial Sloan Kettering Cancer Center, Commack, New York, United States|Memorial Sloan Kettering Cancer Center, Harrison, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Sarah Cannon Cancer Center, Nashville, Tennessee, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, United States|South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas, United States|St Vincent's Hospital, Darlinghurst, New South Wales, Australia|Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest, Bordeaux, France|Gustave Roussy, Villejuif Cedex, France|Prince of Wales Hospital, Hong Kong, Shatin, New Territories, Hong Kong|National Cancer Center Hospital East, Kashiwa, Chiba, Japan|Kanagawa Cancer Center, Yokohama, Kanagawa, Japan|Osaka University Hospital, Suita-shi, Osaka, Japan|Shizuoka Cancer Center, Nagaizumi, Shizuoka, Japan|National Cancer Center Hospital, Chuo-ku, Tokyo, Japan|Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|National University Hospital, Singapore, Singapore|Hospital Universitario Vall d'Hebron, Barcelona, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|China Medical University Hospital, Taichung City, Taiwan|National Cheng-Kung Uni. Hosp., Tainan, Taiwan","https://ClinicalTrials.gov/show/NCT04521686"
1664,"Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System","Recruiting","No Results Available","Central Nervous System Tumor","Drug: tozuleristide|Device: Canvas imaging system|Procedure: Surgical resection of tumor","Cedars-Sinai Medical Center, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT04743310"
1665,"A Study of Abemaciclib (LY2835219) in Combination With Temozolomide and Irinotecan and Abemaciclib in Combination With Temozolomide in Children and Young Adult Participants With Solid Tumors","Recruiting","No Results Available","Relapsed Solid Tumor|Refractory Solid Tumor","Drug: Abemaciclib|Drug: Irinotecan|Drug: Temozolomide","Phoenix Children's Hospital, Phoenix, Arizona, United States|University of Minnesota Hospital, Minneapolis, Minnesota, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|UZ-Gent, Gent, Belgium|Centre Leon Berard, Lyon, Rhône-Alpes, France|Institut Curie, Paris, France|Gustave Roussy, Villejuif Cedex, France|Charité Campus Virchow-Klinikum, Berlin, Germany|Universtitätsklinikum Essen AöR, Essen, Germany|Hopp-Kindertumorzentrum Heidelberg (KiTZ), Heidelberg, Germany|Policlinico Gemelli - Università Cattolica del Sacro Cuore, Roma, Italy|National Cancer Center Hospital, Chuo-ku, Tokyo, Japan|Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona], Spain|Hospital Infantil Universitario Niño Jesús, Madrid, Madrid, Comunidad De, Spain|Hospital Universitario La Fe de Valencia, Valencia, Spain","https://ClinicalTrials.gov/show/NCT04238819"
1666,"A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations","Recruiting","No Results Available","Locally Advanced Solid Tumors|Metastatic Solid Tumors|Lymphoma|Primary CNS Tumors","Drug: Oral repotrectinib (TPX-0005)","Children's Hospital Los Angeles, Los Angeles, California, United States|University of California, Los Angeles, Los Angeles, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Arnold Palmer Hospital for Children, Orlando, Florida, United States|Maine Children's Cancer Program, Scarborough, Maine, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Cleveland Clinic, Cleveland, Ohio, United States|Penn State Children's Hospital at Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|The University of Texas Southwestern Medical Center, Children's Medical Center of Dallas, Dallas, Texas, United States|MD Anderson Cancer Center, Houston, Texas, United States|Sydney Children's Hospital, Sydney, New South Wales, Australia|The Children's Hospital at Westmead, Westmead, New South Wales, Australia|Queensland Children's Hospital, South Brisbane, Queensland, Australia|Perth Children's Hospital, Nedlands, Western Australia, Australia|Stollery Children's Hospital, Edmonton, Alberta, Canada|Seoul National University Hospital, Seoul, Korea, Republic of|Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of|Asan Medical Center, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|National University Hospital, Singapore, Singapore|KK Women's and Children's Hospital, Singapore, Singapore|National Taiwan University Hospital, Taipei City, Taiwan|Taipei Medical University Hospital, Taipei, Taiwan","https://ClinicalTrials.gov/show/NCT04094610"
1667,"Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas","Active, not recruiting","No Results Available","Brain and Central Nervous System Tumors","Drug: GDC-0084|Radiation: radiation therapy","St. Jude Children's Research Hospital, Memphis, Tennessee, United States","https://ClinicalTrials.gov/show/NCT03696355"
1668,"5-ALA in Recurrent Glioma","Unknown status","No Results Available","Glioma","Drug: 5-ala","Barrow Neurological Institute at St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States","https://ClinicalTrials.gov/show/NCT02119338"
1669,"A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations","Active, not recruiting","No Results Available","Advanced Malignancies That Harbor IDHR132 Mutations","Drug: IDH305","Dana Farber Cancer Institute SC (1), Boston, Massachusetts, United States|Columbia University Medical Center- New York Presbyterian Onc Dept., New York, New York, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, United States|Novartis Investigative Site, Melbourne, Victoria, Australia|Novartis Investigative Site, Parkville, Victoria, Australia|Novartis Investigative Site, Leuven, Belgium|Novartis Investigative Site, Toronto, Ontario, Canada|Novartis Investigative Site, Koeln, Nordrhein-Westfalen, Germany|Novartis Investigative Site, Heidelberg, Germany|Novartis Investigative Site, Jena, Germany|ErasmusMC Cancer lnstitute, Neuro-Oncology, Rm G3-55, Rotterdam, Netherlands|Novartis Investigative Site, Singapore, Singapore|Novartis Investigative Site, Barcelona, Catalunya, Spain","https://ClinicalTrials.gov/show/NCT02381886"
1670,"FMISO-PET in Brain Tumors and SCS Effect","Terminated","No Results Available","Malignant Glioma","Drug: 18F-FMISO|Procedure: PET without SCS|Device: SCS|Procedure: PET without/with SCS|Radiation: Radiotherapy|Drug: Temozolomide","Dr. Negrin University Hospital, Las Palmas, Spain|Instituto Tecnologico Servicios Sanitarios, in MD Anderson Cancer Center, Madrid, Madrid, Spain","https://ClinicalTrials.gov/show/NCT01868906"
1671,"Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With Radiotherapy","Unknown status","No Results Available","Brain Neoplasms","Radiation: Partial brain re-irradiation.|Drug: Metformin|Behavioral: low carbohydrate diet","Sheba Medical Center, Ramat Gan, Israel","https://ClinicalTrials.gov/show/NCT02149459"
1672,"Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents","Terminated","No Results Available","Gliomas","Drug: Cilengitide|Drug: Temozolomide","University Children´s Hospital, Halle, Saxonia-Anhalt, Germany","https://ClinicalTrials.gov/show/NCT01517776"
1673,"A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors","Completed","No Results Available","Brain Neoplasms","Drug: Tumor fluorescence","Southern Illinois University School of Medicine, Springfield, Illinois, United States","https://ClinicalTrials.gov/show/NCT01128218"
1674,"A Study of the Specificity and Sensitivity of 5-ALA Fluorescence in Malignant Brain Tumors","Withdrawn","No Results Available","Brain Neoplasms","Drug: 5-aminolevulinic acid",,"https://ClinicalTrials.gov/show/NCT00977795"
1675,"Intra-operative Variation in Size of Brain Tumors After Craniotomy","Completed","No Results Available","Brain Tumor, Primary",,"Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu And Kashmir, India","https://ClinicalTrials.gov/show/NCT04365647"
1676,"Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)","Completed","No Results Available","Advanced Cancers","Drug: Lenalidomide|Drug: Bevacizumab|Drug: Sorafenib|Drug: Temsirolimus|Drug: Oxaliplatin|Drug: Leucovorin|Drug: 5-fluorouracil","University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01183663"
1677,"Pharmacokinetics (PK) Study of AC480 for Recurrent Glioma","Completed","No Results Available","Glioma","Drug: AC480","The Preston Robert Tisch Brain Tumor Center at Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00979173"
1678,"Histopathologic Evaluation of High Grade Brain Tumors by High Order Diffusion Tensor Imaging","Completed","No Results Available","High Grade Brain Tumor","Other: peritumoral glial cell infiltration","CHU Clermont-Ferrand, Clermont-Ferrand, France","https://ClinicalTrials.gov/show/NCT01699269"
1679,"Phase I/II Cabazitaxel for Recurrent Malignant Glioma","Withdrawn","No Results Available","Brain Cancer","Drug: Cabazitaxel",,"https://ClinicalTrials.gov/show/NCT01740570"
1680,"Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features","Unknown status","No Results Available","Carcinoid|Neuroendocrine","Drug: Seneca Valley Virus (biological agent)","Cancer Centers of Florida, Ocoee, Florida, United States|Central Indiana Cancer Centers, Indianapolis, Indiana, United States|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|New York Oncology Hematology P.C., Albany, New York, United States|Dayton Oncology & Hematology, P.A ., Kettering, Ohio, United States|Cancer Centers of the Carolinas, Greenville, South Carolina, United States|Mary Crowley Research Center, Dallas, Texas, United States|Tyler Cancer Center, Tyler, Texas, United States|Virginia Oncology Associates, Norfolk, Virginia, United States|Northwest Cancer Specialists - Vancouver Cancer Center, Vancouver, Washington, United States","https://ClinicalTrials.gov/show/NCT00314925"
1681,"Alport Syndrome Treatments and Outcomes Registry","Recruiting","No Results Available","Alport Syndrome",,"University of Minnesota, Minneapolis, Minnesota, United States","https://ClinicalTrials.gov/show/NCT00481130"
1682,"Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer","Completed","Has Results","Solid Tumor","Drug: Selinexor|Drug: Acetaminophen","Moffitt Cancer Center, Tampa, Florida, United States|Karmanos Cancer Institute, Detroit, Michigan, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|Gabrail Cancer Center, Canton, Ohio, United States|Princess Margaret Hospital, Toronto, Ontario, Canada|Rigshospitalet, Copenhagen, Denmark","https://ClinicalTrials.gov/show/NCT01607905"
1683,"Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors","Completed","No Results Available","Solid Tumors","Drug: INC280","Highlands Oncology Group, Fayetteville, Arkansas, United States|University of Chicago SC, Chicago, Illinois, United States|Karmanos Cancer Institute Wayne St Karmanos, Detroit, Michigan, United States|Sarah Cannon Research Institute Dept of Onc, Nashville, Tennessee, United States|University of Texas/MD Anderson Cancer Center Dept of Onc, Houston, Texas, United States|Novartis Investigative Site, Westmead, New South Wales, Australia|Novartis Investigative Site, Woolloongabba, Queensland, Australia|Novartis Investigative Site, Ottawa, Ontario, Canada|Novartis Investigative Site, Toronto, Ontario, Canada|Novartis Investigative Site, La Tronche, France|Novartis Investigative Site, LILLE Cédex, France|Novartis Investigative Site, Strasbourg Cedex, France|Novartis Investigative Site, Essen, Germany|Novartis Investigative Site, Frankfurt, Germany|Novartis Investigative Site, Freiburg, Germany|Novartis Investigative Site, Gottingen, Germany|Novartis Investigative Site, Hannover, Germany|Novartis Investigative Site, Oldenburg, Germany|Novartis Investigative Site, Hong Kong, Hong Kong|Novartis Investigative Site, Shatin, New Territories, Hong Kong|Novartis Investigative Site, Haifa, Israel|Novartis Investigative Site, Kfar Saba, Israel|Novartis Investigative Site, Ramat Gan, Israel|Novartis Investigative Site, Tel Aviv, Israel|Novartis Investigative Site, Ancona, AN, Italy|Novartis Investigative Site, Meldola, FC, Italy|Novartis Investigative Site, Milano, MI, Italy|Novartis Investigative Site, Milano, MI, Italy|Novartis Investigative Site, Reggio Emilia, RE, Italy|Novartis Investigative Site, Seoul, Gyeonggi Do, Korea, Republic of|Novartis Investigative Site, Gyeonggi do, Korea, Korea, Republic of|Novartis Investigative Site, Seoul, Korea, Korea, Republic of|Novartis Investigative Site, Seoul, Korea, Korea, Republic of|Novartis Investigative Site, Seoul, Seocho Gu, Korea, Republic of|Novartis Investigative Site, Utrecht, The Netherlands, Netherlands|Novartis Investigative Site, Amsterdam, Netherlands|Novartis Investigative Site, Rotterdam, Netherlands|Novartis Investigative Site, Oslo, Norway|Novartis Investigative Site, Singapore, Singapore|Novartis Investigative Site, Granada, Andalucia, Spain|Novartis Investigative Site, Oviedo, Asturias, Spain|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Zaragoza, Spain|Novartis Investigative Site, Tainan, Taiwan ROC, Taiwan|Novartis Investigative Site, Taipei, Taiwan ROC, Taiwan|Novartis Investigative Site, Songkhla, Hat Yai, Thailand","https://ClinicalTrials.gov/show/NCT01324479"
1684,"Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas","Completed","No Results Available","Malignant Glioma","Biological: REOLYSIN®","University of Alabama at Birmingham, Birmingham, Alabama, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|The Ohio State University Medical Center and Arthur G. James Cancer Hospital and Richard J. Solove Research Center, Columbus, Ohio, United States","https://ClinicalTrials.gov/show/NCT00528684"
1685,"Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors","Completed","Has Results","Primary Brain Tumors|Metastatic Malignant Neoplasm to Brain","Drug: 4-Demethyl-4-cholestryloxycarbonylpenclomedine","Tulane University Medical Center, New Orleans, Louisiana, United States|Detroit Clinical Research Centers, Lansing, Michigan, United States|The University of Texas Health Science Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02038218"
1686,"Panitumumab and Irinotecan for Malignant Gliomas","Terminated","Has Results","Malignant Glioma of Brain","Drug: Irinotecan|Drug: Panitumumab","The Preston Robert Tisch Brain Tumor Center at Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01017653"
1687,"Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer","Completed","No Results Available","Breast Neoplasms|Ovarian Neoplasms|Prostatic Neoplasms|Lung Neoplasms|Gastrointestinal Neoplasms","Drug: Motexafin Gadolinium","University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00120939"
1688,"Antineoplaston Therapy in Treating Patients With Brain Tumors","Completed","Has Results","Refractory Brain Tumors","Drug: Antineoplaston therapy (Atengenal + Astugenal)","Burzynski Clinic, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00003457"
1689,"Antineoplaston Therapy in Treating Children With Brain Tumors","Completed","Has Results","Childhood Brain Tumors","Drug: Antineoplaston therapy (Atengenal + Astugenal)","Burzynski Clinic, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00003458"
1690,"Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors","Completed","No Results Available","Brain and Central Nervous System Tumors|Metastatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific","Drug: carboplatin|Drug: tamoxifen citrate|Drug: topotecan hydrochloride|Other: pharmacological study","City of Hope Comprehensive Cancer Center, Duarte, California, United States","https://ClinicalTrials.gov/show/NCT00541138"
1691,"Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors","Completed","No Results Available","Brain and Central Nervous System Tumors|Chemotherapeutic Agent Toxicity|Infertility",,"Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT00499798"
1692,"A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors","Completed","No Results Available","Brain and Central Nervous System Tumors|Metastatic Cancer","Drug: temsirolimus|Other: pharmacological study|Other: cytokine levels","City of Hope Comprehensive Cancer Center, Duarte, California, United States","https://ClinicalTrials.gov/show/NCT00784914"
